id|sentence|entity1|entity2|pos1|pos2|arg1|arg2|ent1_type1|ent2_type|label
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|pomalidomide|CRBN|13|20|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22982773|To gain a better understanding of this oxime specificity problem for future design of improved reactivators, we conducted a QSAR analysis for oxime reactivation of AChE inhibited by OP agents and their analogues.|oxime|AChE|24|27|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR
9256165|Exposure of stimulated fetal rat calvaria osteoblasts (FRCO) to sulfasalazine did not show accumulation of the intracellular sPLA2 protein as tested by western blot; however, enzymatic activity of PLA2 in disrupted cells was definitely increased.|sulfasalazine|PLA2|12|33|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
9013583|We demonstrate that several other NSAIDs, including fenoprofen, ibuprofen, and flufenamic acid, are also PPARgamma ligands and induce adipocyte differentiation of C3H10T1/2 cells.|ibuprofen|PPARgamma|11|19|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18055877|Using primary human T-lymphocytes, we show that the heterocyclic thionamides carbimazole and propylthiouracil inhibit synthesis of the proinflammatory cytokines tumor necrosis factor (TNF)alpha and interferon (IFN)gamma.|carbimazole|interferon (IFN)gamma|12|29|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23531031|Methods: Stabilized anaplastic thyroid cancer cell lines (BHT-101 and CAL-62) and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the histone deacetylase inhibitor LBH589.|LBH589|histone deacetylase|33|30|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
23220589|AChE was easier reactivated after paraoxon treatment.|paraoxon|AChE|6|1|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR
23623843|Administration of KBTP (200, 400 and 800mg/kgbw) in mice ahead of CCl4 injection could observably antagonize the CCl4-induced increases in serum ALT, AST, TG and TC, and the hepatic MDA and 8-iso-PGF2a levels, respectively.|CCl4|ALT|21|25|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|thiazolidinedione|peroxisome proliferator-activated receptor gamma|11|21|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10047461|These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 kinase activities.|Tomudex|cyclin E|20|40|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
10193663|Kinetic studies comparing the binding of [3H]eletriptan and [3H]sumatriptan to the human recombinant 5-HT1B and 5-HT1D receptors expressed in HeLa cells revealed that both radioligands bound with high specificity (>90%) and reached equilibrium within 10-15 min.|[3H]eletriptan|human recombinant 5-HT1B|7|18|Arg1:T12|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|glutamine|kynurenine aminotransferase I|25|12|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
15078100|QR2 catalyzes the two-electron reduction of menadione via the oxidation of N-alkylated or N-ribosylated nicotinamides.|menadione|QR2|7|1|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23395669|We concluded that sophocarpine could alleviate hepatocyte steatosis and the potential mechanism might be the activated signaling pathway of AMPK.|sophocarpine|AMPK|4|20|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR
8842678|MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imipramine, maprotiline, amitriptyline, zimeldine, nomifensine, and viloxazine.|imipramine|MAO-B|18|1|Arg1:T2|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
8740147|In addition, another drug that is both a substrate of uptake1 and a MAO inhibitor, debrisoquine, was investigated in the study.|debrisoquine|MAO|18|15|Arg1:T23|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR
9873034|Bulky imidazoles like clotrimazole block NO synthesis by inhibiting assembly of the iNOS dimer, revealing a new means to control cellular NO synthesis.|NO|iNOS|6|13|Arg1:T12|Arg2:T49|CHEMICAL|GENE-Y|PRODUCT-OF
9626023|Some NSAIDs (eg, flurbiprofen, ketoprofen) were COX-1 selective, some (eg, ibuprofen, naproxen) were essentially nonselective, while others (eg, diclofenac, mefenamic acid) were COX-2 selective.|diclofenac|COX-2|31|37|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
10768298|RESULTS: Topiramate Ki values for HCA I, HCA II, HCA IV, and HCA VI were approximately 100, 7, 10, and >100 microM, respectively.|Topiramate|HCA IV|3|13|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
17340133|Cytokine challenge at low L: -arginine also enhances iNOS mRNA expression, but translation into iNOS protein is diminished, leading to lowered nitric oxide production.|L: -arginine|iNOS|5|10|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23164673|Transduction with constitutively active forms of GSK-3β could protect against the downregulation of p65 and upregulation of cleaved-PARP that are induced by cinobufagin treatment.|cinobufagin|PARP|23|19|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17606858|Conversely fenofibrate increased peroxisome proliferator-activated receptor-alpha, peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression, and acetyl coenzyme A carboxylase phosphorylation (P<0.05 for all) in aldosterone-infused hearts; uncoupling protein-3 and medium-chain acyl coenzyme A dehydrogenase protein expression decreased with fenofibrate (P<0.05 and P<0.01, respectively, versus aldosterone-infused), suggesting that improved myocardial remodeling is independent of fatty acid oxidation.|fenofibrate|peroxisome proliferator-activated receptor-gamma coactivator-1alpha|2|8|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10882160|In human volunteers, both entacapone and tolcapone dose-dependently inhibit the COMT activity in erythrocytes, improve the bioavailability and decrease the elimination of levodopa, and inhibit the formation of 3-O-methyldopa (3-OMD).|entacapone|COMT|6|12|Arg1:T31|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
23435367|  Ferredoxin 1 (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including steroid hormone synthesis in mammalian tissues.|steroid|Ferredoxin 1|21|1|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF
12126787|The AGE-induced increases in VEGF expression and PKC activation were inhibited by the pan-specific PKC inhibitor, calphostin C, and by the antioxidant drug and compounds, gliclazide, N-acetylcysteine, and vitamin E.|calphostin C|PKC|18|15|Arg1:T3|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
16232421|On the other hand, the FUM1 (fumarase) gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all.|fumarate|FUM1|19|7|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF
23274898|ATP-dependent 2-NBDG uptake was also inhibited by the G protein βγ subunit-interacting peptide βark-ct and by the phosphatidylinositol 3-kinase-γ (PI3Kγ) inhibitor AS605240.|AS605240|PI3Kγ|24|21|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23322164|This shows that CPT2 and CACT are crucial for mitochondrial acylcarnitine formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R.|acylcarnitine|CPT2|11|4|Arg1:T5|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
23271002|CAN significantly inhibited the production of NO and the release of TNF-α induced by LPS in macrophage RAW 264.7. Western blot showed that CAN can downregulate the expression of iNOS protein.|CAN|iNOS|25|31|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23291264|Interestingly, tubular CCL2 mRNA levels increased soon after cisplatin administration, whereas CCL2 mRNA levels in whole kidney first decreased and then increased.|cisplatin|CCL2|10|14|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15713990|In this study we investigated whether detectable FPPs activity was present in human colorectal cancer (CRC), also evaluating in vitro the role of this enzyme in the growth and apoptosis of CRC cells by using Pamidronate (PAM), a FPPs activity inhibitor.|PAM|FPPs|41|45|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23059626|mRNA levels of receptor activator of nuclear factor kappa-B (RANK), its ligand RANKL, tumor necrosis factor alpha (TNF-α) and RANKL/osteoprotegerin (OPG) ratio were diminished in the periodontium of CCL3(-/-) mice and in the group treated with Met-RANTES.|Met|receptor activator of nuclear factor kappa-B|48|4|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12023506|Comparing the K(i) values with the therapeutically relevant concentrations of unbound inhibitors in the plasma, probenecid alone was predicted to inhibit hOAT4-mediated organic anion transport in vivo.|probenecid|hOAT4|20|26|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
6701456|The binding of FHA-HIS was inhibited on 35-79% of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine.|clemastine|FHA|21|4|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23228696|Furthermore, metformin was able to not only decrease the paclitaxel-induced p38 MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.|metformin|p38|3|12|Arg1:T3|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
11006272|In radioligand binding assays, membranes prepared from COS-7 cells transfected with LTB(4)-R2 cDNA displayed high affinity (K(d) = 0.17 nm) for [(3)H]LTB(4).|[(3)H]LTB(4)|LTB(4)-R2|32|13|Arg1:T27|Arg2:T39|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23601990|The results showed that most of the synthesized compounds exhibited nanomolar potency against CEase, much better than the parent flavonoids.|flavonoids|CEase|21|14|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|AM411|CB(1)|229|224|Arg1:T9|Arg2:T39|CHEMICAL|GENE-Y|AGONIST
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HCB|glutathione S-transferase placental form|35|9|Arg1:T19|Arg2:T28|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
9873034|The N-terminal oxygenase domain (amino acids 1-498; iNOSox) in each subunit binds heme, L-Arg, and tetrahydrobiopterin (H4B), is the site of NO synthesis, and is responsible for the dimeric interaction, which must occur to synthesize NO.|NO|iNOSox|30|10|Arg1:T21|Arg2:T51|CHEMICAL|GENE-Y|PRODUCT-OF
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|NKCC2|20|14|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|3-NP|succinate dehydrogenase|6|22|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
23624852|RESULTS: VTA NMDAR blockade with AP-5 decreased, while VTA NMDAR activation with NMDA increased NAc peak phasic DA release.|NMDA|NMDAR|15|12|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
19259968|RESULTS: The antiallodynic action of nortriptyline was not affected by cotreatment with the alpha(2)-AR antagonist yohimbine, the beta(1)-AR antagonists atenolol or metoprolol, or the beta(3)-AR antagonist SR 59230A.|yohimbine|alpha(2)-AR|21|15|Arg1:T17|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST
11067741|Argininosuccinate synthetase, a key enzyme in the metabolism of l-citrulline to l-arginine, increased as well, perhaps in response to dimunition of the intracellular arginine pool corresponding to the observed high output of NO*.|l-citrulline|Argininosuccinate synthetase|11|1|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE
23589499|Docking experiments for the most active compounds into the MAO-B and MAO-A binding pockets highlighted different interactions between the derivative classes (2-arylbenzofurans and 3-arylcoumarins), and provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of these scaffolds.|3-arylcoumarins|MAO-A|25|12|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|cibenzoline|NCX|17|25|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
8710929|These events are stimulated by NE and by guanethidine, an hNET substrate, and they are blocked by cocaine and the antidepressant desipramine.|desipramine|hNET|24|12|Arg1:T11|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
11179439|The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells.|dexrazoxane|DNA topoisomerase II|7|3|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23381681|At the beginning of the calving and breeding seasons, cows supplemented with Se had greater (P < 0.01) whole blood Se concentration (WBSe) and glutathione peroxidase activities (GSH-Px) than cows receiving no supplemental Se; cows fed seleno-yeast had greater (P ≤ 0.05) WBSe than cows fed sodium selenite, but GSH-Px did not differ (P ≥ 0.25) between the two sources.|Se|glutathione peroxidase|14|30|Arg1:T23|Arg2:T38|CHEMICAL|GENE-N|ACTIVATOR
18061638|Norethisterone activated PR, AR, and ERalpha.|Norethisterone|ERalpha|1|8|Arg1:T22|Arg2:T58|CHEMICAL|GENE-Y|ACTIVATOR
15494548|Valdecoxib potently inhibits recombinant COX-2, with an IC(50) of 0.005 microM; this compares with IC values of 0.05 microM for celecoxib, 0.5 microM for rofecoxib, and 5 microM for etoricoxib.|etoricoxib|COX-2|37|5|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
23446230|  Cytochrome P450 epoxygenase 2J2 (CYP2J2) metabolizes arachidonic acids to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system.|arachidonic acids|CYP2J2|9|6|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
16530878|Glutamine synthetase activity and glutamine de novo synthesis were measured using, respectively, a standard enzymatic assay and [13C]-nuclear magnetic resonance spectroscopy.|glutamine|Glutamine synthetase|5|1|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF
15261283|Compound 2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole, expressed clozapine-like in vitro binding profile at D(2), 5-HT(2A) and alpha 1 receptors and a higher affinity for 5-HT(1A) receptors than clozapine.|2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole|5-HT(2A)|2|30|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8344937|alpha 2M-methylamine, which binds with high affinity to alpha 2MR/LRP, did not bind to gp330.|methylamine|LRP|3|12|Arg1:T3|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR
18061638|Danazol activated PR and AR.|Danazol|AR|1|5|Arg1:T2|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|L-serine|(L-serine dehydratase|19|2|Arg1:T1|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE
23489628|Identification and synthesis of N-(thiophen-2-yl) benzamide derivatives as BRAF(V600E) inhibitors.|N-(thiophen-2-yl) benzamide|BRAF|5|12|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23348500|NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5-mediated responses in both recombinant and native systems.|NCFP|mGlu5|1|11|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|tiagabine|GAT1|3|21|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
23435367|  Ferredoxin 1 (FDX1; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including steroid hormone synthesis in mammalian tissues.|steroid hormone|FDX1|21|4|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|PRODUCT-OF
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|estrone sulfate|OAT3|19|22|Arg1:T22|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
23466342|The suppression of MDR1 promoter activity and protein expression was mediated through mollugin-induced activation of AMP-activated protein kinase (AMPK).|mollugin|AMP-activated protein kinase|13|16|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|ethynylestradiol|multidrug resistance-associated protein 2|24|35|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|nifedipine|Ca(v)1.2|56|59|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23570999|Wattakaka volubilis steroidal glycoside mixture (WVSM) and PPG (1-50μM) significantly inhibited the COX-2 and iNOS enzymes resulting in low levels of PGE2 and NO in LPS-induced RAW 264.7 macrophage cells.|steroidal glycoside|iNOS|3|19|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
23327877|Uptake of the radiolabeled model substrates estradiol 17β-glucuronide, estrone 3-sulfate, and dehydroepiandrosterone sulfate (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either OATP1B1 or OATP1B3.|DHEAS|OATP1B1|17|40|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|l-valine|LAT3|29|11|Arg1:T15|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
17620346|The in vitro covalent binding was inhibited in the presence of beta-aminopropionitrile, D-penicillamine, and hydralazine, which suggested that the aldehyde group of allysine in human elastin was relevant to the covalent binding.|hydralazine|human elastin|17|28|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
17082235|Our work shows that sulfonylureas and glinides additionally bind to PPARgamma and exhibit PPARgamma agonistic activity.|sulfonylureas|PPARgamma|5|11|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17092971|These drug effects on Ca(2+) mobilization and ERK2 phosphoprotein expression were mediated through dopamine hD(2L) receptors, as they all were blocked by (-)raclopride, whereas (-)raclopride and other dopamine D(2) receptor antagonists (haloperidol, risperidone, ziprasidone, olanzapine, clozapine and quetiapine) were inactive on their own in both assays.|ziprasidone|dopamine D(2) receptor|54|42|Arg1:T13|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|camphor|TRPV3|6|17|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR
10381812|The expression of each alpha1-adrenoceptor was significantly decreased by in vivo application of antisense oligonucleotides targeted against each subtype.|oligonucleotides|alpha1-adrenoceptor|15|5|Arg1:T1|Arg2:T4|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23402841|The values of mean corpuscular hemoglobin concentration and mean corpuscular hemoglobin increased in the STX group.|STX|hemoglobin|15|6|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17442055|Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain.|kynurenate|aspartate aminotransferase|7|2|Arg1:T18|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|Pristimerin|cyclooxygenase-2|1|26|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15942707|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|VEGF|3|12|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|COX-2|5|39|Arg1:T9|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11319232|Triacsin C, a competitive inhibitor of both ACS1 and ACS4, inhibited ACS activity similarly in endoplasmic reticulum, MAM, and mitochondria, suggesting that a hitherto unidentified triacsin-sensitive ACS is present in mitochondria.|Triacsin C|ACS|1|14|Arg1:T9|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR
19549602|Truncation of amitriptyline binding motif on TrkA abrogates the receptor dimerization by amitriptyline.|amitriptyline|TrkA|3|7|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23200901|The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.|hypaconitine|efflux transporters|16|4|Arg1:T29|Arg2:T48|CHEMICAL|GENE-N|SUBSTRATE
23590882|These results support the hypothesis that apoplastic amino acids acting through heteromeric GLR3.2/GLR3.4 channels affect lateral root development via Ca(2+) signaling in the phloem.|amino acids|GLR3.2|8|13|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|PART-OF
23325562|Conversely, AMPK inhibitor compound C or GSK3β inhibitor SB216763 blocked the cleavages of PARP and caspase 3 induced by ursolic acid in HepG2 cells.|compound C|AMPK|5|3|Arg1:T1|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
2112956|We tested these five acyl-CoA dehydrogenases for their ability to dehydrogenate valproyl-CoA using pure enzyme preparations isolated from rat liver mitochondria.|valproyl-CoA|acyl-CoA dehydrogenases|12|5|Arg1:T13|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE
14633536|  UNLABELLED: The effect of dopamine D2 receptor antagonists, such as chlorpromazine and haloperidol, on pupil size in awake subjects suggests that these drugs might also alter pupillary reflex dilation and pupil size during general anesthesia.|haloperidol|dopamine D2 receptor|15|6|Arg1:T14|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST
23288946|PLD2 interacts functionally with the glycerol channel aquaporin-3 (AQP3) to produce phosphatidylglycerol (PG); however, wounding resulted in decreased PG production, suggesting a potential PG deficiency in wounded cells.|phosphatidylglycerol|PLD2|14|1|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF
23641955|In this study, liver and kidney relative activity factors were developed for UGT1A1, 1A9 and 2B7 to allow for in vitro-in vivo extrapolation of intrinsic clearance data to whole organ clearance using recombinant human UGT isoforms applying this to laropiprant as a model substrate.|laropiprant|human UGT|42|36|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE
10200266|  The MWFE polypeptide of mammalian complex I (the proton-translocating NADH-quinone oxidoreductase) is 70 amino acids long, and it is predicted to be a membrane protein.|amino acids|NADH-quinone oxidoreductase|16|11|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|PART-OF
22986217|In addition, soy isoflavones regulated plasma glucose, leptin and adiponectin contents after treatment for two months.|isoflavones|adiponectin|5|12|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
18450949|Administration of cevimeline hydrochloride, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one.|cevimeline hydrochloride|M3 muscarinic receptor|3|7|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|AGONIST
9873034|Clotrimazole also bound to iNOSox dimers in the absence of L-Arg and H4B and caused their dissociation.|Clotrimazole|iNOSox|1|5|Arg1:T39|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23453838|Analogs with Z=Br, I, or OTs were weak inhibitors of the AChEs, and methyl phosphonates (R=Me) were more potent than the corresponding ethyl phosphonates (R=Et).|Z=Br, I, or OTs|AChEs|3|14|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
8589992|Cell lines stably expressing EAA3a protein formed homomeric ligand-gated ion channels responsive, in order of decreasing affinity to domoate, kainate, L-glutamate and (RS)-alpha-amino-3-hydroxy-5- methylisoxazole-propionate (AMPA).|(RS)-alpha-amino-3-hydroxy-5- methylisoxazole-propionate|EAA3a|26|5|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11969359|The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and milrinone, reduced the GM-CSF release in a concentration dependent manner.|milrinone|PDE3|17|13|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23591111|HDAC inhibition was observed for 3, to a lesser extent than SAHA, and rationalized by molecular docking into the active site of HDAC8.|SAHA|HDAC|13|1|Arg1:T7|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|dopamine|EC 1.14.16.1|7|19|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
16819260|Among them, tamibarotene (Am80) is an RARalpha- and RARbeta-specific (but RARgamma- and RXRs-nonbinding) synthetic retinoid that is effective in the treatment of psoriasis patients and relapsed APL.|Am80|RARbeta|6|12|Arg1:T8|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16298345|To do this we cloned and expressed CCR5 from rhesus macaque and compared the binding properties of [125I]-MIP-1beta and [3H]-maraviroc with human recombinant CCR5.|125I|human recombinant CCR5|19|28|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18715952|PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).|PGE(2)|EP(4)|1|39|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12470615|Resiquimod-stimulated pDC also produce a number of other cytokines including TNF-alpha and IP-10.|Resiquimod|cytokines|1|9|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|Hydrogen sulfide|cystathionine beta-synthase|1|26|Arg1:T1|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF
16010590|CONCLUSIONS: The combination of TFT with the antifolates AG337, ZD1694 and GW1843 is mainly additive when the drugs are given simultaneously and this is mediated by an additive TS inhibition and DNA damage.|GW1843|TS|14|31|Arg1:T22|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR
16627864|METHODS: Anesthetized rats received either Ringer's (Vehicle/Shock), 10 microg/kg/min of the beta(1)-adrenoceptor agonist dobutamine (Dob/Shock), or 10 microg/kg/min dobutamine and 500 microg/kg/min of the beta(1)-adrenoceptor antagonist esmolol (Dob/Esmolol/Shock) for 6 h.|esmolol|beta(1)-adrenoceptor|43|37|Arg1:T23|Arg2:T45|CHEMICAL|GENE-Y|ANTAGONIST
22406476|Rectal mucosal samples from patients given aspirin had reduced phosphorylation of S6K1 and S6.|aspirin|S6|7|14|Arg1:T12|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
23265465|We also applied the metabolite to mouse adipocytes and found that 2-HPPA was less effective at reducing leptin secretion than the parent compound genistein.|genistein|leptin|24|18|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|I3S|c-Src|60|73|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR
23407783|The CRF(1) receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and D-cycloserine.|SSR125543|CRF(1) receptor|8|2|Arg1:T15|Arg2:T19|CHEMICAL|GENE-Y|ANTAGONIST
17409426|Sulindac sulfide inhibited 14-3-3epsilon proteins in HT-29 and DLD-1 cells in a time- and concentration-dependent manner.|Sulindac sulfide|14-3-3epsilon proteins|1|4|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|beta-alanine|GAT2|10|28|Arg1:T22|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
12085361|In rats, rifamycin SV and rifampicin were shown to interfere with hepatic organic anion uptake by inhibition of the organic anion transporting polypeptides Oatp1 and Oatp2.|rifamycin SV|Oatp1|4|25|Arg1:T3|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
23208609|In line with the increased CYP19A1 mRNA expression, 2-ITX increased catalytic activity of aromatase in H295R cells as measured by cognate aromatase assays.|2-ITX|CYP19A1|10|6|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20426763|Second messenger studies revealed the presence of phospholipase C-coupled 5HT(2A) receptors in h-CM and h-TM cells where they stimulated phosphoinositide (PI) hydrolysis and mobilized intracellular Ca(2+) when challenged with a variety of 5HT(2A-C) receptor agonists (e.g. alpha-methyl-5HT, (R)-DOI, alpha-methyl-5HT, BW-723C86, MK-212, mCPP, cabergoline, AL-34662).|cabergoline|5HT(2A)|65|10|Arg1:T13|Arg2:T39|CHEMICAL|GENE-Y|AGONIST
23291559|  KCNK1, a member of the family of two-pore K(+) ion channels, is specifically induced in the livers of male mice after phenobarbital treatment.|phenobarbital|KCNK1|27|1|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|ACTIVATOR
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|alcoholamines|histamine H1-receptor|17|13|Arg1:T4|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST
11243491|METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [buspirone (partial 5-HT1A agonist), anpirtoline (5-HT1B agonist)] in the mouse forced swimming test.|buspirone|5-HT1A|60|63|Arg1:T25|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
10334992|Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor.|bile acids|farnesoid X receptor|6|13|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23583603|Both ICI treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ERα) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.|ICI|estrogen receptor alpha|2|16|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15133083|bis(Ethyl) oligoamine analogues of polyamines, such as SL-11144 and SL-11158, as well as arylamine analogues [BW-1, a bis(phenylbenzyl) 3-7-3 analogue] blocked uptake and interconversion of spermine at micromolar levels and, in the case of BW-1, acted as substrate for PAO.|BW-1|PAO|47|53|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
23020787|Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.|quinolone|efflux transporters|8|23|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
23494106|Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and JWH-122 which caused a decrease of TNFα and IL-12/23p40.|JWH-122|TNFα|32|38|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1868500|Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.|fibric acids|LDL|4|27|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23494944|AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase (AChE) in all regions.|AlCl3|AChE|1|18|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23500491|Previous studies have revealed that the ATP binding step is crucial both for the power stroke to produce motility and for the inter-domain regulation of ATPase activity to guarantee the processive movement of dimeric KIFs. Here, we report the first crystal structure of KIF4 complexed with the non-hydrolyzable ATP analog, AMPPNP (adenylyl imidodiphosphate), at 1.7Å resolution.|ATP|KIF4|51|46|Arg1:T3|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23385959|These findings are the first to show that long-term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38(MAPK) phosphorylation and caspase activity in the striatum.|Mn|MAPK|12|33|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|ACTIVATOR
10516958|  Ziprasidone is a novel antipsychotic agent which binds with high affinity to 5-HT1A receptors (Ki = 3.4 nM), in addition to 5-HT1D, 5-HT2, and D2 sites.|Ziprasidone|5-HT1D|1|25|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23313623|Km and Vmax values of entecavir were 250 μM and 0.83 nmol/mg protein/30s (OAT1) and 23 μM and 1.1 nmol/mg protein/30 s (OAT3), respectively.|entecavir|OAT1|6|15|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
12137927|Chronic treatment with the NET inhibitor, desipramine (DMI), reduced NET levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.|desipramine|NET|8|14|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10755406|A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C.|mitomycin C|NQO1|14|9|Arg1:T17|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE
10891536|  5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (TS).|FdUrd|thymidylate synthase|8|36|Arg1:T29|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
2833901|Similarly, felodipine and the p-chloro analogue inhibited myosin light chain kinase activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate.|p-chloro|myosin light chain kinase|6|9|Arg1:T4|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|rizatriptan|5-ht1f|10|22|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|Phenelzine|MAO-B|1|12|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
17408613|In this study, irbesartan was investigated in comparison with fenfluramine, an established satiating drug, and the angiotensin converting enzyme (ACE) inhibitor captopril.|captopril|ACE|27|24|Arg1:T16|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
10365684|Exposure to MMI (1 microM and 10 microM) or PTU (10 microM and 100 microM) for 2 days caused a significant increase in cellular TPO activity; 100 microM MMI inhibited cellular TPO activity.|MMI|TPO|34|37|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
12170055|The analgesic action of meperidine was blocked by naloxone but not by the alpha 2-adrenoceptor antagonists yohimbine and RX821002.|yohimbine|alpha 2-adrenoceptor|17|14|Arg1:T9|Arg2:T31|CHEMICAL|GENE-N|ANTAGONIST
10688973|The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist (-)-quadazocine exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.|(-)-quadazocine|opioid receptor|14|11|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|ANTAGONIST
22983118|At concentrations that produced similar levels of neuronal death, DOI promoted a higher increase in the activity of both caspases than MDMA.|MDMA|caspases|23|21|Arg1:T24|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR
12652111|A combination of cilostazol (>15 microM) and the PDE4 selective inhibitor, rolipram (5 microM), inhibited levels of cytosolic cAMP-PDE activity similar to those inhibited by milrinone on its own.|cilostazol|cAMP-PDE|4|26|Arg1:T20|Arg2:T48|CHEMICAL|GENE-N|INHIBITOR
12907245|Vinblastine, doxorubicin, or etoposide (VP-16) induced apoptotic cell death in KB-3 carcinoma cells, with similar kinetic profiles of PARP cleavage, caspase 3 activation, and mitochondrial cytochrome c release.|etoposide|caspase 3|6|27|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR
15478125|Some sulfamates were also shown to possess potent inhibitory activity against acyl coenzyme A:cholesterol acyltransferase, an enzyme involved in cholesterol metabolism.|sulfamates|acyl coenzyme A:cholesterol acyltransferase|2|12|Arg1:T11|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
23537005|The present study provides a comprehensive characterization of the oxidative metabolism of BDE-47 by human liver microsomes and P450 2B6.|BDE-47|P450 2B6|13|19|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
15210974|Furthermore, there is a high degree of correlation between binding affinities of a series of LEV derivatives to SV2A in fibroblasts and to the LEV-binding site in brain.|LEV|SV2A|17|20|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10471277|Labeling with [(125)I]IAS was blocked by 10 microM (-)-alprenolol and inhibited by addition of GTP gamma S, and [125I]IAS migrated at the same position on an SDS-PAGE gel as the beta 2AR labeled by the antagonist photoaffinity label [125I]iodoazidobenzylpindolol ([125I]IABP).|GTP|beta 2AR|24|44|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
23063590|Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that artemisinic acid regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA (HMG CoA) reductase gene, which was mediated through reduced expression of the CCAAT/enhancer-binding protein (C/EBP) α gene.|artemisinic acid|hydroxymethylglutaryl CoA (HMG CoA) reductase|16|28|Arg1:T15|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12898700|The oxidative stress conditions following DEM treatment activate L-cystine transport in TR-MUL cells due to the enhanced transcription of the xCT gene.|DEM|xCT|6|21|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|HSD|6|35|Arg1:T21|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
23403272|Furthermore, inhibition of HO-1 with zinc protoporphyrin IX (ZNPP) significantly reversed the protective effect of Paeoniflorin against radiation-induced damage in EA.hy926 cells.|ZNPP|HO-1|11|5|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23597507|Intraplantar or intrathecal administered Phα1β reduced both nocifensive behavior and mechanical hypersensitivity induced by capsaicin similarly to that observed with SB366791, a specific TRPV1 antagonist.|SB366791|TRPV1|21|25|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|ANTAGONIST
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide|5-HT receptor|10|1|Arg1:T17|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST
16982784|We also showed that (i) k3 was the rate-limiting step for the hydrolysis of cefotaxime by Asp104Lys, (ii) the Km for cefotaxime of the doubly substituted Asp104Lys Gly238Ser variant approached that of the Gly238Ser beta-lactamase as pH increased, and (iii) Lys at position 104 functions in an energetically additive manner with the Gly238Ser substitution to enhance catalysis of cephalothin.|cephalothin|Gly238Ser|67|61|Arg1:T8|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE
2394753|  In a recent study it has been shown that mitochondrial creatine kinase from chicken brain (Mia-CK) and heart (Mib-CK) are two distinct isoenzymes differing in ten out of the thirty N-terminal amino acids (Hossle, J.P., Schlegel, J., Wegmann, G., Wyss, M., Bohlen, P., Eppenberger, H.M., Wallimann, T., and Perriard J.C. (1988) Biochem.|N-terminal amino acids|Mia-CK|35|17|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|PART-OF
12183691|Several organic anions such as valproate, as well as organic cations, significantly inhibited carnitine and TEA uptake by OCTN2, and valproate showed Na(+)-dependent inhibition of OCTN2-mediated TEA uptake.|Na(+)|OCTN2|26|33|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
16885432|The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modafinil affects wakefulness by interacting with catecholamine transporters in brain.|modafinil|NET|25|13|Arg1:T10|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1328609|  Etorphine, a potent opioid agonist, has been reported to bind to both mu and epsilon opioid receptors.|Etorphine|opioid|1|5|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|AGONIST
18559268|Taxanes with affinities for microtubules well above their affinities for P-glycoprotein are shown not to be affected by multidrug resistance.|Taxanes|P-glycoprotein|1|11|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
23396090|In contrast, liposomal CDDP induced expression of genes from DNA damage pathways and several genes of the extrinsic pathway of apoptosis (TNFRSF10B-DR5, CD70-TNFSF7).|CDDP|TNFRSF10B|5|24|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23042728|  In utero exposure to valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, causes neural tube, heart, and limb defects.|VPA|histone deacetylase|8|12|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|phospho-Akt|3|11|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|nateglinide|PPARgamma|17|24|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|sertindole|human ether-a-go-go-related gene|4|34|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
11309248|Digoxin (10(-5) M) or digitoxin (10(-5) M), but not ouabain, decreased the expression of P450scc and steroidogenic acute regulatory (StAR) protein in rat granulosa cells.|Digoxin|P450scc|1|27|Arg1:T22|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|etravirine|hPXR|3|15|Arg1:T4|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR
2833901|Felodipine and the p-chloro analogue inhibited Ca2+/calmodulin-dependent caldesmon kinase with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.|Felodipine|caldesmon kinase|1|8|Arg1:T38|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR
15011952|The triphosphates of 4'-thio-FAC (4'-thio-FACTP) exhibited the potent inhibitory action against DNA polymerase alpha, whereas it showed moderate inhibition against DNA polymerase beta and little inhibition against DNA polymerase gamma.|4'-thio-FACTP|DNA polymerase gamma|6|31|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|methoxy|DAT|38|59|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|NO|inducible NO synthase|11|22|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
23340252|Cellular fractionation assays demonstrated that TF treatment promoted the activating serine phosphorylation of GR, augmenting its cytoplasmic-to-nuclear translocation as well as its enrichment at glucocorticoid response elements on the glucocorticoid-induced leucine zipper gene promoter.|serine|GR|11|14|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PART-OF
10768298|  PURPOSE: This study investigated the effectiveness of topiramate (TPM) as an inhibitor of six isozymes of carbonic anhydrase (CA).|topiramate|CA|9|23|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23374869|In most instances, C6-substituted phthalides exhibit MAO-B specific inhibition.|phthalides|MAO-B|6|8|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
23220589|The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.|BT-05|AChE|25|5|Arg1:T18|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR
12795776|After pretreatment with placebo, the terbutaline infusion caused a significant decrease in serum potassium and increases in serum glucose and insulin.|terbutaline|insulin|7|22|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12170055|CONCLUSION: Meperidine is a potent agonist at the alpha2 adrenoceptors at its clinically relevant concentrations, especially at the alpha(2B)-adrenoceptor subtype.|Meperidine|alpha(2B)-adrenoceptor|3|21|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
10598120|Prolonged vasopeptidase inhibition increased median survival time after the start of treatment by 99 and 31% compared with vehicle and captopril, respectively (median survival times: 146, 221, and 290 days with vehicle, captopril, and omapatrilat, respectively; p < 0.001 for all comparisons).|captopril|vasopeptidase|22|2|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|pelargonidin|CYP1A1|3|8|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23178381|Western blot analysis revealed that aspidin PB inhibited PI3K expression, phosphorylation of Ser473 Akt and Ser9 GSK3β followed by up-regulation of nonsteroidal anti-inflammatory drugs activated gene-1 (NAG-1) expression.|aspidin PB|GSK3β|6|18|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
10887187|Finally, cysteine 53 in the M1P1 external loop is required for functional expression of TWIK-2 but is not critical for subunit self-assembly.|cysteine|M1P1 external loop|3|7|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|PART-OF
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|kinase|1|8|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine|acetylcholinesterase|47|2|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
11319222|The thiazolidinedione (TZD) insulin-sensitizing drugs and peroxisome proliferator-activated receptor gamma (PPARgamma) ligands, troglitazone, rosiglitazone, and pioglitazone, strongly and specifically inhibited only ACS4, with an IC(50) of less than 1.5 microm.|TZD|ACS4|4|30|Arg1:T34|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23401472|Bisulfite sequence analysis revealed that the CpG-rich region near the UGT1A1 promoter (-85 to +40) was hypermethylated (83%) in the kidney, whereas it was hypomethylated (37%) in the liver.|CpG|UGT1A1 promoter|7|11|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|PART-OF
23194750|Isolated rat femoral arteries segments were mounted in a wire myograph and challenged with 100mM KCl or phenylephrine (PE), in the absence or presence of troglitazone, rosiglitazone, pioglitazone, LY294002 (PI3K inhibitor) and 10-DEBC (Akt inhibitor).|troglitazone|PI3K|29|37|Arg1:T17|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
10373451|Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).|cGMP|human phosphodiesterase|14|7|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
23295228|  Potassium ions are non-essential activators of several aldehyde dehydrogenases (ALDHs), whereas a few others require the cation for activity.|Potassium|aldehyde dehydrogenases|1|8|Arg1:T1|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|DVS|hNET|15|2|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22406476|Aspirin changed nucleotide ratios and activated AMPK in CRC cells.|Aspirin|AMPK|1|7|Arg1:T2|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|chlorpromazine sulfoxide|calmodulin|41|3|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|normeperidine|SERT|19|48|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18423812|INTERVENTIONS: In the 8-week run-in period, all participants received the ACE inhibitor cilazapril (5 mg), the ARB telmisartan (80 mg), and the diuretic hydrochlorothiazide (12.5 mg) as double RAAS blockade to achieve the target blood pressure of less than 130/80 mm Hg. Participants were then randomly assigned to 2 treatment sequences, either the addition of spironolactone (25 mg) (triple RAAS blockade) through 8 weeks followed by double RAAS blockade through 8 weeks (sequence 1) or double RAAS blockade followed by triple RAAS blockade (sequence 2).|cilazapril|ACE|15|13|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23523258|These results suggested that 3-day treatment of Sch B could increase concentration and oral bioavailability of drug metabolized by CYP3A.|Sch B|CYP3A|8|20|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
9843368|Crystallographic comparison with the structurally related rat tyrosine hydroxylase binary complex with the oxidized cofactor 7,8-dihydrobiopterin revealed overlapping binding sites for the catechols and the cofactor, compatible with a competitive type of inhibition of the catechols versus BH4.|catechols|rat tyrosine hydroxylase|37|7|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23212742|Examination of the plasma monohydroxy metabolite/25OHD3 ratios indicated selective induction of the CYP3A4-dependent 4β-hydroxylation pathway of 25OHD3 elimination.|25OHD3|CYP3A4|7|13|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR
12657913|  The effects of histamine H1-receptor antagonists, promethazine and homochlorcyclizine, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.|promethazine|histamine H1-receptor|8|4|Arg1:T16|Arg2:T29|CHEMICAL|GENE-Y|ANTAGONIST
23469927|  Soman forms a stable, covalent bond with tyrosine 411 of human albumin, with tyrosines 257 and 593 in human transferrin, and with tyrosine in many other proteins.|Soman|human albumin|1|12|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
19997047|  The phosphodiesterase inhibitor pentoxifylline (PTX) exerts multiple beneficial immunomodulatory effects in states of hyperinflammation.|pentoxifylline|phosphodiesterase|4|2|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23570914|In a cell-based model, bleomycin suppressed Nrf2 activation via extracellular signal-related kinase phosphorylation, enhancing intracellular reactive oxygen species in lung fibroblasts and stimulating abnormal cell proliferation and collagen secretion.|bleomycin|Nrf2|6|8|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23254196|Here, we report that genistein at physiologically relevant concentrations (0.1-10 μM) significantly inhibited thrombin-induced increase in endothelial monolayer permeability.|genistein|thrombin|6|17|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
17015480|TReP-132 synergizes with progesterone-bound PR to trans activate the p21 and p27 gene promoters at proximal Sp1-binding sites.|progesterone|PR|4|5|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23478260|We report that two common variants of high-temperature requirement A1 (HTRA1) that increase the inherited risk of neovascular age-related macular degeneration (NvAMD) harbor synonymous SNPs within exon 1 of HTRA1 that convert common codons for Ala34 and Gly36 to less frequently used codons.|Ala|HTRA1|40|12|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|PART-OF
15240345|Mitochondria, which produce glyoxylate from hydroxyproline metabolism, contained both alanine:glyoxylate aminotransferase (AGT)2 and glyoxylate reductase activities, which can convert glyoxylate to glycine and glycolate, respectively.|glyoxylate|glyoxylate reductase|28|21|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
17486539|In contrast, the RA catabolising enzymes Cyp26A1 and Cyp26B1 which are known to be RA-responsive were not expressed at all in the developing eye.|RA|Cyp26B1|5|10|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE
16765071|The purified antibody was immunoreactive with 6-nitrotryptophan residue containing Cu, Zn-SOD but not immunoreactive with Cu, Zn-SOD, Mn-SOD, bovine serum albumin, and 3-nitrotyrosine residue containing Mn-SOD.|6-nitrotryptophan|SOD|7|20|Arg1:T17|Arg2:T44|CHEMICAL|GENE-N|PART-OF
12565907|  Human epidermal melanocytes hold the full capacity for autocrine de novo synthesis/regulation/recycling of the essential cofactor 6-tetrahydrobiopterin (6BH(4)) for conversion of L-phenylalanine via phenylalanine hydroxylase to L-tyrosine and for production of L-Dopa via tyrosine hydroxylase to initiate both pigmentation and catecholamine synthesis in these neural crest-derived cells.|6-tetrahydrobiopterin|tyrosine hydroxylase|17|39|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
10328230|Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.|batimastat|MMP-2|9|6|Arg1:T15|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
11118042|Sulindac sulfone inhibited COX-2 protein expression, which resulted in a decrease in prostaglandin synthase E2 production.|Sulindac sulfone|COX-2|1|4|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23607523|This includes nonribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) required for the formation of the benzopyranopyrrole core unit, as well as a suite of tailoring enzymes (e.g., four halogenases, an O-methyltransferase, and an N-glycosyltransferase) necessary for further modifications of the core structure.|benzopyranopyrrole|PKS|21|13|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF
23430109|Ponatinib (AP24534) is a multikinase inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia, irrespective of BCR-ABL KD mutation.|Ponatinib|multikinase|1|7|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
25598831|Canagliflozin, dapagliflozin, and empagliflozin are SGLT2 inhibitors approved as treatments for T2DM in the United States, Europe, and other countries.|empagliflozin|SGLT2|6|8|Arg1:T15|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
2125244|  The concentration of estramustine phosphate required to inhibit the assembly or to induce the disassembly of chick brain MAP2:tubulin microtubules is markedly dependent upon the microtubule protein concentration.|estramustine phosphate|chick brain MAP2|4|17|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR
11447307|This brief review summarizes the evidence linking endothelin-1 to the pathophysiology of chronic heart failure and the clinical results obtained in patients during acute, intravenous and more prolonged, oral administration with bosentan, a mixed ET(A)/ET(B)-receptor antagonist.|bosentan|ET(A)|34|38|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
23583258|Oxysterol-dependent NOX1 activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.|phenolic acids|NOX1|28|2|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
23551063| At a substrate concentration of 20 µM, the most active HFC glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300 µM UGT1A6 was about 10 times better catalyst than the other recombinant UGTs. The activities of UGTs 1A3, 1A8, 1A9, 2B4 and 2B7 were low, whereas UGT1A1 and UGT2B17 exhibited no HFC glucuronidation activity.|HFC|UGT1A6|12|19|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|naratriptan|5-HT1D|8|19|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23607712|Therefore, in addition to its previously described functions, synaptotagmin-1 is involved in a rapid vesicular Ca(2+) sequestration through a Ca(2+) /H(+) antiport.|Ca(2+)|synaptotagmin-1|25|11|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|Troglitazone|PPARgamma|1|26|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11330337|"However, fasciculin-2, a potent peptide inhibitor of acetylcholinesterase (IC50 24 nM), did prevent catabolism of acetylcholine in rat brain membranes with an atypical inhibition isotherm of [3H]-oxotremorine-M binding, thus permitting an estimation of the ""global affinity"" of acetylcholine (Ki 85 nM) for [3H]-oxotremorine-M-labelled muscarinic receptors in rat brain."|[3H]-oxotremorine-M|muscarinic receptors|32|60|Arg1:T21|Arg2:T50|CHEMICAL|GENE-N|DIRECT-REGULATOR
20372850|Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.|pyrimidine|thymidylate synthase|4|11|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|PRODUCT-OF
23639249|Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis.|Indoxyl 3-sulfate|c-Src|1|9|Arg1:T14|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR
17075268|  BACKGROUND: Histamine synthesized by histidine decarboxylase (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.|Histamine|HDC|3|9|Arg1:T3|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H2R|1|16|Arg1:T1|Arg2:T59|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|Akt|1|6|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
16885432|In vitro, modafinil inhibited [(3)H]dopamine (IC(50) = 6.4 microM), [(3)H]norepinephrine (IC(50) = 35.6 microM), and [(3)H]serotonin (IC(50) > 500 microM) transport via the human DAT, NET, and SERT.|[(3)H]dopamine|human DAT|6|60|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|EGFR|1|19|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
17197042|Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.|foscarnet|DNA polymerase|15|7|Arg1:T8|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
14654525|SU11248 is an oral multitargeted kinase inhibitor with selectivity for fms-related tyrosine kinase 3/Flk2 (FLT3), platelet-derived growth factor receptor alpha/beta, vascular endothelial growth factor receptor 1/2, and KIT receptor tyrosine kinases.|SU11248|tyrosine kinases|1|35|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
10085232|These studies show clearly that, in all three GSTs, an aspartate residue at position 208 is a prerequisite for high activity in aflatoxin-exo-8,9-epoxide conjugation, although this alone is not sufficient; other residues in the vicinity, particularly residues 103-112, are important, perhaps for the optimal orientation of the aflatoxin-exo-8,9-epoxide in the active site for catalysis to occur.|aflatoxin-exo-8,9-epoxide|GSTs|25|10|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|DIRECT-REGULATOR
23244065|The three-step approach of CliEn-seq involves in vivo synthesis of S-adenosyl-L-methionine (SAM) analogues from cell-permeable methionine analogues by engineered SAM synthetase (methionine adenosyltransferase or MAT), in situ chromatin modification by engineered PMTs, subsequent enrichment and sequencing of the uniquely modified chromatins.|SAM|SAM synthetase|13|22|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|PRODUCT-OF
23519392|Amprenavir efficiently activated PXR and induced PXR target gene expression in vitro and in vivo.|Amprenavir|PXR|1|7|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23291118|The 8-MOP analogs 19 and 24, incorporating at position 5 of the psoralen nucleus a butyl acrylate or a tert-butyl cinnamate moiety, were the most powerful inhibitors of soybean LOX and inhibited effectively lipid peroxidation.|8-MOP|soybean LOX|2|31|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
10411647|Infrared spectroscopic studies revealed a reduced thermal stability both of the apo-and the holo-hTH1 on binding of H4biopterin and Lerythro-dihydrobiopterin (H2biopterin).|Lerythro-dihydrobiopterin|hTH1|20|15|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16313925|Preferential inhibition of human phosphodiesterase 4 by ibudilast.|ibudilast|human phosphodiesterase 4|8|4|Arg1:T16|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
17321471|The non-selective adenosine receptor agonist NECA, and the selective A(2A) receptor agonist CGS21680 also inhibited TNF-alpha production even more potently (IC(50)=4.8 and 2.3 nM, respectively).|NECA|adenosine receptor|6|3|Arg1:T23|Arg2:T45|CHEMICAL|GENE-N|AGONIST
1600046|While the substituted benzamide prokinetics (for example, metoclopramide, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.|metoclopramide|5-HT4|10|39|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
10626836|Neuron, 21 (1998) 907-918) further confirms that lithium enhances GluR3 responses by reducing desensitization, since lithium's effects are reversed in this mutant.|lithium|GluR3|12|14|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR
23142547|Rev1 stably interacts with Rad5 (a central component of the template switching pathway) via the C-terminal region of Rev1 and the N-terminal region of Rad5.|C|Rev1|18|21|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PART-OF
15210974|LEV and related compounds bind to SV2A expressed in fibroblasts, indicating that SV2A is sufficient for LEV binding.|LEV|SV2A|1|7|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14633707|The observation that Ras-transformed cells can be sensitized to killing by ionizing radiation with GW572016 demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.|GW572016|Ras|15|4|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
15306222|Our results showed that the affinities of alpha1D-AR and alpha1B-AR for carvedilol are higher than that of the beta1-AR subtype, a major target in heart failure treatment.|carvedilol|beta1-AR|12|19|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11319222|A non-TZD PPARgamma ligand, GW1929, which is 7-fold more potent than rosiglitazone, inhibited ACS1 and ACS4 poorly with an IC(50) of greater than 50 microm, more than 100-fold higher than was required for rosiglitazone, thereby demonstrating the specificity of TZD inhibition.|GW1929|ACS1|6|17|Arg1:T8|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
20590599|Other ligands (e.g. denopamine for beta(1); clenbuterol, AZ 40140d, salbutamol for beta(2)) were found to have subtype-selective intrinsic efficacy.|salbutamol|beta(2)|18|20|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15618457|Incubation of eosinophils with isoproterenol or formoterol dose-dependently inhibited both spontaneous eosinophil apoptosis and apoptosis induced by Fas receptor activation.|isoproterenol|Fas receptor|5|18|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
1983158|CD1 mice were used, treated with saline, morphine CHl (5 mg/kg), and 1 or 10 mg/kg of the H1-antihistaminics tripelennamine, chlorpheniramine, diphenhydramine and cyclizine and the H2-antihistaminics ranitidine and cimetidine, all compounds by s.c. route.|cyclizine|H1|31|24|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
1665782|Therefore, in the present studies, animals were rendered tolerant to the delta-opioid receptor-selective agonist [D-Pen2,D-Pen5]enkephalin (DPDPE), and receptor binding activities were measured.|[D-Pen2,D-Pen5]enkephalin|delta-opioid receptor|17|14|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
17223709|  Saccharopine dehydrogenase [N6-(glutaryl-2)-L-lysine:NAD oxidoreductase (L-lysine forming)] catalyzes the final step in the alpha-aminoadipate pathway for lysine biosynthesis.|lysine|Saccharopine dehydrogenase|26|1|Arg1:T12|Arg2:T40|CHEMICAL|GENE-Y|PRODUCT-OF
23313376|PTE also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.|PTE|p21|1|47|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|IMP|AdSS|17|4|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
16384941|Production of fluorescent reduced nicotinamide adenine dinucleotide (NADH) was used to measure enzymatic activity of mutant IMPDH1 proteins.|NADH|IMPDH1|9|19|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF
10420171|"These considerations illustrate the need to have additional research tools with which to test the ""DA hypothesis."" One strategy is to identify drugs which bind to the DA transporter (DAT ligands) but which do not inhibit DA uptake as effectively as cocaine."|DA|DAT|42|34|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
23416003|  Bicyclic pyrazinone and pyrimidinone amides were designed and synthesized as potent TF-FVIIa inhibitors.|Bicyclic pyrazinone and pyrimidinone amides|TF|1|12|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
23382381|Cellular responses to DNA damage induced by etoposide or doxorubicin include down-regulation of endogenous supervillin coincident with increases in p53.|etoposide|p53|8|20|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15606893|Dissociation of [3H]S-citalopram from a complex with the SERT double-mutant, N208Q/N217Q, which has been suggested to be unable to self-assemble into oligomeric complexes, is retarded to an extent similar to that found with the wild-type, raising the possibility that the allosteric mechanism is mediated within a single subunit.|[3H]S-citalopram|SERT|3|12|Arg1:T18|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17355958|Oxidation of Grx1 induced a complex pattern of disulfide-bonded dimers and oligomers formed between Cys-8 and either Cys-79 or Cys-83.|Cys|Grx1|20|3|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|PART-OF
1346768|All three subtypes have been shown to inhibit the activation of adenylate cyclase and thus reduce the levels of cAMP.|cAMP|adenylate cyclase|20|12|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PRODUCT-OF
11054378|The decrease in substrate phosphorylation by IKK-alpha and -beta is associated with a decrease in autophosphorylation of IKKs and can be antagonized by excess adenosine triphosphate.|adenosine triphosphate|IKKs|25|18|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
18480678|In both rodent and primate animal models, the binding of radiolabeled d-MPH to dopamine transporter was found to be selective, saturable, and reversible, whereas binding of l-MPH was diffuse and nonspecific.|d-MPH|dopamine transporter|13|15|Arg1:T24|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
9581512|  The protein tyrosine kinase (PTK) inhibitor piceatannol is also an inhibitor of the rat liver cyclic AMP-dependent protein kinase (PKA) catalytic subunit (cAK), rat brain Ca(2+)- and phospholipid-dependent protein kinase C (PKC), avian gizzard Ca(2+)-calmodulin-dependent myosin light chain kinae (MLCK), and of wheat embryo Ca(2+)-dependent protein kinase (CDPK) (IC50 values 3, 8, 12, and 19 microM, respectively).|piceatannol|PKC|9|44|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
15044619|Inhibitors of MRP1 (sulfinpyrazone, verapamil) and GST (dicumarol, curcumin) completely reversed the GSTM1-associated resistance to VCR, indicating that a MRP efflux function is necessary to potentiate GSTM1-mediated resistance to VCR.|sulfinpyrazone|MRP1|5|3|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
19119014|  Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.|methazolamide|CA|38|18|Arg1:T8|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
10682715|Iontophoresis of +/- propranolol, whose serotonergic actions include antagonism and partial agonism at 5-HT1 receptors, also increased serotonin and decreased firing (n=4).|+/- propranolol|5-HT1|3|15|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST
19057128|MMP-2 and MMP-9 expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and captopril inhibited them.|captopril|MMP-2|16|1|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16926278|Binding of cGMP to GAF-A increases cNPK phosphorylation of PDE5 and improves catalytic site affinity for cGMP or inhibitors.|cGMP|GAF-A|3|5|Arg1:T15|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR
17046555|Inhibition of PKC by treatment of the cells with calphostin C, GF10923X, and LY379196 totally suppressed AGE-mediated p47phox translocation and ROS generation.|LY379196|p47phox|16|20|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15765929|We studied the in vitro effect of piclamilast (RP73401), a selective phosphodiesterase (PDE)-4 inhibitor, compared to theophylline and prednisolone, on respiratory burst of sputum cells from mild asthmatics and COPD patients.|piclamilast|phosphodiesterase (PDE)-4|8|15|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
10089512|In order to address one aspect of the feasibility of performing time-resolved studies on AChE, a data set has been collected using the Laue technique on a trigonal crystal of Torpedo californica AChE soaked with the reversible inhibitor edrophonium, using a total X-ray exposure time of 24 ms.|edrophonium|Torpedo californica AChE|40|32|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR
3440035|The most potent compound, D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid (lorglumide, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent CCK antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini.|lorglumide|CCK|20|43|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
17899080|To improve FVIII secretion, a 14-amino-acid-long polypeptide with (G3) or without (G0; control) three N-linked glycosylation consensus sites was inserted upstream of the NH(2) terminus of a B-domain deleted FVIII protein.|NH(2)|FVIII|30|39|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|PART-OF
23284002|In conclusion, this study provides the first evidence implicating that TSA inhibits TGF-β-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-ARE signaling.|TSA|ARE|12|23|Arg1:T10|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
19203467|RESULTS: Both PLZ and VIG inhibited GABA-T and elevated GABA levels.|PLZ|GABA-T|4|8|Arg1:T46|Arg2:T77|CHEMICAL|GENE-Y|INHIBITOR
10401556|Combined concentration-ratio analysis demonstrated that tamsulosin, which does not discriminate between alpha 1A- and alpha 1L-adrenoceptors, and RS-17053 competed for binding at the same site in the SMA.|tamsulosin|alpha 1L-adrenoceptors|6|16|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|DIRECT-REGULATOR
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|1,2,3,7,8-pentachlorodibenzo-p-dioxin|vtg1|10|16|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11489456|In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).|d-fenfluramine|5-HT2A|8|37|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|AGONIST
23583884|This initial action was accompanied by up-regulation of cyclooxygenase-2 (COX-2), an important inflammation marker within 1h after TCDD treatment.|TCDD|COX-2|21|11|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|SR141716A|CB(1)|119|99|Arg1:T32|Arg2:T49|CHEMICAL|GENE-Y|ANTAGONIST
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Ezrin|32|21|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16298345|  The aim of this study was to determine if macaque represents a suitable species for the pre-clinical evaluation of novel CCR5 antagonists, such as maraviroc (UK-427,857).|maraviroc|CCR5|26|21|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST
22982445|Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice.|Leukotriene D4|CysLT₁ R|1|9|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR
12498985|DEM caused a rapid (5-30 min) phosphorylation of p38(MAPK).|DEM|MAPK|1|13|Arg1:T23|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
23473803|Our data suggest that moexipril is a bona fide PDE4 inhibitor that may provide the starting point for development of novel PDE4 inhibitors with an improved therapeutic window.|moexipril|PDE4|5|10|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
16735460|Using site-directed mutagenesis, histidine (H), lysine (K), and arginine (R) residues of fNaDC-3 were replaced by alanine (A), isoleucine (I), or leucine (L).|lysine|fNaDC-3|10|22|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|PART-OF
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|M&B-28767|EP3|14|2|Arg1:T25|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23142599|To better understand chemical effects on vitellogenin gene regulation, we tested the hypothesis that activation of the aryl hydrocarbon receptor 2 (AHR2) by dioxin inhibits the estrogen receptor pathway regulation of 3 vitellogenin genes (vtg1-3) in vivo, using zebrafish (Danio rerio) as a model teleost.|dioxin|aryl hydrocarbon receptor 2|27|19|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR
23312283|FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor (FXR), a bile acid-activated nuclear receptor.|bile acid|farnesoid X receptor|23|15|Arg1:T13|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR
20605094|The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors.|adamantyl|human isoform II|14|7|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1666931|Mononuclear leukocyte beta 2-adrenergic receptor densities (and binding affinities), measured with 125I-labelled pindolol, and isoproterenol-stimulated cyclic AMP accumulation, in samples from patients with insulin-dependent diabetes mellitus (IDDM) with diabetic autonomic neuropathy (n = 8), were no different from those in samples from patients with IDDM without neuropathy (n = 8), or from non-diabetic subjects (n = 8).|isoproterenol|beta 2-adrenergic receptor|19|3|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Rac-3|32|13|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23212742|With human hepatocytes, treatment with phenobarbital, hyperforin, carbamazepine, and rifampin significantly increased the levels of CYP3A4, but not CYP24A1 or CYP27B1 mRNA.|carbamazepine|CYP3A4|11|20|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23373444|Zr(IV) increased Hb binding constant to α-ZrP by 43-fold, and affinity enhancements followed the trend Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III).|Zr(IV)|Hb|1|6|Arg1:T42|Arg2:T66|CHEMICAL|GENE-N|DIRECT-REGULATOR
10683249|  Quinone oxidoreductases are flavoproteins that catalyze two-electron reduction and detoxification of quinones.|quinones|Quinone oxidoreductases|12|1|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE
16819260|  Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of nuclear hormone receptor superfamily.|Retinoid|nuclear hormone receptor|1|32|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR
8930173|  To identify selective compounds for nonadrenergic I1-imidazoline receptors (I1), the affinities of 22 ligands for [125I]p-iodoclonidine binding have been compared at human platelet I1-imidazoline binding sites (analyzed under norepinephrine mask of alpha-2 AR) and at human alpha-2A, alpha-2B and alpha-2C adrenoceptors stably expressed on transfected Chinese hamster ovary cells.|[125I]p-iodoclonidine|human platelet I1-imidazoline binding sites|19|28|Arg1:T2|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR
23527529|IPI-926 is both a substrate and inhibitor (IC50 = 1.9 µM) of P-glycoprotein.|IPI-926|P-glycoprotein|1|15|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|SUBSTRATE
17112405|Pranlukast, ketamine and edaravone decreased NMDA-induced injury; pranlukast (0.1 mg/kg) and ketamine inhibited the upregulated expression of the CysLT1 receptor.|ketamine|CysLT1 receptor|16|23|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|N|PDE5Delta1-321|17|23|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|PART-OF
10200320|15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus.|15d-PGJ2|NFkappaB|1|24|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
23639249|In the present study, using in vitro Th17 differentiation model, we examined effects of AhR activation by indoxyl 3-sulfate (I3S), a uremic toxin, on Th17 differentiation and investigated underlying mechanisms.|indoxyl 3-sulfate|AhR|20|17|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR
23317165|Modifications on the imidazole scaffold have led to a large amount of potent p38α MAP kinase inhibitors.|imidazole|p38α|4|14|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|betaine|GAT2|8|28|Arg1:T21|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
17168665|Other FASN inhibitors such as the cerulenin derivative C75, the beta-lactone orlistat, the green tea polyphenol epigallocatechin-3-gallate (EGCG) and other naturally occurring flavonoids (i.e., luteolin, quercetin, and kaempferol), as well as the antibiotic triclosan, have been identified and have been shown to limit cancer cell growth by inducing apoptotic cell death.|EGCG|FASN|21|2|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
11716850|  Mitiglinide (KAD-1229), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells.|KAD-1229|insulin|3|15|Arg1:T15|Arg2:T62|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12172398|  PURPOSE: The effect of gemfibrozil is mediated by the activation of peroxisome proliferator-activated receptor alpha (PPAR alpha).|gemfibrozil|PPAR alpha|6|18|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|ACTIVATOR
12065695|Rheumatoid synovial cells expressed PPARgamma mRNA, and the PPARgamma ligands 15-deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone reduced the proliferation and induced apoptosis in synovial cells.|troglitazone|PPARgamma|22|10|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23557993|During differentiation, DPHD promoted early expression of osteoblast transcription factors, RUNX2 and osterix.|DPHD|osterix|4|15|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15358979|In this sample of neuroleptic-refractory schizophrenic patients, olanzapine and clozapine showed a different pattern of occupancy of D2-like receptor despite a common lack of extrapyramidal side-effects.|olanzapine|D2-like receptor|9|19|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23639538|A dihydrochalcone and several homoisoflavonoids from Polygonatum odoratum are activators of adenosine monophosphate-activated protein kinase.|homoisoflavonoids|adenosine monophosphate-activated protein kinase|5|12|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
23246471|Poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-b-PCL) micelles were loaded with paclitaxel (cytotoxic agent), cyclopamine (hedgehog inhibitor), and gossypol (Bcl-2 inhibitor).|gossypol|Bcl-2|30|32|Arg1:T18|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23592780|Human albumin serum (HSA) is the most abundant protein in plasma and is glycated by glucose.|glucose|HSA|18|5|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8808167|  Ebastine is a long-acting nonsedating second generation histamine H1 receptor antagonist which binds preferentially to peripheral H1 receptors in vivo.|Ebastine|H1 receptors|1|17|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11785774|COX-1 and COX-2 inhibitor, piroxicam (0.02 and 0.2 microg) and compound NS-398 (0.01 and 0.1 microg), respectively, were given intracerebroventricularly (i.c.v.) 15 min prior to i.c.v. adrenergic receptor agonists: phenylephrine (30 microg) and clonidine (10 microg), an alpha1- and alpha2-adrenergic agonist, and isoprenaline (20 microg) a non-selective beta-adrenergic agonist and clenbuterol (10 microg) a selective beta2-adrenergic agonist.|clenbuterol|adrenergic receptor|71|38|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|AGONIST
16627864|METHODS: Anesthetized rats received either Ringer's (Vehicle/Shock), 10 microg/kg/min of the beta(1)-adrenoceptor agonist dobutamine (Dob/Shock), or 10 microg/kg/min dobutamine and 500 microg/kg/min of the beta(1)-adrenoceptor antagonist esmolol (Dob/Esmolol/Shock) for 6 h.|dobutamine|beta(1)-adrenoceptor|23|17|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|AGONIST
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|TIC|MRP2|9|28|Arg1:T20|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|3β-hydroxysteroid dehydrogenase|6|32|Arg1:T21|Arg2:T45|CHEMICAL|GENE-N|INHIBITOR
17475673|In conclusion, immortalized SHR and WKY PTE cells take up l-alanine mainly through a high-affinity Na(+)-dependent amino acid transporter, with functional features of ASCT2 transport.|l-alanine|ASCT2|12|30|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
20497523|Next, effects of ER agonists (ethinyl-estradiol, an ERalpha selective agonist (ERA-63) and a selective ERbeta agonist (ERB-79) on the development of a tetanus toxoid (TT)-specific delayed type hypersensitivity response in wild type (WT) and in ERalpha- or ERbeta-deficient mice were investigated.|ERA-63|ERalpha|15|11|Arg1:T16|Arg2:T41|CHEMICAL|GENE-Y|AGONIST
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|AVM|P-gp|4|13|Arg1:T17|Arg2:T47|CHEMICAL|GENE-N|ACTIVATOR
23353701|Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.|AdOx|SAHH|6|19|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
9581512|Interaction with calmodulin may contribute to the inhibition of MLCK and CDPK by piceatannol.|piceatannol|MLCK|14|10|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23523101|The protective effect of HSYA can be significantly attenuated by GW9662 via blocking PPARγ (p<0.05 or p<0.01).|GW9662|PPARγ|11|14|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
14629008|TMP caused induction of DnaK, DnaJ, GroEL, ClpB, and IbpA/B Hsps.|TMP|ClpB|1|11|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|ACTIVATOR
23621381|Areas covered: An extensive literature search was performed to analyze clinical cases of acute pancreatitis reported in the literature or to the Food and Drug Administration (FDA), in randomized clinical trials, and in observational studies with five DPP-4 inhibitors: sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin.|sitagliptin|DPP-4|46|43|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
17979301|Affinity of V782A for cGMP, vardenafil, sildenafil, tadalafil, or IBMX was reduced 5.5-, 23-, 10-, 3-, and 12-fold, respectively.|IBMX|V782A|14|3|Arg1:T13|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
11698075|These data indicate that a [3H]dofetilide binding assay using HERG membranes may help identify compounds that prolong the QT interval.|[3H]dofetilide|HERG|6|13|Arg1:T15|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12411515|In conclusion, halothane, isoflurane and sevoflurane inhibit complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain.|isoflurane|NADH:ubiquinone oxidoreductase|6|13|Arg1:T10|Arg2:T48|CHEMICAL|GENE-N|INHIBITOR
17284757|OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of FADS2 affects the PUFA biosynthetic pathway and consequently modifies the effect of alpha-linolenic acid (ALA) on myocardial infarction (MI).|alpha-linolenic acid|FADS2|31|19|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
17619763|Sutent and sorafenib are orally available inhibitors of the VEGFR and platelet derived growth factor receptor (PDGFR).|sorafenib|PDGFR|3|18|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
23500659|Furthermore, SIL significantly protected against testosterone-provoked decline in mRNA expression of P21(WAF1/Cip1) and Bax/Bcl-xl ratio as well as caspase-3 activity.|testosterone|caspase-3|7|23|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
16396637|An increase in liver ApoB mRNA correlated with an 82% and 46% increase in ApoB and triacylglycerol production respectively using in vivo Triton WR 1339.|Triton WR 1339|ApoB|25|17|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10688973|The related piperidines ohmefentanyl and sufentanil and the nonselective opioid receptor agonist etorphine were less potent nociceptin receptor agonists.|piperidines|nociceptin receptor|3|17|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|AGONIST
11330337|"However, fasciculin-2, a potent peptide inhibitor of acetylcholinesterase (IC50 24 nM), did prevent catabolism of acetylcholine in rat brain membranes with an atypical inhibition isotherm of [3H]-oxotremorine-M binding, thus permitting an estimation of the ""global affinity"" of acetylcholine (Ki 85 nM) for [3H]-oxotremorine-M-labelled muscarinic receptors in rat brain."|[3H]-oxotremorine-M|muscarinic receptors|56|60|Arg1:T23|Arg2:T50|CHEMICAL|GENE-N|DIRECT-REGULATOR
23371303|Although not a β-lactam, the chemical structure of avibactam closely resembles portions of the cephem bicyclic ring system, and avibactam has been shown to bond covalently to β-lactamases.|avibactam|β-lactamases|22|30|Arg1:T41|Arg2:T59|CHEMICAL|GENE-N|DIRECT-REGULATOR
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AR|23|15|Arg1:T5|Arg2:T31|CHEMICAL|GENE-Y|PART-OF
14761877|The effects of activin A and DHT to increase PSA production were synergistic or additive.|DHT|PSA|7|10|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23295227|  Only one crystal structure is currently available for tumor marker AKR1B10, complexed with NADP(+) and tolrestat, which is an aldose reductase inhibitor (ARI) of the carboxylic acid type.|tolrestat|AKR1B10|20|11|Arg1:T1|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23601990|The structure-activity relationships revealed that the free hydroxyl group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of CEase.|hydroxyl|CEase|8|29|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
17008880|Taken together, vitamin C uptake is increased in UVB-irradiated keratinocytes through the translocation of SVCT-1 and regulates inflammatory response in the skin via the downregulation of IL-8 and MCP-1 production.|vitamin C|MCP-1|4|30|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23291264|Urinary levels of KIM-1 also increased 3-fold after cisplatin administration.|cisplatin|KIM-1|9|4|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
14610216|hOAT1 and hOAT3, but not hOAT2 and hOAT4 mediated the uptake of furosemide.|furosemide|hOAT1|14|1|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
9622938|  delta 1-pyrroline 5-carboxylate synthetase (P5C synthetase) catalyzes the ATP and the NAD(P)H-dependent conversion of L-glutamate to glutamate semialdehyde (GSA) which is the metabolic precursor for proline biosynthesis.|GSA|P5C synthetase|26|6|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF
17223000|METHODS: The effect of leukotriene D(4) and the leukotriene receptor antagonist, pranlukast hydrate (ONO-1078) on the regulation of MUC2/5AC gene expression and mucin secretion were observed in human airway NCI-H292 epithelial cells.|ONO-1078|leukotriene receptor|20|13|Arg1:T12|Arg2:T29|CHEMICAL|GENE-N|ANTAGONIST
9521275|Treatment using a combination of testosterone and the aromatase inhibitor testolactone may have significantly better effects on sexual function and also seizure frequency than testosterone alone.|testolactone|aromatase|11|9|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
23645677|The inhibitors KN-92 and H89 were able to block both pathways in mutant TRPC6 expressing cells, as well as the prolonged elevation of intracellular calcium levels upon carbachol stimulation seen in these cells.|carbachol|TRPC6|29|14|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR
9730867|The observed inhibition on IFN-gamma, GM-CSF, and IL-3 mRNA was blocked by the selective beta2AR antagonist ICI 118,551 (10(-6) M) and by timolol (10(-6) M), a nonselective antagonist.|timolol|GM-CSF|30|7|Arg1:T1|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17327402|  The carboxylation of glutamic acid residues to gamma-carboxyglutamic acid (Gla) by the vitamin K-dependent gamma-glutamyl carboxylase (gamma-carboxylase) is an essential posttranslational modification required for the biological activity of a number of proteins, including proteins involved in blood coagulation and its regulation.|gamma-carboxyglutamic acid|gamma-carboxylase|8|20|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|growth-factor receptor tyrosine kinase|1|23|Arg1:T2|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR
11406192|In contrast, the structurally unrelated AMPA receptor potentiator CX 516 did not inhibit [(3)H]LY395153 binding at concentrations of up to 600 microM.|[(3)H]LY395153|AMPA receptor|15|7|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|Cabozantinib|MET|1|14|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23384967|  Bisphenol A (BPA) and diethylstilbestrol (DES) are endocrine-disrupting chemicals that interact with the human pregnane X receptor (PXR).|DES|human pregnane X receptor|9|18|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17389249|The data can be explained with a model in which the D439N mutation results in a dramatic slowing of Na(+) binding and a reduced affinity of the substrate-bound EAAC1 for Na(+).|Na(+)|EAAC1|34|32|Arg1:T11|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|phenethylamine|DAT|20|26|Arg1:T9|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR
9497025|The three D4-selective compounds, CP-293,019 (5.6-17.8 mg/kg), U-101,387 (3-30 mg/kg) and L-745,870 (1-10 mg/kg), also significantly blocked the losses in PPI produced by apomorphine.|L-745,870|D4|18|3|Arg1:T12|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
15306222|The affinity rank order and pKi values of ARs for carvedilol were as follows: alpha1D-AR (8.9)>alpha1B-AR (8.6)>beta1-AR (8.4)>beta2-AR (8.0)>alpha1A-AR (7.9)?alpha2C-AR (5.9)>alpha2B-AR (5.5)>alpha2A-AR (5.3).|carvedilol|beta2-AR|11|31|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|Probenecid|ATPase|1|16|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile|insulin|10|50|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
22846225|The myristoylated ζ-pseudosubstrate peptide, ZIP, potently inhibits PKMζ biochemically in vitro, within cultured cells, and within neurons in hippocampal slices, and reverses LTP maintenance and erases long-term memory storage.|myristoylated ζ-pseudosubstrate peptide|PKMζ|2|10|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|pregnenolone|3 beta-HSD|21|11|Arg1:T1|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE
15132128|  PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (TP) inside target tissues.|5-fluorouracil|thymidine phosphorylase|12|17|Arg1:T10|Arg2:T43|CHEMICAL|GENE-Y|PRODUCT-OF
9254673|The results show that (1) smaller diameter TG neurons (<30 microm) respond to L-glutamate and kainate, and the currents gated by kainate desensitize with prolonged agonist exposure; (2) all kainate receptor subunits are detected to some extent by reverse transcriptase-PCR, whereas glutamate receptor subunits GluR5 and KA-2 are expressed at high levels in the TG; (3) there is an obvious similarity between the features of native kainate receptor channels in TG neurons and of heteromeric recombinant GluR5(R)/KA-2 channels in pharmacological properties, desensitization, rectification, ion permeability, and mean channel conductance; and (4) the age-dependent increase in GluR5 and KA-2 RNA levels in the TG is correlated well with an increased number of kainate-sensitive cells during postnatal development.|kainate|KA-2|136|122|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23265191|Here, by comparing the biochemical and spectroscopic properties of quaternary (ISCU/NFS1/ISD11/FXN) and ternary (ISCU/NFS1/ISD11) complexes, we show that FXN stabilizes the quaternary complex and controls iron entry to the complex through activation of cysteine desulfurization.|cysteine|ISCU|40|13|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|PART-OF
9587031|Methylenetetrahydrofolate reductase deficiency impairs methyltetrahydrofolate synthesis, defects in cytosolic reduction of hydroxocobalamin (CblC/D) impair the synthesis of both methyl- and adenosyl cobalamin and deficiencies of methionine synthase (CblE/G) are associated with defective methyl cobalamin synthesis.|methyl cobalamin|methionine synthase|38|29|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|KA|KATI|10|16|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF
23535185|Galangin decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8.|Galangin|interleukin|1|18|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11893059|Donepezil hydrochloride inaugurates a new class of AChE inhibitors with longer and more selective action and with manageable adverse effects.|Donepezil hydrochloride|AChE|1|8|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR
23142789|Transient receptor potential cation channel, subfamily V, member 6 (TRPV6) and transient receptor potential cation channel, subfamily V, member 5 (TRPV5) are Ca entry channels responsible for Ca absorption in the kidney and intestine, respectively.|Ca|TRPV6|36|13|Arg1:T30|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE
23615073|Result showed that vitamin C treatment resulted in markedly reduced c-Rel nuclear translocation.|vitamin C|c-Rel|4|11|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23339625|Time-dependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats.|dexamethasone|cytochrome P450 3A|15|9|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
17139155|OPH catalyzes the hydrolysis reaction of organophosphorus compounds to produce electrochemically active compounds such as p-nitrophenol and thiols from parathion and VX, respectively.|p-nitrophenol|OPH|16|1|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|PRODUCT-OF
9398183|The Y337 (F330) in mammalian acetylcholinesterase, which is replaced by A328 in human butyrylcholinesterase, is implicated in the binding of ligands such as huperzine A, edrophonium, and acridines and one end of bisquaternary compounds such as BW284C51 and decamethonium.|acridines|acetylcholinesterase|34|8|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|DIRECT-REGULATOR
23612487|S1P activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3β and the nuclear translocation of β-catenin, followed by the increase of the transcriptional activity by β-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells.|S1P|glycogen synthase kinase-3β|1|16|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
1868500|Absorbable drugs (fibric acids, nicotinic acid, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.|fibric acids|low-density lipoproteins|4|24|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
16579965|Finally, TAP1 over-expressing cells accumulated alpha-TOS at higher levels compared to their normal counterparts.|alpha-TOS|TAP1|7|3|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
6319437|Since both TFP and W-7 are potent inhibitors of calmodulin, we investigated the possibility that inhibition of calmodulin was responsible for the loss of receptors.|W-7|calmodulin|5|10|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23183084|Altogether, our data in this Z-12 cell model suggest that the beneficial effects of treatment with progestin observed in endometriosis patients might arise from decreased pre-receptor metabolism of the protective progesterone by the SRD5A1 and AKR1C enzymes.|progesterone|SRD5A1|32|35|Arg1:T13|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|tumor necrosis factor-α|5|42|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23085120|All these results suggest that B12H substantially protected CGNs against glutamate-induced neuronal excitotoxicity via activating α7nAChR/PI3-K/Akt cascade.|glutamate|Akt|11|17|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|ICA|EAG|19|25|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17373776|The E1013D variant showed coupling between glutamine hydrolysis at the glutaminase site and 2-oxoglutarate-dependent L-glutamate synthesis at the synthase site, but a sigmoid dependence of initial velocity on L-glutamine concentration.|glutamine|E1013D|7|2|Arg1:T18|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE
23148920|The NaHS-induced eNOS phosphorylation and NO production were not affected by a PI3K/Akt inhibitor (wortmannin).|wortmannin|Akt|16|14|Arg1:T8|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR
16547010|Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase.|HQL-79|human hematopoietic prostaglandin D synthase|6|13|Arg1:T25|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|IKK-beta|1|30|Arg1:T18|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
23212742|With human hepatocytes, treatment with phenobarbital, hyperforin, carbamazepine, and rifampin significantly increased the levels of CYP3A4, but not CYP24A1 or CYP27B1 mRNA.|phenobarbital|CYP3A4|7|20|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23478802|We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted cysteines crucial for electrophile activation (C621S, C641S, C665S).|serine|C621S|19|26|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|PART-OF
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|MCP-1|1|15|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17289088|  Lymphocytes possess the essential components of a cholinergic system, including acetylcholine (ACh); choline acetyltransferase (ChAT), its synthesizing enzyme; and both muscarinic and nicotinic ACh receptors (mAChRs and nAChRs, respectively).|ACh|ChAT|14|20|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF
11959556|Cefditoren showed no difference in PBP affinity based on penicillin or cefditoren MICs, indicating a different PBP target for this agent.|Cefditoren|PBP|1|6|Arg1:T7|Arg2:T39|CHEMICAL|GENE-N|DIRECT-REGULATOR
23551063|UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-glucuronic acid than the other UGTs. 5.|UDP|UGTs|14|19|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE
12927226|RESULTS: Eprosartan tended to lower mean AP, it slightly increased heart rate (HR) (p<0.05), and markedly increased circulating Ang-II levels (p<0.01).|Eprosartan|Ang-II|3|28|Arg1:T11|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17442055|The novel KAT had a pH optimum of 8.0 and a low capacity to transaminate glutamine or alpha-aminoadipate (the classic substrates of KAT I and KAT II, respectively).|alpha-aminoadipate|KAT II|18|27|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23410161|Finally, compounds derived from the xanthine scaffold afford neuroprotection in Parkinson's disease through mechanisms that include dual adenosine A2A receptor antagonism and MAO-B inhibition.|xanthine|adenosine A2A receptor|7|20|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
23293300|In human hepatocytes, BOC inhibited CYP3A-mediated metabolism of midazolam, OATP1B-mediated hepatic uptake of pitavastatin, and both the uptake and metabolism of atorvastatin.|BOC|CYP3A|5|7|Arg1:T13|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
17185414|NVP-TAE684 also induced down-regulation of CD30 expression, suggesting that CD30 may be used as a biomarker of therapeutic NPM-ALK kinase activity inhibition.|NVP-TAE684|CD30|1|11|Arg1:T4|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12907443|Weekly subcutaneous decitabine produces cumulative increases in HbF and total hemoglobin through a noncytotoxic mechanism of action.|decitabine|HbF|3|8|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|hexestrol|estrogen receptor|11|34|Arg1:T7|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10898598|In mice, POCl(3) inhibits serum butyrylcholinesterase (BuChE) at a sublethal dose and muscle but not brain AChE at a lethal dose.|POCl(3)|BuChE|4|12|Arg1:T23|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23598363|Our findings indicate that imatinib protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.|imatinib|BAX|5|22|Arg1:T7|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
23229510|We identified one compound, E235 (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide), that activated the ISR and dose-dependently increased levels of ATF4 in transformed cells.|E235|ATF4|6|36|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23376608|In the presence of apigenin, diminution of p38 and p53 did not affect cell survival although apigenin activated the phosphorylation of p38 and p53 via increased c-Myc levels.|apigenin|c-Myc|18|28|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
19531491|The recently discovered hyperinsulinism/hyperammonemia disorder showed that the loss of allosteric inhibition of GDH by GTP causes excessive secretion of insulin.|GTP|insulin|16|21|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23519392|Computational docking studies combined with site-direct mutagenesis identified several key residues within the ligand binding pocket of PXR that constitute points of interaction with amprenavir.|amprenavir|PXR|25|18|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23416191|Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy.|HJC0123|STAT3|7|13|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
23521080|One exception is tranexamic acid (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to fibrin.|lysine|fibrin|14|22|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|rhodamine 123|P-gp|24|22|Arg1:T18|Arg2:T49|CHEMICAL|GENE-N|SUBSTRATE
23473803|  PDE4 is one of eleven known cyclic nucleotide phosphodiesterase families and plays a pivotal role in mediating hydrolytic degradation of the important cyclic nucleotide second messenger, cyclic 3'5' adenosine monophosphate (cAMP).|cyclic 3'5' adenosine monophosphate|PDE4|28|1|Arg1:T9|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|diazepam|AChE|34|14|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
7909690|The reaction, N-carbamyl-L-aspartate-->L-dihydroorotate (CA-asp-->DHO) catalyzed by malarial dihydroorotase is inhibited by L-6-thiodihydroorotate (TDHO) in vitro (Ki = 6.5 microM), and TDHO, as the free acid or methyl ester, induces a major accumulation of CA-asp in malaria.|CA-asp|malarial dihydroorotase|9|16|Arg1:T24|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|carbidopa|AAAD|16|14|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|glutathione|Slc25a11|38|25|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|DMI|beta2-AR|43|24|Arg1:T20|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17185414|NVP-TAE684 treatment resulted in a rapid and sustained inhibition of phosphorylation of NPM-ALK and its downstream effectors and subsequent induction of apoptosis and cell cycle arrest.|NVP-TAE684|ALK|1|14|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
17125913|In conclusion, our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.|Cd|kinases|8|22|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
23256819|Second, in order to study the response of RHE to chemical sensitizers, the ((13)C)methyldodecanesulfonate was chosen as an NMR probe, and we compared adducts formed on human serum albumin (HSA) in solution and adducts formed in RHE.|((13)C)methyldodecanesulfonate|HSA|16|40|Arg1:T9|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10082498|At 4 hours, losartan blocked 43% of the Ang II-induced systolic blood pressure increase; valsartan, 51%; and irbesartan, 88% (P<0.01 between drugs).|valsartan|Ang II|18|11|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
20517484|Rasagiline is a novel, potent, and irreversible monoamine oxidase type B (MAO-B) inhibitor which has been approved for treatment of PD.|Rasagiline|monoamine oxidase type B|1|10|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR
18079279|DHEA induced both PPARalpha mRNA and protein levels, as well as PP2A message in primary rat hepatocytes.|DHEA|PPARalpha|1|4|Arg1:T20|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15481993|  The synthesis and pharmacological evaluation of new water-soluble phosphoramidate derivatives of the COX-2 selective inhibitor cimicoxib (4) are described.|phosphoramidate|COX-2|9|13|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
23284002|Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.|Trichostatin A|NF-E2-related factor 2|1|16|Arg1:T24|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17645691|These included, biliverdin-IX alpha reductase and the sodium-dependent vitamin C transport proteins SVCT1 and SVCT2, whose expression levels were enhanced in maternal and fetal liver by melatonin treatment.|melatonin|SVCT1|29|14|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|TMAO|FMO3|29|12|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|adrenaline|phenylalanine hydroxylase|3|16|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
8102973|It was found that clozapine is selective for the dopamine D4 vs.|clozapine|dopamine D4|5|10|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
23435541|In these MR clusters, NADPH oxidase subunits gp91(phox) and p47(phox) were aggregated and were markedly blocked by both statins.|statins|gp91(phox)|26|9|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|FADS|28|46|Arg1:T10|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
15252033|The PPACK-bound structure of W215A/E217A is identical to the structure of the PPACK-bound slow form of thrombin.|PPACK|E217A|2|6|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR
22750078|THPP-1 significantly increased phosphorylation of proteins in the striatum involved in synaptic plasticity, including the a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid receptor (AMPA) GluR1 subunit, extracellular receptor kinase (ERK), and cAMP-response element binding protein (CREB).|THPP-1|amino-3-hydroxy-5-methylisoxazole-4-proprionic acid receptor|1|18|Arg1:T13|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|carbetocin|OT|25|27|Arg1:T11|Arg2:T48|CHEMICAL|GENE-Y|AGONIST
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|MDA|human recombinant 5-HT2B receptors|34|42|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|vardenafil|L765A|7|18|Arg1:T15|Arg2:T46|CHEMICAL|GENE-N|DIRECT-REGULATOR
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|collagen|1|16|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
16765071|  We have previously reported on the formation of 6-nitrotryptophan by the reaction of reactive nitrogen species with a tryptophan residue in human Cu, Zn-superoxide dismutase (SOD) (F.|6-nitrotryptophan|SOD|9|28|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|PART-OF
17602574|However, upon addition of NO to CDO in the presence of substrate l-cysteine, a low-spin {FeNO}7 (S = 1/2) signal that accounts for approximately 85% of the iron within the enzyme develops.|l-cysteine|CDO|14|8|Arg1:T3|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE
11723241|To gain further insight into the binding site, we examined the minimal structural changes necessary to transform low-affinity binding of dofetilide by the related bovine ether a-go-go channel bEAG to high-affinity binding of HERG.|dofetilide|bEAG|22|30|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17089011|SK-Br3 cells cultured in the presence of topoisomerase IIalpha (TOP2A) inhibitors doxorubicin and etopoxide (VP-16) demonstrated a 2- to 3-fold increase in FAS promoter activity when compared with control cells growing in drug-free culture conditions.|etopoxide|topoisomerase IIalpha|16|8|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
12840797|  Erlotinib HCl (Tarceva; Genentech, Inc, South San Francisco, CA) is an orally available, highly selective, reversible inhibitor of epidermal growth factor receptor (HER1/EGFR) tyrosine kinase.|Erlotinib HCl|HER1|1|32|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
17355958|Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity.|cysteines|human cytosolic and mitochondrial glutaredoxins|5|7|Arg1:T25|Arg2:T38|CHEMICAL|GENE-N|PART-OF
23032515|This compound also produced a dose-dependent decrease in the expression of apoptotic proteins (cleaved PARP and caspase-3) induced by l-buthionine-(S,R)-sulfoximine (BSO) plus glutamate and stimulated glutathione and glutathione S-transferase activity.|BSO|caspase-3|30|18|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|catalase|4|24|Arg1:T27|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR
9730867|Concanavalin A (Con A)-induced IFN-gamma, GM-CSF, and IL-3 mRNAs are dose-dependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol.|fenoterol|beta2AR|30|28|Arg1:T9|Arg2:T45|CHEMICAL|GENE-Y|AGONIST
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|glycine|5-Aminolevulinic acid synthase|23|1|Arg1:T6|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
15132128|5-FU interferes with DNA synthesis by blocking thymidylate synthase (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD).|5-FU|TS|1|11|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
15572277|Aminophylline and DPCPX but not 8pSPT also reversed the protective action of A1/A2 adenosine receptor agonist, 2-chloroadenosine (2-CADO) and selective A1 adenosine receptor agonist, R-N6-phenylisopropyloadenosine (R-PIA), against 3-NPA-evoked convulsions.|R-PIA|A1 adenosine receptor|31|24|Arg1:T27|Arg2:T41|CHEMICAL|GENE-Y|AGONIST
15655513|In a human whole blood assay, IC(50) values for lumiracoxib were 0.13 microM for COX-2 and 67 microM for COX-1 (COX-1/COX-2 selectivity ratio 515).|lumiracoxib|COX-1|14|24|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
17184764|  We have previously shown that retinoic acid (RA) synthesized by the retinaldehyde dehydrogenase 2 (RALDH2) is required in forebrain development.|retinoic acid|RALDH2|6|18|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF
9587066|Gitelman's syndrome results from mutations in the SLC12A3 gene encoding the human thiazide-sensitive sodium chloride cotransporter, leading to impaired reabsorption of sodium chloride in the distal convoluted tubule.|sodium chloride|SLC12A3|24|9|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
23291264|Interestingly, tubular CCL2 mRNA levels increased soon after cisplatin administration, whereas CCL2 mRNA levels in whole kidney first decreased and then increased.|cisplatin|CCL2|10|14|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10027835|Drugs inhibiting both MAO-A and MAO-B to a similar extent (tranylcypromine) or combinations of selective MAO-A and MAO-B inhibitors (esuprone plus LU 53439) had no advantage over MAO-A inhibition alone, but were less well tolerated.|tranylcypromine|MAO-B|12|6|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
23589499|3-(4'-Methoxyphenyl)-6-nitrocoumarin (15), with the same substitution pattern as that of compound 8, was found to be the most active MAO-B inhibitor of the coumarin series (IC50 =3 nM).|coumarin|MAO-B|32|28|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23403203|Taken together, these findings indicate that antofine induces Cx43 gap junction disassembly by the PKCβ signaling pathway.|antofine|PKCβ|8|16|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|putrescine|PAO|34|28|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|PRODUCT-OF
15102890|Reciprocally, glyburide blocked SR-BI-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 (IC(50) approximately 275-300 microM).|glyburide|SR-BI|3|5|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
17200663|Interphotoreceptor retinoid-binding protein (IRBP) is a component of the interphotoreceptor matrix (IPM) and is known to bind visual cycle retinoids.|retinoids|IRBP|24|5|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8842678|MAO-A was inhibited by the following drugs (in ascending order of potency) : nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine.|maprotiline|MAO-A|22|1|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
23145773|Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis.|2,5-thiophene amides|17β-hydroxysteroid dehydrogenase type 2|4|11|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23303191|Comparison of different human cell types revealed ∼50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.|UDP|Has1|37|31|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
20426763|As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose).|AL-34662|5HT(2C)|9|46|Arg1:T20|Arg2:T26|CHEMICAL|GENE-Y|AGONIST
17427197|  Elevated extracellular D-glucose increases transforming growth factor beta1 (TGF-beta1) release from human umbilical vein endothelium (HUVEC).|D-glucose|transforming growth factor beta1|3|5|Arg1:T6|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23313623|Moreover, OAT1 and OAT3 are the targets of DDI between entecavir and JBP485.|JBP485|OAT3|14|5|Arg1:T16|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
18604229|The principal aim of the study was to find amiodarone analogues that retained human ether-a-go-go-related protein (hERG) channel inhibition but with reduced cytotoxicity.|amiodarone|human ether-a-go-go-related protein (hERG) channel|10|14|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
15369444|With the advent of newer third generation aromatase inhibitors (anastrozole, letrozole and exemestane) toxicities have been documented to be less and in some cases they are more efficacious than the standard, tamoxifen.|letrozole|aromatase|13|8|Arg1:T18|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
23295224|Biocatalytic production of alpha-hydroxy ketones and vicinal diols by yeast and human aldo-keto reductases.|alpha-hydroxy ketones|yeast and human aldo-keto reductases|4|10|Arg1:T18|Arg2:T36|CHEMICAL|GENE-N|PRODUCT-OF
22841391|Subsequently, we confirmed these proteins with the Western blotting approach, and found that methylselenol increased the expression of GADD 153 and p21 but reduced the level of c-Myc, E2F1 and Phos p38 MAP kinase.|methylselenol|GADD 153|16|21|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16899342|  Voltage-dependent calcium channels (VDCCs) are heteromultimeric complexes that mediate calcium influx into cells in response to changes in membrane potential.|calcium|VDCCs|12|5|Arg1:T15|Arg2:T25|CHEMICAL|GENE-N|SUBSTRATE
23429912|This study focuses on determining whether treatment of TCDD-exposed UGS organ cultures with RSPO2 and/or RSPO3 is capable of rescuing the inhibitory effects of TCDD on canonical Wnt signaling and prostatic bud formation.|TCDD|Wnt|25|28|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|spermidine|SSAT|7|19|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
23046379|Immunohistochemical analysis also revealed that LPS-induced lipocalin-2 is expressed by brain endothelial cells and is partly co-localised with cyclooxygenase-2 (Cox-2), the rate-limiting enzyme for the production of inflammatory induced prostaglandin E(2) (PGE(2) ), which is the key mediator of fever.|prostaglandin E(2)|cyclooxygenase-2|33|19|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF
17526944|Dexamethasone increased DAX-1 expression and concordantly decreased StAR protein and mRNA in testicular cells.|Dexamethasone|StAR|1|8|Arg1:T23|Arg2:T50|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16730121|Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.|ramelteon|MT1/MT2 receptor|3|10|Arg1:T14|Arg2:T18|CHEMICAL|GENE-N|AGONIST
7909690|Pyrazofurin induces accumulation of orotate and orotidine in malaria, consistent with inhibition of orotidine 5'-monophosphate (OMP) decarboxylase with subsequent dephosphorylation of the OMP accumulated.|Pyrazofurin|orotidine 5'-monophosphate (OMP) decarboxylase|1|15|Arg1:T4|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
10368299|E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized and evaluated by the Eisai Company in Japan.|N-benzylpiperidine|acetylcholinesterase|15|16|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
10688973|The affinity and functional profile of opioids possessing activity at the nociceptin receptor was determined using [3H]nociceptin and nociceptin-stimulated [35S]GTPgammaS binding.|[35S]GTPgammaS|nociceptin receptor|23|12|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23228696|Furthermore, metformin was able to not only decrease the paclitaxel-induced p38 MAPK-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.|metformin|MAPK|3|13|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
23542513|  In this study, we found that 5-hydroxy-3,6,7,8,3'4'-hexamethoxyflavone (5HHMF) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase (iNOS) in BV2 microglia.|5HHMF|iNOS|12|35|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16449355|In cirrhotic rats, Western blot analysis revealed a 170% increase in renal neutral endopeptidase protein content (P < 0.03), mainly in the proximal nephron and macula densa, and both candoxatrilat dosages increased plasma ANP levels, urinary volume, and urinary excretion of sodium, ANP, and cGMP compared with vehicle alone (all P < 0.03).|candoxatrilat|ANP|36|40|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23117572|Expression of Na(+)/I(-) symporter (NIS (SLC5A5)), the glycoprotein responsible for iodide transport, has been demonstrated in normal testicular tissue.|iodide|NIS|23|13|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE
22491023|  Xanthurenic acid (XA), a molecule arising from tryptophan metabolism by transamination of 3-hydroxykynurenine, has recently been identified as an endogenous Group II (mGlu2 and mGlu3) metabotropic glutamate (mGlu) receptor ligand in vitro.|Xanthurenic acid|metabotropic glutamate (mGlu) receptor|1|32|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR
22619007|In addition, Silibinin caused an increase in p53 and p21 protein level as well as mRNA levels.|Silibinin|p53|4|9|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23066988|Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by co-incubation with the AMPK inhibitor compound C.|Metformin|ghrelin|1|4|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16857832|  The transsulfuration pathway, which aids in regulating homocysteine concentration and mediates cysteine synthesis, may be sensitive to vitamin B-6 status because cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CGL) require pyridoxal 5'-phosphate (PLP).|homocysteine|cystathionine gamma-lyase|9|30|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|GSH|human hematopoietic prostaglandin (PG) D synthase|25|7|Arg1:T5|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16997906|These pyridoxal-5'-phosphate-dependent decarboxylases belong to the alanine racemase (AR) structural family together with diaminopimelate decarboxylase (DapDC), which catalyzes the final step of lysine biosynthesis in bacteria.|lysine|DapDC|28|19|Arg1:T6|Arg2:T18|CHEMICAL|GENE-N|PRODUCT-OF
10690753|Felbamate produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV).|Felbamate|NR2B|1|36|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
1898092|p-Nitrophenyl acetate, substrate for esterase activity by the enzyme, partially prevented the protective effect of NAD+ against proteolysis.|p-Nitrophenyl acetate|esterase|1|6|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
8836655|Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.|ketanserin|5-HT2|13|20|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST
19498041|Relative agonist efficacy was measured at two points after M(3) receptor activation: the stimulation of guanosine 5'-O-(3-[(35)S]thio)triphosphate binding to G alpha subunits, and the subsequent increase in intracellular calcium levels.|guanosine 5'-O-(3-[(35)S]thio)triphosphate|G alpha|20|35|Arg1:T6|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR
19302827|This paracrine prostacyclin release, in turn, promoted differentiation and COX-2 induction in neighboring VSMC that were not exposed to iloprost.|prostacyclin|COX-2|3|12|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17082235|  Most drugs currently employed in the treatment of type 2 diabetes either target the sulfonylurea receptor stimulating insulin release (sulfonylureas, glinides), or target the peroxisome proliferator-activated receptor (PPARgamma) improving insulin resistance (thiazolidinediones).|sulfonylureas|insulin|21|18|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23455312|Finally, carotid artery-infusion of HENA (45 μM) dilated the pial cerebral arterioles via selective BK-channel targeting.|HENA|BK-channel|6|18|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR
17427197|TGF-beta1 and high D-glucose increased p42/44(mapk) and Smad2 phosphorylation, an effect blocked by PD-98059 (MEK1/2 inhibitor).|D-glucose|Smad2|4|11|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
11406192|The prototypic AMPA receptor potentiator cyclothiazide competitively inhibited [(3)H]LY395153 binding with a potency (K(i) approximately 7 microM) comparable to EC(50) values reported in electrophysiological studies.|cyclothiazide|AMPA receptor|6|3|Arg1:T3|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|Δ(9)-tetrahydrocannabinol|CB(1)|73|9|Arg1:T28|Arg2:T47|CHEMICAL|GENE-Y|AGONIST
23122079|Moreover, use of the pharmacological AMP-activated protein kinase (AMPK) inhibitor compound C revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells.|compound C|AMPK|14|18|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|ICI 182,780|ER|1|24|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|N|caspase-3|6|22|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
16897483|  Alcohol dehydrogenases (ADH) participate in the biosynthetic pathway of aroma volatiles in fruit by interconverting aldehydes to alcohols and providing substrates for the formation of esters.|aldehydes|Alcohol dehydrogenases|18|1|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
23367873|EXPERT OPINION: JAK inhibitor therapy is entering a significant new era with the advent on the market of the JAK1/2 inhibitor ruxolitinib and the pan-JAK inhibitor tofacitinib, with unprecedented speed of development.|tofacitinib|JAK|28|27|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
11134654|Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine.|almotriptan|5-HT receptor|4|8|Arg1:T26|Arg2:T40|CHEMICAL|GENE-N|AGONIST
23591777|On the other hand, MSM raised SOD and CAT activities as well as CYP2E1 level in liver tissues.|MSM|SOD|6|8|Arg1:T17|Arg2:T42|CHEMICAL|GENE-N|ACTIVATOR
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|(5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione|PPAR|3|52|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|ZD6474|tyrosine kinase|25|21|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
7511163|  5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone (MET-CAMO) and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone (N-CPM-MET-CAMO) were tested in opioid receptor binding assays and in the mouse tail-flick test in order to characterize the affinity, selectivity and antinociceptive properties of these two compounds.|N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone|opioid receptor|17|31|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR
23435916|The underlying mechanism of the anti-inflammatory action of pristimerin was correlated with down-regulation of nuclear factor-κB and the mitogen-activated protein kinase signal pathway.|pristimerin|nuclear factor-κB|9|15|Arg1:T10|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
15554912|Eplerenone competed strongly for [(3)H]-dexamethasone binding to a MR/GR chimera containing amino acids 804-874 of the MR and weakly to a chimera containing amino acids 672-803 of the MR.|amino acids|MR|30|35|Arg1:T18|Arg2:T44|CHEMICAL|GENE-Y|PART-OF
12470615|Here, we characterize the activation of human pDC with the TLR7 agonists imiquimod and resiquimod.|resiquimod|TLR7|16|12|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|AGONIST
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|homochlorcyclizine|histamine H1-receptor|45|13|Arg1:T29|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST
12850267|Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs.   Kynurenic acid (KA) is an endogenous glutamate receptor antagonist at the level of the different ionotropic glutamate receptors.|KA|ionotropic glutamate receptors|16|31|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST
16973761|This suggests that Asn2.65(101) recognizes Gly10NH2 of GnRH II.|Gly10NH2|GnRH II|9|11|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|PART-OF
17408613|Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats.|irbesartan|AT1 receptor|9|6|Arg1:T21|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
23386704|This study in patients with highly variable serum levels of 25-hydroxyvitamin D could not reveal any relationship between vitamin D and 4β-hydroxycholesterol, an endogenous biomarker of CYP3A activity.|4β-hydroxycholesterol|CYP3A|22|28|Arg1:T8|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
11470741|  Cerivastatin is used in the treatment of hypercholesterolemia to inhibit 3-hydroxy 3-methylglutaryl coenzyme A reductase and thus prevent the synthesis of cholesterol precursors, such as farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), responsible, respectively, for translocation of Ras and Rho to the cell membrane, a step required for their cell signaling, leading to cell proliferation and migration.|GGPP|3-hydroxy 3-methylglutaryl coenzyme A reductase|36|11|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|camphor|TRPA1|6|19|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|desipramine|F316C|32|19|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|DIRECT-REGULATOR
15478125|An impressing number of inhibitors of STSs of the sulfamate type have been reported in the last years, with several compounds, such as 667COUMATE among others, progressing to clinical trials for the treatment of hormone-dependent tumors (breast and prostate cancers).|sulfamate|STSs|10|7|Arg1:T28|Arg2:T49|CHEMICAL|GENE-N|INHIBITOR
17228780|  Adult-onset citrullinemia (CTLN2) is a rare hereditary metabolic disorder characterized by highly increased concentration of citrulline and ammonia in the plasma, which is ascribed to a deficiency of argininosuccinate synthetase (ASS), one of the urea cycle enzymes mainly located in the liver.|citrulline|ASS|18|35|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE
14626653|Inhibition of PDE5 blocks the hydrolysis of cyclic guanosine monophosphate (GMPc) and results in increased arterial blood flow leading to enlargement of the corpus cavernosum and resulting in erection.|cyclic guanosine monophosphate|PDE5|8|3|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE
19531491|Subsequent studies demonstrated that wild-type and hyperinsulinemia/hyperammonemia forms of GDH are inhibited by the green tea polyphenols, epigallocatechin gallate and epicatechin gallate.|epigallocatechin gallate|GDH|19|10|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
9374794|Under voltage-clamp conditions, cisapride block of HERG is dose dependent with a half-maximal inhibitory concentration of 6.5 nM at 22 degrees C (n = 25 cells).|cisapride|HERG|5|8|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|pyruvate|(L-serine dehydratase|22|2|Arg1:T2|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF
23391631|The results showed that Pb(2+) significantly induced cardiotoxicity and heart failure as evidenced by increase cardiac enzymes, lactate dehydrogenase and creatine kinase and changes in histopathology in vivo.|Pb(2+)|lactate dehydrogenase|5|22|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
10567199|RIHP and fractional excretion of sodium (FE(Na)) were measured before and after direct renal interstitial volume expansion in control rats (n=7), rats infused with the COX-1 inhibitor piroxicam (n=6, 1.5 mg/kg), and rats infused with the COX-2 inhibitors NS-398 (n=5, 1.5 mg/kg) and meloxicam (n=6, 0.3 mg/kg).|meloxicam|COX-2|59|49|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23515287|These results indicate that 3β-diol induces OT promoter activity via ER-β-cHRE interactions.|3β-diol|cHRE|5|12|Arg1:T7|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|PGE1|EP3|31|2|Arg1:T32|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9486667|Thus, our results indicate that important determinants of dofetilide binding are localized to the pore region of HERG.|dofetilide|HERG|10|19|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16245075|Effects of granulocyte colony-stimulating factor (G-CSF) and neutrophil elastase inhibitor (ONO-5046) on acid-induced lung injury in rats.|ONO-5046|neutrophil elastase|14|10|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
15936988|Simvastatin, an HMG-CoA reductase inhibitor with mild inhibition of LFA-1, induced the production of interleukin (IL)-18, tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma in human peripheral blood mononuclear cells (PBMC).|Simvastatin|interleukin (IL)-18|1|17|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23339663|Also, the inhibition of AChE by CBDP is unexpected, from a structural standpoint, i.e., considering the narrowness of AChE active site and the bulkiness of CBDP.|CBDP|AChE|30|23|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12582227|db/db mice treated with DRF 2655 showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and carnitine acetyltransferase, respectively.|DRF 2655|phosphoenolpyruvate carboxykinase|5|13|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|IL-6|30|24|Arg1:T15|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
1712335|In anesthetized spontaneously hypertensive rats, the antihypertensive activity of carvedilol was nearly abolished by combined pretreatment of the rats with high doses of the alpha 1 adrenoceptor antagonist, prazosin (1 mg/kg, iv), and the nonselective beta adrenoceptor antagonist, propranolol (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by carvedilol may be accounted for by blockade of beta and alpha 1 adrenoceptors.|prazosin|alpha 1 adrenoceptor|31|26|Arg1:T15|Arg2:T40|CHEMICAL|GENE-N|ANTAGONIST
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|24R, 25-(OH)(2)D(3)|PKC|10|26|Arg1:T7|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|nortriptyline|G400L|28|25|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|lenalidomide|CRBN|7|20|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23249624|Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases.|dabrafenib|V600E|13|10|Arg1:T15|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|lanreotide|SSTR2|16|20|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17427197|TGF-beta1 and high D-glucose increased p42/44(mapk) and Smad2 phosphorylation, an effect blocked by PD-98059 (MEK1/2 inhibitor).|PD-98059|Smad2|18|11|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23042953|Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.|amino acids|5A apolipoprotein|2|10|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|PART-OF
22878908|TZDs also inhibited alkaline phosphatase activity (58-75%, p<0.046) and osteocalcin production (52-75%, p<0.031).|TZDs|alkaline phosphatase|1|4|Arg1:T15|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
14626653|Contra-indications (co-administration with drugs increasing nitric oxide) and side-effects (headache and flushing due to vasodilatation) of vardenafil are similar to those of other PDE5 inhibitors.|vardenafil|PDE5|21|28|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
8836655|These results suggest that epinastine, although identified as a 5-HT antagonist, acts as a 5-HT1 agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional 5-HT1-like receptor, located to sensory nerves.|epinastine|5-HT1|5|17|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|AGONIST
12183670|To eliminate the interaction of bupropion with DAT or NET, nomifensine or desipramine, respectively, was included in the superfusion buffer.|bupropion|DAT|6|8|Arg1:T30|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
2226440|The high-affinity binding of L-noradrenaline to phenylalanine hydroxylase, as studied by equilibrium microdialysis (anaerobically) and ultrafiltration (aerobically), shows positive cooperativity (h = 1.9); at pH 7.2 and 20 degrees C the rat enzyme binds about 0.5 mol L-noradrenaline/mol subunit with a half-maximal binding (S50) at 0.25 microM L-noradrenaline.|L-noradrenaline|phenylalanine hydroxylase|5|7|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12085361|In complementary RNA (cRNA)-injected Xenopus laevis oocytes, rifamycin SV (10 micromol/L) cis-inhibited human organic anion transporting polypeptide C (SLC21A6) (OATP-C), human organic anion transporting polypeptide 8 (SLC21A8) (OATP8), human organic anion transporting polypeptide B (SLC21A9) (OATP-B), and human organic anion transporting polypeptide A (SLC21A3) (OATP-A) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes.|rifamycin SV|human organic anion transporting polypeptide 8|12|32|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
17884974|Ex vivo IC(50) values (COX-1: 105.2 micromol/L; COX-2: 26.3 micromol/L) of acetaminophen compared favorably with its in vitro IC(50) values.|acetaminophen|COX-1|20|9|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
16690332|NO rebinding in HNS from Staphylococcus aureus (SA-HNS) is faster than that measured for either Bacillus anthracis (BA-HNS) or for eNOS(HD) in both oxidized and reduced forms in the presence of arginine.|NO|SA-HNS|1|9|Arg1:T20|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
23454149|Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and p-Akt.|DMBT|p-Akt|5|18|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23547652|  Small molecules bearing hydroxamic acid as the zinc binding group (ZBG) have been the most effective histone deacetylase inhibitors (HDACi) to date.|zinc|histone deacetylase|8|19|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
17308037|These data support the conclusion that renal ecto-phosphodiesterase activity is not mediated by PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7, PDE9, PDE10, or PDE11 and is inhibited by high concentrations of dipyridamole.|dipyridamole|phosphodiesterase|41|9|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
17553661|  4-Hydroxynonenal (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (GST) isoforms.|alpha,beta-unsaturated aldehyde|glutathione S-transferase|8|21|Arg1:T24|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE
9873034|The N-terminal oxygenase domain (amino acids 1-498; iNOSox) in each subunit binds heme, L-Arg, and tetrahydrobiopterin (H4B), is the site of NO synthesis, and is responsible for the dimeric interaction, which must occur to synthesize NO.|amino acids|iNOSox|6|10|Arg1:T16|Arg2:T51|CHEMICAL|GENE-Y|PART-OF
17125913|In conclusion, our results indicate that Cd increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and PDGFRalpha kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.|Cd|c-jun|8|29|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
23293300|The inhibitory potency of BOC was lower than known inhibitors of CYP3A (ketoconazole), OATP1B (rifampin), or both (telaprevir).|telaprevir|OATP1B|25|17|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
12837382|1,7-Heptylene-bis-N,N'-syn-2-pyridiniumaldoxime, the most potent of the alkylene-linked dimeric reactivators, was readily synthesized using bistriflate and is 100 times more potent than 2-PAM in reactivating hAChE poisoned by isoflurophate.|bistriflate|hAChE|18|29|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
23583259|Results from mechanistic studies indicated that rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, bound to the ligand-binding domain of hPXR, as assessed by a transactivation assay and by a competitive ligand-binding assay using time-resolved fluorescence resonance energy transfer; triggered nuclear translocation of a green fluorescence protein-tagged hPXR, as visualized by confocal imaging; and recruited steroid receptor coactivator-1 (SRC-1), SRC-2, and SRC-3 to hPXR, as demonstrated by mammalian two-hybrid assays.|rilpivirine|hPXR|7|77|Arg1:T28|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23605050|Our study revealed that high glucose/Fe concentrations in MIN6 cells induced an increase of the Bcl2/Bax ratio, an indicator of increased cell apoptosis.|glucose|Bax|6|17|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12842269|Unlike OFQ II(1-17), high concentrations of its C-terminal extension, OFQ II(1-28), stimulated [35S]-GTPgammaS binding in a mu (mu) opioid receptor-like distribution and the effect was blocked by naloxone.|naloxone|mu (mu) opioid receptor|42|29|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
11488610|Changes in the accessibility of Trp residues upon pyridoxal-P binding strongly supported a significant conformational change in GAD.|pyridoxal-P|GAD|9|18|Arg1:T27|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10365684|Exposure to MMI (1 microM and 10 microM) or PTU (10 microM and 100 microM) for 2 days caused a significant increase in cellular TPO activity; 100 microM MMI inhibited cellular TPO activity.|PTU|TPO|12|29|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR
23353701|Treatment with adenosine dialdehyde (AdOx), an inhibitor of transmethylation-suppressive adenosylhomocysteine (SAH) hydrolase (SAHH), enhanced the level of SAH and effectively blocked the proliferation, migration, and invasion of cancer cells; the treatment also induced the differentiation of C6 glioma cells and suppressed the neovascular genesis of eggs in a dose-dependent manner.|AdOx|adenosylhomocysteine (SAH) hydrolase|6|13|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
17234158|Here, we report that the antifibrotic drug 5-methyl-1-phenyl-2-(1H)-pyridone (pirfenidone, PFD) elicits growth-inhibitory effects and reduces TGF-beta2 protein levels in human glioma cell lines.|PFD|TGF-beta2|17|24|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|carnitine|Carnitine acetyltransferases|13|1|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
16543605|We have cloned and characterized a CYP51 from MAC that functions as a lanosterol 14alpha-demethylase.|lanosterol|CYP51|14|7|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
11489456|Pre-treatment with the selective 5-HT2C receptor antagonist, SB-242084 (0.3-3 mg/kg), dose-dependently inhibited both d-fenfluramine- (3 mg/kg) and d-norfenfluramine-induced (2 mg/kg) hypophagia.|d-fenfluramine|5-HT2C|18|5|Arg1:T16|Arg2:T31|CHEMICAL|GENE-Y|AGONIST
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|dronedarone|ion channel|10|2|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23551063|UGT1A6 exhibited a significantly higher Vmax and Km values toward both HFC and UDP-glucuronic acid than the other UGTs. 5.|HFC|UGTs|12|19|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|(5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione|peroxisome proliferator-activated receptor|3|48|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR
23416065|About 99% of a dose of diflunisal is unavailable for reaction with the target enzyme, because diflunisal strongly binds to human serum albumin (HSA).|diflunisal|HSA|19|27|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12697717|All-trans-retinoic acid did not affect 17 beta HSDXI expression or activity, but addition of the retinoid together with cAMP significantly decreased activity over cAMP alone (32% vs.|cAMP|17 beta HSDXI|20|6|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
23339625|We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively.|DEX-P|CYP3A|39|53|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|dipeptidyl peptidase-4|1|5|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23246867|Taken together, these data suggest that glucose-mediated activation of Cdc42 leads to activation of PAK1 and prompts activation of its downstream targets Raf-1, MEK1/2 and ERK1/2 to elicit F-actin remodeling and recruitment of insulin granules to the plasma membrane to support the sustained phase of insulin release.|glucose|Cdc42|8|11|Arg1:T6|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR
8827452|Thus, PHBP was a heterodimer composed of 50-kDa and 17-kDa subunits, bridged by a disulfide linkage.|disulfide|PHBP|17|3|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|PART-OF
12227806|  A streamlined and high-yielding synthesis of aprepitant (1), a potent substance P (SP) receptor antagonist, is described.|aprepitant|substance P (SP) receptor|7|14|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|ANTAGONIST
15843826|In addition, VEGF-induced formation of tube-like structures in vitro and neovascularization in mouse corneas were significantly inhibited by Am80.|Am80|VEGF|20|4|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|ibuprofen|PGH synthase-2|18|36|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23047912|Nevertheless, low L-BMAA concentrations (≥ 0.1mM, 48 h) increased protein ubiquitination, 20S proteasomal and caspase 12 activity, expression of the endoplasmic reticulum (ER) stress marker CHOP, and enhanced phosphorylation of elf2α in SH-SY5Y cells.|L-BMAA|20S proteasomal|4|17|Arg1:T15|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
19930708|Exemestane increased EGFR activation 15 min after its application in H23 cells.|Exemestane|EGFR|1|3|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
22349823|They display sensitivity to TK inhibitors, including gefitinib and erlotinib.|gefitinib|TK|9|5|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
10727523|Probenecid and furosemide inhibited, whereas under certain conditions sulfinpyrazone, penicillin G, and indomethacin greatly stimulated, MRP2-mediated NEM-GS uptake.|penicillin G|MRP2|12|20|Arg1:T18|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR
23357361|β-Asarone regulates p15 expression by regulation of Oct-1 binding.|β-Asarone|p15|1|3|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23416191|The most potent compound 5 (HJC0123) has demonstrated to inhibit STAT3 promoter activity, downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values.|HJC0123|STAT3|7|20|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|oxysterols|liver X receptor|8|14|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR
23169610|  3-Methylcholanthrene (MC) is a readily metabolized aryl hydrocarbon receptor (AHR) agonist.|3-Methylcholanthrene|aryl hydrocarbon receptor|1|9|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
23448346|These results provide an example that attachment of a bulky side chain to the C-7α position of E2 can produce ER antagonists with ER affinity comparable to that of ICI-182,780.|ICI-182,780|ER|30|24|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12188035|The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with rat GR, whereas BM and esterified-DEX had full transactivation agonistic activity.|DEX|rat GR|23|16|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|fananserin|5-HT receptor|78|1|Arg1:T10|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST
22982445|LTD4 also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and NF-κB p65 in the hippocampus and cortex.|LTD4|CysLT(1)R|1|11|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23567956|Compounds JL40 and JL432 presenting higher lipoxygenase inhibitory activity among the tested derivatives, were found to present a promising anti-inflammatory in vivo result, as well as antioxidant and LOX inhibitory profile.|JL432|lipoxygenase|4|7|Arg1:T21|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
10373224|In both vascular preparations, candesartan caused a marked decrease in the maximal contractile response of the angiotensin II (Ang II) concentration-response curve.|candesartan|Ang II|6|21|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23303191|Transfected Has2 and particularly Has3 consumed enough UDP-sugars to reduce their content in COS-1 cells.|sugars|Has3|9|5|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23159329|Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.|methamphetamine|CREB|4|21|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR
23455323|We demonstrate that activation of STAT3 serine-727 and tyrosine-705 phosphorylations is promoted by B-RAF(V600E) activity and that the Mcl-1 promoter is dependent on a STAT consensus-site for B-RAF-mediated activation.|serine|STAT3|7|6|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|PART-OF
19057128|MMP-2 and MMP-9 expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and captopril inhibited them.|captopril|MMP-9|16|3|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|acetyl-CoA|FAS|11|5|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
23306790|We found that VA upregulated the DNA binding activity of NF-κB, but that the antioxidants glutathione and N-acetyl-l-cysteine, as well as NF-κB inhibitor MG132, and mutant-IκB (m-IκB) transfection, significantly downregulated VA/TRAIL-induced cell death by inhibiting caspase-3 and NF-κB activities.|MG132|caspase-3|26|42|Arg1:T4|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
23547652|Subsequent optimization led to several novel 3HPT-based HDACi that are selective for HDAC 6 and HDAC 8.|3HPT|HDAC 8|7|16|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23028140|During long-term treatment with imatinib 400 mg once or twice daily, up to 65 or 75% of its hepatic elimination was predicted to occur via CYP2C8, and only about 35 or 25% by CYP3A4, due to dose- and time-dependent autoinactivation of CYP3A4 by imatinib.|imatinib|CYP2C8|5|28|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
23643631|Melamine activates NFκB/COX-2/PGE2 pathway and increases NADPH oxidase-dependent ROS production in macrophages and human embryonic kidney cells.|Melamine|NFκB|1|3|Arg1:T16|Arg2:T33|CHEMICAL|GENE-N|ACTIVATOR
10475242|Here, we report the characterization of a PPARgamma specific monoclonal antibody (MAb), PgammaA53.25, and its use to monitor PPARgamma expression in the noncommitted pluripotent murine mesenchymal stem cell line, C3H10T1/2, treated with TZDs. MAb PgammaA53.25 was raised against a region in the N-terminal domain of human PPARgamma shared by splice variants PPARgamma1 and PPARgamma2.|N|human PPARgamma|51|54|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|PART-OF
20089905|Ibuprofen activates PPARgamma in neuron-like PC12 and B104 cells.|Ibuprofen|PPARgamma|1|3|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR
23558747|We analysed the role of the MBD in MeCP2-chromatin associations in vivo using an MeCP2 mutant Rett syndrome mouse model (Mecp2(tm)(1)(.)(1)(Jae)) in which exon 3 deletion results in an N-terminal truncation of the protein, including most of the MBD.|N|Mecp2|47|22|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|PART-OF
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|risperidone|5-HT2A|11|1|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST
23376120|Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-κB and MAPKs activation via the phosphatidylinositol 3-kinase signaling.|Gastrodin|NF-κB|1|13|Arg1:T15|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR
10421446|With DEPQ-inhibited wild-type mouse acetylcholinesterase (AChE), the reactivation kinetic profile demonstrated one-phase exponential association only when 2-[hydroxyimino methyl]-1-methylpyridinium chloride (2-PAM) and 1-(2-hydroxy-iminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridi nium)-dimethyl ether hydrochloride (HI-6) were used as reactivators.|DEPQ|AChE|2|7|Arg1:T18|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
23220609|The in vivo estrogenicity of BzP was supported by in vitro results from the human estrogen receptor α (hERα)-coactivator recruiting assay and in silico molecular docking analysis performed in this study.|BzP|hERα|6|20|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|EP1|10|7|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
23296101|Furthermore, sensitization to FITC is also enhanced by menthol, which activates TRPA1 and TRPM8.|FITC|TRPM8|5|16|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR
23435916|Similarly, pristimerin inhibited the release of pro-inflammatory cytokines, namely, tumor necrosis factor-α and interleukin-6, induced by LPS.|pristimerin|interleukin-6|3|17|Arg1:T9|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
9497025|The three D4-selective compounds, CP-293,019 (5.6-17.8 mg/kg), U-101,387 (3-30 mg/kg) and L-745,870 (1-10 mg/kg), also significantly blocked the losses in PPI produced by apomorphine.|U-101,387|D4|12|3|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23526814|  Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (HDAC) inhibitors.|pyrrole|HDAC|5|33|Arg1:T2|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR
23568856|  The dopamine transporter (DAT) is a sodium-coupled symporter protein responsible for modulating the concentration of extraneuronal dopamine in the brain.|dopamine|DAT|19|5|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|dasatinib|ABL|8|23|Arg1:T18|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
16899342|The drugs gabapentin and pregabalin interact with the alpha2delta subunit of the P/Q-type VDCCs. Gabapentin and pregabalin slow the rate of inactivation in recombinant P/Q-type VDCCs, expressed in Xenopus oocytes.|Gabapentin|P/Q-type VDCCs|16|26|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR
15771438|Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II.|sulfamide|human CA-II|17|26|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23284002|Human immortalized corneal fibroblasts were treated with TGF-β in the presence of TSA, the NAD(P)H oxidase inhibitor diphenyleneiodonium (DPI), the antioxidant N-acetyl-cysteine (NAC), the NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) activator sulforaphane, or small interfering RNA.|diphenyleneiodonium|NAD(P)H oxidase|23|16|Arg1:T15|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR
12470615|Results indicate that imiquimod and resiquimod induce IFN-alpha and IFN-omega from purified pDC, and pDC are the principle IFN-producing cells in the blood.|imiquimod|IFN-alpha|4|8|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23085979|Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced Cx43 protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner.|TCDD|Cx43|15|27|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|Bax|30|26|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15892618|Other promising new drugs currently under preclinical and clinical evaluation, are VEGFR2 inhibitor PTK787/ZK 222584, thalidomide, farnesyl transferase inhibitor R115777 (tipifarnib, Zarnestra(TM)), matrix metalloproteinase inhibitors, proteasome inhibitor bortezomib (Velcade(TM)), mammalian target of rapamycin (mTOR) inhibitors, cyclooxygenase-2 (COX-2) inhibitors, platelet derived growth factor receptor (PDGF-R) inhibitors, protein kinase C (PKC) inhibitors, mitogen-activated protein kinase kinase (MEK) 1/2 inhibitors, Rous sarcoma virus transforming oncogene (SRC) kinase inhibitors, histondeacetylase (HDAC) inhibitors, small hypoxia-inducible factor (HIF) inhibitors, aurora kinase inhibitors, hedgehog inhibitors, and TGF-beta signalling inhibitors.|bortezomib|proteasome|39|37|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
19683471|  Insulin receptor substrates (IRS) serine phosphorylation is a time-controlled physiological feedback mechanism in insulin signaling that is hijacked by metabolic and inflammatory stresses to promote insulin resistance.|serine|IRS|7|5|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|PART-OF
23064031|NFD abrogated EGF-induced phosphorylation of EGF receptor (EGFR) and phosphatidylinositol 3-kinase (PI3K)/Akt.|NFD|PI3K|1|15|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
15887238|Imatinib stimulated the rapid release of soluble HB-EGF and the subsequent induction of membrane-bound HB-EGF, which correlated with biphasic MAPK activation.|Imatinib|HB-EGF|1|15|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23291559|Here, we have determined the molecular mechanism of this male-specific activation of the Kcnk1 gene and characterized KCNK1 as a phenobarbital-inducible antihyperplasia factor.|phenobarbital|KCNK1|22|19|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
23064031|Furthermore, the EGFR inhibitor AG1478 inhibited EGF-induced MMP-9 expression, cell migration and invasion, as well as the activation of PI3K/Akt, suggesting that PI3K/Akt activation occur downstream of EGFR activation.|AG1478|PI3K|6|27|Arg1:T10|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
12842269|Unlike OFQ II(1-17), high concentrations of its C-terminal extension, OFQ II(1-28), stimulated [35S]-GTPgammaS binding in a mu (mu) opioid receptor-like distribution and the effect was blocked by naloxone.|C|OFQ II(1-17)|12|2|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|PART-OF
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|efavirenz|CYP3A4|6|19|Arg1:T5|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23535287|A luciferase reporter assay also demonstrated that CSA-activated signaling resulted in the increased transcriptional activity of Nrf2 through binding to the antioxidant response element (ARE) enhancer sequence.|CSA|antioxidant response element|8|22|Arg1:T11|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|BMS-354825|SRC|10|20|Arg1:T19|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
22982776|  Human liver prolidase, a metal-dependent dipeptidase, is being tested as a potential catalytic bioscavenger against organophosphorus (OP) chemical warfare nerve agents.|organophosphorus|dipeptidase|18|7|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|SUBSTRATE
23434506|WS-CoQ10 did not alter the mRNA expression levels of Tp53 (at a concentration of 1.0μgmL(-1)) and exhibited neuroprotective activity by stimulating cisplatin-inhibited neurite outgrowth in nerve growth factor (NGF)-differentiated PC12 cells (at a concentration of 0.1μgmL(-1)).|cisplatin|NGF|27|35|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
20204178|Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed PTH mRNA expression and serum PTH effectively in the 5/6 NX rats, but paricalcitol was less potent in raising serum Ca than doxercalciferol.|doxercalciferol|PTH|35|12|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17194716|Validation of this pharmacophore was performed by predicting the IC(50) of a test set of commercially available (n = 19) and CP-320626-related (n = 48) CYP51 inhibitors.|CP-320626|CYP51|27|33|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
11444497|Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.|irbesartan|AT1-receptor|8|4|Arg1:T16|Arg2:T28|CHEMICAL|GENE-N|ANTAGONIST
10340919|METHODS: COX-1 inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).|meloxicam|COX-1|30|3|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
12569076|  1 The principal aim of the present study was to determine whether long-term treatment of human lung mast cells (HLMC) with the clinically-relevant beta(2)-adrenoceptor agonists, salbutamol and terbutaline, leads to desensitization of beta(2)-adrenoceptor-mediated responses in these cells.|salbutamol|beta(2)-adrenoceptor|33|26|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
18773878|RTX treatment also induced foci of RAD51, gamma-H2AX, phospho-Chk1, and phospho-NBS1, although the extent of co-localization with RPA2 foci varied.|RTX|gamma-H2AX|1|9|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17645691|Melatonin or silymarin also reduced OCP-induced signs of apoptosis (increased caspase-3 activity and Bax-alpha upregulation) in all the organs assayed.|Melatonin|caspase-3|1|12|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
23322164|Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.|acylcarnitines|Carnitine palmitoyltransferase 2|16|1|Arg1:T23|Arg2:T46|CHEMICAL|GENE-Y|PRODUCT-OF
10381000|To begin to examine whether these changes are mediated by alterations in gene expression for tryptophan hydroxylase (TPH), the rate-limiting enzyme in 5-HT biosynthesis, we quantitated its mRNA levels by competitive reverse transcription-polymerase chain reaction (RT-PCR).|5-HT|tryptophan hydroxylase|26|16|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF
17075268|Dexamethasone suppresses histamine synthesis by repressing both transcription and activity of HDC in allergic rats.|Dexamethasone|HDC|1|12|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
11695891|A small-molecule inhibitor of NOS (3-Br-7-nitroindazole, 7-NIBr) is profoundly neuroprotective in mouse models of stroke and Parkinson's disease.|3-Br-7-nitroindazole|NOS|7|5|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|PDGFR|1|17|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
15655513|In a human whole blood assay, IC(50) values for lumiracoxib were 0.13 microM for COX-2 and 67 microM for COX-1 (COX-1/COX-2 selectivity ratio 515).|lumiracoxib|COX-1|14|26|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|benzamidine|plasmin|12|8|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AKR1B10|24|18|Arg1:T6|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
23261524|The reduction of BiFC signal mediated by nutlin-3 was correlated with an increase in Puma transactivation, PARP cleavage, and cell death.|nutlin-3|PARP|8|18|Arg1:T1|Arg2:T5|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23524313|Elevated levels of total cholesterol and LDL-cholesterol, along with hepatic cholesterol content in a high fat group were found to be significantly reduced by fisetin.|fisetin|LDL|26|7|Arg1:T12|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kushenol H|DGAT|24|52|Arg1:T19|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|1,2,3,7,8-pentachlorodibenzo-p-dioxin|vtg3|10|20|Arg1:T11|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
22815248|A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after CCl4 and PC administration alone.|CCl4|LDH|35|14|Arg1:T22|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
23526814|  Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase (HDAC) inhibitors.|tert-butylcarbamate|histone deacetylase|23|30|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|diclofenac|COX|27|6|Arg1:T12|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR
7665369|Ergovaline inhibition of the binding of the D2-specific radioligand, [3H]YM-09151-2, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas dopamine was much less potent (370 +/- 160 nM).|[3H]YM-09151-2|D2|11|8|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23475432|Glutathione-S-transferase, a phase II enzyme, was inhibited by both arsenic and nicotine but no such inhibition was noted in arsenic-treated animals pre-exposed to nicotine.|nicotine|Glutathione-S-transferase|14|1|Arg1:T22|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
23071106|Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca(2+) channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells.|gliclazide|Insulin|12|1|Arg1:T21|Arg2:T48|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
12213059|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (54) was found to bind and activate the SUR1/Kir6.2 K(ATP) channels in the low nanomolar range and to be at least 1000 times more potent than the reference compound diazoxide with respect to inhibition of insulin release from rat islets.|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|insulin|1|51|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
1929324|Strain JR4 (erg3 erg11), which produces 14-methylfecosterol [14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol) as the major sterol in the presence or absence of fenpropimorph, was also found to be resistant to the drug.|14-methylfecosterol|erg3|10|4|Arg1:T23|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF
16230360|At micromolar concentrations, procainamide was found to be a partial competitive inhibitor of DNMT1, reducing the affinity of the enzyme for its two substrates, hemimethylated DNA and S-adenosyl-l-methionine.|procainamide|DNMT1|5|15|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|RAGE|1|37|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12646997|The potencies of selectivity of icariin and papaverine on PDE5 (PDE4/PDE5 of IC(50)) were 167.67 times and 4.54 times, respectively.|icariin|PDE5|6|13|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
23561191|In this study, we investigated if ω- and β-oxidation mediate catabolism of the AR homologue C19:0 to form 3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), using 3 in vitro platforms, human cytochrome P450 4F2 (CYP4F2), human liver S9, and HepG2 cells.|DHPPA|CYP4F2|30|44|Arg1:T5|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF
23333834|The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.|YR-11|TRAP|3|36|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
17253779|Unlike mouse RetSat (mRetSat), zRetSat A had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or all-trans-7,8-dihydroretinol, respectively.|all-trans-7,8-dihydroretinol|zRetSat A|30|8|Arg1:T3|Arg2:T47|CHEMICAL|GENE-Y|PRODUCT-OF
23446230|Moreover, overexpressed CYP2J2 and EETs inhibited Ang II-induced macrophage migration in a VSMC-macrophage coculture system.|EETs|Ang II|6|8|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
16926278|Truncated proteins with a complete GAF-B were dimers, but those lacking the N-terminal 46 amino acids of GAF-B were monomers, indicating that these residues are vital for GAF-B-mediated PDE5 dimerization.|amino acids|GAF-B|16|19|Arg1:T2|Arg2:T27|CHEMICAL|GENE-N|PART-OF
23632005|Our results showed that cisplatin increased the levels of oxidant parameters such as lipid peroxidation (thio barbituric acid reactive substance (TBARS)) and myeloperoxidase (MPO) in brain tissue and suppressed the effects of antioxidants such as total glutathione (GSH) and superoxide dismutase (SOD).|cisplatin|SOD|5|51|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23142547|Deletion analysis revealed that the C-terminal 21-amino acid sequence of Rev1 is uniquely required for its interaction with Rad5 and is essential for its non-catalytic function.|C|Rev1|6|11|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|PART-OF
16627864|Blockade of the HO pathway after preconditioning and the combined pretreatment with dobutamine and esmolol decreased PDR(ICG) (Dob/SnMP/Shock: 12.6 +/- 4.24%/min, p = 0.011; Dob/Esmolol/Shock: 10.2 +/- 4.34%/min, p = 0.008).|esmolo|HO|15|4|Arg1:T6|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
9399970|In pigeons trained to discriminate 1.7 mg/kg dezocine from saline, a series of opioids with activity at the mu opioid receptor substituted completely for the dezocine stimulus with a rank order of potency similar to that obtained in other assays sensitive to the effects of mu agonists (i.e., fentanyl >[-]-cyclazocine >buprenorphine = butorphanol >l-methadone >nalbuphine >[-]-metazocine >morphine).|morphine|mu opioid receptor|72|20|Arg1:T34|Arg2:T47|CHEMICAL|GENE-N|AGONIST
23388095|We examined the effects of PHD inhibiton by dimethyloxalylglycine on the vasomotor responses of isolated rat aorta and aortic vascular smooth muscle cells (VSMCs) in a model of cold ischemia/warm reperfusion.|dimethyloxalylglycine|PHD|9|6|Arg1:T14|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
10898598|Most importantly, POCl(3)-induced electric eel AChE inhibition prevents postlabeling with [(3)H]diisopropyl phosphorofluoridate; i.e., both compounds phosphorylate at Ser-200 in the catalytic triad.|POCl(3)|electric eel AChE|4|9|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
17337452|Taken together, these results demonstrate that for hHint1; 1) the efficiency (k(cat)/K(m)) of acylated AMP hydrolysis, but not maximal catalytic turnover (k(cat)), is dependent on homodimerization and 2) the hydrolysis of lysyl-AMP generated by LysRS is not dependent on homodimerization if the monomer structure is similar to the wild-type structure.|lysyl-AMP|LysRS|52|55|Arg1:T7|Arg2:T33|CHEMICAL|GENE-Y|PRODUCT-OF
23086198|Cell homogenates prepared from human embryonic kidney (HEK)293 cells overexpressing wild-type UGT2A2 (termed UGT2A2_i1) exhibited glucuronidation activity, as observed by reverse-phase ultra-pressure liquid chromatography, against 1-hydroxy-(OH)-pyrene, 1-naphthol, and hydroxylated benzo(a)pyrene metabolites, whereas homogenates prepared from HEK293 cells overexpressing UGT2A3 only showed activity against simple PAHs like 1-OH-pyrene and 1-naphthol.|hydroxylated benzo(a)pyrene|UGT2A2|42|15|Arg1:T4|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
23297412|In cultured cardiomyocytes, cardiomyocyte hypertrophy induced by the α(1)-agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol, both of which down-regulated p300 protein levels but not p300 mRNA levels.|resveratrol|p300|26|32|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-isopropylamino|K(ATP) channels|11|51|Arg1:T16|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
9614060|Increased Cat3-mediated cationic amino acid transport functionally compensates in Cat1 knockout cell lines.|amino acid|Cat3|4|2|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-serine|L-serine dehydratase|24|1|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
10449190|Only 1R,2S-ephedrine showed significant agonist activity on human beta3-AR with an EC50 = 45 betaM and a maximal response of 31%.|1R,2S-ephedrine|human beta3-AR|2|8|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|AGONIST
1472079|In addition, in rat microsome incubations, the net amount of 4-OHCIPC glucuronide was also indirectly increased by cadmium through a reduction in the activity of beta-glucuronidase.|4-OHCIPC glucuronide|beta-glucuronidase|13|28|Arg1:T22|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE
11578145|PAD is an inhibitor of S-adenosylhomocysteinase (EC 3.3.1.1), which is necessary for conversion of SeMet to SeCyH.|SeMet|EC 3.3.1.1|18|8|Arg1:T1|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE
17513393|Because Cu deficiency results in upregulation of Gclc and an increase in the biosynthesis of glutathione, it is plausible that the net flux of homocysteine through the transsulfuration pathway is increased.|homocysteine|Gclc|26|8|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
8676079|IL-1, TNF alpha, PGE2, parathyroid hormone (PTH) and 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) similarly induced production of IL-11 by osteoblasts, but IL-6, IL-4, and TGF beta did not.|1 alpha,25-dihydroxyvitamin D3|IL-11|14|29|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|bepridil|NCX|12|25|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
1327384|The affinities derived for these antagonists against [3H]-RS-15385-197 were similar to the values obtained for the displacement of [3H]-yohimbine indicating the alpha 2-adrenoceptor nature of the binding site.|[3H]-yohimbine|alpha 2-adrenoceptor|22|28|Arg1:T3|Arg2:T39|CHEMICAL|GENE-N|DIRECT-REGULATOR
17334413|(2) Does in vivo administration of (R)-(alpha)-(-)-methylhistamine dihydrobromide (RAMH) (H3R agonist), thioperamide maleate (H3R antagonist) or histamine, in the absence/presence of thioperamide maleate, to bile duct ligated (BDL) rats regulate cholangiocyte proliferation?|(R)-(alpha)-(-)-methylhistamine dihydrobromide|H3R|9|26|Arg1:T20|Arg2:T48|CHEMICAL|GENE-Y|AGONIST
23583931|MRS2179, a P2Y1R blocker, prevented potentiation in EDL, but not soleus muscles, suggesting that in fast muscles ATP activates P2Y1 but not P2X receptors.|ATP|P2Y1|22|24|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
23220614|While SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by ISO.|SB203580|p38|9|12|Arg1:T3|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
18055877|Carbimazole inhibited NF-kappaB via the small GTPase Rac-1, whereas propylthiouracil inhibited the phosphorylation of IkappaBalpha by its kinase inhibitor of kappaB kinase alpha.|propylthiouracil|IkappaBalpha|11|16|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|alpha 2-macroglobulin receptor|30|13|Arg1:T2|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-(S)-sec-butylamino|K(ATP) channels|16|51|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
8646863|The pharmacologic properties of fluticasone propionate-including high lipophilicity, high selectivity and affinity for the glucocorticoid receptor, low systemic absorption, and rapid metabolism and clearance-combine to give fluticasone propionate a high therapeutic index.|fluticasone propionate|glucocorticoid receptor|5|16|Arg1:T2|Arg2:T5|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23345579|After aging and digestion with pepsin at pH 2, peptide FGES198AGAAS from Sp-tabun thiocholine had a mass of 902.2 m/z in negative mode, indicating that it had aged by deamination, whereas peptide FGES198AGAAS from Rp-tabun thiocholine had a mass of 874.2 m/z in negative mode, indicating that it had aged by O-dealkylation.|Rp-tabun thiocholine|pepsin|38|6|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
23229509|Exchange of domains between the two isoforms indicates that the C1b domain and the N-terminus of the C1a domain are important for directing selective regulation of AC7 by the G(13) pathway.|N|C1a domain|15|18|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PART-OF
23394205|Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): a potent and selective inhibitor of ATR protein kinase with monotherapy in vivo antitumor activity.|4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole|ATR protein kinase|3|33|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
1403790|Other serotonergic compounds failed to produce substantial clozapine-appropriate responding: the 5-HT3 antagonist, ondansetron; the 5-HT1A agonists, (+-)-8-hydroxy-2-(di-n-propylamino)tetralin and BMY 14802; the 5-HT1A/1B agonist, RU24969; the 5-HT1A partial agonist, NAN190; the 5-HT1C/2 antagonist, mesulergine; the 5-HT1 agonist, I-5-hydroxytryptophane; and the 5-HT1C/2 agonist, quipazine.|ondansetron|5-HT3|15|12|Arg1:T38|Arg2:T58|CHEMICAL|GENE-N|ANTAGONIST
11006278|However, inter-helical distances calculated and determined by EPR for PGHS-2 complexed with arachidonic acid, flurbiprofen, and SC-58125 were in close agreement with those obtained from the cognate crystal structures.|flurbiprofen|PGHS-2|17|11|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9563368|The resulting half-life of the FP active steroid-receptor complex is >10 hours, compared with approximately 5, 7.5, and 4 hours for budesonide, 17-BMP, and triamcinolone acetonide, respectively.|triamcinolone acetonide|steroid-receptor|31|8|Arg1:T3|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFP|COX-1|7|17|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23086748|We found that Ag NPs were highly cytotoxic to hepatocytes (LC(50) lactate dehydrogenase: 2.5 μg/cm(2)) and affected hepatocyte homeostasis by reducing albumin release.|Ag|albumin|4|31|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23353698|ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.|quercetin|pleiotropic kinase|22|19|Arg1:T13|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
1687367|At beta 1-adrenoceptors, the affinity of the compound RR-SR was about 3 times that of labetalol.5. As labetalol is a mixture of active (RR and SR) and inactive (SS and SR) enantiomers (in terms of alpha and beta receptor actions), the combination of RR and SR may be a valuable substitute for labetalol in the treatment of systemic hypertension.|labetalol|beta 1-adrenoceptors|17|2|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23384446|Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.|CPA|SERCA|43|58|Arg1:T22|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
11118042|Sulindac sulfide inhibits cyclooxygenase (COX) enzyme activities and has been reported to suppress ras-dependent signaling.|Sulindac sulfide|ras|1|16|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
12183691|Several organic anions such as valproate, as well as organic cations, significantly inhibited carnitine and TEA uptake by OCTN2, and valproate showed Na(+)-dependent inhibition of OCTN2-mediated TEA uptake.|valproate|OCTN2|24|33|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|3β-hydroxyl|estrogen receptor-α|25|39|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12110374|It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.|indomethacin|cyclooxygenase|14|8|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
1712335|We therefore conclude that carvedilol, at antihypertensive doses, is an antagonist of beta 1, beta 2, and alpha 1 adrenoceptors, and also of calcium channels in vascular smooth muscle.(ABSTRACT TRUNCATED AT 400 WORDS)|carvedilol|calcium channels|5|29|Arg1:T19|Arg2:T44|CHEMICAL|GENE-N|ANTAGONIST
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|acetazolamide|MCA|12|51|Arg1:T6|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
12063169|These results indicate that hOAT4 mediates the high-affinity transport of OTA on the apical side of the proximal tubule, whereas the transport characteristics of OTA are distinct from those by basolateral OATs.|OTA|hOAT4|26|5|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
1407010|  Radioligand binding studies were performed in membranes of rabbit whole brain and striatum using the novel iodinated radioligand for 5-hydroxytryptamine 5-HT1B and 5-HT1D sites, Serotonin-5-O-Carboxymethyl-Glycyl[125I]Tyrosinamide ([125I]GTI).|[125I]GTI|5-hydroxytryptamine 5-HT1B|34|21|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17038304|Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT).|Biotin|sodium-dependent multivitamin transporter|1|11|Arg1:T24|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
7853212|Histamine H1 receptor antagonists (mepyramine, diphenhydramine, chlorpheniramine and triprolidine) inhibited the lidocaine 3-hydroxylation activity catalyzed by P450 2D1 but did not inhibit the testosterone hydroxylation activities catalyzed by P450s other than P450 2D forms.|testosterone|P450 2D|28|36|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|SUBSTRATE
23434506|WS-CoQ10 did not alter the mRNA expression levels of Tp53 (at a concentration of 1.0μgmL(-1)) and exhibited neuroprotective activity by stimulating cisplatin-inhibited neurite outgrowth in nerve growth factor (NGF)-differentiated PC12 cells (at a concentration of 0.1μgmL(-1)).|CoQ10|NGF|2|35|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR
23319419|ICA-105574 interacts with a common binding site to elicit opposite effects on inactivation gating of EAG and ERG potassium channels.|ICA-105574|ERG|1|18|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|diethylstilbestrol|estrogen receptor|9|34|Arg1:T6|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT3|61|49|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|fulvestrant|ER|4|24|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
12141946|Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin.|flavin|spermine oxidase|7|8|Arg1:T29|Arg2:T47|CHEMICAL|GENE-N|PART-OF
11393267|Reactivation potentials of BuChE (the difference between oxime-reactivated and -unreactivated enzyme activity) declined significantly with time after organophosphate ingestion.|oxime|BuChE|9|4|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
17498508|Incretin-receptor activation leads to glucose-dependent insulin secretion, induction of beta-cell proliferation, and enhanced resistance to apoptosis.|glucose|insulin|5|6|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9760035|Both carbetocin, carbetocin metabolite I and carbetocin metabolite II displayed binding affinities to the myometrial oxytocin receptor of a similar magnitude as oxytocin.|carbetocin|oxytocin receptor|8|17|Arg1:T26|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9138687|A-61603, a selective agonist at alpha 1A adrenoceptors behaved as a full agonist relative to NA and yielded monophasic E/[A] curves with a p[A50] of 7.59 +/- 0.04 (n = 15).||alpha 1A adrenoceptors|17|7|Arg1:T32|Arg2:T43|CHEMICAL|GENE-Y|AGONIST
3094574|Tyrosinase catalyzes an unusual oxidative decarboxylation of 3,4-dihydroxymandelate.|3,4-dihydroxymandelate|Tyrosinase|8|1|Arg1:T26|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
16702329|GW9662, a PPARgamma antagonist, prevented (P < 0.01) the lutein-induced iNOS mRNA downregulation in HD11 cells.|GW9662|iNOS|1|15|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23604717|Furthermore, SAL-2 inhibited HNE-induced activation of mitogen-activated protein kinases.|SAL-2|mitogen-activated protein kinases|3|8|Arg1:T21|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR
11481271|The following alpha(2)-adrenoceptor antagonists were applied: BRL44408 (alpha(2A)-selective), ARC239 (alpha(2B)- and alpha(2C)-selective), and prazosin (alpha(2B)- and alpha(2C)-selective).|ARC239|alpha(2B)|21|23|Arg1:T21|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST
12531805|SU11248 is a recently described selective inhibitor with selectivity for split kinase domain RTKs, including platelet-derived growth factor receptors, vascular endothelial growth factor receptors, and KIT.|SU11248|vascular endothelial growth factor receptors|1|22|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
10381787|In contrast, the administration of 7.5 and 15 mg of meloxicam caused dose-dependent reductions in monocyte COX-2 activity by 51% and 70%, respectively, and in platelet COX-1 activity by 25% and 35%, respectively.|meloxicam|COX-1|12|32|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23122161|Rosemary extract and its hexane fraction are important for the prevention of phosphorylation of MAPKs, thereby blocking NF-kB activation, which in turn leads to decreased expression of iNOS and COX-2, thus preventing inflammation.|hexane|NF-kB|5|19|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
23444386|Studies on the kinetics of the hSULT2A1-catalyzed sulfation of dehydroepiandrosterone (DHEA) showed the effects of disulfide bond formation on the substrate inhibition characteristics of the enzyme.|DHEA|hSULT2A1|12|7|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|GST|4|49|Arg1:T27|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|L-deprenyl|MAO-B|15|26|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|beta-alanine|GAT3|5|23|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
8986981|Peripheral intravenous injections of WB 4101 (a competitive alpha 1A-adrenoceptor antagonist), but not clorethylclonidine (CEC, an alpha 1B-adrenoceptor antagonist), significantly blunted (P < .05, ANOVA) the mesenteric vasoconstrictor responses to methoxamine.|WB 4101|alpha 1A-adrenoceptor|5|10|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ANTAGONIST
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|Raf|1|10|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23194750|Compounds bearing the thiazolidinedione structure have also been shown to inhibit phosphoinositide 3-kinase (PI3K).|thiazolidinedione|phosphoinositide 3-kinase|4|12|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
23288144|Our results showed that SUN induced the CYP1A1 mRNA, protein, and activity levels in a concentration-dependent manner in MCF7 cells.|SUN|CYP1A1|5|8|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15840408|ONO-AE1-259-01 a prostanoid EP2-receptor agonist, ONO-AE1-329, a prostanoid EP4-receptor agonist, and ONO-1301 inhibited TNF-alpha production and T-cell proliferation.|ONO-AE1-259|prostanoid EP2-receptor|1|3|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|V654A|24|11|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR
11078056|Selective COX-2 inhibitors, such as meloxicam, celecoxib (SC-58635), and rofecoxib (MK-0966), are NSAIDs that have been modified chemically to preferentially inhibit COX-2 but not COX-1.|SC-58635|COX-2|11|2|Arg1:T13|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
1407010|The pharmacological profile of [125I]GTI binding was fully comparable to that reported previously in human and other brain preparations known to possess 5-HT1D sites (using either [3H]5-HT or [125I]GTI) and displayed a characteristic rank order of affinity: 5-carboxamido-tryptamine greater than 5-HT = dihydroergotamine greater than or equal to ergotamine greater than or equal to sumatriptan greater than or equal to CGS 12066 greater than or equal to metergoline greater than yohimbine greater than or equal to methysergide greater than ICYP greater than 8-OH-DPAT greater than or equal to CP 93129 greater than (-)pindolol greater than ketanserin greater than isamoltane greater than mesulergine greater than corynanthine greater than buspirone greater than MDL 72222.|CGS 12066|5-HT1D|74|27|Arg1:T28|Arg2:T41|CHEMICAL|GENE-N|DIRECT-REGULATOR
23478802|Electrophilic chemicals activate both insect and vertebrate TRPA1 via covalent modification of cysteine residues in the amino-terminal region.|cysteine|TRPA1|13|8|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|PART-OF
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|AXL|3|47|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
12615691|Anesthetized rabbits were treated with the selective P2Y12 antagonists AR-C69931 MX (3 microg x kg x min(-1) IV) or clopidogrel (25 mg/kg orally).|clopidogrel|P2Y12|25|8|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|erlotinib|tyrosine kinase|37|31|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
23567241|Among 12 parabens with linear alkyl chains ranging in length from C1 to C12, heptylparaben (C7) and pentylparaben (C5) showed the most potent ERα and ERβ agonistic activity in the order of 10(-7)M and 10(-8)M, respectively, and the activities decreased in a stepwise manner as the alkyl chain was shortened to C1 or lengthened to C12.|parabens|ERβ|3|31|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|AGONIST
18393142|This overview focuses on the indirect antithrombin dependent pentasaccharide derivatives of idraparinux and on the most advanced oral direct inhibitors to factor Xa (rivaroxaban and apixaban) and IIa (dabigatran).|rivaroxaban|factor Xa|25|22|Arg1:T4|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
12601049|RESULTS: At concentrations devoid of cytotoxicity, budesonide inhibited VEGF secretion as well as mRNA expression in ARPE-19 cells in a dose-dependent manner.|budesonide|VEGF|9|11|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23229512|Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis.|Vitamin K2|Bak|1|9|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10683249|The mNQO activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 2,6-dichlorophenolindophenol and menadione.|2,6-dichlorophenolindophenol|mNQO|19|2|Arg1:T14|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE
1744096|Studies with 14 different Cbl analogues with alterations in various portions of the corrin ring and the nucleotide showed that all of the analogues were able to fully activate human methionine synthase when they were reduced with 2-mercaptoethanol.|Cbl|human methionine synthase|5|30|Arg1:T2|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR
23632082|This conductance was suppressed by nonselective TRPC channel blockers 2-APB, flufenamic acid and ML204, enhanced by La(3+) in a subpopulation of cells, and unchanged by the TRPV1 antagonist capsazepine or a Na(+) /Ca(2+) exchanger blocker KB-R7943.|flufenamic acid|TRPC|12|7|Arg1:T3|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23416002|Amino acid derived quinazolines as Rock/PKA inhibitors.|quinazolines|Rock|4|6|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
12085361|Inhibition of human liver OATPs can explain the previously observed effects of rifamycin SV and rifampicin on hepatic organic anion elimination.|rifamycin SV|human liver OATPs|13|3|Arg1:T12|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR
3917545|Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone.|phenylbutazone|prostaglandin H synthase|10|3|Arg1:T34|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR
10548525|Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.|rosiglitazone|peroxisome proliferator-activated receptor gamma|14|9|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR
17349707|The specific activity of bGlcNAc 2-epimerase (124Umg(-1) protein) for the conversion of N-acetyl-d-glucosamine to N-acetyl-d-manosamine was about four-fold higher than that of porcine N-acetyl-d-glucosamine 2-epimerase.|N-acetyl-d-manosamine|bGlcNAc 2-epimerase|20|5|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
11861317|In contrast, pregnanolone sulphate (3alpha5betaS), a negative modulator of the NMDA receptor that acts at a distinct site from PS, inhibited all four subtypes, but was approximately 4 fold more potent at NR1/NR2C and NR1/NR2D than at NR1/NR2A and NR1/NR2B receptors.|pregnanolone sulphate (3alpha5betaS)|NR2B|4|47|Arg1:T22|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
23287710|In conclusion our in vitro results demonstrate that exposure to high doses of glycidamide/acrylamide - exceeding the dietary exposure of the general population by far - can induce genes with growth promoting potential like the oncogene cMYC and genes involved in the MAPK pathway.|acrylamide|MAPK|15|43|Arg1:T6|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23001627|SOD levels of serum and hippocampus tissue were significantly increased and MDA levels were significantly decreased in the PTU + Vit E and PTU + L-T4 + Vit E groups than the PTU and PTU + L-T4 groups.|Vit E|SOD|21|1|Arg1:T11|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
2112956|Since four other human acyl-CoA dehydrogenases did not dehydrogenate isobutyryl-CoA, 2-methylbutyryl-CoA (obligatory intermediates from valine and isoleucine, respectively) nor valproyl-CoA, it is reasonable to assume that valproyl-CoA is dehydrogenated by 2-methyl-branch-chain acyl-CoA dehydrogenase in man as well.|valproyl-CoA|2-methyl-branch-chain acyl-CoA dehydrogenase|32|36|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
10405348|Cytokines, such as interleukin 6 (IL-6) and tumour necrosis factor alpha (TNFalpha) or prostaglandin E(2) (PGE(2)), can stimulate aromatase activity.|PGE(2)|aromatase|25|33|Arg1:T8|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR
12898700|We found that TR-MUL5 cells exhibited [(14)C]L-cystine uptake activity and expressed xCT and 4F2hc, which involve system x(c) (-).|[(14)C]L-cystine|4F2hc|7|20|Arg1:T9|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE
23220413|Treatment with TDCPP also significantly increased transcription of genes involved in thyroid hormone synthesis (tshβ, slc5a5 and tg) and thyroid development (hhex, nkx2.1 and pax8) as a compensatory mechanism for decreased T4 concentrations.|TDCPP|pax8|3|30|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9399970|In pigeons trained to discriminate 1.7 mg/kg dezocine from saline, a series of opioids with activity at the mu opioid receptor substituted completely for the dezocine stimulus with a rank order of potency similar to that obtained in other assays sensitive to the effects of mu agonists (i.e., fentanyl >[-]-cyclazocine >buprenorphine = butorphanol >l-methadone >nalbuphine >[-]-metazocine >morphine).|butorphanol|mu opioid receptor|61|20|Arg1:T30|Arg2:T47|CHEMICAL|GENE-N|AGONIST
15646817|In Experiment 2, TT-235 induced a significant decrease (p<0.05) in oxytocin receptor number and binding affinity at both 0.5 and 4 hours compared with controls.|TT-235|oxytocin receptor|5|16|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15192023|Thus, hydralazine activates the HIF pathway through inhibition of PHD activity and initiates a pro-angiogenic phenotype.|hydralazine|PHD|3|11|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
10027835|The data thus suggest that selective MAO-A inhibitors such as esuprone may be an interesting new approach for the treatment of epilepsy.|esuprone|MAO-A|11|7|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
10909982|4-chloro-6-[(2,3-xylidine)-pirimidinylthio] acetic acid (WY-14,643), a specific ligand of the PPAR-alpha subtype, causes the most dramatic increase in UCP-3 mRNA, whereas troglitazone, a specific activator of PPAR-gamma, also significantly increases UCP-3 mRNA abundance in skeletal muscle of lactating mice.|WY-14,643|UCP-3|11|28|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|4-methoxybenzyl ester|SERT|14|48|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9631585|A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide.|mitoxantrone|DNA-topoisomerase II|29|23|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23415904|Thus, in mouse, 11βHSD1 influenced the abundance and balance of circulating and tissue levels of 7βOHC and 7KC, promoting reduction of 7KC.|7βOHC|11βHSD1|18|6|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF
8469910|We report that the phospholipase A2 and diacylglycerol lipase inhibitor quinacrine (1-10 mumol l-1) inhibited the thyroliberin stimulated prolactin (rPRL) production in a dose-dependent way in a rat pituitary tumour cell line (GH4Cl cells).|quinacrine|phospholipase A2|11|5|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|nucleotide|EPAC|29|49|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|flavonolignans|OATP2B1|22|12|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
10490901|The proliferative effects of TGF-alpha (1.0 ng/ml) were not affected significantly by a monoclonal antiepidermal growth factor receptor antibody (1-100 ng/ml) and were almost completely blocked by specific inhibitors of signal transducers such as genistein (10(-5) M), 1-6[[17beta-3methoxyestra-1,3, 5(10)-trien-17-yl]amino]hexyl]-1H-pyrrol2,5-dione (U-73122; 0(-5) M), wortmannin (5 x 10(-7) M), sphingosine (5 x 10(-6) M), 2'-amino-3'-methoxyflavone (PD98059; 5 x 10(-5) M), and rapamycin (10 ng/ml).|PD98059|TGF-alpha|98|5|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17513393|Real-time RT-PCR was used to determine the expression of the subunits of glutamate-cysteine ligase (Gcl) in liver that catalyzes the rate-limiting step in glutathione biosynthesis.|glutathione|glutamate-cysteine ligase|26|13|Arg1:T15|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF
11689471|Salicylates inhibited ATPase activity stimulated by this specific heptapeptide but did not block ATP binding or induce BiP expression.|ATP|ATPase|14|3|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR
17138652|Immunohistochemical assays showed that in tumors from parental and CMV xenografts, estradiol decreased estrogen receptor-alpha expression and induced progesterone receptor expression and Akt phosphorylation, effects that were inhibited by tamoxifen, AG825, and R25C-Akt1 by 89, 82, and 77% for progesterone receptor expression and 48, 66, and 73% for pAkt expression, respectively.|AG825|progesterone receptor|34|47|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-AE3-240|EP(1)|14|1|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
15169831|These findings indicate that VTA GABA neurons are coupled electrically via gap junctions and that the inhibitory effect of ethanol on electrical transmission is primarily via inhibition of NMDA receptor-mediated excitation, not via enhancement of GABA receptor-mediated inhibition.|ethanol|GABA receptor|20|37|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
8799556|The quinazoline antagonists, prazosin, doxazosin and alfuzosin displayed high affinity but were non selective for the three cloned human alpha 1 adrenoceptors.|quinazoline|human alpha 1 adrenoceptors|2|21|Arg1:T29|Arg2:T52|CHEMICAL|GENE-N|DIRECT-REGULATOR
7929150|The two NH2-terminal truncated vectors deleted, respectively, 1) the 29-amino acid putative targeting sequence and 2) 51 amino acids, yielding a protein equivalent to a carbonic anhydrase (CA) V isolated from mouse liver mitochondria; and both vectors produced homogeneous protein fractions.|NH2|carbonic anhydrase (CA) V|3|31|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|PART-OF
17513393|Hepatic betaine-homocysteine methyltransferase (Bhmt), which catalyzes one of the two ways that homocysteine can be remethylated to methionine, was downregulated by Cu deficiency.|methionine|betaine-homocysteine methyltransferase|21|2|Arg1:T20|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF
23065141|However, exposure to 6OH-DCA and NOH-DCA reduces IL-2 secretion and NFAT activity but has no effect on calcium flux.|6OH-DCA|IL-2|5|9|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
20624440|  Rasagiline is a propargylamine and irreversible monoamine oxidase (MAO) B inhibitor used for the treatment of Parkinson's disease (PD).|propargylamine|monoamine oxidase (MAO) B|4|7|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
23292655|We show that UAAs inserted in the N-terminal domain of N-methyl-D-aspartate receptors (NMDARs) serve as photo-crosslinkers that lock the receptor in a discrete conformational state in response to UV photo treatment.|N|NMDARs|8|14|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF
15016471|GTK also catalyzes the transamination of cystathionine, lanthionine, and thialysine to the corresponding alpha-keto acids, which cyclize to ketimines.|alpha-keto acids|GTK|16|1|Arg1:T38|Arg2:T72|CHEMICAL|GENE-Y|PRODUCT-OF
2889803|Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolam.|triazolobenzodiazepines|Benzodiazepine receptor|5|1|Arg1:T19|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
9486667|Molecular determinants of dofetilide block of HERG K+ channels.|dofetilide|HERG|4|7|Arg1:T16|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
2248058|Here again moclobemide preferentially inhibited MAO-A; it was equipotent to clorgyline and brofaromine in these tests, and 2-4 times as potent as cimoxatone and harmaline.|clorgyline|MAO-A|12|6|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
18055877|Taken together, our data demonstrate that thioureylenes with a common, heterocyclic structure inhibit inflammation and immune function via the NF-kappaB pathway.|thioureylenes|NF-kappaB|8|22|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
23402371|This study demonstrates, for the first time, that inhibition of CDCF uptake in MDCKII-ABCC2 vesicles not only provides a screening assay to assess MRP2 drug-drug interaction potential, but is also predictive of human MRP2-mediated biliary excretion.|CDCF|MRP2|13|26|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE
18055877|Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.|Thionamides|nuclear factor-kappaB|1|6|Arg1:T14|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
20566645|Mutations in the Ca(2+) sensor, troponin C (TnC), were generated to increase/decrease the Ca(2+) sensitivity of cardiac skinned fibers to create the characteristic effects of DCM, HCM, and RCM.|Ca(2+)|TnC|4|13|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12974388|The AdoMetDC of the filarial parasite Onchocerca volvulus, however, is not only stimulated by putrescine but also by the naturally occuring polyamines spermidine and spermine.|polyamines|AdoMetDC|24|2|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|ACTIVATOR
12213053|The 4',7,8-trichloro analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).|mazindol|DAT|8|20|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23589499|Docking experiments for the most active compounds into the MAO-B and MAO-A binding pockets highlighted different interactions between the derivative classes (2-arylbenzofurans and 3-arylcoumarins), and provided new information about the enzyme-inhibitor interaction and the potential therapeutic application of these scaffolds.|2-arylbenzofurans|MAO-B|23|10|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|Δ(9)-tetrahydrocannabinol|CB(1)|34|29|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|AGONIST
23468189|Based on our previously published work on CXCR4 antagonists, we have synthesized a series of aryl sulfonamides that inhibit the CXCR4/CXCL12 interaction.|aryl sulfonamides|CXCL12|17|23|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
23073075|  Fingolimod (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (S1PR) subtypes.|Fingolimod|sphingosine-1-phosphate receptor|1|20|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR
11772142|  UNLABELLED: Rabeprazole is an inhibitor of the gastric proton pump.|Rabeprazole|gastric proton pump|3|9|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
23551329|Results of RT-PCR analysis showed decrease of p53 mRNA level and no significant difference in Bcl-2 and Bax mRNA expressions in DEX-treated rats.|DEX|p53|22|8|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
20497523|As seen in the AA model, the selective ERbeta agonist ERB-79 did not suppress inflammation.|ERB-79|ERbeta|12|10|Arg1:T7|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
23401472|Treatment with 5-aza-2'-deoxycytidine (5-Aza-dC), an inhibitor of DNA methylation, resulted in an increase of UGT1A1 mRNA expression in both cell types, but the increase was much larger in HK-2 cells than in HuH-7 cells.|5-aza-2'-deoxycytidine|UGT1A1|3|19|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11350858|The stimulation of AChE synthesis induced by CGRP was mimicked by direct activation of AC with 3 - 30 microM forskolin.|forskolin|AC|21|15|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR
12188035|The esterified-BM, however, had only partial transactivation agonistic activity in cells transfected with rat GR, whereas BM and esterified-DEX had full transactivation agonistic activity.|BM|rat GR|20|16|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR
17315258|  Mammalian mitochondrial dihydrolipoamide dehydrogenase (DLDH, EC 1.8.1.4) catalyzes NAD(+)-dependent oxidation of dihydrolipoamide in vivo and can also act as a diaphorase catalyzing in vitro nicotinamide adenine dinucleotide (reduced form) (NADH)-dependent reduction of electron-accepting molecules such as ubiquinone and nitroblue tetrazolium (NBT).|nitroblue tetrazolium|Mammalian mitochondrial dihydrolipoamide dehydrogenase|51|1|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
12409268|It is caused by a deficiency of propionyl-CoA carboxylase (PCC, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to D-methylmalonyl-CoA.|D-methylmalonyl-CoA|PCC|27|11|Arg1:T8|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|(+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride|beta(2)-adrenoceptor|48|74|Arg1:T12|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
10518812|The survey reveals that mometasone furoate, a new inhaled steroid with topical activity, has the greatest binding affinity for the glucocorticoid receptor, followed by fluticasone propionate, budesonide, triamcinolone acetonide, and dexamethasone.|budesonide|glucocorticoid receptor|31|23|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23435615|Additionally, there was a significant difference in plasma concentrations of (R)-5-hydroxyomeprazole among CYP2C19 genotype groups, whereas no significant differences were observed in that of (S)-5-hydroxyomeprazole.|(S)-5-hydroxyomeprazole|CYP2C19|30|17|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE
15563582|Indomethacin, sulindac sulfide, and zomepirac displaced [3H]PGD2 binding at the mouse CRTH2 receptor (mCRTH2) with comparable affinity (Ki = 1.5 +/- 0.1, 2.5 +/- 0.4, and 3.3 +/- 0.3 microM, respectively).|zomepirac|mouse CRTH2 receptor|7|16|Arg1:T28|Arg2:T46|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23619284|  Tandutinib is a novel inhibitor of tyrosine kinases FLT3, PDGFR and KIT.|Tandutinib|FLT3|1|9|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23294566|Androgen treatment also induced p300 and RNA Pol II recruitment to androgen receptor enhancers of AGR2 and initiated local chromatin remodelling and the formation of RNA Pol II-containing androgen receptor transcription complexes.|Androgen|RNA Pol II|1|26|Arg1:T13|Arg2:T37|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
15755648|Regioisomers having a 2,4-difluorophenyl substituent attached to the C-4 (COX-2 IC(50)=0.087microM; COX-2 S.I. >1149), or C-5 (COX-2 IC(50)=0.77microM, SI>130), position of 11 exhibited the most potent and selective COX-2 inhibitory activity relative to the reference drug celecoxib (COX-1 IC(50)=33.1microM; COX-2 IC(50)=0.07microM; COX-2 S.I.=472).|2,4-difluorophenyl|COX-2|4|11|Arg1:T26|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
23454208|Notably, the activated caspases that appeared with luteolin treatment cleaved Beclin-1, and the expression of LC3II remained the same even after cells were challenged with Beclin-1 siRNA, demonstrating that luteolin induces Beclin-1-independent autophagy.|luteolin|caspases|9|5|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR
23349208|Both fatty acids, but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)γ-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.|fatty acids|cytokine|2|22|Arg1:T12|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
17611697|Am-80, Tamibarotene, binds to retinoic acid receptor alpha (RARalpha) more specifically than all-trans retinoic acid.|Tamibarotene|retinoic acid receptor alpha|3|7|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|amino acids|ERG|10|21|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|PART-OF
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|penicillin|flanking conserved motifs|36|6|Arg1:T10|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
23059626|Our results showed that bone remodeling was significantly decreased in CCL3(-/-) and CCR1(-/-) mice and in animals treated with Met-RANTES (an antagonist of CCR5 and CCR1).|Met|CCR1|26|33|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|ANTAGONIST
15161930|Comparison of the ligand-bound LBDs of ERRgamma and ERalpha reveals small but significant differences in the architecture of the ligand binding pockets that result in a slightly shifted binding position of diethylstilbestrol and a small rotation of 4-hydroxytamoxifen in the cavity of ERRgamma relative to ERalpha.|diethylstilbestrol|ERRgamma|32|7|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11489456|In contrast, the hypophagic effect of d-fenfluramine and d-norfenfluramine was unaffected by prior treatment with the highly selective 5-HT2B receptor antagonists, SB-215505 (0.3-3 mg/kg) and RS-127445 (1-3 mg/kg) or the 5-HT2A receptor antagonists MDL 100,907 (0.003-0.03 mg/kg) and ketanserin (0.2, 0.5 mg/kg).|d-norfenfluramine|5-HT2A|10|37|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|AGONIST
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|pyruvate|Monocarboxylate transporters|20|1|Arg1:T6|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE
12142814|However, those for P4-H activity remained uniformly elevated after one hundred days on NTBC, the PIIINP biomarker even increasing above its grossly abnormal, initial level.|NTBC|P4-H|15|5|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|ACTIVATOR
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|MEK|3|15|Arg1:T12|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
12942109|  Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma.|acetylenic retinoid|retinoid receptors|4|18|Arg1:T6|Arg2:T12|CHEMICAL|GENE-N|DIRECT-REGULATOR
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|isocarboxazid|MAO-B|3|12|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|rosiglitazone|PPARgamma|3|26|Arg1:T4|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23247010|  Monomeric carbonyl reductase 1 (CBR1, SDR21C1) is a member of the short-chain dehydrogenase/reductase superfamily and is involved in the metabolism of anthracycline anti-cancer drugs, prostaglandins, and isatin, which is an endogenous inhibitor of monoamine oxidases.|anthracycline|dehydrogenase|25|16|Arg1:T3|Arg2:T36|CHEMICAL|GENE-N|SUBSTRATE
17253779|zRetSat A also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (vitamin A2), a second endogenous form of vitamin A in zebrafish.|all-trans-3,4-didehydroretinol|zRetSat A|12|1|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|PDGFR|3|23|Arg1:T12|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
15664409|As thiamine metabolism deficiencies have been seen in placental infarcts previously, these indicate that PP20/hTPK may have a role in placental diseases.|thiamine|hTPK|2|17|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
12660248|  In mammals, methionine adenosyltransferase (MAT), the enzyme responsible for S-adenosylmethionine (AdoMet) synthesis, is encoded by two genes, MAT1A and MAT2A.|S-adenosylmethionine|MAT|14|7|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF
11511086|The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel.|sertindole|human brain K(+) channel|4|11|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
10502685|EPR studies on the photo-induced intermediates of ferric NO complexes of rat neuronal nitric oxide synthase trapped at low temperature.|ferric NO|rat neuronal nitric oxide synthase|8|12|Arg1:T24|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23430162|CONCLUSIONS: The present study demonstrated that chronic treatment with ethanol enhanced the rewarding effects of morphine by up-regulating functional changes in μ-opioid receptor, mediated by GRK2.|ethanol|GRK2|11|28|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17545671|RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by rosiglitazone treatment of adipocytes.|rosiglitazone|cAspAT|25|6|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11520216|Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase.|Ellagitannins|squalene epoxidase|1|9|Arg1:T17|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23523101|HSYA was able to effectively inhibit oxidative stress mediated hepatic injury by increasing the activities of antioxidant enzymes, up regulating the expression of PPARγ and MMP-2, and down regulating the expression of TGF-β1 and TIMP-1, and reducing α-SMA level.|HSYA|TGF-β1|1|35|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16773504|Molecular genetic studies revealed a heterozygote missense mutation, MCCA-R385S, converting arginine to serine in a highly conserved region of the MCCA gene.|serine|MCCA|15|23|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|PART-OF
11511086|We conclude that erg3 can be blocked by certain antipsychotic drugs like sertindole and pimozide.|pimozide|erg3|15|4|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23229510|We identified one compound, E235 (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide), that activated the ISR and dose-dependently increased levels of ATF4 in transformed cells.|(N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide)|ATF4|7|36|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23261757|Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats.|gentamicin|hemopexin|17|7|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|Cl-|( Glu1]Pg|31|10|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
2907566|At 10(-7) M, labetalol, dilevalol, amosulalol and KF-4317 were beta 2-adrenoceptor antagonists as they inhibited the relaxant responses of rat aorta to procaterol.|labetalol|beta 2-adrenoceptor|8|16|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST
12646997|The inhibitory effects of icariin on PDE5 and PDE4 activities were investigated by the two-step radioisotope procedure with [(3)H]-cGMP/[(3)H]-cAMP.|[(3)H]-cGMP|PDE5|19|7|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11319222|  Inhibition by triacsins and troglitazone of long chain fatty acid incorporation into cellular lipids suggests the existence of inhibitor-sensitive and -resistant acyl-CoA synthetases (ACS, EC ) that are linked to specific metabolic pathways.|troglitazone|acyl-CoA synthetases|5|22|Arg1:T25|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
10933891|The induction in UCP-3 expression was not accompanied by changes in the mitochondrial membrane potential of rat primary preadipocytes after bezafibrate or Wy-14,643 treatment.|bezafibrate|UCP-3|21|4|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23537701|  Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family.|Tetrahydrocannabinol|CB2|1|31|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
10670413|It was concluded that PGE1 selectively reduces both N- and R-type Ca2+ currents by activating a G-protein probably through the EP3 receptor in paratracheal ganglion cells.|PGE1|G-protein|5|17|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|ACTIVATOR
17308037|Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.|8-methoxymethyl-3-isobutyl-1-methylxanthine|PDE1|5|3|Arg1:T23|Arg2:T57|CHEMICAL|GENE-N|INHIBITOR
10839333|A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.|quetiapine|dopamine D2 receptor|7|22|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2270485|Mutational analysis showed that a cluster of three residues (His18, His21, and Glu174) in hGH and His188 from the hPRLbp (conserved in all PRL receptors but not GH receptors) are probable Zn2+ ligands.|Zn2+|hPRLbp|38|24|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16292755|Hepatic ACAT activity was significantly lower in both vitamin E and probucol groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.|vitamin E|ACAT|9|2|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|ampicillin|PBP|24|19|Arg1:T24|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR
17273750|We also found that the cimetidine-mediated down-regulation of NCAM expression in HSG cells did not occur via blocking of the histamine receptor, even though H2R expression was observed on HSG cells, as two other H2R antagonists, famotidine and ranitidine, did not show similar effects.|famotidine|H2R|40|37|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST
6621777|From these results, it is proposed that tyrosine hydroxylase activity determines p-HPAA concentrations by regulating p-tyrosine availability.|p-tyrosine|tyrosine hydroxylase|17|9|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
23028140|In the beginning of imatinib treatment, the fractions of its hepatic clearance mediated by CYP2C8 and CYP3A4 were predicted to approximate 40 and 60%, respectively.|imatinib|CYP3A4|5|18|Arg1:T17|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
9836297|Mutation of Ser165 to alanine had no significant effect (less than 2-fold) on the affinity of any of the catecholamines for the alpha 2a-adrenoceptor, and in particular, the ratios of affinities between the corresponding (-)- and (+)-enantiomers of the catecholamines were not altered by the point mutation at Ser165.|alanine|alpha 2a-adrenoceptor|5|25|Arg1:T25|Arg2:T41|CHEMICAL|GENE-Y|PART-OF
23264615|Cortisol and IFNT stimulated endometrial HSD11B1 expression and activity, increased endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium.|Cortisol|HSD11B1|1|6|Arg1:T18|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
23146691|Emodin-6-O-β-D-glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo.|Emodin-6-O-β-D-glucoside|HMGB1|1|3|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
3917545|Most reducing cofactors for the peroxidase protect PHS and prostacyclin synthase from inactivation by hydroperoxides.|hydroperoxides|PHS|15|8|Arg1:T19|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR
15866500|These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5-fluoro-2'-deoxyuridine monophosphate (FdUMP).|5-fluoro-2'-deoxyuridine monophosphate|TS|25|18|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|carnitine octanoyltransferase|39|17|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
15106733|Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.|Salicylate|NF-kappaB|1|9|Arg1:T9|Arg2:T48|CHEMICAL|GENE-N|ACTIVATOR
2897127|All compounds inhibited histamine-stimulated adenylate cyclase and H+ secretion in a concentration-dependent manner.|histamine|adenylate cyclase|4|5|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
15736931|The kinetic parameters indicate that the main effect of the mutation of Arg228 to lysine is on the k(cat) of Glc-T, which increases 3-4-fold, both in the absence and in the presence of LA; simultaneously, the k(cat) for the Gal-T reaction is reduced 30-fold.|lysine|Glc-T|15|24|Arg1:T1|Arg2:T39|CHEMICAL|GENE-N|PART-OF
23229509|  Regulation of multiple adenylyl cyclases (AC) provides unique inputs to mediate the synthesis of cAMP, a ubiquitous second messenger that controls many aspects of cellular function.|cAMP|adenylyl cyclases|17|4|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|PRODUCT-OF
22818713|Based on our results, silibinin may attenuate the phenylephrine-induced hypertrophic response of H9c2 cells via antioxidant mechanisms involving mainly the inhibition of the intracellular signaling pathways mediated by ERK1/2 MAPKs and Akt.|phenylephrine|MAPKs|10|31|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR
23512537|Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes.|Beclomethasone Dipropionate|Cytochrome P450 3A|3|6|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
10874136|It is also converted to hydroquinone by the soluble two-electron reductase, DT-diaphorase, and is conjugated with GSH by glutathione S-transferase.|hydroquinone|DT-diaphorase|6|13|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|N|PDE5Delta1-465|17|46|Arg1:T18|Arg2:T56|CHEMICAL|GENE-Y|PART-OF
23122079|These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity.|phillyrin|LKB1|5|21|Arg1:T15|Arg2:T21|CHEMICAL|GENE-Y|ACTIVATOR
8344937|Thin sections of rabbit renal proximal tubules bound 125I-labeled uPA.PAI-1 and rRAP in the apical part of proximal tubules corresponding to the localization of gp330.|125I|PAI-1|9|12|Arg1:T5|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15240345|Mitochondria, which produce glyoxylate from hydroxyproline metabolism, contained both alanine:glyoxylate aminotransferase (AGT)2 and glyoxylate reductase activities, which can convert glyoxylate to glycine and glycolate, respectively.|glycine|alanine:glyoxylate aminotransferase (AGT)2|30|12|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
23063590|Furthermore, cAMP production and protein kinase A (PKA) activity were suppressed by artemisinic acid.|artemisinic acid|protein kinase A|16|6|Arg1:T13|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
23368743|These results underscore a role for TRPML1 in zinc metabolism.|zinc|TRPML1|9|7|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
17353078|CONCLUSIONS: Pre-treatment with fluvastatin suppresses the release of plasma TNF-alpha, increases plasma IL-10, and NO production, and decreases the levels of markers of organ injury associated with endotoxic shock, so ameliorating LPS-induced organ damage amongst conscious rats.|fluvastatin|TNF-alpha|5|11|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|norepinephrine|OAT3|11|22|Arg1:T20|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
23085435|Furthermore, N-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.|BPs|Bim|4|24|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
6687626|Here we report the amino acid sequence of the bovine oxytocin-neurophysin I (OT-NpI) precursor which was derived from sequence analysis of the cloned cDNA.|amino acid|bovine oxytocin-neurophysin I (OT-NpI) precursor|5|10|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|PART-OF
23466342|These results suggest that mollugin treatment enhanced suppression of P-gp expression by inhibiting the NF-κB signaling pathway and COX-2 expression, as well as attenuating CRE transcriptional activity through AMPK activation.|mollugin|AMPK|5|30|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
8836617|  We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.|(4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate)|histamine H1 receptor|53|77|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST
12177684|In vivo flibanserin binds equally to 5-HT(1A) and 5-HT(2A) receptors.|flibanserin|5-HT(1A)|3|7|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR
19663609|  Conivaptan, the first vasopressin receptor antagonist approved by the FDA, is available for the treatment of hyponatremia in euvolemic and hypervolemic patients.|Conivaptan|vasopressin receptor|1|5|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|ANTAGONIST
15740719|In contrast, the binding of barusiban was significantly improved when the transmembrane domains 1 and 2 were transferred from the oxytocin receptor to the vasopressin V2 receptor.|barusiban|vasopressin V2 receptor|7|26|Arg1:T11|Arg2:T46|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22552008|Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBN(YW/AA).|Lenalidomide|CRBN|1|7|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23273517|Docking of nilotinib and of analogues 2a-c to the binding pocket of Abl and of Kit showed that the lack of shape complementarity in Kit is compensated by the stabilizing effect from its juxtamembrane region.|nilotinib|Kit|3|16|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15123288|Herein we utilize a library of SRC2 peptidomimetics to select for specific inhibitors of the interaction of SRC2 with the two estrogen receptor (ER) isoforms, ERalpha and ERbeta, in the presence of three different ligands: 17beta-estradiol, diethylstilbesterol, and genistein.|genistein|ER|46|25|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
21262851|Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists.|dihydropyridine|L-VGCC|23|27|Arg1:T3|Arg2:T38|CHEMICAL|GENE-N|ANTAGONIST
23468426|To investigate this and solution-phase results with other tripeptides δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-Xaa, we have crystallised AhCV and δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-S-methylcysteine (AhCmC) with IPNS and solved crystal structures for the resulting complexes.|δ-(L-α-aminoadipoyl)-L-homocysteinyl-D-S-methylcysteine|IPNS|21|30|Arg1:T29|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|rizatriptan|human 5-HT1B|10|16|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1438284|The mutant W279A displayed strongly reduced inhibition by the peripheral site-specific ligand propidium relative to wild-type Torpedo AcChoEase, whereas inhibition by the catalytic-site inhibitor edrophonium was unaffected.|edrophonium|Torpedo AcChoEase|26|17|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
11980628|It is important to note that the inhibitory effect of SOM230 was relatively selective for GH and IGF-I in that insulin and glucagon secretion was inhibited only at higher doses of SOM230.|SOM230|IGF-I|11|18|Arg1:T15|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|polyamine|spermidine/spermine N(1)-acetyltransferase|2|12|Arg1:T21|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
23404443|Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of insulin (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).|glucose|insulin|85|73|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10460702|  Activation of endothelial nitric oxide synthase (eNOS) results in the production of nitric oxide (NO) that mediates the vasorelaxing properties of endothelial cells.|nitric oxide|endothelial nitric oxide synthase|15|3|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
23568856|DAT ligands have traditionally been divided into two categories: cocaine-like inhibitors and amphetamine-like substrates.|cocaine|DAT|11|1|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
11054378|RESULTS: NF-kappaB/Rel activity induced by tumor necrosis factor alpha, 12-O-tetradecanoylphorbol-13-acetate, or overexpression of NF-kappaB-inducing kinase, IKK-alpha, IKK-beta, or constitutively active IKK-alpha and IKK-beta mutants was inhibited dose dependently by sulfasalazine.|sulfasalazine|NF-kappaB-inducing kinase|36|17|Arg1:T17|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
23623838|Adult NIC offspring showed more intense NPY staining in the paraventricular nucleus (PVN) (+21%) and increased number of POMC-positive cells in the: arcuate nucleus (+33%), as an increase in fiber density of α-MSH in PVN (+85%).|NIC|α-MSH|2|43|Arg1:T7|Arg2:T9|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15736931|Comparison of the crystal structures of UDP-Gal- and UDP-Glc-bound beta4Gal-T1 reveals that the O4 hydroxyl group in both Gal and Glc moieties forms a hydrogen bond with the side chain carboxylate group of Glu317.|carboxylate|beta4Gal-T1|31|10|Arg1:T25|Arg2:T50|CHEMICAL|GENE-Y|PART-OF
16609060|For some, pharmacologic inhibitors are available, including sorafenib for BRAF, farnesyltransferase inhibitors for NRAS, PD-0325901 for mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, rapamycin analogues for mammalian target of rapamycin, and agents that inhibit either vascular endothelial growth factor or its receptors.|sorafenib|BRAF|10|12|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23547652|Subsequent optimization led to several novel 3HPT-based HDACi that are selective for HDAC 6 and HDAC 8.|3HPT|HDAC 6|7|13|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
11237340|Both the spectrophotometric and the radiometric methods are based on the conversion of 5-methyltetrahydrofolate to tetrahydrofolate by methionine synthase.|tetrahydrofolate|methionine synthase|16|18|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF
15982930|Thalidomide reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60.|Thalidomide|VEGF|1|15|Arg1:T11|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23248236|Ebselen [2-phenyl-1,2 benzisoselenazol-3(2H)-one], a well-known antioxidant and a substrate for mammalian TrxR and Trx, is rapidly bacteriocidal for methicillin-resistant Staphylococcus aureus by an unknown mechanism.|Ebselen|mammalian TrxR|1|18|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
14737100|Increased phosphorylation of p95ErbB2 and AKT in response to HRG was abrogated to varying degrees by GW572016.|GW572016|p95ErbB2|17|4|Arg1:T1|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
11350858|To assess the effect of CGRP on AChE synthesis, myotubes were pre-exposed to the irreversible AChE inhibitor diisopropyl fluorophosphate (DFP) and treated with CGRP or forskolin, an adenylyl cyclase (AC) activator.|diisopropyl fluorophosphate|AChE|19|17|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
15814851|  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P450 enzyme complex called aromatase.|estrogen|aromatase|7|20|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
23554428|The present study characterized the kinetics of the separate R- and S- enantiomers of lorazepam by human liver microsomes (HLM) and by a panel of recombinant human UDP-glucuronosyltransferase (UGT) enzymes.|lorazepam|UGT|15|32|Arg1:T16|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
14654525|SU11248 is an oral multitargeted kinase inhibitor with selectivity for fms-related tyrosine kinase 3/Flk2 (FLT3), platelet-derived growth factor receptor alpha/beta, vascular endothelial growth factor receptor 1/2, and KIT receptor tyrosine kinases.|SU11248|kinase|1|6|Arg1:T1|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
23142558|The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.|17-β-oestradiol|cannabinoid CB2 receptor|2|9|Arg1:T5|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15942707|Treatment with carvedilol is associated with a reversal of abnormal regulation of HIF-1alpha, VEGF, BNP, and NGF-beta in the hypertrophic myocardium.|carvedilol|BNP|3|17|Arg1:T8|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|GDP|AdSS|31|4|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF
17979301|  The molecular bases for phosphodiesterase 5 (PDE5) catalytic-site affinity for cyclic guanosine monophosphate (cGMP) and potency of inhibitors are poorly understood.|cGMP|phosphodiesterase 5|17|5|Arg1:T3|Arg2:T52|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12646997|The potencies of selectivity of icariin and papaverine on PDE5 (PDE4/PDE5 of IC(50)) were 167.67 times and 4.54 times, respectively.|icariin|PDE5|6|10|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
15261283|Two compounds with benztriazole group had a 5-HT(2A)/D(2) binding ratio characteristic for atypical neuroleptics (>1, pK(i) values).|benztriazole|D(2)|4|13|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
6703688|Alanine:glyoxylate aminotransferase (AGT) in the liver catalyzes most of the glyoxylate transamination in mammalian tissues (E.|glyoxylate|Alanine:glyoxylate aminotransferase|15|1|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|SUBSTRATE
16319075|Because ASIC1b and -3 subunits are mainly expressed in peripheral neurons, our data identified ASIC1a-containing Ca2+-permeable ASIC as a novel central target of Pb2+ action, which may contribute to Pb2+ neurotoxicity.|Ca2+|ASIC1a|17|16|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23587660|Therefore, Korean pear juice may alleviate alcohol-hangover and its detoxification of alcohol seems to be modified by the genetic variation of ALDH2.|alcohol|ALDH2|13|23|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE
10658902|Loffler, Species-related inhibition of human and rat dihyroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives, Biochem.|isoxazol|human and rat dihyroorotate dehydrogenase|13|6|Arg1:T16|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
21631396|NFAT cooperates with c-Jun, a compound of the AP-1 complex, to activate target genes, and we also found that PSE inhibited both JNK activation and AP-1 transcriptional activity.|PSE|JNK|23|26|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
15219414|Inhibition was not overcome by increased cortisol concentration, and no inhibition by oxandrolone was observed in cells expressing GR alone, confirming that non-competitive mechanisms were involved.|cortisol|GR|7|20|Arg1:T16|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR
8263811|Affinities for the major nonadrenergic [125I]PIC binding site were highly comparable to human subtype-I1 imidazol(in)e receptor sites in the brain stem (rank order: moxonidine > clonidine > cirazoline > IDX > amiloride).|IDX|human subtype-I1 imidazol(in)e receptor|39|16|Arg1:T7|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|Rilpivirine|hPXR|1|19|Arg1:T10|Arg2:T47|CHEMICAL|GENE-Y|AGONIST
23528299|As a potent synthetic APN inhibitor (IC50=850nM, versus bestatin of 8.1μM), LB-4b was determined to have more significant block effects to cancer cell invasion and angiogenesis than bestatin.|LB-4b|APN|16|5|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
16735460|In [14C]succinate uptake and TEVC experiments performed simultaneously on the same oocytes, uptake was similar to or higher than WT, whereas succinate-induced currents were either comparable (K114R) to, or considerably smaller (K114E, K114I, K114Q) than, those evoked by WT.|[14C]succinate|K114E|2|41|Arg1:T6|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE
23423713|Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h.|TCDD|Cyp1a2|18|24|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15128769|DBA/2J-mated CBA/J female mice were randomized in three groups: 1) control females, 2) mice exposed to stress on gestation day 5.5, and 3) mice exposed to stress and substituted with dydrogesterone, a progestogen with a binding profile highly selective for the progesterone receptor on gestation day 5.5. On gestation days 7.5, 9.5, and 10.5, mice of each group were sacrificed, and the frequency of CD8(+) cells and cytokine expression (IL-4, IL-12, TNF-alpha, IFN-gamma) in blood and uterus cells was evaluated by flow cytometry.|dydrogesterone|progesterone receptor|37|49|Arg1:T8|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23371965|  Phenethylisothiocyanate (PEITC), a naturally occurring isothiocyanate and potent cancer chemopreventive agent, works by multiple mechanisms, including the inhibition of cytochrome P450 (P450) enzymes, such as CYP2E1, that are involved in the bioactivation of carcinogens.|isothiocyanate|CYP2E1|9|34|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H1R|1|14|Arg1:T1|Arg2:T57|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12411515|In conclusion, halothane, isoflurane and sevoflurane inhibit complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain.|sevoflurane|complex I|8|10|Arg1:T11|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR
17263187|Prescription medications targeting chronic constipation currently include polyethylene glycol, lactulose and tegaserod, a serotonin type 4 receptor partial agonist.|tegaserod|serotonin type 4 receptor|13|16|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|AGONIST
23307549|Ruxolitinib is a small-molecule inhibitor of JAK1 and JAK2 and recently became the first drug approved by the United States Food and Drug Administration for the treatment of symptomatic intermediate- or high-risk myelofibrosis.|Ruxolitinib|JAK1|1|7|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|cerivastatin|HMG-CoA reductase|10|26|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
16540317|Human methionine aminopeptidase type 2 in complex with L- and D-methionine.|L- and D-methionine|Human methionine aminopeptidase type 2|9|1|Arg1:T5|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15456329|This has been attributed mainly to the non-acidic chemical properties of nabumetone but also to its COX-1/COX-2 inhibitor profile.|nabumetone|COX-1|12|17|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
18061638|Dienogest activate PR (EC50=3.4 or 10.5 nmol/l) with antagonistic activity on AR (EC50=420.6 or 775.0 nmol/l) but not agonistic nor antagonistic action on GR, MR (3000 nmol/l).|Dienogest|AR|1|14|Arg1:T17|Arg2:T48|CHEMICAL|GENE-Y|ANTAGONIST
9406449|Molecular weight and isoelectric point of both purified enzymes were determined to be 60 KDa and pH 4, while optimum temperature and pH to yield the maximal activity were about 37 degrees C and pH 8.5. Metallic ions, NaCl and protamine sulfate reduced, and heparin increased, both LPL activities.|sulfate|LPL|45|53|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR
8986981|Activation of alpha 1-adrenoceptors was documented by observing dose-dependent increases in mesenteric perfusion pressure after intramesenteric arterial injection of methoxamine; alpha 2-adrenoceptor activity was confirmed by finding similar increases in mesenteric perfusion pressure after intramesenteric arterial injections of BHT 933.|BHT 933|alpha 2-adrenoceptor|40|22|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|ACTIVATOR
16547010|HQL-79 selectively inhibited PGD2 production by H-PGDS-expressing human megakaryocytes and rat mastocytoma cells with an IC50 value of about 100 microm but only marginally affected the production of other prostanoids, suggesting the tight functional engagement between H-PGDS and cyclooxygenase.|HQL-79|H-PGDS|1|7|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
10907719|  UNLABELLED: Apparent muscarinic acetylcholine (mAch) receptor occupancy in mouse cerebral cortex, hippocampus, and striatum by scopolamine, an antagonist, and biperiden, a relatively selective M1 antagonist, was estimated with competitive binding studies using two different radioligands: 3H-N-methyl piperidyl benzilate (3H-NMPB) and 3H-quinuclidinyl benzilate (3H-QNB).|scopolamine|muscarinic acetylcholine (mAch) receptor|21|4|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|ANTAGONIST
23295229|As the Mg(2+) ion concentration was increased, there was a consistent decrease of the enzyme catalytic turnover from 0.31 s(-1) (0 μM Mg(2+)) to 0.050 s(-1) (6000 μM Mg(2+)) and a distinct shift in steady-state conformational population from one that favors the ALDH1-NADH complex with the shorter fluorescence lifetime (33% excess) in the absence of magnesium ion to one that favors the ALDH1-NADH complex with the longer fluorescence lifetime (13% excess) at 6000 μM Mg(2+).|NADH|ALDH1|64|63|Arg1:T11|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10530931|Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.|2-carbonyl|muscarinic receptor|11|6|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|ANTAGONIST
1438284|Modeling showed that two such residues, Phe-288 and Phe-290, replaced by leucine and valine, respectively, in BtChoEase, may prevent entrance of butyrylcholine into the acyl-binding pocket.|Phe|BtChoEase|10|21|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
23277230|Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.|Fisetin|IL-1β|1|28|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12646997|The inhibitory effects of icariin on PDE5 and PDE4 activities were investigated by the two-step radioisotope procedure with [(3)H]-cGMP/[(3)H]-cAMP.|[(3)H]-cAMP|PDE4|26|9|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|DIRECT-REGULATOR
10697523|Thymidylate synthase is inhibited by 5-fluorodeoxyuridine monophosphate, forming an inactive ternary complex with intracellular folate.|5-fluorodeoxyuridine monophosphate|Thymidylate synthase|6|1|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
16855072|  Sitagliptin (MK-0431) is an oral, potent, and selective dipeptidyl peptidase-IV (DPP-4) inhibitor developed for the treatment of type 2 diabetes.|Sitagliptin|dipeptidyl peptidase-IV|1|13|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23291050|The present investigation was undertaken to explore the in vivo inhibition of the freshwater gastropod snail Planorbarius corneus cholinesterase (ChE) and carboxylesterases (CES) activities by the organophosphorus pesticides azinphos-methyl (AZM) and chlorpyrifos (CPF).|organophosphorus|Planorbarius corneus cholinesterase|31|17|Arg1:T10|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
7678677|Alprenolol and BAAM also caused surmountable antagonism of isoprenaline responses, and this beta 1-adrenoceptor antagonism was slowly reversible.|Alprenolol|beta 1-adrenoceptor|1|14|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ANTAGONIST
17006762|The distribution of LDH isozymes in primary cultures of cortical neurons does not directly reflect the kinetics of LDH and the capacity for lactate oxidation.|lactate|LDH|24|19|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE_PRODUCT-OF
23512787|Taken together, our data demonstrate that puerarin attenuates MPTP-induced dopaminergic neuronal degeneration via modulating GDNF expression, PI3K/Akt pathway and GSH activation, which subsequently ameliorate MPTP-induced ROS formation and decrease of Lamp 2A expression.|MPTP|Lamp 2A|28|34|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
7909690|Atovaquone, a naphthoquinone, is a moderate inhibitor of dihydroorotate dehydrogenase in vitro (Ki = 27 microM) but induces major accumulations of CA-asp and DHO.|naphthoquinone|dihydroorotate dehydrogenase|4|11|Arg1:T33|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
12388412|These findings suggest that RhBG and RhCG may play important and cell-specific roles in ammonium transport and signaling in these regions of the kidney.|ammonium|RhBG|15|5|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
18996527|Nicotinic acid (NA), a widely used drug to lower elevated plasma lipid levels, induced NNMT enzyme activity in white adipose tissue of mice.|Nicotinic acid|NNMT|1|19|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
22982445|These results suggest that LTD4 increases Aβ peptide burden via activation of CysLT(1)R, which further affects APP levels and activity of β- and γ-secretases via the NF-κB pathway.|LTD4|CysLT(1)R|5|13|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|ACTIVATOR
16533791|YM-359445 had greater antitumor activity than other VEGFR2 tyrosine kinase inhibitors.|YM-359445|tyrosine kinase|1|9|Arg1:T3|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|dofetilide|IKr|26|2|Arg1:T9|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|LU 43839|MAO-A|78|76|Arg1:T19|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
23353901|Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.|mCPP|5-HT2C|14|2|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|AGONIST
11331292|We now report the identification of two phenylalanine residues in transmembrane domain 7 of the alpha(1a)-adrenergic receptor (Phe-312 and Phe-308) that are a major site of antagonist affinity.|Phe|alpha(1a)-adrenergic receptor|23|16|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|PART-OF
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|ESI-09|Rap1|23|40|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23305444|Discovery and evaluation of novel inhibitors of mycobacterium protein tyrosine phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid scaffold.|6-Hydroxy-benzofuran-5-carboxylic acid|mycobacterium protein tyrosine phosphatase B|15|8|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
11455568|The effects of Cox inhibition were not rate limiting, based on experiments in which PLA(2) was activated with melittin or inhibited with quinacrine.|quinacrine|PLA(2)|27|16|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
16543605|The cytochrome P450 enzyme, CYP51, catalyzes an essential early step in sterol metabolism, removing a methyl group from lanosterol in animals and fungi, or from obtusifoliol in plants.|sterol|cytochrome P450|14|2|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|malonyl-CoA|FAS|13|5|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
15133083|SL-11158 inhibited SSAT activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine.|spermine|SSAT|28|3|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|DIRECT-REGULATOR
16757355|Thus, sorafenib may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling).|sorafenib|Raf|3|23|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|TGF-β1|1|22|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1472079|Cadmium did not increase the breakdown of UDPGA by microsomal UDPGA pyrophosphatase but strongly decreased (30-66%) the synthesis of the cofactor in the cytosol by inhibiting UDP-glucose dehydrogenase (UDPGDH).|UDPGA|pyrophosphatase|8|12|Arg1:T1|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
21600945|The increasing effect of TPM on O(2)((-)) level was not significantly affected by the B1R antagonist SSR240612.|SSR240612|B1R|25|23|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|ANTAGONIST
23019138|In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)].|capsazepine|vanilloid receptor type I|49|44|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
12650833|On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block PP1, and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception.|cantharidin|PP1|19|31|Arg1:T19|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
23000442|In the present study, a cocktail probe assay was performed for determination of the selective inhibitory effect of mollugin on cytochrome P450 (CYP) enzymes in human liver microsomes (HLM).|mollugin|cytochrome P450|20|22|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR
23157629|  The serotonin (5-HT) receptors of type 6 (5-HT6) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long C-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.|C|serotonin (5-HT) receptors|33|2|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF
7853212|The Ki values of these antagonists for the catalytic activity of P450 2D1 were low and were similar to those of quinine and quinidine, which are specific inhibitors of P450 2D forms.|quinidine|P450 2D|24|31|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
23432061|The functional significance of cardiac TRP channels is likely connected to the alteration of membrane potential or Ca2+ entry into a noncontractile compartment, where gene expression responsible for various cardiac diseases is induced.|Ca2+|TRP channels|18|6|Arg1:T2|Arg2:T3|CHEMICAL|GENE-N|SUBSTRATE
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|GW1843|TS|44|42|Arg1:T26|Arg2:T52|CHEMICAL|GENE-Y|INHIBITOR
10027835|Drugs inhibiting both MAO-A and MAO-B to a similar extent (tranylcypromine) or combinations of selective MAO-A and MAO-B inhibitors (esuprone plus LU 53439) had no advantage over MAO-A inhibition alone, but were less well tolerated.|esuprone|MAO-B|23|20|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
12535612|GAD67 exhibits a higher binding constant for PLP binding, making it more difficult to dissociate PLP from holoGAD67 than holoGAD65.|PLP|holoGAD65|17|21|Arg1:T10|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17869551|  Nitric oxide (NO) is an important vasorelaxant produced along with L-citrulline from L-arginine in a reaction catalyzed by endothelial nitric oxide synthase (eNOS).|L-arginine|endothelial nitric oxide synthase|15|21|Arg1:T29|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
9710435|Based on these results, we conclude that the NSAIDs ibuprofen and salicylic acid inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR Cl- channels as well as basolateral membrane K+ channels.|salicylic acid|CFTR|13|30|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|SLC12A1|20|3|Arg1:T10|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
23116643|Furthermore, RA significantly inhibited the CCl(4)-induced apoptosis, which was evident from decreased cleavage of caspase-3.|CCl(4)|caspase-3|7|21|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
21600945|Stimulation of B1R with a selective agonist (des-Arg(9)-BK, 10 muM; 30 min) increased O(2)((-))production which was prevented by apocynin and diphenyleneiodonium (NADPH oxidase inhibitors).|des-Arg(9)-BK|B1R|9|3|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|AGONIST
10207608|Likewise, IL-2 steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM AACOCF3.|BPB|IL-2|25|3|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23462886|In this phase IIb clinical trial, 258 patients with type 2 diabetes completed a 12-week protocol with 50, 100, or 150 mg of MSDC-0160 (an mTOT modulator), 45 mg pioglitazone HCl (a PPAR-γ agonist), or a placebo.|pioglitazone HCl|PPAR-γ|36|40|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|AGONIST
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|terlipressin|V(1a)|41|43|Arg1:T14|Arg2:T51|CHEMICAL|GENE-Y|AGONIST
15072849|Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro.|Imiquimod|Toll-like receptor-7|1|4|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|AGONIST
23261715|In this study, we found that the reductase activity of AKR1B19 was activated to about 5-fold immediately after the addition of 10 μM SH-reagents (p-chloromercuriphenylsulfonic acid and p-chloromercuribenzoic acid) in the absence or presence of NADPH.|p-chloromercuribenzoic acid|AKR1B19|30|12|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR
19344392|Sirolimus and second-generation mTOR inhibitors, such as temsirolimus and everolimus, are safe and relatively well-tolerated, making them potentially attractive as single agents or in combination with conventional cytotoxics and other targeted therapies.|everolimus|mTOR|11|4|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|TK|4|16|Arg1:T3|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
12970106|Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.|dihydroergotamine|5-HT2C|4|8|Arg1:T26|Arg2:T45|CHEMICAL|GENE-Y|AGONIST
23449197|  7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-β (TGF-β) type I receptor (also known as activin receptor-like kinase 5 or ALK5) inhibitor.|TASP0382088|ALK5|12|37|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23621381|In rather short-term clinical trials with well-selected diabetic patients, no increased risk of acute pancreatitis has been observed with any of the five commercialized DPP-4 inhibitors: sitagliptin, vildagliptin, saxagliptin, alogliptin, and linagliptin.|alogliptin|DPP-4|35|26|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
17034761|Our results demonstrated that auranofin suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of COX-2, a pro-inflammatory enzyme.|auranofin|NF-kappaB|5|13|Arg1:T8|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
12181427|  To identify amino acid residues involved in PDE3-selective inhibitor binding, we selected eight presumed interacting residues in the substrate-binding pocket of PDE3A using a model created on basis of homology to the PDE4B crystal structure.|amino acid|PDE3A|3|23|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|PART-OF
8161345|At doses of 20 micrograms/kg, however, 5-ethynyl-2-pyrimidinone and 5-ethynyluracil produced equivalent inactivation of DPD.|5-ethynyluracil|DPD|11|16|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
15695169|The affinity of ramelteon for hamster brain MT3 binding sites was extremely weak (Ki: 2.65 microM) compared to melatonin's affinity for the MT3 binding site (Ki: 24.1 nM).|ramelteon|MT3|4|27|Arg1:T14|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
23289710|Incubation of in vitro transcribed tRNA[Ser]Sec with recombinant Trit1 transfers [(14)C]dimethylallyl pyrophosphate to tRNA([Ser]Sec).|[(14)C]dimethylallyl pyrophosphate|Trit1|15|13|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23602989|The selective CaMKIIα inhibitor KN-62 reversed the blockade produced by ionomycin and K(+)-depolarization.|KN-62|CaMKIIα|5|3|Arg1:T22|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR
23318726|Treatment of HDP cells with a c-Jun NH2-terminal kinase (JNK) inhibitor also reduced butein-induced HO-1 expression, and butein treatment led to increased JNK phosphorylation.|butein|JNK|21|26|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR
16843091|However, several promising nonpeptide, vasopressin receptor antagonists have been described; these agents are VPA-985 (lixivaptan), YM-087 (conivaptan), OPC-41061 (tolvaptan), and SR-121463.|VPA-985|vasopressin receptor|17|7|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|ANTAGONIST
15102890|Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide.|glyburide|SR-BI|14|3|Arg1:T13|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23482500|Results suggest that sorafenib uptake in human hepatocytes occurs via passive diffusion, and by OCT1 and a rifamycin-sensitive transporter.|sorafenib|OCT1|4|16|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
11056242|RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on MCP-1 expression.|danazol|MCP-1|26|71|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
10464780|The rate-limiting step of the BH4 synthesis is catalyzed by GTP cyclohydrolase I (GCH).|BH4|GTP cyclohydrolase I|6|11|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|arginine|Argininosuccinate synthetase|24|1|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF
15236843|  To determine the role played by Tyr(356 (7.43)) in the rat beta(1)-adrenoceptor in binding the antagonists (+/-)cyanopindolol (4-[3-(t-butylamino]-3-(2'-cyano-indoloxy)-2-propanolol) and its iodinated analogue (+/-)[(125)Iodo]cyanopindolol (1-(t-butylamino]-3-(2'-cyano-3'-iodo-indoloxy)-2-propanolol), Tyr(356 (7.43)) was mutated to either Phe or Ala and binding affinities determined for wild type and mutant rat beta(1)-adrenoceptors.|(+/-)[(125)Iodo]cyanopindolol|rat beta(1)-adrenoceptor|47|16|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17069932|This finding indicates that GAT-1 is an important GABA transporter in white matter and suggests that white matter GABA uptake is inhibited during tiagabine therapy.|GABA|GABA transporter|19|9|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE
23394218|Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.|AZD5363|kinases|24|35|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
19119014|Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with chlorthalidone, trichloromethiazide, and furosemide being efficient inhibitors against CA II (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).|trichloromethiazide|CA II|22|30|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
10932681|Orlistat inhibits pancreatic lipase and can block 30% of triglyceride hydrolysis in subjects eating a 30% fat diet.|Orlistat|pancreatic lipase|1|3|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
10823899|With this mechanism of regulation, acute application of AMPH would reduce DA uptake not only by direct competition for uptake, but also by reducing the available cell-surface DAT.|DA|DAT|13|30|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
23598363|While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, imatinib inhibited the cisplatin-induced nuclear accumulation of c-Abl/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.|cisplatin|c-Abl|24|28|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23536517|Pancreatic tissues of rats and blood samples were obtained.Tau treatment significantly decreased serum amylase activity (p < 0.001), total injury score (p < 0.001), malondialdehyde levels (p < 0.001) and myeloperoxidase (MPO) activity (p < 0.001).|Tau|serum amylase|11|13|Arg1:T6|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
7518029|In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).|haloperidol|prolactin|5|26|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kuraridin|DGAT|14|52|Arg1:T11|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|nipecotic acid|GAT2|10|21|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
24365491|It lowered the production of tumour necrosis factor-alpha (TNF-alpha) in the beginning of acute liver failure induced by D-GalN/LPS.|D-GalN|TNF-alpha|21|10|Arg1:T1|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|5alpha-DHP|3alpha-HSDs|6|22|Arg1:T14|Arg2:T46|CHEMICAL|GENE-N|SUBSTRATE
23432582|However, the involvement of the caspase-dependent pathway in the process of cell death induced by either BSC 3g or 3n is discarded since cell death could not be prevented by pretreatment with the pancaspase inhibitor z-VAD-fmk.|z-VAD-fmk|caspase|37|36|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
23397055|Adenosine and N(6)-cyclopentyl-adenosine (CPA, A1R agonist) constricted MVs but not MAs. Adenosine and CPA (0.001-10 µM) inhibited neurogenic constrictions and NE release in MAs and MVs. DOCA-salt arteries were resistant to adenosine and CPA-mediated inhibition of NE release and constriction.|N(6)-cyclopentyl-adenosine|A1R|3|11|Arg1:T24|Arg2:T27|CHEMICAL|GENE-Y|AGONIST
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|38|18|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12170055|CONCLUSION: Meperidine is a potent agonist at the alpha2 adrenoceptors at its clinically relevant concentrations, especially at the alpha(2B)-adrenoceptor subtype.|Meperidine|alpha2 adrenoceptors|3|10|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|AGONIST
10735801|Inhibition of epsilon1/zeta1, epsilon2/zeta1, epsilon3/zeta1, and epsilon4/zeta1 channels by meperidine was dependent on pH, with more inhibition at acidic pH and less inhibition at alkaline pH.|meperidine|epsilon3/zeta1|13|7|Arg1:T10|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
23219337|Wogonin had no effect on VEGF-C production in LM8 cells, or VEGFR-3 expression in human lymphatic endothelial cells (HLECs), however, it inhibited VEGF-C-induced VEGFR-3 phosphorylation in HLECs. The anti-tumor and anti-metastatic actions of wogonin may be associated with the inhibition of VEGF-C-induced lymphangiogenesis through a reduction in VEGF-C-induced VEGFR-3 phosphorylation by the inhibition of COX-2 expression and IL-1β production in TAMs.|wogonin|VEGFR-3|40|55|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
17979301|Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.|amino acids|phosphodiesterase-5|2|5|Arg1:T42|Arg2:T60|CHEMICAL|GENE-Y|PART-OF
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|L-Arg|inducible nitric oxide synthase|24|2|Arg1:T9|Arg2:T58|CHEMICAL|GENE-Y|SUBSTRATE
1647395|  Estramustine is a novel anti-microtubule drug shown to bind MAP-1 and MAP-2 (microtubule-associated proteins) in vitro.|Estramustine|MAP-2|1|12|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23122079|Phillyrin strongly inhibited high glucose-induced fatty acid synthase (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation.|Phillyrin|FAS|1|10|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|penicillin|PBP|22|19|Arg1:T22|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR
17223000|Pranlukast hydrate (ONO-1078, 100 microM) downregulated the leukotriene D(4)-induced MUC2/5AC gene expression and mucin secretion.|leukotriene D(4)|mucin|11|21|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17603555|  BACKGROUND AND PURPOSE: AMP-activated protein kinase (AMPK) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).|phenformin|AMP-activated protein kinase|16|5|Arg1:T42|Arg2:T55|CHEMICAL|GENE-Y|ACTIVATOR
23132743|The VDR also has immunomodulatory actions that are dependent on its ligand, 1,25-dihydroxyvitamin D.|1,25-dihydroxyvitamin D|VDR|14|2|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFU|COX-2|5|18|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23219337|Wogonin had no effect on VEGF-C production in LM8 cells, or VEGFR-3 expression in human lymphatic endothelial cells (HLECs), however, it inhibited VEGF-C-induced VEGFR-3 phosphorylation in HLECs. The anti-tumor and anti-metastatic actions of wogonin may be associated with the inhibition of VEGF-C-induced lymphangiogenesis through a reduction in VEGF-C-induced VEGFR-3 phosphorylation by the inhibition of COX-2 expression and IL-1β production in TAMs.|Wogonin|VEGFR-3|1|29|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
12110374|It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate.|indomethacin|COX|14|10|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR
23430162|CONCLUSIONS: The present study demonstrated that chronic treatment with ethanol enhanced the rewarding effects of morphine by up-regulating functional changes in μ-opioid receptor, mediated by GRK2.|morphine|GRK2|17|28|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8161345|5-Ethynyl-2(1H)-pyrimidinone was rapidly oxidized to 5-ethynyluracil by aldehyde oxidase.|5-ethynyluracil|aldehyde oxidase|10|12|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
17258485|Phorbol 12-myristate 13 acetate (PMA), the phorbol ester activator of protein kinase C, caused a 37% decrease in the I(SC) response to ASC.|phorbol ester|protein kinase C|10|14|Arg1:T8|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR
23200255|N-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition.|pyridazinone|PDE3|4|13|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR
23063590|The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by artemisinic acid treatment.|artemisinic acid|TRP-2|29|25|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|FAD synthetase|28|43|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
23281044|We identified benzo[e]pyridoindoles (BePI) as powerful aurora kinase inhibitors.|BePI|aurora kinase|9|13|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
15287725|Using site-directed mutagenesis, we have identified the strong lysine-binding site present within apo(a) kringle IV type 10 as an important site within the C-terminal half of the molecule, which is involved in maintaining the closed conformation of apo(a).|lysine|apo(a) kringle IV type 10|10|14|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|PART-OF
23354070|Moreover, molecular dynamics simulations have identified an allosteric mechanism by which binding of palinurin leads to GSK-3β inhibition.|palinurin|GSK-3β|15|18|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23288051|Mechanistic studies reveal that the NOGEL is dependent upon repair of O(6)-methylguanine (O(6)MeG) by the suicide enzyme O(6)MeG-DNA methyltransferase (MGMT).|O(6)MeG|MGMT|18|35|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
17604186|Compared with normal control group, PTZ-kindled mice had significantly higher levels of malondialdehyde, nitrite, myeloperoxidase but had lower levels of reduced glutathione in the whole brain homogenate.|PTZ|myeloperoxidase|7|18|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23604717|We found that SAL-2 inhibited HNE-mediated IKK phosphorylation, IκBα degradation and nuclear translocation of p65 which are linked to NF-κB activation.|HNE|IKK|6|7|Arg1:T19|Arg2:T34|CHEMICAL|GENE-N|ACTIVATOR
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|Nexavar|RAF|6|14|Arg1:T13|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|barusiban|oxytocin receptor|11|16|Arg1:T28|Arg2:T58|CHEMICAL|GENE-Y|ANTAGONIST
15037867|Another 5-HT(2A) receptor polymorphism consists of the silent thymidine-cytosine substitution (102T>C), which has been controversially associated with schizophrenia.|cytosine|5-HT(2A)|13|2|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|PART-OF
12183691|We previously found a single amino acid change in OCTN2, Ser467Cys (S467C), in the Japanese population and observed a decreased carnitine transport but unchanged organic cation transport compared with wild type.|carnitine|OCTN2|25|10|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|cGMP|F786A|5|21|Arg1:T14|Arg2:T47|CHEMICAL|GENE-N|DIRECT-REGULATOR
22951949|The mechanism of DEDTC-induced apoptosis in neuronal model cells is thought to occur through the death receptor signaling triggered by DEDTC-copper complex in low concentration that is associated with the activation of caspase 8.|DEDTC-copper|caspase 8|21|33|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|dienestrol|estrogen receptor|13|42|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11319222|These results, together with previous data showing that triacsin C and troglitazone strongly inhibit triacylglycerol synthesis compared with other metabolic pathways, suggest that ACS1 and ACS4 catalyze the synthesis of acyl-CoAs used for triacylglycerol synthesis and that lack of inhibition of a metabolic pathway by triacsin C does not prove lack of acyl-CoA involvement.|triacylglycerol|ACS1|36|26|Arg1:T21|Arg2:T50|CHEMICAL|GENE-Y|PRODUCT-OF
23605695|  Pasireotide (Signifor(®)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of corticotropin from the pituitary adenoma in patients with Cushing's disease.|Pasireotide|corticotropin|1|24|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23164673|Furthermore, we validated the inhibition of GSK-3β/NF-κB signaling following cinobufagin treatment.|cinobufagin|NF-κB|11|9|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
22750078|THPP-1 exhibits nanomolar potency on the PDE10A enzyme, demonstrates excellent pharmacokinetic properties in multiple preclinical animal species, and is selective for PDE10A over other PDE families of enzymes.|THPP-1|PDE10A|1|7|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
10207608|Taken together, these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.|AACOCF3|PLA2|12|8|Arg1:T13|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines|AChE|38|4|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23598363|Surprisingly, the conditional deletion of Trp63, but not ΔNp63, in oocytes inhibited apoptosis, as well as the accumulation of c-Abl and TAp73 caused by cisplatin.|cisplatin|c-Abl|29|24|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17545671|Finally, the amounts of RORalpha and cAspAT mRNAs were similarly increased by TZD treatment of human adipose tissue explants, confirming coordinated regulation.|TZD|cAspAT|14|8|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
13129570|  2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid (1) is a potent AMPA receptor agonist with moderate affinity for native kainic acid (KA) receptors, whereas (S)-E-4-(2,2-dimethylpropylidene)glutamic acid (3) show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors.|2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid|AMPA receptor|1|17|Arg1:T1|Arg2:T31|CHEMICAL|GENE-N|AGONIST
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|c-kit|4|32|Arg1:T3|Arg2:T53|CHEMICAL|GENE-Y|INHIBITOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|NS-187|Src|27|16|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
15661821|Glucose infusion increased mRNA expression for POMC, but not for the anorectic neuropeptide CART, or the orexigenic neuropeptides NPY and AGRP, in the arcuate nucleus of the fetal hypothalamus.|Glucose|POMC|1|7|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|rimonabant|CB(1)|45|29|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|AGONIST-INHIBITOR
23197773|In the present studies, the effects of CB(1) agonists [(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (AM411), 9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol (AM4054), R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212.2), Δ(9)-tetrahydrocannabinol (Δ(9)-THC), (R)-(+)-arachidonyl-1'-hydroxy-2'-propylamide (methanandamide)], CB(1) antagonists [5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (SR141716A), 5-(4-alkylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM4113)], and dopamine (DA)-related [methamphetamine, (±)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide (SKF82958), (R)-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390), (6aR)-5,6,6a,7-tetrahydro-6-propyl-4H-dibenzo[de,g]quinoline-10,11-diol (R-(-)-NPA), haloperidol] and opioid (morphine, naltrexone) drugs on scheduled-controlled responding under a 30-response fixed ratio schedule of stimulus-shock termination in squirrel monkeys were compared before and during chronic treatment with the long-acting CB(1) agonist AM411 (1.0 mg/kg per day, i.m.).|(6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol|CB(1)|15|9|Arg1:T22|Arg2:T47|CHEMICAL|GENE-Y|AGONIST
21955206|Inhibition of the NF-kappaB pathway was responsible for this effect since the colchicoside inhibited RANKL-induced NF-kappaB activation, activation of IkappaB kinase (IKK) and suppressed inhibitor of NF-kappaBalpha (IkappaBalpha) phosphorylation and degradation, an inhibitor of NF-kappaB.|colchicoside|IkappaBalpha|13|32|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
7567987|Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of L-5-hydroxytryptophan to serotonin and that of L-3,4-dihydroxyphenylalanine to dopamine.|L-3,4-dihydroxyphenylalanine|Aromatic L-amino acid decarboxylase|15|1|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
20426763|These functional responses were blocked by selective 5HT(2) receptor antagonists with the 5HT(2A) antagonist, M-100970, exhibiting the highest potency.|M-100970|5HT(2)|22|8|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|ANTAGONIST
23454149|Western blotting demonstrated that DMBT effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and p-Akt.|DMBT|p-VEGFR-2|5|13|Arg1:T12|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
14626653|  Vardenafil (Levitra), recently launched in Belgium by Bayer and Glaxo-SmithKline, is a new drug that potently and selectively inhibits phosphodiesterase type 5 (PDE5) in the cavernosum tissue of the penis.|Levitra|PDE5|3|28|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
2891463|However, betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol.|levobunolol|beta 1-adrenergic receptor|19|11|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|ICI-118,5511|beta(2)-adrenoceptor|70|74|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
9313928|16,16-dimethyl-PGE2 and two putative EP1 antagonists, AH6809 and SC-19220, did not show any significant binding to this receptor.|AH6809|EP1|8|5|Arg1:T8|Arg2:T76|CHEMICAL|GENE-Y|ANTAGONIST
2453744|  Acebutolol is a relatively new beta-adrenoceptor blocking antagonist, possessing both beta 1-adrenoceptor selectivity and partial agonist activity (PAA).|Acebutolol|beta 1-adrenoceptor|1|12|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|AGONIST
19057128|These findings indicate that captopril attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of MMP-2 and MMP-9 in rats.|captopril|MMP-2|5|19|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide|5-HT1A|10|7|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
17125913|Cd rapidly increased c-jun, c-fos and PDGFA expression.|Cd|c-fos|1|6|Arg1:T10|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
11319222|Troglitazone exhibited a mixed type inhibition of ACS4.|Troglitazone|ACS4|1|8|Arg1:T2|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
23478800|The ROS scavenger N-acetyl l-cysteine and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of cucurbitacin I on Rac1 activation.|cucurbitacin I|Rac1|16|19|Arg1:T5|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
1705633|  Enalkiren (A-64662), a potent, dipeptide renin inhibitor, mimics the transition state of the human renin substrate, angiotensinogen.|A-64662|human renin|3|19|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23159986|The compound D-limonene induced a dose dependent increase in HDN severity and renal biomarker changes without altering BUN, creatinine or NAG: (1) minimal induction of HDN and no altered biomarkers at 10 mg/kg/day, (2) mild induction of HDN with increased αGST and μGST at 50 mg/kg/day and (3) marked induction of HDN with increased αGST, μGST and albumin at 300 mg/kg/day.|D-limonene|αGST|3|48|Arg1:T4|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
12927226|CONCLUSIONS: AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.|eprosartan|AT1|6|3|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ANTAGONIST
23583910|A N,N-dimethylaminopropyl derivative showed promising inhibition of Trypanosoma cruzi OSC in combination with low cytotoxicity, and showed significant reduction of cholesterol biosynthesis in a human cell line.|cholesterol|Trypanosoma cruzi OSC|24|10|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
23411280|  Histidine decarboxylase (HDC) catalyses the formation of histamine, a bioactive amine.|histamine|HDC|10|4|Arg1:T8|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|ICAM-1|7|12|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23122161|Also, the methanol extract and the hexane fraction inhibited LPS-induced MAPKs and NF-kB activation associated with the inhibition of iNOS or COX-2 expression.|hexane|NF-kB|8|14|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|haloperidol|preproenkephalin A|18|21|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23238783|The bupropion metabolic ratio appears to detect known differences in CYP2B6 activity associated with genetic polymorphism, across different ethnic groups.|bupropion|CYP2B6|2|11|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
21194017|Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA(A)-R.|amino acids|bovine brain GABA(A)-R|21|29|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|PART-OF
8441637|  All DNA (cytosine-5)-methyltransferases contain a single conserved cysteine.|cysteine|DNA (cytosine-5)-methyltransferases|11|2|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE
23645248|In contrast, TSH-induced differentiation of progenitor cells, in particular the expression of the sodium iodide symporter, was significantly inhibited by 17beta-oestradiol.In conclusion, oestrogen stimulated growth and simultaneously inhibited differentiation of thyroid nodules derived stem/progenitor cells.|17beta-oestradiol|sodium iodide symporter|24|16|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
10373451|The deduced amino acid sequence contains 779 amino acids, including a putative cGMP binding sequence in the amino-terminal portion of the molecule and a catalytic domain that is 16-47% identical in amino acid sequence to those of other PDE families.|amino acids|PDE|8|41|Arg1:T2|Arg2:T28|CHEMICAL|GENE-N|PART-OF
10658902|With respect to the substrate dihydroorotate, atovaquone was an uncompetitive inhibitor of human dihydroorotate dehydrogenase (Kiu = 11.6 microM) and a non-competitive inhibitor of the rat enzyme (Kiu = 905/ Kic = 1,012 nM).|dihydroorotate|human dihydroorotate dehydrogenase|6|14|Arg1:T19|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR
23605050|The Bcl2/Bax ratio increased and Mfn2 expression decreased in MIN6 cells after glucose stimulation.|glucose|Mfn2|13|6|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10365684|  Methimazole (MMI) and propylthiouracil (PTU) are common antithyroid drugs for treating hyperthyroidism because the 2 drugs inhibit thyroid peroxidase (TPO)-catalyzed thyroid hormone formation.|Methimazole|thyroid peroxidase|1|22|Arg1:T1|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
7739347|  To find out the reason of weak addiction property of dihydroetorphine, we compared the affinities of dihydroetorphine to the type selective opioid receptor and inhibition effect on the adenylyl cyclase activity with those of etorphine.|etorphine|adenylyl cyclase|36|30|Arg1:T3|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
15736931|In this study, we show that mutation of Arg228, a residue in the vicinity of Glu317, to lysine (R228K-Gal-T1) results in a 15-fold higher Glc-T activity, which is further enhanced by LA to nearly 25% of the Gal-T activity of the wild type.|lysine|Gal-T|21|45|Arg1:T31|Arg2:T55|CHEMICAL|GENE-N|PART-OF
23527317|  A series of N-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [(3)H]dopamine uptake.|lobelane|vesicular monoamine transporter|5|24|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
20512624|A possible role of the non-GAT1 GABA transporters in transfer of GABA from GABAergic to glutamatergic neurons in mouse cerebellar neuronal cultures.|GABA|GABA transporters|12|7|Arg1:T29|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE
15353592|Lactisole inhibits the activity of the human T1R1/T1R3 receptor, and, as predicted, blocked the umami taste of l-glutamate in human taste tests.|Lactisole|T1R3|1|9|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
23205634|Bile acids strongly decrease the basal ABCG2-ATPase activity both in the wild-type ABCG2 and in the mutant variant.|Bile acids|ABCG2|1|7|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23589329|Thus, arsenic activates Nrf2 through a non-canonical mechanism (p62-dependent), leading to a chronic, sustained activation of Nrf2.|arsenic|Nrf2|3|5|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Asp|ALDH|13|21|Arg1:T8|Arg2:T32|CHEMICAL|GENE-N|PART-OF
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|NO|iNOS|17|6|Arg1:T1|Arg2:T52|CHEMICAL|GENE-Y|PRODUCT-OF
23583931|  During repetitive stimulation of skeletal muscle, extracellular ATP levels raise, activating purinergic receptors, increasing Ca(2+) influx, and enhancing contractile force, a response called potentiation.|ATP|purinergic receptors|9|14|Arg1:T15|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR
17337452|Engineered monomeric human histidine triad nucleotide-binding protein 1 hydrolyzes fluorogenic acyl-adenylate and lysyl-tRNA synthetase-generated lysyl-adenylate.|lysyl|lysyl-tRNA synthetase|15|13|Arg1:T18|Arg2:T48|CHEMICAL|GENE-Y|PRODUCT-OF
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|haem oxygenase 1|1|19|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20188727|Phenformin but not metformin inhibits a number of variants of K(ATP) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (Kir6.1/SUR2B and Kir6.2/SUR2B) and pancreatic beta-cells (Kir6.2/SUR1).|Phenformin|K(ATP)|1|11|Arg1:T19|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|cGMP|Q817A|4|43|Arg1:T33|Arg2:T58|CHEMICAL|GENE-N|DIRECT-REGULATOR
9256165|Sulfasalazine and CL 42A markedly inhibited extracellular release of sPLA2.|Sulfasalazine|sPLA2|1|10|Arg1:T14|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
2268554|4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM.|4-MA|5 alpha-reductase|1|6|Arg1:T10|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
17088426|We propose a model whereby compartmentalized PDEs, rather than representing an enzymatic barrier to cAMP diffusion, act as a sink to drain the second messenger from discrete locations, resulting in multiple and simultaneous domains with different cAMP concentrations irrespective of their distance from the site of cAMP synthesis.|cAMP|PDEs|50|7|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
17223000|Pranlukast hydrate (ONO-1078, 100 microM) downregulated the leukotriene D(4)-induced MUC2/5AC gene expression and mucin secretion.|ONO-1078|MUC2/5AC|4|17|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|SLPI|4|34|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|afatanib|EGFR|41|30|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
12085361|100 micromol/L rifampicin inhibited OATP-C- and OATP8-, OATP-B- and OATP-A-mediated BSP uptake by 66%, 96%, 25%, and 49%, respectively.|BSP|OATP-B|12|9|Arg1:T7|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
14504136|Interestingly, 5-CT-induced cardiac sympatho-inhibition was abolished by methiothepin, the cocktail of antagonists/inhibitors, GR 127935 or the combination of SB224289 (5-HT1B) plus BRL15572 (5-HT1D), but remained unchanged when SB224289 or BRL15572 were given separately.|SB224289|5-HT1B|22|24|Arg1:T13|Arg2:T47|CHEMICAL|GENE-Y|ANTAGONIST
10639181|Derivatization of the carboxylate moiety in moderately selective COX-1 inhibitors, such as 5,8,11,14-eicosatetraynoic acid (ETYA) and arylacetic and fenamic acid NSAIDs, exemplified by indomethacin and meclofenamic acid, respectively, generated potent and selective COX-2 inhibitors.|indomethacin|COX-1|28|9|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
1407010|The pharmacological profile of [125I]GTI binding was fully comparable to that reported previously in human and other brain preparations known to possess 5-HT1D sites (using either [3H]5-HT or [125I]GTI) and displayed a characteristic rank order of affinity: 5-carboxamido-tryptamine greater than 5-HT = dihydroergotamine greater than or equal to ergotamine greater than or equal to sumatriptan greater than or equal to CGS 12066 greater than or equal to metergoline greater than yohimbine greater than or equal to methysergide greater than ICYP greater than 8-OH-DPAT greater than or equal to CP 93129 greater than (-)pindolol greater than ketanserin greater than isamoltane greater than mesulergine greater than corynanthine greater than buspirone greater than MDL 72222.|sumatriptan|5-HT1D|68|27|Arg1:T27|Arg2:T41|CHEMICAL|GENE-N|DIRECT-REGULATOR
23273999|The most intensive stimulating DOAs were further investigated and compared with the known P-gp model substrates sertraline and verapamil.|verapamil|P-gp|19|14|Arg1:T13|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE
9563368|The resulting half-life of the FP active steroid-receptor complex is >10 hours, compared with approximately 5, 7.5, and 4 hours for budesonide, 17-BMP, and triamcinolone acetonide, respectively.|budesonide|steroid-receptor|26|8|Arg1:T29|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR
23589302|In the present report, we show that Fer associates with the activated PDGFbeta receptor (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and Tyr1021.|Tyr|PDGFRbeta|28|17|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|PART-OF
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|norepinephrine|NET|6|20|Arg1:T27|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
10768298|RESULTS: Topiramate Ki values for HCA I, HCA II, HCA IV, and HCA VI were approximately 100, 7, 10, and >100 microM, respectively.|Topiramate|HCA I|3|7|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
15219414|Conversely, experiments in cell culture systems demonstrated significant antagonism of cortisol-induced transcriptional activation by oxandrolone in cells expressing both the AR and GR.|oxandrolone|GR|16|24|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST
23583931|The ATP required for potentiation of skeletal muscle contraction is released via pannexin hemichannels.|ATP|pannexin|2|13|Arg1:T21|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE
12213829|Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the ATP inhibition of K(IR)6.2/SUR1, but had no effect on homomeric K(IR)6.2 channels.|ATP|K(IR)6.2|25|28|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
23315277|Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to SiO(2) NPs, the messenger RNA level of apoptotic genes (caspase-3 and caspase-9) were upregulated in a dose-dependent manner.|SiO(2)|caspase-9|15|31|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|pyridinium oximes|AChE|22|14|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
23432586|Conclusions: We suggest that, among others, FKBP52 expression and function are altered in platelets from DM2 patients, contributing to the altered Ca(2+) entry and hyperaggregability in these cells.|Ca(2+)|FKBP52|26|10|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
17471183|  New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their cytochrome P450 enzyme inhibition profiles, allow improved deductions concerning their effects and interactions and indicate which of the TCAs are the most useful.|tricyclic|cytochrome P450|7|22|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
23301897|In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-κB (p65) inhibitory activity in an ELISA assay.|sesquiterpene|NF-κB|28|37|Arg1:T5|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
14585280|For these reasons, the use of irreversible DNA methyltransferase inhibitors, such as 5-azacytidine and Decitabine, appears to be a promising option for the treatment of MDS and acute myeloid leukemia.|5-azacytidine|DNA methyltransferase|15|9|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
14757700|In contrast, menthol- and icilin-activated TRPM8 currents were suppressed by low pH.|menthol|TRPM8|4|7|Arg1:T17|Arg2:T46|CHEMICAL|GENE-Y|ACTIVATOR
20007701|This expression system allowed identification of a new substrate, acriflavine, and isolation of mutants with modified affinity to tetrabenazine (TBZ), a non-competitive inhibitor of VMAT2 that is used in the treatment of various movement disorders including Tourette syndrome and Huntington chorea.|tetrabenazine|VMAT2|21|30|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
10579749|The mode of (functional) AT1 receptor antagonism has been characterized as surmountable/noncompetitive (losartan, tasosartan, eprosartan) or insurmountable/noncompetitive (candesartan, saprisartan, zolasartan, irbesartan, valsartan, telmisartan, E3174).|irbesartan|AT1|31|7|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|iron|transferrin|27|33|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23384967|  Bisphenol A (BPA) and diethylstilbestrol (DES) are endocrine-disrupting chemicals that interact with the human pregnane X receptor (PXR).|diethylstilbestrol|human pregnane X receptor|7|18|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15106733|The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and PGE2 release.|PD098059|cytokine|11|14|Arg1:T4|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23201927|In addition, the PI3K inhibitor partially blocked the effects of Sal B on the upregulation of Bcl-2 and Bcl-xl protein expression, and downregulation of Bax protein expression.|Sal B|Bcl-xl|12|20|Arg1:T18|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17046555|Treatment of the cells with the NADPH oxidase inhibitors, apocynin and diphenylene iodonium, inhibited these effects.|diphenylene iodonium|NADPH oxidase|13|7|Arg1:T15|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
9614060|System y+ cationic amino acid transport is mediated by proteins encoded by a family of genes, Cat1, Cat2, and Cat3.|amino acid|System y+|4|1|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
23486447|Amitriptyline, clomipramine, doxepin, imipramine, and trimipramine are demethylated by CYP2C19 to pharmacologically active metabolites.|clomipramine|CYP2C19|3|14|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE
18604229|Specifically, B2-O-CH(2)-CH(2)-N-piperidine and B2-O-CH(2)-CH(2)-N-pyrrolidine revealed a higher affinity towards hERG channels than amiodarone.|B2-O-CH(2)-CH(2)-N-pyrrolidine|hERG|13|27|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7905294|The inhibition was unaffected by the clamping-voltage and by a mutation [NR1-NR2A(N595Q)] that prevents the Mg(2+)-blockade of the channels, indicating that the mechanism of action of ethanol differs from that of Mg2+.|ethanol|NR2A|37|14|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
15840408|ONO-AE1-259-01 a prostanoid EP2-receptor agonist, ONO-AE1-329, a prostanoid EP4-receptor agonist, and ONO-1301 inhibited TNF-alpha production and T-cell proliferation.|ONO-AE1-329|TNF-alpha|7|17|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10500149|10, 3beta-methylcarbonate-androst-5-ene-7,17-dione] that have no androgenic activity and could also block the Adiol-induced AR transactivation in prostate cancer PC-3 cells.|Adiol|AR|15|16|Arg1:T23|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR
20204178|Both drugs at the tested doses (0.042-0.33 mug/kg) suppressed PTH mRNA expression and serum PTH effectively in the 5/6 NX rats, but paricalcitol was less potent in raising serum Ca than doxercalciferol.|paricalcitol|PTH|26|12|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15059893|Treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine for 5 days restored TIG1 expression in all eight silenced cell lines tested.|5-aza-2'-deoxycytidine|DNA methyltransferase|7|4|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
20497523|The selective ERbeta agonist ERB-79 had no effect on arthritis symptoms in this model.|ERB-79|ERbeta|5|3|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|AGONIST
16980198|Ingestion of competitive inhibitors of 11beta-HSD2 such as liquorice and carbenoxolone result in a similar but milder clinical phenotype.|carbenoxolone|11beta-HSD2|11|6|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23583910|A N,N-dimethylaminopropyl derivative showed promising inhibition of Trypanosoma cruzi OSC in combination with low cytotoxicity, and showed significant reduction of cholesterol biosynthesis in a human cell line.|N,N-dimethylaminopropyl|Trypanosoma cruzi OSC|2|10|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
10639181|Derivatization of the carboxylate moiety in moderately selective COX-1 inhibitors, such as 5,8,11,14-eicosatetraynoic acid (ETYA) and arylacetic and fenamic acid NSAIDs, exemplified by indomethacin and meclofenamic acid, respectively, generated potent and selective COX-2 inhibitors.|5,8,11,14-eicosatetraynoic acid|COX-1|14|9|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
15561708|  The molybdenum cofactor sulfurase ABA3 from Arabidopsis thaliana specifically regulates the activity of the molybdenum enzymes aldehyde oxidase and xanthine dehydrogenase by converting their molybdenum cofactor from the desulfo-form into the sulfo-form.|molybdenum|aldehyde oxidase|15|17|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
9040115|There is, however, much information on the direct (acute and chronic) effects of alcohol on the binding properties of opioid receptors, as well as modulation of opioid peptide synthesis and secretion (e.g. a suggested increase in beta-endorphin release).|alcohol|beta-endorphin|18|44|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
2453744|  Acebutolol is a relatively new beta-adrenoceptor blocking antagonist, possessing both beta 1-adrenoceptor selectivity and partial agonist activity (PAA).|Acebutolol|beta-adrenoceptor|1|6|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ANTAGONIST
23508685|We found that Egr1, a transcription factor whose promoter activity was positively regulated by the 5-HT2A receptor agonist TCB-2, binds less to the mGlu2 promoter in frontal cortex of 5-HT2A-KO as compared to wild-type mice.|TCB-2|5-HT2A|20|17|Arg1:T2|Arg2:T8|CHEMICAL|GENE-Y|AGONIST
17260025|  A chemical biology approach identifies a beta 2 adrenergic receptor (beta2AR) agonist ARA-211 (Pirbuterol), which causes apoptosis and human tumor regression in animal models.|ARA-211|beta2AR|15|12|Arg1:T9|Arg2:T41|CHEMICAL|GENE-Y|AGONIST
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|O2|iNOS|27|6|Arg1:T13|Arg2:T52|CHEMICAL|GENE-Y|SUBSTRATE
23085120|All these results suggest that B12H substantially protected CGNs against glutamate-induced neuronal excitotoxicity via activating α7nAChR/PI3-K/Akt cascade.|B12H|PI3-K|6|17|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR
23500772|Compared with DM8W group, SOD and ALDH2 in EtOH+DM8W group was increased, MDA was decreased.|EtOH|ALDH2|10|8|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15985434|To understand this interaction, we determined the crystal structure of PDXK in complex with (R)-roscovitine, N6-methyl-(R)-roscovitine, and O6-(R)-roscovitine, the two latter derivatives being designed to bind to PDXK but not to CDKs. Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal-binding site of PDXK rather than in the anticipated ATP-binding site.|roscovitines|PDXK|55|63|Arg1:T21|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2832297|After loperamide administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an ACTH increase; the pattern of ACTH response to CRH was slightly delayed.|loperamide|ACTH|2|4|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
18450949|Administration of chloroquine (50 mg/kg for 7 days po), a denaturant of lysosomes, increased the AQP5 protein level reduced by CTD.|chloroquine|AQP5|3|20|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11120594|In the present study, we show that norepinephrine and terbutaline stimulate the beta2AR to decrease the level of IL-2 produced by freshly isolated murine splenic naive CD4+ T cells from either Balb/C or DO11.10 transgenic mice and activated polyclonally with anti-CD3 and anti-CD28 mAbs.|norepinephrine|beta2AR|9|14|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
23319419|With the exception of three residues, the specific amino acids that form the putative binding pocket for ICA in ERG are conserved in EAG.|amino acids|EAG|10|25|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|PART-OF
16018973|We present our studies to demonstrate that HM74A, but not HM74, binds niacin at high affinities and effectively mediates Gi signaling events in human embryonic kidney HEK293 cells as well as in 3T3L1 adipocytes expressing HM74A.|niacin|HM74A|15|8|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR
23515287|The Androgen Metabolite, 5α-Androstane-3β,17β-Diol (3β-Diol), Activates the Oxytocin Promoter Through an Estrogen Receptor-β Pathway.|5α-Androstane-3β,17β-Diol|Oxytocin Promoter|5|12|Arg1:T19|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|Procaine|norepinephrine transporter|1|17|Arg1:T26|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
10841524|H(+) transport by NHE3 and the novel transporter is inhibited by cAMP, albeit to different extents.|cAMP|NHE3|15|7|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|tumor necrosis factor alpha|1|3|Arg1:T18|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
17185414|We have identified a highly potent and selective small-molecule ALK inhibitor, NVP-TAE684, which blocked the growth of ALCL-derived and ALK-dependent cell lines with IC(50) values between 2 and 10 nM.|NVP-TAE684|ALK|13|22|Arg1:T1|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR
11980628|It is important to note that the inhibitory effect of SOM230 was relatively selective for GH and IGF-I in that insulin and glucagon secretion was inhibited only at higher doses of SOM230.|SOM230|GH|11|16|Arg1:T15|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR
9610840|  Sesamin (a non-fat portion of sesame seed oil) inhibits delta-5 desaturase activity resulting in an accumulation of dihomo-gamma-linolenic acid (DGLA) which can displace arachidonic acid (AA) and decrease the formation of pro-inflammatory mediators.|DGLA|delta-5 desaturase|23|12|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|Ser|phospho-Rb|43|42|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|ARE|10|13|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
8788445|Co-administration of haloperidol shifts the dose-response curve to the left and elevates the maximal response to 70% through a blockade of sigma 1 receptors, but the curve remains biphasic.|haloperidol|sigma 1 receptors|3|23|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
10208549|Following a single oral administration, both bis(7)-tacrine and tacrine produced dose-dependent inhibitions of AChE in rat brain, but bis(7)-tacrine exhibited higher efficacy and AChE/BChE selectivity than tacrine.|bis(7)-tacrine|AChE|8|19|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
15771438|Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.|sulfamide|carbonic anhydrase-II|5|11|Arg1:T16|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
19549602|Amitriptyline binds the extracellular domain of both TrkA and TrkB and promotes TrkA-TrkB receptor heterodimerization.|Amitriptyline|TrkA|1|8|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15730717|0 approximately 400 micromol/L of IN could down-regulate the expression of p-STAT1 or p-STAT5 in a dose-response manner, p-STATs were distributed mainly in the nucleus as scattering spots.|IN|p-STAT1|6|12|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23611809|These are drugs that were previously reported to be substrates for UGT1A4 or UGT1A3 and that contain in their structure either tertiary aliphatic amines, cyclic amines, or an imidazole group.|cyclic amines|UGT1A3|26|14|Arg1:T21|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W|VEGF|23|38|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hCNT2|11|22|Arg1:T12|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17692905|Similarly, the tube formation induced by standard VEGF, FGF-2, or TNF-alpha was 100% inhibited by enoxaparin, and 70-90% by dalteparin, whereas minor or no inhibition was observed with UFH.|dalteparin|FGF-2|26|11|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|methyl|ERβ|29|45|Arg1:T15|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
19928382|At doses that produced equal increases in wake, DA-releasing (amphetamine, methamphetamine, phentermine) and several DAT-inhibiting agents (cocaine, bupropion, and methylphenidate) produced RHS during the first few hours after the onset of sleep recovery.|methylphenidate|DAT|28|20|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
12213829|The L0 linker has been reported to be required for glibenclamide binding, and DeltaNK(IR)6.2/SUR1 channels exhibit reduced labeling of K(IR) with (125)I-azidoglibenclamide, implying that the K(IR) N terminus and L0 of SUR1 are in proximity.|N|K(IR)|42|38|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|PART-OF
23050902|It was reported previously that FVII gene (F7) expression was up-regulated by ribavirin treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.|ribavirin|F7|15|9|Arg1:T6|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10381508|An Arg/Ser substitution in the second epidermal growth factor-like module of factor IX introduces an O-linked carbohydrate and markedly impairs activation by factor XIa and factor VIIa/Tissue factor and catalytic efficiency of factor IXa.   Factor IXR94S is a naturally occurring hemophilia B defect, which results from an Arg 94 to Ser mutation in the second epidermal growth factor (EGF)-like module of factor IX.|Ser|factor IX|53|67|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|PART-OF
23566269|We identified a series of 4-hydroxypyridazin-3(2H)-one derivatives as novel DAAO inhibitors with high potency and substantial cell permeability using fragment-based drug design.|4-hydroxypyridazin-3(2H)-one|DAAO|6|14|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23603004|Results showed that naringin of 60 and 120mg/kg significantly reduced PQ-induced upregulations of TNF-α, TGF-β1, MMP-9 and TIMP-1, levels of pulmonary malonaldehyde and hydroxyproline, as well as pulmonary fibrosis deposition, while increased activities of SOD, GSH-Px and HO-1.|naringin|MMP-9|4|18|Arg1:T14|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23505344|  Pathways are computed for transport of H2O and CO in myoglobin (Mb), using the single sweep and zero-temperature string methods in a fully atomistic, explicitly solvated model system.|CO|myoglobin|9|11|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE
1327384|alpha 2A-Adrenoceptor selective compounds, oxymetazoline and BRL 44409, showed high affinity for [3H]-RS-15385-197 binding in the human platelet and lower affinity in the neonate lung, while the alpha 2B-selective compounds, prazosin and imiloxan, showed high affinity for [3H]-RS-15385-197 binding in the neonate lung.This suggests that [3H]-RS-15385-197 labels both alpha2A- and alpha2B-adrenoceptor subtypes.4. Prazosin and methysergide inhibited the binding of [3H]-RS-15385-197 in the rat cerebral cortex in a simple manner consistent with an interaction at a single site.|oxymetazoline|alpha 2A-Adrenoceptor|6|1|Arg1:T4|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18237195|In the absence of Cl-, melatonin served as a 1e- substrate for MPO compound I, but at higher concentration it limited the reaction by its dissociation from the corresponding complex.|melatonin|MPO|7|14|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
23543737|In the current study, we extend these findings to show that the ability of astrocytes to buffer extracellular glutamate is reduced when CaMKII is inhibited.|glutamate|CaMKII|20|24|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
10913016|In the presence of the beta(2)-adrenoceptor antagonist ICI-118551 (ICI, 10 microM), Iso caused an increase in [(14)C]phenylalanine incorporation, protein and RNA mass, cell volume, and cross-sectional area.|ICI-118551|beta(2)-adrenoceptor|12|6|Arg1:T7|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST
15206110|Even though its inability to shift between the trivalent and a divalent oxidation state precludes that gallium behaves as an iron analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with transferrin and transferrin receptor-mediated endocytosis.|gallium|transferrin receptor|17|43|Arg1:T24|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR
22982773|Rate constants for reactivation of OP-inhibited AChE by even the best oximes, such as HI-6 and obidoxime, can vary >100-fold between OP-AChE conjugates that are easily reactivated and those that are difficult to reactivate.|obidoxime|AChE|18|7|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR
2901134|Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.|Cysteamine|somatostatin|1|5|Arg1:T17|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23485615|CK significantly inhibited DMN-induced increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, fibrosis score, and hepatic malondialdehyde and collagen content.|DMN|AST|4|17|Arg1:T11|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
10611634|In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT(1A) sites versus marked antagonist actions at halpha(2)-ARs. While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.|fluparoxan|halpha(2)-ARs|6|24|Arg1:T50|Arg2:T59|CHEMICAL|GENE-N|ANTAGONIST
23063590|Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by artemisinic acid.|artemisinic acid|macrophage migration inhibitory factor|31|20|Arg1:T11|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|carnitine octanoyltransferase|32|17|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
14633707|The observation that Ras-transformed cells can be sensitized to killing by ionizing radiation with GW572016 demonstrates that EGFR KIs could potentially be used to radiosensitize tumors in which radioresistance is dependent on Ras-driven autocrine signaling through EGFR.|GW572016|EGFR|15|18|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23046389|The domestic animals also showed marked species differences in the AO activity and affinity toward zoniporide.|zoniporide|AO|16|11|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|sulpiride|preproenkephalin A|12|21|Arg1:T10|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|rofecoxib|COX|15|6|Arg1:T6|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR
2855105|In all patients loperamide induced a significant fall in plasma ACTH levels.|loperamide|ACTH|4|11|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|hyperforin|beta2-AR|29|24|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23142425|Subjects carrying the UGT2B7 268 His/Tyr or Tyr/Tyr genotype had significantly lower total NNAL than those carrying His/His genotype.|Tyr|UGT2B7|7|4|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|PART-OF
17369473|In hearts treated with phenformin for 18 min and then perfused for 20 min with Krebs-Henseleit buffer, [AMP] began to increase at 26 min and AMPK activity was elevated at 36 min.|phenformin|AMPK|5|29|Arg1:T38|Arg2:T58|CHEMICAL|GENE-N|ACTIVATOR
9765513|  We examined the effects of the calcium channel blockers nitrendipine, diltiazem, verapamil, bepridil, and mibefradil on the cloned HERG and KvLQT1/IsK K+ channels.|nitrendipine|calcium channel|10|7|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|T432S|4|9|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
15695169|Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.|ramelteon|MT1|4|11|Arg1:T18|Arg2:T37|CHEMICAL|GENE-Y|AGONIST
22659408|Purified synaptosomes were selectively prelabeled with [(3)H]glycine through the neuronal transporter GlyT2 and subsequently depolarized by superfusion with 12 mM KCl. The selective mGluR2/3 agonist LY379268 inhibited the K(+)-evoked overflow of [(3)H]glycine in a concentration-dependent manner (EC(50) about 0.2 nM).|[(3)H]glycine|GlyT2|7|18|Arg1:T11|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23423713|In vitro, V(5+) decreased the TCDD-mediated induction of Cyp1a1 mRNA, protein, and catalytic activity levels.|V(5+)|Cyp1a1|4|13|Arg1:T19|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17606858|Furthermore, in aldosterone-untreated hearts, fenofibrate decreased transforming growth factor-beta, collagen type III (P<0.05 for both), and collagen type I (P<0.01) protein expression.|fenofibrate|collagen type I|7|25|Arg1:T8|Arg2:T33|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10670413|Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2.|17-phenyl-trinor-PGE2|EP1|16|19|Arg1:T14|Arg2:T48|CHEMICAL|GENE-Y|AGONIST
16278927|In conclusion, of the seven NSAIDs investigated, niflumic acid was the most potent inhibitor of recombinant UGT1A9 via 4-MUG in a competitive manner.|niflumic acid|UGT1A9|10|19|Arg1:T1|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
17202804|Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.|testosterone|human androgen receptor|5|9|Arg1:T26|Arg2:T69|CHEMICAL|GENE-Y|ACTIVATOR
7513381|  To compare in vivo effects of eleven compounds of different classes of histamine H1-receptor antagonists (alcoholamines: diphenhydramine, carbinoxamine, and clemastine; ethylenediamines: mepyramine, tripelennamine, and clemizole; alkylamines: triprolidine and chlorpheniramine; piperazines: meclizine and homochlorcyclizine; phenothiazines: promethazine) on neuronal uptake of dopamine (DA), noradrenaline (NA), and 5-hydroxytryptamine (5-HT), the effects on the turnover of these monoamines were examined in the mouse brain, based on the alpha-methyl-p-tyrosine-induced depletion of DA and NA or probenecid-induced accumulation of 5-hydroxyindoleacetic acid.|tripelennamine|histamine H1-receptor|30|13|Arg1:T22|Arg2:T57|CHEMICAL|GENE-Y|ANTAGONIST
15627430|The excellent correlation between in vitro antagonist activities of antipsychotics at muscarinic M2 receptors and their in vivo potencies to increase acetylcholine release, suggests that olanzapine, clozapine, as well as thioridazine and chlorpromazine, increase acetylcholine release via blockade of terminal muscarinic M2 autoreceptors.|olanzapine|muscarinic M2 autoreceptors|27|45|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23583884|In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and NF-κB activation induced by TCDD can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.|TCDD|NF-κB|20|16|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR
14596599|Formation of pyruvate by SDH is a two-step reaction in which the hydroxyl group of serine is cleaved to produce aminoacrylate, and then the aminoacrylate is deaminated by nonenzymatic hydrolysis to produce pyruvate.|hydroxyl|SDH|13|5|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|PART-OF
23339663|The series of crystallographic snapshots reveals that AChE and BChE react with the opposite enantiomers and that an induced-fit rearrangement of Phe297 enlarges the active site of AChE upon CBDP binding.|Phe|AChE|22|28|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
23643752|As seen with phagocytotic microglia, the CB2 antagonist, AM630, increased Iba-1 positive microglia in the absence of URB597 treatment.|AM630|CB2|11|8|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST
12213829|We hypothesize that L0 interacts with the K(IR) N terminus in ligand-inhibited K(ATP) channels and put forward a model, based on the architecture of BtuCD, MsbA, and the KcsA channel, in which TMD0-L0 links the MDR-like core of SUR with the K(IR) pore.|N|K(IR)|12|8|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|PART-OF
8600944|Dexamethasone (DEX) inhibited the anti-CD3-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.|Dexamethasone|IL-5|1|12|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17980251|AZD6140 is a reversible oral P2Y(12) receptor antagonist that has been studied in ACS patients in comparison with clopidogrel (DISPERSE-2 study).|clopidogrel|P2Y(12)|22|6|Arg1:T21|Arg2:T29|CHEMICAL|GENE-Y|ANTAGONIST
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Nucleotide|nucleotide-binding domains|1|21|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
23591125|The induced 'ischemic depression' was lasting and sensitive to an acute administration of brain-derived neurotrophic factor or bryostatin-1, a relatively selective activator of protein kinase Cε, during the induction phase.|bryostatin-1|protein kinase Cε|19|26|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|mitoxantrone|TOP2|38|29|Arg1:T17|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
23200901|Bidirectional transport assays of the Aconitum alkaloids were performed with or without P-gp (cyclosporine A and verapamil), BCRP (Ko143) and MRP2 (MK571) inhibitors.|Ko143|BCRP|23|21|Arg1:T22|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
2521824|We conclude that androgens can stimulate human and murine osteoblastic cell proliferation in vitro, and induce expression of the osteoblast-line differentiation marker ALP, presumably by an androgen receptor mediated mechanism.|androgens|osteoblast-line differentiation marker|4|21|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
9145928|Both the hydroxyl and the ether oxygen atoms of the oxypropanol moiety seem to be required for binding at wild-type 5-HT1A receptors.|oxypropanol|5-HT1A|11|21|Arg1:T23|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23066988|Metformin significantly reduced ghrelin secretion and proghrelin mRNA production and both these effects were blocked by co-incubation with the AMPK inhibitor compound C.|compound C|proghrelin|22|7|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8301142|Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts.|Retinoic acid|IL-6|1|6|Arg1:T21|Arg2:T48|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23093496|This study showed that, in addition to ADP and ATP, other ATP derivatives are not only ligands of P2Y(12) but also agonists.|ATP|P2Y(12)|14|21|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17373776|The E1013D variant showed coupling between glutamine hydrolysis at the glutaminase site and 2-oxoglutarate-dependent L-glutamate synthesis at the synthase site, but a sigmoid dependence of initial velocity on L-glutamine concentration.|L-glutamate|E1013D|15|2|Arg1:T20|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF
17645691|These included, biliverdin-IX alpha reductase and the sodium-dependent vitamin C transport proteins SVCT1 and SVCT2, whose expression levels were enhanced in maternal and fetal liver by melatonin treatment.|vitamin C|SVCT1|10|14|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
12388748|Culture of HepG2 cells with griseofulvin has now been shown to induce both the formation of intracellular aggregates containing K18 as well as an increase in the abundance of K18 mRNA.|griseofulvin|K18|6|30|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23256625|This study provides a mechanistic understanding of the in vivo inhibition of transporters and enzymes by GSK1292263.|GSK1292263|transporters|17|13|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
10567921|  The N-terminus of the type 1 interferon receptor subunit, IFNAR1, has high amino acid sequence similarity to the receptor binding B subunit of the Escherichia coli-derived verotoxin 1, VT1.|N|type 1 interferon receptor subunit|2|5|Arg1:T14|Arg2:T40|CHEMICAL|GENE-Y|PART-OF
23085435|  Nitrogen-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small G-proteins.|bisphosphonates|G-proteins|2|17|Arg1:T3|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|JNK|11|35|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|efavirenz|hPXR|6|19|Arg1:T12|Arg2:T47|CHEMICAL|GENE-Y|AGONIST
22815248|In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and cytochrome P450, compared to the CCl4 only group.|CCl4|cytochrome P450|30|24|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR
23639801|CID16020046 concentration-dependently inhibited LPI-induced activation of nuclear factor of activated T-cells (NFAT), nuclear factor kappa of activated B cells (NF-κB) and serum response element (SRE), translocation of NFAT and NF-κB, and GPR55 internalization.|LPI|nuclear factor of activated T-cells|4|7|Arg1:T12|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR
18794803|The CRAF inhibitor sorafenib was found to induce a time-dependent reduction in both BAD phosphorylation and Bcl-2 expression in the D594G/G469E lines only.|sorafenib|CRAF|4|2|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
16395286|Minocycline showed more potent inhibition on MMP-9 mRNA expression, starting at 1 (P<0.005) and further at more than 30 (P<0.001) mg/kg/day.|Minocycline|MMP-9|1|7|Arg1:T12|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23470629|Measurement of Transport Activities of 3β-Hydroxy-Δ(5)-bile Acids in Bile Salt Export Pump and Multidrug Resistance-Associated Proteins Using LC-MS/MS.|3β-Hydroxy-Δ(5)-bile Acids|Multidrug Resistance-Associated Proteins|6|18|Arg1:T10|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE
12170055|Meperidine inhibited the production of forskolin-stimulated cyclic adenosine monophosphate mediated by all receptor subtypes but was most effective at the alpha(2B) adrenoceptor (alpha(2B), 0.6 microm; alpha(2A), 1.3 mm; alpha(2C), 0.3 mm), reaching the same level of inhibition (approximately 70%) as achieved with the alpha2-adrenoceptor agonist dexmedetomidine.|Meperidine|alpha(2B) adrenoceptor|1|21|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR
17611273|In hippocampal dentate gyrus, MPH-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of neural cell adhesion molecule).|MPH|NET|6|14|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12085361|100 micromol/L rifampicin inhibited OATP-C- and OATP8-, OATP-B- and OATP-A-mediated BSP uptake by 66%, 96%, 25%, and 49%, respectively.|BSP|OATP-A|12|11|Arg1:T7|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
17308037|Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity.|BRL-50481|PDE7|65|63|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
23193181|Based on animal and in vitro studies, resveratrol reverts these risk factors via stimulation of silent mating type information regulation 2 homolog 1 (SIRT1), but data in human subjects are scarce.|resveratrol|SIRT1|9|26|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|ACTIVATOR
16010590|CONCLUSIONS: The combination of TFT with the antifolates AG337, ZD1694 and GW1843 is mainly additive when the drugs are given simultaneously and this is mediated by an additive TS inhibition and DNA damage.|TFT|TS|6|31|Arg1:T19|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR
12668769|The ratio between the GDC/SHMT and C1-THF synthase/SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1.|[(13)C]formate|C1-THF synthase|23|7|Arg1:T12|Arg2:T57|CHEMICAL|GENE-Y|SUBSTRATE
12697717|Collectively, these results suggest a role for 17 beta HSDXI in androgen metabolism during steroidogenesis and a possible role in nonsteroidogenic tissues including paracrine modulation of 5 alpha-androstane-3 alpha, 17 beta-diol levels.|androgen|17 beta HSDXI|13|9|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
15814851|The potent and selective third-generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were introduced into the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies.|anastrozole|aromatase|9|6|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|GRE|4|14|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
17553661|HepG2 cells transfected with an hGSTA4 vector construct exhibited high steady-state hGSTA4 mRNA, high GST-4-HNE catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells.|4-HNE|GST-4|17|16|Arg1:T27|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE
15133856|Ang II level in plasma and mesenteric arteries in SHR group was the same or lower than that in WKY group, and was higher in irbesartan group and lower in imidapril group.|imidapril|Ang II|32|1|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23541125|The fine particulate (PM < 2.5 μm) of wood smoke were the most potent TRPA1 agonists and several chemical constituents of wood smoke particulate, 3,5-ditert-butylphenol, coniferaldehyde, formaldehyde, perinaphthenone, agathic acid, and isocupressic acid, were TRPA1 agonists.|agathic acid|TRPA1|36|44|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|AGONIST
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|benzolamide|hCA VI|31|35|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
16926278|GAF-B contributes to dimerization of PDE5, inhibition of cGMP binding to GAF-A, and sequestration of the phosphorylation site.|cGMP|GAF-A|10|13|Arg1:T17|Arg2:T49|CHEMICAL|GENE-N|DIRECT-REGULATOR
6150080|Positive staining of mitochondria was achieved in the presence of the MAO substrate, tryptamine.|tryptamine|MAO|15|12|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|SUBSTRATE
15650315|The aim of this study was to determine the mechanism of pranlukast-induced interleukin-5 (IL-5) inhibition in allergic inflammation.|pranlukast|interleukin-5|12|13|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
7739347|Dihydroetorphine and etorphine have almost the same binding affinities to all types (mu, delta, and kappa) of opioid receptors and antagonist binding sites, and have similar inhibition activities to forskolin stimulated adenylyl cyclase.|etorphine|adenylyl cyclase|3|37|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|amino acids|LAT3|21|11|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23382458|Ketoconazole decreased the P-gp-mediated apixaban efflux in Caco-2 and the P-gp-cDNA-transfected cell monolayers, but did not affect the apixaban efflux to a meaningful extent in the BCRP-cDNA-transfected cell monolayers.|apixaban|P-gp|20|11|Arg1:T1|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
25225185|In the lateral geniculate nucleus, brexpiprazole displayed alpha1B-adrenoceptor antagonistic action.|brexpiprazole|alpha1B-adrenoceptor|7|9|Arg1:T10|Arg2:T37|CHEMICAL|GENE-Y|ANTAGONIST
23380305|Here we report that systemic administration of the non-imidazole histamine H3 receptor antagonist 4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile (ABT-239, 3 mg/kg) increased c-Fos expression dose-dependently in rat cortex and nucleus basalis magnocellularis (NBM) but not in the nucleus accumbens (NAcc) nor striatum, and augmented acetylcholine and histamine release from rat prefrontal cortex.|ABT-239|c-Fos|31|37|Arg1:T13|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22878908|We have previously reported that TZDs reduce estrogen synthesis by inhibiting aromatase activity in human granulosa cells (HGC).|estrogen|aromatase|8|12|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
23357361|β-Asarone appeared to increase expression of lamin B1, p53, p21, but not lamin A/C.|β-Asarone|p53|1|10|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|hydroxyl|dopamine transporter|45|56|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR
14720519|In the present work, we found for the first time that uPAR stimulation with the amino-terminal fragment (ATF) of urokinase devoid of proteolytic activity transactivates the EGFR in mammary MCF-7 cells through a mechanism involving Src and a metalloproteinase, as indicated by its sensitivity to selected inhibitors.|amino|urokinase|17|23|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|PART-OF
15650315|RESULTS: Pretreatment of lung tissues with pranlukast alone significantly decreased the amount of IL-5 protein in the culture medium by 40%.|pranlukast|IL-5|8|15|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|epsilon-aminocaproic acid|tissue plasminogen activator|40|22|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|IL-1RI|6|29|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10224140|When expressed in Xenopus laevis oocytes, OAT3 mediated the uptake of organic anions, such as p-aminohippurate (Km = 65 microM), ochratoxin A (Km = 0.74 microM), and estrone sulfate (Km = 2.3 microM) and a cationic compound, cimetidine.|estrone sulfate|OAT3|36|8|Arg1:T26|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE
16469680|Selective COX-2 inhibition with nimesulide and COX-1 inhibition with low-dose aspirin appear to be well-tolerated in the short-term.|aspirin|COX-1|11|7|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23284002|In conclusion, this study provides the first evidence implicating that TSA inhibits TGF-β-induced ROS accumulation and myofibroblast differentiation via enhanced Nrf2-ARE signaling.|TSA|Nrf2|12|22|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23267011|DNA polymerase minor groove interactions modulate mutagenic bypass of a templating 8-oxoguanine lesion.|8-oxoguanine|DNA polymerase minor groove|12|1|Arg1:T22|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
10626810|In this report, we evaluated the growth-inhibitory effects of sulindac sulfide, a COX-1 and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines.|NDGA|lipoxygenase|41|45|Arg1:T27|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
12411515|Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria.|isoflurane|complex I|3|12|Arg1:T41|Arg2:T57|CHEMICAL|GENE-Y|INHIBITOR
12652111|  We investigated the basis for the difference in the cardiotonic effects of the PDE3 inhibitors cilostazol and milrinone in the rabbit heart.|cilostazol|PDE3|16|14|Arg1:T34|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR
17603759|  L-2-hydroxyglutaric aciduria is a metabolic disorder in which L-2-hydroxyglutarate accumulates as a result of a deficiency in FAD-linked L-2-hydroxyglutarate dehydrogenase, a mitochondrial enzyme converting L-2-hydroxyglutarate to alpha-ketoglutarate.|L-2-hydroxyglutarate|L-2-hydroxyglutarate dehydrogenase|9|19|Arg1:T20|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|TFT|TS|36|28|Arg1:T25|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|oxymorphone|CYP2D6|33|24|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
20497523|In the TT-specific DTH model, EE and the selective ERalpha agonist ERA-63 suppressed the TT-specific swelling response in WT and ERbetaKO mice but not in ERalphaKO mice.|ERA-63|ERalpha|13|11|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
16982784|  Among the TEM-type extended-spectrum beta-lactamases (ESBLs), an amino acid change at Ambler position 104 (Glu to Lys) results in increased resistance to ceftazidime and cefotaxime when found with other substitutions (e.g., Gly238Ser and Arg164Ser).|Lys|ESBLs|21|7|Arg1:T3|Arg2:T40|CHEMICAL|GENE-N|PART-OF
16926278|To probe potential PDE5 R domain effects on catalytic site affinity for certain inhibitors, four N-terminal truncation mutants were generated: PDE5Delta1-321 contained GAF-B domain, C domain, and the sequence between GAF-A and -B; PDE5Delta1-419 contained GAF-B and C domain; PDE5Delta1-465 contained the C domain and the C-terminal portion of GAF-B; and PDE5Delta1-534 contained only C domain.|C|PDE5Delta1-534|53|59|Arg1:T20|Arg2:T58|CHEMICAL|GENE-Y|PART-OF
2877081|  Nizatidine (LY139037), a selective histamine H2-receptor antagonist, is a potent inhibitor of gastric acid secretion.|LY139037|histamine H2-receptor|3|8|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|ANTAGONIST
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|2,3,7,8-tetrachlorodibenzodioxin|CYP1A1|25|8|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|brinzolamide|hCA VI|18|35|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23256625|This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the HMG-coA reductase inhibitors simvastatin and rosuvastatin.|GSK1292263|GPR119|9|13|Arg1:T14|Arg2:T37|CHEMICAL|GENE-Y|AGONIST
8760245|beta 2-Adrenoceptor activation results in increases in Na-K-ATPase and Na transport as a consequence of increased apical sodium entry.|sodium|Na-K-ATPase|18|8|Arg1:T19|Arg2:T42|CHEMICAL|GENE-N|SUBSTRATE
23266269|Moreover, ganodermanondiol increased cellular glutathione levels and the expression of the glutamine-cysteine ligase gene in a dose-dependent manner.|ganodermanondiol|glutamine-cysteine ligase|3|13|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10658902|With respect to the quinone co-substrate of the dihydroorotate dehydrogenase, atovaquone (Kic = 2.7 microM) and dichloroally-lawsone (Kic = 9.8 nM) were shown to be competitive inhibitors of human dihydroorotate dehydrogenase.|atovaquone|human dihydroorotate dehydrogenase|12|34|Arg1:T6|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
23583884|In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and NF-κB activation induced by TCDD can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells.|TCDD|cytokine|20|14|Arg1:T8|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR
20605094|  We investigated the inhibitory activity of several 1,3,4-thiadiazole-sulfonamides against all catalytically active CA (EC 4.2.1.1), CA I-XV.|1,3,4-thiadiazole-sulfonamides|CA|8|13|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|matrix metalloproteinase-13|17|20|Arg1:T16|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23384446|Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the G protein-coupled receptor agonist acetylcholine (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump.|ACh|G protein-coupled receptor|36|30|Arg1:T20|Arg2:T38|CHEMICAL|GENE-N|AGONIST
22708686|The agonist activity was antagonized by the selective kappa-opioid blocker nor-binaltorphimine (nor-BNI).|nor-BNI|kappa-opioid|13|9|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|alpha 2MR|30|21|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|leptin|1|25|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23611809|In conclusion, this study expands the understanding of the substrate specificity of UGT2B10, highlighting its preference for tertiary amines with higher affinities and clearance values than those of UGT1A4 and UGT1A3.|tertiary amines|UGT2B10|20|14|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
12488248|Probenecid-sensitive uptake of p-aminohippurate (PAH, an Oat1 and Oat3 substrate) and estrone sulfate (ES, an Oat3 substrate) in rat Oat3-expressing oocytes was significantly trans-stimulated by preloading the oocytes with the dicarboxylate glutarate (GA).|Probenecid|Oat1|1|9|Arg1:T23|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
11426832|The Ki values of betamipron, cilastatin, KW-3902 and probencid for human-OAT1 were 23.6, 1470, 7.82 and 12.1 microM, whereas those for human-OAT3 were 48.3, 231, 3.70 and 9.0 microM.|cilastatin|human-OAT3|7|27|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23287700|Results indicate that AM4054 serves as an effective CB(1) discriminative stimulus, with an onset and time course of action comparable with that of the CB(1) agonist Δ(9)-tetrahydrocannabinol, and that the inverse agonist rimonabant and the neutral antagonist AM4113 produce dose-related rightward shifts in the AM4054 dose-effect curve, indicating that both drugs surmountably antagonize the discriminative stimulus effects of AM4054.|AM4054|CB(1)|72|29|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|AGONIST
23319419|ICA is a mixed agonist of mutant EAG and EAG/ERG chimera channels that inactivate by a combination of slow and fast mechanisms.|ICA|ERG|1|11|Arg1:T17|Arg2:T22|CHEMICAL|GENE-Y|AGONIST
17168665|Other FASN inhibitors such as the cerulenin derivative C75, the beta-lactone orlistat, the green tea polyphenol epigallocatechin-3-gallate (EGCG) and other naturally occurring flavonoids (i.e., luteolin, quercetin, and kaempferol), as well as the antibiotic triclosan, have been identified and have been shown to limit cancer cell growth by inducing apoptotic cell death.|cerulenin|FASN|7|2|Arg1:T10|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
8799556|(+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned human alpha 1D adrenoceptors.|Rec 15/2739|human alpha 1D adrenoceptors|14|46|Arg1:T4|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23273999|ATPase stimulation kinetics could be modeled for the entactogen 3,4-methylenedioxy-α-ethylphenethylamine (3,4-BDB), the hallucinogen 2,5-dimethoxy-4-iodoamphetamine (DOI), the abused alkaloid glaucine, the opioid-like drugs N-iso-propyl-1,2-diphenylethylamine (NPDPA), and N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA), with K(m) and V(max) values within the same range as for verapamil or sertraline.|3,4-BDB|ATPase|12|1|Arg1:T2|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
23473803|With this objective, we utilised a high-throughput computational approach that identified moexipril, a well tolerated and safe angiotensin-converting enzyme (ACE) inhibitor, as a PDE4 inhibitor.|moexipril|angiotensin-converting enzyme|13|20|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
23228696|Overall, our results suggest that inhibition of the p38 MAPK signaling by metformin coupled with paclitaxel therapy in human NSCLC cells may be a clinically useful combination, which however will require further validation.|metformin|MAPK|14|11|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
9059856|In order to perform a pharmacological characterization of these receptors, competition binding experiments were carried out using the muscarinic receptor antagonists pirenzepine, (11(2-diethyl-amino)methyl)-1-piperidinylacetyl-5-11-dihydro-6H-py rido(14) benzodiazepine (AF-DX 116), himbacine, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), dicyclomine and hexahydro-sila-difenidol (HHSD).|HHSD|muscarinic receptor|55|20|Arg1:T27|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST
15866500|These findings suggest that the mechanism of antiproliferative toxicity of capecitabine is at least partly due to TS inhibitory activity of its active metabolite 5-fluoro-2'-deoxyuridine monophosphate (FdUMP).|FdUMP|TS|28|18|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
22552008|Long-term selection for lenalidomide resistance in H929 myeloma cell lines was accompanied by a reduction in CRBN, while in DF15R myeloma cells resistant to both pomalidomide and lenalidomide, CRBN protein was undetectable.|lenalidomide|CRBN|4|17|Arg1:T2|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|bepridil|ion channel|12|2|Arg1:T8|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
1407010|Autoradiographic studies were performed on rabbit brain slices using [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and mesulergine (in order to mask 5-HT1A and 5-HT1C binding sites) and [125I]CYP (iodocyanopindolol) in the presence of 3 mumol/l isoprenaline and 100 nmol/l 8-OH-DPAT (in order to mask beta adrenoceptor and 5-HT1A binding sites).|8-OH-DPAT|5-HT1C|21|31|Arg1:T9|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|Akt1|3|10|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|5-methylurapidil|alpha 1-adrenoceptor|18|3|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
17929831|AdSS from the thermophilic archaea, Methanocaldococcus jannaschii (MjAdSS) is 345 amino acids long against an average length of 430-457 amino acids for most mesophilic AdSS.|amino acids|MjAdSS|14|10|Arg1:T14|Arg2:T24|CHEMICAL|GENE-Y|PART-OF
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|NIS|hNET|79|74|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
9059856|In brush-border membranes, the receptor found match in terms of affinity for the antagonists with the muscarinic M1 receptor subtype (Ki pirenzepine, 13.6 +/- 8.2 nM; Ki AF-DX 116, 1680 +/- 271 nM; Ki himbacine, 212 +/- 6.5 nM; Ki 4-DAMP.|AF-DX 116|muscarinic M1 receptor subtype|32|18|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST
10598120|BIO TO-2 cardiomyopathic hamsters (CMHs) in the early stages of dilated heart failure were treated with vehicle or maximal ACE inhibitory doses of captopril (750 micromol/kg/day) or omapatrilat (200 micromol/kg/day).|captopril|ACE|26|22|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23229511|In addition, 17-AAG treatment reduced cell viability, CDK2, CDK4, cyclin E, cyclin D1, and phosphorylated Rb levels in AhR-expressing lung AD cells.|17-AAG|cyclin E|4|14|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23367873|Progression in the field has taken a recent step forward with the approval of ruxolitinib (Jakafi), a selective inhibitor of JAK1/2 and very recently tofacitinib (Xeljanz), a pan-JAK inhibitor.|tofacitinib|JAK|28|35|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
2248058|Phenelzine, isocarboxazid and tranylcypromine were nonspecific, inhibiting MAO-A and MAO-B to about the same extent.|Phenelzine|MAO-A|1|10|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23604722|FBP suppressed the production of reactive oxygen species (ROS) but did not affect cyclooxygenase-2 expression and prostaglandin E2 production in endothelial cells stimulated with LPS.|prostaglandin E2|cyclooxygenase-2|19|16|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|PRODUCT-OF
23291050|ChE activity was measured with acetylthiocholine as substrate and CES activity was measured with four substrates: p-nitrophenyl acetate, p-nitrophenyl butyrate, 1- and 2-naphthyl acetate.|p-nitrophenyl acetate|CES|18|10|Arg1:T18|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE
16781459|Both H(2)S solution prepared by bubbling pure H(2)S gas and NaSH, a H(2)S donor, dose dependently induced HO-1 expression through the activation of the extracellular signal-regulated kinase (ERK).|H(2)S|ERK|2|43|Arg1:T25|Arg2:T64|CHEMICAL|GENE-N|ACTIVATOR
11920914|Peripheral site ligands accelerate inhibition of acetylcholinesterase by neutral organophosphates.|organophosphates|acetylcholinesterase|10|7|Arg1:T16|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23473805|Rp1 and actinomycin D reduced Src activity, and overexpression of active Src decreased the synergistic effect of Rp1 with actinomycin D.|Rp1|Src|1|6|Arg1:T7|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
17632548|10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref.|glutathione|microsomal prostaglandin E synthase 1|22|37|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
9059856|In brush-border membranes, the receptor found match in terms of affinity for the antagonists with the muscarinic M1 receptor subtype (Ki pirenzepine, 13.6 +/- 8.2 nM; Ki AF-DX 116, 1680 +/- 271 nM; Ki himbacine, 212 +/- 6.5 nM; Ki 4-DAMP.|himbacine|muscarinic M1 receptor subtype|41|18|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
20372850|  Thymidine kinase-1 (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo pyrimidine synthesis, respectively.|pyrimidine|thymidylate synthase|20|7|Arg1:T16|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF
18045203|Compounds 1 and 2 potently displaced (3)H-NMS binding at m1, m3 and m4 receptors, but were less potent at the m2 and m5 subtypes.|(3)H-NMS|m5|7|28|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23639626|The induction of IGFBP-4 protein was dependent on a functional aryl hydrocarbon receptor and was preceded by a rapid increase in the level of IGFBP-4 mRNA indicating that IGFBP-4 is a previously unknown transcriptional target of TCDD in 5L cells.|TCDD|IGFBP-4|37|25|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23611809|These are drugs that were previously reported to be substrates for UGT1A4 or UGT1A3 and that contain in their structure either tertiary aliphatic amines, cyclic amines, or an imidazole group.|imidazole|UGT1A3|31|14|Arg1:T22|Arg2:T43|CHEMICAL|GENE-Y|SUBSTRATE
2882965|Interference with lipoxygenase enzymes, rather than a steroid-like inhibition of arachidonic acid release from intracellular phospholipids, seems to be the mode of action.|arachidonic acid|lipoxygenase|12|3|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE
23178380|In contrast to parenteral delivery of rBChE, which currently requires posttranslational modification for good plasma stability, an unmodified aer-rBChE pretreatment given 1-40h prior to >1 LD50 of aer-paraoxon (Px) was able to prevent inhibition of circulating cholinesterase in a dose-dependent manner.|paraoxon|cholinesterase|32|42|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ACTIVATOR
17602574|Moreover, the CDO active site is essentially unreactive toward NO in the absence of substrate, suggesting an obligate ordered binding of l-cysteine prior to NO.|NO|CDO|27|4|Arg1:T40|Arg2:T57|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23429263|  The pro-apoptotic BCL-2 family member BOK is widely expressed and resembles the multi-BH domain proteins BAX and BAK based on its amino acid sequence.|amino acid|BAK|22|18|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|PART-OF
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFP|COX-2|7|13|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
22614004|We have previously shown that the inhibitor of pyruvate dehydrogenase kinase (PDK) dichloroacetate (DCA) activates glucose oxidation and induces apoptosis in cancer cells in vitro and in vivo.|dichloroacetate|pyruvate dehydrogenase kinase|15|9|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23612487|These findings suggest that S1P activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of β-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively.|S1P|osteoptotegerin|5|29|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
21413019|The rate-limiting polyamine biosynthetic enzymes, ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase, are essential for mammalian development, with knockout of the genes encoding these enzymes, Odc1 and Amd1, causing early embryonic lethality in mice.|polyamine|S-adenosylmethionine decarboxylase|3|13|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|PRODUCT-OF
10460702|These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the eNOS selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).|L-Nomega -monomethyl-L-arginine|eNOS|31|23|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST
23620436|MNU-induced lesions presented markers indicative of an aggressive phenotype: lack of basal cells, rupture of the smooth muscle cell layer, loss of E-cadherin, and high MGMT staining.|MNU|E-cadherin|1|26|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23229512|Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for VK2-induced cytochrome c (cyt c) release and cell death.|VK2|cytochrome c|33|34|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12227806|Practical asymmetric synthesis of aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction.|aprepitant|NK-1 receptor|5|10|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|ANTAGONIST
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|Rivastigmine|AChE|1|15|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
23466488|The objective of the present investigation was to evaluate l-glutamine increases glucagon like peptide-1 (GLP-1) (7-36) amide secretion in streptozotocin-nicotinamide (STZ-NTM) induced diabetic Sprague Dawley rats.|l-glutamine|GLP-1|10|16|Arg1:T18|Arg2:T55|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17067304|Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, BDNF and ChAT that was eliminated by olanzapine treatment.|quinpirole|ChAT|7|19|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16782438|The concentration of imatinib necessary to inhibit RET in vitro, however, makes it impossible to conclude that imatinib monotherapy will be a good option for systemic therapy of MTC.|imatinib|RET|4|8|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
22815248|A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after CCl4 and PC administration alone.|CCl4|alanine aminotransferase|35|8|Arg1:T22|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|citrulline|AS|20|13|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
17324065|Repeated cocaine resulted in CREB phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine, but rats challenged after 2 drug-free days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell.|cocaine|CREB|28|43|Arg1:T9|Arg2:T12|CHEMICAL|GENE-N|ACTIVATOR
15114505|  Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (DGAT).|kushenol H|diacylglycerol acyltransferase|24|49|Arg1:T19|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|acenaphthene|P450 2A13|23|6|Arg1:T29|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|Raf-1|4|16|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23512537|CYP3A4 and CYP3A5 metabolized BDP via hydroxylation ([M4] and [M6]) and dehydrogenation ([M5]) at similar rates; CYP3A7 did not metabolize BDP.|BDP|CYP3A4|5|1|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23220590|At therapeutic drug levels (0.015 mM) and physiologically relevant concentrations of ethanol (10 mM) and acetaldehyde (10 μM) in target tissues, cimetidine could weakly inhibit (<5%) the activities of ADH1B2 and ADH1B3 in liver, ADH2 in liver and small intestine, ADH4 in stomach, and ALDH1A1 in the three tissues, but not significantly affect ADH1A, ADH1B1, ADH1C1/2, or ALDH2.|ethanol|ADH4|14|54|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
10500149|  Our earlier report suggested that androst-5-ene-3beta,7beta-diol (Delta(5)-androstenediol or Adiol) is a natural hormone with androgenic activity and that two potent antiandrogens, hydroxyflutamide (Eulexin) and bicalutamide (Casodex), fail to block completely the Adiol-induced androgen receptor (AR) transactivation in prostate cancer cells.|Adiol|AR|44|48|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W dihydrochloride|E-selectin|20|36|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|choline|flavin mono-oxygenase|26|5|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
16326016|Given that glutamine is the predominant precursor for releasable pools of glutamate, our observation that estradiol increases glutamine synthetase gene and protein expression suggests that hormonal regulation of glutamate neurotransmission involves hormonally responsive glia.|glutamate|glutamine synthetase|30|19|Arg1:T9|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE
23414802|In this study, a novel series of 2-hydroxydiarylamide derivatives were synthesized and evaluated for inhibiting TMPRSS4 serine protease activity and suppressing cancer cell invasion.|2-hydroxydiarylamide|serine protease|9|18|Arg1:T1|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR
10879806|Flutamide administration decreased body weight gain, serum IGF-I levels, hepatic IGF-I mRNA, and GH receptor mRNA content.|Flutamide|IGF-I|1|9|Arg1:T12|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|ethynylestradiol|Mrp2|24|40|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|glutathione|DIC|38|16|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
17334413|  Histamine regulates many functions by binding to four histamine G-coupled receptor proteins (H1R, H2R, H3R and H4R).|Histamine|H3R|1|18|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8697470|After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received aurintrycarboxilic acid (ATA), an inhibitor of platelet glycoprotein Ib/von Willebrand factor interaction (10 mg/kg i.v. bolus).|aurintrycarboxilic acid|glycoprotein Ib|97|107|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
17403374|Furthermore, the enzymatic activity of alanine aminotransferase (ALT), which converts the critical gluconeogenic amino acid alanine into pyruvate, is decreased (approximately 50%) in KLF15-/- hepatocytes.|alanine|alanine aminotransferase|20|7|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE
17604186|With this background, the present study was designed to explore the possible effect of nimesulide (a preferential COX-2 inhibitor) against pentylenetetrazol (PTZ)-induced kindling epilepsy in mice.|nimesulide|COX-2|16|20|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23274898|Electrical Stimuli Release ATP to Increase GLUT4 Translocation and Glucose Uptake via PI3Kγ-Akt-AS160 in Skeletal Muscle Cells.|Glucose|GLUT4|10|7|Arg1:T24|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|desoxypeganine|acetylcholinesterase|19|10|Arg1:T13|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
19997047|Inhibition of interferon gamma and TNF-alpha production increased from 7% (+/-1%) and 31% (+/-6%) (PTX alone) to 49% (+/-2%) and 69% (+/-6%), respectively.|PTX|TNF-alpha|24|6|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
1327384|The selective alpha 2-adrenoceptor antagonists, idazoxan, yohimbine, rauwolscine and WY 26703 displaced [3H]-RS-15385-197 binding to rat cerebral cortex in a simple manner with Hill slopes close to unity.|idazoxan|alpha 2-adrenoceptor|7|3|Arg1:T33|Arg2:T46|CHEMICAL|GENE-N|ANTAGONIST
23146758|Direct assessment of aromatase activity by dibenzylfluorescein assay and indirect assessment of aromatase activity by measurement of the conversion of testosterone to estradiol confirmed that 5-OH-BDE-47 and 6-OH-BDE-47 stimulate aromatase activity.|testosterone|aromatase|21|13|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE
23074173|We demonstrated that deferasirox increased expression of the metastasis suppressor protein N-myc downstream-regulated gene 1 and upregulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1) while decreasing cyclin D1 levels.|deferasirox|cyclin-dependent kinase inhibitor p21|4|19|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23223023|  Metabolic profiling of plasma nonesterified fatty acids discovered that palmitic acid (PA), a natural peroxisome proliferator-activated receptor γ (PPARγ) ligand, is a reliable type 2 diabetes biomarker.|palmitic acid|PPARγ|10|23|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23247009|  Aldose reductase (AR) catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).|aldehydes|AR|12|4|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
23271742|Here we found that arsenic trioxide, a frontline agent for acute promyelocytic leukemia, inhibits ΔNp63 but not TAp63 expression in time- and dose-dependent manners.|arsenic trioxide|ΔNp63|5|17|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16860312|Administration of dimaprit (1-10 mg/kg x 2), an H2/H4 agonist, mimicked the protective effect of histamine, and the effect of dimaprit is reversed by thioperamide, whereas neither H1 nor H2 antagonists altered the outcome caused by dimaprit.|thioperamide|H4|30|13|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|phenethylamine|TA1|20|27|Arg1:T9|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR
23339682|Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively.|caffeine|CYP1A2|44|19|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17603555|  BACKGROUND AND PURPOSE: AMP-activated protein kinase (AMPK) is activated by metformin, phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).|AICAR|AMPK|25|9|Arg1:T27|Arg2:T57|CHEMICAL|GENE-Y|ACTIVATOR
17606858|Conversely fenofibrate increased peroxisome proliferator-activated receptor-alpha, peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression, and acetyl coenzyme A carboxylase phosphorylation (P<0.05 for all) in aldosterone-infused hearts; uncoupling protein-3 and medium-chain acyl coenzyme A dehydrogenase protein expression decreased with fenofibrate (P<0.05 and P<0.01, respectively, versus aldosterone-infused), suggesting that improved myocardial remodeling is independent of fatty acid oxidation.|fenofibrate|acetyl coenzyme A carboxylase|2|15|Arg1:T10|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
10373451|Of the PDE inhibitors tested, dipyridamole was most effective, with IC50 values of 1.2 and 0.45 microM for inhibition of cAMP and cGMP hydrolysis, respectively.|dipyridamole|PDE|7|3|Arg1:T10|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
14642426|Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of IL-6 level in macrophage rather than in the brain.|ginseng saponins|IL-6|12|41|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23261705|Furthermore, insulin-stimulated T-I cell proliferation and the expression of cell cycle regulatory proteins CDK4, CCND3 and PCNA were also blocked by rapamycin.|rapamycin|cell cycle regulatory proteins|24|11|Arg1:T1|Arg2:T25|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23357976|  Type 2 11β-hydroxysteroid dehydrogenase encoded by the HSD11B2 gene converts cortisol to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids.|cortisol|Type 2 11β-hydroxysteroid dehydrogenase|11|1|Arg1:T7|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
17369473|Metformin and phenformin, which are biguanides, have been reported to increase AMPK activity without increasing AMP/ATP.|phenformin|AMPK|3|14|Arg1:T25|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
11426832|Organic anion transport inhibitors including betamipron, cilastatin, KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine) and probenecid significantly inhibited human-OAT1- and human-OAT3-mediated organic anion uptake in a dose-dependent manner.|cilastatin|human-OAT3|8|24|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
16860312|Neither mepyramine (3 mg/kg x 2), an H1 antagonist, nor cimetidine (15 mg/kg x 2), an H2 antagonist, affected the outcome in histamine-treated rats.|cimetidine|H2|15|24|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|tumor necrosis factor-α|1|18|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16305240|2004, 126, 8167-8180.) showed that when AdoCbl is bound to the MMCM active site, no enzymatic perturbation of the Co3+ Cbl electronic structure occurs, even in the presence of substrate (analogues).|AdoCbl|MMCM|11|16|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17124432|Neuronal NE reuptake may be impaired in individuals with renal disease and/or hypertension due to dysfunction of the NE transporter.|NE|NE transporter|2|19|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE
17321471|The selective A(2A) receptor antagonist ZM241385 (30 nM), but not the selective A(2B) receptor antagonist MRS1754 (30 nM), blocked the inhibitory effect of NECA and CGS21680 on TNF-alpha release.|ZM241385|TNF-alpha|9|40|Arg1:T29|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|SKF 89976-A|GAT3|5|30|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
17929114|The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias.|imatinib|tyrosine kinase|6|3|Arg1:T34|Arg2:T56|CHEMICAL|GENE-N|INHIBITOR
15871445|  Intolerance reactions to acetyl salicylic acid (ASA) and nonsteroidal anti-inflammatory drugs (NSAIDs) are common and caused by inhibition of COX-1 enzyme.|acetyl salicylic acid|COX-1|4|24|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
21600945|TPM-increased B1R mRNA was prevented by co-treatments with N-acetyl-l-cysteine (potent antioxidant), diphenyleneiodonium (NADPH oxidase inhibitor), IL-1Ra (interleukin-1R antagonist) and SN-50 (specific inhibitor of NF-kB activation) but not by pentoxifylline (TNF-alpha release inhibitor), indomethacin and niflumic acid (COX-1 and -2 inhibitors).|pentoxifylline|TNF-alpha|39|41|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
23353902|In both females and males, FLU reversed the nuclear levels of GR and pGR246 without affecting CORT and GR mRNA levels.|FLU|pGR246|7|15|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15814851|Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.|imidazole|aromatase|14|2|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|acyl-CoAs|CrAT|11|4|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23066988|Our results show that Metformin directly inhibits stomach ghrelin production and secretion through AMPK.|Metformin|ghrelin|5|9|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23368743|The recent identification of zinc permeability of the lysosomal ion channel TRPML1 (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1 in zinc transport.|zinc|transient receptor potential mucolipin 1|5|14|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
9059856|1.5 +/- 0.4 nM; Ki dicyclomine, 5.1 +/- 0.8 nM; Ki HHSD, 34.3 +/- 7.3 nM), whereas the receptor in basal plasma membrane seems to be of the muscarinic M2 receptor subtype (Ki pirenzepine, 202 +/- 48 nM; Ki AF-DX 116, 124 +/- 60 nM; Ki himbacine, 20.6 +/- 4.8 nM; Ki 4-DAMP, 4.5 +/- 1.2 nM; Ki dicyclomine, 54.6 +/- 22 nM; Ki HHSD, 89.2 +/- 15.8 nM).|pirenzepine|muscarinic M2 receptor subtype|41|35|Arg1:T8|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|isoflurane|NADH:ubiquinone oxidoreductase|7|20|Arg1:T27|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR
23567241|These results indicate that parabens are selective agonists for ERβ over ERα; their interactions with ERα/β are dependent on the size and bulkiness of the alkyl groups; and they are metabolized by carboxylesterases, leading to attenuation of their estrogenic activity.|parabens|ERβ|5|10|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|AGONIST
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|c-Jun N-terminal protein kinase|11|30|Arg1:T1|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23395669|Moreover, compared with the model group, sophocarpine could significantly increase P-AMPKα (>5.82-fold), AMPKα (>1.29-fold) and ACC (>3.27-fold) protein expressions, and reduce P-ACC (<0.30-fold) and HNF-4α (<0.20-fold) protein expression.|sophocarpine|ACC|9|25|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|acetylcarnitine|Carnitine acetyltransferases|15|1|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
23248200|Interestingly, several oral antidiabetics (glyburide, glimepiride, troglitazone, pioglitazone, glipizide, gliclazide, and tolbutamide), but not metformin, were identified as significant inhibitors of the OATP1B1-mediated transport of rosuvastatin.|glyburide|OATP1B1|7|34|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
15899831|Concordant with this activity, in human umbilical vein endothelial cells, AZD2171 inhibited VEGF-stimulated proliferation and KDR phosphorylation with IC50 values of 0.4 and 0.5 nmol/L, respectively.|AZD2171|KDR|13|18|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
17553661|The alpha class human GSTA4-4 enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward 4-HNE conjugation.|4-HNE|human GSTA4-4|17|4|Arg1:T22|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE
23385959|These findings are the first to show that long-term exposure to Mn during a critical period of neurodevelopment causes motor coordination dysfunction with parallel increment in oxidative stress markers, p38(MAPK) phosphorylation and caspase activity in the striatum.|Mn|caspase|12|37|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR
2828423|Immunological titration of opioid binding activity from rat brain showed that the antibody was able to displace specific binding of [3H]etorphine (universal opioid) and [3H]dihydromorphine (mu opioid) from rat membranes, but was ineffective against the binding of [3H]ethylketocyclazocine (kappa [3H]D-Ala2,D-Leu5-enkephalin (delta opioid) or [3H]phencyclidine (phencyclidine/sigma receptor ligand).|[3H]dihydromorphine|mu opioid|30|35|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14610216|hOAT1, hOAT3, and hOAT4 but not hOAT2, mediated the uptake of bumetanide.|bumetanide|hOAT4|15|6|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
17315049|Like other DPP-4 inhibitors, sitagliptin reduces hemoglobin A1c (HbA1c), fasting and postprandial glucose by glucose-dependent stimulation of insulin secretion and inhibition of glucagon secretion.|sitagliptin|DPP-4|6|3|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
7665369|Ergovaline inhibition of the binding of the D2-specific radioligand, [3H]YM-09151-2, exhibited a KI (inhibition constant) of 6.9 +/- 2.6 nM, whereas dopamine was much less potent (370 +/- 160 nM).|Ergovaline|D2|1|8|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18056045|The inhibitory effects of the nitrogen-containing BPs (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their inhibition of farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.|zoledronate|farnesyl pyrophosphate synthase|17|28|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23500387|Our study demonstrated that curcumin inhibited OVA-induced increases in eosinophil count; interleukin (IL)-17A level were recovered in bronchoalveolar lavage fluid increased IL-10 level in bronchoalveolar lavage fluid.|curcumin|interleukin (IL)-17A|5|13|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
22815312|When the E(max) and EC(50) values were compared with those for carbamazepine and rifampin, estradiol was found to be as potent an inducer of CYP2B6 as rifampin and carbamazepine.|rifampin|CYP2B6|34|32|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|ACTIVATOR
17097861|In the present study, glucose-stimulated insulin secretion was significantly increased in GalN-treated rats compared to controls.|GalN|insulin|13|7|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
20557886|ICI 182780, an estrogen receptor antagonist and R,R-THC, an estrogen receptor beta antagonist, counteracted the effect of 3beta-Adiol while bicalutamide, an androgen receptor antagonist, had minor effects.|bicalutamide|androgen receptor|25|28|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|Akt|3|15|Arg1:T9|Arg2:T34|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23000451|This prompted the design of variants of BChE which exhibit significantly improved catalytic activity against (-)-cocaine.|(-)-cocaine|BChE|16|8|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE
23148920|Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells.|nitric oxide|endothelial nitric oxide synthase|4|11|Arg1:T36|Arg2:T47|CHEMICAL|GENE-Y|PRODUCT-OF
10667230|Suramin inhibited the anchorage-independent growth induced by IGF-1 or TGF alpha only at an IC50 of 100 micrograms/ml.|Suramin|IGF-1|1|8|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|E3174|AT1|30|4|Arg1:T32|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST
23046524|Based on these studies, the frequency of spontaneous tail contractions at 26 hpf - a developmental stage with minimal AChE expression and activity - was significantly higher following exposure to paraoxon concentrations as low as 31.2 nM.|paraoxon|AChE|32|21|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR
15694390|Expression of monocyte chemotactic protein-1 and interferon-gamma inducible protein-10 mRNA in response to IFN-gamma was significantly suppressed in the presence of NDGA, as was tyrosine-phosphorylation of JAK and STAT.|NDGA|STAT|22|30|Arg1:T11|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR
10517265|The CCK receptor antagonists blocked, in a dose-dependent manner, the response to 5-HT and to the selective agonists at 5-HT3 and 5-HT4 receptors, 2-methyl-5-hydroxytryptamine (2-Me-5-HT) and 5-methoxytryptamine (5-MeOT), respectively.|2-methyl-5-hydroxytryptamine|5-HT3|27|22|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|AGONIST
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|mazindol|hNET|81|74|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|flavin mononucleotide|Riboflavin kinase|25|1|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|Cabozantinib|RET|1|43|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
14633707|Thus, Ras utilizes autocrine signaling through EGFR to increase radioresistance, and the EGFR KI GW572016 acts as a radiosensitizer.|GW572016|Ras|17|3|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|17 alpha-hydroxy pregnenolone|Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase|23|1|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE
11716850|Binding experiments on mitiglinide, nateglinide, and repaglinide to SUR1 expressed in COS-1 cells revealed that they inhibit the binding of [3H]glibenclamide to SUR1 (IC50 values: mitiglinide, 280 nM; nateglinide, 8 microM; repaglinide, 1.6 microM), suggesting that they all share a glibenclamide binding site.|repaglinide|SUR1|43|28|Arg1:T6|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1328609|  Etorphine, a potent opioid agonist, has been reported to bind to both mu and epsilon opioid receptors.|Etorphine|epsilon opioid receptors|1|17|Arg1:T1|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
16547651|Glufosinate inhibits glutamine synthetase and blocks biosynthesis of glutamine.|glutamine|glutamine synthetase|9|3|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|PRODUCT-OF
23291630|The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.|navitoclax|BCL-2-like 1|15|24|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23604717|SAL-2 also downregulated COX-2 and iNOS expression induced by HNE, but salicylate did not.|HNE|COX-2|10|4|Arg1:T16|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12445705|However, 5-HT(1A) agonism may be important only for quetiapine-induced ACh release.|quetiapine|5-HT(1A)|13|3|Arg1:T22|Arg2:T56|CHEMICAL|GENE-Y|AGONIST
10485486|Likewise, the catalytic activity of the G2 checkpoint kinase, hChk1, was only marginally suppressed by caffeine but was inhibited potently by the structurally distinct radiosensitizer, UCN-01.|UCN-01|checkpoint kinase|30|9|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
11799102|Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.|Aliskiren|Ang II receptor|1|21|Arg1:T14|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST
23214926|  An effective method for the total synthesis of 1 (AMF-26), a potentially promising new anticancer drug that disrupts the Golgi system by inhibiting the ADP-ribosylation factor 1 (Arf1) activation, has been developed for the first time.|AMF-26|Arf1|11|32|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
7944828|The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).|spiroxatrine|5-HT1A|44|41|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
19996149|In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium-glucose cotransporter type II inhibitor, in animals and humans.|BMS-512148|sodium-glucose cotransporter type II|9|14|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
1315825|  OBJECTIVE: Candoxatril (UK79,300) is an orally available inhibitor of the neutral endopeptidase (E.C.3.4.24.11) which degrades atrial natriuretic factor (ANF).|Candoxatril|E.C.3.4.24.11|3|17|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23200945|  Previous studies showed that fitter yeast (Saccharomyces cerevisiae) that can grow by fermenting glucose in the presence of allyl alcohol, which is oxidized by alcohol dehydrogenase I (ADH1) to toxic acrolein, had mutations in the ADH1 gene that led to decreased ADH activity.|acrolein|alcohol dehydrogenase I|36|28|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|PRODUCT-OF
2886573|Exercise as well as isoprenaline infusion caused 100% increases in lymphocyte beta 2-adrenoceptor density; these increases were completely abolished by ICI 118,551, but not affected by bisoprolol.|isoprenaline|beta 2-adrenoceptor|5|13|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|dopamine|phenylalanine 4-monooxygenase|7|13|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
23103565|To demonstrate whether PDGF-BB induced ROS formation affects PKA dependent pathways, the effects of PDGF-BB on phosphorylation of serine 157 of vasodilator stimulated protein (VASP) a classical target of PKA were analysed.|serine|VASP|20|27|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|PART-OF
8842678|MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imipramine, maprotiline, amitriptyline, zimeldine, nomifensine, and viloxazine.|zimeldine|MAO-B|24|1|Arg1:T5|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
20512624|Additionally, tiagabine, SKF 89976-A, betaine, beta-alanine, nipecotic acid and guvacine were used to inhibit the GAT1, betaine/GABA (BGT1), GAT2 and GAT3 transporters.|nipecotic acid|GAT2|12|28|Arg1:T23|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
23056222|Finally, DMF suppressed unilateral ureteral obstruction (UUO)-induced renal fibrosis and alpha-SMA, fibronectin and type 1 collagen expression in the obstructed kidneys from UUO mice, along with increased and decreased expression of Nrf2 and phospho-Smad3, respectively.|DMF|fibronectin|3|17|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15102535|The present results showed that the cyclooxygenase-2 inhibitor, parecoxib, when administered parenterally, has potent antihyperalgesic, anti-inflammatory, antipyretic effects and has a better safety profile than with ketorolac, with sparing of cyclooxygenase-1 in the stomach in these animal models.|ketorolac|cyclooxygenase-1|32|37|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23393127|We hypothesized that CREB is activated by a distinct signaling pathway in response to pulsatile GnRH in a frequency-dependent manner to dictate the FSHβ transcriptional response.|GnRH|CREB|16|4|Arg1:T7|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|betamipron|human-OAT1|5|11|Arg1:T12|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
12513997|Interestingly, the allele of PRO1 was shown to enhance the activities of gamma-glutamyl kinase and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of L-proline synthesis from L-glutamate and which together may form a complex in vivo.|L-proline|gamma-glutamyl kinase|30|14|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF
8836655|Pretreatment of the tissues with combined 5-HT1/5-HT2 antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction.|methysergide|5-HT1|10|7|Arg1:T18|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST
2146972|  We have previously shown that human placental estradiol-17 beta dehydrogenase (EC 1.1.1.62; 17 beta-EDH) catalyzes the conversion of estradiol-17 beta to estrone and stereospecifically reduces NAD+ to [4-pro-S]NADH, [( 4-B]NADH).|NAD+|human placental estradiol-17 beta dehydrogenase|29|6|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
23497867|Considering apoptosis-related factors, the polysaccharides suppressed AKT activity through the inhibition of AKT phosphorylation at Thr(308) and/or Ser(473).|Ser|AKT|22|14|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PART-OF
15161930|Although no natural ligand is known, ERRgamma is deactivated by the estrogen receptor (ER) agonist diethylstilbestrol and the selective ER modulator 4-hydroxytamoxifen but does not significantly respond to estradiol or raloxifene.|diethylstilbestrol|estrogen receptor|19|13|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
23561191|In this study, we investigated if ω- and β-oxidation mediate catabolism of the AR homologue C19:0 to form 3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA), using 3 in vitro platforms, human cytochrome P450 4F2 (CYP4F2), human liver S9, and HepG2 cells.|3,5-dihydroxybenzoic acid|CYP4F2|20|44|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|PRODUCT-OF
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|prazosin|adrenoceptor|11|40|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|ANTAGONIST
23643094|Although it has been shown that NDGA induces Nrf2 nuclear translocation in renal epithelial LLC-PK1 cells in culture, it is unknown if NDGA may induce Nrf2 translocation in vivo.|NDGA|Nrf2|7|9|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
23073075|Neuroprotection was attenuated by pertussis toxin, and inhibited by the selective type-1 S1PR (S1P1R) antagonist, W146, and by inhibitors of the mitogen associated protein kinase (MAPK) and the phosphatidylinositol-3-kinase (PtdIns-3-K) pathways.|W146|S1P1R|20|16|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|sulfonylureas|PPARgamma|11|24|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|cGMP|Y612A|4|31|Arg1:T33|Arg2:T57|CHEMICAL|GENE-N|DIRECT-REGULATOR
23295227|Structural analysis of the V301L AKR1B10-fidarestat complex displayed enzyme-inhibitor interactions similar to those of the AR-fidarestat complex.|fidarestat|AKR1B10|7|6|Arg1:T23|Arg2:T54|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23562928|  The purpose of this study is to investigate the effects of n-hexane extracts from bones and internal organs of Japanese eel, Anguilla japonica (HEE), on cyclooxygenase-2 (COX-2)-dependent prostaglandin D2 (PGD2) generation in stem cell factor (SCF), IL-10, plus LPS-induced mouse bone marrow-derived mast cells (BMMCs) and on passive cutaneous anaphylaxis (PCA) in mice.|PGD2|COX-2|38|32|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|c-Kit|24|28|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|TEA|S467C|8|16|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|AG013736|VEGFRs|31|36|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
1983158|CD1 mice were used, treated with saline, morphine CHl (5 mg/kg), and 1 or 10 mg/kg of the H1-antihistaminics tripelennamine, chlorpheniramine, diphenhydramine and cyclizine and the H2-antihistaminics ranitidine and cimetidine, all compounds by s.c. route.|cimetidine|H2|37|34|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23607712|Therefore, in addition to its previously described functions, synaptotagmin-1 is involved in a rapid vesicular Ca(2+) sequestration through a Ca(2+) /H(+) antiport.|H(+)|synaptotagmin-1|30|11|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10773011|Similar results were obtained with the specific COX-2 inhibitor NS-398 (10-30 microM) but not with the selective COX-1 inhibitor valeryl salicylate (10-300 microM).|NS-398|COX-2|10|8|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
23154533|Her MPO-ANCA titer was 21 ELISA units (EUs) before PTU treatment but increased to 259 EUs at 22 days after PTU treatment.|PTU|MPO|23|2|Arg1:T14|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23086198|  UDP-glucuronosyltransferase A1 (UGT2A1) is expressed in the lung and exhibits activity against polycyclic aromatic hydrocarbons (PAHs), suggesting UGT2A1 involvement in the local metabolism of PAH tobacco carcinogens.|PAHs|UDP-glucuronosyltransferase A1|19|1|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
11455568|The membrane-associated signaling pathways include rapid production of diacylglycerol and activation of protein kinase C (PKC), as well as activation of phospholipase A(2) (PLA(2)), increased production of arachidonic acid, and increased production of prostaglandins.|prostaglandins|PLA(2)|47|31|Arg1:T14|Arg2:T37|CHEMICAL|GENE-N|PRODUCT-OF
8755512|Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.|thalidomide|alpha1-acid glycoprotein|3|5|Arg1:T7|Arg2:T14|CHEMICAL|GENE-N|DIRECT-REGULATOR
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|HQL-79|H-PGDS|34|16|Arg1:T8|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12177684|Flibanserin seems to act via direct or indirect stimulation of 5-HT(1A), DA, and opioid receptors in those animal models.|Flibanserin|5-HT(1A)|1|11|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|arginine|EC 6.3.4.5|24|6|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF
2362440|  We have copurified human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase, which synthesize progesterone from pregnenolone and androstenedione from fetal dehydroepiandrosterone sulfate, from microsomes as a homogeneous protein based on electrophoretic and NH2-terminal sequencing data.|dehydroepiandrosterone sulfate|human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase|25|4|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
14530799|Moreover, recent in vitro studies suggest that memantine abrogates beta-amyloid (Abeta) toxicity and possibly inhibits Abeta production.|memantine|Abeta|9|19|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23254196|Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).|Ser|myosin light chain|23|16|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|PART-OF
23512537|It is possible that variations in cytochrome P450 3A enzyme-mediated metabolism of BDP may contribute to this phenomenon.|BDP|cytochrome P450 3A|13|7|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE
16876889|  Serine hydroxymethyltransferase (SHMT) catalyses the reversible conversion of serine and tetrahydrofolate to glycine and methylene-tetrahydrofolate.|tetrahydrofolate|SHMT|13|4|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE
22966070|Tub tyrosine phosphorylation (Tub-p-tyr) is modulated by nutritional status.|tyrosine|Tub|2|1|Arg1:T5|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
23415833|  Profenofos is a direct acting phosphorothioate organophosphorus (OP) pesticide capable of inhibiting β-esterases such as acetylcholinesterase, butyrylcholinesterase, and carboxylesterase.|Profenofos|acetylcholinesterase|1|18|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23270965|Meanwhile, the serum level of KC (a functional homolog of IL-8 and the main proinflammatory alpha chemokine in mice) in apoE(-/-) mice was up to 357pg/ml in SFO-HD treated group.|SFO|alpha chemokine|34|18|Arg1:T3|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
16199482|This reduction of late Ca2+ signals also appeared after >72 h of treatment with subnanomolar 5alpha-androstane-3beta,17beta-diol (3beta-Adiol), an endogenous dihydrotestosterone metabolite with ER-beta binding activity.|dihydrotestosterone|ER-beta|24|27|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23325562|Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3β at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.|ursolic acid|AMPK|3|9|Arg1:T13|Arg2:T37|CHEMICAL|GENE-N|ACTIVATOR
10207608|Taken together, these data demonstrated that PLA2 inhibitors BPB and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes.|AACOCF3|IL-2|12|17|Arg1:T13|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10076535|Analogous to the antiandrogens, bicalutamide and hydroxyflutamide, binding of estramustine phosphate metabolites to the androgen receptor was observed.|bicalutamide|androgen receptor|6|17|Arg1:T2|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16781459|Interestingly, the inhibitory effect of H(2)S on NF-kappaB activation was reversed by the transient transfection with HO-1 siRNA, but was mimicked by either HO-1 gene transfection or treatment with carbon monoxide (CO), an end product of HO-1.|carbon monoxide|HO-1|36|46|Arg1:T11|Arg2:T53|CHEMICAL|GENE-Y|PRODUCT-OF
10933891|Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the UCP-3 induction achieved after bezafibrate and Wy-14, 643 treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.|bezafibrate|UCP-3|29|25|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17194761|  Aspartoacylase catalyzes hydrolysis of N-acetyl-l-aspartate to aspartate and acetate in the vertebrate brain.|N-acetyl-l-aspartate|Aspartoacylase|5|1|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|alpha-linolenic acid|D6D|23|5|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
18568240|CONCLUSION: PTX-mediated phosphodiesterase inhibition occurs partially through a Protein kinase A-independent pathway and may serve as a useful tool in the attenuation of LPS-induced inflammation.|PTX|phosphodiesterase|3|4|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|carbetocin|vasopressin V1A/oxytocin receptor|35|25|Arg1:T21|Arg2:T45|CHEMICAL|GENE-N|AGONIST
15561708|Besides mitochondrial AtNFS1 and plastidial AtNFS2, which are both proposed to be involved in iron-sulfur cluster formation, ABA3 is proposed to be a third and cytosolic NifS-like cysteine desulfurase in A.|iron-sulfur|AtNFS2|16|6|Arg1:T9|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
10839989|N(5)-Substituted H(4)biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and N(5)-hydroxymethyl H(4)biopterin inhibited phenylalanine hydroxylase, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect.|N(5)-Substituted H(4)biopterin|dihydropteridine reductase|1|21|Arg1:T8|Arg2:T48|CHEMICAL|GENE-Y|SUBSTRATE
17494951|Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS.|1400W dihydrochloride|VEGF|20|38|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12213829|These effects resemble those seen with N-terminal deletions (DeltaN) of K(IR)6.0, and application of Ntp to DeltaNK(ATP) channels decreased their P(O(max)) and apparent IC(50) for ATP in the absence of Mg(2+).|ATP|DeltaNK(ATP) channels|45|24|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
17034761|The results suggest that the suppression of TLR4 activity by auranofin may be the molecular mechanism through which auranofin exerts anti-rheumatic activity.|auranofin|TLR4|11|8|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
10368299|RESULTS: Our experimental structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.|E2020|TcAChE|8|9|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10405348|2-MeOE2 also reduced basal and TNFalpha-stimulated aromatase activities by 46% and 56% respectively.|2-MeOE2|aromatase|1|7|Arg1:T19|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK receptors|27|45|Arg1:T5|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR
23295227|Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.|Val|AR|24|30|Arg1:T20|Arg2:T52|CHEMICAL|GENE-Y|PART-OF
14508322|CONCLUSIONS: These results indicate that etomidate acts as an agonist at alpha2-adrenoceptors, which appears in vivo primarily as an alpha2B-receptor-mediated increase in blood pressure.|etomidate|alpha2-adrenoceptors|7|13|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|AGONIST
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|R 24571|calmodulin|27|57|Arg1:T5|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
15975002|  Irinotecan (CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I (Topo I).|Irinotecan|DNA topoisomerase I|1|27|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
17125913|Cd rapidly increased c-jun, c-fos and PDGFA expression.|Cd|c-jun|1|4|Arg1:T10|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|5-HT(1B)|6|31|Arg1:T56|Arg2:T81|CHEMICAL|GENE-Y|AGONIST
16722247|An increasing number of studies concerning the identification of single nucleotide polymorphisms in the hNET gene and their potential association with disease as well as the functional investigation of naturally occurring or induced amino acid variations in hNET have contributed to a better understanding of NET function, regulation and genetic contribution to disorders.|nucleotide|hNET|11|15|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|PART-OF
2120879|The smooth muscle relaxant, W-7, which is believed relatively specific in inhibiting the Ca2(+)-calmodulin interaction, depressed hyposmolarity-induced PRL secretion in a dose-dependent manner (r = -0.991, p less than 0.01).|W-7|PRL|6|25|Arg1:T9|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23085120|  Bis(12)-hupyridone (B12H), derived from the Chinese medicinal component huperzine A, was originally designed as a novel acetylcholinesterase (AChE) inhibitor.|Bis(12)-hupyridone|acetylcholinesterase|1|25|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
16472148|  Cilostazol was developed as a selective inhibitor of cyclic nucleotide phosphodiesterase 3 (PDE3).|Cilostazol|cyclic nucleotide phosphodiesterase 3|1|9|Arg1:T1|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
22944069|Furthermore treatment of the cells with MG132, an inhibitor of the 26S proteasome, prevented the destabilizing effect of lithium on AChE-S.|MG132|26S proteasome|7|13|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
12527923|It is especially effective against MMP-2 and -9 more so than other MMP inhibitors such as Marimastat, Ro 32-3555 and D-2163.|Ro 32-3555|MMP|19|13|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
23339663|TOCP is metabolized to cresyl saligenin phosphate (CBDP), a potent irreversible inhibitor of butyrylcholinesterase (BChE), a natural bioscavenger present in the bloodstream, and acetylcholinesterase (AChE), the off-switch at cholinergic synapses.|cresyl saligenin phosphate|BChE|5|19|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23548896|Here we report the solution structure of the SH2 domain of C-terminal Src kinase (Csk) in complex with a longer phosphopeptide from Csk-binding protein (Cbp).|C|Csk|12|16|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|PART-OF
15740719|The binding domain of barusiban differs from the binding domain of the agonists and the nonselective oxytocin receptor antagonist d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin that has been used in previous studies.|d(CH2)5[Tyr-(Me)2,Thr4,Orn8,Tyr9]vasotocin|oxytocin receptor|20|17|Arg1:T17|Arg2:T47|CHEMICAL|GENE-Y|ANTAGONIST
16690332|NO rebinding in HNS from Staphylococcus aureus (SA-HNS) is faster than that measured for either Bacillus anthracis (BA-HNS) or for eNOS(HD) in both oxidized and reduced forms in the presence of arginine.|NO|HNS|1|4|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|DIRECT-REGULATOR
16964330|The sordarins group are protein synthesis inhibitors that work by blocking the function of fungal translation elongation factor 2.|sordarins|fungal translation elongation factor 2|2|15|Arg1:T7|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
15204055|The patients were divided into two groups according to the 5HT-2A affinity of the individual medications (high 5HT-2A affinity--clozapine, olanzapine, risperidone vs.|olanzapine|5HT-2A|24|19|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15133856|Ang II level in plasma and mesenteric arteries in imidapril group was significantly lower than that in irbesartan group (P<0.05).|irbesartan|Ang II|18|1|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16319075|Moreover, Pb2+ inhibited the ASIC-mediated membrane depolarization and the elevation of intracellular Ca2+ concentration.|Pb2+|ASIC|3|6|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
8600944|Dexamethasone (DEX) inhibited the anti-CD3-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested.|DEX|IL-5|3|12|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|Fe|Tf|29|35|Arg1:T14|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
15106733|The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and PGE2 release.|PD098059|ERK|11|5|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
10365684|The presence of cyclic adenosine monophosphate (cAMP)-generating system (forskolin) in TSH-free medium increased MMI-mediated TPO activity.|forskolin|TPO|13|20|Arg1:T20|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR
17168665|Though the exact mode of action of these FASN inhibitors is under discussion, it has been revealed that depletion of end-product fatty acids, toxic intracellular accumulation of supra-physiological concentrations of the FASN substrate malonyl-CoA and/or limited membrane synthesis and/or functioning by altered production of phospholipids partitioning into detergent-resistant membrane microdomains (lipid raft-aggregates), can explain, at least in part, the cytostatic, cytotoxic as well as the apoptotic effects occurring upon pharmacological inhibition of FASN activity in cancer cells.|fatty acids|FASN|23|9|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
11451212|In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist.|olmesartan medoxomil|angiotensin II type AT1 receptor|8|12|Arg1:T17|Arg2:T27|CHEMICAL|GENE-Y|ANTAGONIST
23557993|The h-OB were 10-100 fold more sensitive to DPHD than transformed osteoblasts: DPHD increased h-OB proliferation at 10nM and, at 100nM, activated MAP kinase signaling within 30min.|DPHD|MAP kinase|14|26|Arg1:T18|Arg2:T31|CHEMICAL|GENE-N|ACTIVATOR
23473803|Experimentally we showed that moexipril and two structurally related analogues acted in the micro molar range to inhibit PDE4 activity.|moexipril|PDE4|5|19|Arg1:T14|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
18450949|Administration of cevimeline hydrochloride, an M3 muscarinic receptor agonist (10 mg/kg for 7 days po), but not pilocarpine (0.3 mg/kg for 7 days po), recovered the AQP5 protein level reduced by CTD and increased the AQP1 protein level above the control one.|cevimeline hydrochloride|AQP1|3|43|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
1472079|In addition, in rat microsome incubations, the net amount of 4-OHCIPC glucuronide was also indirectly increased by cadmium through a reduction in the activity of beta-glucuronidase.|cadmium|beta-glucuronidase|20|28|Arg1:T23|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
23050902|These data suggest that ribavirin-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, AFF4 and ELL3, to F7, and modulates FVII mRNA transcription elongation.|ribavirin|F7|5|22|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|Pristimerin|inducible NO synthase|1|22|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23434829|Furthermore, knockdown of OPN enhanced cell death caused by other drugs, including paclitaxel, doxorubicin, actinomycin-D, and rapamycin, which are also P-gp substrates.|paclitaxel|P-gp|15|27|Arg1:T3|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
23336565|To determine if the up-regulation of PDGFβ receptors is neuroprotective, primary hippocampal neurons were incubated with the 5-HT7 receptor agonist, LP 12, for 24 h.|LP 12|5-HT7|23|19|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
15661821|Glucose infusion increased circulating glucose and insulin concentrations, mean lipid locule size (532.8 +/- 3.3 microm2 versus 456.7 +/- 14.8 microm2) and total unilocular fat mass (11.7 +/- 0.6 g versus 8.9 +/- 0.6 g) of the perirenal fat depot.|Glucose|insulin|1|7|Arg1:T6|Arg2:T34|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23486447|Amitriptyline, clomipramine, doxepin, imipramine, and trimipramine are demethylated by CYP2C19 to pharmacologically active metabolites.|doxepin|CYP2C19|5|14|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE
10494028|Under serum conditions allowing apo CIII secretion, treatment with the peroxisome-proliferator activated receptor (PPAR)alpha activators fenofibrate, gemfibrozil and Wy-14643 result in a marked lowering of apo CIII secretion and gene expression, this effect being most pronounced with Wy-14643.|gemfibrozil|apo CIII|22|31|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10368299|CONCLUSIONS: Our study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE versus butyrylcholinesterase (BChE).|E2020|AChE|14|36|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23234246|The in vitro binding affinity of the benzenesulfonamide rhenium complexes yielded IC(50) values ranging from 3 to 116 nM in hypoxic CA-IX expressing HeLa cells.|benzenesulfonamide rhenium|CA-IX|8|25|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
19852528|Oral palonosetron is likely to be a useful addition to oral formulations of other 5-HT3 receptor antagonists in preventing CINV in patients receiving MEC.|palonosetron|5-HT3 recepto|2|15|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|bisindolylmaleimide I|PKC|24|22|Arg1:T10|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR
14508322|In membranes from HEK293 cells transfected with alpha2-receptors, etomidate inhibited binding of the alpha2-antagonist, [3H]RX821002, with higher potency from alpha2B- and alpha2C-receptors than from alpha2A-receptors (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm).|etomidate|alpha2A-receptors|10|31|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15671155|Also, prophylactic, as well as therapeutic, treatment with the CSE inhibitor, DL-propargylglycine (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (MPO) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; PAG, 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.|PAG|CSE|18|13|Arg1:T22|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23478800|Here we found that the anticancer agent cucurbitacin I, a Jak2 inhibitor, reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells.|cucurbitacin I|Jak2|8|12|Arg1:T9|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
23234812|CM from PFF-treated osteocytes without SrRan enhanced Ki67 expression but reduced Runx2 and Ocn expression in osteoblasts.|SrRan|Ocn|6|14|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12930836|When expressed in Xenopus oocytes, the encoded protein designated LAT3 (L-type amino acid transporter 3) transported neutral amino acids such as l-leucine, l-isoleucine, l-valine, and l-phenylalanine.|l-isoleucine|LAT3|27|11|Arg1:T14|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23259865|  Tyrosyl-DNA phosphodiesterase I (Tdp1) plays a key role in the repair of damaged DNA resulting from the topoisomerase I (Top1) inhibitor camptothecin and a variety of other DNA-damaging anticancer agents.|camptothecin|topoisomerase I|26|20|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR
23266270|Furthermore, DPEP inhibited the LPS-induced phosphorylation of inhibitor κB (IκB)-α and NF-κB p50.|DPEP|p50|3|17|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
23229509|On stimulation by G(s), the activities of ACs can be further selectively modulated by other pathways to ensure precise control of intracellular cAMP responses to specific stimuli.|cAMP|ACs|27|12|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|PRODUCT-OF
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|Eletriptan|5-HT1D|1|19|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
18073378|METHODS: Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 6a is an extension of ABCSG Trial 6, in which hormone receptor-positive postmenopausal patients received 5 years of adjuvant tamoxifen, with or without the aromatase inhibitor aminoglutethimide, for the first 2 years of therapy.|aminoglutethimide|aromatase|42|40|Arg1:T9|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
16230360|By doing so, procainamide significantly decreased the processivity of DNMT1 on hemimethylated DNA.|procainamide|DNMT1|5|11|Arg1:T9|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23059626|mRNA levels of receptor activator of nuclear factor kappa-B (RANK), its ligand RANKL, tumor necrosis factor alpha (TNF-α) and RANKL/osteoprotegerin (OPG) ratio were diminished in the periodontium of CCL3(-/-) mice and in the group treated with Met-RANTES.|Met|RANKL|48|16|Arg1:T3|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17234158|PFD leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.|PFD|pro-protein convertase|1|26|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
17355958|Human Grx1 and Grx2 contain Cys-Pro-Tyr-Cys and Cys-Ser-Tyr-Cys active sites and have three and two additional structural Cys residues, respectively.|Cys-Pro-Tyr-Cys|Grx2|6|4|Arg1:T18|Arg2:T34|CHEMICAL|GENE-Y|PART-OF
23201180|The paraoxonase 1 from human serum (PON1) is a phosphotriesterase (PTE) that hydrolyses several xenobiotics including drugs and organophosphorus compounds (OPs).|organophosphorus|phosphotriesterase|23|12|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE
16982784|  Among the TEM-type extended-spectrum beta-lactamases (ESBLs), an amino acid change at Ambler position 104 (Glu to Lys) results in increased resistance to ceftazidime and cefotaxime when found with other substitutions (e.g., Gly238Ser and Arg164Ser).|Lys|TEM-type extended-spectrum beta-lactamases|21|3|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|PART-OF
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|AKT|10|46|Arg1:T12|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR
9059856|1.5 +/- 0.4 nM; Ki dicyclomine, 5.1 +/- 0.8 nM; Ki HHSD, 34.3 +/- 7.3 nM), whereas the receptor in basal plasma membrane seems to be of the muscarinic M2 receptor subtype (Ki pirenzepine, 202 +/- 48 nM; Ki AF-DX 116, 124 +/- 60 nM; Ki himbacine, 20.6 +/- 4.8 nM; Ki 4-DAMP, 4.5 +/- 1.2 nM; Ki dicyclomine, 54.6 +/- 22 nM; Ki HHSD, 89.2 +/- 15.8 nM).|AF-DX 116|muscarinic M2 receptor subtype|49|35|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
2087492|The suppressive effect of ceruletide on barrel rotation could be partially countered by MK-329, a selective peripheral CCK (CCK-A) receptor antagonist.|MK-329|CCK|14|19|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|ANTAGONIST
8827452|The amino acid sequence deduced from the nucleotide sequence of the cloned PHBP cDNA exhibited significant homology to that of hepatocyte growth factor activator (HGFA).|nucleotide|PHBP|8|13|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|PART-OF
10917903|Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of eicosapentaenoic acid (EPA) blocked Delta-5-desaturase activity, the terminal enzymatic step in AA synthesis.|EPA|Delta-5-desaturase|16|19|Arg1:T22|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
23183084|Similarly favorable effects were seen for dienogest, which promoted significant reduction of AKR1C1 and AKR1C2 expression and also showed no effect on PR-B protein levels.|dienogest|AKR1C2|7|16|Arg1:T6|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15192023|Hydralazine dose-dependently inhibited PHD activity and induced nonhydroxylated HIF-1alpha, evidence for HIF stabilization specifically by inhibition of PHD enzyme activity.|Hydralazine|PHD|1|4|Arg1:T11|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
3004501|Similar concentrations also inhibited the formation of leukotriene C4 (LTC4) by LTC synthetase, a detergent-solubilized cell free particulate enzyme from RBL cells which is capable of coupling LTA4 to glutathione.|leukotriene C4|LTC synthetase|8|14|Arg1:T12|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF
16014042|Moreover, uptake of l-cystine also increased (about tenfold) in Xenopus oocytes expressing hxCT and h4F2hc.|l-cystine|hxCT|5|16|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23470287|To study the molecular mechanism, results from luciferase assay, nuclear translocation of NF-κB, and Western blot indicated that the mechanism of the anti-inflammatory effects of SA9 might be suppression of intracellular generation of ROS and inhibition of NF-κB activation in ECs. SA9 is a prototype of a novel class of antioxidant with anti-inflammatory effects in ECs. It may represent a new therapeutic approach for preventing endothelial activation in cardiovascular disorders.|SA9|NF-κB|29|41|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
23147415|HZ mice are also more sensitive to the peripheral application of the selective AChE inhibitor donepezil or the mixed inhibitor physostigmine; extracellular ACh levels rise significantly after administration of both drugs; also glucose levels are moderately increased indicating potentially non-cholinergic effects of donepezil.|donepezil|AChE|16|14|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
16982809|ATRA regulates gene expression via the activation of the retinoic acid receptor (RAR)alpha in human DCs, and RARalpha acutely regulates CD1d expression.|ATRA|CD1d|1|25|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|alanine aminotransferase|8|47|Arg1:T3|Arg2:T25|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23468082|Ridaforolimus is a selective inhibitor of mTOR that has demonstrated positive clinical activity in endometrial cancer.|Ridaforolimus|mTOR|1|7|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
2922761|In contrast, serum alkaline phosphatase was elevated in animals dosed with 13cisRA or 4HPR but not in those dose with ROAc. For this enzyme, the electrophoretic pattern on agarose gel showed a decrease, compared to controls, in the major isozyme in serum of ROAc-dosed animals.|13cisRA|alkaline phosphatase|13|5|Arg1:T15|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23337567|Additionally, these effects of ATO on γ-H2AX, Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.|ATO|cip1|6|20|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23541436|FCEO significantly inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2, respectively.|prostaglandin E2|cyclooxygenase (COX)-2|10|29|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
14672731|  The specific pharmacological profile of the 19-norprogestin nomegestrol acetate (NOMAC) is, at least in part, defined by its pattern of binding affinities to the different steroid hormone receptors.|19-norprogestin|steroid hormone receptors|7|30|Arg1:T29|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT1|60|64|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
20007701|  The vesicular neurotransmitter transporter VMAT2 is responsible for the transport of monoamines into synaptic and storage vesicles.|monoamines|vesicular neurotransmitter transporter|12|2|Arg1:T15|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
10485486|These data suggest that the radiosensitizing effects of caffeine are related to inhibition of the protein kinase activities of ATM and ATR and that both proteins are relevant targets for the development of novel anticancer agents.|caffeine|ATM|9|20|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|D6D|26|8|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|PRODUCT-OF
10229494|Previous studies have indicated that PLMs occur in the rat brain synaptosomal and retinal membranes, and they are activated under halothane anesthesia.|halothane|PLMs|22|6|Arg1:T11|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR
23179775|  Adrenal insufficiency may be caused by the destruction or altered function of the adrenal gland with a primary deficit in cortisol secretion (primary adrenal insufficiency) or by hypothalamic-pituitary pathologies determining a deficit of ACTH (secondary adrenal insufficiency).|cortisol|ACTH|21|36|Arg1:T3|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|receptor tyrosine kinases|1|41|Arg1:T4|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
11799102|In conclusion, the renin inhibitor Aliskiren dose-dependently decreases Ang II levels in humans following oral administration.|Aliskiren|renin|7|5|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
23583258|This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and IL-8, caused by a mixture of oxysterols representative of a high cholesterol diet.|cholesterol|interleukins|33|17|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23183084|Different effects were seen for progesterone, which significantly decreased SRD5A1, PR-B and HSD17B2 protein levels.|progesterone|HSD17B2|6|15|Arg1:T7|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
8740147|Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.|Amezinium|uptake1|1|7|Arg1:T32|Arg2:T57|CHEMICAL|GENE-N|SUBSTRATE
7769797|Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans.|remikiren|renin|9|6|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23544613|The highest DPmax of 15 was achieved in a one-step and two-step synthesis of oligo(p-xylylene sebacamide) catalyzed by CLEA cutinase.|oligo(p-xylylene sebacamide)|CLEA cutinase|15|22|Arg1:T8|Arg2:T16|CHEMICAL|GENE-N|SUBSTRATE
23482500|[(14)C]Sorafenib (0.5 to 5 μM) uptake was significantly higher in hOCT1-transfected CHO cells compared to mock cells, and inhibited by the general OCT inhibitor, MPP(+).|MPP(+)|OCT|35|32|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
23639801|Here we show that the compound CID16020046 ((4-[4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo [3,4-c] pyrazol-5-yl] benzoic acid) is a selective GPR55 antagonist.|CID16020046|GPR55|7|32|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST
16940412|Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin.|E7389|tubulin|14|28|Arg1:T23|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR
17016511|Late INa induced by the VGSC long QT mutant R1623Q was reduced by resveratrol and quercetin.|quercetin|R1623Q|16|10|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23591110|Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part I).|aryl amides|histamine H3 receptor|6|12|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|ANTAGONIST
17442055|  The tryptophan metabolite kynurenic acid (KYNA), which is produced enzymatically by the irreversible transamination of l-kynurenine, is an antagonist of alpha7 nicotinic and NMDA receptors and may thus modulate cholinergic and glutamatergic neurotransmission.|KYNA|alpha7 nicotinic and NMDA receptors|7|25|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|ANTAGONIST
15840408|Both prostaglandins inhibited tumor necrosis factor (TNF)-alpha production and T-cell proliferation of lipopolysaccharide-treated human peripheral blood mononuclear cells (PBMC).|prostaglandins|tumor necrosis factor (TNF)-alpha|2|4|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10685879|Procaine also inhibited uptake of norepinephrine (NE) and serotonin (5-HT) by the norepinephrine transporter (NET) or serotonin transporter (SERT) expressed in COS cells.|Procaine|NET|1|20|Arg1:T26|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
12200198|Long-term administration of propargylamines to rats increased the activities of antioxidative enzymes superoxide dismutase (SOD) and catalase in the brain regions containing dopamine neurons.|propargylamines|catalase|4|19|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR
23591044|Oviduct ER-α, ER-β and uterine ER-β were down-regulated by either ethanol or melatonin.|melatonin|ER-β|14|7|Arg1:T28|Arg2:T50|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
18506437|This report reviews the recent advances in the knowledge of the mechanism of action as well as the molecular basis and interethnic variations of TPMT and inosine triphosphate pyrophosphatase (ITPase; EC 3.6.1.19), another enzyme implicated in thiopurine toxicity.|thiopurine|inosine triphosphate pyrophosphatase|41|27|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
9313928|The two receptors were discriminated by butaprost, AH-13205 and AH-6809 that bound to the EP2 receptor but not to the EP4 receptor, and by 1-OH-PGE1 that bound to the EP4 but not to the EP2 receptor.|butaprost|EP2|7|16|Arg1:T19|Arg2:T83|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|SKI-606|Abl|9|17|Arg1:T31|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
2270485|Zinc mediation of the binding of human growth hormone to the human prolactin receptor.|Zinc|human growth hormone|1|7|Arg1:T12|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16298345|[3H]-maraviroc bound with high affinity to CCR5 from macaque (K(d) = 1.36+/-0.07 nM) and human (K(d) = 0.86 +/- 0.08 nM), but was found to dissociate approximately 10-fold more quickly from macaque CCR5.|[3H]-maraviroc|CCR5|1|10|Arg1:T10|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
10823899|Conversely, DAT inhibitors, such as cocaine, mazindol, and nomifensine, when administered with AMPH, blocked the reduction in [(3)H]DA uptake and the redistribution of DAT immunofluorescence to the cytosol.|nomifensine|DAT|13|3|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
17088426|By using pharmacological and genetic manipulation of phosphodiesterases (PDEs), we demonstrate that compartmentalized PDE4B and PDE4D are responsible for selectively modulating the concentration of cAMP in individual subcellular compartments.|cAMP|PDE4B|28|17|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
23086198|These data suggest that, although UGT2A1 is the only UGT2A enzyme active against PAH proximate carcinogens (including PAH diols), both UGTs 2A1 and 2A2 play an important role in the local detoxification of procarcinogenic monohydroxylated PAH metabolites.|PAH|UGT2A1|15|7|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23318726|Butein also increased heme oxygenase-1 (HO-1) protein expression and HO activity.|Butein|heme oxygenase-1|1|4|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11885959|  Non-steroidal anti-inflammatory drugs (NSAIDs) are competitive inhibitors of cyclooxygenase (COX), the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid.|steroidal|COX|2|13|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
17929831|  Adenylosuccinate synthetase (AdSS) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate, in a reaction driven by the hydrolysis of GTP to GDP.|adenylosuccinate|AdSS|20|4|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|guvacine|GAT2|13|21|Arg1:T15|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
15367040|Levetiracetam binds selectively and with high affinity to a synaptic vesicle protein known as SV2A, thought to be involved with synaptic vesicle exocytosis and presynaptic neurotransmitter release.|Levetiracetam|synaptic vesicle protein|1|10|Arg1:T1|Arg2:T4|CHEMICAL|GENE-N|DIRECT-REGULATOR
23642478|  A series of benzenesulfonamides incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the β-carbonic anhydrase (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA.|cyanoacrylamide|ScCA|6|30|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|cilastatin|human-OAT3|21|25|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
2857786|Ambenonium was a less potent antagonist of tissue responses to acetylcholine, and the underestimation in the pKB (as compared to that obtained with bethanechol) could be eliminated by prior treatment of tissues with the acetylcholinesterase inhibitor neostigmine.|neostigmine|acetylcholinesterase|40|38|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
16298345|Maraviroc inhibited binding of [125I]-MIP-1beta to CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM, respectively) and antagonised MIP-1beta induced intracellular calcium release mediated through CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89, respectively).|125I|CCR5|6|10|Arg1:T8|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
23643730|Take together, our results demonstrated that juglone might induce the apoptosis in LNCaP cell via down-regulation of AR expression.|juglone|AR|8|19|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23542513|Taken together, our findings indicate that 5HHMF suppresses NO production through modulation of iNOS, consequently suppressing NF-κB activity and induction of Nrf2-dependent HO-1 activity.|5HHMF|NF-κB|8|19|Arg1:T9|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
16547010|  We determined the crystal structure of human hematopoietic prostaglandin (PG) D synthase (H-PGDS) as the quaternary complex with glutathione (GSH), Mg2+, and an inhibitor, HQL-79, having anti-inflammatory activities in vivo, at a 1.45-A resolution.|Mg2+|human hematopoietic prostaglandin (PG) D synthase|28|7|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|iron|Tf|27|35|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
16418149|  Leptin is a 167 amino acid protein encoded by the obesity gene that is synthesized in adipose tissue and interacts with receptors in the hypothalamus linked to the regulation of appetite and metabolism.|amino acid|Leptin|5|1|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PART-OF
23277230|Fisetin treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1β (plasma), serum nitric oxide (NO) with an elevation in plasma insulin.|Fisetin|p65|1|21|Arg1:T1|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23178381|Western blot analysis revealed that aspidin PB inhibited PI3K expression, phosphorylation of Ser473 Akt and Ser9 GSK3β followed by up-regulation of nonsteroidal anti-inflammatory drugs activated gene-1 (NAG-1) expression.|aspidin PB|PI3K|6|9|Arg1:T15|Arg2:T31|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
11723241|To gain further insight into the binding site, we examined the minimal structural changes necessary to transform low-affinity binding of dofetilide by the related bovine ether a-go-go channel bEAG to high-affinity binding of HERG.|dofetilide|bovine ether a-go-go channel|22|26|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23246867|Similar to MIN6 β cells, human islets elicited glucose-stimulated PAK1 activation that was sensitive to the PAK1 inhibitor, IPA3.|IPA3|PAK1|21|18|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
10768100|Troglitazone reduces plasminogen activator inhibitor-1 expression and secretion in cultured human adipocytes.|Troglitazone|plasminogen activator inhibitor-1|1|3|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11979347|These results indicate that MTHFR genotype influences the correlation of Hcy level with vitamin B12 and folate levels in HD patients.|folate|MTHFR|17|5|Arg1:T23|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE
14744615|This response was: (1) partly blocked in dogs pretreated intravenously with the antagonists SB224289 (5-HT(1B); 2,3,6,7-tetrahydro-1'-methyl-5-[2'-methyl-4' (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl]furo[2,3-f]indole-3-spiro-4'-p iperidine hydrochloride), rauwolscine (alpha(2)), BRL44408 (alpha(2A); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole) or MK912 (alpha(2C); (2S,12bS)-1'3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2Hbenzo[b]furo[2,3-a]q uinazoline)-2,4'-pyrimidin-2'-one); (2) markedly blocked after SB224289 plus rauwolscine; and (3) unaffected after BRL15572 (5-HT(1D); 1-(3-chlorophenyl)-4-[3,3-diphenyl (2-(S,R) hydroxypropanyl) piperazine] hydrochloride) or imiloxan (alpha(2B)).|rauwolscine|alpha(2)|42|44|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|ANTAGONIST
14761877|In contrast to their opposing actions on cell growth, both activin A and DHT upregulated PSA gene expression and increased PSA secretion by LNCaP cells.|DHT|PSA|15|22|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23361846|  Methadone N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.|Methadone|CYP3A4|1|24|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
8799556|RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes.|RS 17053|alpha 1D|1|26|Arg1:T39|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23643744|Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment.|phencyclidine|metabotropic glutamate receptor 5|25|5|Arg1:T21|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR
16801455|  Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and mitochondrial arginase II.|L-arginine|arginase I|22|36|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|batracylin|TOP2|64|57|Arg1:T21|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23583258|This report concerns the marked up-regulation in differentiated CaCo-2 colonic epithelial cells of two key inflammatory interleukins, IL-6 and IL-8, caused by a mixture of oxysterols representative of a high cholesterol diet.|oxysterols|interleukins|28|17|Arg1:T11|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23468082|CONCLUSIONS: These encouraging preclinical findings suggest the inhibition of both FGFR2 and mTOR by the ponatinib-ridaforolimus combination may provide a new therapeutic strategy to treat advanced endometrial cancers with dual pathway dysregulation.|ponatinib|FGFR2|17|12|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23643744|We wanted to determine whether behavioural and GABAergic functional deficits induced by the NMDA receptor channel blocker, phencyclidine (PCP), could be reversed by repeated administration of two drugs known to enhance GABAergic transmission: the positive allosteric modulator (PAM) of the metabotropic glutamate receptor 5 (mGluR5), ADX47273, and the partial agonist of the α7 nicotinic acetylcholine receptor (α7 nAChR), SSR180711.|SSR180711|α7 nicotinic acetylcholine receptor|73|64|Arg1:T17|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
23219525|  The combinations of the endothelin-1 receptor antagonists bosentan or ambrisentan with the phosphodiesterase 5 inhibitors sildenafil or tadalafil are current standard therapies of advanced pulmonary arterial hypertension.|ambrisentan|endothelin-1 receptor|10|5|Arg1:T24|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|amiodarone|NCX|8|25|Arg1:T6|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23211523|Furthermore, knockdown of Brms1L significantly attenuated GnRH-induced FSHβ expression.|GnRH|FSHβ|8|9|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15674236|Because minocycline inhibits matrix metalloprotease-9 (MMP-9), we also compared minocycline's protective effect in wild type (wt) and MMP-9 knock-out (ko) mice.|minocycline|matrix metalloprotease-9|2|4|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23053666|Cu-dependent tyrosinase activity was also markedly reduced in both types of CLDN knockdown cells when incubated with the substrate l-DOPA.|l-DOPA|tyrosinase|20|2|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
10947967|In contrast, 2, 4-dioxo-5-acetamido-6-phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopamine-beta-hydroxylase.|ascorbate|PAM|29|33|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11006272|Three LTB(4) receptor antagonists, 14,15-dehydro-LTB(4), LTB(4)-3-aminopropylamide, and U-75302, had high affinity for LTB(4)-R1 but not for LTB(4)-R2.|LTB(4)-3-aminopropylamide|LTB(4)-R1|14|27|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9387868|Cocaine significantly decreased the abundance of the SERT mRNA within the dlDR and DAT mRNA abundance within the SNc and the PBP, and increased the abundance of the NET mRNA within the LC.|Cocaine|NET|1|30|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17289088|  Lymphocytes possess the essential components of a cholinergic system, including acetylcholine (ACh); choline acetyltransferase (ChAT), its synthesizing enzyme; and both muscarinic and nicotinic ACh receptors (mAChRs and nAChRs, respectively).|ACh|choline acetyltransferase|14|17|Arg1:T11|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|VEGF|1|29|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline alphoscerate|acetylcholinesterase|10|13|Arg1:T20|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
23356880|Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase (LOX)-pathway (one having as precursors the polyunsaturated fatty acids containing a cis-cis-1,4-pentadiene system).|polyunsaturated fatty acids|LOX|29|20|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE
23292752|FXa inhibitors, e.g. rivaroxaban and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa. Both agents have a rapid onset of action, a wide therapeutic window, little or no interaction with food and other drugs, minimal inter-patient variability, and display similar pharmacokinetics in different patient populations.|apixaban|FXa|8|22|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
15975002|  Irinotecan (CPT-11, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) has exhibited clinical activities against a broad spectrum of carcinomas by inhibiting DNA topoisomerase I (Topo I).|Irinotecan|Topo I|1|31|Arg1:T1|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
10580458|Rofecoxib specifically inhibits COX-2 and has demonstrated a low potential for causing upper GI injury.|Rofecoxib|COX-2|1|4|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
14587496|  BACKGROUND: Rivastigmine is a carbamate drug designed to inhibit both acetylcholinesterase and butyrylcholinesterase by reversibly covalently bonding to these enzymes.|carbamate|acetylcholinesterase|6|12|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|1-m-chlorophenylpiperazine|5-HT2A|17|12|Arg1:T8|Arg2:T61|CHEMICAL|GENE-Y|AGONIST
23639738|  Cholesterol esterase (CE) induced surface erosion of poly(ethylene carbonate) (PEC) and drug release from PEC under mild physiological environment was investigated.|PEC|Cholesterol esterase|16|1|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
10727523|These results indicate that MRP1 is a more efficient transporter of glutathione conjugates and free glutathione than MRP2, whereas several anions are preferred substrates for MRP2.|glutathione|MRP2|12|18|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23313376|Furthermore, PTE treatment directly inhibited the phosphorylation of JAK2 at Tyr 1007 and the downstream activation of STAT3.|Tyr|JAK2|12|10|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|PART-OF
21631396|Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways.|Pseudoephedrine|NF-kappaB|1|7|Arg1:T13|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
11723241|Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.|dofetilide|EAG-related K(+) channels|6|16|Arg1:T15|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|bisdioxopiperazines|DNA topoisomerase II|2|18|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
11920914|  The rates of inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) by paraoxon, haloxon, DDVP and enantiomers of neutral alkyl methylphosphonyl thioates and cationic alkyl methylphosphonyl thiocholines were measured in the presence and absence of AChE peripheral site inhibitors: gallamine, d-tubocurarine, propidium, atropine and derivatives of coumarin.|alkyl methylphosphonyl thioates|EC 3.1.1.7|24|11|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
22967140|Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol, a selective ERα agonist-PPT [4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol], a selective ERβ agonist-DPN [2,3-bis(4-hydroxyphenyl)-propionitrile], a selective ERα antagonist-MPP [1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride] or a selective ERβ antagonist-PHTPP (4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol).|1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol|ERα|54|51|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
16293341|  MELANOTAN (NDP-MSH) binds the MC1 receptor to significantly increase the eumelanin content of human skin cells.|MELANOTAN|MC1 receptor|1|7|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17429625|Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.|dasatinib|SRC|8|20|Arg1:T18|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
10224140|Acidic metabolites of neurotransmitters derived from dopamine, epinephrine, norepinephrine, and serotonin inhibited the uptake of estrone sulfate via OAT3.|epinephrine|OAT3|9|22|Arg1:T19|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
11444497|Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.|losartan|AT1-receptor|6|4|Arg1:T15|Arg2:T28|CHEMICAL|GENE-N|ANTAGONIST
11426832|These results suggest that betamipron and probenecid could inhibit both human-OAT1- and human-OAT3-mediated organic anion transport in vivo, whereas cilastatin could inhibit only human-OAT3-mediated one.|betamipron|human-OAT3|5|13|Arg1:T12|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|LYSO-7|PPAR|19|52|Arg1:T8|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR
23561166|In addition, fisetin supplementation significantly reduced hepatic mRNA abundance of FAS, ATPCL and G6Pase compared to the control group.|fisetin|G6Pase|4|16|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11270983|Dazoxiben (inhibitor of thromboxane synthase) inhibited, to the same extent as indometacin and ridogel, the response to higher concentrations of endothelin-1.|indometacin|thromboxane synthase|15|5|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
11986668|Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.|Minocycline|cytochrome c|1|3|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1475066|  Male Sprague-Dawley rats when administered sc a sublethal dose of organophosphorus cholinesterase inhibitors such as the nerve agents, soman (100 micrograms/kg, sc), sarin (110 micrograms/kg, sc), tabun (200 micrograms/kg, sc), or VX (12 micrograms/kg, sc), developed seizures and severe muscle fasciculations within 15-20 min, lasting for 4-6 hr.|VX|cholinesterase|45|12|Arg1:T9|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
7518029|Haloperidol decreased the amount of SP mRNA by 20% while sulpiride increased it by 20%.|sulpiride|SP|12|6|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10398211|We topically applied the nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine, on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet.|NG-nitro-L-arginine|nitric oxide synthase|13|5|Arg1:T1|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
12904467|Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.|topiramate|GluR5|9|4|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
14596599|The holo-SDH contained PLP-OMS aldimine in the active site, indicating that OMS can form the Schiff base linkage with PLP, but the subsequent dehydration did not occur.|OMS|holo-SDH|13|2|Arg1:T33|Arg2:T50|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17369473|Metformin and phenformin, which are biguanides, have been reported to increase AMPK activity without increasing AMP/ATP.|biguanides|AMPK|7|14|Arg1:T26|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
2270485|Scatchard analysis indicated a stoichiometry of one Zn2+ per hGH.hPRLbp complex.|Zn2+|hGH|8|10|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23642478|Benzenesulfonamides incorporating cyanoacrylamide moieties strongly inhibit Saccharomyces cerevisiae β-carbonic anhydrase.|cyanoacrylamide|Saccharomyces cerevisiae β-carbonic anhydrase|4|8|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|Nexavar|MEK|6|15|Arg1:T13|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
11971019|NO derived from inducible NO synthase (iNOS) can activate macrophage apoptosis.|NO|inducible NO synthase|1|4|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
10611634|In guinea pigs, antagonist actions of yohimbine at 5-HT(1B) receptors are revealed by blockade of hypothermia evoked by the 5-HT(1B) agonist, GR46,611.|yohimbine|5-HT(1B)|8|10|Arg1:T44|Arg2:T77|CHEMICAL|GENE-Y|ANTAGONIST
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|ketone|MCTs|25|4|Arg1:T7|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE
12445705|Although only clozapine and ziprasidone are directly acting 5-HT(1A) agonists, WAY100635, a selective 5-HT(1A) antagonist, partially attenuates these atypical APD-induced increases in cortical DA release that may be due to combined 5-HT(2A) and D(2) blockade.|clozapine|5-HT(1A)|3|9|Arg1:T27|Arg2:T57|CHEMICAL|GENE-Y|AGONIST
11969359|The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and milrinone, reduced the GM-CSF release in a concentration dependent manner.|amrinone|PDE3|15|13|Arg1:T9|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23001627|SOD levels of serum and hippocampus tissue were significantly increased and MDA levels were significantly decreased in the PTU + Vit E and PTU + L-T4 + Vit E groups than the PTU and PTU + L-T4 groups.|L-T4|SOD|26|1|Arg1:T13|Arg2:T40|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
9480923|Consistent with these results, the translocation of cPLA2 protein as well as the release of arachidonic acid, a principal product of phospholipase A2, was rapidly induced by the addition of C2-ceramide in a Rac-dependent manner.|arachidonic acid|phospholipase A2|17|24|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|PRODUCT-OF
17008880|Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane.|vitamin C|SVCT-1|13|20|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF
23537701|  Tetrahydrocannabinol (THC), the major psychoactive component of marijuana, is a cannabinoid agonist that exerts its effects by activating at least two specific receptors (CB1 and CB2) that belong to the seven transmembrane G-protein coupled receptor (GPCR) family.|THC|CB1|3|29|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|ACTIVATOR
8589992|The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.|DNQX|EAA3a|28|14|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22983118|Moreover, 24h exposure to DOI promoted an increase in cytochrome c in the cytoplasmatic fraction of neurons.|DOI|cytochrome c|6|11|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22841397|Insulin secretion increased from the islets of biotin-supplemented mice, together with the messenger RNA (mRNA) expression of several transcription factors regulating insulin expression and secretion, including forkhead box A2, pancreatic and duodenal homeobox 1 and hepatocyte nuclear factor 4α.|biotin|pancreatic and duodenal homeobox 1|8|35|Arg1:T16|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12085361|Rifampicin (10 micromol/L) inhibited OATP8-mediated BSP uptake by 50%, whereas inhibition of OATP-C-, OATP-B-, and OATP-A-mediated BSP transport was below 15%.|BSP|OATP-A|23|22|Arg1:T4|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|Akt|47|20|Arg1:T14|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23401473|OATP1B1-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 µM, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 µM, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 µM, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 µM, respectively).|silychristin|OATP1B3|61|3|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Nucleotide|SUR|1|24|Arg1:T16|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR
23028140|Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.|imatinib|CYP2C8|11|9|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE
10430100|  We studied the antitumor activity and toxicity of ZD1694 (tomudex), a specific inhibitor of thymidylate synthase (TS), in nude mice bearing human head and neck squamous cell carcinoma A253 and FaDu xenografts.|tomudex|thymidylate synthase|11|18|Arg1:T23|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
17513393|Because Cu deficiency results in upregulation of Gclc and an increase in the biosynthesis of glutathione, it is plausible that the net flux of homocysteine through the transsulfuration pathway is increased.|glutathione|Gclc|16|8|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|risperidone|5-HT2C|11|3|Arg1:T4|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|PD166326|Abl|12|17|Arg1:T32|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
23368743|The recent identification of zinc permeability of the lysosomal ion channel TRPML1 (transient receptor potential mucolipin 1), and the evidence of abnormal zinc levels in cells deficient in TRPML1, suggested a role for TRPML1 in zinc transport.|zinc|TRPML1|40|38|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
14610216|hOAT1 and hOAT3, but not hOAT2 and hOAT4 mediated the uptake of furosemide.|furosemide|hOAT3|14|3|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
23161664|Cadmium (Cd), an inducer of reactive oxygen species, inhibited HIF-1α mRNA expression and HIF-1α binding to the LO gene in Co-treated cells as revealed by RT-PCR and ChIP assays, respectively.|Cadmium|HIF-1α|1|18|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23261757|Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats.|gentamicin|VDBP|17|11|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
2083404|Although the precise mechanism of the protective action of trilisate is unknown, our data support the possibility of interaction between salicylate and ASA on cyclo-oxygenase locus in the respiratory tract in ASA-intolerant patients.|ASA|cyclo-oxygenase|24|26|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
23340651|Our results demonstrate that 3% O(2) augmented proliferation of BMSC, as well as the formation of colonies in the colony-forming unit assay (CFU-A), the percentage of quiescent cells, and the expression of stemness markers Rex-1 and Oct-4, thereby suggesting an increase in the stemness of culture when exposed to hypoxia.|O(2)|Oct-4|7|46|Arg1:T11|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23466229|PF-04859989 as a template for structure-based drug design: identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency.|pyrazole|KAT II|13|17|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
9231746|We have examined the effect of dihydropyridine Ca2+-channel blockers felodipine and nicardipine on CaMPDE.|dihydropyridine|Ca2+-channel|7|8|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23581876|The effect of sex and cytochrome P450 (P450) enzyme induction on the enantioselective metabolism of PCB 136 was studied using liver tissue slices prepared from naïve control (CTL), phenobarbital (PB; CYP2B inducer) or dexamethasone (DEX; CYP3A inducer) pretreated adult Sprague-Dawley rats.|PCB 136|cytochrome P450|18|6|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE
23528300|  A series of benzoxazole compounds containing oxamic acid were synthesized and screened for the PTP1B inhibition.|benzoxazole|PTP1B|4|15|Arg1:T1|Arg2:T4|CHEMICAL|GENE-Y|INHIBITOR
23220614|While SP600125 (a JNK inhibitor) and SB203580 (a p38 inhibitor) markedly prevented the expression of these proteins induced by ISO.|SP600125|JNK|2|5|Arg1:T2|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|Androstanol|CARs|1|20|Arg1:T8|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|ammonia|EC 4.3.1.17|24|6|Arg1:T8|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF
2386945|Pimozide and thioridazine had no effect on the estradiol binding properties of the MCF-7 ER, nor did pimozide interfere with the induction of progesterone receptors by estradiol.|estradiol|ER|9|15|Arg1:T29|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11430635|In view of the role of CA in acid-base balance as well as the fact that an increase or decrease in its activity is accompanied by an increase or decrease in intra- and extracellular pH, our results suggest that: firstly, CA activation induced by indomethacin might cause changes in COX activity; secondly, PGs are synthetized as a consequence of the changes in COX activity, a hypothesis that requires further study.|indomethacin|CA|48|44|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR
15730717|CONCLUSIONS: IN could significantly inhibit the proliferation of CML cells, the mechanism of which might be related to the suppression of STATs/Bcl-X(L) signal transduction pathway.|IN|STATs|3|24|Arg1:T8|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
23471964|These findings establish a novel mechanism by which maspin utilizes its cysteine thiols to inhibit oxidative stress and cell growth.|cysteine thiols|maspin|12|9|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|PART-OF
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|collagen type I|1|8|Arg1:T3|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|lovastatin|HMG-CoA reductase|14|26|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23465614|Of the compounds active in the present assay system, the most potent compound 7, platyphyllonol-5-O-β-d-xylopyranoside, significantly suppressed the induction of peroxisome proliferator activated receptor γ (PPARγ and CCAAT/enhancer binding protein α (C/EBPα) protein expression, and inhibited adipocyte differentiation induced by troglitazone, a PPARγ agonist.|platyphyllonol-5-O-β-d-xylopyranoside|C/EBPα|17|37|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23292752|Although parenteral oral direct thrombin inhibitors (DTIs), such as argatroban and bivalirudin, have been on the market for years, DTIs such as dabigatran are novel synthetic thrombin antagonists.|dabigatran|thrombin|28|32|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|Wy-14643|PPARalpha|19|34|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
17537429|ANP increased glucose uptake in both adult and neonatal myocytes, under oxygenation and hypoxia, and GLUT4 favored this increase.|glucose|GLUT4|3|18|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
23453071|Furthermore, BRN-250 inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.|BRN-250|VEGF receptor 2|3|14|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
10411647|On phosphorylation of Ser40 by protein kinase A, the affinity for H4biopterin increased ([S]0.5 = 11 +/- 2 microM) and the negative cooperativity was amplified (h = 0.27 +/- 0.03).|Ser40|protein kinase A|4|6|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE
12840797|  Erlotinib HCl (Tarceva; Genentech, Inc, South San Francisco, CA) is an orally available, highly selective, reversible inhibitor of epidermal growth factor receptor (HER1/EGFR) tyrosine kinase.|Tarceva|epidermal growth factor receptor|4|27|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23371965|Liquid chromatography mass spectroscopy analysis of the inactivated CYP2E1 apo-protein suggests that a reactive sulfur atom generated during desulfurization of PEITC is involved in the inactivation of CYP2E1.|PEITC|CYP2E1|21|28|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
23396419|Uptake of dioscin by rat liver slices and isolated rat hepatocytes was inhibited significantly by Oatp modulators, such as ibuprofen (Oatp1a1 inhibitor), digoxin (Oatp1a4 substrate), and glycyrrhizic acid (Oatp1b2 inhibitor), but not by TEA or p-aminohippurate.|dioscin|Oatp|3|16|Arg1:T11|Arg2:T29|CHEMICAL|GENE-N|SUBSTRATE
23479389|[6]-Gingerol derived from Zingiber officinale Roscoe (ginger) was identified as a novel angiotensin II type 1 receptor antagonist, with an IC50 value of 8.173 µM.|[6]-Gingerol|angiotensin II type 1 receptor|1|18|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|ANTAGONIST
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|lanreotide|SSTR5|16|29|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23159986|The compound D-limonene induced a dose dependent increase in HDN severity and renal biomarker changes without altering BUN, creatinine or NAG: (1) minimal induction of HDN and no altered biomarkers at 10 mg/kg/day, (2) mild induction of HDN with increased αGST and μGST at 50 mg/kg/day and (3) marked induction of HDN with increased αGST, μGST and albumin at 300 mg/kg/day.|D-limonene|αGST|3|64|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23229511|Although treatment with 17-AAG reduced AhR levels and AhR-regulated gene expression in lung AD cells, AhR expression increased anticancer activity of 17-AAG.|17-AAG|AhR|4|6|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23416173|For example, organophosphates, which inhibit acetylcholinesterase as do the drugs used in treating AD symptoms, have also been shown to lead to microtubule derangements and tau hyperphosphorylation, a hallmark of AD.|organophosphates|tau|4|29|Arg1:T1|Arg2:T2|CHEMICAL|GENE-Y|ACTIVATOR
23201003|Moreover, 1,25(OH)(2)D(3) decreased expression of Oat1 and Oat3 in rat kidney.|1,25(OH)(2)D(3)|Oat1|3|17|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
2833901|Again, inhibition of the actin-activated myosin Mg2+-ATPase and myosin filament assembly by felodipine and the p-chloro analogue could be reversed by raising the calmodulin concentration.|p-chloro|myosin|17|7|Arg1:T20|Arg2:T62|CHEMICAL|GENE-N|INHIBITOR
23396419|(-)-Epigallocatechin gallate, cyclosporin A, rifampicin, and telmisartan inhibited transport of dioscin in OATP1B3-HEK293 cells.|cyclosporin A|OATP1B3|7|19|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
10693877|  OBJECTIVE: This randomized, double-blind study tested the hypothesis that rofecoxib, a drug that specifically inhibits cyclooxygenase 2, would cause fewer gastroduodenal ulcers than ibuprofen (in a multicenter trial), and its side effects would be equivalent to those of placebo (in a prespecified analysis combining the results with another trial of identical design).|rofecoxib|cyclooxygenase 2|12|19|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|methazolamide|hCA VI|10|35|Arg1:T22|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
15627430|Since thioridazine binds with similar high affinities to muscarinic receptors as olanzapine and clozapine, muscarinic autoreceptor blockade was ruled out as a primary mechanism [Neuropsychopharmacology 26 (2002) 583].|olanzapine|muscarinic receptors|12|9|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|SR 59230A|beta-adrenoceptor|31|2|Arg1:T8|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST
23473805|Rp1 treatment resulted in an accumulation of doxorubicin or rhodamine 123 by decreasing MDR-1 activity in doxorubicin-resistant cells.|doxorubicin|MDR-1|8|14|Arg1:T23|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|acylated sulfanilamide|CA V|26|4|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|tasosartan|AT1|40|4|Arg1:T2|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST
15478125|The X-ray crystal structure of the best-studied isozyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.|sulfamates|CA II|15|10|Arg1:T3|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
15639300|  Inhibitors of phosphodiesterase type 4 (PDE4) act by increasing intracellular concentrations of cyclic AMP, which has a broad range of anti-inflammatory effects on various key effector cells involved in asthma and chronic obstructive pulmonary disease (COPD).|cyclic AMP|PDE4|15|7|Arg1:T13|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
18559268|Insight into the structural basis for this improvement was gained with molecular modeling and NMR data obtained for microtubule-bound docetaxel.|docetaxel|microtubule|20|19|Arg1:T4|Arg2:T9|CHEMICAL|GENE-N|DIRECT-REGULATOR
23583884|TCDD also caused a fast (within 30min as judged by the increase in its mRNA level) activation of cytosolic phospholipase A2 (cPLA2).|TCDD|cytosolic phospholipase A2|1|21|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20188727|Phenformin but not metformin inhibits a number of variants of K(ATP) including the cloned equivalents of currents present in vascular and non-vascular smooth muscle (Kir6.1/SUR2B and Kir6.2/SUR2B) and pancreatic beta-cells (Kir6.2/SUR1).|Phenformin|Kir6.1|1|29|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
8469910|The lipoxygenase inhibitor nafazatrom (5-50 mumol-1) also dose-dependently inhibited the thyroliberin stimulated rPRL production, while the cyclo-oxygenase inhibitor indomethacin had no such effect on rPRL production.|nafazatrom|rPRL|4|15|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23256625|In vitro, GSK1292263 demonstrated little/weak inhibition (IC50 values >30 μM) towards CYPs (CYP1A2, 2C9, 2C19, 2D6, 3A4), Pgp, OATP1B3, or OCT2.|GSK1292263|OCT2|4|34|Arg1:T13|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
11669456|S2 hOAT1 and S2 hOAT3 exhibited a time- and dose-dependent, and a saturable increase in uptake of [3H]-OTA, with apparent Km values of 0.42 microM (hOAT1) and 0.75 microM (hOAT3).|[3H]-OTA|hOAT3|19|38|Arg1:T3|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
23317165|This review will summarize the developments of small molecule p38α MAP kinase inhibitors based on the imidazole core scaffolds in recent 10 years.|imidazole|MAP kinase|17|11|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
23537747|In conclusion, nobiletin attenuates HGF-induced HepG2 cells metastasis involving both ERK and PI3K/Akt pathways and are potentially useful as anti-metastatic agents for the treatment of hepatoma.|nobiletin|HGF|4|6|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23466232|  Several members of a new family of non-sugar-type α-glycosidase inhibitors, bearing a 5-(p-toluenesulfonylamino)phthalimide moiety and various substituent at the N2 position, were synthesized and their activities were investigated.|5-(p-toluenesulfonylamino)phthalimide|α-glycosidase|14|9|Arg1:T3|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
23583603|Both ICI treatments, induced a significant decrease (p<0.01) in uterine estrogen receptor alpha (ERα) content, had no effect on uterine progesterone receptor (PR) protein expression and caused marked nuclear localization of cyclin D1, in both luminal and glandular uterine epithelium, as compared to vehicle-treated animals.|ICI|ERα|2|20|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|meclofenamate|PGH synthase-2|23|36|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
12137927|Chronic treatment with the NET inhibitor, desipramine (DMI), reduced NET levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.|desipramine|NET|8|5|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
15982930|These results demonstrated that thalidomide might inhibit growth of tumors through COX-2 degradation independent of antiangiogenesis.|thalidomide|COX-2|5|12|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|riboflavin|flavokinase|19|9|Arg1:T7|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|parkin|14|33|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8589992|The relative potency of compounds in displacing [3H]-kainate binding to EAA3a receptor was: domoate > kainate > L-glutamate = quisqualate > 6,7-dinitroquinoxaline-2,3-dione (DNQX) = CNQX > AMPA > dihydrokainate > NMDA.|L-glutamate|EAA3a|22|14|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10611634|In [(35)S]GTPgammaS binding protocols, yohimbine exerts antagonist actions at halpha(2A)-AR, h5-HT(1B), h5-HT(1D), and hD(2) sites, yet partial agonist actions at h5-HT(1A) sites.|yohimbine|hD(2)|12|34|Arg1:T39|Arg2:T74|CHEMICAL|GENE-Y|ANTAGONIST
17352516|As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved HbA(1c) to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to metformin.|metformin|HbA(1c)|42|17|Arg1:T5|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
6150080|Staining around the edges of the brown fat cells was observed with the SSAO substrates, tyramine and benzylamine.|benzylamine|SSAO|19|14|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
23569176|However, until future studies elucidate the magnitude of functional change, caution is warranted in rare instances of extensive metabolism by catechol-O-methyltransferase in Bcrp-knockouts and intestinal carboxylesterase in Mdr1a-knockout rats, specifically for molecules with free catechol groups and esters subject to gut wall hydrolysis.|catechol|catechol-O-methyltransferase|38|23|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
18604229|Specifically, B2-O-CH(2)-CH(2)-N-piperidine and B2-O-CH(2)-CH(2)-N-pyrrolidine revealed a higher affinity towards hERG channels than amiodarone.|amiodarone|hERG|30|27|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23144001|Real-time fluorescence turn-on detection of alkaline phosphatase activity with a novel perylene probe.|perylene|alkaline phosphatase|12|6|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|DIRECT-REGULATOR
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|pindolol|human beta-adrenergic receptors|51|73|Arg1:T18|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST
23085435|  Nitrogen-containing bisphosphonates (N-BPs) induce apoptosis in tumor cells by inhibiting the prenylation of small G-proteins.|N|G-proteins|4|17|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
24261583|  INTRODUCTION: Macitentan is a novel dual endothelin receptor antagonist (ERA) showing sustained receptor occupancy.|Macitentan|endothelin receptor|3|8|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ANTAGONIST
9730867|Concanavalin A (Con A)-induced IFN-gamma, GM-CSF, and IL-3 mRNAs are dose-dependently inhibited by the nonselective betaAR agonist isoproterenol and by the selective beta2AR agonist fenoterol.|fenoterol|IL-3|30|13|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10401556|The potency of the selective alpha 1D-adrenoceptor antagonist BMY 7378 against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective alpha 1A-adrenoceptor antagonist RS-17053 against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement.|BMY 7378|alpha 1D-adrenoceptor|9|6|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST
23611809|Using recombinant UGT2B10, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.|tamoxifen|UGT2B10|25|3|Arg1:T17|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
11785774|COX-1 and COX-2 inhibitor, piroxicam (0.02 and 0.2 microg) and compound NS-398 (0.01 and 0.1 microg), respectively, were given intracerebroventricularly (i.c.v.) 15 min prior to i.c.v. adrenergic receptor agonists: phenylephrine (30 microg) and clonidine (10 microg), an alpha1- and alpha2-adrenergic agonist, and isoprenaline (20 microg) a non-selective beta-adrenergic agonist and clenbuterol (10 microg) a selective beta2-adrenergic agonist.|clonidine|adrenergic receptor|48|38|Arg1:T12|Arg2:T39|CHEMICAL|GENE-N|AGONIST
1472079|In contrast, in native rat liver microsomes, glucuronidation of 4-OHCIPC was increased by cadmium through activation of microsomal 4-OHCIPC glucuronosyl transferase.|cadmium|glucuronosyl transferase|16|22|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|ACTIVATOR
9669506|The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter.|paroxetine|5-HT transporter|6|17|Arg1:T14|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15787205|  Bupropion has an antidepressant effect through blocking the dopamine transporter.|Bupropion|dopamine transporter|1|9|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
12713596|Expression of cyclooxygenase-1, prostaglandin synthases, and prostaglandin E2/D2 production were colocalized in new tissue at the margin of the wound.|prostaglandin E2/D2|cyclooxygenase-1|9|3|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF
1434122|  Ketotifen, a histamine H1-receptor antagonist and mast cell stabilizer, significantly protected the rat gastric mucosa against lesions induced by necrotizing agents, histamine or compound 48/80.|Ketotifen|histamine H1-receptor|1|4|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|ANTAGONIST
16651698|  Multiple exposure to theophylline, a phosphodiesterase (PDE) inhibitor, induces acinar hypertrophy in the salivary gland.|theophylline|phosphodiesterase|4|7|Arg1:T2|Arg2:T8|CHEMICAL|GENE-N|INHIBITOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|PD166326|Src|12|16|Arg1:T32|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
1666931|In addition, platelet alpha 2-adrenergic receptor densities (and binding affinities), measured with 3H-labelled yohimbine, and adrenaline-induced suppression of cyclic AMP contents did not differ among the three groups.|3H-labelled yohimbine|alpha 2-adrenergic receptor|17|5|Arg1:T7|Arg2:T15|CHEMICAL|GENE-N|DIRECT-REGULATOR
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine|AChE|69|4|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|breast cancer resistance protein|43|10|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
23386702|  Carboxylesterases hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.|esters|Carboxylesterases|3|1|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
8836655|Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect.|thioperamide|histamine H3|23|30|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST
23499662|However, it is now evident that pannexins function as unapposed membrane channels and the major role of Panx1 is that of an ATP release channel.|ATP|Panx1|24|19|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
22846225|Furthermore, we demonstrate the standard concentrations of ZIP, but not scrambled ZIP, inhibit the ability of PKMζ to potentiate AMPAR responses at postsynaptic sites, the physiological function of the kinase.|ZIP|PKMζ|9|20|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23238299|Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA.|chelidonine|CYP3A4|13|34|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1327384|alpha 2A-Adrenoceptor selective compounds, oxymetazoline and BRL 44409, showed high affinity for [3H]-RS-15385-197 binding in the human platelet and lower affinity in the neonate lung, while the alpha 2B-selective compounds, prazosin and imiloxan, showed high affinity for [3H]-RS-15385-197 binding in the neonate lung.This suggests that [3H]-RS-15385-197 labels both alpha2A- and alpha2B-adrenoceptor subtypes.4. Prazosin and methysergide inhibited the binding of [3H]-RS-15385-197 in the rat cerebral cortex in a simple manner consistent with an interaction at a single site.|BRL 44409|alpha 2A-Adrenoceptor|8|1|Arg1:T5|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23404505|We report for the first time that VEGF-D binds heparin, and that the C-terminal propeptide significantly enhances this interaction (removal of this propeptide from full-length VEGF-D completely prevents heparin binding).|C|VEGF-D|15|28|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|PART-OF
22846225|(2012) had also claimed that staurosporine, a general kinase inhibitor that does not effectively inhibit PKMζ biochemically in vitro, nonetheless indirectly blocked the PKMζ fusion protein overexpressed in cultured cells by inhibiting phosphoinositide-dependent protein kinase-1 (PDK1).|staurosporine|PKMζ|8|28|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
8073394|The present study utilized blood from normal volunteers and 125I-fibrinogen in a dilute whole blood clot assay to determine the relative concentrations of lysine analogues required for inhibition of clot lysis induced by exogenous t-PA.|125I|fibrinogen|10|11|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR
2268554|Cyproterone acetate, a progestin used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit 3 beta-HSD activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.|Cyproterone acetate|3 beta-HSD|1|32|Arg1:T14|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|3-ethynylphenanthrene|P450 2A13|35|6|Arg1:T3|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
12904467|Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons.|topiramate|kainate-receptor|9|5|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|ANTAGONIST
12067524|  BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (GABA).|gamma-aminobutyric acid|GAD|20|9|Arg1:T1|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF
12141946|In attempting to clone the PAO involved in this back-conversion pathway, we encountered an oxidase that preferentially cleaves spermine in the absence of prior acetylation by SSAT.|spermine|SSAT|20|28|Arg1:T16|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE
23578993|Serum markers of liver damage (AST, ALT, ALP and Bilirubin) were increased by CCl4 and TAA intoxication (p<0.001), whereas co-treatment with NAC reversed such changes (p<0.001).|TAA|ALT|20|9|Arg1:T4|Arg2:T39|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HEP|GST-P|33|14|Arg1:T18|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
8384226|RESULTS: Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF/IL-8 of GM-CSF primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of IL-3 primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L).|Nedocromil sodium|IL-8|3|13|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
23583931|Phosphorylation on Ser and Thr residues of pannexin1 was increased during potentiation, possibly mediating HC opening.|Thr|pannexin1|5|8|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|PART-OF
23284002|Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling.|Trichostatin A|antioxidant response element|1|19|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23160941|The aforementioned peptides were much less efficacious at mFpr2, which responded better to the synthetic hexapeptide WKYMVm, the synthetic agonists Quin-C1 (a substituted quinazolinone), and compound 43 (a nitrosylated pyrazolone derivative).|quinazolinone|mFpr2|27|9|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|AGONIST
23050902|In the present study, we investigated the molecular mechanism of ribavirin-induced up-regulation of F7 expression in HepG2 (human hepatoma cell line).|ribavirin|F7|12|15|Arg1:T8|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|pimozide|human ether-a-go-go-related gene|6|34|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23353698|ABT-737 is a BH3 mimetic agent which binds Bcl-2, Bcl-XL and Bcl-w with high affinity, while weakly interacts with Mcl-1 and Bfl-1.|ABT-737|Bcl-w|1|13|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7518029|In the striatum, sulpiride and haloperidol had different effects: sulpiride induced a higher increase than haloperidol of both preproenkephalin A (PPA) mRNA (+67% versus +47%) and D2 dopamine receptor (D2R) mRNAs (+72% versus +40%).|sulpiride|PPA|12|24|Arg1:T10|Arg2:T37|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15554912|In contrast with results with the MR antagonists eplerenone and spironolactone, amino acids 820-844 are sufficient in themselves to confer high-affinity aldosterone binding to the MR, suggesting that the binding determinants of the two antagonists are similar to each other but differ from those of aldosterone.|eplerenone|MR|9|7|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
20089905|Elucidation of the novel molecular mechanisms linking ibuprofen to RhoA inhibition may provide additional therapeutic targets to the disorders characterized by RhoA activation, including spinal cord injuries and Alzheimer's disease.|ibuprofen|RhoA|8|10|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|aspartate aminotransferase|8|53|Arg1:T3|Arg2:T27|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
17389249|Furthermore, the D439N mutation converted l-glutamate, THA, and PDC, which are activating substrates for the wild-type anion conductance, but not l-aspartate, into transient inhibitors of the EAAC1(D439) anion conductance.|l-glutamate|D439N|7|4|Arg1:T5|Arg2:T28|CHEMICAL|GENE-N|SUBSTRATE
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|IFN-gamma|7|25|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|14|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
10740137|  BACKGROUND: Statins are the most effective agents currently available for lowering plasma levels of low-density lipoprotein cholesterol (LDL-C) and are the mainstay of therapy for hyperlipidemia.|Statins|low-density lipoprotein|3|16|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
12709047|Depending on arginine utilization, location and regulation of ASS are quite different.|arginine|ASS|3|10|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|N|Bim|6|26|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
14506273|These studies indicate that multiple domains of the OCTN2 transporter are required for carnitine transport and identify transmembrane residues important for carnitine recognition.|carnitine|OCTN2|14|9|Arg1:T10|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS1|4|8|Arg1:T32|Arg2:T61|CHEMICAL|GENE-Y|INHIBITOR
12177684|In vitro and in microiontophoresis, flibanserin behaves as a 5-HT(1A) agonist, a very weak partial agonist on dopamine D(4) receptors, and a 5-HT(2A) antagonist.|flibanserin|5-HT(2A)|7|32|Arg1:T10|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|GSH|OGC|40|23|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE
10709635|  gamma-Butyrobetaine hydroxylase catalyse the last step in carnitine biosynthesis, the formation of L-carnitine from gamma-butyrobetaine, a reaction dependent on Fe2+, alpha-ketoglutarate, ascorbate and oxygen.|L-carnitine|gamma-Butyrobetaine hydroxylase|14|1|Arg1:T12|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF
2262902|  To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v. adenosine agonists, N6-(R-phenylisopropyl)adenosine (R-PIA), N6-(S-phenylisopropyl)adenosine, 5'-(N-cyclopropyl)-carboxamidoadenosine, antagonists, theophylline and 8-p-(sulfophenyl)theophylline as well as enprofylline on ethanol-(i.p.)-induced motor incoordination was evaluated by rotorod.|enprofylline|adenosine|64|28|Arg1:T19|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST
16449355|In cirrhotic rats, Western blot analysis revealed a 170% increase in renal neutral endopeptidase protein content (P < 0.03), mainly in the proximal nephron and macula densa, and both candoxatrilat dosages increased plasma ANP levels, urinary volume, and urinary excretion of sodium, ANP, and cGMP compared with vehicle alone (all P < 0.03).|candoxatrilat|ANP|36|52|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23416173|For example, organophosphates, which inhibit acetylcholinesterase as do the drugs used in treating AD symptoms, have also been shown to lead to microtubule derangements and tau hyperphosphorylation, a hallmark of AD.|organophosphates|acetylcholinesterase|4|8|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR
23146690|Taken together, the data provide evidence that the synergistic antiproliferative effect of resveratrol and clofarabine is linked to the inhibition of Akt and Sp1 activities, and suggest that this combination may have therapeutic value in treatment of malignant mesothelioma.|resveratrol|Akt|14|23|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
17092971|  Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine D(2) receptor partial agonists based largely on their activity in second messenger-based assays of dopamine D(2) receptor signalling.|(-)3-PPP|dopamine D(2) receptor|10|18|Arg1:T21|Arg2:T50|CHEMICAL|GENE-Y|AGONIST
23295224|Three of the AKRs used (AKR1B1, AKR1B10 and AKR3C1) could produce 2,3-butanediol from acetoin.|2,3-butanediol|AKR3C1|15|11|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|PRODUCT-OF
13679187|Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors.|ambenonium|AChE|8|11|Arg1:T7|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
10381508|Recombinant factor IXR94S was activated by factor XIa/calcium with an approximately 50-fold reduced rate and by factor VIIa/tissue factor/phospholipid/calcium with an approximately 20-fold reduced rate compared with wild-type factor IX.|calcium|R94S|9|4|Arg1:T4|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR
17210712|They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of arginine with rhArg, to citrulline, which is converted back to arginine via ASS.|ornithine|OTC|18|11|Arg1:T12|Arg2:T54|CHEMICAL|GENE-Y|SUBSTRATE
7832763|  The enzyme cyclo-oxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of prostaglandins.|arachidonic acid|cyclo-oxygenase|8|3|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
10891536|When DLD-1/FdUrd cells expressing increased TS mRNA were treated with FdUrd and F3(d)Thd for only 4 h, the resistance ratios of DLD-1/FdUrd cells to parental DLD-1 cells were markedly different for FdUrd and F3(d)Thd, suggesting that the cytotoxicity with short-time exposure to F3(d)Thd is due to a mechanism other than TS inhibition, although the cytotoxicity of F3(d)Thd in the short-time is low compared to that of long-time exposure.|F3(d)Thd|TS|53|65|Arg1:T20|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|3,4-methylenedioxyamphetamine|human recombinant 5-HT2B receptors|32|42|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15860753|We observed dose-dependent GR activation with 100- and 500-microg doses of FP, and to a lesser extent with 50 microg salmeterol alone.|FP|GR|12|4|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
23604720|From the 10 isolated compounds, methyl-3,5-di-O-caffeoylquinate showed the most potent inhibition, with IC50 values of 0.30 and 0.67 μM for rAR and rhAR, respectively.|methyl-3,5-di-O-caffeoylquinate|rAR|7|23|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23270965|Furthermore, compared with control groups, the plaque endothelium level of p75(NTR) was 3-fold increased and the liver level of p75(NTR) was 17.4-fold increased by SFO-HD.|SFO|p75(NTR)|33|25|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|TCDD|STAT3|62|79|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|ACTIVATOR
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|entecavir|hOAT3|9|4|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|tyrosine kinase|1|14|Arg1:T2|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|DFU|COX-1|5|10|Arg1:T12|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
15936988|In the presence of IL-18, simvastatin suppressed the expression of ICAM-1 and CD40 as well as the production of IL-12, TNF-alpha and IFN-gamma in PBMC, contributing to the anti-inflammatory effect of simvastatin.|simvastatin|TNF-alpha|7|23|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20566645|Steady-state fluorescence was utilized to assess Ca(2+) affinity in isolated cardiac (c)TnCs containing F27W and did not necessarily mirror the fiber Ca(2+) sensitivity.|Ca(2+)|cardiac (c)TnCs|7|14|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11509829|A variety of stimuli such as aldosterone, cell shrinkage, insulin or TGF-beta1 stimulate transcription and activate the SGK1 kinase.|aldosterone|SGK1|7|20|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|ACTIVATOR
23473803|With this objective, we utilised a high-throughput computational approach that identified moexipril, a well tolerated and safe angiotensin-converting enzyme (ACE) inhibitor, as a PDE4 inhibitor.|moexipril|PDE4|13|29|Arg1:T12|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
9117115|At the alpha 1B-adrenoceptor of the rat spleen and rabbit corpus cavernosum penis, tamsulosin again acted as a competitive antagonist but with a significantly lower affinity (pKB = 8.9-9.2).|tamsulosin|alpha 1B-adrenoceptor|15|3|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR
15175324|When coexpressed with the m(2) acetylcholine (ACh) receptor in Xenopus oocytes, agonist-activated GIRK1(F137S)- and GIRK2-mediated currents are inhibited by halothane, whereas in the absence of ACh, high concentrations of halothane induce GIRK1(F137S)-mediated currents.|halothane|F137S|42|46|Arg1:T12|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
11578145|PPG is an effective inhibitor of the pyridoxal 5'-phosphate (PLP)-containing enzyme bacterial L-methionine gamma-lyase (EC 4.4.1.11) contributing to the alpha,gamma-elimination reaction of SeMet and cystathionine gamma-lyase (EC 4.4.1.1) relating to conversion of SeMet to SeCyH.|SeMet|cystathionine gamma-lyase|42|32|Arg1:T9|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE
23478800|Interestingly, disruption of the RhoA-ROCK pathway prevented the inhibitory effect of cucurbitacin I on Rac1 activation by heregulin.|cucurbitacin I|Rac1|13|16|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|glycine|ALAS|23|5|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|SUBSTRATE
12589193|Arginase also induces nitric oxide synthase activity by competing for arginine availability in the extracellular environment, and producing polyamines, which may modulate macrophage activation.|arginine|Arginase|11|1|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|5-methylurapidil|alpha(1D)|7|30|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
15072849|In peripheral lymphocytes of healthy and diseased subjects, IMQ induced a significant increase of perforin(+) CTLs within 12h in all experiments performed.|IMQ|perforin|10|16|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11319232|Troglitazone, a second ACS4 inhibitor, inhibited ACS activity <10% in microsomes and mitochondria and 45% in MAM.|Troglitazone|ACS4|1|5|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
17032653|Here we show that RDH12 localizes to the photoreceptor inner segments and that deletion of this gene in mice slows the kinetics of all-trans-retinal reduction, delaying dark adaptation.|all-trans-retinal|RDH12|24|5|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|SUBSTRATE
17341305|PR isoform B levels were low in virgin control mice and increased after progestin treatment in both strains.|progestin|PR isoform B|14|1|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23074173|We demonstrated that deferasirox increased expression of the metastasis suppressor protein N-myc downstream-regulated gene 1 and upregulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1) while decreasing cyclin D1 levels.|deferasirox|cyclin D1|4|28|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23535185|Furthermore, galangin attenuated IgE-mediated passive cutaneous anaphylaxis and the expression of histamine receptor 1 at the inflamed tissue.|galangin|histamine receptor 1|3|13|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16679384|Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes.|nomifensine|hemoglobin|3|13|Arg1:T26|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Mg-nucleotide|SUR|15|24|Arg1:T17|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR
23388705|Pretreatment of mice with a phosphorylated prodrug of nitrobenzylmercaptopurine riboside, an inhibitor of mENT1, significantly decreased brain exposure to tecadenoson compared with that of the untreated (control) group, suggesting involvement of mENT1 in transport of tecadenoson across the blood-brain barrier (BBB).|nitrobenzylmercaptopurine|mENT1|9|15|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
15229223|Melatonin acts as a calmodulin antagonist inducing conformational changes in the ERalpha-calmodulin (CaM) complex, thus impairing the binding of E(2).ERalpha.CaM complex to DNA and, therefore, preventing ERalpha-dependent transcription.|Melatonin|calmodulin|1|5|Arg1:T17|Arg2:T35|CHEMICAL|GENE-N|ANTAGONIST
12842269|Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.|GTPgammaS|opioid receptors|3|15|Arg1:T9|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|N|cardiac troponin C|14|18|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PART-OF
23397055|The A2A adenosine receptor agonist CGS21680 (C23H29N7O6.HCl.xH2O) (0.001-0.1 μM) did not alter NE oxidation currents.|CGS21680|A2A adenosine receptor|6|2|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
2120879|Removing medium Ca2+, blocking Ca2+ channels with 50 mumol/l verapamil, or inhibiting calmodulin activation with 20 mumol/l trifluoperazine, 10 mumol/l chlorpromazine or 10 mumol/l pimozide almost completely blocked hyposmolarity-induced secretion.|pimozide|calmodulin|28|15|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
2886573|  To characterize beta 1- and beta 2-adrenoceptor mediated effects in man the influence of the selective beta 1-adrenoceptor antagonist bisoprolol and the selective beta 2-adrenoceptor antagonist ICI 118,551 on changes in blood pressure, heart rate and lymphocyte beta 2-adrenoceptor density evoked by dynamic exercise or isoprenaline infusion was studied in 12 male normotensive volunteers.|bisoprolol|beta 1-adrenoceptor|20|17|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST
11159707|It was also confirmed that the treatment of ADX rats with dexamethasone, PDTC or dexamethasone plus PDTC completely inhibit NF-kappaB activation caused by absence of endogenous glucucorticoid.|dexamethasone|NF-kappaB|12|21|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
15016471|The roles of GTK in (a) brain nitrogen, sulfur, and aromatic amino acid/kynurenine metabolism, (b) brain alpha-keto acid metabolism, (c) bioactivation of certain electrophiles in brain, (d) prodrug targeting, and (e) maintenance of normal blood pressure deserve further study.|nitrogen|GTK|10|4|Arg1:T23|Arg2:T70|CHEMICAL|GENE-Y|SUBSTRATE
23291630|The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers.|navitoclax|BCL-X(L)|15|27|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
16595573|In addition, roxithromycin is an inhibitor of the drug transporter P-glycoprotein, possibly leading to accumulation of cyclophosphamide in endothelial cells.|roxithromycin|P-glycoprotein|4|12|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
23639801|CID16020046 concentration-dependently inhibited LPI-induced activation of nuclear factor of activated T-cells (NFAT), nuclear factor kappa of activated B cells (NF-κB) and serum response element (SRE), translocation of NFAT and NF-κB, and GPR55 internalization.|LPI|NF-κB|4|38|Arg1:T12|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR
20184869|We determined whether an angiotensin-converting enzyme (ACE) inhibitor, captopril, inhibits MMP-2 activity in peritoneal effluents from patients on CAPD, and simulated molecular models of the MMP-2-captopril complex.|captopril|angiotensin-converting enzyme|12|5|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|p85alphaPI-3K|1|16|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|gramine|acetylcholinesterase|23|10|Arg1:T15|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|VEGF receptor 2|3|16|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
14504136|I.v. continuous infusions of the agonists 5-carboxamidotryptamine (5-CT; 5-HT1/7 and recombinant 5-ht5A/5B), CP 93129 (r5-HT1B), sumatriptan (5-HT1B/1D), PNU-142633 (5-HT1D) and ergotamine (5-HT1B/1D and recombinant 5-ht5A/5B) mimicked the above sympatho-inhibition to 5-HT.|PNU-142633|5-HT1D|29|31|Arg1:T5|Arg2:T42|CHEMICAL|GENE-Y|AGONIST
23631463|In the current study, we show that systematic modification of an aminoalkylindole scaffold identifies two new compounds with dual CB1R antagonist/CB2R agonist activity.|aminoalkylindole|CB2R|13|23|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|AGONIST
23604717|Collectively, SAL-2 inhibited COX-2 and iNOS gene expression through suppression of NF-κB leading to the inhibition of PGE2 synthesis.|SAL-2|COX-2|3|5|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1438284|The mutated enzyme was also inhibited well by the bulky, BtChoEase-selective organophosphate inhibitor (tetraisopropylpyrophosphoramide, iso-OMPA).|organophosphate|BtChoEase|13|12|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
15673388|CONCLUSION: Oral quinidine is effective in suppressing the gain of function in IKr responsible for some cases of short QT syndrome with a mutation in HERG and thus restoring normal rate dependence of the QT interval and rendering ventricular tachycardia/ventricular fibrillation noninducible.|quinidine|IKr|4|14|Arg1:T2|Arg2:T9|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
15381832|Both inhibitors, moreover, caused the reduction in the gastric mucosal cell phospholipid secretory responses to beta-adrenergic agonist-generated second messenger, cAMP as well as adenyl cyclase activator, forskolin.|forskolin|adenyl cyclase|31|27|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR
11092898|A strong shift in TCA affinity (IC(50)) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine).|nortriptyline|S399P|28|24|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
15655513|However, consistent with its low COX-1 inhibitory activity, lumiracoxib at a dose of 100 mg kg(-1) orally caused no ulcers and was significantly less ulcerogenic than diclofenac (P<0.05).|lumiracoxib|COX-1|11|7|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23435615|The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers.|(R)-omeprazole|CYP2C19|2|9|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
21631396|However, phosphorylation of the p65/RelA subunit was clearly inhibited by PSE in stimulated cells.|PSE|RelA|12|7|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|AZM|MCA|14|51|Arg1:T7|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
23571427|Screening assays with 12 available human recombinant UDP-glucuronosyltransferases (UGTs) demonstrated that UGT1A9 was the predominant UGT isoform involved in R-ornidazole glucuronidation, whereas S-ornidazole glucuronidation was almost exclusively catalyzed by UGT2B7.|R-ornidazole|UGT|22|18|Arg1:T14|Arg2:T28|CHEMICAL|GENE-N|SUBSTRATE
17207582|The GRIP1 reduction was inhibited by MK-801, an N-methyl-d-aspartate (NMDA) receptor antagonist, but not by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), an AMPA receptor antagonist.|CNQX|AMPA receptor|22|26|Arg1:T15|Arg2:T51|CHEMICAL|GENE-N|ANTAGONIST
17468175|Potential binding conformations of D1 and D2 receptors were obtained, and the D1-SPD and D2-SPD complexes were generated, which are in good agreement with most of experimental data.|SPD|D2|17|16|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23542513|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-κB suppression and Nrf-2-dependent heme oxygenase-1 induction.|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone|heme oxygenase-1|1|17|Arg1:T22|Arg2:T52|CHEMICAL|GENE-Y|ACTIVATOR
9013583|In this report, we show that indomethacin binds and activates peroxisome proliferator-activated receptor gamma (PPARgamma), a ligand-activated transcription factor known to play a pivotal role in adipogenesis.|indomethacin|peroxisome proliferator-activated receptor gamma|8|12|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
16897483|Two highly divergent ADH genes (15% identity at the amino acid level) of Cantaloupe Charentais melon (Cucumis melo var.|amino acid|ADH|12|4|Arg1:T9|Arg2:T26|CHEMICAL|GENE-N|PART-OF
22972179|2-Deoxyglucose increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2.|2-Deoxyglucose|TSC2|1|10|Arg1:T7|Arg2:T8|CHEMICAL|GENE-Y|ACTIVATOR
23624148|Sciadopitysin also decreased the production of tumor necrosis factor-a (TNF-α) induced by antimycin A, a mitochondrial electron transport inhibitor.|Sciadopitysin|TNF-α|1|11|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23353901|Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (PAT)-type 5-HT2C agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.|PAT|5-HT2C|25|28|Arg1:T19|Arg2:T42|CHEMICAL|GENE-Y|AGONIST
17114825|Tryptophan-dependent tRNAtrp aminoacylation catalyzed by TrpRS can be inhibited by its substrate tryptophan at physiological concentrations was demonstrated.|tryptophan|TrpRS|13|6|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
14596599|Formation of pyruvate by SDH is a two-step reaction in which the hydroxyl group of serine is cleaved to produce aminoacrylate, and then the aminoacrylate is deaminated by nonenzymatic hydrolysis to produce pyruvate.|aminoacrylate|SDH|21|5|Arg1:T24|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
23386703|Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.|apixaban|factor Xa|6|9|Arg1:T15|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|TGF-alpha|1|18|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
2568212|  The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating histamine H1-receptor antagonists terfenadine, astemizole, loratadine, and acrivastine are reviewed.|terfenadine|histamine H1-receptor|22|19|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST
23391631|In contrast, at the in vitro level, Pb(2+) treatment induced both β-MHC and α-MHC mRNA levels in time- and dose-dependent manner.|Pb(2+)|β-MHC|10|17|Arg1:T5|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|oxoglutaramic acid|KATI|27|16|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
23645249|Herein, we report that post-weaning dietary exposure to soy protein isolate and its bioactive isoflavone genistein lowered mammary adiposity and increased mammary tumor suppressor PTEN and E-cadherin expression in female mice, relative to control casein diet.|isoflavone|E-cadherin|16|28|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10598120|BIO TO-2 cardiomyopathic hamsters (CMHs) in the early stages of dilated heart failure were treated with vehicle or maximal ACE inhibitory doses of captopril (750 micromol/kg/day) or omapatrilat (200 micromol/kg/day).|omapatrilat|ACE|32|22|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|Co|hypoxia-inducible factor (HIF)-1α|21|9|Arg1:T13|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20426763|These functional responses were blocked by selective 5HT(2) receptor antagonists with the 5HT(2A) antagonist, M-100970, exhibiting the highest potency.|M-100970|5HT(2A)|22|16|Arg1:T15|Arg2:T42|CHEMICAL|GENE-Y|ANTAGONIST
14716684|[(131)I]MIBG uptake in PC12 cells, which express the NET endogenously, was 20- to 28-fold lower than in transduced cells.|[(131)I]MIBG|NET|1|16|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
23603339|In primary human hepatocytes, DHEA diminished the increase in CYP1A activities (7-ethoxyresorufin O-dealkylation and phenacetin O-dealkylation) and in CYP1A2 mRNA level induced by 3-methylcholanthrene, but did not alter the amount of CYP1A1 and CYP1B1 mRNA.|3-methylcholanthrene|CYP1A2|27|22|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23512732|EGCG significantly inhibited expressions of α-SMA and collagen type I mRNA and reduced α-SMA and collagen protein levels at concentrations of 10-20 µg/mL.|EGCG|α-SMA|1|14|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1665782|When delta-receptor binding was determined by using [3H]DPDPE, a 40-50% decrease in binding in the midbrain and cortex, and 25-35% decrease in binding in the striatum were observed after 3 or 4 days of DPDPE treatment.|[3H]DPDPE|delta-receptor|8|2|Arg1:T15|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|sildenafil|Q817A|8|43|Arg1:T35|Arg2:T58|CHEMICAL|GENE-N|DIRECT-REGULATOR
23289710|Incubation of in vitro transcribed tRNA[Ser]Sec with recombinant Trit1 transfers [(14)C]dimethylallyl pyrophosphate to tRNA([Ser]Sec).|[(14)C]dimethylallyl pyrophosphate|tRNA([Ser]Sec)|15|24|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23396419|Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans.|dioscin|organic anion-transporting polypeptides|11|3|Arg1:T20|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|3-NP|SDH|6|25|Arg1:T17|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
22818713|Moreover, silibinin repressed the phenylephrine-induced phosphorylation of ERK1/2 kinases, while it appeared to inhibit the weakly activated by phenylephrine phosphorylation of Akt.|silibinin|Akt|3|24|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23412992|Previous data from our groups and from others point to the sodium/potassium pump (the Na+/K+-ATPase, i.e., NaK) with its highly specific ligands (i.e., cardiotonic steroids) as a new target for combating cancers associated with dismal prognoses, including gliomas, melanomas, non-small cell lung cancers, renal cell carcinomas, and colon cancers.|steroids|sodium/potassium pump|31|12|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR
8600944|In vitro studies with blood-derived T cells, however, show inhibition of all three cytokines by GCS.|GCS|cytokines|18|16|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23266270|DPEP inhibited LPS-induced phosphorylation of ERK, JNK, and p38.|DPEP|p38|1|11|Arg1:T12|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
23402744|We previously demonstrated that developmental exposure to a mixture of polychlorinated biphenyls (PCBs) which was reconstituted according to the congener pattern found in human breast milk caused feminization of sweet preference as a sexually dimorphic behavior in adult male rats, following decreases in aromatase activity in the brain of newborn male pups.|PCBs|aromatase|14|47|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
8760245|Both dimethylamiloride and monensin prevented metaproterenol activation of Na-K-ATPase.|dimethylamiloride|Na-K-ATPase|2|9|Arg1:T3|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|protein kinase A|4|7|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
16297435|Choline alphoscerate or rivastigmine, but not choline increased acetylcholine levels as well as [(3)H]hemicholinium-3 binding used as a marker of high affinity cholinergic transporter.|[(3)H]hemicholinium-3|cholinergic transporter|15|30|Arg1:T11|Arg2:T30|CHEMICAL|GENE-N|DIRECT-REGULATOR
15261283|Compound 2, 5-[2-[4-(2,3-dimethyl-phenyl)-piperazin-1-yl]ethyl]1H-benzotriazole, expressed clozapine-like in vitro binding profile at D(2), 5-HT(2A) and alpha 1 receptors and a higher affinity for 5-HT(1A) receptors than clozapine.|clozapine|alpha 1 receptors|19|35|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR
23376608|In the c-Myc siRNA-transfected and apigenin-treated cells, compared with the apigenin-treated control cells, apoptosis and phosphorylation of p38 and p53 were ameliorated.|apigenin|p53|6|22|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
23000442|Incubation of isoform-specific substrate probes CYPs with mollugin (0-25μM) in HLM resulted in strong inhibition of CYP1A2-catalyzed phenacetin O-deethylation, showing IC(50) values of 1.03 and 3.55μM without and with pre-incubation, respectively.|phenacetin|CYP1A2|20|19|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|L-serine|SDH|19|1|Arg1:T1|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
17273750|Apaf-1 activity was also detected in HSG cells in a dose-dependent manner after treatment with cimetidine.|cimetidine|Apaf-1|16|1|Arg1:T2|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
23454527|N-acetylcysteine (NAC, 33 mM) and the c-jun N-terminal kinase (JNK) inhibitor (SP600125, 33 μM) further decreased the viability in the presence of DEP (200 μg/ml) and 3.3% FCS.|SP600125|c-jun N-terminal kinase|18|10|Arg1:T4|Arg2:T9|CHEMICAL|GENE-N|INHIBITOR
23386703|BCRP appeared to play a more important role for absorption and intestinal and renal elimination of apixaban than P-gp in transporter-KO rats after oral and i.v. dosing, which led to a higher level of active renal excretion in rat than other species.|apixaban|P-gp|17|19|Arg1:T2|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE
23340252|TF or Cort each increased insulin-stimulated lipogenesis, an effect resulting from increased lipogenic gene expression and enhanced insulin-stimulated dephosphorylation of acetyl-coenzyme A carboxylase.|Cort|insulin|3|6|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
11488610|  Cofactor and tryptophan accessibility of the 65-kDa form of rat brain glutamate decarboxylase (GAD) was investigated by fluorescence quenching measurements using acrylamide, I-, and Cs+ as the quenchers.|tryptophan|GAD|3|15|Arg1:T4|Arg2:T49|CHEMICAL|GENE-Y|PART-OF
2268554|4-MA, a well known 5 alpha-reductase inhibitor, is also a potent inhibitor of 3 beta-HSD with a Ki value of 56 nM.|4-MA|3 beta-HSD|1|16|Arg1:T10|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
23317159|Many other JAK2 inhibitors such as TG101348 or SAR302503, SB1518, CEP701 and LY2784544 are now under investigation for MPN development.|SB1518|JAK2|11|3|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23625915|Activation of AMPK using AICAR resulted in STIM1 phosphorylation on serine residues and prevented PAR-1-induced Ca2+ entry.|AICAR|PAR-1|5|15|Arg1:T4|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23537890|Additionally, quercetin treatment in d-GalN/LPS treated rats significantly increased HO-1 mRNA and its protein expressions.|quercetin|HO-1|3|11|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT3|21|35|Arg1:T8|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
15963471|  Thiazolidinediones are a new class of anti-diabetic agents which increase insulin sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of insulin-responsive genes involved in glucose and lipid metabolism.|Thiazolidinediones|insulin|1|32|Arg1:T1|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17429625|  PURPOSE: Dasatinib (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.|Dasatinib|BCR|3|17|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23194750|Analysis of phospho-Akt (ser 473) in lysates from rat arteries (by immunoblot) revealed that thiazolidinediones, LY294002 and 10-DEBC, at the same concentration and kinetics inhibiting vasoconstriction, produced a similar decrease of Akt phosphorylation.|thiazolidinediones|Akt|19|39|Arg1:T7|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
11304699|To mechanistically evaluate this regional selectivity, we assessed cyclo-oxygenase-2 (COX-2) expression in the uninvolved mucosa and demonstrated a 3- to 4-fold excess in the distal relative to the proximal bowel in both MIN mice and AOM-treated rats.|AOM|COX-2|39|12|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
12110374|Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent.|prostaglandin E(2)|COX-2|10|7|Arg1:T21|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE
17181139|Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators.|carprofen|COX-2|9|6|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23376608|In conclusion, our results indicate that apigenin induces apoptosis mediated via c-Myc with concomitant phosphorylation of p53 and p38 in FRO ATC cells.|apigenin|p53|8|18|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
23353736|  A series of MMP-1 inhibitors have been identified based upon a methyl rosmarinate scaffold using structure-based drug design methods.|methyl rosmarinate|MMP-1|12|4|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|X-linked inhibitor of apoptosis protein|47|34|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11885959|  Non-steroidal anti-inflammatory drugs (NSAIDs) are competitive inhibitors of cyclooxygenase (COX), the enzyme that mediates biosynthesis of prostaglandins and thromboxanes from arachidonic acid.|arachidonic acid|COX|26|13|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|SUBSTRATE
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|collagen type I|17|44|Arg1:T16|Arg2:T44|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23247009|In addition, BGG-mediated inhibition of AR prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.|BGG|p38|4|14|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10421446|With DEPQ-inhibited wild-type mouse acetylcholinesterase (AChE), the reactivation kinetic profile demonstrated one-phase exponential association only when 2-[hydroxyimino methyl]-1-methylpyridinium chloride (2-PAM) and 1-(2-hydroxy-iminomethyl-1-pyridinium)-1-(4-carboxy-aminopyridi nium)-dimethyl ether hydrochloride (HI-6) were used as reactivators.|2-PAM|AChE|28|7|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|ACTIVATOR
22080037|Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase.|Mercury|inducible nitric oxide synthase|1|8|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22982445|The results demonstrated that intracerebral infusions of LTD4 (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of Aβ1-40 and Aβ1-42 in the hippocampus and cortex through increased activity of β- and γ-secretases accompanied with increased expression of amyloid precursor protein (APP).|LTD4|Aβ1-40|8|34|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|MPTP|UCHL- 1|26|40|Arg1:T8|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|2,3,7,8-tetrachlorodibenzodioxin|AhR|25|35|Arg1:T12|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR
11018726|  Tyrosine-175 located in the active site of human glyoxalase II was replaced by phenylalanine in order to study the contribution of this residue to catalysis.|phenylalanine|human glyoxalase II|14|8|Arg1:T10|Arg2:T14|CHEMICAL|GENE-Y|PART-OF
23028140|In vitro, CYP2C8 inhibitors and CYP3A4 inhibitors inhibited the depletion of 0.1 µM imatinib by 45 and 80%, respectively, and the formation of the main metabolite of imatinib, N-desmethylimatinib, by >50%.|imatinib|CYP2C8|15|4|Arg1:T12|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|(+)-[(3)H]isradipine|Ca(v)1.3|3|26|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23620199|The conjugate combines two strategies: the anti-HER2 activity of trastuzumab, and the targeted intracellular delivery of mertansine, a tubulin polymerisation inhibitor which interferes with mitosis and promotes apoptosis.|mertansine|tubulin|19|22|Arg1:T5|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
23291264|Levels of both CCL2 and kidney injury molecule-1 (KIM-1) in the whole kidney increased after cisplatin administration.|cisplatin|CCL2|18|4|Arg1:T14|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23530019|Zebra finch liver microsomes metabolized nicotine and bupropion (CYP2B substrate) but not coumarin (CYP2A substrate).|nicotine|CYP2B|6|10|Arg1:T2|Arg2:T27|CHEMICAL|GENE-N|SUBSTRATE
17321471|The selective A(2A) receptor antagonist ZM241385 (30 nM), but not the selective A(2B) receptor antagonist MRS1754 (30 nM), blocked the inhibitory effect of NECA and CGS21680 on TNF-alpha release.|MRS1754|A(2B) receptor|25|19|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
17210712|Therefore, pretreatment tumor gene expression profiling of ASS and OTC could aid in predicting tumor response to arginine depletion with arginine-depleting enzymes.|arginine|arginine-depleting enzymes|19|22|Arg1:T3|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE
17340133|These results demonstrate that the availability of L: -arginine can play a role in the control of gene expression by augmenting the DNA-binding activity of NF-kappaB, which can affect the initiation and progression of dermal inflammation.|L: -arginine|NF-kappaB|8|27|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR
10727523|Both MRP1 and MRP2 actively transported leukotriene C(4) and N-ethylmaleimide glutathione (NEM-GS), although the relative affinity of MRP2 for these substrates was found to be significantly lower than that of MRP1.|leukotriene C(4)|MRP1|7|2|Arg1:T12|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
17075268|Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and HDC mRNA induced by TDI in TDI-sensitized rats.|dexamethasone|HDC|3|18|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23157629|  The serotonin (5-HT) receptors of type 6 (5-HT6) are quite different from all other 5-HT receptors, as they include a short third cytoplasmatic loop and a long C-terminal tail, and one intron located in the middle of the third cytoplasmatic loop.|C|5-HT6|33|11|Arg1:T2|Arg2:T8|CHEMICAL|GENE-Y|PART-OF
15161930|In contrast to the complexes of the ERalpha LBD with 4-hydroxytamoxifen or raloxifene, helix 12 of antagonist-bound ERRgamma does not occupy the coactivator groove but appears to be completely dissociated from the LBD body.|raloxifene|ERalpha LBD|13|8|Arg1:T16|Arg2:T35|CHEMICAL|GENE-N|DIRECT-REGULATOR
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|long-chain fatty acids|FAS|16|5|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
16855178|Colonic cyclooxygenase-2 and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ATB-429, but not by mesalamine.|ATB-429|cyclooxygenase-2|15|2|Arg1:T7|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23305993|  The compound (5Z)-5-[(5-bromo-1H-indol-3-yl)methylene]-3-(4-chlorobenzyl)-thiazolidine-2,4-dione (LYSO-7) was synthesised in order to obtain a new type of anti-inflammatory drug, designed with hybrid features to inhibit cyclooxygenase (COX) and also to activate peroxisome proliferator-activated receptor (PPAR).|LYSO-7|peroxisome proliferator-activated receptor|19|48|Arg1:T8|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR
23449197|Discovery of 7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): a potent and selective transforming growth factor-β type I receptor inhibitor as a topical drug for alopecia.|7-methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole|transforming growth factor-β type I receptor|3|20|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
10403635|In phosphotriesterase and physostigmine-treated mice, a 4- and 2-fold higher sarin dose, respectively, was needed to cause a 50% inhibition of brain AChE activity.|sarin|AChE|12|27|Arg1:T11|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
23291050|In addition, results obtained when the snails were exposed sequentially to the pesticides showed that the sequence AZM/CPF produced at 48 h a higher ChE inhibition than the sequence CPF/CPF.|CPF|ChE|32|26|Arg1:T7|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23632082|This conductance was suppressed by nonselective TRPC channel blockers 2-APB, flufenamic acid and ML204, enhanced by La(3+) in a subpopulation of cells, and unchanged by the TRPV1 antagonist capsazepine or a Na(+) /Ca(2+) exchanger blocker KB-R7943.|ML204|TRPC|15|7|Arg1:T4|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
9059856|Radioligand binding assay, using [3H]N-methyl-scopolamine as tracer, showed the existence of acetylcholine muscarinic receptors in brush-border (Kd 0.28 +/- 0.04 nM; Bmax 9.4 +/- 1.6 fmol/mg protein) and basal plasma membranes (Kd 0.24 +/- 0.05 nM; Bmax 34.3 +/- 6.3 fmol/mg protein).|[3H]N-methyl-scopolamine|acetylcholine muscarinic receptors|6|17|Arg1:T15|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|BRL-49653|apo CIII|14|25|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|33|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE
2112956|Valproyl-CoA was dehydrogenated at a significant rate (0.167 mumol/min per mg protein) only by rat 2-methyl-branched-chain acyl-CoA dehydrogenase.|Valproyl-CoA|2-methyl-branched-chain acyl-CoA dehydrogenase|1|18|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|SUBSTRATE
17959709|In addition, the molecular configuration of vardenafil differs from that of sildenafil when bound to PDE5.|sildenafil|PDE5|13|17|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1881457|Phenelzine is a more potent monoamine oxidase inhibitor than is N2-acetylphenelzine.|Phenelzine|monoamine oxidase|1|6|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
23562928|  The purpose of this study is to investigate the effects of n-hexane extracts from bones and internal organs of Japanese eel, Anguilla japonica (HEE), on cyclooxygenase-2 (COX-2)-dependent prostaglandin D2 (PGD2) generation in stem cell factor (SCF), IL-10, plus LPS-induced mouse bone marrow-derived mast cells (BMMCs) and on passive cutaneous anaphylaxis (PCA) in mice.|PGD2|cyclooxygenase-2|38|30|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|PRODUCT-OF
23059626|The expression of the osteoblast markers runt-related transcription factor 2 (RUNX2) and periostin was decreased, while osteocalcin (OCN) was augmented in CCL3(-/-) and Met-RANTES-treated mice.|Met|OCN|32|22|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
21926191|Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.|Cabozantinib|VEGFR2|1|10|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
11980628|The infusion of 10 microg/kg/h of SOM230 using subcutaneously implanted minipumps decreased plasma IGF-I levels far more effectively than SMS 201-995.|SOM230|IGF-I|7|14|Arg1:T9|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT1|61|47|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|KIT|3|45|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23231967|  The influence of diverse methoxyphenyl substitution patterns on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold is herein explored in order to modulate the A(3) adenosine receptor antagonistic profile.|N-(2,6-diarylpyrimidin-4-yl)acetamide|A(3) adenosine receptor|10|24|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|ANTAGONIST
16232421|A double mutant of the two fumarate reductase isozyme genes (OSM1 and FRDS) showed a succinate productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.|succinate|fumarate reductase|18|7|Arg1:T6|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF
9313928|M&B-28767, a putative EP3 agonist, and misoprostol, a putative EP2/EP3 agonist, also bound to this receptor with Ki values of 120 nM.|misoprostol|EP2|11|15|Arg1:T12|Arg2:T78|CHEMICAL|GENE-Y|AGONIST
23220560|Moreover, we demonstrated that in utero exposure to low-level MeHg suppresses the expression of Rac1, Cdc42, and RhoA, which play key roles in the migration of cerebrocortical neurons during the early stage of brain development, suggesting that the MeHg-induced migratory disturbance of cerebrocortical neurons is likely associated with the Rho GTPases signal pathway.|MeHg|Rac1|11|16|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
19337422|  Tolvaptan is a selective arginine vasopressin (AVP) V(2) receptor blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia.|Tolvaptan|arginine vasopressin (AVP) V(2) receptor|1|5|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
17827008|From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.|AZD6140|P2Y12 receptor|4|13|Arg1:T5|Arg2:T8|CHEMICAL|GENE-Y|ANTAGONIST
10076535|Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.|EMP|androgen receptor|8|15|Arg1:T46|Arg2:T63|CHEMICAL|GENE-Y|ANTAGONIST
23643631|Furthermore, melamine-induced ROS production could be attenuated by apocynin, a NOX inhibitor.|apocynin|NOX|10|13|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
23453071|Furthermore, BRN-250 inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway.|BRN-250|VEGFR2|3|18|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|AM2389|CB1|42|2|Arg1:T20|Arg2:T29|CHEMICAL|GENE-Y|AGONIST
15694390|However, the 5-LO products, leukotriene B(4) (LTB(4)) and leukotriene C(4), were not detected in cells treated with IFN-gamma, indicating that the effect of NDGA seemed to be independent of 5-LO inhibition.|LTB(4)|5-LO|13|4|Arg1:T14|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF
23557840|Continuing our previous work, we take the first steps of structure-activity relationship exploration and show that 1,3,4-oxadiazol-2-ones can serve as scaffold for both selective FAAH and MAGL inhibitors, and also function as a dual FAAH/MAGL inhibitor at sub-micromolar IC50 values.|1,3,4-oxadiazol-2-ones|MAGL|18|38|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
12416991|Two-substrate kinetic analysis and dead-end inhibition studies for 5alpha-DHP reduction and allopregnanolone oxidation indicated that 3alpha-HSD type III utilized a ternary complex (sequential) kinetic mechanism, with nicotinamide adenine dinucleotide cofactor binding before steroid substrate and leaving after steroid product.|steroid|3alpha-HSD type III|41|16|Arg1:T11|Arg2:T41|CHEMICAL|GENE-Y|PRODUCT-OF
23229510|E235 also activated DNA damage response signaling, resulting in increased levels of Ser15-phosphorylated p53, γ-H2AX, and phosphorylated checkpoint kinase 2 (Chk2), although E235 does not appear to cause physical DNA damage.|E235|phosphorylated p53|1|15|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11146120|Clenbuterol caused significant increases in both NGF mRNA and protein in 3T3 cells; with maxima at 10 nM and at 8-12 h exposure.|Clenbuterol|NGF|1|7|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22552008|Lenalidomide and pomalidomide inhibited autoubiquitination of CRBN in HEK293T cells expressing thalidomide-binding competent wild-type CRBN, but not thalidomide-binding defective CRBN(YW/AA).|pomalidomide|CRBN|3|15|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
12601049|Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression.|corticosteroid|VEGF|12|16|Arg1:T24|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
18061638|Danazol activated PR and AR.|Danazol|PR|1|3|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR
22370636|Whole-exome analysis of the Pik3ca(H1047R)-driven mammary tumors identified multiple mutations, including Trp53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors.|Trp|H1047R|17|7|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|PART-OF
17315049|Sitagliptin, a DPP-4 inhibitor, is orally active and has been shown to be efficacious and safe in clinical studies.|Sitagliptin|DPP-4|1|4|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
15655513|Lumiracoxib inhibited purified COX-1 and COX-2 with K(i) values of 3 and 0.06 microM, respectively.|Lumiracoxib|COX-2|1|6|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
16010590|The drug interaction may partly be dependent on the folate homeostasis since WiDr/F cells growing at low folate conditions show pronounced synergism in growth inhibition, two-sided TS inhibition and DNA damage, especially when TFT is combined with the tight-binding TS inhibitor GW1843.|GW1843|TS|44|28|Arg1:T26|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-8713|EP(1)|12|1|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
2268554|  Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and androst-5-ene-3 beta, 17 beta-diol) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.|17 alpha-hydroxy pregnenolone|3 beta-HSD|23|11|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE
12563315|This anti-lipolytic effect of nicotinic acid involves the inhibition of cyclic adenosine monophosphate (cAMP) accumulation in adipose tissue through a G(i)-protein-mediated inhibition of adenylyl cyclase.|nicotinic acid|adenylyl cyclase|5|30|Arg1:T11|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|coumestrol|estrogen receptor|15|34|Arg1:T9|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23500659|Testosterone significantly decreased ER-β and increased ER-α and AR expressions as compared to the control group and these effects were significantly ameliorated by SIL.|Testosterone|ER-α|1|7|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12709047|  Argininosuccinate synthetase (ASS, EC 6.3.4.5) catalyses the condensation of citrulline and aspartate to form argininosuccinate, the immediate precursor of arginine.|citrulline|EC 6.3.4.5|13|6|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
23424204|In conclusion, BPA has adverse effects on phosphorylation of Akt, GLUT4 translocation and (14)C-glucose oxidation.|BPA|GLUT4|4|13|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK-B|27|43|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|24R, 25-(OH)(2)D(3)|PKC|42|38|Arg1:T9|Arg2:T38|CHEMICAL|GENE-N|ACTIVATOR
23515287|The dihydrotestosterone metabolite, 5α-androstane-3β,17β-diol (3β-diol), binds and activates estrogen receptor-β (ER-β), the predominant ER in the PVN.|5α-androstane-3β,17β-diol|ER-β|5|16|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17673606|Using hNET in transfected human embryonic kidney-293 cells, this difference in potency for DVS at sites labeled by [(3)H]NIS was found to distinguish DVS, the DVS analog rac-(1-[1-(3-chloro-phenyl)-2-(4-methylpiperazin-1-yl)-ethyl]cyclohexanol (WY-46824), methylphenidate, and the cocaine analog 3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester (RTI-55) from other hNET antagonists, such as NIS, mazindol, tricyclic antidepressants, and cocaine.|3beta-(4-iodophenyl)tropane-2beta-carboxylic acid methyl ester|hNET|61|2|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|ANTAGONIST
12513997|L-proline accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding gamma-glutamyl kinase.|L-proline|gamma-glutamyl kinase|1|19|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|epinephrine|human beta-adrenergic receptors|18|73|Arg1:T3|Arg2:T33|CHEMICAL|GENE-N|AGONIST
8622118|Injection of in vitro-transcribed RNA from this clone into Xenopus laevis oocytes results in the robust expression of homo-oligomeric cation channels that can be gated by L-glutamate (EC50 = 1.2 +/- 0.3 micron) and several other glutamate receptor agonists; rank order of potency: glutamate >> kainate > ibotenate > AMPA.|ibotenate|glutamate receptor|53|39|Arg1:T8|Arg2:T22|CHEMICAL|GENE-N|AGONIST
12141946|Substrate specificity using lysates of oxidase-transfected HEK-293 cells revealed that the newly identified oxidase strongly favoured spermine over N (1)-acetylspermine and that it failed to act on N (1)-acetylspermidine, spermidine or the preferred PAO substrate, N (1), N (12)-diacetylspermine.|spermine|oxidase|17|14|Arg1:T27|Arg2:T46|CHEMICAL|GENE-N|SUBSTRATE
10905636|Michaelis-Menten constants and turnover numbers for PGH2 were 141 microM and 10.8 min(-1) for GSTM2-2 and 1.5 mM and 130 min(-1) for GSTM3-3, respectively.|PGH2|GSTM2-2|7|18|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|SUBSTRATE
15478125|The X-ray crystal structure of the best-studied isozyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.|topiramate|CA II|20|10|Arg1:T5|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
15953344|  Monocarboxylate transporters (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, pyruvate, as well as ketone bodies.|lactate|Monocarboxylate transporters|18|1|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE
21926191|Cabozantinib (XL184) is a small-molecule kinase inhibitor with potent activity toward MET and VEGF receptor 2 (VEGFR2), as well as a number of other receptor tyrosine kinases that have also been implicated in tumor pathobiology, including RET, KIT, AXL, and FLT3.|XL184|kinase|3|8|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
17513393|The net effect of increased Gclc and decreased Bhmt would be a decrease in homocysteine as a result of Cu deficiency.|homocysteine|Bhmt|15|9|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
8392199|  It was recently reported that acute cocaine pretreatment can reduce the (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced 5-hydroxytryptamine2 (5-HT2)-receptor mediated head-twitch response (HTR) in mice via indirect stimulation of adrenergic alpha 2- and serotonergic 5-HT1A-receptors.|cocaine|adrenergic alpha 2|7|41|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
10980326|Blood samples were taken from both alcohol-dependent and control subjects to determine 5-HTTLPR genotypes using PCR of lymphocyte DNA, and to perform platelet [3H]paroxetine binding (binding capacity: B(max); and dissociation constant: K(D)).|[3H]paroxetine|5-HTTLPR|25|13|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23386702|  Carboxylesterases hydrolyze esters, amides, and thioesters to produce carboxylic acids and resulting alcohols, amines, and thiols, respectively.|amines|Carboxylesterases|17|1|Arg1:T5|Arg2:T37|CHEMICAL|GENE-N|PRODUCT-OF
22750078|THPP-1 exhibits nanomolar potency on the PDE10A enzyme, demonstrates excellent pharmacokinetic properties in multiple preclinical animal species, and is selective for PDE10A over other PDE families of enzymes.|THPP-1|PDE10A|1|24|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23542513|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-κB suppression and Nrf-2-dependent heme oxygenase-1 induction.|5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone|Nrf-2|1|16|Arg1:T22|Arg2:T51|CHEMICAL|GENE-Y|ACTIVATOR
12411515|To test the hypothesis that complex I is a target of volatile anaesthetics, we examined the effects of these agents on NADH:ubiquinone oxidoreductase (EC 1.6.99.3) activity using the ubiquinone analogue DBQ (decylubiquinone) as substrate.|ubiquinone|NADH:ubiquinone oxidoreductase|34|23|Arg1:T37|Arg2:T54|CHEMICAL|GENE-N|SUBSTRATE
10047461|The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.|Tomudex|cyclin E|15|19|Arg1:T2|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17510465|Modulation of the function of CD36 (CD36-/- mice), p38(MAPK) (SB203580), COX-1 (indomethacin), and glycoprotein Ib alpha (Nk-protease, 6D1 antibody) induced approximately 50% inhibition.|indomethacin|COX-1|22|20|Arg1:T9|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
15814851|Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.|estrogens|aromatase|13|3|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
11578145|The results of this study indicated that SeMet was directly metabolized to CH(3)SeH by an alpha,gamma-elimination enzyme analogous to bacterial L-methionine gamma-lyase, in addition to the generally acceptable pathway via SeCyH.|SeMet|bacterial L-methionine gamma-lyase|8|26|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|SUBSTRATE
12566304|EGF-stimulated phosphorylation of ERK and Bad is blocked by pretreatment with U0126, a selective MAP kinase kinase (MKK)1/2 inhibitor.|U0126|ERK|12|4|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
15814851|Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs.|flavonoid|aromatase|18|2|Arg1:T18|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
6433001|The results suggest that calmodulin antagonists bind to a protein associated with the [3H]nitrendipine binding site that has a hydrophobic domain similar to that exposed on calmodulin by Ca++, but that this protein is not calmodulin itself.|[3H]nitrendipine|calmodulin|14|5|Arg1:T10|Arg2:T34|CHEMICAL|GENE-N|DIRECT-REGULATOR
23353736|Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).|methyl rosmarinate|matrix metalloproteinase-1|5|12|Arg1:T2|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
15730717|0 approximately 400 micromol/L of IN could down-regulate the expression of p-STAT1 or p-STAT5 in a dose-response manner, p-STATs were distributed mainly in the nucleus as scattering spots.|IN|p-STATs|6|20|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23238299|Treatment of Caco-2 cells with 50 μg/ml alkaloid extract and 50 μM chelidonine for up to 48 h resulted in a significant decrease in mRNA levels of P-gp/MDR1, MRP1, BCRP, CYP3A4, GST, and hPXR and in a significant increase in caspase-3 and caspase-8 mRNA.|chelidonine|MRP1|13|30|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23295227|In the crystal structure, a significant motion of loop A was observed between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.|Phe|AKR1B10|23|18|Arg1:T5|Arg2:T33|CHEMICAL|GENE-Y|PART-OF
12623106|These radiotracers are close analogues of reboxetine, a potent and selective ligand for the norepinephrine transporter (NET).|reboxetine|norepinephrine transporter|7|16|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23353698|In this cell line, quercetin down-regulated Mcl-1 through the inhibition of PI3K/Akt signaling pathway, leading to Mcl-1 instability.|quercetin|PI3K|6|13|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
17034761|IRF3 activation induced by MyD88-independent signaling components, TRIF and TBK1, was also downregulated by auranofin.|auranofin|TRIF|17|9|Arg1:T1|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11736858|H1-receptor occupancies in cortex were approximately 10% by ebastine and > or = 50% by either dose of (+)-chlorpheniramine (95% confidence interval for difference in the mean receptor occupancies: 27%, 54% for 2 mg and 35%, 62% for 6 mg vs ebastine, respectively).|(+)-chlorpheniramine|H1-receptor|21|1|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|p-aminohippurate|hOAT1|22|2|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
12358053|It was hypothesised that the nonselective COX inhibitor flunixin would retard repair of bile-injured colon by preventing production of reparative prostaglandins, whereas the selective COX-2 inhibitor, etodolac would not inhibit repair as a result of continued COX-1 activity.|etodolac|COX-2|29|26|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
22585533|β-eudesmol-induced apoptosis was accompanied by cleavage of caspase-3, caspase-9, and poly (ADP-ribose) polymerase; downregulation of Bcl-2 expression; release of cytochrome c from mitochondria; and decrease in mitochondrial membrane potential (MMP).|β-eudesmol|Bcl-2|1|21|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12488248|Probenecid-sensitive uptake of p-aminohippurate (PAH, an Oat1 and Oat3 substrate) and estrone sulfate (ES, an Oat3 substrate) in rat Oat3-expressing oocytes was significantly trans-stimulated by preloading the oocytes with the dicarboxylate glutarate (GA).|Probenecid|rat Oat3|1|25|Arg1:T23|Arg2:T50|CHEMICAL|GENE-Y|INHIBITOR
19427182|These results strongly suggest that ABCA1 is substantially involved in hepatic alpha-tocopherol secretion.|alpha-tocopherol|ABCA1|12|6|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF
16223973|Here we report that the SA SOM230 can also act by a nonpituitary-mediated inhibition of IGF-I action.|SOM230|IGF-I|7|16|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|benzamidine|gp330|12|10|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23376440|Arsenite-induced ROS generation and COX-2 expression were significantly attenuated by treatment with melatonin (a ROS scavenger), but enhanced by DL-buthionine-(S, R)-sulfoximine (BSO, an inhibitor of gamma-glutamylcysteine synthetase (γ-GCS) resulting in lower GSH and increased ROS levels).|melatonin|COX-2|13|5|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15526107|The aim of this study was to characterize the ISA of the beta-adrenoceptor blocker carteolol in healthy volunteers.|carteolol|beta-adrenoceptor|15|13|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
18056045|The inhibitory effects of the nitrogen-containing BPs (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their inhibition of farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.|zoledronate|FPPS|17|32|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|nicardipine|CaMPDE|24|17|Arg1:T13|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
21600945|Stimulation of B1R with a selective agonist (des-Arg(9)-BK, 10 muM; 30 min) increased O(2)((-))production which was prevented by apocynin and diphenyleneiodonium (NADPH oxidase inhibitors).|apocynin|B1R|36|3|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23542819|In a high-throughput screen for modulators of KCNQ2 channel, a fundamental player modulating neuronal excitability, Mancozeb, was found to significantly potentiate KCNQ2 activity.|Mancozeb|KCNQ2|18|25|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
10494028|Under serum conditions allowing apo CIII secretion, treatment with the peroxisome-proliferator activated receptor (PPAR)alpha activators fenofibrate, gemfibrozil and Wy-14643 result in a marked lowering of apo CIII secretion and gene expression, this effect being most pronounced with Wy-14643.|Wy-14643|apo CIII|24|31|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23339682|Methods: Cocktail approach was used to evaluate the influence of IR and IPC on the activities of CYP1A2, CYP2C9, CYP2E1, CYP2D6 and CYP3A4, which were reflected by the changes of pharmacokinetic parameters of five specific probe drugs: caffeine, chlorzoxazone, tolbutamide, metoprolol and midazolam, respectively.|tolbutamide|CYP2E1|48|23|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7828655|The results showed that treatment with EEDQ, which blocked 80% to 85% of the dopamine D2 and dopamine D1 receptors in substantia nigra, increased the levels of dopamine D2 receptor mRNA in substantia nigra by about 27%.|EEDQ|dopamine D1 receptors|7|21|Arg1:T21|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
23453039|The expression of regucalcin is stimulated through the action of insulin in liver cells in vitro and in vivo and it is decreased in the liver of rats with type I diabetes induced by streptozotocin administration in vivo.|streptozotocin|regucalcin|35|4|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|pralidoxime|AChE|25|14|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
23294566|Both AGR genes were also transcriptionally activated by ≥ 5 nM oestradiol but not by isotype selective or nonselective oestrogen receptor agonists in DUCaP cells that harbour a high-level of wild-type androgen receptor.|oestradiol|AGR|12|2|Arg1:T21|Arg2:T47|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
10193663|Eletriptan, like sumatriptan, zolmitriptan, naratriptan and rizatriptan had highest affinity for the human 5-HT1B, 5-HT1D and putative 5-ht1f receptor.|zolmitriptan|5-ht1f|6|22|Arg1:T9|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15606893|Dissociation of [3H]S-citalopram from a complex with the SERT double-mutant, N208Q/N217Q, which has been suggested to be unable to self-assemble into oligomeric complexes, is retarded to an extent similar to that found with the wild-type, raising the possibility that the allosteric mechanism is mediated within a single subunit.|[3H]S-citalopram|N208Q|3|15|Arg1:T18|Arg2:T28|CHEMICAL|GENE-N|DIRECT-REGULATOR
17273750|  It has been reported that cimetidine, a histamine type-2 receptor (H2R) antagonist, inhibits the growth of glandular tumors such as colorectal cancer.|cimetidine|histamine type-2 receptor|6|9|Arg1:T8|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
11728431|In the presence of alpha(2)-adrenoceptor antagonism, cannabinoid CB(1) receptor activation by WIN-55,212-2 was much more effective in inhibiting the release of [(3)H]noradrenaline.|WIN-55,212-2|cannabinoid CB(1) receptor|20|12|Arg1:T1|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR
12538485|In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.|SU11248|platelet-derived growth factor receptors|6|19|Arg1:T9|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|dacomitinib|tyrosine kinase|43|31|Arg1:T6|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
23287710|In conclusion our in vitro results demonstrate that exposure to high doses of glycidamide/acrylamide - exceeding the dietary exposure of the general population by far - can induce genes with growth promoting potential like the oncogene cMYC and genes involved in the MAPK pathway.|acrylamide|cMYC|15|37|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11511086|  The antipsychotic drugs sertindole and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; erg1).|sertindole|cardiac K(+) channel|4|24|Arg1:T7|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23586470|Although fluorescence intensities from S Kα level were much weaker than Ni Kα signals, we could detect the location of S atoms in recombinant Xcad-11 proteins.|S|Xcad-11|5|26|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|PART-OF
23424207|Acute intoxication with Cd was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).|Cd|glutathione reductase|4|35|Arg1:T27|Arg2:T54|CHEMICAL|GENE-Y|INHIBITOR
23583258|Besides this direct activity, an excess of phenolic compounds detectable in red wine, may exert an additional indirect action by blocking oxysterol-related NOX1 induction, thus totally preventing the pro-oxidant and pro-inflammatory events triggered by dietary oxysterols.|phenolic|NOX1|9|25|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23522834|  Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson's disease and this Letter describes the SAR of a series of dihydropteridinone based Plk-2 inhibitors.|dihydropteridinone|Plk-2|25|27|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|INHIBITOR
14596599|  SDH (L-serine dehydratase, EC 4.3.1.17) catalyzes the pyridoxal 5'-phosphate (PLP)-dependent dehydration of L-serine to yield pyruvate and ammonia.|pyruvate|EC 4.3.1.17|22|6|Arg1:T2|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF
14629008|Trimethoprim induces heat shock proteins and protein aggregation in E.|Trimethoprim|heat shock proteins|1|3|Arg1:T12|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR
23303191|  Mammals have three homologous genes encoding proteins with hyaluronan synthase activity (Has1-3), all producing an identical polymer from UDP-N-acetylglucosamine and UDP-glucuronic acid.|glucuronic acid|hyaluronan synthase|25|9|Arg1:T16|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
15126366|PKC-delta in particular showed a different pattern of translocation in response to I3A and PMA.|PMA|PKC-delta|15|1|Arg1:T21|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17067304|Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, BDNF and ChAT that was eliminated by olanzapine treatment.|quinpirole|BDNF|7|17|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23204517|Mutations in the acidic sequence of PEP-19 that inhibit or prevent it from modulating Ca(2+) binding to CaM greatly inhibit its effect on ATP-induced Ca(2+) release.|Ca(2+)|CaM|15|21|Arg1:T13|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15736931|  Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from UDP-Gal to GlcNAc in the presence of Mn(2+) ion (Gal-T activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency.|UDP-Gal|Beta-1,4-galactosyltransferase I|10|1|Arg1:T30|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
7832763|Both NS-398 and Dup-697 exhibited time-dependent inactivation of hCOX-2, as did indomethacin on both enzymes.|NS-398|hCOX-2|2|9|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
15942707|Treatment with carvedilol reversed both protein and mRNA of HIF-1alpha, VEGF, BNP, and NGF-beta to the baseline values.|carvedilol|NGF-beta|3|17|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
21955206|Inhibition of the NF-kappaB pathway was responsible for this effect since the colchicoside inhibited RANKL-induced NF-kappaB activation, activation of IkappaB kinase (IKK) and suppressed inhibitor of NF-kappaBalpha (IkappaBalpha) phosphorylation and degradation, an inhibitor of NF-kappaB.|colchicoside|NF-kappaBalpha|13|30|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
20512624|The inhibitory action of beta-alanine and high concentrations of nipecotic acid and guvacine on GABA transport strongly suggests that also GAT2 or GAT3 (HUGO nomenclature) could play a role.|guvacine|GAT3|13|23|Arg1:T15|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
1407010|  Radioligand binding studies were performed in membranes of rabbit whole brain and striatum using the novel iodinated radioligand for 5-hydroxytryptamine 5-HT1B and 5-HT1D sites, Serotonin-5-O-Carboxymethyl-Glycyl[125I]Tyrosinamide ([125I]GTI).|[125I]GTI|5-HT1D|34|24|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|flavonolignans|OATP1B1|22|6|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
15306222|The affinity rank order and pKi values of ARs for carvedilol were as follows: alpha1D-AR (8.9)>alpha1B-AR (8.6)>beta1-AR (8.4)>beta2-AR (8.0)>alpha1A-AR (7.9)?alpha2C-AR (5.9)>alpha2B-AR (5.5)>alpha2A-AR (5.3).|carvedilol|ARs|11|9|Arg1:T11|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR
10460702|We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating eNOS activation.|[3H]L-arginine|eNOS|9|26|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
20426763|Furthermore, quantitative autoradiography revealed a relatively high specific binding of [(3)H]-5HT and [(3)H]-ketanserin to 5HT(2) receptors in human CE and longitudinal ciliary muscle (CM).|[(3)H]-5HT|5HT(2)|12|28|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12564662|Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, respectively.|Valdecoxib|COX-1|1|10|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
15860753|We initially demonstrated significant GR activation 60 minutes after inhalation of 800 microg beclomethasone dipropionate in six healthy subjects.|beclomethasone dipropionate|GR|14|5|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR
10882160|Entacapone and tolcapone are new potent, selective and reversible nitrocatechol-type COMT inhibitors.|tolcapone|COMT|3|12|Arg1:T13|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
9117115|At the alpha 1B-adrenoceptor of the rat spleen and rabbit corpus cavernosum penis, tamsulosin again acted as a competitive antagonist but with a significantly lower affinity (pKB = 8.9-9.2).|tamsulosin|alpha 1B-adrenoceptor|15|3|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|ANTAGONIST
12177684|In vivo flibanserin binds equally to 5-HT(1A) and 5-HT(2A) receptors.|flibanserin|5-HT(2A)|3|12|Arg1:T16|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|8-pCPT-2'-O-Me-cAMP-AM|insulin|1|4|Arg1:T7|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
11243491|METHODS: Different classes of antidepressants [imipramine (tricyclic), maprotiline (noradrenline reuptake inhibitor), venlafaxine (mixed serotonin and noradrenaline reuptake inhibitors), fluvoxamine and sertraline (selective serotonin reuptake inhibitor)] were tested in the same randomised experimental session, alone and in combination with 5-HT1A and 5-HT1B receptor agonists [buspirone (partial 5-HT1A agonist), anpirtoline (5-HT1B agonist)] in the mouse forced swimming test.|anpirtoline|5-HT1B|67|69|Arg1:T26|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
23142559|Furthermore, TNF-α-induced CXCL8 secretion was (i) inhibited by the MR antagonist tiotropium and the M3R antagonist 4-DAMP and (ii) enhanced by the M1/M3R agonist pilocarpine and the cholinesterase inhibitor physostigmine.|4-DAMP|CXCL8|20|4|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|felodipine|PDE 1B1|22|8|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
19427182|First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased alpha-tocopherol secretion in a dose-dependent manner.|alpha-tocopherol|ATP-binding cassette transporter A1|27|16|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF
8667211|Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II.|acetazolamide|CA I|7|9|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
16679384|Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes.|dihydroisoquinolinium|cytochrome P450|6|20|Arg1:T27|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|chemokines|47|11|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17427197|D-glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium.|D-glucose|Smad2|1|19|Arg1:T20|Arg2:T58|CHEMICAL|GENE-Y|ACTIVATOR
9765513|  We examined the effects of the calcium channel blockers nitrendipine, diltiazem, verapamil, bepridil, and mibefradil on the cloned HERG and KvLQT1/IsK K+ channels.|bepridil|calcium channel|16|7|Arg1:T23|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
14530799|Like other NMDA receptor antagonists, memantine at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory.|memantine|NMDA receptor|7|3|Arg1:T20|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST
8566141|The distribution pattern of Fos induced by amantadine was more similar to those seen with dopaminomimetics than with N-methyl-D-aspartate (NMDA) receptor antagonists.|amantadine|Fos|8|5|Arg1:T3|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23249626|Here, we leveraged protein engineering to modify the PK characteristics of the native molecule by fusing FST315 to a murine IgG(1) Fc and removing the intrinsic heparan sulfate-binding activity of follistatin.|sulfate|follistatin|32|35|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|alpha(2)-adrenergic receptors|6|12|Arg1:T56|Arg2:T84|CHEMICAL|GENE-N|ANTAGONIST
23160941|When stably expressed in transfected rat basophilic leukemia (RBL-2H3) cells, mFpr1 was readily activated by N-formylated peptides derived from Listeria monocytogenes (fMIVTLF), Staphylococcus aureus (fMIFL), and mitochondria (fMMYALF).|N|mFpr1|19|14|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
22552008|CRBN mediated antiproliferative activities of lenalidomide and pomalidomide in myeloma cells, as well as lenalidomide- and pomalidomide-induced cytokine production in T cells.|lenalidomide|cytokine|16|19|Arg1:T14|Arg2:T34|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|amiodarone|ion channel|8|2|Arg1:T6|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
10531013|Caffeine inhibits the checkpoint kinase ATM.|Caffeine|ATM|1|6|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
12697717|A 17 beta HSDXI construct with a stretch of 20 adenosines was found to produce significantly more enzyme activity than constructs containing 15 or less adenosines (43% vs.|adenosines|17 beta HSDXI|11|2|Arg1:T18|Arg2:T40|CHEMICAL|GENE-Y|PART-OF
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|Co|LO|21|3|Arg1:T13|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23353902|In both females and males, FLU reversed the nuclear levels of GR and pGR246 without affecting CORT and GR mRNA levels.|FLU|GR|7|13|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23478802|We used whole-cell recordings of human embryonic kidney cells heterologously expressing either wild-type TRPA1 or TRPA1 with three serine-substituted cysteines crucial for electrophile activation (C621S, C641S, C665S).|serine|C665S|19|30|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|PART-OF
23557706|Inhibition of mTOR by low dose rapamycin decreases HG-induced Nox4 and Nox1, NADPH oxidase activity and podocyte apoptosis.|rapamycin|Nox1|7|12|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|propranolol|beta-adrenoceptor|54|2|Arg1:T12|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST
16874462|To further investigate the molecular basis of POX-induced apoptosis, we utilized the DLD-1.POX cells to show that cells overproducing POX exhibit an L-proline-dependent apoptotic response.|L-proline|POX|24|21|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
23142599|Pre-treatment with 400 pptr 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) or 1,2,3,7,8-pentachlorodibenzo-p-dioxin inhibited the EE2 induction of vtg1, vtg2 and vtg3 by >95% (p≤0.05).|EE2|vtg3|13|20|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23139020|  Cytochrome P450 (P450)-derived arachidonic acid (AA) metabolites serve pivotal physiological roles.|arachidonic acid|Cytochrome P450|7|1|Arg1:T3|Arg2:T5|CHEMICAL|GENE-N|PRODUCT-OF
23254196|Genistein also reduced the formation of stress fibers by thrombin and suppressed thrombin-induced phosphorylation of myosin light chain (MLC) on Ser(19)/Thr(18) in endothelial cells (ECs).|Ser|MLC|23|20|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|PART-OF
15120421|At 10(-6)M in transcription assays, none of these compounds showed progestin agonist activity, whereas mifepristone and its monodemethylated metabolite manifested slight glucocorticoid agonist activity.|mifepristone|glucocorticoid|21|28|Arg1:T14|Arg2:T45|CHEMICAL|GENE-Y|AGONIST
16857832|  The transsulfuration pathway, which aids in regulating homocysteine concentration and mediates cysteine synthesis, may be sensitive to vitamin B-6 status because cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CGL) require pyridoxal 5'-phosphate (PLP).|cysteine|CGL|13|33|Arg1:T25|Arg2:T33|CHEMICAL|GENE-Y|PRODUCT-OF
14505791|  The potent histamine H(1)-receptor antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine.|Xyzal|histamine H(1)-receptor|26|3|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST
23050902|We observed that ribavirin enhanced ELL3 recruitment to F7, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.|ribavirin|ELL3|4|6|Arg1:T16|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23103562|TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.|cisplatin|JNK|7|9|Arg1:T16|Arg2:T47|CHEMICAL|GENE-N|ACTIVATOR
23558747|We analysed the role of the MBD in MeCP2-chromatin associations in vivo using an MeCP2 mutant Rett syndrome mouse model (Mecp2(tm)(1)(.)(1)(Jae)) in which exon 3 deletion results in an N-terminal truncation of the protein, including most of the MBD.|N|MeCP2|47|9|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|PART-OF
23552101|PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase β type I (pip5k1β), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].|PI(4,5)P2|PIP5K1B|36|1|Arg1:T2|Arg2:T20|CHEMICAL|GENE-Y|PRODUCT-OF
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|ICRF-154|DNA topoisomerase II|11|18|Arg1:T10|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
10567199|RIHP and fractional excretion of sodium (FE(Na)) were measured before and after direct renal interstitial volume expansion in control rats (n=7), rats infused with the COX-1 inhibitor piroxicam (n=6, 1.5 mg/kg), and rats infused with the COX-2 inhibitors NS-398 (n=5, 1.5 mg/kg) and meloxicam (n=6, 0.3 mg/kg).|NS-398|COX-2|51|49|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23271742|Furthermore, we found that arsenic trioxide activates the Pirh2 promoter and consequently induces Pirh2 expression.|arsenic trioxide|Pirh2|6|15|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|inducible nitric oxide synthase|5|29|Arg1:T9|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10422661|In order to investigate the role of cyclooxygenase (COX) isozymes, relatively selective COX1 (piroxicam) and COX2 N-[2-cyclohexyloxy-4-nitrophenyl] metanesulfonamide (NS-398) inhibitors were administered i.th.|N-[2-cyclohexyloxy-4-nitrophenyl] metanesulfonamide|COX2|22|21|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
10502685|Although the nitric oxide (NO) complex of the ferric heme was EPR-silent, photo-illumination at 5 K to the NO complex of the ferric nNOS in the substrate-free form produced a new high spin EPR signal similar to that of the ferric heme of N(omega)-nitro-L-arginine-bound nNOS, suggesting that the photo-dissociated NO might move away from the heme.|NO|nNOS|22|27|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11741285|A 100:1 molar ratio of ribostamycin to PDI was almost sufficient to completely inhibit the chaperone activity of PDI.|ribostamycin|PDI|6|19|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|1,3,4-thiadiazole-2-sulfonamide|CA V|31|4|Arg1:T5|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
14506273|The progressive substitution of the N terminus of OCTN2 with OCTN1 resulted in a decrease in carnitine transport associated with a progressive increase in the Km toward carnitine from 3.9 +/- 0.5 to 141 +/- 19 microM.|N|OCTN1|6|11|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|PART-OF
14508322|In alpha2B-receptor-expressing HEK293 cells, etomidate rapidly increased phosphorylation of the extracellular signal-related kinases ERK1/2.|etomidate|ERK1/2|6|15|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR
10933891|Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes.|Wy-14,643|uncoupling protein-3|12|15|Arg1:T13|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23046389|Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.|zoniporide|aldehyde oxidase|7|9|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
23295386|Furthermore, a humanized CYP3A4/3A7 mouse model showed in vivo induction of CYP3A4 mRNA and protein by [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY14,643) in liver but not in intestine, whereas hepatic occupancy of PBRs by PPARα was ligand independent.|4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid|CYP3A4|19|13|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12713596|Accordingly, wound tissue from SC-560-treated mice (selective cyclooxygenase-1 inhibitor) and diclofenac-treated mice (nonselective cyclooxygenase inhibitor), but not celecoxib-treated mice (selective cyclooxygenase-2 inhibitor), and wound tissue from cyclooxygenase-1-deficient animals exhibited a severe loss of prostaglandin E2/D2 at the wound site, and this change was associated with an impairment in the normal wound morphology.|prostaglandin E2/D2|cyclooxygenase|43|18|Arg1:T12|Arg2:T22|CHEMICAL|GENE-N|PRODUCT-OF
16819260|  Retinoid is a collective term for compounds which bind to and activate retinoic acid receptors (RARalpha, beta, gamma and RXRalpha, beta, gamma), members of nuclear hormone receptor superfamily.|Retinoid|retinoic acid receptors|1|13|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|DIRECT-REGULATOR
23200901|The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.|aconitine|efflux transporters|12|4|Arg1:T27|Arg2:T48|CHEMICAL|GENE-N|SUBSTRATE
10421446|In experiments with D74N AChE, for which the inhibition potency of charged organophosphate (OP) was two to three orders less than wild-type enzyme, edrophonium had no effect on the reactivation by LuH6 and TMB4 and the time courses of reactivation were monophasic.|organophosphate|D74N|14|4|Arg1:T12|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|barusiban|oxytocin receptor|11|8|Arg1:T28|Arg2:T52|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8799556|The affinity estimate for prazosin on human prostate was lower than the corresponding binding affinity determined at alpha 1A adrenoceptors and RS 17053 was a very weak antagonist on human prostate (pA2 = 6.0) relative to the high affinity (pKi = 8.6) determined at cloned human alpha 1A adrenoceptors.|RS 17053|human alpha 1A adrenoceptors|22|50|Arg1:T20|Arg2:T45|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23473805|Rp1 treatment resulted in an accumulation of doxorubicin or rhodamine 123 by decreasing MDR-1 activity in doxorubicin-resistant cells.|Rp1|MDR-1|1|14|Arg1:T22|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
23639249|Phosphorylation of c-Src, which was shown to be activated by AhR ligands, was also increased by I3S and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.|4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine|STAT3|29|51|Arg1:T13|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23211523|GnRH caused a sustained increase in nuclear β-catenin levels, which was significantly reduced by c-Jun N-terminal kinase (JNK) inhibition.|GnRH|β-catenin|1|8|Arg1:T5|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22659088|This localization is in turn dependent on the Homer family of scaffolding proteins which bind to a small motif on the distal C-termini of mGluR1 and 5, localize the receptors near the PSD, strengthen coupling to post-synaptic effectors and simultaneously uncouple the mGluRs from extra-synaptic effectors such as voltage dependent ion channels.|C|mGluR1 and 5|23|25|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|PART-OF
17259377|Sulfasalazine (also as a representative of the salicylates) inhibited the diabetes-induced upregulation of several inflammatory gene products, which are regulated by NF-kappaB, including vascular cell adhesion molecule, intracellular adhesion molecule-1, inducible nitric oxide synthase, and cyclooxygenase-2 in whole-retinal lysate.|Sulfasalazine|cyclooxygenase-2|1|43|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
15917650|It is through inhibition of c-kit that imatinib is also used clinically in the treatment of gastrointestinal stromal tumours.|imatinib|c-kit|8|6|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
12213053|The 4',7,8-trichloro analogue (38) of mazindol was the most potent and selective ligand for HEK-hDAT cells (DAT K(i) = 1.1 nM; SERT/DAT = 1283 and NET/DAT = 38).|4',7,8-trichloro|NET|2|33|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14757700|TRPM8 (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and icilin.|menthol|Ca(2+)-permeable channel|22|7|Arg1:T35|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
17537429|Hypoxia increased glucose uptake in adult cardiomyocytes but not in neonatal cells and this increase in glucose uptake was mediated by GLUT4.|glucose|GLUT4|17|22|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
15509185|The wide variability in the pharmacokinetic properties of tramadol can partly be ascribed to CYP polymorphism.|tramadol|CYP|9|15|Arg1:T12|Arg2:T41|CHEMICAL|GENE-N|SUBSTRATE
9525919|We report here the use of Met methyl groups as site-specific structural markers to identify drug binding sites for trifluoperazine and bepridil on cTnC.|bepridil|cTnC|22|24|Arg1:T9|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17341305|The expression of ER-alpha and PR isoform A in virgin mice was surprisingly much higher in BALB/c than in C57BL/6 mammary glands, and both receptors were downregulated in progestin-treated BALB/c mice (P < 0.05).|progestin|PR isoform A|30|6|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
21600945|TPM-increased B1R mRNA was prevented by co-treatments with N-acetyl-l-cysteine (potent antioxidant), diphenyleneiodonium (NADPH oxidase inhibitor), IL-1Ra (interleukin-1R antagonist) and SN-50 (specific inhibitor of NF-kB activation) but not by pentoxifylline (TNF-alpha release inhibitor), indomethacin and niflumic acid (COX-1 and -2 inhibitors).|diphenyleneiodonium|B1R|15|2|Arg1:T17|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
22732443|The LTD can be blocked by systemic application of the selective GluN2B antagonist Ro25-6981 (6 mg/kg, i.p.) or a synthetic peptide Tat-GluA2(3Y) (3 μmol/kg, i.p.) that interferes with the endocytosis of AMPA receptors.|Ro25-6981|GluN2B|14|12|Arg1:T1|Arg2:T3|CHEMICAL|GENE-Y|ANTAGONIST
3146348|  The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain tissue plasminogen activator (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by epsilon-aminocaproic acid (EACA), as well as fibrin(ogen).|EACA|t-PA|43|26|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
23422569|SIRT1 co-precipitated with PPARα and nicotinamide increased the acetylation of the PPARα coactivator PGC-1α, which was suppressed by resveratrol.|nicotinamide|PGC-1α|6|14|Arg1:T5|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|AG013736|PDGFR-beta|31|40|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
17417877|FCS-binding studies with the fluorescently labeled ligand Alexa532-noradrenaline (Alexa532-NA) binding to beta2-AR of C6 cells showed a significant reduction in total beta2-AR binding after preincubation with hyperforin and hyperoside for 3 days, respectively, which was also found for DMI.|Alexa532-NA|beta2-AR|10|14|Arg1:T17|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12085361|Direct transport of rifampicin could be shown for OATP-C (apparent K(m) value 13 micromol/L) and OATP8 (2.3 micromol/L).|rifampicin|OATP-C|4|9|Arg1:T8|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE
18574460|CONCLUSIONS AND IMPLICATIONS: Halogenated propofol analogues constitute a novel class of sodium channel-blocking drugs possessing almost 100-fold higher potency compared with the local anaesthetic and anti-arrhythmic drug lidocaine.|Halogenated propofol|sodium channel|5|13|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23064031|NFD suppressed EGF-mediated protein levels of c-Jun and c-Fos, and reduced MMP-9 expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity.|NFD|MMP-9|1|13|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23535185|Galangin decreased expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8.|Galangin|IL-8|1|27|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
20387803|None were found to bind to ERalpha, but Rb1(S) and 20(S)-Rg3 were shown to bind to peroxisome proliferator-activated receptor gamma.|20(S)-Rg3|peroxisome proliferator-activated receptor gamma|15|25|Arg1:T10|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14737100|  The expression of the NH2 terminally truncated ErbB2 receptor (p95ErbB2) in breast cancer correlates with metastatic disease progression compared with the expression of full-length p185ErbB2.|NH2|ErbB2|5|8|Arg1:T3|Arg2:T28|CHEMICAL|GENE-Y|PART-OF
22884520|Defects resulting in slowed release of cholesterol from late endosomes and lysosomes or reduction in sterol-27-hydroxylase activity lead to specific blocks in oxysterol production and impaired LXR-dependent gene activation.|oxysterol|sterol-27-hydroxylase|23|16|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|PRODUCT-OF
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|CGP20712A|beta(1)-adrenoceptor|36|40|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
9732824|Both the 5 alpha-reductase inhibitor finasteride and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.|doxazosin|alpha 1-adrenoceptor|16|8|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|ANTAGONIST
23482500|Hepatocyte uptake of [(14)C]sorafenib was not Na(+)-dependent or influenced by the organic anion transporter 2 (OAT2) inhibitor ketoprofen.|ketoprofen|organic anion transporter 2|30|22|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
23161217|Taken together, suramin improves the outcome of FPG transplantation, most likely by inhibition of TNF-α and TGF-β formation.|suramin|TNF-α|4|17|Arg1:T5|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
23639249|Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis.|Indoxyl 3-sulfate|STAT3|1|11|Arg1:T14|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|NO|AS|21|13|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF
23303191|Hyaluronan synthesis driven by HAS2 was less affected by glucosamine addition, and HAS3 was not affected at all.|glucosamine|HAS2|10|5|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
1400062|The 5-lipoxygenase-activating protein inhibitor MK886, administered orally 2-6 h before perfusion, also inhibited the pressor response to PAF as well as LT production, as did DEC.|MK886|5-lipoxygenase-activating protein|5|2|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
11078056|COX-2 produces prostaglandins that inhibit apoptosis and stimulate angiogenesis and invasiveness.|prostaglandins|COX-2|3|1|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|GDP|Adenylosuccinate synthetase|31|1|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF
23643730|Moreover, we found that juglone significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (PSA) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT).|juglone|PSA|6|22|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
18715952|EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth.|ONO-8713|EP(3) receptor|12|6|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|ANTAGONIST
1600046|Some 5-HT3 antagonists have 5-HT4 agonist activity (for example, renzapride, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.|renzapride|5-HT3|12|2|Arg1:T14|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
10639181|Only the amide derivatives of ETYA and meclofenamic acid inhibit COX-2; the esters are either inactive or nonselective.|meclofenamic acid|COX-2|8|11|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
15787205|The average occupancy of bupropion on DAT was similar to the international findings at 20.84% in 9 depressed patients.|bupropion|DAT|5|7|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23200945|The E67Q substitution near the catalytic zinc was shown previously to increase the Michaelis constant for acetaldehyde and to decrease turnover for ethanol oxidation.|zinc|E67Q|7|2|Arg1:T1|Arg2:T18|CHEMICAL|GENE-N|PART-OF
14693528|  This study compared the plasma amprenavir pharmacokinetics of the human immunodeficiency virus (HIV) protease inhibitors amprenavir (Agenerase) 1,200 mg twice daily (BID) and the amprenavir prodrug GW433908, a formulation that substantially reduces the number of tablets per dose compared with amprenavir, at doses of 1,395 mg and 1,860 mg BID, in combination with abacavir 300 mg BID and lamivudine 150 mg BID in patients with HIV infection.|amprenavir|human immunodeficiency virus (HIV) protease|18|10|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|bEAG|4|8|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|tacrine|acetylcholinesterase|16|10|Arg1:T9|Arg2:T45|CHEMICAL|GENE-Y|INHIBITOR
10735801|Any antinociceptive and neuroprotective benefit from the N-methyl-D-aspartate-receptor antagonist property of meperidine may be pH dependent.|meperidine|N-methyl-D-aspartate-receptor|12|8|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST
23437843|6'-Sulfonyloxy derivatives exhibited outstanding affinities to MAO-A (7.0 nM < IC50 < 49 nM, much higher than moclobemide) and a pronounced MAO-A/B selectivity.|6'-Sulfonyloxy|MAO-A|1|7|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8392199|The present results further support the previously suggested hypothesis that acute cocaine administration inhibits the 5-HT2-receptor function by increasing the synaptic concentration of norepinephrine and serotonin via inhibition of their uptake and therefore indirectly stimulating the respective inhibitory adrenergic alpha 2- and serotonergic 5-HT1A-receptors.|cocaine|5-HT2|12|16|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR
1403790|Other reference compounds such as the typical antipsychotics, chlorpromazine and thioridazine; the selective dopamine D-2 antagonists, droperidol and sulpiride; the dopamine D-1 antagonist, SCH 23390; the antimuscarinics, atropine and scopolamine; the antihistamines, pyrilamine and diphenhydramine; the alpha-1 antagonist, prazosin; and the antidepressants, imipramine and chloromipramine also failed to produce clozapine-appropriate responding.|droperidol|dopamine D-2|20|16|Arg1:T4|Arg2:T48|CHEMICAL|GENE-N|ANTAGONIST
23333834|The peptide YR-11 (YLEIEFSLKHR), obtained by direct substitution of cysteine with a serine residue in the template sequence, significantly (p<0.05) inhibited RANK-RANKL binding, and RANKL induced TRAP activity and formation of multinucleated osteoclasts without any cytotoxicity.|YR-11|RANK|3|30|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|COX-2|37|26|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF
16010590|TS inhibition (14.3%) and DNA damage (8%) were more pronounced than expected (P<0.05) when TFT was combined with GW1843 in WiDr/F cells, in contrast to AG337 and ZD1694, which showed inhibiting effects as expected (additive).|TFT|TS|25|1|Arg1:T15|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
23473804|To this end, 158N murine oligodendrocytes were treated with 7KC or 7βOHC inducing an apoptotic mode of cell death characterized by condensation/fragmentation of the nuclei, dephosphorylation of Akt and GSK3, mitochondrial depolarization involving Mcl-1, and caspase-3 activation.|7KC|caspase-3|11|40|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR
17434872|Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.|lumiracoxib|cyclooxygenase-2|10|8|Arg1:T25|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefuroxime|PBPs|44|52|Arg1:T14|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR
23536521|A decrease in ADA activity was observed when the slices were exposed to organoselenium at the concentrations of 1, 10 and 30 µM.|organoselenium|ADA|14|4|Arg1:T13|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23093023|Blood pressure was increased in rats exposed to IH, and treatment with the PDK-1 inhibitor OSU-03012 [2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-acetamide] (33 mg/day) lowered blood pressure in IH but not sham group rats.|OSU-03012|PDK-1|17|15|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
12909199|Bupropion and its metabolites lacked affinity for nicotinic acetylcholinergic receptors, but all antagonized (-)nicotine-induced 86Rb+ efflux in cells expressing alpha3beta4 nicotinic cholinergic receptors.|Bupropion|alpha3beta4 nicotinic cholinergic receptors|1|24|Arg1:T14|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
23238783|These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of CYP2B6 activity in women, when measured by the metabolism of bupropion.|bupropion|CYP2B6|29|5|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
11723241|Low concentrations of dofetilide produced block of bEAG T432S/A443S; unlike HERG, block was almost irreversible.|dofetilide|HERG|4|12|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23462233|This is the first study to establish the in vivo relevance of AOX in neonicotinoid metabolism in mammals and one of the first for xenobiotics in general.|neonicotinoid|AOX|15|13|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE
10370904|2) Radioligand and functional studies at the N-methyl-D-aspartate (NMDA) type glutamate receptor characterize budipine as a low-affinity, uncompetitive antagonist with fast kinetics and moderate voltage-dependency at the phencyclidine (PCP) binding site, comparable to that observed with amantadine, thereby counteracting an increased excitatory glutamatergic activity.|budipine|N-methyl-D-aspartate (NMDA) type glutamate receptor|17|9|Arg1:T25|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST
17531267|Contrary to most of their counterparts in animal cells, the higher plant GPX homologues identified so far possess cysteine instead of selenocysteine in their active site.|cysteine|GPX|20|14|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|PART-OF
10823899|Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.|Amphetamine|human dopamine transporter|1|4|Arg1:T24|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
23479079|Both ROCK-1 and ROCK-2 (Rho kinases) were activated by sulfide, and sulfide-induced cell blebbing was suppressed by a ROCK inhibitor, suggesting that a Rho pathway is involved in sulfide-induced blebbing in lymphocytes.|sulfide|ROCK-2|12|4|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|ACTIVATOR
23279865|Structure-based design, synthesis and evaluation of novel anthra[1,2-d]imidazole-6,11-dione derivatives as telomerase inhibitors and potential for cancer polypharmacology.|anthra[1,2-d]imidazole-6,11-dione|telomerase|9|16|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
23161664|Overexpression of LO was associated with upregulation of hypoxia-inducible factor (HIF)-1α at mRNA levels in cobalt (Co)-treated cells.|cobalt|hypoxia-inducible factor (HIF)-1α|19|9|Arg1:T12|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16897043|Nucleotide binding to the pore reduces the activity or channel open probability, whereas Mg-nucleotide binding and/or hydrolysis in the nucleotide-binding domains of SUR antagonize this inhibitory action to stimulate channel openings.|Mg-nucleotide|nucleotide-binding domains|15|21|Arg1:T17|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
9662053|Single strand conformational polymorphism analysis and nucleotide sequencing of the promoter and entire coding region of the CPE gene in 269 Japanese subjects with NIDDM, 28 nondiabetic obese subjects and 104 nonobese and nondiabetic controls revealed three nucleotide changes, a G-to-T substitution at nucleotide -53, a G-to-A substitution at nucleotide -144 (relative to start of transcription) in the promoter region and a silent G-to-A substitution in codon 219.|nucleotide|CPE|53|18|Arg1:T3|Arg2:T7|CHEMICAL|GENE-Y|PART-OF
23183186|Finally, the Pak1(-/-) mice exhibited reduced brainstem gcg level and abolished β-cat Ser675 phosphorylation in brain neurons after insulin treatment.|Ser|β-cat|17|16|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|PART-OF
23064031|The specific PI3K inhibitor, wortmannin, blocked significantly EGF-induced cell migration and invasion.|wortmannin|PI3K|6|3|Arg1:T9|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
14718599|The L-proline uptake was saturable and mediated by a single transport system (hPAT1) with an affinity constant of 2.0 +/- 0.2 mM.|L-proline|hPAT1|2|14|Arg1:T20|Arg2:T42|CHEMICAL|GENE-Y|SUBSTRATE
1929324|Strain JR4 (erg3 erg11), which produces 14-methylfecosterol [14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol) as the major sterol in the presence or absence of fenpropimorph, was also found to be resistant to the drug.|14 alpha-methyl-ergosta-8,24(28)-dien- 3-beta-ol|erg3|12|4|Arg1:T24|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF
23291050|ChE activity was measured with acetylthiocholine as substrate and CES activity was measured with four substrates: p-nitrophenyl acetate, p-nitrophenyl butyrate, 1- and 2-naphthyl acetate.|p-nitrophenyl butyrate|CES|21|10|Arg1:T19|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|losartan|AT1|36|4|Arg1:T1|Arg2:T44|CHEMICAL|GENE-Y|ANTAGONIST
23611809|  Recent observations revealed that human UDP-glucuronosyltransferase (UGT) 2B10 catalyzes N-glucuronidation of amine-containing compounds.|amine|human UDP-glucuronosyltransferase (UGT) 2B10|14|5|Arg1:T3|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE
11689471|Aspirin and salicylate bind to immunoglobulin heavy chain binding protein (BiP) and inhibit its ATPase activity in human fibroblasts.|Aspirin|ATPase|1|17|Arg1:T12|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|BMY 7378|alpha 1-adrenoceptor|20|3|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
23567243|Western blot assay demonstrated that DICO decreased Bcl-2 level and induced Bax translocation to cause cytochrome c release.|DICO|Bcl-2|6|8|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11156594|[(3)H]-prazosin binds to alpha(1) adrenoceptors on these cells and is displaceable by unlabelled prazosin in concentrations up to 10(-7) M.|prazosin|alpha(1) adrenoceptors|23|10|Arg1:T9|Arg2:T24|CHEMICAL|GENE-N|DIRECT-REGULATOR
23541637|Aldosterone-induced ENaC and basal Na(+)/K(+)-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIIIβ trans Golgi signalling in M1 cortical collecting duct cells.|Aldosterone|ENaC|1|2|Arg1:T14|Arg2:T38|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
7567987|Aromatic L-amino acid decarboxylase catalyzes the decarboxylation of L-5-hydroxytryptophan to serotonin and that of L-3,4-dihydroxyphenylalanine to dopamine.|L-5-hydroxytryptophan|Aromatic L-amino acid decarboxylase|9|1|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
16819260|Among them, tamibarotene (Am80) is an RARalpha- and RARbeta-specific (but RARgamma- and RXRs-nonbinding) synthetic retinoid that is effective in the treatment of psoriasis patients and relapsed APL.|retinoid|RARalpha|20|10|Arg1:T9|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Caprelsa|epidermal growth-factor receptors|3|49|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|23|18|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol|CB1|54|2|Arg1:T23|Arg2:T29|CHEMICAL|GENE-Y|AGONIST
23042728|  In utero exposure to valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, causes neural tube, heart, and limb defects.|valproic acid|histone deacetylase|5|12|Arg1:T6|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
1744096|Spectral studies employing CN-Cbl and Me-Cbl showed that both forms of Cbl must be converted to Cob(II)alamin before they can bind to human apomethionine synthase and convert it to its activated holoenzyme form.|Cob(II)alamin|human apomethionine synthase|17|27|Arg1:T41|Arg2:T55|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT3|17|10|Arg1:T22|Arg2:T46|CHEMICAL|GENE-Y|SUBSTRATE
14737100|GW572016, a reversible small molecule inhibitor of EGFR and ErbB2 tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts.|GW572016|tyrosine kinases|1|12|Arg1:T4|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
15967876|We found that although inactivation facilitated cisapride block of the HERG K+ current, it was not coupled with cisapride block of HERG when the Cs+ current was recorded.|cisapride|HERG|7|11|Arg1:T10|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
10334992|Results presented here show that bile acids are physiological ligands for the farnesoid X receptor (FXR), an orphan nuclear receptor.|bile acids|FXR|6|17|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15887238|Together, these results suggested that imatinib affects EGFR activation and signaling pathways through rapid release and increased expression of endogenous EGFR-activating ligands.|imatinib|EGFR|7|22|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12589193|RECENT FINDINGS: The metabolism of arginine is determined by the expression of the arginine metabolizing enzymes inducible nitric oxide synthase and two arginase isoforms (arginase I and II).|arginine|inducible nitric oxide synthase|15|18|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|OTA|D6D|34|5|Arg1:T16|Arg2:T25|CHEMICAL|GENE-Y|PRODUCT-OF
15606893|Dissociation of [3H]S-citalopram from SERT is most potently inhibited by S-citalopram followed by R-citalopram, sertraline, serotonin and paroxetine.|sertraline|SERT|19|8|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23530018|These five CGPs also inhibited [(3)H]E217βG uptake by MRP4.|CGPs|MRP4|3|15|Arg1:T21|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
23339663|TOCP is metabolized to cresyl saligenin phosphate (CBDP), a potent irreversible inhibitor of butyrylcholinesterase (BChE), a natural bioscavenger present in the bloodstream, and acetylcholinesterase (AChE), the off-switch at cholinergic synapses.|cresyl saligenin phosphate|acetylcholinesterase|5|31|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
23566514|Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.|4-aminopyrrolopyrimidine|kinase|6|8|Arg1:T8|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR
23619386|Rapamycin inhibits proteinase and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations.|Rapamycin|peptidase|1|6|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
23422569|To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of SIRT1 (nicotinamide, sirtinol, EX527) in aorta segments isolated from young Wistar rats.|EX527|SIRT1|38|32|Arg1:T16|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
23449197|  7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-5-yl]-1,3-benzothiazole 11 (TASP0382088) was synthesized and evaluated as transforming growth factor-β (TGF-β) type I receptor (also known as activin receptor-like kinase 5 or ALK5) inhibitor.|TASP0382088|transforming growth factor-β (TGF-β) type I receptor|12|19|Arg1:T6|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
12826849|The mole fractions of recombinant Galpha(i1) bound to [35S]GTPgammaS were 0.49 +/- 0.02 and 0.60 +/- 0.02 at 10 and 20 min, respectively.|[35S]GTPgammaS|Galpha(i1)|12|6|Arg1:T2|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15175324|Mutated GIRK channels showed normal currents when activated by ACh but exhibited different pharmacological properties toward halothane.|ACh|GIRK|10|2|Arg1:T15|Arg2:T46|CHEMICAL|GENE-N|ACTIVATOR
17200663|Serum albumin and serum retinol-binding protein (sRBP), proteins capable of binding retinoids, have also been reported to be components of the IPM.|retinoids|serum retinol-binding protein|15|4|Arg1:T12|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23337567|Additionally, these effects of ATO on γ-H2AX, Chk1, Chk2, p53, and p21(waf1/cip1) were reduced by an ATM inhibitor.|ATO|p21|6|17|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23085435|Furthermore, N-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced Bim expression.|N|phosphorylated extracellular signal-regulated kinase|3|8|Arg1:T10|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23515287|The dihydrotestosterone metabolite, 5α-androstane-3β,17β-diol (3β-diol), binds and activates estrogen receptor-β (ER-β), the predominant ER in the PVN.|dihydrotestosterone|ER-β|2|16|Arg1:T10|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|COX-1|37|24|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF
7824160|In all cases at both the 5-HT2A and 5-HT2C receptors, the affinities of the isomers of MDMA and MDA were at least 2-3 orders of magnitude less than 5-HT.|MDMA|5-HT2A|18|7|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23411280|  Histidine decarboxylase (HDC) catalyses the formation of histamine, a bioactive amine.|amine|HDC|14|4|Arg1:T10|Arg2:T15|CHEMICAL|GENE-Y|PRODUCT-OF
9614060|System y+ cationic amino acid transport is mediated by proteins encoded by a family of genes, Cat1, Cat2, and Cat3.|amino acid|Cat2|4|20|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|isoflurane|complex I|7|17|Arg1:T27|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR
15561708|Although different in its physiological function, the mechanism of ABA3 for sulfur mobilization was found to be similar to NifS proteins.|sulfur|NifS|13|21|Arg1:T22|Arg2:T47|CHEMICAL|GENE-Y|SUBSTRATE
23583884|Further, TCDD exposure could induce phosphorylation- and ubiquitination-dependent degradation of IкBα, and the translocation of NF-κB p65 from the cytosol to the nucleus in this microglial cell line.|TCDD|IкBα|3|12|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|ACTIVATOR
18056711|Crystallographic data reveal that a conserved Gly residue (located at the juncture between the linker and C-terminal domains) is at one end of a short alpha-helix, which extends to the active site Tyr covalently linked to the DNA.|C|alpha-helix|18|28|Arg1:T24|Arg2:T38|CHEMICAL|GENE-N|PART-OF
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS|4|2|Arg1:T32|Arg2:T60|CHEMICAL|GENE-N|INHIBITOR
19119014|  Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.|Thiazide|carbonic anhydrase|1|15|Arg1:T1|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|BRL49653|PPARgamma|5|38|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15509185|The O-demethylation of tramadol to M1, the main analgesic effective metabolite, is catalysed by cytochrome P450 (CYP) 2D6, whereas N-demethylation to M2 is catalysed by CYP2B6 and CYP3A4.|tramadol|cytochrome P450 (CYP) 2D6|4|17|Arg1:T10|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
7911719|Following inactivation of alpha 1B-adrenoceptors by chloroethylclonidine treatment, alpha lA-adrenoceptors can fully compensate and mediate inotropic effects by promoting influx of extracellular Ca2+ at least partly via voltage-operated channels.Therefore, we speculate that alpha 1B-adrenoceptors exert a tonic inhibitory effect on alpha 1A-adrenoceptors.|Ca2+|voltage-operated channels|24|29|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|SUBSTRATE
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|IκB-α|11|19|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
10891536|  5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (TS).|5-Fluorouracil|thymidylate synthase|1|36|Arg1:T1|Arg2:T51|CHEMICAL|GENE-Y|INHIBITOR
23122079|Phillyrin attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of LKB1/AMP-activated protein kinase-dependent signalling.|Phillyrin|AMP-activated protein kinase|1|16|Arg1:T16|Arg2:T36|CHEMICAL|GENE-N|ACTIVATOR
11723241|HERG/I(Kr) channels are blocked selectively by class III antiarrhythmic methanesulfonanilide drugs such as dofetilide.|dofetilide|HERG|17|1|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
17234158|PFD leads to a reduction of TGF-beta2 mRNA levels and of the mature TGF-beta2 protein due to decreased expression and direct inhibition of the TGF-beta pro-protein convertase furin.|PFD|TGF-beta2|1|14|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23194750|Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.|thiazolidinediones|PI3K|6|9|Arg1:T23|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
23552851|Treatment of A549 and H1299 cells with dioscin caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR.|dioscin|mTOR|8|31|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
11054378|Sulfasalazine inhibited tumor necrosis factor alpha-induced activation of endogenous IKK in Jurkat T cells and SW620 colon cells, as well as the catalytic activity of purified IKK-alpha and IKK-beta in vitro.|Sulfasalazine|IKK|1|10|Arg1:T18|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
18559268|Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.|taxane|microtubules|3|6|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR
16803890|Interestingly, knockdown of endogenous AC by RNA interference attenuated cyclooxygenase 2 induction by TNFalpha and subsequent PGE(2) biosynthesis.|PGE(2)|cyclooxygenase 2|18|11|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
23337530|In THP-1 cells, anagliptin reduced lipopolysaccharide-induced TNF-α production with inhibiting ERK phosphorylation and nuclear translocation of nuclear factor-κB.|anagliptin|nuclear factor-κB|5|18|Arg1:T10|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
22406476|Aspirin and metformin (an activator of AMPK) increased inhibition of mTOR and Akt, as well as autophagy in CRC cells.|metformin|mTOR|3|13|Arg1:T10|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
23086198|These data suggest that, although UGT2A1 is the only UGT2A enzyme active against PAH proximate carcinogens (including PAH diols), both UGTs 2A1 and 2A2 play an important role in the local detoxification of procarcinogenic monohydroxylated PAH metabolites.|diols|UGT2A1|21|7|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23515287|Treatment of ovariectomized rats with estradiol benzoate or 3β-diol for 4 days increased OT mRNA selectively in the midcaudal, but not rostral PVN compared with vehicle-treated controls.|3β-diol|OT|9|14|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23549262|In addition to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses.|lipoxin A4|FPR2|8|38|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
14757700|TRPM8 (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and icilin.|icilin|Ca(2+)-permeable channel|26|7|Arg1:T7|Arg2:T51|CHEMICAL|GENE-N|ACTIVATOR
15866114|In cases of chorioamnionitis regardless of betamethasone treatment, placental 11beta HSD-2 expression and activity was decreased compared to controls.|betamethasone|11beta HSD-2|7|11|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
10681601|The production of [(3)H]-L-citrulline from [(3)H]-L-arginine in tissue extracts enriched in superficial layers indicated that nNOS specific activity is as high in the opossum as in the rat.|[(3)H]-L-citrulline|nNOS|4|28|Arg1:T8|Arg2:T11|CHEMICAL|GENE-N|PRODUCT-OF
12416991|Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).|allopregnanolone|human 3 alpha-hydroxysteroid dehydrogenase type III|3|7|Arg1:T38|Arg2:T51|CHEMICAL|GENE-Y|PRODUCT-OF
3440035|  Derivatives of 5-(dipentylamino)-5-oxo-pentanoic acid are a new class of non-peptide cholecystokinin (CCK) antagonists.|5-(dipentylamino)-5-oxo-pentanoic acid|CCK|3|17|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hCNT3|9|36|Arg1:T8|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
16014042|  BACKGROUND: System x(-) (c) is a heterodimeric transporter, comprised of a light chain, xCT, and heavy chain, 4F2hc, which mediates the sodium-independent exchange of cystine and glutamate at the plasma membrane.|glutamate|System x(-) (c)|38|3|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|acetyl-CoA|CrAT|34|4|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23521080|One exception is tranexamic acid (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to fibrin.|TXA|plasminogen|7|20|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
16313925|The attenuated inflammatory and allergic responses from the potent and preferential PDE4 inhibition of ibudilast may have contributed significantly to its beneficial pharmacological responses and distinguishes ibudilast from the other ophthalmic solutions in the treatment of ocular allergy.|ibudilast|PDE4|15|12|Arg1:T15|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
22967140|Adult ovariectomised rats were divided into six groups and injected either with vehicle or a single dose of oestradiol, a selective ERα agonist-PPT [4,4',4″-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol], a selective ERβ agonist-DPN [2,3-bis(4-hydroxyphenyl)-propionitrile], a selective ERα antagonist-MPP [1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride] or a selective ERβ antagonist-PHTPP (4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol).|MPP|ERα|53|51|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
12185406|The validity of this mechanism has been questioned because the affinity of bupropion for the DAT is quite low.|bupropion|DAT|13|16|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8484964|Purification of nonantibiotic insulinase inhibitors from bacitracin.|bacitracin|insulinase|7|4|Arg1:T4|Arg2:T7|CHEMICAL|GENE-N|INHIBITOR
22552008|Overexpression of CRBN wild-type protein, but not CRBN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated reductions in c-myc and IRF4 expression and increases in p21(WAF-1) expression.|pomalidomide|IRF4|22|27|Arg1:T20|Arg2:T41|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16686685|The Na channel block caused by lidocaine and RSD1235 can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells.|RSD1235|Na channel|9|2|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
9288901|This indicates that the PH-20 hyaluronidases, like numerous enzymes that hydrolyze glycosidic bonds, have acidic amino acids in their active site.|acidic amino acids|PH-20 hyaluronidases|17|5|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|PART-OF
23220614|ISO significantly inhibited the levels of ERK1/2 kinase and increased the expression of JNK and p38 kinases.|ISO|p38|1|16|Arg1:T20|Arg2:T42|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23591777|On the other hand, MSM raised SOD and CAT activities as well as CYP2E1 level in liver tissues.|MSM|CAT|6|10|Arg1:T17|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR
23636303|Local LC citalopram effect was abolished by LC presence of the 5-HT3 receptor antagonist MDL72222 (1 μM) but not the 5-HT1/2 receptor antagonist methiothepin (1 μM).|methiothepin|5-HT1/2|26|23|Arg1:T2|Arg2:T20|CHEMICAL|GENE-N|ANTAGONIST
16472148|In this review, the novel action mechanism (s) of cilostazol are overviewed with the focus on the action of cilostazol in in vitro and in vivo studies as a maxi-K channel opener targeting anti-apoptotic signaling pathways.|cilostazol|maxi-K channel|23|33|Arg1:T12|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR
23531031|Results: Our results demonstrate that treatment with LBH589 leads to NIS RNA expression as shown by RT-PCR and luciferase assay, and to protein expression as determined by immunofluorescence in vitro and by immunohistochemistry in xenograft tumors.|LBH589|NIS|9|12|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12085361|Rifampicin (10 micromol/L) inhibited OATP8-mediated BSP uptake by 50%, whereas inhibition of OATP-C-, OATP-B-, and OATP-A-mediated BSP transport was below 15%.|BSP|OATP-B|23|19|Arg1:T4|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
16973761|Mutating Asp2.61(97) to Glu or Ala, Asn2.65(101) to Ala, or Lys3.32(120) to Gln decreased potency of GnRH II-stimulated inositol phosphate production.|Ala|GnRH II|9|28|Arg1:T17|Arg2:T49|CHEMICAL|GENE-Y|PART-OF
11319222|The thiazolidinedione (TZD) insulin-sensitizing drugs and peroxisome proliferator-activated receptor gamma (PPARgamma) ligands, troglitazone, rosiglitazone, and pioglitazone, strongly and specifically inhibited only ACS4, with an IC(50) of less than 1.5 microm.|rosiglitazone|ACS4|20|30|Arg1:T36|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23623790|GABAA receptor modulation by piperine and a non-TRPV1 activating derivative.|piperine|TRPV1|5|9|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR
15985434|  Pyridoxal kinase (PDXK) catalyzes the phosphorylation of pyridoxal, pyridoxamine, and pyridoxine in the presence of ATP and Zn2+.|pyridoxamine|Pyridoxal kinase|12|1|Arg1:T16|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
23237828|These results imply the functional MEK1/ERK-mediated pathway is necessary for the cycloheximide stimulation of SOCS-3 gene expression.|cycloheximide|SOCS-3|12|15|Arg1:T2|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|17β-estradiol|CARs|7|20|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline|AChE|8|15|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
23313794|The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) PhIP (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.|PhIP|superoxide dismutase|23|31|Arg1:T8|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
23543412|Challenge with nicotine triggered phosphorylation of the extracellular signal-regulated kinase (ERK) and the thymoma viral proto-oncogene (Akt) followed by activation of the mTORC1-dependent p70 ribosomal S6 protein kinase.|nicotine|Akt|3|20|Arg1:T16|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR
11330337|Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors.|[3H]-oxotremorine-M|muscarinic receptors|4|16|Arg1:T41|Arg2:T56|CHEMICAL|GENE-N|DIRECT-REGULATOR
20590599|KEY RESULTS: Several agonists were found to be highly subtype selective because of selective affinity (e.g. salmeterol and formoterol, for the beta(2)-adrenoceptor over the beta(1) or beta(3)), while others (e.g. isoprenaline) had little affinity-selectivity.|salmeterol|beta(2)-adrenoceptor|20|26|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|AGONIST
15114505|These data suggest that the lavandulyl side chain and the position of the hydroxy group are important for high DGAT inhibitory activity.|lavandulyl|DGAT|6|20|Arg1:T17|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
9138687|Experiments with alpha 1-adrenoceptor antagonists of varying subtype selectivities (RS-17053, SNAP 5089, tamsulosin, 5-methylurapidil, BMY 7378, HV 723 and REC 15/2739) revealed parallel dextral shifts of E/[A] curves to A-61603.|tamsulosin|alpha 1-adrenoceptor|16|3|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|ANTAGONIST
12761331|"Via large-scale, random screening of a portion of the receptorome, we have discovered that the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA, ""Ecstasy"") and its N-demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) each preferentially bind to and activate human recombinant 5-HT2B receptors."|N|human recombinant 5-HT2B receptors|30|42|Arg1:T16|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17041099|Methylthioadenosine phosphorylase (MTAP) salvages purines by releasing adenine from methylthioadenosine and is often deleted in mesothelioma.|methylthioadenosine|MTAP|12|4|Arg1:T12|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
10933891|  Uncoupling proteins (UCPs) are inner mitochondrial membrane transporters which act as pores for H(+) ions, dissipating the electrochemical gradient that develops during mitochondrial respiration at the expense of ATP synthesis.|H(+)|UCPs|16|4|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
12023686|Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.|valsartan|AT1|10|7|Arg1:T37|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
2386945|Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide.|W-12|calmodulin|13|9|Arg1:T13|Arg2:T41|CHEMICAL|GENE-Y|ANTAGONIST
23254198|Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, Akt, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by BZA.|BZA|survivin|47|29|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23142789|The expression levels of Ca transport genes, TRPV5 and calbindin-D9k (CaBP-9k), in the kidney were decreased after treatment with OP and BPA.|Ca|TRPV5|5|9|Arg1:T7|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23485614|Both interventions restored the liver function markers (alanine transaminase: ALT, aspartate transaminase: AST, alkaline phosphatase: ALP, total bilirubin and total protein) and hepatic antioxidants (superoxide dismutase: SOD, catalase: CAT, reduced glutathione: GSH and glutathione peroxidase: GPx) to the normal levels than elevated levels noticed on paracetamol control at P<0.001.|paracetamol|GPx|62|51|Arg1:T17|Arg2:T37|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
18559268|Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.|paclitaxel|microtubules|19|6|Arg1:T6|Arg2:T13|CHEMICAL|GENE-N|DIRECT-REGULATOR
15621150|It inhibits the inducible isoform of the enzyme inosine-monophosphate dehydrogenase (IMPDH II) via its active metabolite mycophenolic acid (MPA).|mycophenolic acid|IMPDH II|19|12|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23371303|  Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes.|NXL104|Ambler class D|4|28|Arg1:T14|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR
15199474|"These results demonstrate that this receptor corresponds to the previously called ""P2t"" platelet receptor and show that the active metabolite of clopidogrel binds in a covalent manner to this receptor, thus explaining how it blocks the aggregating effect of ADP on platelets."|clopidogrel|platelet receptor|24|15|Arg1:T11|Arg2:T23|CHEMICAL|GENE-N|DIRECT-REGULATOR
22064666|Although genetic polymorphisms in the endothelial nitric oxide synthase (eNOS) gene may impair endogenous NO formation, there is little information about how eNOS polymorphisms and haplotypes affect the responses to sildenafil.|NO|eNOS|17|11|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|PRODUCT-OF
8667211|Indomethacin abolished the inhibitory effect of acetazolamide on CA I and CA II.|acetazolamide|CA II|7|12|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
10381000|In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (GTPCH), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (BH4), the obligate cofactor for TPH.|BH4|GTP cyclohydrolase I|29|12|Arg1:T6|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
16926278|All PDE5 constructs had similar affinities for 3-isobutyl-1-methylxanthine, sildenafil, tadalafil, and UK-122764, but mutants containing a complete GAF-B had 7- to 18-fold higher affinity for vardenafil-based compounds compared with those lacking a complete GAF-B.|3-isobutyl-1-methylxanthine|GAF-B|8|22|Arg1:T4|Arg2:T33|CHEMICAL|GENE-N|DIRECT-REGULATOR
11401111|Carvedilol reduced mortality and heart failure in patients with higher pre-treatment plasma N-BNP and adrenomedullin.|Carvedilol|N-BNP|1|13|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23419638|Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR.|pelargonidin|AhR|6|12|Arg1:T20|Arg2:T39|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15671155|Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS) utilize L-cysteine as substrate to form H2S.|H2S|Cystathionine-gamma-lyase|16|1|Arg1:T16|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
23314308|However, they were increased by nearly 40% in response to BAY K 8644 (10(-7)M) and were inhibited by nifedipine (10(-7)M), indicating that activation of the LTCCs was essential.|nifedipine|LTCCs|27|41|Arg1:T19|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
14610216|hOAT1, hOAT3, and hOAT4 but not hOAT2, mediated the uptake of bumetanide.|bumetanide|hOAT1|15|1|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23093496|Molecular docking studies revealed a binding pocket for the ATP derivatives that is bordered by transmembrane helices 3, 5, 6, and 7 in human P2Y(12,) with Y(105), E(188), R(256), Y(259), and K(280) playing a particularly important role in ligand interaction.|ATP|human P2Y(12,)|10|27|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22841391|Subsequently, we confirmed these proteins with the Western blotting approach, and found that methylselenol increased the expression of GADD 153 and p21 but reduced the level of c-Myc, E2F1 and Phos p38 MAP kinase.|methylselenol|p21|16|24|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
21262851|Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (DHP) L-VGCC antagonists.|pentobarbital|Ca(v)1.3|11|1|Arg1:T2|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
10208549|Following a single oral administration, both bis(7)-tacrine and tacrine produced dose-dependent inhibitions of AChE in rat brain, but bis(7)-tacrine exhibited higher efficacy and AChE/BChE selectivity than tacrine.|bis(7)-tacrine|BChE|25|35|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
22422627|SB203580 (a specific inhibitor of p38 kinase) markedly suppressed the increased expression of collagen type I and α-SMA in TGF-β1-induced NPDFs. Berberine exerts suppressive effects on phenotype changes and ECM production in NPDFs via p38 signaling pathway interference.|SB203580|α-SMA|1|20|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
7912539|Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective beta 2-adrenoceptor agonist salbutamol 8 mg (SAL), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors.|SAL|beta 2-adrenoceptor|25|18|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|AGONIST
23583510|Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors.|tetrahydrocurcuminoid dihydropyrimidinone|acetylcholinesterase|3|8|Arg1:T12|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23631499|The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity, CRP, NF-κB, and MCP-1 accompanied with a significant depletion in the Ach level.|AlCl3|NF-κB|7|22|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23353698|ABT-737 is a BH3 mimetic agent which binds Bcl-2, Bcl-XL and Bcl-w with high affinity, while weakly interacts with Mcl-1 and Bfl-1.|ABT-737|Bcl-2|1|9|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15991886|Lubiprostone activates a specific chloride channel (CLC2) on cells lining the gut, thereby naturally increasing intestinal fluid secretion.|Lubiprostone|CLC2|1|8|Arg1:T16|Arg2:T27|CHEMICAL|GENE-Y|ACTIVATOR
23339663|Also, the inhibition of AChE by CBDP is unexpected, from a structural standpoint, i.e., considering the narrowness of AChE active site and the bulkiness of CBDP.|CBDP|AChE|8|6|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
2362440|  We have copurified human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase and steroid 5----4-ene-isomerase, which synthesize progesterone from pregnenolone and androstenedione from fetal dehydroepiandrosterone sulfate, from microsomes as a homogeneous protein based on electrophoretic and NH2-terminal sequencing data.|progesterone|human placental 3 beta-hydroxy-5-ene-steroid dehydrogenase|18|4|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|PRODUCT-OF
23557706|Inhibition of mTOR by low dose rapamycin decreases HG-induced Nox4 and Nox1, NADPH oxidase activity and podocyte apoptosis.|rapamycin|Nox4|7|10|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11426832|The Ki values of betamipron, cilastatin, KW-3902 and probencid for human-OAT1 were 23.6, 1470, 7.82 and 12.1 microM, whereas those for human-OAT3 were 48.3, 231, 3.70 and 9.0 microM.|betamipron|human-OAT1|5|13|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
11103883|5-HT2A- and 5-HT2C-receptor antagonistic potencies of clozapine, olanzapine, risperidone, sertindole and ziprasidone were compared in the same models.|clozapine|5-HT2C|7|3|Arg1:T2|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
9730867|Secretion of GM-CSF protein in the presence of increasing concentrations of isoproterenol followed a similar pattern as observed for GM-CSF mRNA.|isoproterenol|GM-CSF|12|3|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11799102|Aliskiren has the potential to become the first orally active renin inhibitor that provides a true alternative to ACE-inhibitors and Ang II receptor antagonists in therapy for hypertension and other cardiovascular and renal diseases.|Aliskiren|renin|1|11|Arg1:T14|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
23411279|Aqueous ethanol (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 μg/ml), with moderate COX-1 (IC(50), 66 μg/ml) and COX-2 (IC(50), 119 μg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.|ethanol|15-LOX|2|19|Arg1:T8|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
15887238|Western blot analysis of cells incubated with imatinib demonstrated activation of EGFR and downstream signaling that was reduced by inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase 1 (MEK1) and EGFR, but not Her2/ErbB2.|imatinib|EGFR|8|12|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|ACTIVATOR
23142559|Western blot analysis revealed that pilocarpine and physostigmine enhanced the TNF-α-induced phosphorylation of ERK1/2 and p38 MAPK and the degradation of IκBα.|physostigmine|IκBα|8|22|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
15866500|Clinical studies in cancer patients treated with the new fluoropyrimidine analogue capecitabine (N4-pentoxycarbonyl-5'-5-fluorocytidine) have shown that plasma 2'-deoxyuridine was significantly elevated after 1 week of treatment, consistent with inhibition of thymidylate synthase (TS).|2'-deoxyuridine|TS|20|37|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
10548525|Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.|BRL 49653|peroxisome proliferator-activated receptor gamma|16|9|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|ACTIVATOR
11799102|There was a dose-dependent decrease in plasma renin activity, Ang I, and Ang II following single doses of Aliskiren starting with 40 mg.|Aliskiren|Ang I|21|11|Arg1:T26|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11861317|Whereas PS potentiated NMDA-, glutamate-, and glycine-induced currents of NR1/NR2A and NR1/NR2B receptors, it was inhibitory at NR1/NR2C and NR1/NR2D receptors.|PS|NR2D|2|24|Arg1:T18|Arg2:T56|CHEMICAL|GENE-Y|INHIBITOR
10579749|Among the current AT1 receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.|candesartan|AT1|24|4|Arg1:T30|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11959556|Cefaclor and cefprozil showed decreased affinity of PRSP but not PISP for all three PBPs. Cefuroxime showed decreased affinity of PISP and PRSP for PBP1a and -2x but no change for PBP2b.|Cefaclor|PBPs|1|15|Arg1:T4|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR
7832763|The competitive inhibitor of hCOX-1, mefenamic acid, also displayed competitive inhibition of hCOX-2.|mefenamic acid|hCOX-2|7|15|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23219339|Western blot analysis revealed that OMT decreased the expression of Bax and repaired the balance of pro- and anti-apoptotic proteins.|OMT|Bax|6|11|Arg1:T14|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23401473|In overexpressing cell lines, OATP1B1- and OATP1B3-mediated estradiol-17β-glucuronide uptake and OATP2B1-mediated estrone-3-sulfate uptake were inhibited by most of the silymarin flavonolignans investigated.|estradiol-17β-glucuronide|OATP1B3|9|8|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
15102890|The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs. Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).|BLT|SR-BI|38|68|Arg1:T8|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
10913016|In the presence of the beta(2)-adrenoceptor antagonist ICI-118551 (ICI, 10 microM), Iso caused an increase in [(14)C]phenylalanine incorporation, protein and RNA mass, cell volume, and cross-sectional area.|[(14)C]phenylalanine|beta(2)-adrenoceptor|25|6|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23419638|Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR.|TCDD|AhR|27|35|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|ACTIVATOR
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|Modafinil|TA1|1|27|Arg1:T7|Arg2:T38|CHEMICAL|GENE-Y|ACTIVATOR
15714982|Docetaxel is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of bcl-2 inactivation, which induce apoptosis.|Docetaxel|bcl-2|1|18|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|ethoxzolamide|hCA VI|12|35|Arg1:T23|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23259865|Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).|indenoisoquinolines|Top1|6|20|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|tyrosine kinase|1|5|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|CFT|rat dopamine transporter|29|40|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17075268|Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and HDC mRNA induced by TDI in TDI-sensitized rats.|TDI|HDC|22|18|Arg1:T7|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Met|ALDH|46|64|Arg1:T10|Arg2:T34|CHEMICAL|GENE-N|PART-OF
18505444|The Kv channel blockers amiodarone, tetraethylammonium and verapamil, as well as increased extracellular K+ levels, inhibited proliferation of cultured MSC.|verapamil|Kv channel|9|2|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23151004|  A number of integral membrane G protein-coupled receptors (GPCRs) share common structural features (including palmytoilated aminoacid residues and consensus sequences specific for interaction with cholesterol) that allow them to interact with lipid rafts, membrane cholesterol-rich microdomains able to regulate GPCR signalling and functions.|palmytoilated aminoacid|GPCRs|18|10|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|PART-OF
19029287|(+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) and Ca(v)-DM brains was reduced to 15.1 and 4.4% of wild type, respectively, indicating that Ca(v)1.3 accounts for 10.7% of brain LTCCs. qPCR revealed that Ca(v)1.1 and Ca(v)1.4 alpha(1) subunits comprised 0.08% of the LTCC transcripts in mouse whole brain, suggesting that they cannot account for the residual binding.|(+)-[(3)H]isradipine|LTCCs|1|55|Arg1:T7|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
17427197|High D-glucose increases L-arginine transport and eNOS expression following TbetaRII activation by TGF-beta1 involving p42/44(mapk) and Smad2 in HUVEC.|D-glucose|eNOS|2|7|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16782438|CONCLUSIONS: Imatinib inhibits RET-mediated MTC cell growth affecting RET protein levels in vitro in a dose-dependent manner.|Imatinib|RET|3|10|Arg1:T3|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23229512|Moreover, VK2-2,3 epoxide, an intracellular metabolite of VK2, was shown to covalently bind to the cysteine-166 residue of Bak.|VK2|Bak|10|22|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|DIRECT-REGULATOR
19302827|Treating VSMC with the prostacyclin analog iloprost induced differentiation (contractile protein expression and contractile morphology), and also up-regulated COX-2 expression, leading to prostacyclin release by VSMC.|iloprost|COX-2|7|22|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8506307|These results demonstrate that the ability of CHO cells to modify glutamic acid residues to gamma-carboxyglutamic acid in secreted factor IX is not limited by the expression of the vitamin K-dependent gamma-carboxylase alone.|gamma-carboxyglutamic acid|factor IX|16|20|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|PART-OF
17434872|Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.|lumiracoxib|human COX-2|30|14|Arg1:T13|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
23019137|Reversal of inhibition by D2 agonist quinpirole was produced by serotonin (50 µM) and by neurotensin (5-10 nM).|quinpirole|D2|7|5|Arg1:T8|Arg2:T32|CHEMICAL|GENE-Y|AGONIST
23523950|We found that AVM induced upregulation of P-gp protein expression, increased P-gp ATPase activity and enhanced cellular efflux of the P-gp substrate rhodamine 123 from cells.|AVM|P-gp|4|8|Arg1:T17|Arg2:T46|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
9631585|  A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia (t-AML) after chemotherapy consisting of treatment with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and an alkylating agent, cyclophosphamide.|etoposide|DNA-topoisomerase II|26|22|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|INHIBITOR
18381445|Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2.|Statins|histone deacetylase|1|7|Arg1:T5|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
15639300|"Ultimately, clinicians will want to know whether PDE4 inhibitors are anything more than expensive ""designer"" theophylline, the archetypal non-selective phosphodiesterase inhibitor."|theophylline|phosphodiesterase|19|24|Arg1:T6|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
15975002|CPT-11 and SN-38 may also stimulate the production of pro-inflammatory cytokines and prostaglandins (PGs), thus inducing the secretion of Na(+) and Cl(-).|CPT-11|cytokines|1|11|Arg1:T2|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23146758|The aromatase inhibitor CGS 16949A abolished this stimulatory activity and reduced estradiol levels in the control and treatment groups.|estradiol|aromatase|12|2|Arg1:T13|Arg2:T23|CHEMICAL|GENE-N|PRODUCT-OF
16297435|Rivastigmine alone or in association with either choline or choline alphoscerate decreased acetylcholinesterase (AChE), whereas choline or choline alphoscerate alone did not affect AChE activity.|choline alphoscerate|AChE|10|15|Arg1:T20|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|D6D|46|8|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
15206110|Even though its inability to shift between the trivalent and a divalent oxidation state precludes that gallium behaves as an iron analogue in every respect, it strongly interferes with cellular acquisition of iron from blood by competitive interaction with transferrin and transferrin receptor-mediated endocytosis.|iron|transferrin receptor|21|43|Arg1:T25|Arg2:T38|CHEMICAL|GENE-N|DIRECT-REGULATOR
15740719|  We have analyzed binding domains of the oxytocin receptor for barusiban, a highly selective oxytocin receptor antagonist, in comparison to the combined vasopressin V1A/oxytocin receptor antagonist atosiban and the agonists oxytocin and carbetocin.|atosiban|vasopressin V1A/oxytocin receptor|29|25|Arg1:T19|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST
10655292|  The feasibility of administering a relatively high dose of the gonadotrophin-releasing hormone (GnRH) antagonist ganirelix by means of a needle-free injection device, which could be useful in the long-term treatment of sex-steroid-dependent disorders, was evaluated in a randomized, crossover study in 16 healthy females.|ganirelix|GnRH|17|14|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
15887238|Inhibitors and neutralizing antibodies against heparin-binding epidermal growth factor-like growth factor (HB-EGF), and to a lesser extent transforming growth factor-alpha, reduced imatinib-mediated mitogen activated protein kinase (MAPK) activation.|imatinib|mitogen activated protein kinase|26|27|Arg1:T2|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR
1438284|The mutated enzyme was also inhibited well by the bulky, BtChoEase-selective organophosphate inhibitor (tetraisopropylpyrophosphoramide, iso-OMPA).|iso-OMPA|BtChoEase|18|12|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
17254025|The latter reaction, catalyzed by aspartoacylase (ASPA), produces acetyl groups plus aspartate and has been proposed to occur in both soluble and membranous subfractions of white matter.|acetyl|aspartoacylase|13|7|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF
16828882|The cholesterol-lowering drug simvastatin inhibits LFA-1 signaling by binding to an allosteric site on CD11a (LFA-1 alpha chain), which leads to immunomodulation.|simvastatin|LFA-1|4|6|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23471769|Adenosine and dipyridamole are nonselective adenosine receptor agonists that have been associated with myocardial infarction (MI) during intravenous infusion.|Adenosine|adenosine receptor|1|6|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|AGONIST
16232421|A double mutant of the two fumarate reductase isozyme genes (OSM1 and FRDS) showed a succinate productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.|succinate|FRDS|18|14|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
23247009|  Aldose reductase (AR) catalyzes the reduction of toxic lipid aldehydes to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).|aldehydes|Aldose reductase|12|1|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE
20980153|The 4-methoxybenzyl ester 8b and 4-nitrobenzyl ester 8c in the meperidine series and 4-methoxybenzyl ester 14a in the normeperidine series exhibited low nanomolar binding affinities at the SERT (K(i) values <2nM) and high SERT selectivity (DAT/SERT >1500 and NET/SERT >1500).|meperidine|SERT|11|48|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|Δ(5)-androstenediol|ERα|7|42|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23261589|This was confirmed on adding LY294002 the PI3K inhibitor which abolished the protection.|LY294002|PI3K|6|8|Arg1:T8|Arg2:T30|CHEMICAL|GENE-N|INHIBITOR
23391631|The direct evidence for the involvement of CYP1A1 in the induction of cardiotoxicity by Pb(2+) was evidenced by the ability of AhR antagonist, resveratrol, to significantly inhibit the Pb(2+)-modulated effect on β-MHC and α-MHC mRNAs. It was concluded that acute lead exposure induced cardiotoxicity through AhR/CYP1A1-mediated mechanism.|Pb(2+)|β-MHC|34|41|Arg1:T9|Arg2:T35|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
19029287|  The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.|DHP|Ca(v)1.3|24|15|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7944828|The effects of D-1997 in the basilar artery were not modified by incubation with either the 5-HT2 receptor antagonist ketanserin (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM).|(+/-)-pindolol|beta-adrenoceptor|62|51|Arg1:T6|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
15561708|Besides mitochondrial AtNFS1 and plastidial AtNFS2, which are both proposed to be involved in iron-sulfur cluster formation, ABA3 is proposed to be a third and cytosolic NifS-like cysteine desulfurase in A.|iron-sulfur|AtNFS1|16|3|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|PRODUCT-OF
22080037|Here, we report biochemical evidence that mercury alone induces NF-κB activation, resulting in the induced expression of COX-2 and iNOS.|mercury|NF-κB|8|11|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
12181427|We changed the residues to alanine using site-directed mutagenesis technique, expressed the mutants in a baculovirus/Sf9 cell system, and analyzed the kinetic characteristics of inhibition of the mutant enzymes by milrinone and cilostazol, specific inhibitors of PDE3.|alanine|PDE3|6|40|Arg1:T5|Arg2:T23|CHEMICAL|GENE-Y|PART-OF
23625779|Amino-functionalized MCM-41 (AM-41) shows an effect on the amount of OVA binding, with 2.5-fold increase in binding capacity (72 mg OVA/g AM-41) compared to nonfunctionalized MCM-41 (29 mg OVA/g MCM-41).|MCM-41|OVA|2|25|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8001268|  We compared the cardiac electrophysiological actions of two types of H1-receptor antagonists--the piperidines, astemizole and terfenadine, and the nonpiperidines, chlorpheniramine and pyrilamine-in vitro in guinea pig ventricular myocytes and in vivo in chloralose-anesthetized dogs.|piperidines|H1-receptor|15|11|Arg1:T21|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST
23246867|IPA3 also ablated glucose-stimulated insulin granule accumulation at the plasma membrane, consistent with its role in sustained/second-phase insulin release.|glucose|insulin|4|5|Arg1:T13|Arg2:T52|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|Seliciclib|cyclin-dependent kinases|8|16|Arg1:T13|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|CYC202|cyclin-dependent kinases|6|16|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|propranolol|human beta-adrenergic receptors|39|73|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST
15148258|6 In conclusion, these data demonstrate that the anticancer drug amsacrine is an antagonist of cloned HERG potassium channels, providing a molecular mechanism for the previously reported QTc interval prolongation during clinical administration of amsacrine.|amsacrine|HERG potassium channels|12|18|Arg1:T4|Arg2:T25|CHEMICAL|GENE-Y|ANTAGONIST
23393220|Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models.|harmaline|CYP2D6|19|15|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
10381508|Recombinant factor IXR94S was activated by factor XIa/calcium with an approximately 50-fold reduced rate and by factor VIIa/tissue factor/phospholipid/calcium with an approximately 20-fold reduced rate compared with wild-type factor IX.|calcium|R94S|20|4|Arg1:T5|Arg2:T32|CHEMICAL|GENE-N|ACTIVATOR
10697523|  Thymidylate synthase and thymidine kinase are key enzymes involved in the de novo and salvage pathways for pyrimidine nucleotide synthesis, respectively.|pyrimidine nucleotide|thymidine kinase|18|4|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|PRODUCT-OF
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|dofetilide|HERG|26|1|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23237733|  Isoliquiritigenin, a herbal ingredient with chalcone structure, has been speculated to be able to inhibit one of the most drug-metabolizing enzymes (DMEs) UDP-glucuronosyltransferase (UGT).|Isoliquiritigenin|UDP-glucuronosyltransferase|1|27|Arg1:T1|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
9843368|Here we present the crystal structure of the dimeric catalytic domain (residues 117-424) of human phenylalanine hydroxylase (hPheOH), cocrystallized with various potent and well-known catechol inhibitors and refined at a resolution of 2.0 A.|catechol|hPheOH|30|21|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|Ru 24969|5-HT2C|22|14|Arg1:T10|Arg2:T62|CHEMICAL|GENE-Y|AGONIST
9760035|All three compounds displayed antagonistic properties against oxytocin in vitro, with carbetocin being the strongest inhibitor (pA2 = 8.21) and carbetocin metabolite II (pA2 = 8.01) being stronger than carbetocin metabolite I (pA2 = 7.81).|carbetocin|oxytocin|35|8|Arg1:T5|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|BCRP|43|15|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
23334943|  BACKGROUND: Two clinical trials have shown that users of 5α-reductase inhibitors finasteride and dutasteride (5-ARIs) have reduced overall prostate cancer risk, while the proportion of high-grade tumors is increased.|dutasteride|5α-reductase|15|11|Arg1:T4|Arg2:T6|CHEMICAL|GENE-N|INHIBITOR
17567713|Recently, it has been shown that the activation of particular T2R bitter taste receptors is partially involved with the bitter aftertaste sensation of saccharin and acesulfame-K.|acesulfame-K|T2R|27|12|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
9587066|Mutations in SLC12A1 coding for the bumetanide-sensitive sodium potassium 2 chloride cotransporter (NKCC2) cause defective reabsorption of sodium chloride in the thick ascending limb of Henle's loop.|sodium chloride|bumetanide-sensitive sodium potassium 2 chloride cotransporter|20|7|Arg1:T10|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
22989705|The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-α), nuclear factor kappa B (NF-κB) genes expression in cisplatin injected rats.|pioglitazone|NF-κB|6|34|Arg1:T19|Arg2:T32|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
16735460|K114I, located within transmembrane helix 4, showed [14C]succinate uptake similar to WT but relatively small inward currents.|[14C]succinate|K114I|10|1|Arg1:T29|Arg2:T43|CHEMICAL|GENE-N|SUBSTRATE
23317159|JAK2 ATP-competitive inhibitors that indirectly inhibit the JAK-STAT pathway are new candidates for the treatment of MPN.|ATP|JAK2|2|1|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23537890|It can be concluded that the quercetin's induction of HO-1 and its byproducts, without concomitant NOS-2 activity reduction, is among mechanisms contributing to the hepatoprotective effect in d-GalN/LPS hepatotoxicity.|quercetin|HO-1|7|11|Arg1:T3|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23478800|Subsequent analysis revealed that cucurbitacin I strongly activates RhoA and the Rho effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers.|cucurbitacin I|RhoA|5|9|Arg1:T12|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
23204517|We show here that the acidic sequence of PEP-19 has intrinsic Ca(2+) binding activity, which may modulate Ca(2+) binding to CaM by stabilizing an initial Ca(2+)-CaM complex or by electrostatically steering Ca(2+) to and from CaM.|Ca(2+)|PEP-19|12|9|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11179439|  The bisdioxopiperazines ICRF-187 (dexrazoxane), ICRF-193, and ICRF-154 are catalytic noncleavable complex-forming inhibitors of DNA topoisomerase II that do not produce protein-linked DNA strand breaks.|ICRF-187|DNA topoisomerase II|3|18|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23376120|Our results showed that gastrodin treatment strongly suppressed nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPKs) family activation and upregulation of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-stimulated H9c2 cardiomyocytes.|gastrodin|IL-6|5|52|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23557993|Effects of DPHD were eliminated by the estrogen receptor antagonist ICI182780.|DPHD|estrogen receptor|3|8|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
3002801|Enprofylline antagonized the 5'-N-ethylcarboxamidoadenosine (NECA)-induced stimulation of platelet adenylate cyclase activity with a KB of 130 microM.|NECA|adenylate cyclase|6|12|Arg1:T7|Arg2:T30|CHEMICAL|GENE-N|ACTIVATOR
11980628|RESULTS: SOM230 binds with high affinity to SRIF receptor subtypes sst1, sst2, sst3 and sst5 and displays a 30- to 40-fold higher affinity for sst1 and sst5 than Sandostatin (octreotide; SMS 201-995) or Somatuline (BIM 23014).|SOM230|sst3|3|16|Arg1:T28|Arg2:T67|CHEMICAL|GENE-N|DIRECT-REGULATOR
15126366|PKC-delta in particular showed a different pattern of translocation in response to I3A and PMA.|I3A|PKC-delta|13|1|Arg1:T20|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14642426|Ginsenosides Rb2, Rd and Rg1 significantly decreased norepinephrine and/or epinephrine-induced increase of IL-6 level in macrophage cell line (RAW 264.7).|norepinephrine|IL-6|9|14|Arg1:T6|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23261865|Selective antagonism of A(2A) adenosine receptors by ZM241385 significantly prevents or delays the appearance of AD and protects from the irreversible block of neurotransmission induced by 9-min OGD in the DG.|ZM241385|A(2A) adenosine receptors|11|4|Arg1:T12|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST
23237733|Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.|4-methylumbelliferone|UGT|13|10|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|SUBSTRATE
15673388|"  INTRODUCTION: The principal aim of this study was to assess the efficacy of quinidine in suppressing IKr in vitro and in modulating the rate dependence of the QT interval in the ""SQT1"" form of the short QT syndrome."|quinidine|IKr|15|18|Arg1:T5|Arg2:T8|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
12657913|  The effects of histamine H1-receptor antagonists, promethazine and homochlorcyclizine, both of which are inhibitors of CYP2D6, on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.|homochlorcyclizine|CYP2D6|10|18|Arg1:T19|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
11553608|ABA3 is a two-domain protein with a N-terminal NifS-like sulfurase domain and a C-terminal domain that might be involved in recognizing the target enzymes.|N|ABA3|8|1|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|PART-OF
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|etravirine|hPXR|3|19|Arg1:T11|Arg2:T47|CHEMICAL|GENE-Y|AGONIST
10082498|This study thus demonstrates that the first administration of the recommended starting dose of irbesartan induces a greater and longer lasting Ang II receptor blockade than that of valsartan and losartan in normotensive subjects.|losartan|Ang II receptor|31|22|Arg1:T7|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23601990|  A series of phosphorylated flavonoids were synthesized and investigated in vitro as inhibitors of pancreatic cholesterol esterase (CEase) and acetylcholinesterase (AChE).|phosphorylated flavonoids|acetylcholinesterase|4|22|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|ALA|Delta 6 desaturase|48|4|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
22708686|The mianserin analogue mirtazapine also displayed kappa-opioid agonist activity.|mirtazapine|kappa-opioid|4|7|Arg1:T23|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
17979301|Catalytic-site affinities for cGMP, vardenafil, sildenafil, tadalafil, or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for Q817A; and 59-, 448-, 71-, 137-, and 93-fold for F820A.|vardenafil|F820A|6|57|Arg1:T34|Arg2:T59|CHEMICAL|GENE-N|DIRECT-REGULATOR
15771438|Topiramate (1) and its sulfamide analogue 4, and 4,5-cyclic sulfate 6 and its sulfamide analogue 5, were compared for inhibition of human CA-II.|4,5-cyclic sulfate|human CA-II|12|26|Arg1:T4|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23526814|Compounds 8 b and 10 c selectively inhibited HDAC6 at the nanomolar level, whereas the other hydroxamates effected an increase in acetyl-α-tubulin levels in human acute myeloid leukemia U937 cells.|hydroxamates|acetyl-α-tubulin|18|23|Arg1:T3|Arg2:T13|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
11350861|In conclusion, AS-8112 is a potent dopamine D2, D3 and 5-HT3 receptors antagonist, and a novel anti-emetic agent with a broad-spectrum of anti-emetic activity.|AS-8112|5-HT3 receptors|4|13|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST
10864881|Betaxolol inhibited specific [(3)H]-batrachotoxinin-A 20-alpha-benzoate ([(3)H]-BTX-B) binding to neurotoxin site 2 in a concentration-dependent manner with an IC(50) value of 9.8 microM.|[(3)H]-BTX-B|neurotoxin site 2|13|23|Arg1:T24|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
9732824|Both the 5 alpha-reductase inhibitor finasteride and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials.|prazosin|alpha 1-adrenoceptor|18|8|Arg1:T5|Arg2:T13|CHEMICAL|GENE-N|ANTAGONIST
1732532|  New (R)-4-benzamido-5-oxopentanoic acid derivatives were synthesized by a stereoconservative procedure and evaluated in vitro for their capacity to inhibit the binding of [125I](BH)-CCK-8 to either rat peripheral (CCK-A) or central (CCK-B) CCK receptors, or the binding of [3H]pentagastrin to rabbit gastric glands, as well as to inhibit, in vivo, the acid secretion induced by pentagastrin infusion in the perfused rat stomach.|125I|CCK-A|27|38|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7853212|In human hepatic microsomes, mepyramine inhibited the debrisoquine 4-hydroxylation activity catalyzed by P450 2D6.|debrisoquine|P450 2D6|9|14|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hENT2|11|20|Arg1:T12|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15943176|  The aim of this study was to compare the in vivo effects on free radical metabolism of 2 non-steroidal anti-inflammatory drugs (NSAIDs): tenoxicam, an oxicam preferentially cyclooxygenase-1 (COX-1) inhibitor, and celecoxib, a sulfonamide selective COX-2 inhibitor.|tenoxicam|cyclooxygenase-1|26|31|Arg1:T2|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
10027835|We compared the following drugs in the kindling model of epilepsy: 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.|selegiline|MAO-A|17|34|Arg1:T15|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
15991886|Lubiprostone activates a specific chloride channel (CLC2) on cells lining the gut, thereby naturally increasing intestinal fluid secretion.|Lubiprostone|chloride channel|1|5|Arg1:T16|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR
23376120|Furthermore, PI3-K/Akt inhibition partially abolished the inhibitory effects of gastrodin on the phosphorylation of inhibitor κB-α (IκB-α), extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), and activity of NF-κB.|gastrodin|p38 MAPK|11|44|Arg1:T1|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
15736931|Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I.|lysine|bovine beta-1,4-galactosyltransferase I|6|12|Arg1:T37|Arg2:T57|CHEMICAL|GENE-Y|PART-OF
23528251|Phenobarbital (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and vascular endothelial growth factor-a.|Phenobarbital|CAR|1|8|Arg1:T4|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
23542513|In addition, cobalt protoporphyrin (CoPP), a specific HO-1 inducer, predominantly suppressed LPS-induced NO production.|cobalt protoporphyrin|HO-1|4|12|Arg1:T20|Arg2:T49|CHEMICAL|GENE-Y|ACTIVATOR
11811354|Cyclooxygenase-1 (COX-1) inhibitors (flurbiprofen, ketoprofen and ketrolack) attenuated the nicotine-induced contraction in a concentration-dependent manner, and cyclooxygenase-2 (COX-2) inhibitors at high concentrations (nimesulide and NS-389) slightly attenuated the contraction.|ketoprofen|COX-1|9|3|Arg1:T16|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
7905294|  Maximal L-glutamate/glycine-evoked currents were inhibited by ethanol in Xenopus laevis oocytes expressing recombinant heteromeric NMDA receptors consisting of NR1-NR2A, NR1-NR2B, and NR1-NR2C subunit combinations.|ethanol|NR1|7|24|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23266270|DPEP inhibited LPS-induced phosphorylation of ERK, JNK, and p38.|DPEP|JNK|1|8|Arg1:T12|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
20600573|However, both compounds have similar molecular mechanisms of neuroprotection in neuronal cell cultures and animal neurodegenerative models, indicating that the neuroprotective effect of rasagiline does not depend on inhibition of MAO-B, but rather is associated with the N-propargyl moiety, which promotes mitochondrial viability and stabilizes permeability transition by regulating Bcl-2 family proteins.|N-propargyl|Bcl-2|41|54|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
11695891|Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism.|nitro indazole|nitric oxide synthase|9|4|Arg1:T14|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
23382458|In human permeability glycoprotein (P-gp)- and breast cancer resistance protein (BCRP)-cDNA-transfected cell monolayers as well as Caco-2 cell monolayers, the apparent efflux ratio of basolateral-to-apical (PcB-A) versus apical-to-basolateral permeability (PcA-B) of apixaban was >10.|apixaban|human permeability glycoprotein|43|2|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|SUBSTRATE
23248200|In conclusion, these studies indicate that several oral antidiabetic drugs affect the OATP1B1-mediated uptake of rosuvastatin in vitro.|rosuvastatin|OATP1B1|17|14|Arg1:T11|Arg2:T23|CHEMICAL|GENE-Y|SUBSTRATE
16326016|Given that glutamine is the predominant precursor for releasable pools of glutamate, our observation that estradiol increases glutamine synthetase gene and protein expression suggests that hormonal regulation of glutamate neurotransmission involves hormonally responsive glia.|estradiol|glutamine synthetase|17|19|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12601049|RU486 treatment prevented budesonide-mediated inhibition of VEGF secretion and VEGF mRNA expression.|RU486|VEGF|1|10|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23550937|IC50 values for an expanded set of curcumin analogues established a rank order of potencies, and analyses of IKKβ and AKT2 enzyme kinetics for 4 revealed a mixed inhibition model, ATP competition dominating.|curcumin|AKT2|8|22|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|cholesterol|LXR|3|18|Arg1:T14|Arg2:T27|CHEMICAL|GENE-N|DIRECT-REGULATOR
16425993|Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) sorafenib, sunitinib, and AG013736, which target multiple VEGFRs as well as PDGFR-beta.|sunitinib|PDGFR-beta|28|40|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
15155769|The M564G mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA.|myristoyl-CoA|CrAT|15|24|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23471964|Also, cells containing a triple-cysteine mutant of maspin showed elevated ERK1/2 activity, a downstream target of ROS, and enhanced proliferation and colony formation.|cysteine|maspin|7|9|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|PART-OF
10653606|Inclusion of resveratrol reduced the melittin-dependent inhibition of PLA(2) and caused an increase in quinacrine-stimulated PLA(2) activity.|quinacrine|PLA(2)|18|19|Arg1:T11|Arg2:T41|CHEMICAL|GENE-N|ACTIVATOR
23231492|"We aim to ""tilt"" the stability of the H1 loop structure from a noncanonical conformation to a (humanized) type 1 canonical conformation by studying the effect of selected mutations to the amino acid sequence of the H1, H2, and proximal residues."|amino acid|H1|36|41|Arg1:T1|Arg2:T11|CHEMICAL|GENE-N|PART-OF
17553661|  4-Hydroxynonenal (4-HNE) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (GST) isoforms.|4-HNE|glutathione S-transferase|3|21|Arg1:T17|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE
23524313|The high fat diet dramatically increased the transcript levels of CYP7A1, which was subsequently reversed by the fisetin.|fisetin|CYP7A1|19|11|Arg1:T14|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|DPP-4|1|17|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
19620795|Since they do not have inhibitory activity against mTORC2 complex, the ability of mTOR inhibition by Temsirolimus is supposed to be 40 to 50% of full inhibition in mTOR kinase.|Temsirolimus|mTOR|18|15|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
23179349|The decrease in insulin and nitric oxide in rats fed the diet high in iron, fat, fructose, and salt was associated with disorders of zinc, copper, and calcium status, as well as with an increase in the relative mass of the gonads.|fructose|insulin|19|4|Arg1:T10|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
8161345|In contrast, xanthine oxidase oxidized 5-ethynyl-2(1H)-pyrimidinone to 5-ethynyluracil with a substrate efficiency that was only 0.02% that of xanthine.|xanthine|xanthine oxidase|25|4|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23354536|The data suggest that the decrease in tissue levels of 5-HT produced by MDMA is accompanied by a decrease in tryptophan hydroxylase activity but cannot be explained by supersensitivity of the 5-HT1a autoreceptor.|5-HT|tryptophan hydroxylase|11|21|Arg1:T1|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
8740147|Amezinium is much less potent as a MAO inhibitor in cells with the uptake2 transporter, such as the myocardial cells of the heart.|Amezinium|MAO|1|8|Arg1:T17|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR
14629008|  Trimethoprim (TMP), an inhibitor of dihydrofolate reductase, decreases the level of tetrahydrofolate supplying one-carbon units for biosynthesis of nucleotides, proteins, and panthotenate.|Trimethoprim|dihydrofolate reductase|1|9|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
11723241|Dofetilide blocked the triply mutated bEAG T432S/A443S/A453S with an IC(50) value of 1.1 microM.|Dofetilide|T432S|1|7|Arg1:T3|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
7678677|We conclude that alprenolol and BAAM are competitive slowly reversible beta 1-adrenoceptor antagonists on rat left atria.|BAAM|beta 1-adrenoceptor|6|11|Arg1:T11|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST
18773878|RTX treatment also induced foci of RAD51, gamma-H2AX, phospho-Chk1, and phospho-NBS1, although the extent of co-localization with RPA2 foci varied.|RTX|RAD51|1|7|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
19427182|First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased alpha-tocopherol secretion in a dose-dependent manner.|alpha-tocopherol|ABCA1|27|21|Arg1:T19|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF
23639626|"By ""working upwards"" from mTOR, we observed that TCDD inhibited endogenous and IGF-I-induced AKT and ERK activation by interfering with tyrosine phosphorylation of insulin receptor substrate 1."|TCDD|AKT|12|17|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
15169831|We evaluated the effects of systemic ethanol (0.05-2.0 g/kg i.p.), the N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine (MK-801; 0.05-0.2 mg/kg i.v.), the connexin-36 gap junction blocker quinidine (5-20 mg/kg i.v.), the fast-acting barbiturate methohexital (Brevital; 5-10 mg/kg i.v.), and the benzodiazepine chlordiazepoxide (Librium; 5-10 mg/kg i.v.), as well as in situ VTA administration of NMDA and the GABA(A) receptor agonist muscimol, on VTA GABA neuron spontaneous activity and internal capsule stimulus-induced poststimulus spike discharges (ICPSDs).|MK-801|N-methyl-D-aspartate (NMDA) receptor|24|16|Arg1:T22|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST
11916794|IMPLICATIONS: Tramadol competitively inhibits norepinephrine transporter function at desipramine-binding sites in the adrenal medullary cells and probably the noradrenergic neurons of the descending inhibitory system.|desipramine|norepinephrine transporter|10|6|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23288144|Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation.|Sunitinib|tyrosine kinase|1|4|Arg1:T16|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
19057128|These findings indicate that captopril attenuates the development of monocrotaline-induced right ventricular hypertrophy in association with inhibition of MMP-2 and MMP-9 in rats.|monocrotaline|MMP-9|10|21|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
17653133|  Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethylarginine to generate L-citrulline and is present in large quantities in the kidney.|L-citrulline|Dimethylarginine dimethylaminohydrolase|11|1|Arg1:T14|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF
23404443|Three variables of cardiac vagal effects (the root mean square of successive differences [rMSSD] in the interbeat interval of the heart rate [IBI], heart-rate variability [HRV] caused by peak-valley respiratory sinus arrhythmia [pvRSA], and high-frequency power [HF]) and heart rate (HR) were obtained at seven time points during the clamps, characterised by increasing levels of insulin (achieved by administering insulin plus glucose, glucose only, glucose and GLP-1, and glucose and GLP-1 combined with arginine).|glucose|insulin|90|73|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23584948|Vandetanib (Caprelsa(®), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase RET (constitutively activated in roughly 60 % of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors.|Vandetanib|epidermal growth-factor receptors|1|49|Arg1:T2|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23453071|  Previously, we have found that BRN-103, a nicotinamide derivative, inhibits vascular endothelial growth factor (VEGF)-mediated angiogenesis signaling in human endothelial cells.|BRN-103|vascular endothelial growth factor|7|14|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
19337422|Prolonged use of tolvaptan leads to increased endogenous levels of AVP and perhaps over-stimulation of V(1A) receptors.|tolvaptan|V(1A) receptors|4|16|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
16997906|  Arginine decarboxylase (ADC) and ornithine decarboxylase (ODC) are involved in the biosynthesis of putrescine, which is the precursor of other polyamines in animals, plants, and bacteria.|putrescine|ornithine decarboxylase|18|7|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|PRODUCT-OF
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|serine|ASCT1|14|7|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
14971907|Several low nanomolar CA V inhibitors were detected (KI values in the range of 4-15 nM), most of them belonging to the acylated sulfanilamide, ureido-benzenesulfonamide, 1,3,4-thiadiazole-2-sulfonamide, and aminobenzolamide type of compounds.|aminobenzolamide|CA V|34|4|Arg1:T6|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
20372850|TAS-102 is a novel drug containing trifluorothymidine, which is phosphorylated by TK-1 to its active monophosphated form, that in turn can inhibit TS.|TAS-102|TK-1|1|13|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
23742252|  The synthesis, preclinical profile, and in vivo efficacy in rat xenograft models of the novel and selective anaplastic lymphoma kinase inhibitor 15b (LDK378) are described.|LDK378|anaplastic lymphoma kinase|26|20|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR
2858236|Bevantolol caused hypertension in pithed rats, an effect attenuated by phentolamine, implying that bevantolol may be an alpha-adrenoceptor agonist.|phentolamine|alpha-adrenoceptor|12|20|Arg1:T12|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
10076535|Analogous to the antiandrogens, bicalutamide and hydroxyflutamide, binding of estramustine phosphate metabolites to the androgen receptor was observed.|estramustine phosphate|androgen receptor|12|17|Arg1:T4|Arg2:T48|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17390078|There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the parathion-treated cells.|parathion|Notch-4|32|17|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22552008|Overexpression of CRBN wild-type protein, but not CRBN(YW/AA) mutant protein, in KMS12 myeloma cells, amplified pomalidomide-mediated reductions in c-myc and IRF4 expression and increases in p21(WAF-1) expression.|pomalidomide|c-myc|22|25|Arg1:T20|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17352516|  Sitagliptin, an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.|Sitagliptin|DPP-4|1|8|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23146871|Results confirm that in these cell lines significant Mn(3+) is transported by the Tf mechanism similarly to Fe(3+)Tf transport; although Mn(3+)Tf transport is markedly slower than other Mn transport mechanisms.|Mn(3+)|Tf|9|17|Arg1:T6|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
11799102|There was a dose-dependent decrease in plasma renin activity, Ang I, and Ang II following single doses of Aliskiren starting with 40 mg.|Aliskiren|Ang II|21|15|Arg1:T26|Arg2:T46|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23201331|It increased the activity of ALP, and osteocalcin was also elevated in response to sweroside (P<0.05).|sweroside|ALP|16|6|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-threonine|L-serine dehydratase|26|1|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|SUBSTRATE
10901669|In contrast, in male rats only exposure to HxCB, which induces mainly CYP2B1 and 2B2, decreased both coagulation factors dramatically up to 88%.|HxCB|coagulation factors|10|21|Arg1:T4|Arg2:T44|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
1712335|The vasopressor response to the calcium channel activator, BAY-K-8644, which is mediated through the opening of voltage dependent calcium channels and the subsequent translocation of extracellular calcium, was significantly inhibited by carvedilol (1 mg/kg, iv), suggesting that carvedilol is also a calcium channel antagonist, consistent with our previous in vitro studies.|carvedilol|voltage dependent calcium channels|35|19|Arg1:T11|Arg2:T38|CHEMICAL|GENE-N|INHIBITOR
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|allopregnanolone|3alpha-HSDs|13|22|Arg1:T23|Arg2:T46|CHEMICAL|GENE-N|PRODUCT-OF
16997906|  Arginine decarboxylase (ADC) and ornithine decarboxylase (ODC) are involved in the biosynthesis of putrescine, which is the precursor of other polyamines in animals, plants, and bacteria.|putrescine|ADC|18|4|Arg1:T8|Arg2:T13|CHEMICAL|GENE-N|PRODUCT-OF
23312283|We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO.|TMA|flavin mono-oxygenase|17|5|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
9581512|  The protein tyrosine kinase (PTK) inhibitor piceatannol is also an inhibitor of the rat liver cyclic AMP-dependent protein kinase (PKA) catalytic subunit (cAK), rat brain Ca(2+)- and phospholipid-dependent protein kinase C (PKC), avian gizzard Ca(2+)-calmodulin-dependent myosin light chain kinae (MLCK), and of wheat embryo Ca(2+)-dependent protein kinase (CDPK) (IC50 values 3, 8, 12, and 19 microM, respectively).|piceatannol|CDPK|9|74|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
8454631|Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2.|flurbiprofen|PGH synthase-2|20|36|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|17 alpha-ethinylestradiol|estrogen receptor|6|42|Arg1:T5|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|sorafenib|tyrosine kinase|19|13|Arg1:T4|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
15794712|Imatinib is a small-molecule tyrosine kinase inhibitor of the ABL fusion gene, platelet derived growth factor receptors (PDGFR) and KIT.|Imatinib|ABL|1|10|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
16757355|Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.|BAY 43-9006|VEGFR|3|22|Arg1:T12|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
23473805|Rp1 and actinomycin D reduced Src activity, and overexpression of active Src decreased the synergistic effect of Rp1 with actinomycin D.|actinomycin D|Src|3|6|Arg1:T8|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23615073|We observed a significant reduction in CSE induced luciferase expression, NF-κB DNA binding, I-κBε degradation and c-Rel nuclear translocation in cells pretreated with vitamin C.|vitamin C|NF-κB|26|12|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
18045203|  Oxybutynin (1) is a non-selective muscarinic receptor antagonist that is used clinically for the treatment of urinary incontinence.|Oxybutynin|muscarinic receptor|1|8|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|ANTAGONIST
12652111|PDE4 activity in failing human heart was lower than in rabbit heart and there was no significant difference in the inhibition of human cytosolic cAMP-PDE by cilostazol and milrinone.|milrinone|human cytosolic cAMP-PDE|29|23|Arg1:T8|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR
9626023|Some NSAIDs (eg, flurbiprofen, ketoprofen) were COX-1 selective, some (eg, ibuprofen, naproxen) were essentially nonselective, while others (eg, diclofenac, mefenamic acid) were COX-2 selective.|naproxen|COX-1|20|11|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23466342|The suppression of MDR1 promoter activity and protein expression was mediated through mollugin-induced activation of AMP-activated protein kinase (AMPK).|mollugin|MDR1 promoter|13|4|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
2083404|However, salicylate moiety appears to interfere with aspirin inhibitory action on platelets and vascular COX.|aspirin|COX|9|16|Arg1:T12|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23567998|Gabapentin was demonstrated to be a LAT1 substrate in brain endothelial cells (LAT1-process; Km=530μM and Vmax=7039pmoles/million cells/min versus other-processes; Km=923μM and Vmax=3656pmoles/million cells/min) and in transfected HEK 293 LAT1 cells (LAT1-process; Km=217μM and Vmax=5192pmoles/million cells/min versus otherprocesses; Km=1546μM and Vmax=3375pmoles/million cells/min).|Gabapentin|LAT1|1|7|Arg1:T8|Arg2:T18|CHEMICAL|GENE-Y|SUBSTRATE
19203467|Only PLZ inhibited MAO and ALA-T and elevated ALA levels.|PLZ|MAO|2|4|Arg1:T50|Arg2:T78|CHEMICAL|GENE-N|INHIBITOR
18559268|Taxanes with affinities for microtubules well above their affinities for P-glycoprotein are shown not to be affected by multidrug resistance.|Taxanes|microtubules|1|5|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR
10765977|Further, nitric oxide synthase inhibitor, L-NMMA, prevented this beneficial action of L-arginine-nitric oxide system on essential fatty acid metabolism.|L-NMMA|nitric oxide synthase|8|3|Arg1:T18|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR
23376608|In the c-Myc siRNA-transfected and apigenin-treated cells, compared with the apigenin-treated control cells, apoptosis and phosphorylation of p38 and p53 were ameliorated.|apigenin|p38|6|20|Arg1:T3|Arg2:T16|CHEMICAL|GENE-N|ACTIVATOR
23566269|  d-Amino acid oxidase (DAAO) catalyzes the oxidation of d-amino acids including d-serine, a coagonist of the N-methyl-d-aspartate receptor.|d-serine|N-methyl-d-aspartate receptor|14|20|Arg1:T11|Arg2:T16|CHEMICAL|GENE-N|AGONIST
17094966|D-serine transport was inhibited by alanine, serine, cysteine, glutamine, and asparagine, but not anionic amino acids or cationic amino acids, suggesting that D-serine transport in Muller cells occurs via ASCT2 rather than ASCT1 or ATB0,+.|D-serine|ASCT2|29|36|Arg1:T2|Arg2:T26|CHEMICAL|GENE-N|SUBSTRATE
16876889|These findings suggest that folate metabolism is compartmentalised in Leishmania and that SHMT RNA levels are responsive to environmental conditions.|folate|SHMT|5|13|Arg1:T10|Arg2:T21|CHEMICAL|GENE-N|SUBSTRATE
7500004|Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants.|cocaine|norepinephrine-transporter|10|5|Arg1:T25|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23401473|OATP1B1-, OATP1B3-, and OATP2B1-mediated substrate transport was inhibited efficiently by silymarin (IC50 values of 1.3, 2.2 and 0.3 µM, respectively), silybin A (IC50 values of 9.7, 2.7 and 4.5 µM, respectively), silybin B (IC50 values of 8.5, 5.0 and 0.8 µM, respectively), and silychristin (IC50 values of 9.0, 36.4, and 3.6 µM, respectively).|silybin B|OATP1B3|44|3|Arg1:T1|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|cocaine|NET|27|16|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
10882160|  When peripheral decarboxylation is blocked by carbidopa or benserazide, the main metabolic pathway of levodopa is O-methylation by catechol-O-methyltransferase (COMT).|O|catechol-O-methyltransferase|18|20|Arg1:T3|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
23050902|It was reported previously that FVII gene (F7) expression was up-regulated by ribavirin treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.|ribavirin|FVII|15|6|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23541125|The fine particulate (PM < 2.5 μm) of wood smoke were the most potent TRPA1 agonists and several chemical constituents of wood smoke particulate, 3,5-ditert-butylphenol, coniferaldehyde, formaldehyde, perinaphthenone, agathic acid, and isocupressic acid, were TRPA1 agonists.|perinaphthenone|TRPA1|34|44|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|AGONIST
23422569|Endothelial dysfunction induced by SIRT1 inhibition was prevented by treatment of the vessels with the NADPH oxidase inhibitor apocynin or superoxide dismutase.|apocynin|NADPH oxidase|19|16|Arg1:T21|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR
7518029|In the pituitary, haloperidol and sulpiride induced similar increases of mRNAs of pro-opiomelanocortin (POMC) (+65% and +73%), prolactin (PRL) (+821% and +840%) and growth hormone (GH) (+32% and +47%), but sulpiride induced a greater increase of D2R mRNA (+125%) than haloperidol (+92%).|haloperidol|pro-opiomelanocortin|5|14|Arg1:T4|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17385063|Responses were blocked by the guanylate cyclase inhibitor methylene blue and were increased by the nitric oxide synthase inhibitor L-NAME, a pattern shared by nitroprusside.|methylene blue|guanylate cyclase|9|6|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
9633680|Levodopa is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and catechol-O-methyltransferase (COMT).|Levodopa|catechol-O-methyltransferase|1|19|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23220614|Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the Bax/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.|ISO|Bax|12|14|Arg1:T22|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
1881457|Acetylation of phenelzine at the N2 position presumably interferes with the inhibition of the transaminase enzymes for gamma-aminobutyric acid and alanine.|gamma-aminobutyric acid|transaminase|18|15|Arg1:T20|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|Catecholamines|phenylalanine hydroxylase|1|16|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|INNO-406|Src|25|16|Arg1:T3|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23591777|Furthermore, cytochrome P450 2E1 (CYP2E1) content was suppressed while proinflammatory cytokines tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels increased in liver tissue after CCl4 administration.|CCl4|CYP2E1|32|7|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11553608|ABA3 contains highly conserved binding motifs for pyridoxal phosphate and for a persulfide.|pyridoxal phosphate|ABA3|8|1|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11369259|Heparin-binding exosite of factor Xa.   Recent studies have indicated that the basic residues Arg(93), Lys(96), Arg(125), Arg(165), Lys(169), Lys(236), and Arg(240) (chymotrypsin numbering) constitute an exosite in the catalytic domain of factor Xa that can effectively bind heparin only if the acidic N-terminal Gla domain of the proteinase was neutralized by physiological levels of calcium.|Arg|chymotrypsin|29|50|Arg1:T11|Arg2:T13|CHEMICAL|GENE-N|PART-OF
17604186|Previous studies have explored the protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) against chemical kindling in mice.|rofecoxib|COX-2|15|18|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|threonine|neutral amino acid transporter|19|3|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
23204517|We show here that the acidic sequence of PEP-19 has intrinsic Ca(2+) binding activity, which may modulate Ca(2+) binding to CaM by stabilizing an initial Ca(2+)-CaM complex or by electrostatically steering Ca(2+) to and from CaM.|Ca(2+)|CaM|22|28|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23500659|Furthermore, SIL significantly protected against testosterone-provoked decline in mRNA expression of P21(WAF1/Cip1) and Bax/Bcl-xl ratio as well as caspase-3 activity.|testosterone|Bcl-xl|7|19|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23473803|Finally, we demonstrated that the PDE4 inhibitory effect of moexipril is functionally able to induce phosphorylation of the small heat shock protein, Hsp20, by cAMP dependent protein kinase A.|moexipril|PDE4|11|7|Arg1:T5|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
11566608|The considerable potential of the epidermal growth factor receptor-selective tyrosine kinase inhibitor, ZD 1839 (Iressa; AstraZeneca) to efficiently treat, and perhaps even prevent, endocrine-resistant breast cancer is highlighted.|Iressa|epidermal growth factor receptor|17|6|Arg1:T4|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
16207494|  In the present study, age-related changes of pyridoxal 5'-phosphate (PLP) synthesizing enzymes, pyridoxal kinase (PLK) and pyridoxine 5'-phosphate oxidase (PNPO), their protein contents and activities were examined in the gerbil hippocampus proper.|pyridoxal 5'-phosphate|pyridoxal kinase|9|17|Arg1:T4|Arg2:T27|CHEMICAL|GENE-N|PRODUCT-OF
23423713|Furthermore, V(5+) significantly inhibited the TCDD-induced AhR-dependent luciferase activity.|TCDD|AhR|10|11|Arg1:T22|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
18996527|  Nicotinamide N-methyltransferase (NNMT) catalyses the conversion of nicotinamide to 1-methylnicotinamide and plays an important role in hepatic detoxification reactions.|1-methylnicotinamide|Nicotinamide N-methyltransferase|12|1|Arg1:T11|Arg2:T17|CHEMICAL|GENE-Y|PRODUCT-OF
2394753|  In a recent study it has been shown that mitochondrial creatine kinase from chicken brain (Mia-CK) and heart (Mib-CK) are two distinct isoenzymes differing in ten out of the thirty N-terminal amino acids (Hossle, J.P., Schlegel, J., Wegmann, G., Wyss, M., Bohlen, P., Eppenberger, H.M., Wallimann, T., and Perriard J.C. (1988) Biochem.|N-terminal amino acids|mitochondrial creatine kinase|35|10|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|PART-OF
17155857|The most advanced compound is the orally active, selective PDE4 inhibitor cilomilast (Ariflo, SB-207499, cis-4-cyano-4-[3-cyclopentyloxy-4-methoxyphenyl]-cyclohexanecarboxylic acid; GlaxoSmithKline).|Ariflo|PDE4|15|11|Arg1:T8|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
1361547|Labetalol (> or = 3 x 10(-8) M) and dilevalol (> or = 10(-8) M) caused surmountable antagonism of the isoprenaline responses of the atria and the pA2 values were 8.60 and 8.98 at the beta 1-adrenoceptors of the rat left atria and 7.90 and 8.31, respectively, on the guinea-pig left atria which has functional beta 1- and beta 2-adrenoceptors.|isoprenaline|beta 1-adrenoceptors|31|46|Arg1:T17|Arg2:T26|CHEMICAL|GENE-N|AGONIST
17141733|Whereas the affinity of Ce6 for LDL and liposomes increases at lower pH, it decreases for albumin.|Ce6|LDL|5|7|Arg1:T8|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|atosiban|OT|59|62|Arg1:T16|Arg2:T54|CHEMICAL|GENE-Y|ANTAGONIST
10405348|Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.|2-methoxyestradiol|aromatase|15|7|Arg1:T21|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
17929114|Because of their strong affinities for the ATP-binding site compared to IM, most ATP-competitive inhibitors may be effective in IM-resistant patients.|IM|ATP-binding site|12|8|Arg1:T10|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
21262851|All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only BDZs and pentobarbital induced a negative shift in Ca(v)1.2 channel inactivation.|pentobarbital|Ca(v)1.2|29|35|Arg1:T6|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
9643444|When given intratracheally with insulin, inhibitors including N-ethylmaleimide, p-chloromercuribenzoic acid, and 1,10-phenanthroline significantly enhanced the absolute bioavailability of insulin and the compound's hypoglycaemic effects.|p-chloromercuribenzoic acid|insulin|11|22|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
15381832|Using [14C]choline-labeled gastric mucosal cells in culture, we show that stimulatory effect of beta-adrenergic agonist, isoproterenol, on phospholipid release was subject to a dose-dependent suppression by EGFR kinase inhibitor, PD153035, as well as wortmannin, a specific inhibitor of PI3K.|PD153035|kinase|37|34|Arg1:T8|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
1327384|The selective alpha 2-adrenoceptor antagonists, idazoxan, yohimbine, rauwolscine and WY 26703 displaced [3H]-RS-15385-197 binding to rat cerebral cortex in a simple manner with Hill slopes close to unity.|[3H]-RS-15385-197|alpha 2-adrenoceptor|16|3|Arg1:T37|Arg2:T46|CHEMICAL|GENE-N|DIRECT-REGULATOR
15748157|Atorvastatin significantly protected from glutamate-induced excitotoxicity as evidenced by propidium iodide staining, nuclear morphology, release of lactate dehydrogenase, and mitochondrial tetrazolium metabolism, but not from oxygen-glucose deprivation or apoptotic cell death.|Atorvastatin|lactate dehydrogenase|1|19|Arg1:T16|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17258485|There was significant inhibition of the I(SC) responses to 30 microM ASC by the flavanoid quercetin (50 microM) and by 100 microM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) and 5-ethylisopropylamiloride (EIPA), blockers of anion exchangers and sodium-proton exchangers, respectively.|DIDS|anion exchangers|31|41|Arg1:T26|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
23148920|The NaHS-induced eNOS phosphorylation and NO production were not affected by a PI3K/Akt inhibitor (wortmannin).|NaHS|eNOS|2|3|Arg1:T6|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
11270983|In rings with endothelium of the previously deendothelialized left anterior descending coronary artery, indometacin (inhibitor of cyclooxygenase) and ridogrel (thromboxane A2 receptor antagonist and inhibitor of thromboxane synthase) inhibited contractions to endothelin-1.|ridogrel|thromboxane synthase|22|31|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|HO-1|10|22|Arg1:T12|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10405348|Both paclitaxel and 2-meOE2 also inhibited stimulation of aromatase activity by IL-6 plus its soluble receptor and PGE(2).|PGE(2)|aromatase|18|9|Arg1:T3|Arg2:T24|CHEMICAL|GENE-Y|ACTIVATOR
23296101|Furthermore, sensitization to FITC is also enhanced by menthol, which activates TRPA1 and TRPM8.|FITC|TRPA1|5|14|Arg1:T17|Arg2:T35|CHEMICAL|GENE-Y|ACTIVATOR
15899831|The novel indole-ether quinazoline AZD2171 is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro.|AZD2171|tyrosine kinase|5|21|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
15878185|Fatty acid synthase (FAS) catalyzes the condensation of acetyl-CoA and malonyl-CoA to generate long-chain fatty acids in the cytoplasm, while the breakdown of fatty acids (beta-oxidation) occurs in mitochondria and is regulated by carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting step for the entry of fatty acids into the mitochondria.|malonyl-CoA|Fatty acid synthase|13|1|Arg1:T7|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|Ca2+|cardiac troponin C|17|18|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23349208|Both fatty acids, but DHA to a lesser extent compared with EPA, selectively and dose-dependently reduced the percentage of cytokine-expressing Th cells in a peroxisome proliferator-activated receptor (PPAR)γ-dependent fashion, whereas the expression of the cell surface marker CD69 was unaltered on activated T cells.|EPA|cytokine|13|22|Arg1:T14|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10871202|We tested the hypothesis that troglitazone, which improves insulin sensitivity and lowers plasma insulin levels in insulin-resistant obese subjects and patients with type 2 diabetes, would also lower circulating PAI-1 antigen concentrations and activity.|troglitazone|PAI-1|6|32|Arg1:T11|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23017395|Results show the hypolipidemic property of FVW-FO and reduced HMG-CoA reductase activity which is proportional to the incorporation of EPA+DHA.|DHA|HMG-CoA reductase|21|10|Arg1:T16|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23423713|Upon co-exposure to V(5+) and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24 h.|V(5+)|Cyp1b1|11|27|Arg1:T15|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17554001|We found that glycine is released from vesicles when VIAAT is coexpressed with either the neuronal transporter GlyT2 or the glial transporter GlyT1.|glycine|VIAAT|4|10|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|SUBSTRATE
17567713|We also found that TRPV1 receptors are activated by CuSO(4), ZnSO(4), and FeSO(4), three salts known to produce a metallic taste sensation.|CuSO(4)|TRPV1|10|5|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR
9614060|However, the apparent affinity for lysine transport was 2.4 times lower in Cat1(-/-) cells when compared with wild type cells, a property characteristic of Cat3-mediated transport.|lysine|Cat3|7|30|Arg1:T8|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
12504917|Reserpine-induced ptosis was reversed by rasagiline at doses above 2 mg x kg(-1) i.p., which inhibit MAO-A as well as MAO-B, but not at MAO-B-selective doses.|Reserpine|MAO-A|1|21|Arg1:T19|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
23183374|AID initiates somatic hypermutation and class switch recombination (CSR) by deaminating cytosine to uracil in specific immunoglobulin (Ig) gene regions.|uracil|AID|16|1|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|PRODUCT-OF
9486667|Thus, the serine in position HERG 620 may participate directly in dofetilide binding; however, an intact C-type inactivation process seems to be crucial for high-affinity drug binding.|serine|HERG|4|7|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|PART-OF
15110853|Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity.|adamantyl|Carbonic anhydrase|10|1|Arg1:T13|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
22815312|At 100 nM total estradiol, a concentration achievable during the third trimester of pregnancy, CYP2B6 activity was predicted to increase by 1.5-3-fold, based on increased CYP2B6 activity and mRNA.|estradiol|CYP2B6|5|29|Arg1:T13|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9013583|The concentration of indomethacin required to activate PPARgamma is in good agreement with that required to induce the differentiation of C3H10T1/2 cells to adipocytes.|indomethacin|PPARgamma|4|8|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|ACTIVATOR
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|mitoxantrone|TOP2|38|23|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
23270990|  Valine residues in the pore region of SK2 (V366) and SK3 (V520) were replaced by either an alanine or a phenylalanine to evaluate the impact on the interactions with the allosteric blocker apamin.|phenylalanine|SK2|25|8|Arg1:T2|Arg2:T17|CHEMICAL|GENE-Y|PART-OF
11319222|A non-TZD PPARgamma ligand, GW1929, which is 7-fold more potent than rosiglitazone, inhibited ACS1 and ACS4 poorly with an IC(50) of greater than 50 microm, more than 100-fold higher than was required for rosiglitazone, thereby demonstrating the specificity of TZD inhibition.|GW1929|PPARgamma|6|3|Arg1:T8|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10047461|The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by Tomudex indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance.|Tomudex|cdk2|15|9|Arg1:T2|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|IL-8|6|22|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12686158|  5-Aminolevulinic acid synthase (ALAS), the first enzyme of the heme biosynthesis pathway, catalyses the pyridoxal 5'-phosphate-dependent condensation between glycine and succinyl-CoA to yield 5-aminolevulinic acid (5-amino-4-oxopentanoate).|succinyl-CoA|5-Aminolevulinic acid synthase|25|1|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|SUBSTRATE
23252711|We have used DSF to demonstrate that the binding of these compounds is independent of the presence or absence of the C-terminal tail region of CDK9, unlike the binding of the CDK9-selective inhibitor 5,6-dichlorobenzimidazone-1-β-d-ribofuranoside (DRB).|5,6-dichlorobenzimidazone-1-β-d-ribofuranoside|CDK9|35|33|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23603059|Quantitative real-time PCR analysis revealed significant increases in the mRNA levels of 2 AT1R subtypes, AT1AR and AT1BR following sodium arsenite (SA) treatment.|sodium arsenite|AT1R|21|14|Arg1:T6|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
12472888|Pre-treatment with arsenite increased protein kinase B (Akt) and extracellular signal regulated kinase 1/2 (ERK1/2) phosphorylation after H2O2.|H2O2|protein kinase B|22|5|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|ACTIVATOR
23188391|  The incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic peptide are secreted by enteroendocrine cells and augment glucose-induced insulin secretion in response to food ingestion in a glucose-dependent manner.|glucose|insulin|17|18|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10200320|In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels.|15d-PGJ2|iNOS promoter|5|7|Arg1:T15|Arg2:T34|CHEMICAL|GENE-N|INHIBITOR
12416991|These results characterize the role of 3alpha-HSD type III in allopregnanolone formation and suggest that activation of this enzyme by fluoxetine is likely not the mechanism by which fluoxetine increases allopregnanolone concentrations.|allopregnanolone|3alpha-HSD type III|11|7|Arg1:T24|Arg2:T44|CHEMICAL|GENE-Y|PRODUCT-OF
11544332|  We have previously isolated from human hemofiltrate an N-terminally truncated form of the hemofiltrate CC chemokine 1 (HCC-1), and characterized HCC-1[9-74] as a strong agonist of CCR1, CCR5, and to a lower extent CCR3.|N|HCC-1|9|19|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|PART-OF
17251447|Ablation of RPE65 in Nrl(-/-) and Rho(-/-) mice led to the absence of 11-cis retinal, but increased the total retinoid content, with retinyl esters representing the most abundant retinoid species.|11-cis retinal|RPE65|20|3|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF
9873034|Imidazole and 1-phenylimidazole promoted iNOSox dimerization, whereas clotrimazole (30 microM) and miconazole (15 microM) did not, and instead inhibited dimerization normally promoted by L-Arg and H4B.|clotrimazole|iNOSox|9|5|Arg1:T34|Arg2:T57|CHEMICAL|GENE-Y|INHIBITOR
12950415|The putative chemopreventive actions include the inhibition of inflammatory cascades and/or reactions involved in cell growth and proliferation, such as cyclo-oxygenase (COX-1 and COX-2), which regulate cell proliferation through the formation of prostaglandins; lipoxygenase; nuclear factor kappaB (NFkappaB), responsible for the subsequent expression of pro-inflammatory molecules; MAP kinases and Bcl-2, as well as the activation of apoptotic processes, such as the stimulation of intestinal sphingomyelinase.|prostaglandins|cyclo-oxygenase|37|22|Arg1:T8|Arg2:T16|CHEMICAL|GENE-N|PRODUCT-OF
17321471|In LPS-stimulated mouse macrophages, adenosine potently inhibited TNF-alpha production and also potentiated PGE(2) release, though less potently (IC(50)=250 nM vs EC(50) approximately 8 microM, respectively).|adenosine|TNF-alpha|6|9|Arg1:T20|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
23313623|Moreover, OAT1 and OAT3 are the targets of DDI between entecavir and JBP485.|entecavir|OAT1|12|3|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
19029287|Inhibition of (+)-[(3)H]isradipine binding to Ca(v)1.2DHP(-/-) (predominantly Ca(v)1.3) and wild-type (predominantly Ca(v)1.2) brain membranes by unlabeled DHPs revealed a 3- to 4-fold selectivity of nitrendipine and nifedipine for the Ca(v)1.2 binding pocket, a finding further confirmed with heterologously expressed channels.|nitrendipine|Ca(v)1.2|54|59|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17325667|Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to MP470, a novel c-Kit/AXL kinase inhibitor.|MP470|c-Kit|24|9|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17325510|The inhibition is presumably through its effects on the Kir6.0 subunit, but not on the SUR subunit, with the binding site different from adenosine triphosphate at the amino acid level.|amino acid|Kir6.0|30|10|Arg1:T15|Arg2:T39|CHEMICAL|GENE-N|PART-OF
11006278|  By using the technique of site-directed spin labeling combined with EPR spectroscopy, we have observed that binding of arachidonic acid and nonsteroidal anti-inflammatory drugs induces conformational changes in the human prostaglandin endoperoxide H(2) synthase enzyme (PGHS-2).|arachidonic acid|human prostaglandin endoperoxide H(2) synthase enzyme|20|31|Arg1:T1|Arg2:T16|CHEMICAL|GENE-N|DIRECT-REGULATOR
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|ester|rat dopamine transporter|9|40|Arg1:T18|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
7853212|Histamine H1 receptor antagonists (mepyramine, diphenhydramine, chlorpheniramine and triprolidine) inhibited the lidocaine 3-hydroxylation activity catalyzed by P450 2D1 but did not inhibit the testosterone hydroxylation activities catalyzed by P450s other than P450 2D forms.|triprolidine|Histamine H1 receptor|12|1|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|ANTAGONIST
12046682|  Thalidomide--removed from widespread clinical use by 1962 because of severe teratogenicity--has anti-angiogenic and immunomodulatory effects, including the inhibition of TNF alpha.|Thalidomide|TNF alpha|1|25|Arg1:T1|Arg2:T4|CHEMICAL|GENE-Y|INHIBITOR
9059856|In order to perform a pharmacological characterization of these receptors, competition binding experiments were carried out using the muscarinic receptor antagonists pirenzepine, (11(2-diethyl-amino)methyl)-1-piperidinylacetyl-5-11-dihydro-6H-py rido(14) benzodiazepine (AF-DX 116), himbacine, 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP), dicyclomine and hexahydro-sila-difenidol (HHSD).|hexahydro-sila-difenidol|muscarinic receptor|53|20|Arg1:T26|Arg2:T34|CHEMICAL|GENE-N|ANTAGONIST
23404739|The two analogues with the highest antimigratory activities, sipholenol A 4β-4-chlorobenzoate and 19,20-anhydrosipholenol A 4β-4-chlorobenzoate esters, also exhibited the most potent inhibition of PTK6 phosphorylation inhibition.|19,20-anhydrosipholenol A 4β-4-chlorobenzoate|PTK6|14|26|Arg1:T7|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|EACA|gp330|17|24|Arg1:T2|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10740137|We found that the 6 statins currently marketed-atorvastatin, cerivastatin, fluvastatin, lovastatin, pravastatin, and simvastatin-differ in their inhibitory action on the HMG-CoA reductase enzyme.|statins|HMG-CoA reductase|6|26|Arg1:T17|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
12185406|This raises the question as to whether a DAT occupancy of less than 22% is therapeutic or whether there is another mechanism involved during treatment with bupropion.|bupropion|DAT|28|9|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23547652|3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition.|Zinc|Histone Deacetylase|4|9|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23580446|Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by rofecoxib(a selective COX-2 inhibitor) and rescued by exogenous PGE2.|PGE2|COX-2|3|2|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|bcr|4|15|Arg1:T3|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
23296142|Insertion of ERα was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).|bisindolylmaleimide|protein kinase C|23|15|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
23281812|Tetrahydropyrroloquinolinone type dual inhibitors of aromatase/aldosterone synthase as a novel strategy for breast cancer patients with elevated cardiovascular risks.|Tetrahydropyrroloquinolinone|aldosterone synthase|1|7|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23231967|Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold.|methoxyaryl|adenosine A3 receptor|9|4|Arg1:T6|Arg2:T11|CHEMICAL|GENE-Y|ANTAGONIST
23313794|The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) PhIP (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control.|PhIP|glutathioneperoxidase|23|37|Arg1:T8|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
10548525|Rosiglitazone (10(-6) M, 4 h) increased p85alphaphosphatidylinositol 3-kinase (p85alphaPI-3K) and uncoupling protein-2 mRNA levels and decreased leptin expression.|Rosiglitazone|uncoupling protein-2|1|19|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
7828655|  To study the influence of dopaminergic activity on the expression of dopamine D2 receptors and glutamic acid decarboxylase in substantia nigra, mice were treated daily for several days with an irreversibly acting dopamine D1 and dopamine D2 receptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) or with a selective irreversible D2 dopamine receptor antagonist fluphenazine-N-mustard.|EEDQ|dopamine D1|43|34|Arg1:T12|Arg2:T39|CHEMICAL|GENE-Y|ANTAGONIST
23293300|BOC, a known substrate for cytochrome P450 (P450) CYP3A and aldo-ketoreductases, was a reversible time-dependent inhibitor (k(inact) = 0.12 minute(-1), K(I) = 6.1 µM) of CYP3A4/5 but not an inhibitor of other major P450s, nor of UDP-glucuronosyltransferases 1A1 and 2B7.|BOC|CYP3A|1|12|Arg1:T8|Arg2:T34|CHEMICAL|GENE-N|SUBSTRATE
23077105|  Multidrug resistance-associated protein 3 (Mrp3; Abcc3) expression and activity are up-regulated in rat liver after in vivo repeated administration of ethynylestradiol (EE), a cholestatic synthetic estrogen, whereas multidrug resistance-associated protein 2 (Mrp2) is down-regulated.|estrogen|multidrug resistance-associated protein 2|32|35|Arg1:T6|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10485486|Similar concentrations of caffeine also inhibit gamma- and UV radiation-induced phosphorylation of p53 on Ser15, a modification that may be directly mediated by the ATM and ATR kinases.|caffeine|ATR|4|28|Arg1:T10|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
10388743|  The crystallographic structure of human coagulation factor VIIa/tissue factor complex bound with calcium ions was used to model the solution structure of the light chain of factor VIIa (residues 1-142) in the absence of tissue factor.|calcium|tissue factor|13|9|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9873034|Imidazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.|Imidazole|iNOSox|1|13|Arg1:T28|Arg2:T56|CHEMICAL|GENE-Y|DIRECT-REGULATOR
1336906|  Dihydrotachysterol3, a reduced (or hydrogenated) analog of vitamin D3 in which the A ring has been rotate through 180 degrees , is, after hepatic 25-hydroxylation, converted in vivo to a dihydroxylated metabolite, termed peak H, which is at present unidentified but with good affinity for the vitamin D receptor.|Dihydrotachysterol3|vitamin D receptor|1|54|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23043184|The results show that CYP2E1 inhibits CYP2B4-mediated metabolism of benzphetamine (BNZ) with a K(i) of 0.04 µM.|BNZ|CYP2B4|12|7|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
17603759|Purified mMDH catalysed the reduction of alpha-ketoglutarate to L-2-hydroxyglutarate with a catalytic efficiency that was about 10(7)-fold lower than that observed with oxaloacetate.|oxaloacetate|mMDH|27|2|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
12141946|  During polyamine catabolism, spermine and spermidine are first acetylated by spermidine/spermine N(1)-acetyltransferase (SSAT) and subsequently oxidized by polyamine oxidase (PAO) to produce spermidine and putrescine, respectively.|spermine|spermidine/spermine N(1)-acetyltransferase|5|12|Arg1:T15|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
15887238|Western blot analysis of cells incubated with imatinib demonstrated activation of EGFR and downstream signaling that was reduced by inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase 1 (MEK1) and EGFR, but not Her2/ErbB2.|imatinib|EGFR|8|12|Arg1:T11|Arg2:T42|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|2-oxobutyrate|SDH|31|4|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF
10611634|Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors.|yohimbine|(AR)s|6|18|Arg1:T56|Arg2:T79|CHEMICAL|GENE-N|AGONIST
23574807|  Twelve alkyl analogues (1-12) of the high-affinity serotonin transporter (SERT) inhibitor 6-nitroquipazine (6-NQ) were synthesized and studied using in vitro radioligand competition binding assays to determine their binding affinity (Ki ).|6-nitroquipazine|SERT|16|13|Arg1:T9|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15102890|The activities of ABCA1 and other ATP binding cassette superfamily members are inhibited by the drug glyburide, and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs. Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM).|glyburide|ABCA1|17|4|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
8301142|13-cis-retinoic acid, retinol, retinaldehyde, all-trans etretin, Ro 13-6298, and 9-cis retinoic acid also inhibited IL-1-induced IL-6 production.|retinaldehyde|IL-6|6|21|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17510490|Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct.|serine|neutral amino acid transporter|14|3|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|(R)-Roscovitine|cyclin-dependent kinases|1|16|Arg1:T11|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
15650315|  BACKGROUND: Pranlukast, a cysteinyl leukotriene receptor 1 (CysLTR1) antagonist, inhibits not only airway smooth muscle contraction, but also allergic inflammation.|Pranlukast|cysteinyl leukotriene receptor 1|3|6|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
19837759|(18)F-AV-45 displayed excellent binding affinity to Abeta plaques in the AD brain by ex vivo autoradiography in transgenic AD model mice.|(18)F-AV-45|Abeta|1|10|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23301856|  Abstract Bombesin and its derivatives exhibit a high affinity for gastrin-releasing peptide receptor (GRPr), which is over-expressed in a variety of human cancers (prostate, pancreatic, lung, etc.).|Bombesin|gastrin-releasing peptide receptor|2|11|Arg1:T11|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23274087|Our results suggest that kinases SAP/JNK and p38 up-regulation may play a role in the early stages of 6-OHDA toxicity to trigger intrinsic pathways for apoptosis and enhanced NF-κB activation.|6-OHDA|NF-κB|19|29|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|ACTIVATOR
11092898|The triple mutation F316C/V356S/G400L produced a 40-fold shift in desipramine affinity.|desipramine|V356S|10|5|Arg1:T2|Arg2:T17|CHEMICAL|GENE-N|DIRECT-REGULATOR
16627864|In addition, the HO pathway was blocked after dobutamine pretreatment with 10 micromol/kg tin-mesoporphyrin-IX (Dob/SnMP/Shock) or animals received 100 mg/kg of the carbon monoxide donor dichloromethane (DCM/Shock).|mesoporphyrin-IX|HO|16|5|Arg1:T28|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
12085361|In complementary RNA (cRNA)-injected Xenopus laevis oocytes, rifamycin SV (10 micromol/L) cis-inhibited human organic anion transporting polypeptide C (SLC21A6) (OATP-C), human organic anion transporting polypeptide 8 (SLC21A8) (OATP8), human organic anion transporting polypeptide B (SLC21A9) (OATP-B), and human organic anion transporting polypeptide A (SLC21A3) (OATP-A) mediated BSP uptake by 69%, 79%, 89%, and 57%, respectively, as compared with uptake into control oocytes.|rifamycin SV|SLC21A9|12|52|Arg1:T18|Arg2:T55|CHEMICAL|GENE-Y|INHIBITOR
23161664|Cadmium (Cd), an inducer of reactive oxygen species, inhibited HIF-1α mRNA expression and HIF-1α binding to the LO gene in Co-treated cells as revealed by RT-PCR and ChIP assays, respectively.|Cd|LO|3|22|Arg1:T5|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12742526|Even though the activities of MAT and GNMT were elevated, the concentration of liver S-adenosylmethionine was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice.|S-adenosylmethionine|GNMT|16|8|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
23325562|Interestingly, ursolic acid increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of GSK3β at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells.|ursolic acid|GSK3β|3|19|Arg1:T13|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
18847313|Plerixafor (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4.|Plerixafor|CXCR4|1|29|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
12904467|Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy.|Topiramate|AMPA-receptor|1|6|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10698696|  Ornithine decarboxylase (ODC) catalyses the first step in the synthesis of the polyamines putrescine, spermidine and spermine.|spermidine|Ornithine decarboxylase|18|1|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|PRODUCT-OF
2986673|Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins.|chlorpromazine|calmodulin|6|10|Arg1:T16|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17979301|Change in affinity for cGMP, vardenafil, sildenafil, or IBMX in Y612F, H613A, L765A, or F786A was less, but affinity of H613A or F786A for tadalafil was weakened 37- and 17-fold, respectively.|vardenafil|H613A|7|16|Arg1:T15|Arg2:T45|CHEMICAL|GENE-N|DIRECT-REGULATOR
23337530|In THP-1 cells, anagliptin reduced lipopolysaccharide-induced TNF-α production with inhibiting ERK phosphorylation and nuclear translocation of nuclear factor-κB.|anagliptin|ERK|5|12|Arg1:T10|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
18336310|  Inhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms present in the eyes (CA I, II, IV and XII), with sulfonamides such as acetazolamide, methazolamide, ethoxzolamide and dichlorophenamide, is still widely used for the systemic treatment of glaucoma.|acetazolamide|EC 4.2.1.1|31|8|Arg1:T5|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
23528251|Cobalt chloride, a typical HIF activator, induced the gene expression of CAR-target genes, including cyp2b9 and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver.|Cobalt chloride|cyp2b9|1|18|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23197773|Dose-response re-determinations during chronic treatment revealed the following: 1) >250-fold (AM411, methanandamide) and >45-fold (AM4054, WIN55,212.2, Δ(9)-THC) rightward shifts in the ED(50) values for CB(1) agonists; 2) >100-fold and >20-fold leftward shifts in the ED(50) values for SR141716A and AM4113, respectively; and 3) approximately 4.8-fold and 10-fold rightward shifts in the ED(50) values for methamphetamine and the DA D(2) agonist R-(-)-NPA, respectively.|R-(-)-NPA|DA D(2)|98|92|Arg1:T19|Arg2:T40|CHEMICAL|GENE-Y|AGONIST
7957034|  Using PET, reduced glucose metabolism (rCMRglu) and increased binding of the mu opiate receptor ligand 11C-carfentanil have been demonstrated in lateral temporal cortex overlying mesial temporal epileptic foci.|11C-carfentanil|mu opiate receptor|19|15|Arg1:T1|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23562928|Anti-inflammatory activity of hexane extracts from bones and internal organs of Anguilla japonica suppresses cyclooxygenase-2-dependent prostaglandin D2 generation in mast cells and anaphylaxis in mice.|prostaglandin D2|cyclooxygenase-2|16|15|Arg1:T8|Arg2:T30|CHEMICAL|GENE-Y|PRODUCT-OF
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|indomethacin|ATPase|5|24|Arg1:T5|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
12488248|GA stimulation of ES transport by oocytes coexpressing rabbit Na(+)-dicarboxylate cotransporter 1 and rat Oat3 was significantly inhibited when the preloading medium contained Li(+) or methylsuccinate (MS) or when Na(+) was absent.|ES|rabbit Na(+)-dicarboxylate cotransporter 1|4|9|Arg1:T31|Arg2:T51|CHEMICAL|GENE-Y|SUBSTRATE
10471277|Labeling with [(125)I]IAS was blocked by 10 microM (-)-alprenolol and inhibited by addition of GTP gamma S, and [125I]IAS migrated at the same position on an SDS-PAGE gel as the beta 2AR labeled by the antagonist photoaffinity label [125I]iodoazidobenzylpindolol ([125I]IABP).|[125I]iodoazidobenzylpindolol|beta 2AR|52|44|Arg1:T6|Arg2:T34|CHEMICAL|GENE-N|DIRECT-REGULATOR
21262851|BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.|ethanol|L-type voltage-gated calcium channels|15|23|Arg1:T19|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR
10567921|  The N-terminus of the type 1 interferon receptor subunit, IFNAR1, has high amino acid sequence similarity to the receptor binding B subunit of the Escherichia coli-derived verotoxin 1, VT1.|N|IFNAR1|2|11|Arg1:T14|Arg2:T46|CHEMICAL|GENE-Y|PART-OF
19897080|The homologous location in the alpha3beta4 AChR is between the serine and valine/phenylalanine rings.|phenylalanine|alpha3beta4 AChR|14|6|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|PART-OF
12023686|The effects of losartan and valsartan on cGMP were completely inhibited by AT2-receptor blockade.|losartan|AT2|4|13|Arg1:T10|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23284002|In addition, TSA induced Nrf2 nuclear translocation and up-regulated the expression of Nrf2-ARE downstream antioxidant genes, whereas Nrf2 knockdown by RNA interference blocked the inhibition of TSA on myofibroblast differentiation.|TSA|ARE|4|15|Arg1:T7|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
14766200|  Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is an enzyme that metabolizes methylated arginine to citrulline and methylamine, thus working to produce nitric oxide (NO).|methylamine|DDAH1|17|5|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|PRODUCT-OF
23446230|However, whether increasing EETs production by CYP2J2 overexpression in vivo could prevent abdominal aortic aneurysm (AAA) remains unknown.|EETs|CYP2J2|5|8|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|PRODUCT-OF
16322797|Its special profile of actions, especially the rise in HDL-cholesterol levels induced by nicotinic acid, is unique among the currently available pharmacological tools to treat lipid disorders.|nicotinic acid|HDL|15|11|Arg1:T7|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
17429625|  PURPOSE: Dasatinib (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance.|BMS-354825|BCR|5|17|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
17228881|The kinetic parameters for the CO2 hydration reaction proved hCA VI to possess a kcat of 3.4 x 10(5) s-1 and kcat/KM of 4.9 x 10(7) M-1 s-1 (at pH 7.5 and 20 degrees C).|CO2|hCA VI|6|10|Arg1:T13|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
2865685|Dose-response curves for stimulation of both rate and force by the beta 2-selective agonists procaterol and zinterol were shifted to a much greater extent by selective blockade of beta 1-adrenoceptors with metoprolol than by selective blockade of beta 2-adrenoceptors with ICI 118,551, suggesting that these compounds caused their effects by activating beta 1-adrenoceptors.(ABSTRACT TRUNCATED AT 400 WORDS)|ICI 118,551|beta 2-adrenoceptors|41|38|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
15465654|  Troglitazone, bosentan and glibenclamide inhibit the bile salt export pump (Bsep) which transports taurocholate into bile.|taurocholate|Bsep|17|13|Arg1:T17|Arg2:T26|CHEMICAL|GENE-Y|SUBSTRATE
11319222|alpha-Tocopherol, whose ring structure forms the non-TZD portion of troglitazone, did not inhibit ACS4, indicating that the thiazolidine-2,4-dione moiety is the critical component for inhibition.|thiazolidine-2,4-dione|ACS4|21|16|Arg1:T6|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|nitric oxide|iNOS|14|6|Arg1:T36|Arg2:T52|CHEMICAL|GENE-Y|PRODUCT-OF
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|(R)-Roscovitine|CDKs|1|19|Arg1:T11|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
23201180|Fenamiphos is recalcitrant to the hydrolysis by alloforms PON1 Q192R of human serum.|Fenamiphos|Q192R|1|10|Arg1:T13|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
15060759|  To verify the hypothesis that the non-conventional partial agonist (-)-CGP12177 binds at two beta(1)-adrenoceptor sites, human beta(1)-adrenoceptors, expressed in CHO cells, were labelled with (-)-[(3)H]-CGP12177.|(-)-CGP12177|beta(1)-adrenoceptor|10|17|Arg1:T25|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16627864|In addition, the HO pathway was blocked after dobutamine pretreatment with 10 micromol/kg tin-mesoporphyrin-IX (Dob/SnMP/Shock) or animals received 100 mg/kg of the carbon monoxide donor dichloromethane (DCM/Shock).|dichloromethane|HO|29|5|Arg1:T32|Arg2:T46|CHEMICAL|GENE-N|INHIBITOR
1665782|Our conclusion is that chronic DPDPE treatment preferentially reduces delta-opioid receptor binding activity.|DPDPE|delta-opioid receptor|6|10|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
3139361|For the binding to the progesterone receptor, both Org 2058 and Org 3236 (or 3-keto-desogestrel) were used as labelled ligands.|Org 2058|progesterone receptor|10|6|Arg1:T23|Arg2:T49|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23050902|We observed that ribavirin enhanced ELL3 recruitment to F7, whereas knockdown of ELL3 diminished ribavirin-induced FVII mRNA up-regulation.|ribavirin|FVII|16|17|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23385959|Notably, the antioxidant Trolox™ reversed the Mn (20 mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the Mn (20 mg/kg)-induced caspase activity and F(2)-isoprostane production.|Trolox|p38|5|16|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|glutathione|MRP2|5|28|Arg1:T18|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
18061638|Norethisterone activated PR, AR, and ERalpha.|Norethisterone|PR|1|3|Arg1:T22|Arg2:T56|CHEMICAL|GENE-Y|ACTIVATOR
23071106|8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM).|tolbutamide|insulin|8|4|Arg1:T8|Arg2:T43|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23458730|Concentration-dependent inhibitory effects of baicalin on the metabolism of dextromethorphan, a dual probe of CYP2D and CYP3A, in rats.|baicalin|CYP3A|5|18|Arg1:T17|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
18715952|PGE(2) is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4).|PGE(2)|prostanoid receptors EP(1)|1|32|Arg1:T2|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23327532|Styrene oxide and 4-vinylphenol possessed similar affinity for CYP2E1.|Styrene oxide|CYP2E1|1|9|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22982773|Rate constants for reactivation of OP-inhibited AChE by even the best oximes, such as HI-6 and obidoxime, can vary >100-fold between OP-AChE conjugates that are easily reactivated and those that are difficult to reactivate.|HI-6|AChE|16|7|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|ACTIVATOR
15730717|Both Bcl-X(L) and COX-2 proteins could be inhibited by IN in a dose-dependent manner.|IN|COX-2|13|7|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
17463062|The results showed that antalarmin increased whereas astressin2B decreased mRNA and protein expression as well as the activity of PGDH in chorion cells.|antalarmin|PGDH|5|20|Arg1:T8|Arg2:T10|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8161345|  5-Ethynyluracil is a potent mechanism-based inactivator of dihydropyrimidine dehydrogenase (DPD, EC 1.3.1.2) in vitro (Porter et al., J Biol Chem 267: 5236-5242, 1992) and in vivo (Spector et al., Biochem Pharmacol, 46: 2243-2248, 1993.|5-Ethynyluracil|EC 1.3.1.2|1|13|Arg1:T1|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23402856|Number and area of preneoplastic foci positive for glutathione S-transferase placental form (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with HEP or HCB alone.|HCB|GST-P|35|14|Arg1:T19|Arg2:T29|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
16765071|We identified M2 pyruvate kinase, elongation factor 2, mitochondrial aconitase, pyruvate carboxylase, and heat shock protein HSP90alpha as candidates for 6-nitrotryptophan residues containing proteins, with peptide coverage over 10%, in crude extracts of peroxynitrite-treated PC12 cells.|6-nitrotryptophan|pyruvate carboxylase|25|14|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|PART-OF
11134654|Almotriptan showed low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors in several species, including the human, while affinity for 5-HT receptors other than 5-HT(1B/1D) was clearly less.|Almotriptan|5-HT(1D)|1|13|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR
23643744|These results show that repeated administration of ADX47273 or SSR180711 reverses certain behavioural and functional deficits induced by PCP, likely through down-regulation or desensitisation of mGluR5s and α7 nAChRs, respectively.|ADX47273|mGluR5s|8|27|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
18655903|In addition to OT and to a lesser extent AVP (pitressin), a number of OT and AVP analogues; such as carbetocin (OT agonist) dDAVP (desmopressin, V(2) agonist), terlipressin (V(1a) agonist), felypressin (V(1a) agonist) and atosiban (Tractocile OT antagonist) are also in clinical use.|Tractocile|OT|61|62|Arg1:T17|Arg2:T54|CHEMICAL|GENE-Y|ANTAGONIST
15155769|Carnitine acetyltransferases (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to acetylcarnitine and free CoA.|acetyl-CoA|Carnitine acetyltransferases|11|1|Arg1:T5|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
23385959|Notably, the antioxidant Trolox™ reversed the Mn (20 mg/kg)-dependent augmentation in p38(MAPK) phosphorylation and reduced the Mn (20 mg/kg)-induced caspase activity and F(2)-isoprostane production.|Mn|p38|8|16|Arg1:T6|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR
22537794|Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.|[2-(trimethylammonium)ethyl]-methanethiosulfonate|DAT|26|37|Arg1:T5|Arg2:T36|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23131177|Characterization of substituted phenylpropylamides as highly selective agonists at the melatonin MT2 receptor.|phenylpropylamides|melatonin MT2 receptor|4|11|Arg1:T12|Arg2:T28|CHEMICAL|GENE-Y|AGONIST
23146871|Manganese transport via the transferrin mechanism.|Manganese|transferrin|1|5|Arg1:T27|Arg2:T40|CHEMICAL|GENE-Y|SUBSTRATE
22982773|QSAR analysis of oxime reactivation of AChE inhibited by these OP compounds and others suggested that the presence of both a large substituent (i.e., ⩾the size of dimethylamine) and an alkoxy substituent in the structure of OP compounds is the common feature that results in resistance to oxime reactivation of OP-AChE conjugates whether the OP is a phosphate, phosphonate or phosphoramidate.|phosphonate|AChE|63|55|Arg1:T11|Arg2:T33|CHEMICAL|GENE-Y|INHIBITOR
23292752|The reversible binding of dabigatran may provide safer and more predictable anticoagulant treatment than seen with irreversible, non-covalent thrombin inhibitors, e.g. hirudin.|dabigatran|thrombin|5|20|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|salbutamol|human beta-adrenergic receptors|26|73|Arg1:T7|Arg2:T33|CHEMICAL|GENE-N|AGONIST
23478802|Our results suggest that modification of multiple cysteine residues by electrophilic compounds can generate both activation and desensitization of the TRPA1 channel.|cysteine|TRPA1|8|21|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|PART-OF
23541086|These data suggest that T-cells can be activated by abacavir through a direct interaction with surface and intracellular major histocompatibility complex (MHC) molecules.|abacavir|MHC|10|23|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|DIRECT-REGULATOR
23469927|The polyclonal antiserum recognized soman-labeled human albumin, soman-mouse albumin, and soman human transferrin but not nonphosphonylated control proteins.|soman|mouse albumin|9|10|Arg1:T17|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|noradrenaline|alpha(1D)|16|30|Arg1:T7|Arg2:T16|CHEMICAL|GENE-Y|AGONIST
23161873|The reduction was more pronounced in the fructose-fed group and attributed to decreased hepatic expression of ACC2, FAS, SCD1, and MTTP and a decrease in the rate of hepatic triglyceride secretion.|fructose|MTTP|8|24|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|STI-571|abl|4|16|Arg1:T3|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
9138687|RS-17053 (N-[2-(2-cyclopropyl methoxy phenoxy) ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole- 3-ethanamine hydrochloride; 10-100 nM), a selective alpha 1 A-adrenoceptor antagonist, produced non-parallel, biphasic, dextral shifts of E/[A] curves to NA, suggesting the involvement of more than one alpha 1-adrenoceptor subtype.|RS-17053|alpha 1 A-adrenoceptor|1|25|Arg1:T28|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST
14585280|The synergistic effect of histone deacetylase inhibitors, including phenylbutyrate (PB), in reactivating silenced genes encouraged clinical studies on the combination of PB and demethylating agents in hematological diseases, characterized by p15 silencing.|phenylbutyrate|histone deacetylase|10|5|Arg1:T5|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
7853212|These results indicate that histamine H1 receptor antagonists such as mepyramine are potent inhibitors of P450 2D forms because of their high affinity for these enzymes.|mepyramine|P450 2D|11|16|Arg1:T4|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
17124432|A silent G1287A nucleotide substitution in exon 9 of the NET gene was studied in human conditions involving hypertension.|nucleotide|G1287A|4|3|Arg1:T4|Arg2:T13|CHEMICAL|GENE-N|PART-OF
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|SU11248|VEGFR2|31|20|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FAD|FADS|36|46|Arg1:T11|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
17034761|Our results first demonstrate that auranofin suppresses the multiple steps in TLR4 signaling, especially the homodimerization of TLR4.|auranofin|TLR4|6|19|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|noroxymorphone|CYP3A|35|17|Arg1:T14|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
15860753|In addition, salmeterol in combination with FP enhanced glucocorticoid response element (GRE)-luciferase reporter gene activity and mitogen-activated protein kinase phosphatase 1 (MKP-1) and secretory leuko-proteinase inhibitor (SLPI) gene induction.|salmeterol|secretory leuko-proteinase inhibitor|4|30|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16973691|beta(1)-Adrenoceptor antagonism (10 mg kg(-1) bisoprolol) prevented 92% (P < 0.05) of apoptosis induced by all three agonists, but clenbuterol-induced apoptosis could also be prevented by 96% (P < 0.05) by beta(2)-AR antagonism (10 mg kg(-1) ICI 118 551).|bisoprolol|beta(1)-Adrenoceptor|14|1|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
16781459|Both H(2)S solution prepared by bubbling pure H(2)S gas and NaSH, a H(2)S donor, dose dependently induced HO-1 expression through the activation of the extracellular signal-regulated kinase (ERK).|H(2)S|HO-1|2|32|Arg1:T25|Arg2:T62|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23470629|The present study demonstrated that human multidrug resistance-associated protein 3 vesicles accepted conjugated 3β-hydroxy-Δ(5)-bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3-sulfate.|taurolithocholic acid 3-sulfate|human multidrug resistance-associated protein 3|30|6|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
23147415|We demonstrate that HZ mice are significantly more sensitive to local AChE inhibition (BW284c51), but remain insensitive to butyrylcholinesterase (BuChE) inhibition (bambuterol).|bambuterol|butyrylcholinesterase|28|22|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
15106733|Salicylate treatment inhibited COX-2 expression induced by TNF-alpha/IFN-gamma and regulated the activation of ERK, IKK and IkappaB degradation and subsequent NF-kappaB activation in MC3T3E1 osteoblasts.|Salicylate|IkappaB|1|18|Arg1:T5|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
17567713|We also found that TRPV1 receptors are activated by CuSO(4), ZnSO(4), and FeSO(4), three salts known to produce a metallic taste sensation.|ZnSO(4)|TRPV1|15|5|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|ACTIVATOR
8643547|Reserpine and ketanserin are slightly more potent inhibitors of VMAT2-mediated transport than of VMAT1-mediated transport, whereas tetrabenazine binds to and inhibits only VMAT2.|tetrabenazine|VMAT2|18|24|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23313336|However, other steroids, including Δ(5)-androstenediol, 5α-androstanediol and 27-hydroxycholesterol, which have a saturated A ring containing a 3β-hydroxyl and a C19 methyl group, also mediate physiological responses through binding to estrogen receptor-α (ERα) and ERβ.|27-hydroxycholesterol|ERβ|15|45|Arg1:T13|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10365684|Reverse transcriptase-polymerase chain reaction (RT-PCR) showed an increase in TPO mRNA by PTU or MMI.|MMI|TPO|17|12|Arg1:T3|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23063590|Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, stem cell factor (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by artemisinic acid.|artemisinic acid|MIF|31|25|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16625817|These include: (i) centrally-acting drugs, such as the noradrenergic and dopaminergic reuptake inhibitor radafaxine, the endocannabinoid antagonist rimonabant, the selective serotonin 5-HT2c agonist APD-356, and oleoyl-estrone; (ii) drugs that target peripheral episodic satiety signals, such as glucagon-like peptide-1 (exenatide, exenatide-LAR and liraglutide), peptide YY (intranasal PYY3-36 and AC-162325) and amylin (pramlintide); (iii) drugs that block fat absorption, such as the novel lipase inhibitors cetilistat and GT-389255; and (iv) a human growth hormone fragment (AOD-9604) that increases adipose tissue breakdown.|GT-389255|lipase|89|85|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR
11340119|  Pyridoxal 5'-phosphate (PLP) stimulation of erythrocyte alanine and aspartate aminotransferase (EALT, EAST) activities is a frequently used functional measure of vitamin B-6 status.|PLP|EALT|4|14|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR
23388705|Binding affinities of the five recombinant human nucleoside transporters for tecadenoson differed (hENT1 > hCNT1 > hCNT3 > hENT2 > hCNT2), and tecadenoson was transported largely by hENT1.|tecadenoson|hCNT1|11|16|Arg1:T12|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17659402|We have previously found that 3-phenyl-CPP blocks hClC-Ka and rClC-K1 from the extracellular side in the pore entrance.|3-phenyl-CPP|hClC-Ka|6|8|Arg1:T6|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23532932|TCPOBOP, a CAR ligand, modestly induced mdr1a.fLUC in pxr(+/+) and pxr(-/-) strains, consistent with CAR's minor role in mdr1a regulation.|TCPOBOP|CAR|1|4|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16864903|Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils.|olopatadine|S100A12|3|10|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23527317|  A series of N-substituted lobelane analogues was synthesized and evaluated for their [(3)H]dihydrotetrabenazine binding affinity at the vesicular monoamine transporter and for their inhibition of vesicular [(3)H]dopamine uptake.|[(3)H]dihydrotetrabenazine|vesicular monoamine transporter|13|24|Arg1:T7|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
17929114|Imatinib mesylate (IM, Gleevec, Novartis Pharmaceuticals, Basel, Switzerland), which specifically inhibits the autophosphorylation of the Abl TK, has improved the treatment of CML.|Imatinib mesylate|Abl|1|23|Arg1:T20|Arg2:T48|CHEMICAL|GENE-Y|INHIBITOR
16230360|Procainamide has been shown to inhibit DNA methyltransferase activity and reactivate silenced gene expression in cancer cells by reversing CpG island hypermethylation.|Procainamide|DNA methyltransferase|1|7|Arg1:T5|Arg2:T17|CHEMICAL|GENE-N|INHIBITOR
12213059|  6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives were synthesized and characterized as activators of adenosine 5'-triphosphate (ATP) sensitive potassium (K(ATP)) channels in the beta-cells by measuring effects on membrane potential and insulin release in vitro.|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|adenosine 5'-triphosphate (ATP) sensitive potassium (K(ATP)) channels|1|15|Arg1:T1|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR
23261528|Moreover, icariin treatment inhibited the phosphorylations of STAT1 and STAT3 in CD4(+) T cells, which were the crucial transcription factors for Th1 and Th17 respectively.|icariin|STAT1|3|9|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|INHIBITOR
23604717|SAL-2 also downregulated COX-2 and iNOS expression induced by HNE, but salicylate did not.|SAL-2|COX-2|1|4|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
1407010|Autoradiographic studies were performed on rabbit brain slices using [3H]5-HT in the presence of 100 nmol/l 8-OH-DPAT and mesulergine (in order to mask 5-HT1A and 5-HT1C binding sites) and [125I]CYP (iodocyanopindolol) in the presence of 3 mumol/l isoprenaline and 100 nmol/l 8-OH-DPAT (in order to mask beta adrenoceptor and 5-HT1A binding sites).|isoprenaline|beta adrenoceptor|49|59|Arg1:T14|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
23470629|The present study demonstrated that human multidrug resistance-associated protein 3 vesicles accepted conjugated 3β-hydroxy-Δ(5)-bile acids along with common bile acids such as glycocholic acid and taurolithocholic acid 3-sulfate.|glycocholic acid|human multidrug resistance-associated protein 3|27|6|Arg1:T8|Arg2:T14|CHEMICAL|GENE-Y|SUBSTRATE
16014042|We also measured the uptake of l-cystine in Xenopus oocytes expressing human xCT and/or 4F2hc or xCT and/or rBAT (a heavy chain homologous to 4F2hc).|l-cystine|rBAT|7|19|Arg1:T11|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
23493374|Co-IP and coimmunolocalization confirmed that Creb1 associated with Mecp2 and cotransfection with glut3-(m)CpG in HT22 cells enhanced glut3 transcription.|(m)CpG|glut3|14|13|Arg1:T2|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12842269|Taken together, these findings support the view that (1) OFQ is the only ppOFQ peptide that binds to and activates the ORL1 receptor and (2) OFQ II(1-28) does not bind or stimulate [35S]-GTPgammaS binding in cells expressing the mu opioid receptor.|[35S]-GTPgammaS|mu opioid receptor|41|50|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11669456|S2 hOAT1 and S2 hOAT3 exhibited a time- and dose-dependent, and a saturable increase in uptake of [3H]-OTA, with apparent Km values of 0.42 microM (hOAT1) and 0.75 microM (hOAT3).|[3H]-OTA|hOAT3|19|5|Arg1:T3|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
14871885|  Metformin, a drug widely used in the treatment of type 2 diabetes, has recently been shown to act on skeletal muscle and liver in part through the activation of AMP-activated protein kinase (AMPK).|Metformin|AMP-activated protein kinase|1|32|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
1600046|While the substituted benzamide prokinetics (for example, metoclopramide, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative 5-HT4 receptor.|cisapride|5-HT4|12|39|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|AGONIST
17884974|Acetaminophen plasma concentrations remained above the in vitro IC(50) for COX-2 for at least 5 h postadministration.|Acetaminophen|COX-2|1|14|Arg1:T13|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
11406192|These data indicate [(3)H]LY395153 is a useful probe for labeling a unique modulatory site on both native and recombinant AMPA receptors.|[(3)H]LY395153|AMPA receptors|4|26|Arg1:T14|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR
23495205|Synthesis and Structure-Activity Relationship Studies of Derivatives of the Dual Aromatase-Sulfatase Inhibitor 4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate.|4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate|Aromatase|13|11|Arg1:T16|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23305993|In transactivation reporter gene assays LYSO-07 showed a pan partial agonist effect on the three PPAR subtypes (PPARγ, PPARα and PPARβ/δ).|LYSO-07|PPAR|6|16|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|AGONIST
23485614|Both interventions restored the liver function markers (alanine transaminase: ALT, aspartate transaminase: AST, alkaline phosphatase: ALP, total bilirubin and total protein) and hepatic antioxidants (superoxide dismutase: SOD, catalase: CAT, reduced glutathione: GSH and glutathione peroxidase: GPx) to the normal levels than elevated levels noticed on paracetamol control at P<0.001.|paracetamol|alanine transaminase|62|9|Arg1:T17|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23581551|  Due to its production of potent antimicrobial oxidants including hypochlorous acid, human myeloperoxidase (MPO) plays a critical role in innate immunity and inflammatory diseases.|hypochlorous acid|human myeloperoxidase|10|13|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|PRODUCT-OF
23643725|In addition, during acute exposure tests performed at the end of the chronic exposure, biofilms chronically exposed to 75 and 150μgL(-1) oxyfluorfen showed a higher CAT activity than controls.|oxyfluorfen|CAT|27|31|Arg1:T1|Arg2:T9|CHEMICAL|GENE-N|ACTIVATOR
10370904|2) Radioligand and functional studies at the N-methyl-D-aspartate (NMDA) type glutamate receptor characterize budipine as a low-affinity, uncompetitive antagonist with fast kinetics and moderate voltage-dependency at the phencyclidine (PCP) binding site, comparable to that observed with amantadine, thereby counteracting an increased excitatory glutamatergic activity.|amantadine|N-methyl-D-aspartate (NMDA) type glutamate receptor|44|9|Arg1:T28|Arg2:T37|CHEMICAL|GENE-N|DIRECT-REGULATOR
10215901|Further results indicated that post-training intra-amygdala infusion of buspirone or the 5-HT1A agonist 8-hydroxy-di-n-propylaminotetralin (8-OH-DPAT) caused a time-dependent and dose-dependent retention deficit.|8-hydroxy-di-n-propylaminotetralin|5-HT1A|14|12|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|AGONIST
23415902|Org 214444-0 is shown to be a stereoselective, nanomolar potent FSHR agonist and selective over the structurally related LHR and TSHR.|Org 214444-0|FSHR|1|12|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|AGONIST
11256847|Rosuvastatin has been shown to be a comparatively potent inhibitor of HMG-CoA reductase activity in a purified preparation of the catalytic domain of the human enzyme, as well as in rat and human hepatic microsomes.|Rosuvastatin|HMG-CoA reductase|1|12|Arg1:T5|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23266270|Furthermore, DPEP inhibited the LPS-induced phosphorylation of inhibitor κB (IκB)-α and NF-κB p50.|DPEP|NF-κB|3|16|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|INHIBITOR
16546990|Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and beta-catenin.|YC-1|JNK|5|23|Arg1:T3|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
23410161|The design strategy for yet another agent, ladostigil, employed the amalgamation of active chemical moieties of the AChE inhibitor rivastigmine, and the monoamine oxidase-B (MAO-B) inhibitor rasagiline, leading to a single compound that targets both enzymes simultaneously.|rasagiline|MAO-B|32|29|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
17046555|Inhibition of PKC by treatment of the cells with calphostin C, GF10923X, and LY379196 totally suppressed AGE-mediated p47phox translocation and ROS generation.|calphostin C|p47phox|10|20|Arg1:T18|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23159329|Distinct roles of methamphetamine in modulating spatial memory consolidation, retrieval, reconsolidation and the accompanying changes of ERK and CREB activation in hippocampus and prefrontal cortex.|methamphetamine|ERK|4|19|Arg1:T11|Arg2:T24|CHEMICAL|GENE-N|ACTIVATOR
23142325|In a previous study using isolated rat liver mitochondria, we observed that ABA inhibited the activity of adenine nucleotide translocator and FoF1-ATPase.|ABA|adenine nucleotide translocator|14|19|Arg1:T7|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
9406449|In LPLs of chickens and rats, values of Ki were 66.7 and 36.4 with triolein emulsion as the substrate, and 832.4 and 66.0 with respective VLDL as the substrate.|triolein|LPLs|16|2|Arg1:T4|Arg2:T11|CHEMICAL|GENE-N|SUBSTRATE
12942109|  Tazarotene is an acetylenic retinoid which is metabolised to tazarotenic acid and which binds selectively to the retinoid receptors RARbeta and RARgamma.|tazarotenic acid|retinoid receptors|10|18|Arg1:T10|Arg2:T12|CHEMICAL|GENE-N|DIRECT-REGULATOR
23619284|  Tandutinib is a novel inhibitor of tyrosine kinases FLT3, PDGFR and KIT.|Tandutinib|KIT|1|13|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
23261524|We used nutlin-3, a well-known disruptor of p53-Mdm2 interaction, to validate the specificity of the assay.|nutlin-3|Mdm2|3|10|Arg1:T2|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
17417877|Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.|hyperoside|beta2-adrenergic receptor|10|4|Arg1:T22|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8842678|MAO-A was inhibited by the following drugs (in ascending order of potency) : nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine.|nomifensine|MAO-A|26|1|Arg1:T22|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
10418979|Like 17beta-estradiol, raloxifene binds with high affinity to both estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta).|17beta-estradiol|estrogen receptor-alpha|2|11|Arg1:T9|Arg2:T43|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23494944|AlCl3 markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase (AChE) in all regions.|AlCl3|COX|1|13|Arg1:T9|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23123646|An increase in the ADP/ATP ratio opens K(ATP) channels, leading to membrane hyperpolarization.|ADP|K(ATP) channels|5|8|Arg1:T3|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
15562257|Mibefradil blocked currents of all Na+ channel isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for Nav1.5).|Mibefradil|Na+ channel|1|6|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
10047461|These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by Tomudex and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 kinase activities.|Tomudex|p27(kip1)|20|31|Arg1:T7|Arg2:T38|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23271742|Together, these data suggest that arsenic degrades ΔNp63 protein at least in part via Pirh2-dependent proteolysis and that inhibition of ΔNp63 expression facilitates tumor cells to arsenic-induced death.|arsenic|ΔNp63|7|9|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15481543|Delta6-fatty acid desaturase (D6D) is the rate-limiting enzyme, which catalyzes the conversion of linoleic acid (LA) and alpha-linolenic acid (ALA) to GLA and octadecatetraenoic acid (OTA).|linoleic acid|Delta6-fatty acid desaturase|17|1|Arg1:T10|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|interleukin-1beta|47|15|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
20223979|Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity.|Thalidomide|ubiquitin ligase|1|14|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|alpha-methyl-dopahydrazine|AAAD|18|14|Arg1:T12|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|thiazolidinedione|PPARgamma|11|26|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16809928|SSTR2 and SSTR5 are usually expressed in GH-secreting pituitary tumors, and both octreotide and lanreotide bind preferentially to SSTR2 and, to a lesser extent, to SSTR5.|octreotide|SSTR2|14|20|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16230360|Because many reports have strongly linked DNMT1 with epigenetic alterations in carcinogenesis, procainamide may be a useful drug in the prevention of cancer.|procainamide|DNMT1|14|7|Arg1:T4|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
17139155|The sensors are composed of AChE and choline oxidase (ChOx) for converting the AChE-generated choline into betaine and hydrogen peroxide (H(2)O(2)), which is electrochemically oxidized at the electrode surface to produce the output signal of the sensor.|choline|choline oxidase|17|8|Arg1:T12|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE
12668769|On the other hand, the accumulation of Ser through the C1-THF synthase/SHMT pathway in glyD plants was 2.5-fold greater than that in WT plants.|Ser|SHMT|9|14|Arg1:T27|Arg2:T69|CHEMICAL|GENE-N|PRODUCT-OF
2506486|  Levels of homovanillic acid (HVA), dihydroxyphenylacetic acid (DOPAC) and dihydroxyphenylglycol (DHPG) in plasma and the striatium were measured after inhibition of monoamine oxidase type A (MAO-A) by clorgyline (4 mg/kg i.p.), MAO-B by (-)deprenyl (1 mg/kg i.p.), both MAO-A and MAO-B by nialamide (75 mg/kg i.p.) or peripheral neuronal MAO by debrisoquin (40 mg/kg i.p.).|clorgyline|monoamine oxidase type A|37|29|Arg1:T9|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
16230360|As further evidence of the specificity of procainamide for DNMT1, procainamide failed to lower genomic 5-methyl-2'-deoxycytidine levels in HCT116 colorectal cancer cells when DNMT1 was genetically deleted but significantly reduced genomic 5-methyl-2'-deoxycytidine content in parental HCT116 cells and in HCT116 cells where DNMT3b was genetically deleted.|procainamide|DNMT1|8|10|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|sunitinib|tyrosine kinase|21|13|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23059626|Met-RANTES treatment also reduced the levels of cathepsin K and metalloproteinase 13 (MMP13).|Met|MMP13|1|14|Arg1:T4|Arg2:T8|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23416003|Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors.|bicyclic pyrazinone and pyrimidinone amides|TF|5|12|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
16735460|Using site-directed mutagenesis, histidine (H), lysine (K), and arginine (R) residues of fNaDC-3 were replaced by alanine (A), isoleucine (I), or leucine (L).|leucine|fNaDC-3|37|22|Arg1:T19|Arg2:T38|CHEMICAL|GENE-Y|PART-OF
20557886|ICI 182780, an estrogen receptor antagonist and R,R-THC, an estrogen receptor beta antagonist, counteracted the effect of 3beta-Adiol while bicalutamide, an androgen receptor antagonist, had minor effects.|ICI 182780|estrogen receptor|1|5|Arg1:T2|Arg2:T37|CHEMICAL|GENE-Y|ANTAGONIST
7858879|Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.|bosentan|ETB|20|25|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|ANTAGONIST
11278845|First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected.|4'-(9-acridinylamino)methanesulfon-m-anisidide|TOP2|41|29|Arg1:T18|Arg2:T37|CHEMICAL|GENE-Y|INHIBITOR
17012403|Six amino acids commonly present in soils (Glu, Gly, alanine, serine, asparagine, and cysteine) as well as the tripeptide glutathione (gamma-glutamyl-cysteinyl-Gly) were found to be strong agonists of the GLR3.3-mediated responses.|cysteine|GLR3.3|20|39|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|AGONIST-ACTIVATOR
11106255|To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells.|NSD-1015|AAAD|29|14|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
24365491|In addition, pseudoephedrine significantly suppressed the production of p-IkappaB-alpha, reducing the degradation of sequestered nuclear factor kappa B (NF-kappaB) in the cytoplasm, and inhibited the translocation of NF-kappaB/p65 to the nucleus, the transcription of TNF-alpha mRNA and the production of TNF-alpha in primary KCs. These results suggest that pseudoephedrine and ephedrine have a potent anti-inflammatory activity against D-GalN/LPS-induced acute liver failure in rats, and this comprehensive anti-inflammatory effect may result from the inhibition of TNF-alpha production.|pseudoephedrine|TNF-alpha|56|83|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
2362440|Pregnenolone and dehydroepiandrosterone protect the dehydrogenase activity, while 5-pregnene-3,20-dione, progesterone, and androstenedione protect isomerase activity from inactivation.|Pregnenolone|dehydrogenase|1|6|Arg1:T24|Arg2:T41|CHEMICAL|GENE-N|ACTIVATOR
1600046|Some 5-HT3 antagonists have 5-HT4 agonist activity (for example, renzapride, zacopride) and others do not (for example, ondansetron, granisetron), while tropisetron in high concentrations is a 5-HT4 antagonist.|zacopride|5-HT3|14|2|Arg1:T15|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
11369259|Heparin-binding exosite of factor Xa.   Recent studies have indicated that the basic residues Arg(93), Lys(96), Arg(125), Arg(165), Lys(169), Lys(236), and Arg(240) (chymotrypsin numbering) constitute an exosite in the catalytic domain of factor Xa that can effectively bind heparin only if the acidic N-terminal Gla domain of the proteinase was neutralized by physiological levels of calcium.|Arg|factor Xa|15|62|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|PART-OF
23607523|A gene cassette encoding C7-cyclitol biosynthetic enzymes was identified upstream of the benzopyranopyrrole-specific ORFs. Targeted disruption of the gene encoding the N-glycosyltransferase, prlH, abolished pyralomicin production, and recombinant expression of PrlA confirms the activity of this enzyme as a sugar phosphate cyclase involved in the formation of the C7-cyclitol moiety.|C7|sugar phosphate cyclase|53|44|Arg1:T1|Arg2:T30|CHEMICAL|GENE-N|PRODUCT-OF
23440928|Scanning force microscopy, circular dichroism and thioflavin T fluorescence experiments showed that carnosine does not modify the conformational features of Aβ42 but nonetheless inhibits amyloid growth.|carnosine|Aβ42|14|22|Arg1:T11|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17513447|In myeloid cells, arginine is mainly metabolized either by inducible nitric oxide (NO) synthases (iNOS) or by arginase 1, enzymes that are stimulated by T helper 1 or 2 cytokines, respectively.|arginine|inducible nitric oxide (NO) synthases|5|11|Arg1:T13|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
10365684|  Methimazole (MMI) and propylthiouracil (PTU) are common antithyroid drugs for treating hyperthyroidism because the 2 drugs inhibit thyroid peroxidase (TPO)-catalyzed thyroid hormone formation.|MMI|thyroid peroxidase|3|22|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
10462128|The beta-adrenergic/5-HT1A receptor antagonist (+/-)pindolol and the selective 5-HT1B/D antagonist GR127935 produced no significant augmentation of venlafaxine-induced changes in either 5-HT or NA.|(+/-)pindolol|5-HT1A|5|3|Arg1:T3|Arg2:T31|CHEMICAL|GENE-Y|ANTAGONIST
18803986|CONCLUSIONS: Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases.|Lapatinib|HER2|3|12|Arg1:T24|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|L-cysteine|CBS|32|29|Arg1:T10|Arg2:T50|CHEMICAL|GENE-Y|SUBSTRATE
16297435|Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.|rivastigmine|cholinesterase|12|10|Arg1:T28|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
17184764|It has been previously shown that retinoids act mainly on cell proliferation and survival in the ventral forebrain by regulating SHH and FGF8 signaling.|retinoids|SHH|7|21|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17409318|  The use of Delta 6 desaturase (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.|DHA|Delta 6 desaturase|46|4|Arg1:T11|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF
23042730|α-TOCO plus a pancaspase inhibitor completely abolished AMD/TNF-induced cytotoxicity.|α-TOCO|pancaspase|1|4|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
23373701|Moreover, the D2R inhibitor raclopride blocked the increase of both GDNF and Zif268 expression following potassium-evoked dopamine release in SH-SY5Y cells.|raclopride|GDNF|6|12|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|vascular endothelial growth factor|1|22|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
21308351|Riboflavin kinase (RFK) also known as flavokinase is involved in the first step of bioactivation of riboflavin (RF) to form flavin mononucleotide (FMN) which can be subsequently converted to FAD in an ATP-dependent reaction catalyzed by FAD synthetase (FADS).|FMN|flavokinase|28|9|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF
23382458|The P-gp- and BCRP-facilitated transport of apixaban was concentration- and time-dependent and did not show saturation over a wide range of concentrations (1-100 μM).|apixaban|P-gp|7|2|Arg1:T11|Arg2:T33|CHEMICAL|GENE-N|SUBSTRATE
23542513|Pyrrolidine dithiocarbamate (PDTC), a specific NF-κB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-κB activity.|PDTC|NF-κB|4|9|Arg1:T16|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
23562496|Xanthohumol and 2-hydroxychalcone induced apoptosis by Bcl-2 downregulation.|2-hydroxychalcone|Bcl-2|3|7|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23591777|Pre-treatment with MSM (400 mg/kg) inhibited the increases of serum ALT and AST activities, decreased hepatic MDA, TNF-α, IL-6 and Bax/Bcl2 ratio compared to CCl4 treated group.|CCl4|AST|30|15|Arg1:T15|Arg2:T37|CHEMICAL|GENE-Y|ACTIVATOR
23583603|Agonistic activity of ICI 182 780 on activation of GSK 3β/AKT pathway in the rat uterus during the estrous cycle.|ICI 182 780|GSK 3β|4|10|Arg1:T14|Arg2:T27|CHEMICAL|GENE-Y|AGONIST
23583259|Results from mechanistic studies indicated that rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, bound to the ligand-binding domain of hPXR, as assessed by a transactivation assay and by a competitive ligand-binding assay using time-resolved fluorescence resonance energy transfer; triggered nuclear translocation of a green fluorescence protein-tagged hPXR, as visualized by confocal imaging; and recruited steroid receptor coactivator-1 (SRC-1), SRC-2, and SRC-3 to hPXR, as demonstrated by mammalian two-hybrid assays.|efavirenz|hPXR|12|55|Arg1:T30|Arg2:T37|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23354536|The response to the 5-HT1a agonist, 8-OHDPAT (0.003-0.5 mg/kg, SC), was assessed using lower lip retraction (LLR), hypoactivity, and 5-hydroxytryptophan (5-HTP) accumulation following decarboxylase inhibition.|5-HTP|decarboxylase|31|35|Arg1:T10|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
16885432|Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells.|Modafinil|NET|1|28|Arg1:T7|Arg2:T39|CHEMICAL|GENE-Y|ACTIVATOR
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, increased hPXR target gene (CYP3A4) expression in primary cultures of human hepatocytes.|Rilpivirine|CYP3A4|1|19|Arg1:T3|Arg2:T44|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23350733|Compound 1 exhibited activity comparable to the clinically approved elastase inhibitor sivelestat in short-term assays and demonstrated superior sustained activity in longer-term assays.|sivelestat|elastase|12|10|Arg1:T1|Arg2:T6|CHEMICAL|GENE-N|INHIBITOR
12411515|Succinate oxidation was unaffected by either isoflurane or sevoflurane, indicating that these agents selectively inhibit complex I (NADH:ubiquinone oxidoreductase).|sevoflurane|NADH:ubiquinone oxidoreductase|9|20|Arg1:T28|Arg2:T51|CHEMICAL|GENE-N|INHIBITOR
11102491|However, haloperidol effectively blocked glutamate toxicity in the same cultures, suggesting that the neurotoxic actions of this amino acid were mostly due to the activation of somatic NMDA receptors.|haloperidol|NMDA receptors|3|30|Arg1:T14|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
23384967|Both BPA and DES (10-50μM) caused a significant activation of the CYP3A4 promoter via the PXR in the DPX2 human hepatoma cell line.|BPA|CYP3A4 promoter|2|14|Arg1:T5|Arg2:T19|CHEMICAL|GENE-N|ACTIVATOR
23435541|In cultured human coronary arterial endothelial cells, confocal microscopy detected the formation of an MRs clustering when they were exposed to OxLDL, and such MR platform formation was inhibited markedly by statins, including pravastatin and simvastatin.|statins|OxLDL|34|23|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
23605050|Additionally, treatment with glucose/iron showed a higher HO activity.|iron|HO|6|9|Arg1:T14|Arg2:T17|CHEMICAL|GENE-N|ACTIVATOR
10494028|Comparison of the activity of a PPARgamma-specific ligand, the antidiabetic thiazolidinedione, BRL-49653 and a PPARalpha ligand Wy-14643 showed a marked decrease of apo CIII secretion and gene expression after activation of PPARalpha but not PPARgamma.|BRL-49653|PPARgamma|14|7|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
14871885|Increases in glucose concentration from 0 to 3 and from 3 to 17 mM inhibited AMPK activity in primary islets from mouse, rat, and human, confirming previous findings in insulinoma cells.|glucose|AMPK|3|16|Arg1:T9|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
11736858|CONCLUSIONS: Ebastine (10 mg orally) causes brain histamine H1-receptor occupation of approximately 10%, consistent with its lower incidence of sedative effect, whereas (+)-chlorpheniramine occupied about 50% of brain H1-receptors even at a low but sedative dose of 2 mg; occupancy of (+)-chlorpheniramine was correlated with plasma (+)-chlorpheniramine concentration.|Ebastine|histamine H1-receptor|3|11|Arg1:T10|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23454149|Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells.|DMBT|Akt|7|17|Arg1:T13|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23000451|Recent studies, however, have demonstrated a promising potential treatment option with the help of the serum enzyme butyrylcholinesterase (BChE), which is capable of breaking down naturally occurring (-)-cocaine before the drug can influence the reward centers of the brain or affect other areas of the body.|(-)-cocaine|butyrylcholinesterase|33|20|Arg1:T3|Arg2:T10|CHEMICAL|GENE-Y|SUBSTRATE
15686475|Hence, it is proposed that a conformational change is induced when ApoCaM interacts with GAD65 or tGAD67, resulting in an increase of GAD affinity for PLP and the activation of GAD.|PLP|GAD|28|25|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16790533|Although NQO1 protected against dopamine-induced proteasomal inhibition, the metabolism of aminochrome by NQO1 led to oxygen uptake because of the generation of a redox-labile cyclized hydroquinone, further demonstrating the lack of involvement of oxygen radicals in proteasomal inhibition.|hydroquinone|NQO1|27|14|Arg1:T33|Arg2:T55|CHEMICAL|GENE-N|PRODUCT-OF
11451212|In vivo, intravenous olmesartan produces a rapid and long-lasting inhibition of All-induced pressor responses in conscious rats.|olmesartan|All|5|13|Arg1:T13|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
7906055|Agmatine, locally synthesized, is an endogenous agonist at imidazoline receptors, a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter.|Agmatine|imidazoline receptors|1|11|Arg1:T11|Arg2:T21|CHEMICAL|GENE-N|AGONIST
11971019|Therefore, we describe arginase- and ODC-dependent macrophage apoptosis, which implicates polyamines in the pathophysiology of H.|polyamines|arginase|13|5|Arg1:T7|Arg2:T20|CHEMICAL|GENE-N|PRODUCT-OF
23305921|  We previously reported that caffeoyl-amino acidyl-hydroxamic acid (CA-Xaa-NHOH) acted as both a good antioxidant and tyrosinase inhibitor, in particular when caffeic acid was conjugated with proline or amino acids having aromatic ring like phenylalanine.|caffeoyl-amino acidyl-hydroxamic acid|tyrosinase|5|18|Arg1:T6|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
18803986|CONCLUSIONS: Lapatinib is a dual inhibitor of the EGFR and HER2 tyrosine kinases.|Lapatinib|tyrosine kinases|3|13|Arg1:T24|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR
7739347|Dihydroetorphine and etorphine have almost the same binding affinities to all types (mu, delta, and kappa) of opioid receptors and antagonist binding sites, and have similar inhibition activities to forskolin stimulated adenylyl cyclase.|Dihydroetorphine|adenylyl cyclase|1|37|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|INHIBITOR
12063084|  Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT(1A) receptors (h5-HT(1A)) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT(1A) receptors in a guanosine-5'-O-(3-[(35)S]thio)-triphosphate ([(35)S]GTP gamma S)-binding assay that was blocked completely by a selective 5-HT(1A) receptor antagonist.|Aripiprazole|dopamine D2 receptors|1|30|Arg1:T1|Arg2:T12|CHEMICAL|GENE-Y|AGONIST
23603382|The mRNA levels of SOD1, CAT, GPx and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+NaAsO2 treatment group.|NaAsO2|CAT|24|7|Arg1:T10|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16014042|Interestingly, in oocytes injected with rBAT with or without xCT, uptake of l-cystine was significantly greater than that in water-injected oocytes.|l-cystine|rBAT|15|7|Arg1:T3|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
2907566|Relaxant and beta 2-adrenoceptor blocking activities of labetalol, dilevalol, amosulalol and KF-4317 on the rat isolated aorta.|labetalol|beta 2-adrenoceptor|8|3|Arg1:T12|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
17251447|Ablation of RPE65 in Nrl(-/-) and Rho(-/-) mice led to the absence of 11-cis retinal, but increased the total retinoid content, with retinyl esters representing the most abundant retinoid species.|retinoid|RPE65|37|3|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|probenecid|hOAT3|19|35|Arg1:T7|Arg2:T42|CHEMICAL|GENE-Y|INHIBITOR
9313928|The EP3 receptor showed the broadest binding profile, and bound sulprostone, M&B-28767, GR63799X, 11-deoxy-PGE1, 16,16-dimethyl-PGE2 and 17-phenyl-PGE2, in addition to PGE2 and PGE1, with Ki values of 0.6-3.7 nM.|PGE2|EP3|29|2|Arg1:T31|Arg2:T88|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9563368|FP is more potent than beclomethasone dipropionate, budesonide, triamcinolone acetonide, and mometasone furoate in inhibiting human T-cell migration and proliferation, inhibiting CD4+ T-cell cytokine and basophil histamine release, attenuating adhesion molecule expression, stimulating inflammatory cell apoptosis, and inducing cellular antiprotease release.|budesonide|cytokine|9|28|Arg1:T8|Arg2:T33|CHEMICAL|GENE-N|INHIBITOR
23537747|Next, nobiletin significantly decreased the levels of phospho-ERK2 and phospho-Akt in ERK2 or Akt siRNA-transfected cells concomitantly with a marked reduction on cell invasion and migration.|nobiletin|ERK2|3|13|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
9563368|FP has an absolute affinity (KD) for the glucocorticoid receptor of 0.5 nmol/L and a relative receptor affinity 1.5-fold higher than beclomethasone-17-monopropionate (17-BMP) and mometasone furoate, 3-fold higher than budesonide, and 20-fold higher than flunisolide and triamcinolone acetonide.|flunisolide|glucocorticoid receptor|41|11|Arg1:T24|Arg2:T34|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23085120|Furthermore, B12H restored the suppressed activation of the Akt pathway caused by glutamate as evidenced by the decreased expressions of pSer473-Akt and pSer9-GSK3β.|glutamate|Akt|14|10|Arg1:T19|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
23578608|Meanwhile, both plant stanyl hemisuccinate and plant stanyl sorbitol succinate could remarkably promote liver X receptor alpha (LXRα) expression, and increased cholesterol 7α-hydroxylase (CYP7A1) expression and faecal total bile acid output to varying degrees.|stanyl hemisuccinate|CYP7A1|5|29|Arg1:T15|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23418859|The results showed that intracoronary injection of salidroside at the onset of reperfusion markedly reduced the apoptosis of cardiomyocytes, significantly increasing Bcl-2 and p-Akt proteins expressions and decreasing Bax and caspase-3 expressions in the hearts subjected to ischemia followed by 120-min reperfusion.|salidroside|Bax|8|30|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Cys|ALDH|48|64|Arg1:T11|Arg2:T34|CHEMICAL|GENE-N|PART-OF
23501055|Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.|Gambogic acid|PHD2|1|7|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
23219593|4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.|4-tert-Octylphenol|cathepsins|1|6|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
2833901|Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.|dihydropyridine|calcium channel|6|7|Arg1:T41|Arg2:T77|CHEMICAL|GENE-N|INHIBITOR
23327877|Compound 6 stimulated OATP1B3-mediated estradiol 17β-glucuronide uptake by increasing the apparent affinity of OATP1B3 for its substrate.|estradiol 17β-glucuronide|OATP1B3|5|4|Arg1:T15|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE
17632548|10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref.|eicosanoid|microsomal prostaglandin E synthase 1|20|37|Arg1:T21|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
15456329|Nabumetone itself is non-acidic and, following absorption, it undergoes extensive first-pass metabolism to form the main circulating active metabolite (6-MNA) which is a much more potent inhibitor of preferentially cyclo-oxygenase (COX)-2.|6-MNA|cyclo-oxygenase (COX)-2|23|34|Arg1:T19|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
15627430|This study compared in vitro binding affinities and functional activities of olanzapine, clozapine, thioridazine, ziprasidone, risperidone, chlorpromazine and scopolamine at muscarinic M2 receptors with their in vivo potencies to increase acetylcholine release in the rat hippocampus.|ziprasidone|muscarinic M2 receptors|18|26|Arg1:T17|Arg2:T38|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17664139|  Two sodium-dependent vitamin C transporter isoforms (SVCT1 and SVCT2) were identified as ascorbic acid transporters, but their roles in skin have, as yet, not been elucidated.|ascorbic acid|SVCT2|15|10|Arg1:T11|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
16437532|  BACKGROUND: Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase.|galantamine|acetylcholinesterase|31|77|Arg1:T12|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23471964|Tumor-suppressive Maspin Functions as a Reactive Oxygen Species Scavenger: IMPORTANCE OF CYSTEINE RESIDUES.|CYSTEINE|Maspin|13|2|Arg1:T8|Arg2:T17|CHEMICAL|GENE-Y|PART-OF
23570789|  A series of imidazopyridazines which are potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) was identified from a high-throughput screen against the isolated enzyme.|imidazopyridazines|PfCDPK1|4|17|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|INHIBITOR
15814851|  Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P450 enzyme complex called aromatase.|Estradiol|cytochrome P450|1|15|Arg1:T1|Arg2:T29|CHEMICAL|GENE-N|PRODUCT-OF
23639249|I3S increased expression of RORγt, the master transcription factor for Th17 differentiation, and stimulated Th17 differentiation, in a comparative manner as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a prototypical AhR ligand.|2,3,7,8-tetrachlorodibenzo-p-dioxin|RORγt|25|5|Arg1:T7|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17088426|Such organization results in the local activation of PKA subsets through the generation of confined intracellular gradients of cAMP, but the mechanisms responsible for limiting the diffusion of cAMP largely remain to be clarified.|cAMP|PKA|19|9|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|ACTIVATOR
23085979|Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by TCDD, siRNA-mediated Cx43 knock-down was not sufficient to stimulate proliferation in contact-inhibited cells.|TCDD|Cx43|18|6|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
23411172|The expression levels of HLA-DR (MHC class II) and CD86 (costimulatory molecule) were measured as an indicator of antigen presentation in TDDCs. A significant decrease in HLA-DR expression was observed in the AP and fractionated procyanidin-treated cells in the presence of ovalbumin (OVA), but no effect on CD86 expression was observed.|procyanidin|HLA-DR|41|32|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
21194017|Using a photo incorporable analogue of the general anesthetic, R(+)etomidate, we identified two transmembrane amino acids that were affinity labelled in purified bovine brain GABA(A)-R.|R(+)etomidate|bovine brain GABA(A)-R|11|29|Arg1:T9|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR
12063084|  Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT(1A) receptors (h5-HT(1A)) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT(1A) receptors in a guanosine-5'-O-(3-[(35)S]thio)-triphosphate ([(35)S]GTP gamma S)-binding assay that was blocked completely by a selective 5-HT(1A) receptor antagonist.|7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinon e|5-HT(1A)|3|65|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|AGONIST
10727523|Probenecid, sulfinpyrazone, indomethacin, furosemide, and penicillin G all significantly increased MRP2-ATPase activity, whereas these compounds acted more as ATPase inhibitors on MRP1.|furosemide|ATPase|7|24|Arg1:T6|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
23313376|PTE, used in combination with a known JAK2/STAT3 inhibitor, AG490, further decreased the viability of osteosarcoma cells.|AG490|STAT3|12|10|Arg1:T7|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
1475066|  Male Sprague-Dawley rats when administered sc a sublethal dose of organophosphorus cholinesterase inhibitors such as the nerve agents, soman (100 micrograms/kg, sc), sarin (110 micrograms/kg, sc), tabun (200 micrograms/kg, sc), or VX (12 micrograms/kg, sc), developed seizures and severe muscle fasciculations within 15-20 min, lasting for 4-6 hr.|tabun|cholinesterase|36|12|Arg1:T8|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
12063084|Combined with previous studies demonstrating the potent partial agonism of aripiprazole at dopamine D2 receptors, this study suggests aripiprazole is the first dopamine-serotonin system stabilizer.|aripiprazole|dopamine D2 receptors|11|13|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|AGONIST
23194750|Isolated rat femoral arteries segments were mounted in a wire myograph and challenged with 100mM KCl or phenylephrine (PE), in the absence or presence of troglitazone, rosiglitazone, pioglitazone, LY294002 (PI3K inhibitor) and 10-DEBC (Akt inhibitor).|LY294002|PI3K|35|37|Arg1:T20|Arg2:T40|CHEMICAL|GENE-N|INHIBITOR
23264615|In study 1, cyclic ewes received vehicle, cortisol, PF 915275 (PF; a selective inhibitor of HSD11B1), cortisol and PF, meloxicam (a selective inhibitor of PTGS2), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus.|meloxicam|PTGS2|28|34|Arg1:T15|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
17139155|The sensors are composed of AChE and choline oxidase (ChOx) for converting the AChE-generated choline into betaine and hydrogen peroxide (H(2)O(2)), which is electrochemically oxidized at the electrode surface to produce the output signal of the sensor.|betaine|ChOx|19|11|Arg1:T13|Arg2:T31|CHEMICAL|GENE-N|PRODUCT-OF
19651196|Presently, a combination of an antimuscarinic agent, e.g. atropine, AChE reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and diazepam are used for the treatment of OP poisoning in humans.|atropine|AChE|12|14|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|ACTIVATOR
23295386|Interestingly, the common phospholipid 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-PC), previously proposed to reflect nutritional status and shown to be a specific endogenous ligand of PPARα, induced CYP3A4 (up to 4-fold) and other biotransformation genes in hepatocytes with similar selectivity and potency as WY14,643.|WY14,643|CYP3A4|47|29|Arg1:T3|Arg2:T11|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17545671|Our data identify cAspAT as a new member of glyceroneogenesis, transcriptionally regulated by TZD via the control of RORalpha expression by PPARgamma in adipocytes.|TZD|cAspAT|15|4|Arg1:T7|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|monoamine|NET|4|16|Arg1:T10|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
23086748|We observed similar effects of Ag NPs on inflammatory mediator expression in vitro and in vivo with increase of interleukin-8 (IL-8)/macrophage inflammatory protein 2, IL-1RI, and tumor necrosis factor-α expression in both models and increased IL-8 protein release in vitro.|Ag|macrophage inflammatory protein 2|6|25|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23500659|Testosterone significantly decreased ER-β and increased ER-α and AR expressions as compared to the control group and these effects were significantly ameliorated by SIL.|Testosterone|AR|1|9|Arg1:T9|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hENT2|9|21|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
17182172|LPS-induced IL-6 production in ATDC5 cells was reduced by Dex or AL-438, showing that AL-438 has similar anti-inflammatory efficacy to Dex in these cells.|AL-438|IL-6|12|2|Arg1:T17|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23578952|Here we studied the effects of the recently developed monoacylglycerol lipase inhibitor JZL184 on basal and stress-induced corticosterone levels in male CD1 mice, and found that this compound dramatically increased basal levels without affecting stress responses.|JZL184|monoacylglycerol lipase|13|10|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
10823899|Conversely, DAT inhibitors, such as cocaine, mazindol, and nomifensine, when administered with AMPH, blocked the reduction in [(3)H]DA uptake and the redistribution of DAT immunofluorescence to the cytosol.|[(3)H]DA|DAT|24|3|Arg1:T21|Arg2:T38|CHEMICAL|GENE-Y|SUBSTRATE
23297412|Here, we show that oral administration of resveratrol, which leads to activation of an NAD(+)-dependent protein deacetylase SIRT1, suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophin-deficient mdx mice.|resveratrol|NAD(+)-dependent protein deacetylase SIRT1|9|17|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|ACTIVATOR
23631440|  New series of pyrrolidine mercaptosulfide, 2-mercaptocyclopentane arylsulfonamide, and 3-mercapto-4-arylsulfonamido pyrrolidine matrix metalloproteinase inhibitors (MMPIs) were designed, synthesized, and evaluated.|2-mercaptocyclopentane arylsulfonamide|matrix metalloproteinase|7|13|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|INHIBITOR
22410778|Exogenous stimulation of PKA activity, achieved by forskolin treatment, protected K-ras-transformed cells from apoptosis induced by glucose deprivation, enhanced complex I activity, intracellular adenosine triphosphate (ATP) levels, mitochondrial fusion and decreased intracellular reactive oxygen species (ROS) levels.|glucose|K-ras|19|13|Arg1:T12|Arg2:T25|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23468082|METHODS: Ponatinib is an oral multitargeted kinase inhibitor that potently inhibits all 4 members of the FGFR family.|Ponatinib|kinase|3|8|Arg1:T7|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
17664139|  Two sodium-dependent vitamin C transporter isoforms (SVCT1 and SVCT2) were identified as ascorbic acid transporters, but their roles in skin have, as yet, not been elucidated.|ascorbic acid|SVCT1|15|8|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
23453838|Analogs with Z=Br, I, or OTs were weak inhibitors of the AChEs, and methyl phosphonates (R=Me) were more potent than the corresponding ethyl phosphonates (R=Et).|methyl phosphonates|AChEs|17|14|Arg1:T9|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
16864903|Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils.|olopatadine|S100|3|17|Arg1:T3|Arg2:T14|CHEMICAL|GENE-N|DIRECT-REGULATOR
23403272|Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway.|Paeoniflorin|NF-E2-related factor 2|1|15|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|ACTIVATOR
11669456|These results indicate that hOAT1, as well as hOAT3, mediates a high-affinity transport of OTA on the basolateral side of the proximal tubule, but hOAT1- and hOAT3-mediated OTA transport are differently influenced by the substrates for the OATs. These pharmacological characteristics of hOAT1 and hOAT3 may be significantly related with the events in the development of OTA-induced nephrotoxicity in the human kidney.|OTA|hOAT1|31|28|Arg1:T1|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
7816863|Moreover, clenbuterol HCl (0.1-0.5 mg/kg, IP), a lipophilic beta 2-adrenoceptor agonist, significantly increased the duration of basal aggressive behavior.|clenbuterol HCl|beta 2-adrenoceptor|3|14|Arg1:T9|Arg2:T17|CHEMICAL|GENE-Y|AGONIST
22790794|We hypothesized that blockade of human K(2P) channels contributes to the electrophysiological efficacy of dronedarone in AF.|dronedarone|human K(2P) channels|18|6|Arg1:T9|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
23291264|Microarray analysis revealed that mRNA levels of several cytokines and chemokines, such as interleukin-1beta, chemokine (C-C motif) ligand (CCL) 2, CCL20, chemokine (C-X-C motif) ligand (CXCL) 1, and CXCL10 were significantly increased after cisplatin treatment in both isolated proximal tubules and whole kidney.|cisplatin|cytokines|47|9|Arg1:T12|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23613149|PbAc increased the activities of lactate dehydrogenase and NADP-malic enzyme, whereas it decreased malate and glucose-6-phosphate dehydrogenase, glucose-6-phosphatase, fructose-1, 6-bisphosphatase, and BBM enzyme activities.|PbAc|lactate dehydrogenase|1|6|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR
23373444|Specific activities of GO/Zr(IV)/α-ZrP and Hb/Zr(IV)/α-ZrP ternary complexes were 2.0 × 10(-3) and 6.5 × 10(-4) M(-1) s(-1), respectively.|α-ZrP|Hb|15|10|Arg1:T6|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR
8836655|Epinastine (WAL 801CL) is an antihistaminic drug with binding affinity at certain other receptors, including alpha-adrenergic receptors and various serotonin (5-HT) receptor subtypes.|Epinastine|alpha-adrenergic receptors|1|19|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR
17664139|UVB-induced oxidative stress in mice resulted in depletion of SVCT1 mRNA levels and led to significantly decreased ascorbic acid uptake in keratinocytes, providing evidence on why ascorbic acid levels are decreased on UVB irradiation in vivo.|ascorbic acid|SVCT1|18|10|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
23373444|Zr(IV) increased Hb binding constant to α-ZrP by 43-fold, and affinity enhancements followed the trend Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III).|Ca(II)|Hb|40|6|Arg1:T48|Arg2:T66|CHEMICAL|GENE-N|DIRECT-REGULATOR
16232421|On the other hand, the FUM1 (fumarase) gene disrupted mutant produced significantly higher levels of fumarate but did not form malate at all.|fumarate|fumarase|19|9|Arg1:T20|Arg2:T38|CHEMICAL|GENE-Y|PRODUCT-OF
23478800|Lastly, we found that RhoA activation by cucurbitacin I is mediated by reactive oxygen species (ROS).|cucurbitacin I|RhoA|9|6|Arg1:T2|Arg2:T25|CHEMICAL|GENE-N|ACTIVATOR
23590882|These results support the hypothesis that apoplastic amino acids acting through heteromeric GLR3.2/GLR3.4 channels affect lateral root development via Ca(2+) signaling in the phloem.|amino acids|GLR3.4|8|14|Arg1:T1|Arg2:T8|CHEMICAL|GENE-N|PART-OF
17016711|Dexamethasone probes glucocorticoid receptor (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.|prednisolone|GR|11|14|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17092971|  Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine D(2) receptor partial agonists based largely on their activity in second messenger-based assays of dopamine D(2) receptor signalling.|Aripiprazole|dopamine D(2) receptor|1|18|Arg1:T1|Arg2:T50|CHEMICAL|GENE-Y|AGONIST
23535287|CSA activated Nrf2 as evaluated by Western blotting.|CSA|Nrf2|1|3|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15546741|In contrast to the pan-RAR/RXR agonistic profile of the lower homologue of 8a, compound 7 (LG100567), retinoids 8 showed selective binding and transactivation of RXR, devoid of significant RAR activation.|LG100567|RAR|18|6|Arg1:T4|Arg2:T8|CHEMICAL|GENE-N|AGONIST
23376161|Catalpol reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), inducible NO synthase (iNOS), and receptor for AGE (RAGE).|Catalpol|receptor for AGE|1|33|Arg1:T7|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10373224|  The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.|EXP 3174|angiotensin II type 1 receptor|26|7|Arg1:T8|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
23469927|The limit of detection on Western blots was 0.01 μg (15 picomoles) of soman-labeled albumin.|soman|albumin|16|17|Arg1:T2|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15726024|CONCLUSION: Psychiatrists should be aware that even second-generation antipsychotics, including ziprasidone, have a propensity to cause side-effects associated with the dopamine D2 receptor blockade, such as galactorrhea.|ziprasidone|dopamine D2 receptor|13|24|Arg1:T11|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
15892618|Other promising new drugs currently under preclinical and clinical evaluation, are VEGFR2 inhibitor PTK787/ZK 222584, thalidomide, farnesyl transferase inhibitor R115777 (tipifarnib, Zarnestra(TM)), matrix metalloproteinase inhibitors, proteasome inhibitor bortezomib (Velcade(TM)), mammalian target of rapamycin (mTOR) inhibitors, cyclooxygenase-2 (COX-2) inhibitors, platelet derived growth factor receptor (PDGF-R) inhibitors, protein kinase C (PKC) inhibitors, mitogen-activated protein kinase kinase (MEK) 1/2 inhibitors, Rous sarcoma virus transforming oncogene (SRC) kinase inhibitors, histondeacetylase (HDAC) inhibitors, small hypoxia-inducible factor (HIF) inhibitors, aurora kinase inhibitors, hedgehog inhibitors, and TGF-beta signalling inhibitors.|tipifarnib|farnesyl transferase|25|20|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Phe|ALDH|15|21|Arg1:T9|Arg2:T32|CHEMICAL|GENE-N|PART-OF
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|FOXO3a|3|27|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
16757355|Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.|sorafenib|vascular endothelial growth factor receptor|4|16|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|prostanoid IP-receptor|10|13|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|AGONIST
23093496|This study showed that, in addition to ADP and ATP, other ATP derivatives are not only ligands of P2Y(12) but also agonists.|ADP|P2Y(12)|9|21|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|AGONIST
3334987|17 beta-Estradiol, equilin, 17 alpha-ethinylestradiol, diethylstilbestrol, hexestrol, dienestrol, coumestrol, and nafoxidine provoked a complete estrogen receptor response: acutely a decrease in the level of cytosolic estrogen receptor and an increase in the nuclear estrogen receptor.|hexestrol|estrogen receptor|11|42|Arg1:T7|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15972446|In addition, PKC412 treatment resulted in a significant decline in the percentage of peripheral blood mast cells and serum histamine level and was associated with a decrease in KIT phosphorylation and D816V KIT mutation frequency.|PKC412|KIT|4|30|Arg1:T7|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23473803|  PDE4 is one of eleven known cyclic nucleotide phosphodiesterase families and plays a pivotal role in mediating hydrolytic degradation of the important cyclic nucleotide second messenger, cyclic 3'5' adenosine monophosphate (cAMP).|cAMP|PDE4|36|1|Arg1:T10|Arg2:T18|CHEMICAL|GENE-N|SUBSTRATE
23416002|Amino acid derived quinazolines as Rock/PKA inhibitors.|Amino acid|PKA|1|7|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
15037867|No significant effects of either polymorphism were associated with altered 5-HT-induced calcium response or fenfluramine-stimulated prolactin release.|fenfluramine|prolactin|15|16|Arg1:T8|Arg2:T23|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15840408|Among prostaglandin E1 receptors (IP/EP1/EP2/EP3/EP4) agonists, ONO-1301, a prostanoid IP-receptor agonist, prevented B7.1 and CD40 expression.|ONO-1301|EP2|10|7|Arg1:T9|Arg2:T29|CHEMICAL|GENE-Y|AGONIST
11330337|Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent.|edrophonium|acetylcholinesterase|18|32|Arg1:T11|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
15554912|Eplerenone competed strongly for [(3)H]-dexamethasone binding to a MR/GR chimera containing amino acids 804-874 of the MR and weakly to a chimera containing amino acids 672-803 of the MR.|[(3)H]-dexamethasone|GR|5|16|Arg1:T16|Arg2:T42|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7929150|These latter two forms of CA V had identical steady-state constants for the hydration of CO2, with maximal values of kcat/Km at 3 x 10(7) M-1 s-1 and kcat at 3 x 10(5) s-1 with an apparent pKa for catalysis of 7.4 determined from kcat/Km. In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, ethoxzolamide, and cyanate, CA V is very similar to CA II.|acetazolamide|CA V|72|79|Arg1:T1|Arg2:T16|CHEMICAL|GENE-Y|INHIBITOR
16885432|In thalamus, modafinil occupied NET sites (5 mg/kg: 16 +/- 7.8%, n = 6; 8 mg/kg: 44 +/- 12%; n = 2).|modafinil|NET|4|6|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11406192|The prototypic AMPA receptor potentiator cyclothiazide competitively inhibited [(3)H]LY395153 binding with a potency (K(i) approximately 7 microM) comparable to EC(50) values reported in electrophysiological studies.|[(3)H]LY395153|AMPA receptor|9|3|Arg1:T4|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
12668769|One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (Gly) as one-carbon (1-C) source.|glycine|glycine decarboxylase complex|33|14|Arg1:T36|Arg2:T59|CHEMICAL|GENE-N|SUBSTRATE
12522078|5 beta-adrenoceptor antagonists also produced relaxation in phenylephrine-constricted rings with an order of potency of (pEC(50) values): bupranolol (5.5) approximately 38;SR 59230A (5.47) approximately 38;cyanopindolol (5.47)>pindolol (5.30)>alprenolol (5.10)>propranolol (4.83)>ICI 118551 (4.60)>CGP 12177A (4.38) approximately 38;CGP 20712A (4.35).|cyanopindolol|beta-adrenoceptor|39|2|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|ANTAGONIST
23264615|  During early pregnancy in sheep, the elongating conceptus secretes interferon-τ (IFNT) and the conceptus as well as endometrial epithelia produce prostaglandins (PG) via PG synthase 2 (PTGS2) and cortisol via hydroxysteroid (11-β) dehydrogenase 1 (HSD11B1).|cortisol|hydroxysteroid (11-β) dehydrogenase 1|36|38|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|PRODUCT-OF
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline|AChE|60|4|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
23142559|Furthermore, TNF-α-induced CXCL8 secretion was (i) inhibited by the MR antagonist tiotropium and the M3R antagonist 4-DAMP and (ii) enhanced by the M1/M3R agonist pilocarpine and the cholinesterase inhibitor physostigmine.|physostigmine|cholinesterase|35|33|Arg1:T10|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23589302|In the present report, we show that Fer associates with the activated PDGFbeta receptor (PDGFRbeta) through multiple autophosphorylation sites, i.e. Tyr579, Tyr581, Tyr740 and Tyr1021.|Tyr|PDGFbeta receptor|28|14|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|PART-OF
16702329|Lutein and eicosapentaenoic acid interact to modify iNOS mRNA levels through the PPARgamma/RXR pathway in chickens and HD11 cell lines.|eicosapentaenoic acid|PPARgamma|3|13|Arg1:T9|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23486447|These drugs and their metabolites, along with desipramine and nortriptyline, undergo hydroxylation by CYP2D6 to less active metabolites.|nortriptyline|CYP2D6|11|16|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE
12850267|One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15).|oxoglutaramic acid|kynurenine aminotransferase I|27|12|Arg1:T9|Arg2:T20|CHEMICAL|GENE-Y|SUBSTRATE_PRODUCT-OF
12498985|Inhibition of p38(MAPK) by SB203580 (10 microM) enhanced DEM-induced increases in L-cystine transport and GSH, whereas inhibition of p42/p44(MAPK) (PD98059, 10 microM) had no effect.|SB203580|p38|8|3|Arg1:T24|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR
23567243|Western blot assay demonstrated that DICO decreased Bcl-2 level and induced Bax translocation to cause cytochrome c release.|DICO|cytochrome c|6|16|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23473053|  A series of benzo[de][1,7]naphthyridin-7(8H)-ones possessing a functionalized long-chain appendage have been designed and evaluated as novel PARP1 inhibitors.|benzo[de][1,7]naphthyridin-7(8H)-ones|PARP1|4|28|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INHIBITOR
23056222|Results showed that DMF increased nuclear levels of Nrf2, and both DMF and adenovirus-mediated overexpression of Nrf2 (Ad-Nrf2) decreased PAI-1, alpha-smooth muscle actin (alpha-SMA), fibronectin and type 1 collagen expression in TGF-beta-treated rat mesangial cells (RMCs) and renal fibroblast cells (NRK-49F).|DMF|type 1 collagen|13|34|Arg1:T11|Arg2:T42|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
11141093|Since this compound retains good AChE inhibitory activity and its hexahydrochromeno[4,3-b]pyrrole moiety is reminiscent of the hexahydropyrrolo[2,3-b]indole of physostigmine (3), we have designed and synthesized carbamates 4-6, and their biological evaluation has been assessed in vitro against human AChE and BChE.|hexahydrochromeno[4,3-b]pyrrole|AChE|11|6|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
23589329|Arsenic inhibits autophagic flux activating the Nrf2-Keap1 pathway in a p62-dependent manner.|Arsenic|Keap1|1|8|Arg1:T10|Arg2:T31|CHEMICAL|GENE-Y|ACTIVATOR
15509185|The O-demethylation of tramadol to M1, the main analgesic effective metabolite, is catalysed by cytochrome P450 (CYP) 2D6, whereas N-demethylation to M2 is catalysed by CYP2B6 and CYP3A4.|N|CYP2B6|25|31|Arg1:T11|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
23266270|Additionally, DPEP suppressed the production of inflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6.|DPEP|cytokines|3|9|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
22634112|The presumed cellular mechanism of action involves the generation of intracellular cAMP, which in turn can activate the effector molecules cAMP-dependent protein kinase (PKA) and Epac.|cAMP|cAMP-dependent protein kinase|12|22|Arg1:T4|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR
23211364|  Candesartan is an angiotensin II type 1 receptor blocker (ARB) that has been to shown to limit ischemic stroke and improve stroke outcome.|Candesartan|angiotensin II type 1 receptor|1|4|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
22708686|When combined, mianserin antagonized the effects of the full kappa-opioid receptor agonists in [(35)S]GTPgammaS assays and reduced the stimulation of p38 MAPK and ERK1/2 phosphorylation by dynorphin A.|[(35)S]GTPgammaS|kappa-opioid receptor|15|11|Arg1:T10|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2832297|After loperamide administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an ACTH increase; the pattern of ACTH response to CRH was slightly delayed.|loperamide|ACTH|2|25|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
16495723|The nonselective monoamine oxidase inhibitors tranylcypromine (0.01-5 mg/kg) and phenelzine (1-25 mg/kg), the monoamine oxidase-A selective compound clorgyline (1-25 mg/kg), and the monoamine oxidase-B selective compounds pargyline (0.005-50 mg/kg) and selegiline (1-25 mg/kg) were tested for substitution 15 min or 24 h following administration, and in combination with 10 mg/kg of cocaine 24 and 48 h after administration.|pargyline|monoamine oxidase-B|35|31|Arg1:T23|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23000445|Wogonoside also suppressed the activation of mammalian target of rapamycin (mTOR) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway.|Wogonoside|mammalian target of rapamycin|1|7|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefprozil|flanking conserved motifs|46|6|Arg1:T15|Arg2:T43|CHEMICAL|GENE-N|DIRECT-REGULATOR
22790794|All functional human K(2P) channels were screened for dronedarone sensitivity, revealing significant and concentration-dependent inhibition of cardiac K(2P)2.1 (TREK1; IC(50) = 26.7 muM) and K(2P)3.1 channels (TASK1; IC(50) = 18.7 muM) with maximum current reduction of 60.3 and 65.5 % in oocytes.|dronedarone|K(2P)2.1|12|22|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
23314308|Addition of LTCC opener BAY K 8644 (10(-7)M) failed to enhance the relaxations.|BAY K 8644|LTCC|5|3|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|ACTIVATOR
12697717|Collectively, these results suggest a role for 17 beta HSDXI in androgen metabolism during steroidogenesis and a possible role in nonsteroidogenic tissues including paracrine modulation of 5 alpha-androstane-3 alpha, 17 beta-diol levels.|5 alpha-androstane-3 alpha, 17 beta-diol|17 beta HSDXI|28|9|Arg1:T10|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
11056242|RESULT(S): Buserelin acetate, a GnRH agonist (0.1-10 ng/mL), had no significant effect on MCP-1 expression, whereas danazol (10(-7)-10(-5) M), a testosterone analog, and dexamethasone, an anti-inflammatory glucocorticoid hormone (10(-12)-10(-6)M), showed a direct and a dose-dependent inhibitory effect on MCP-1 expression.|testosterone|MCP-1|40|71|Arg1:T3|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
23578688|  A series of carbamoylmethylene linked prodrugs of 1 (BMS-582949), a clinical p38α inhibitor, were synthesized and evaluated.|BMS-582949|p38α|10|15|Arg1:T6|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
15175324|When coexpressed with the m(2) acetylcholine (ACh) receptor in Xenopus oocytes, agonist-activated GIRK1(F137S)- and GIRK2-mediated currents are inhibited by halothane, whereas in the absence of ACh, high concentrations of halothane induce GIRK1(F137S)-mediated currents.|halothane|GIRK1|30|19|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
9730867|The selective beta1AR antagonist atenolol (0.3 x 10(-6) M) did not have any effect.|atenolol|beta1AR|5|3|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST
23318726|Furthermore, butein treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements (AREs).|butein|AREs|3|26|Arg1:T18|Arg2:T22|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23261705|Pharmacological inhibition of MTORC1 with rapamycin abrogated the insulin-induced phosphorylation of EIF4EBP1, RPS6KB1 and its downstream effector, RPS6.|rapamycin|MTORC1|6|4|Arg1:T2|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
18056711|In the presence of drug, the linker is rigid and this alpha-helix extends to include Gly and the preceding Leu.|Leu|alpha-helix|21|13|Arg1:T27|Arg2:T39|CHEMICAL|GENE-N|PART-OF
23313376|PTE also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27.|PTE|Caspase3|1|39|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23466488|l-glutamine decreased plasma glucose, increased plasma and pancreatic insulin, increased plasma and colonic active GLP-1 (7-36) amide secretion as well as decreased oxidative stress in streptozotocin-nicotinamide induced diabetic rats.|l-glutamine|GLP-1|1|17|Arg1:T16|Arg2:T53|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17182172|Dex and Pred caused a reduction in cell proliferation and proteoglycan synthesis, whereas exposure to AL-438 had no effect.|Pred|proteoglycan|3|11|Arg1:T14|Arg2:T24|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
10365684|In conclusion, MMI and PTU at therapeutic concentrations can increase TPO mRNA and cellular TPO activity, although the 2 drugs inhibit the TPO-H2O2-mediated catalytic reaction.|MMI|TPO|4|25|Arg1:T4|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
16781459|Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide.|Hydrogen sulfide|nuclear factor-kappaB|1|8|Arg1:T36|Arg2:T68|CHEMICAL|GENE-N|INHIBITOR
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|amino acid|PBP|3|19|Arg1:T23|Arg2:T60|CHEMICAL|GENE-N|PART-OF
23015691|Androstanol and androstenol, estrone, 17β-estradiol, TCPOBOP, and CITCO showed compound-specific but similar affinities for both CARs. The CAR-SRC1 interaction was ligand dependent but exhibited a different ligand profile between the seal and the mouse.|CITCO|CARs|12|20|Arg1:T5|Arg2:T11|CHEMICAL|GENE-N|DIRECT-REGULATOR
23177789|Protein tyrosine phosphatase 1B inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma pentaphyllum saponins.|triterpenes|Protein tyrosine phosphatase 1B|9|1|Arg1:T6|Arg2:T13|CHEMICAL|GENE-Y|INHIBITOR
16316409|As CRABPI was elevated far more than any other genes, we observed that the retinoids, all-trans retinoic acid and 9-cis retinoic acid, that bind CRABPI, promoted nitroblue tetrazolium-associated functional cell differentiation in p75NTR PC-3 cells, but not in neo control PC-3 cells.|retinoids|CRABPI|16|28|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17260025|beta2AR stimulation of cAMP formation and protein kinase A (PKA) activation leads to Raf-1 (but not B-Raf) kinase inactivation, inhibition of Mek-1 kinase and decreased phospho-extracellular signal-regulated kinase (Erk)1/2 levels.|cAMP|kinase|4|28|Arg1:T4|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
17352516|Improvements from baseline in mean glycosylated haemoglobin (HbA(1c)) were significantly greater with sitagliptin monotherapy than with placebo in patients with type 2 diabetes.|sitagliptin|glycosylated haemoglobin|18|6|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17076770|In addition, they compromised the ability of dexamethasone to suppress the evoked release of ACTH from the excised tissue in vitro, a process which requires the translocation of ANXA1 from the cytoplasm to the cell surface of FS cells.|dexamethasone|ACTH|9|16|Arg1:T1|Arg2:T6|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23430109|  Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the FLT3 inhibitors AC220 (quizartinib) and sorafenib.|quizartinib|FLT3|32|28|Arg1:T4|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
17526944|Dexamethasone increased DAX-1 expression and concordantly decreased StAR protein and mRNA in testicular cells.|Dexamethasone|DAX-1|1|3|Arg1:T23|Arg2:T49|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9836297|The alpha 2a-adrenoceptor contains three hydroxyl bearing amino acids at a position corresponding to this site (Thr393-Tyr394-Thr395).|hydroxyl|alpha 2a-adrenoceptor|6|2|Arg1:T16|Arg2:T39|CHEMICAL|GENE-Y|PART-OF
23174265|Sprague-Dawley rats treated with a non-selective cannabinoid agonist (CP55940, 50μg/kg, 7 days, i.p.) showed enhanced co-immunoprecipitation of β-Arrestin 2 and ERK1/2, enhanced pERK protein levels, and enhanced expression of β-Arrestin 2 mRNA and protein levels in PFCx. In a neuronal cell line, we found that selective CB(2) receptor agonists upregulate β-Arrestin 2, an effect that was prevented by selective CB(2) receptor antagonist JTE-907 and CB(2) shRNA lentiviral particles.|JTE-907|β-Arrestin 2|80|64|Arg1:T4|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
3143355|During the course of glycine oxidation catalysed by the matrix extract a steady-state equilibrium in the production and utilization of 5,10-methylene-H4 folate was reached, suggesting that glycine cleavage and SHMT are linked together via a soluble pool of H4 folate.|H4 folate|SHMT|40|31|Arg1:T4|Arg2:T23|CHEMICAL|GENE-Y|PRODUCT-OF
9669506|Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (Ki = 74 nM) and a very low affinity for the norepinephrine transporter (Ki = 1.26 microM).|venlafaxine|5-HT transporter|3|20|Arg1:T26|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9231746|Felodipine and nicardipine have similar affinities for 60-kDa CaMPDE isozymes but bring about different levels of enzyme inhibition, suggesting the possibility of designing specific drugs that can protect the enzyme from inhibition by dihydropyridine Ca2+-channel blockers.|dihydropyridine|CaMPDE|35|9|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
12818701|alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.|BMY-7378|alpha(1D)-adrenoceptor|101|75|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|ANTAGONIST
17251447|RESULTS: In comparison to wild-type mice, the retina of Nrl(-/-) mice contained elevated levels of RPE65 and cellular retinaldehyde-binding protein (CRALBP), suggesting a particular role of these two proteins for the retinoid metabolism of cones.|retinoid|CRALBP|40|27|Arg1:T14|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23265880|A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol.|(2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol|serotonin transporters|24|13|Arg1:T8|Arg2:T15|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23270282|These two families of guanidine alkaloids clearly showed a structure-activity relationship with the crambescins acting on voltage-gated potassium channels, while Cramb816 blocks the voltage-gated calcium channel Cav1 with higher potency than nifedipine.|Cramb816|voltage-gated calcium channel|22|25|Arg1:T18|Arg2:T62|CHEMICAL|GENE-N|INHIBITOR
23583259|  Rilpivirine and etravirine are second generation non-nucleoside reverse transcriptase inhibitors approved recently by the United States Food and Drug Administration for the treatment of human immunodeficiency virus-1 infection.|etravirine|reverse transcriptase|3|8|Arg1:T9|Arg2:T54|CHEMICAL|GENE-Y|INHIBITOR
16425993|Sorafenib has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and PDGFR-beta.|Sorafenib|PDGFR-beta|1|29|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|acetazolamide|CA V|12|29|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
16368818|  Cyclooxygenase-1 (COX-1) inhibition by a selective inhibitor valeryl salicylate, or nonselective inhibitors at 10 mg/kg, including aspirin, ibuprofen, indomethacin, and picroxicam, attenuated by 29%-46% the duration of loss of righting reflex induced by diazepam (20 mg/kg) in mice.|picroxicam|Cyclooxygenase-1|28|1|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
10768298|METHODS: The inhibition constants (Ki) of TPM and acetazolamide (AZM) for CA I, CA II, CA III, CA IV, CA V, and CA VI were determined for human (HCA), rat (RCA), or mouse (MCA).|TPM|CA I|10|17|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|INHIBITOR
23066090|Herein, we report the identification and characterization of 3-(5-tert-butyl-isoxazol-3-yl)-2-[(3-chloro-phenyl)-hydrazono]-3-oxo-propionitrile (ESI-09), a novel noncyclic nucleotide EPAC antagonist that is capable of specifically blocking intracellular EPAC-mediated Rap1 activation and Akt phosphorylation, as well as EPAC-mediated insulin secretion in pancreatic β cells.|nucleotide|insulin|29|50|Arg1:T5|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
12582227|  OBJECTIVE: Preclinical evaluation of DRF 2655, a peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent.|DRF 2655|PPARalpha|6|15|Arg1:T11|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
23178182|UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801.|MK-801|NMDA receptor|25|22|Arg1:T18|Arg2:T40|CHEMICAL|GENE-N|ANTAGONIST
18055877|Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.|Thionamides|Rac1|1|11|Arg1:T14|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
17673606|Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporter.|Desvenlafaxine succinate|human norepinephrine transporter|1|10|Arg1:T23|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST
23220742|P505-15 (also known as PRT062607) is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.|PRT062607|SYK|6|20|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23465612|Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.|dihydroisoquinoline|BACE-1|5|6|Arg1:T5|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
11885959|Accordingly, docking of different COX inhibitors, including selective and non-selective ligands: rofecoxib, ketoprofen, suprofen, carprofen, zomepirac, indomethacin, diclofenac and meclofenamic acid were undertaken using the AMBER program.|ketoprofen|COX|17|6|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|DIRECT-REGULATOR
17016711|Dexamethasone probes glucocorticoid receptor (GR) function, while prednisolone probes both GR and mineralocorticoid receptor (MR) function.|prednisolone|mineralocorticoid receptor|11|16|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17434872|Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency.|2,6-dichloro|human COX-2|17|14|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
16982784|We also showed that (i) k3 was the rate-limiting step for the hydrolysis of cefotaxime by Asp104Lys, (ii) the Km for cefotaxime of the doubly substituted Asp104Lys Gly238Ser variant approached that of the Gly238Ser beta-lactamase as pH increased, and (iii) Lys at position 104 functions in an energetically additive manner with the Gly238Ser substitution to enhance catalysis of cephalothin.|cefotaxime|Asp104Lys|17|19|Arg1:T4|Arg2:T30|CHEMICAL|GENE-N|SUBSTRATE
23532918|Ifenprodil, known as the GluNR2B antagonist of reference, was chosen as the template for the elaboration of probes.|Ifenprodil|GluNR2B|1|6|Arg1:T9|Arg2:T24|CHEMICAL|GENE-Y|ANTAGONIST
23605695|Pasireotide has a receptor binding profile that is distinct from that of other somatostatin analogues, binding with high affinity to somatostatin receptor subtype 5, which is strongly over expressed in corticotroph adenoma cells.|Pasireotide|somatostatin receptor subtype 5|1|22|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23220614|Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the ISO-induced the Bax/Bcl-2 ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.|U0126|Bax|3|14|Arg1:T21|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23449981|Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen.|ceramide|SM synthase|11|17|Arg1:T7|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
16757355|Further characterization of sorafenib revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis.|sorafenib|platelet-derived growth factor receptor|4|28|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
10611634|In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT(1A) sites versus marked antagonist actions at halpha(2)-ARs. While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.|yohimbine|h5-HT(1A)|4|14|Arg1:T49|Arg2:T58|CHEMICAL|GENE-Y|AGONIST
17207582|EGTA and 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetra acetic acid tetrakis (BAPTA), two Ca2+ chelators, but not nifedipine, an L-type Ca2+ channel blocker, prevented GRIP1 degradation.|nifedipine|L-type Ca2+ channel|28|31|Arg1:T21|Arg2:T52|CHEMICAL|GENE-N|INHIBITOR
10207608|Pretreatment of the splenocytes with both BPB and AACOCF3 suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced IL-2 secretion in a concentration-dependent manner.|AACOCF3|IL-2|9|16|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
19029287|  The L-type calcium channel (LTCC) isoforms Ca(v)1.2 and Ca(v)1.3 display similar 1,4-dihydropyridine (DHP) binding properties and are both expressed in mammalian brain.|1,4-dihydropyridine|Ca(v)1.2|22|9|Arg1:T8|Arg2:T25|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23552101|PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase β type I (pip5k1β), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2].|phosphatidylinositol 4-phosphate|pip5k1β|23|10|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|SUBSTRATE
23615471|Treatment with CAPE decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.|CAPE|phospho-FoxO3a|3|32|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23376440|Arsenite-induced ROS generation and COX-2 expression were significantly attenuated by treatment with melatonin (a ROS scavenger), but enhanced by DL-buthionine-(S, R)-sulfoximine (BSO, an inhibitor of gamma-glutamylcysteine synthetase (γ-GCS) resulting in lower GSH and increased ROS levels).|DL-buthionine-(S, R)-sulfoximine|γ-GCS|23|39|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
12646997|RESULTS: Icariin and papaverine showed dose-dependent inhibitory effects on PDE5 and PDE4 activities.|Icariin|PDE4|3|13|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23500772|Compared with DM8W group, SOD and ALDH2 in EtOH+DM8W group was increased, MDA was decreased.|EtOH|SOD|10|6|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
16292755|Hepatic mRNA expressions of apo B-100 and apo C-III were significantly lower in probucol group than in other groups.|probucol|apo B-100|14|5|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|FKHR|1|8|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|ACTIVATOR
23527529|IPI-926 is both a substrate and inhibitor (IC50 = 1.9 µM) of P-glycoprotein.|IPI-926|P-glycoprotein|1|15|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|SU11248|tyrosine kinase|31|21|Arg1:T17|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
23396419|(-)-Epigallocatechin gallate, cyclosporin A, rifampicin, and telmisartan inhibited transport of dioscin in OATP1B3-HEK293 cells.|dioscin|OATP1B3|17|19|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|SUBSTRATE
22975155|Computational molecular modeling of RS41A and RS194B interactions with VX inhibited hAChE, bound reversibly in Michaelis type complex and covalently in the pentacoordinate reaction intermediate suggests that the faster reactivation reaction is a consequence of a tighter RS194B interactions with hAChE peripheral site (PAS) residues, in particular with D74, resulting in lower interaction energies for formation of both the binding and reactivation states.|RS41A|hAChE|5|12|Arg1:T1|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
22659408|Glycine release is regulated by metabotropic glutamate receptors sensitive to mGluR2/3 ligands and activated by N-acetylaspartylglutamate (NAAG).|NAAG|metabotropic glutamate receptors|18|6|Arg1:T32|Arg2:T43|CHEMICAL|GENE-N|ACTIVATOR
2833901|These observations suggest that some of the pharmacological actions of felodipine on smooth muscle may involve inhibition of calmodulin-dependent enzymes which are functionally involved in the regulation of smooth muscle contraction.|felodipine|calmodulin-dependent enzymes|11|19|Arg1:T22|Arg2:T66|CHEMICAL|GENE-N|INHIBITOR
12818701|alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.|WB-4101|alpha(1A)-Adrenoceptor|18|1|Arg1:T19|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
15887238|  Imatinib mesylate is a tyrosine kinase inhibitor of the ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases.|Imatinib mesylate|ABL|1|10|Arg1:T1|Arg2:T38|CHEMICAL|GENE-Y|INHIBITOR
23142425|Subjects carrying the UGT2B7 268 His/Tyr or Tyr/Tyr genotype had significantly lower total NNAL than those carrying His/His genotype.|His|UGT2B7|18|4|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|PART-OF
16686685|However, pretreatment with agents that block late I(Na), like lidocaine, mexiletine, and RSD1235, a novel mixed ion channel blocker for the rapid pharmacologic conversion of atrial fibrillation, significantly attenuates the prolonging effects of Class III agents or those induced by ATX-II, a specific toxin that delays Na channel inactivation and amplifies late I(Na) greatly, mimicking LQT3.|RSD1235|ion channel|20|25|Arg1:T21|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
17353509|Fenofibrate also increased myocardial hypertrophy, cardiac fibrosis, and the ratio of matrix metalloproteinase-2/tissue inhibitor of matrix metalloproteinase-2 in PO PPARalpha-deficient mice.|Fenofibrate|matrix metalloproteinase-2|1|14|Arg1:T2|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15899831|Collectively, the data obtained with AZD2171 are consistent with potent inhibition of VEGF signaling, angiogenesis, neovascular survival, and tumor growth.|AZD2171|VEGF|7|14|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INHIBITOR
12183670|Thus, bupropion acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits DAT and NET function.|bupropion|DAT|3|28|Arg1:T17|Arg2:T43|CHEMICAL|GENE-Y|INHIBITOR
10334992|When bound to bile acids, FXR repressed transcription of the gene encoding cholesterol 7alpha-hydroxylase, which is the rate-limiting enzyme in bile acid synthesis, and activated the gene encoding intestinal bile acid-binding protein, which is a candidate bile acid transporter.|bile acid|cholesterol 7alpha-hydroxylase|23|14|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|PRODUCT-OF
23266503|The decrease in expression of matrix metalloproteinases (MMP)-2 and MMP-9 may contribute to the effects of baicalein.|baicalein|MMP-9|20|13|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23146695|These findings demonstrate that puerarin successfully reverses hepatotoxicity in CCl(4)-induced HF rats via the underlying mechanisms of regulating serum enzymes and attenuating TNF-α/NF-κB pathway for anti-inflammation response, as well as improving metabolic function in liver tissue.|puerarin|NF-κB|5|28|Arg1:T2|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|pyrano[2,3-b]quinolines|butyrylcholinesterase|17|7|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INHIBITOR
23165153|Pretreatment of the resistant cells with a potent proteasome inhibitor Z-Leu-Leu-Leu-al augmented the CDDP sensitization elicited by the AKR inhibitors.|Z-Leu-Leu-Leu-al|proteasome|11|9|Arg1:T6|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
16829128|"Similar to menthol, both camphor and cinnamaldehyde (initially reported to be specific activators of TRPV3 and TRPA1, respectively) also modulate other thermoTRPs. Therefore, we find that many ""sensory compounds"" presumed to be specific have a promiscuous relationship with thermoTRPs."|menthol|TRPA1|3|19|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|ACTIVATOR
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|valproate|S467C|12|16|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|INHIBITOR
10874136|In myocardial preparations isolated from guinea pigs treated with beta-naphthoflavone (80 mg/kg i.p.for 2 days), DT-diaphorase activity was enhanced (+36% with respect to control animals, P < 0.|beta-naphthoflavone|DT-diaphorase|10|19|Arg1:T1|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR
23295229|  Aldehyde dehydrogenase 1 (ALDH1A1) catalyzes the oxidation of toxic aldehydes to carboxylic acids.|aldehydes|ALDH1A1|12|5|Arg1:T26|Arg2:T44|CHEMICAL|GENE-Y|SUBSTRATE
23440867|Targeted agents currently approved or under investigation for SCCHN include epidermal growth factor receptor (EGFR) monoclonal antibodies (cetuximab, panitumumab, zalutumumab, nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib, erlotinib, lapatinib, afatanib, dacomitinib), vascular endothelial growth factor receptor (VEGFR) inhibitors (bevacizumab, sorafenib, sunitinib, vandetanib) and various inhibitors of other pathways and targets, including phosphatidylinositol 3' kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR), MET and insulin-like growth factor receptor (IGF-1R).|lapatinib|tyrosine kinase|39|31|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|INHIBITOR
23303191|Comparison of different human cell types revealed ∼50-fold differences in the content of UDP-N-acetylhexosamines and UDP-glucuronic acid, correlating with the expression level of Has1, suggesting cellular coordination between Has1 expression and the content of UDP-sugars.|UDP|Has1|16|25|Arg1:T9|Arg2:T30|CHEMICAL|GENE-Y|SUBSTRATE
23295224|Three of the AKRs used (AKR1B1, AKR1B10 and AKR3C1) could produce 2,3-butanediol from acetoin.|acetoin|AKR3C1|17|11|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|SUBSTRATE
10460702|We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating eNOS activation.|[3H]L-Arg|eNOS|14|26|Arg1:T15|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
23566884|The immunoblotting assays indicate that tomatidine is very effective in suppressing the phosphorylation of Akt and extracellular signal regulating kinase (ERK).|tomatidine|ERK|6|22|Arg1:T17|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
1744096|We observed that the removal of the labeled upper axial ligands from CN-Cbl and Me-Cbl both paralleled the activation of human apomethionine synthase.|Me-Cbl|human apomethionine synthase|15|21|Arg1:T35|Arg2:T54|CHEMICAL|GENE-Y|ACTIVATOR
12531805|We show that SU11248 also has potent activity against wild-type FLT3 (FLT3-WT), FLT3-ITD, and FLT3 activation loop (FLT3-Asp835) mutants in phosphorylation assays.|SU11248|FLT3|4|13|Arg1:T9|Arg2:T34|CHEMICAL|GENE-Y|INHIBITOR
24365491|In addition, pseudoephedrine significantly suppressed the production of p-IkappaB-alpha, reducing the degradation of sequestered nuclear factor kappa B (NF-kappaB) in the cytoplasm, and inhibited the translocation of NF-kappaB/p65 to the nucleus, the transcription of TNF-alpha mRNA and the production of TNF-alpha in primary KCs. These results suggest that pseudoephedrine and ephedrine have a potent anti-inflammatory activity against D-GalN/LPS-induced acute liver failure in rats, and this comprehensive anti-inflammatory effect may result from the inhibition of TNF-alpha production.|pseudoephedrine|p65|4|34|Arg1:T6|Arg2:T29|CHEMICAL|GENE-Y|INHIBITOR
10405348|Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.|paclitaxel|tumor necrosis factor alpha|13|3|Arg1:T20|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
12477282|Experimental manipulation of the intracellular GSSG concentration during inhibition of cellular prooxidant production demonstrated that increased intracellular GSSG is a primary signal that is directly or indirectly required for CpG-induced NF-kappaB activation but is not in itself sufficient to trigger this in the absence of CpG ODN.|GSSG|NF-kappaB|18|31|Arg1:T4|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
18055877|Using primary human T-lymphocytes, we show that the heterocyclic thionamides carbimazole and propylthiouracil inhibit synthesis of the proinflammatory cytokines tumor necrosis factor (TNF)alpha and interferon (IFN)gamma.|propylthiouracil|tumor necrosis factor (TNF)alpha|14|21|Arg1:T12|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23561118|Results showed that EEAP and quercetin but not ferulic acid protected β-cells from glucotoxicity through several mechanisms, including: (1) maintaining β-cell viability; (2) suppressing reactive oxygen species production; (3) reducing characteristic features of apoptosis; (4) inhibiting the activation of caspase-9 and caspase-3 and the cleavage of poly (ADP-ribose) polymerase; (5) upregulating pancreatic and duodenal homeobox 1 gene expression and the insulin secretagogue action of pancreatic β-cells.|quercetin|caspase-3|6|55|Arg1:T9|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
10076535|Down-regulation of prostate-specific antigen (PSA) expression, an AR-target gene, by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor.|bicalutamide|AR|17|11|Arg1:T19|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
11785774|The clenbuterol-induced ACTH and corticosterone responses were considerably impaired by pretreatment with piroxicam, and slightly less potently by NS-398.|piroxicam|ACTH|13|3|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23589329|Collectively, these findings provide evidence that arsenic causes prolonged activation of Nrf2 through autophagy dysfunction, possibly providing a similar scenario to constitutive activation of Nrf2 found in certain human cancers.|arsenic|Nrf2|8|27|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
15972446|Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.|PKC412|tyrosine kinase|7|4|Arg1:T10|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
9873034|  Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O2.|nitric oxide|inducible nitric oxide synthase|14|2|Arg1:T36|Arg2:T58|CHEMICAL|GENE-Y|PRODUCT-OF
16940412|Of the two tubulin structures available, we selected for modeling the complex of a stathmin fragment with two tubulin heterodimers with two bound colchicinoid molecules and a single bound vinblastine between the two heterodimers (Nature (Lond) 435:519-522, 2005).|vinblastine|stathmin|31|16|Arg1:T20|Arg2:T33|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10685879|Among the LAs tested, procaine and other ester-type LAs inhibited [3H]DA uptake and binding of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (CFT), a cocaine analogue, in COS cells expressing rat dopamine transporter (DAT).|[3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane|DAT|20|44|Arg1:T21|Arg2:T45|CHEMICAL|GENE-Y|DIRECT-REGULATOR
6433001|However, calmodulin antagonists were found to inhibit [3H]nitrendipine binding with the order of potency: pimozide greater than less than calmidazolium (R 24571) greater than trifluoperazine greater than chlorpromazine greater than promethazine greater than chlorpromazine sulfoxide, that correlates quite well with the potency of these drugs as inhibitors of calmodulin-dependent processes.|R 24571|calmodulin|27|3|Arg1:T5|Arg2:T32|CHEMICAL|GENE-N|DIRECT-REGULATOR
23238103|To control for possible interactions between the expression of the estrogen receptor genes and other learning-related steroid receptors, androgen receptors (AR), corticosterone-binding glucocorticoid receptors (GR) and mineralocorticoid receptors (MR) were also measured.|corticosterone|MR|26|36|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23117572|In NTERA cells treated with the histone deacetylase inhibitors SAHA and valproic acid, a significant increase in NIS mRNA (about 60- and 30-fold vs control, P<0.001 and P<0.01 respectively) and protein levels, resulting in enhanced ability to uptake radioiodine, was observed.|valproic acid|NIS|12|19|Arg1:T2|Arg2:T14|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17008880|Taken together, vitamin C uptake is increased in UVB-irradiated keratinocytes through the translocation of SVCT-1 and regulates inflammatory response in the skin via the downregulation of IL-8 and MCP-1 production.|vitamin C|IL-8|4|28|Arg1:T2|Arg2:T16|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
19281809|  The low-affinity sodium glucose cotransporter (SGLT2) is responsible for most of the glucose reabsorption in the kidney and has been highlighted as a novel therapeutic target for the treatment of diabetes.|glucose|sodium glucose cotransporter|15|3|Arg1:T25|Arg2:T32|CHEMICAL|GENE-N|SUBSTRATE
10340919|METHODS: COX-1 inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily).|diclofenac|COX-1|34|3|Arg1:T17|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
15694390|Nordihydroguaiaretic acid inhibits IFN-gamma-induced STAT tyrosine phosphorylation in rat brain astrocytes.|Nordihydroguaiaretic acid|IFN-gamma|1|4|Arg1:T17|Arg2:T47|CHEMICAL|GENE-Y|INHIBITOR
23085435|The present results indicated that N-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways.|BPs|MEK|7|33|Arg1:T13|Arg2:T29|CHEMICAL|GENE-N|INHIBITOR
17409318|The accumulation of the post-D6D products of 22:5n-3, 24:6n-3 and DHA, in cell phospholipids was saturated at concentrations of >18 microM ALA.|DHA|D6D|12|6|Arg1:T20|Arg2:T29|CHEMICAL|GENE-Y|PRODUCT-OF
12504917|Reserpine-induced ptosis was reversed by rasagiline at doses above 2 mg x kg(-1) i.p., which inhibit MAO-A as well as MAO-B, but not at MAO-B-selective doses.|rasagiline|MAO-B|6|25|Arg1:T21|Arg2:T40|CHEMICAL|GENE-Y|INHIBITOR
23542513|In addition, 5HHMF blocked LPS-induced phosphorylation of IκB, resulting in suppression of the nuclear translocation of nuclear factor-κB (NF-κB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression.|5HHMF|nuclear factor-κB|4|19|Arg1:T13|Arg2:T35|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
12504917|However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and MAO-B by tranylcypromine together with the monoamine precursors.|rasagiline|MAO-B|34|76|Arg1:T25|Arg2:T44|CHEMICAL|GENE-Y|INHIBITOR
8522988|The recombinant human 5-HT6 receptor is positively coupled to adenylyl cyclase and has pharmacological properties similar to the rat receptor with high affinity for several typical and atypical antipsychotics, including clozapine.|clozapine|human 5-HT6 receptor|32|3|Arg1:T6|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17653850|  Agmatine is an endogenous amine that is synthesized following the decarboxylation of L-arginine by arginine decarboxylase.|L-arginine|arginine decarboxylase|13|15|Arg1:T10|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
23415904|The 7KC/7βOHC ratio was similarly increased when NADPH generation was restricted by disruption of hexose-6-phosphate dehydrogenase.|7KC|hexose-6-phosphate dehydrogenase|2|15|Arg1:T26|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
23220590|At therapeutic drug levels (0.015 mM) and physiologically relevant concentrations of ethanol (10 mM) and acetaldehyde (10 μM) in target tissues, cimetidine could weakly inhibit (<5%) the activities of ADH1B2 and ADH1B3 in liver, ADH2 in liver and small intestine, ADH4 in stomach, and ALDH1A1 in the three tissues, but not significantly affect ADH1A, ADH1B1, ADH1C1/2, or ALDH2.|ethanol|ALDH2|14|76|Arg1:T1|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
15695169|Ramelteon showed very high affinity for human MT1 (Mel1a) and MT2 (Mel1b) receptors (expressed in Chinese hamster ovary [CHO] cells), and chick forebrain melatonin receptors (consisting of Mel1a and Mel1c receptors) with Ki values of 14.0, 112, and 23.1 pM, respectively, making the affinities of ramelteon for these receptors 3-16 times higher than those of melatonin.|Ramelteon|MT2|1|13|Arg1:T9|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23313623|In hOAT1- and hOAT3-HEK293 cells, uptake of entecavir was significantly higher compared to vector-HEK293 cells and was markedly inhibited by p-aminohippurate, benzylpenicillin, and JBP485.|p-aminohippurate|hOAT3|22|4|Arg1:T9|Arg2:T31|CHEMICAL|GENE-Y|INHIBITOR
11959556|  Amino acid alterations in or flanking conserved motifs making up the active binding sites of penicillin-binding proteins (PBPs) 1a, 2b, and 2x of pneumococci were correlated with changes in affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor for these PBPs. Four penicillin-susceptible (PSSP), eight penicillin-intermediate (PISP), and six penicillin-resistant (PRSP) pneumococci were studied by DNA sequencing of the penicillin-binding sites of the pbp1a, -2x, and -2b genes of strains and by determining 50% inhibitory concentrations of the seven agents for PBP1a, -2x, and -2b.|cefprozil|PBPs|46|52|Arg1:T15|Arg2:T44|CHEMICAL|GENE-N|DIRECT-REGULATOR
16298345|However, as with the human receptor, maraviroc was shown to be a high affinity, potent functional antagonist of macaque CCR5 thereby indicating that the macaque should be a suitable species in which to evaluate the pharmacology, safety and potential mechanism-related toxicology of novel CCR5 antagonists.|maraviroc|CCR5|9|48|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|ANTAGONIST
23334403|  PURPOSE: To characterise further the previously observed cytochrome P450 3A4 (CYP3A4) interaction of the dual orexin receptor antagonist almorexant.|almorexant|orexin receptor|22|19|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|ANTAGONIST
23567045|The Lac-GLN formulation contained N-lactobionyl-dioleoyl phosphatidylethanolamine (Lac-DOPE), a ligand for the asialoglycoprotein receptor (ASGR), and an antibiotic peptide gramicidin A.|N-lactobionyl-dioleoyl phosphatidylethanolamine|asialoglycoprotein receptor|5|15|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR
10351938|Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils.|fluticasone propionate|cPLA2|10|3|Arg1:T25|Arg2:T36|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
2386945|Although numerous mechanisms of action of pimozide and thioridazine have been identified, both drugs are calmodulin antagonists at drug concentrations that inhibit breast cancer cell growth in vitro.|thioridazine|calmodulin|9|17|Arg1:T9|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST
23208609|Expression of particular steroidogenic genes, including the one encoding for aromatase (CYP19A1), was significantly upregulated after incubation of H295R cells with 2-ITX, 4-ITX, and 2,4-diethyl-TX.|2,4-diethyl-TX|aromatase|31|12|Arg1:T9|Arg2:T32|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
8384226|RESULTS: Nedocromil sodium inhibited the chemotactic response toward FMLP and NAF/IL-8 of GM-CSF primed eosinophils approximately 60% (inhibitory concentration of 50% [IC50] approximately 1 to 10 nmol/L), whereas these responses of IL-3 primed eosinophils was completely inhibited (IC50 approximately 1 nmol/L).|Nedocromil sodium|IL-3|3|40|Arg1:T8|Arg2:T11|CHEMICAL|GENE-Y|INHIBITOR
23449888|p14ARF perturbs the androgen-induced interaction between the N terminus and C terminus of AR.|C|AR|11|14|Arg1:T5|Arg2:T22|CHEMICAL|GENE-Y|PART-OF
15618457|Isoproterenol rapidly induced phosphorylation of Akt and FKHR in eosinophils in a PI3K-dependent manner.|Isoproterenol|PI3K|1|13|Arg1:T7|Arg2:T18|CHEMICAL|GENE-N|ACTIVATOR
15240345|Incubations with purified lactate dehydrogenase suggested that this enzyme was responsible for the metabolism of glycolate to oxalate in HepG2 cells.|oxalate|lactate dehydrogenase|18|4|Arg1:T33|Arg2:T39|CHEMICAL|GENE-N|PRODUCT-OF
1280065|Inhibition of binding of both plasminogen and plasmin to gp330 by benzamidine was similar, although EACA inhibited the binding of plasmin to gp330 slightly more than the binding of plasminogen to gp330.|EACA|plasminogen|17|31|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23419872|Our previous studies showed that overexpression of two mitochondrial anion transporters, the dicarboxylate (DIC, Slc25a10) and oxoglutarate (OGC, Slc25a11) carriers, in NRK-52E cells resulted in increased mitochondrial uptake of glutathione (GSH) and protection from chemically induced apoptosis.|GSH|Slc25a10|40|18|Arg1:T1|Arg2:T17|CHEMICAL|GENE-Y|SUBSTRATE
23159986|HDN induced by D-limonene was reversible, but with a variable renal biomarker pattern over time: Day 8 there was increased αGST, μGST and albumin; on Day 15 increased clusterin, albumin and Kim-1.|D-limonene|Kim-1|4|37|Arg1:T6|Arg2:T31|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22614004|Using pharmacologic and molecular approaches that suppress the prolyl-hydroxylase (PHD)-mediated inhibition of HIF1α, we show that DCA inhibits HIF1α by both a PHD-dependent mechanism (that involves a DCA-induced increase in the production of mitochondria-derived α-ketoglutarate) and a PHD-independent mechanism, involving activation of p53 via mitochondrial-derived H(2)O(2), as well as activation of GSK3β.|DCA|GSK3β|21|67|Arg1:T12|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
20426763|As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose).|AL-34662|5HT(2C)|9|46|Arg1:T20|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16757355|A novel class of biaryl urea that inhibits C-RAF kinase was discovered using a combination of medicinal and combinatorial chemistry approaches.|biaryl urea|kinase|5|10|Arg1:T5|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
8643547|Catecholamines exhibit a 3-fold higher affinity, and histamine exhibits a 30-fold higher affinity, for VMAT2.|Catecholamines|VMAT2|1|17|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15155769|In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain acyl-CoAs. Another CrAT mutant, M564A, was prepared and tested in the same way, with similar results.|acyl-CoAs|COT|32|20|Arg1:T15|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
11669456|These OTA uptakes were inhibited by several substrates for the OATs. Para-aminohippuric acid (PAH), probenecid, piroxicam, octanoate and citrinin inhibited [3H]-OTA uptake by hOAT1 and hOAT3 in a competitive manner (Ki = 4.29-3080 microM), with the following order of potency: probenecid > octanoate > PAH > piroxicam > citrinin for hOAT1; probenecid > piroxicam > octanoate> citrinin > PAH for hOAT3.|piroxicam|hOAT1|21|33|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|INHIBITOR
8667211|  Previous studies by this research team proved that vasodilating prostaglandins (PGs) E1, E2 and I2 inhibit carbonic anhydrase (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs. Relying on these findings, as well as on our clinical observations, we studied in vitro and in vivo the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on CA I and CA II.|PGs|CA|12|23|Arg1:T9|Arg2:T20|CHEMICAL|GENE-N|INHIBITOR
12213059|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells.|6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide|ATP sensitive potassium channels|1|12|Arg1:T17|Arg2:T31|CHEMICAL|GENE-N|ACTIVATOR
10328230|  We have examined the effects of the synthetic matrix metalloproteinase inhibitor, batimastat (BB-94) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice.|batimastat|matrix metalloproteinase|13|9|Arg1:T13|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
23231492|"We aim to ""tilt"" the stability of the H1 loop structure from a noncanonical conformation to a (humanized) type 1 canonical conformation by studying the effect of selected mutations to the amino acid sequence of the H1, H2, and proximal residues."|amino acid|H2|36|43|Arg1:T1|Arg2:T12|CHEMICAL|GENE-N|PART-OF
12177684|In vitro and in microiontophoresis, flibanserin behaves as a 5-HT(1A) agonist, a very weak partial agonist on dopamine D(4) receptors, and a 5-HT(2A) antagonist.|flibanserin|dopamine D(4) receptors|7|23|Arg1:T10|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
23205634|Both wild-type ABCG2 and its R482G mutant variant require cholesterol for full activity, although they exhibit different cholesterol sensitivities.|cholesterol|R482G|10|6|Arg1:T5|Arg2:T21|CHEMICAL|GENE-N|ACTIVATOR
23473801|In conclusion, hinokitiol may inhibit platelet activation by inhibiting the PLCγ2-PKC cascade and hydroxyl radical formation, followed by suppressing the activation of MAPKs and Akt.|hinokitiol|Akt|4|27|Arg1:T7|Arg2:T25|CHEMICAL|GENE-N|INHIBITOR
15650315|CONCLUSION: Our results indicate that pranlukast inhibits IL-5 synthesis via a mechanism distinct from CysLTR1 antagonism.|pranlukast|IL-5|7|9|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|SB 200646A|5-HT receptor|58|1|Arg1:T7|Arg2:T27|CHEMICAL|GENE-N|ANTAGONIST
23540839|  The fragment indole-6-carboxylic acid (1F1), previously identified as a flap site binder in a fragment-based screen against HIV protease (PR), has been cocrystallized with pepstatin-inhibited PR and with apo-PR.|indole-6-carboxylic acid|PR|3|32|Arg1:T1|Arg2:T10|CHEMICAL|GENE-N|DIRECT-REGULATOR
8788445|The analgesic actions of (-)-pentazocine are readily reversed by nor-binaltorphimine, but not by the mu-selective opioid receptor antagonist beta-funaltrexamine, implying a kappa 1-opioid receptor mechanism of action.|beta-funaltrexamine|mu-selective opioid receptor|23|19|Arg1:T7|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST
16867246|METHODS: We identified seven SNP(single nucleotide polymorphism) (-141Cins>del, TaqIB, TaqID, Ser311Cys, rs6275, rs6277 and TaqIA) in the DRD2 gene in 146 schizophrenic inpatients (59 with EPS and 87 without EPS according to the Simpson-Angus Scale) treated with chlorpromazine after 8 weeks.|nucleotide|Ser311Cys|9|21|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|PART-OF
23296101|These results show that phthalate esters activate TRPA1 and TRPV1 with selectivity.|phthalate esters|TRPV1|5|10|Arg1:T5|Arg2:T29|CHEMICAL|GENE-Y|ACTIVATOR
23047001|Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).|BTZs|GSK-3β|10|22|Arg1:T7|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23388705|We studied the binding and transmembrane transport of tecadenoson by recombinant human equilibrative nucleoside transporters (hENTs) hENT1 and hENT2, and human concentrative nucleoside transporters (hCNTs) hCNT1, hCNT2, and hCNT3 in vitro and by mouse mENT1 in vivo.|tecadenoson|hCNT2|9|33|Arg1:T8|Arg2:T37|CHEMICAL|GENE-Y|SUBSTRATE
23219887|Finally, our comparative sequence analyses revealed that the residues equivalent to Asp121 and Phe170 are highly conserved in many ALDH families irrespective of their substrate specificity-suggesting that they perform a role in catalysis additional or different to binding of the substrate-and that the positions Met124, Cys301, and Cys303 are hot spots changed during evolution to confer aldehyde specificity to several ALDH families.|Cys|ALDH|51|64|Arg1:T12|Arg2:T34|CHEMICAL|GENE-N|PART-OF
17526944|These observations strongly support the concept that dexamethasone suppresses rat testicular testosterone production, at least in part, by increasing the amount of complexed DAX-1-SF-1 in these cells, which leads directly to decreased availability of free SF-1 and, therefore, decreased activation of transcription of the rat StAR gene.|dexamethasone|DAX-1|8|26|Arg1:T5|Arg2:T39|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
19203467|RESULTS: Both PLZ and VIG inhibited GABA-T and elevated GABA levels.|VIG|GABA-T|6|8|Arg1:T47|Arg2:T77|CHEMICAL|GENE-Y|INHIBITOR
23396090|In contrast, liposomal CDDP induced expression of genes from DNA damage pathways and several genes of the extrinsic pathway of apoptosis (TNFRSF10B-DR5, CD70-TNFSF7).|CDDP|DR5|5|25|Arg1:T1|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
14660028|Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-buta nol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors.|(+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2 -yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate|beta(1)-adrenoceptor|6|40|Arg1:T10|Arg2:T22|CHEMICAL|GENE-Y|ANTAGONIST
22537794|Studies with the Y335A DAT mutant showed that the R- and S-enantiomers tolerated the inward-facing conformation better than cocaine, which was further supported by [2-(trimethylammonium)ethyl]-methanethiosulfonate reactivity on the DAT E2C I159C.|cocaine|DAT|19|5|Arg1:T4|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
11319222|The ACS inhibitor triacsin C strongly inhibited ACS1 and ACS4, but not ACS5.|triacsin C|ACS4|4|10|Arg1:T32|Arg2:T62|CHEMICAL|GENE-Y|INHIBITOR
23435916|Pristimerin suppressed not only the generation of nitric oxide (NO) and prostaglandin E2, but also the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysacharide (LPS) in murine macrophage RAW264.7 cells.|prostaglandin E2|cyclooxygenase-2|14|26|Arg1:T7|Arg2:T13|CHEMICAL|GENE-Y|PRODUCT-OF
16763553|Further, cholesterol metabolites, predominantly the oxysterols, the natural ligands for liver X receptor (LXR), induced these genes via upregulation of sterol regulatory element binding protein-1c (SREBP-1c) that bound to the regulatory regions of these genes.|cholesterol|liver X receptor|3|14|Arg1:T14|Arg2:T26|CHEMICAL|GENE-N|DIRECT-REGULATOR
22512587|The present work aims towards examining the functional and structural features that facilitate the binding of small molecules based on Thiazolidinedione pharmacophore to PPARs. The intent of this article is to review all the reported thiazolidinediones and associated groups of PPARγ ligands.|thiazolidinediones|PPARγ|37|42|Arg1:T2|Arg2:T6|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15606893|Characterization of an allosteric citalopram-binding site at the serotonin transporter.|citalopram|serotonin transporter|5|9|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16722247|An increasing number of studies concerning the identification of single nucleotide polymorphisms in the hNET gene and their potential association with disease as well as the functional investigation of naturally occurring or induced amino acid variations in hNET have contributed to a better understanding of NET function, regulation and genetic contribution to disorders.|amino acid|hNET|34|38|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|PART-OF
8102973|the D2 receptor by a factor of 2.8. Other compounds with dopamine D4 receptor selectivity were (+)-apomorphine (8.7), (+)-N-propyl-norapomorphine (NPA) (2.4) and melperone (1.3).|melperone|dopamine D4 receptor|37|13|Arg1:T15|Arg2:T32|CHEMICAL|GENE-Y|ANTAGONIST
14744615|This response was: (1) partly blocked in dogs pretreated intravenously with the antagonists SB224289 (5-HT(1B); 2,3,6,7-tetrahydro-1'-methyl-5-[2'-methyl-4' (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carbonyl]furo[2,3-f]indole-3-spiro-4'-p iperidine hydrochloride), rauwolscine (alpha(2)), BRL44408 (alpha(2A); 2-[2H-(1-methyl-1,3-dihydroisoindole)methyl]-4,5-dihydroimidazole) or MK912 (alpha(2C); (2S,12bS)-1'3'-dimethylspiro(1,3,4,5',6,6',7,12b-octahydro-2Hbenzo[b]furo[2,3-a]q uinazoline)-2,4'-pyrimidin-2'-one); (2) markedly blocked after SB224289 plus rauwolscine; and (3) unaffected after BRL15572 (5-HT(1D); 1-(3-chlorophenyl)-4-[3,3-diphenyl (2-(S,R) hydroxypropanyl) piperazine] hydrochloride) or imiloxan (alpha(2B)).|imiloxan|alpha(2B)|140|142|Arg1:T3|Arg2:T16|CHEMICAL|GENE-Y|ANTAGONIST
21262851|BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (L-VGCCs), which could contribute to reduced neuronal excitability.|neurosteroids|L-VGCCs|18|28|Arg1:T20|Arg2:T53|CHEMICAL|GENE-N|INHIBITOR
23219161|The protein is formed by an N-terminal helicase-like domain, a C-terminal DNA polymerase domain, and a large central domain that spans between the two.|C|C-terminal DNA polymerase domain|12|12|Arg1:T2|Arg2:T10|CHEMICAL|GENE-N|PART-OF
17603759|  L-2-hydroxyglutaric aciduria is a metabolic disorder in which L-2-hydroxyglutarate accumulates as a result of a deficiency in FAD-linked L-2-hydroxyglutarate dehydrogenase, a mitochondrial enzyme converting L-2-hydroxyglutarate to alpha-ketoglutarate.|L-2-hydroxyglutarate|L-2-hydroxyglutarate dehydrogenase|26|19|Arg1:T11|Arg2:T31|CHEMICAL|GENE-Y|SUBSTRATE
9007522|NS-49, an alpha 1A-adrenoceptor agonist, selectively increases intraurethral pressure in dogs.|NS-49|alpha 1A-adrenoceptor|1|4|Arg1:T21|Arg2:T27|CHEMICAL|GENE-Y|AGONIST
12652111|A combination of cilostazol (>15 microM) and the PDE4 selective inhibitor, rolipram (5 microM), inhibited levels of cytosolic cAMP-PDE activity similar to those inhibited by milrinone on its own.|rolipram|PDE4|16|12|Arg1:T21|Arg2:T47|CHEMICAL|GENE-N|INHIBITOR
15210974|These experimental results suggest that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A, supporting previous indications that LEV possesses a mechanism of action distinct from that of other antiepileptic drugs.|LEV|SV2A|12|6|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17163232|This trial investigated the possibility of pharmacokinetic interactions between the AT1 receptor antagonist olmesartan medoxomil and the thiazide diuretic hydrochlorothiazide in healthy subjects.|olmesartan medoxomil|AT1 receptor|14|11|Arg1:T13|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
23123425|The results showed that oral administration of quercetin at doses of 30-60 mg/kg to hyperlipidemia rats for 14 days were highly effective in decreasing the levels of serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT) and aspartate aminotransferase (AST).|quercetin|AST|8|56|Arg1:T3|Arg2:T11|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23200736|In addition, tigecycline dose-dependently decreased cytochrome c release and caspase-3 activity.|tigecycline|caspase-3|4|11|Arg1:T11|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
10653606|Activation of PLA(2) with melittin inhibited 24R, 25-(OH)(2)D(3)-dependent stimulation of PKC, and inhibition of PLA(2) with quinacrine stimulated PKC in response to 24R, 25-(OH)(2)D(3).|quinacrine|PLA(2)|36|31|Arg1:T8|Arg2:T37|CHEMICAL|GENE-N|INHIBITOR
15627430|Since thioridazine binds with similar high affinities to muscarinic receptors as olanzapine and clozapine, muscarinic autoreceptor blockade was ruled out as a primary mechanism [Neuropsychopharmacology 26 (2002) 583].|clozapine|muscarinic receptors|14|9|Arg1:T13|Arg2:T36|CHEMICAL|GENE-N|DIRECT-REGULATOR
17082235|Glinides, sulfonylureas, and other acidified sulfonamides may be promising leads in the development of new PPARgamma agonists.|Glinides|PPARgamma|1|18|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|AGONIST
19651196|The mechanism of OP poisoning involves inhibition of acetylcholinesterase (AChE) leading to inactivation of the enzyme which has an important role in neurotransmission.|OP|AChE|4|11|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
9873034|Imidazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron.|miconazole|iNOSox|8|13|Arg1:T31|Arg2:T56|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2125244|Analysis of this relationship shows that estramustine phosphate and tubulin compete for common MAP2 sites, that MAP2 can bind 5-6 moles.mole-1 estramustine phosphate, and that the Kd of these sites is congruent to 20 microM estramustine phosphate.|estramustine phosphate|MAP2|7|14|Arg1:T2|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23220748|These results suggest that glutathione-conjugated TIC metabolites (TIC-SGs), which were formed in the liver after P450s-mediated metabolism and were excreted extensively into bile by MRP2, mediated the observed alterations of the bile composition.|TIC|P450s|6|19|Arg1:T19|Arg2:T33|CHEMICAL|GENE-N|PRODUCT-OF
14508322|Inhibition of binding of the alpha2-receptor antagonist [3H]RX821002 to recombinant alpha2-receptors by etomidate was tested in human embryonic kidney (HEK293) cells in vitro.|etomidate|alpha2-receptors|16|14|Arg1:T14|Arg2:T31|CHEMICAL|GENE-N|DIRECT-REGULATOR
16291873|Binding sites for hERG blockers have been mapped within the inner cavity of the channel and include aromatic residues in the S6 helix (Tyr-652, Phe-656) and residues in the pore helix (Thr-623, Ser-624, Val-625).|Ser|hERG|38|4|Arg1:T10|Arg2:T19|CHEMICAL|GENE-Y|PART-OF
10193665|Among neuroleptics, the four most potent compounds at the human serotonin transporter were triflupromazine, fluperlapine, chlorpromazine, and ziprasidone (K(D) 24-39 nM); and at the norepinephrine transporter, chlorpromazine, zotepine, chlorprothixene, and promazine (K(D) 19-25 nM).|zotepine|norepinephrine transporter|40|35|Arg1:T17|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10548268|The irreversible MAO-B inhibitors, pargyline (30 mg/kg) and l-deprenyl (3-10 mg/kg) also decreased responding maintained by ethanol reinforcement; these results are consistent with previous findings that both drugs decreased ethanol intake in mice.|l-deprenyl|MAO-B|12|3|Arg1:T2|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
14508322|In alpha2B-receptor-expressing HEK293 cells, etomidate rapidly increased phosphorylation of the extracellular signal-related kinases ERK1/2.|etomidate|extracellular signal-related kinases|6|12|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|ACTIVATOR
7909690|Atovaquone, a naphthoquinone, is a moderate inhibitor of dihydroorotate dehydrogenase in vitro (Ki = 27 microM) but induces major accumulations of CA-asp and DHO.|Atovaquone|dihydroorotate dehydrogenase|1|11|Arg1:T32|Arg2:T35|CHEMICAL|GENE-Y|INHIBITOR
23603339|The androgen receptor seemed to be involved in DHEA-mediated diminishment of CYP1A2 induction, which was attenuated in the presence of bicalutamide, the androgen receptor antagonist.|bicalutamide|androgen receptor|22|25|Arg1:T20|Arg2:T40|CHEMICAL|GENE-Y|ANTAGONIST
10688973|The nonselective opioid receptor partial agonist buprenorphine and the nonselective opioid receptor antagonist (-)-quadazocine exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.|buprenorphine|opioid receptor|7|3|Arg1:T1|Arg2:T15|CHEMICAL|GENE-N|AGONIST
10864881|Comparison of all the beta-adrenoceptor antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>atenolol.|timolol|beta-adrenoceptor|24|5|Arg1:T30|Arg2:T44|CHEMICAL|GENE-N|ANTAGONIST
14967461|Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2).|PKI166|Her2|21|38|Arg1:T12|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
12907245|In contrast, doxorubicin and VP-16 induced p53, and inhibition of p53 decreased drug-induced cell death, suggesting a pro-apoptotic role for p53.|VP-16|p53|6|8|Arg1:T11|Arg2:T28|CHEMICAL|GENE-Y|ACTIVATOR
8666140|Single-strand conformational analysis and nucleotide sequencing of the entire coding region of the PC3 gene in 102 Japanese subjects with NIDDM revealed missense mutations in exons 2 (Arg/Gln53) and 14 (Gln/Glu638), neither of which was associated with NIDDM in this population.|nucleotide|Gln/Glu638|5|34|Arg1:T1|Arg2:T12|CHEMICAL|GENE-N|PART-OF
10947967|  C-terminal amidation, a required post-translational modification for the bioactivation of many neuropeptides, entails sequential enzymic action by peptidylglycine alpha-mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5).|C|EC 4.3.2.5|1|34|Arg1:T1|Arg2:T19|CHEMICAL|GENE-Y|PART-OF
23395003|  Polycomb repressive complex 1 (PRC1) catalyzes lysine 119 monoubiquitylation on H2A (H2AK119ub1) and regulates pluripotency in embryonic stem cells (ESCs).|lysine|H2A|9|15|Arg1:T1|Arg2:T25|CHEMICAL|GENE-N|PART-OF
17521299|Biochemical analysis revealed that systemic 3-NP administration significantly increased lipid peroxidation and nitrite levels, depleted reduced glutathione levels and reduced succinate dehydrogenase (SDH) activity in the brains of rats, whereas administration of naproxen, a nonselective COX inhibitor (10 and 20 mg/kg p.o.) and valdecoxib, a selective COX-2 inhibitor (5 and 10 mg/kg p.o.) significantly attenuated 3-NP-induced oxidative stress.|naproxen|COX|37|41|Arg1:T3|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
16918396|The data produced has highlighted that the atypical profile of APD such as olanzapine and clozapine may reflect antagonism of the 5-HT(2A) and 5-HT(2C) receptors, whilst that of, ziprasidone and quetiapine may reflect partial agonist activity at the 5-HT(1A) receptor, and that of aripiprazole may reflect partial agonist activity at the 5-HT(1A) receptor as well as is its claimed partial agonist activity at the dopamine D(2) receptor.|clozapine|5-HT(2C)|16|27|Arg1:T8|Arg2:T20|CHEMICAL|GENE-Y|ANTAGONIST
11979347|A common polymorphism in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C-->T substitution at nucleotide 677, is associated with homocysteine (Hcy) level elevation.|C|MTHFR|13|9|Arg1:T18|Arg2:T53|CHEMICAL|GENE-Y|PART-OF
2248058|Moclobemide is a relatively weak MAO-A inhibitor in vitro and yet more potent in vivo than other reversible inhibitors, suggesting that the compound may be converted in vivo to an active form.|Moclobemide|MAO-A|1|6|Arg1:T15|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23047001|Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).|ATP|glycogen synthase kinase-3β|15|18|Arg1:T8|Arg2:T13|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23517028|Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design.|Arylpiperazine|β1-Adrenergic Receptor|13|6|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR
7816863|Intraperitoneal administration of (+/- )propranolol HCl (2.5-10 mg/kg), a nonselective beta-adrenoceptor antagonist, dose dependently attenuated the desipramine-induced enhancement of aggressive behavior without significantly affecting the basal aggressive responses.|(+/- )propranolol HCl|beta-adrenoceptor|4|16|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|ANTAGONIST
23589499|MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations.|2-Arylbenzofurans|MAO|5|1|Arg1:T13|Arg2:T26|CHEMICAL|GENE-N|INHIBITOR
17869551|As further support, alpha-methyl-DL-aspartate, an inhibitor of argininosuccinate synthase (AS), a component of the citrulline-NO cycle, inhibited NO production in a dose-dependent manner.|NO|argininosuccinate synthase|24|10|Arg1:T5|Arg2:T34|CHEMICAL|GENE-Y|PRODUCT-OF
23237828|Treatment with actinomycin D prevented cycloheximide-stimulated SOCS-3 mRNA expression, suggesting that the effect of cycloheximide requires new mRNA synthesis.|actinomycin D|SOCS-3|3|7|Arg1:T5|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23073075|  Fingolimod (FTY720), a novel drug approved for the treatment of relapsing-remitting multiple sclerosis, activates different sphingosine-1-phosphate receptor (S1PR) subtypes.|FTY720|sphingosine-1-phosphate receptor|3|20|Arg1:T6|Arg2:T27|CHEMICAL|GENE-N|ACTIVATOR
22708686|In [(35)S]GTPgammaS assays, mianserin selectively activated kappa-opioid receptors.|[(35)S]GTPgammaS|kappa-opioid receptors|2|14|Arg1:T18|Arg2:T41|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22708686|In rat striatum and nucleus accumbens, mianserin stimulated [35S]GTPgammaS binding in a nor-BNI-sensitive manner with maximal effects lower than those of the full kappa-opioid agonists (-)-U50,488 and dynorphin A.|[35S]GTPgammaS|kappa-opioid|10|28|Arg1:T5|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
2833901|Felodipine and the p-chloro analogue inhibited Ca2+/calmodulin-dependent caldesmon kinase with similar potencies (IC50 = 17.4 microM), whereas the oxidized and t-butyl analogues caused no inhibition.|p-chloro|caldesmon kinase|4|8|Arg1:T39|Arg2:T44|CHEMICAL|GENE-N|INHIBITOR
12177684|  Flibanserin has preferential affinity for serotonin 5-HT(1A), dopamine D(4k), and serotonin 5-HT(2A) receptors.|Flibanserin|5-HT(1A)|1|7|Arg1:T1|Arg2:T40|CHEMICAL|GENE-Y|DIRECT-REGULATOR
8799556|RS 17053 showed high affinity and selectivity for alpha 1A adrenoceptors (pKi 8.6) relative to alpha 1B (pKi = 7.3) and alpha 1D (pKi = 7.1) subtypes.|RS 17053|alpha 1B|1|18|Arg1:T39|Arg2:T58|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23583485|The IC50 values were 1.61μg/mL, 20.06μg/mL, 34.76μg/mL (CYP3A4/midazolam), 46.73μg/mL (CYP3A4/testosterone), and 54.52μg/mL, respectively.|testosterone|CYP3A4|17|16|Arg1:T5|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
15126366|I3A was unable to cause the same extent of association of the C1b domain of PKC-delta with lipids, compared with PMA or the physiological regulator diacylglycerol, and was able to partially block the association induced by these agents, measured by surface plasmon resonance.|PMA|PKC-delta|22|16|Arg1:T4|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23376438|The ZEN metabolites induced loss of mitochondrial membrane potential (MMP), mitochondrial changes in Bcl-2 and Bax proteins, and cytoplasmic release of cytochrome c and apoptosis-inducing factor (AIF).|ZEN|apoptosis-inducing factor|2|29|Arg1:T23|Arg2:T40|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23535287|Our study indicated that treatment of HepG2 cells with CSA induces Nrf2-dependent ARE activity and gene expression of heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutamate-cysteine ligase modifier subunits by activation of PI3K/AKT, ERK and JNK signaling pathways.|CSA|PI3K|10|45|Arg1:T12|Arg2:T20|CHEMICAL|GENE-N|ACTIVATOR
17653133|  Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethylarginine to generate L-citrulline and is present in large quantities in the kidney.|dimethylarginine|Dimethylarginine dimethylaminohydrolase|8|1|Arg1:T8|Arg2:T16|CHEMICAL|GENE-Y|SUBSTRATE
10768100|RESULTS: Exposure of in vitro differentiated subcutaneous adipocytes from young normal-weight females to 1 microgram/ml troglitazone for 72 h caused a reduction of both PAI-1 secretion (by 29 +/- 5%; p < 0.01) and PAI-1 mRNA expression (by 26 +/- 3%; p < 0.05).|troglitazone|PAI-1|17|40|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23583258|Oxysterol-dependent NOX1 activation, as well as interleukin synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular phenolic acids and flavonoids.|Oxysterol|interleukin|1|8|Arg1:T17|Arg2:T30|CHEMICAL|GENE-N|INDIRECT-UPREGULATOR
23522182|RESULTS: HbA1c was reduced numerically from baseline by 0.3-0.8% with AZD1656 and by 0.1% with placebo over the first 2 months of treatment, after which effects of AZD1656 started to decline.|AZD1656|HbA1c|13|3|Arg1:T7|Arg2:T17|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10381787|Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.|meloxicam|cyclooxygenase-1|10|5|Arg1:T11|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23357361|Since β-asarone induced lamin B1 expression, a model is proposed in which β-asarone inhibits colorectal cancer by inducing senescence through lamin B1.|β-asarone|lamin B1|14|22|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10947967|In contrast, 2, 4-dioxo-5-acetamido-6-phenylhexanoic acid, which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both PAM and dopamine-beta-hydroxylase.|ascorbate|dopamine-beta-hydroxylase|17|35|Arg1:T5|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23146871|Mn(2+) is transported into cells via a number of mechanisms, while Mn(3+) is believed to be transported similarly to iron (Fe) via the transferrin (Tf) mechanism.|Mn(3+)|transferrin|16|33|Arg1:T11|Arg2:T34|CHEMICAL|GENE-Y|SUBSTRATE
23604717|Collectively, SAL-2 inhibited COX-2 and iNOS gene expression through suppression of NF-κB leading to the inhibition of PGE2 synthesis.|PGE2|COX-2|19|5|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|PRODUCT-OF
23376440|These data indicate that arsenite promotes an induction of ROS, which results in an induction of COX-2 expression through activation of the MAPK pathway.|arsenite|COX-2|5|18|Arg1:T8|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12527923|It is especially effective against MMP-2 and -9 more so than other MMP inhibitors such as Marimastat, Ro 32-3555 and D-2163.|D-2163|MMP|22|13|Arg1:T5|Arg2:T18|CHEMICAL|GENE-N|INHIBITOR
22846225|Chelerythrine, a redox-sensitive PKC inhibitor that inhibits PKMζ and disrupts LTP maintenance and memory storage, was also reported by Wu-Zhang et al.|Chelerythrine|PKC|1|5|Arg1:T14|Arg2:T35|CHEMICAL|GENE-N|INHIBITOR
23435541|In addition, colocalization of acid sphingomyelinase (ASM) and ceramide was induced by OxLDL, which was blocked by statins.|statins|acid sphingomyelinase|22|6|Arg1:T16|Arg2:T30|CHEMICAL|GENE-Y|INHIBITOR
15500910|  Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP.|aspartate|AdSS|19|4|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23478800|Moreover, they established that the inhibitory effect of cucurbitacin I on Rac1 activity involves the alteration of the balance between Rho and Rac.|cucurbitacin I|Rac1|10|13|Arg1:T6|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
14730417|The aim of this study was, therefore, to provide comparative binding characteristics of agonists (epinephrine, norepinephrine, isoproterenol, fenoterol, salbutamol, salmeterol, terbutalin, formoterol, broxaterol) and antagonists (propranolol, alprenolol, atenolol, metoprolol, bisoprolol, carvedilol, pindolol, BRL 37344, CGP 20712, SR 59230A, CGP 12177, ICI 118551) at all three subtypes of human beta-adrenergic receptors in an identical cellular background.|CGP 20712|human beta-adrenergic receptors|56|73|Arg1:T20|Arg2:T33|CHEMICAL|GENE-N|ANTAGONIST
11971019|Apoptosis was abolished by inhibition of ODC and was restored by the polyamines spermidine and spermine.|polyamines|ODC|13|7|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF
23333834|Results confirmed that YR-11 peptide inhibited pro-inflammatory cytokines in the sera and hind paw tissues of AIA rats through its suppressive effect on RANKL induced nuclear translocation of NF-κB.|YR-11|cytokines|4|8|Arg1:T5|Arg2:T24|CHEMICAL|GENE-N|INHIBITOR
22552008|Our studies demonstrate that thalidomide, lenalidomide and another immunomodulatory drug, pomalidomide, bound endogenous CRBN and recombinant CRBN-DNA damage binding protein-1 (DDB1) complexes.|pomalidomide|DDB1|13|25|Arg1:T10|Arg2:T32|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23228696|In this current study, paclitaxel was found to increase phosphorylation of mitogen-activated protein kinase (MAPK) kinase 3/6 (MKK3/6)-p38 MAPK as well as protein and mRNA levels of ERCC1 in H1650 and H1703 cells.|paclitaxel|MAPK|6|25|Arg1:T13|Arg2:T33|CHEMICAL|GENE-N|ACTIVATOR
8710929|These events are stimulated by NE and by guanethidine, an hNET substrate, and they are blocked by cocaine and the antidepressant desipramine.|NE|hNET|6|12|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
23604720|From the 10 isolated compounds, methyl-3,5-di-O-caffeoylquinate showed the most potent inhibition, with IC50 values of 0.30 and 0.67 μM for rAR and rhAR, respectively.|methyl-3,5-di-O-caffeoylquinate|rhAR|7|25|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
23468082|CONCLUSIONS: These encouraging preclinical findings suggest the inhibition of both FGFR2 and mTOR by the ponatinib-ridaforolimus combination may provide a new therapeutic strategy to treat advanced endometrial cancers with dual pathway dysregulation.|ridaforolimus|FGFR2|18|12|Arg1:T6|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
15794712|Imatinib is a small-molecule tyrosine kinase inhibitor of the ABL fusion gene, platelet derived growth factor receptors (PDGFR) and KIT.|Imatinib|tyrosine kinase|1|5|Arg1:T5|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
23598363|Our findings indicate that imatinib protects oocytes from cisplatin-induced cell death by inhibiting c-Abl kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.|cisplatin|BAX|9|22|Arg1:T8|Arg2:T43|CHEMICAL|GENE-Y|ACTIVATOR
23147415|We demonstrate that HZ mice are significantly more sensitive to local AChE inhibition (BW284c51), but remain insensitive to butyrylcholinesterase (BuChE) inhibition (bambuterol).|bambuterol|BuChE|28|24|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23599431|The latter effect was mimicked by a CXCR7-selective agonist TC14012 and abolished by siRNA knockdown of CXCR7.|TC14012|CXCR7|10|8|Arg1:T1|Arg2:T34|CHEMICAL|GENE-Y|AGONIST
16599255|Some of the new compounds proved in a slightly modified colorimetric Ellmann's assay to be potent inhibitors of acetylcholinesterase and of butyrylcholinesterase which is another catalytic enzyme hydrolysing acetylcholine.|acetylcholine|acetylcholinesterase|30|20|Arg1:T6|Arg2:T15|CHEMICAL|GENE-Y|SUBSTRATE
10381000|In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (GTPCH), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (BH4), the obligate cofactor for TPH.|tetrahydrobiopterin|GTP cyclohydrolase I|27|12|Arg1:T5|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
11553608|The purified recombinant protein possesses a cysteine desulfurase activity, is yellow in color, and shows a NifS-like change in absorbance in the presence of L-cysteine.|L-cysteine|cysteine desulfurase|27|7|Arg1:T1|Arg2:T35|CHEMICAL|GENE-N|SUBSTRATE
23432582|Moreover, since reduced levels of p21CIP1 and Chk2 proteins but no change in p53 levels could be detected in MCF-7 cells after BSC 3g or 3n treatment our results suggest that BSC treated cells die from lethal mitosis.|BSC|p21CIP1|24|7|Arg1:T2|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23643664|A similar pattern of susceptibility is observed following acute exposure to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the resistance of TIDA neurons to MPTP is associated with increased expression of parkin and ubiquitin carboxy-terminal hydrolase L-1 (UCHL- 1).|MPTP|parkin|26|33|Arg1:T8|Arg2:T29|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15210974|  Here, we show that the synaptic vesicle protein SV2A is the brain binding site of levetiracetam (LEV), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy.|LEV|synaptic vesicle protein SV2A|19|7|Arg1:T12|Arg2:T17|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15892618|Imatinib mesilate (STI-571, Gleevec(TM)), an inhibitior of bcr-abl TK, which was primarily designed to treat chronic myeloid leukemia is also an inhibitor of c-kit receptor TK, and is currently the drug of choice for the therapy of metastatic gastrointestinal stromal tumors (GISTs), which frequently express constitutively activated forms of the c-kit-receptor.|Imatinib mesilate|bcr|1|15|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
10405348|  The aromatase enzyme, which converts androstenedione to oestrone, regulates the availability of oestrogen to support the growth of hormone-dependent breast tumours.|androstenedione|aromatase|7|2|Arg1:T9|Arg2:T35|CHEMICAL|GENE-Y|SUBSTRATE
10220509|Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.|prostaglandin|cyclooxygenase 2|10|4|Arg1:T10|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF
10471277|Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol.|[(125)I]iodoazidosalmeterol|beta 2-adrenergic receptor|17|8|Arg1:T31|Arg2:T40|CHEMICAL|GENE-N|DIRECT-REGULATOR
9572299|As seen for spermidine stimulation, high-affinity haloperidol inhibition is governed by the region around amino acid 198, based on results from chimeric murine NR2A/NR2B (epislon1/epsilon2) receptors.|amino acid|NR2B|16|27|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|PART-OF
1744096|Methylcobalamin (Me-Cbl) is tightly bound to methionine synthase and is required for enzymatic activity.|Me-Cbl|methionine synthase|3|9|Arg1:T12|Arg2:T50|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12660248|Restoration of l-methionine rapidly down-regulates MAT2A mRNA levels; for this effect, l-methionine needs to be converted into AdoMet.|AdoMet|MAT2A|20|6|Arg1:T13|Arg2:T36|CHEMICAL|GENE-Y|PRODUCT-OF
23071106|Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca(2+) channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells.|nicardipine|L-type Ca(2+) channel|40|33|Arg1:T24|Arg2:T50|CHEMICAL|GENE-N|INHIBITOR
11078056|Selective COX-2 inhibitors, such as meloxicam, celecoxib (SC-58635), and rofecoxib (MK-0966), are NSAIDs that have been modified chemically to preferentially inhibit COX-2 but not COX-1.|rofecoxib|COX-2|15|30|Arg1:T1|Arg2:T14|CHEMICAL|GENE-Y|INHIBITOR
23238783|The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.|bupropion|CYP2B6|12|9|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
8344937|  Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP).|Ca2+|LRP|30|29|Arg1:T2|Arg2:T21|CHEMICAL|GENE-N|DIRECT-REGULATOR
8605869|TWIK-1 channels are probably involved in the control of background K+ membrane conductances.|K+|TWIK-1|11|1|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE
23518299|In addition, SFN protected 6-OHDA-induced apoptosis via blocking DNA fragmentation and caspase-3 activation.|SFN|caspase-3|4|13|Arg1:T17|Arg2:T25|CHEMICAL|GENE-Y|INHIBITOR
8032658|In addition several ligands known to act as agonists at either 5-HT2A or 5-HT2C receptors including 1-m-chlorophenylpiperazine (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.|m-CPP|5-HT2A|19|12|Arg1:T9|Arg2:T61|CHEMICAL|GENE-Y|AGONIST
23486479|Structural Explanation for Allolactose (lac Operon Inducer) Synthesis by lacZ β-Galactosidase and the Evolutionary Relationship between Allolactose Synthesis and the lac Repressor.|Allolactose|β-Galactosidase|4|13|Arg1:T29|Arg2:T39|CHEMICAL|GENE-N|PRODUCT-OF
12126787|The AGE-induced increases in VEGF expression and PKC activation were inhibited by the pan-specific PKC inhibitor, calphostin C, and by the antioxidant drug and compounds, gliclazide, N-acetylcysteine, and vitamin E.|calphostin C|VEGF|18|5|Arg1:T3|Arg2:T26|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|nilotinib|Abl|20|17|Arg1:T1|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
23146690|In combination with clofarabine, the ability of resveratrol to reduce the contents of Sp1 and its target gene products was also evident in a time- and dose-dependent experiment.|clofarabine|Sp1|4|15|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23374869|Inhibition of monoamine oxidase by phthalide analogues.|phthalide|monoamine oxidase|6|3|Arg1:T24|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
15277241|GSTZ1-1 is identical with maleylacetoacetate isomerase, which catalyzes the penultimate step in the catabolic pathways for phenylalanine and tyrosine.|phenylalanine|maleylacetoacetate isomerase|18|5|Arg1:T9|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
23220590|Human alcohol dehydrogenases and aldehyde dehydrogenases (ALDHs), the principal enzymes responsible for metabolism of ethanol, are complex enzyme families that exhibit functional polymorphisms among ethnic groups and distinct tissue distributions.|ethanol|ALDHs|18|8|Arg1:T10|Arg2:T38|CHEMICAL|GENE-N|SUBSTRATE
2833901|The cAMP phosphodiesterase was inhibited completely by felodipine and the p-chloro analogue with IC50 values of 3.7 and 1.5 microM respectively.|p-chloro|cAMP phosphodiesterase|11|2|Arg1:T26|Arg2:T67|CHEMICAL|GENE-N|INHIBITOR
15379894|The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice.|nordihydroguaiaretic acid|arachidonic acid 5-lipoxygenase|6|2|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
11959556|Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.|cefditoren|PBP|28|19|Arg1:T26|Arg2:T60|CHEMICAL|GENE-N|DIRECT-REGULATOR
16926278|Truncated proteins with a complete GAF-B were dimers, but those lacking the N-terminal 46 amino acids of GAF-B were monomers, indicating that these residues are vital for GAF-B-mediated PDE5 dimerization.|N|GAF-B|14|19|Arg1:T1|Arg2:T27|CHEMICAL|GENE-N|PART-OF
23485615|Reverse transcription polymerase chain reaction (RT-PCR) and western blot analyses revealed that CK inhibited DMN-induced increases in matrix metalloproteinase-13 (MMP-13), tissue inhibitor of metalloproteinase-1 (TIMP-1), and tumor necrosis factor-α (TNF-α) mRNA, and collagen type I and α-smooth muscle actin protein.|DMN|α-smooth muscle actin|17|48|Arg1:T16|Arg2:T45|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23319419|Mutations introduced into EAG to replicate the ICA binding site in ERG did not alter the functional response to ICA.|ICA|ERG|8|12|Arg1:T4|Arg2:T28|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23117790|Small interfering RNA directed BDNF, orexin-A, and SB334867 [N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea; a specific orexin-1 receptor antagonist] were administered directly into the hypothalamus.|SB334867|orexin-1 receptor|10|21|Arg1:T7|Arg2:T26|CHEMICAL|GENE-Y|ANTAGONIST
17510490|Therefore, either Phgdh or ASCT1 is provided to each segment of renal tubules, suggesting that metabolic interplay mediated by L-serine biosynthesis and supply may exist in the kidney too.|L-serine|Phgdh|22|4|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|PRODUCT-OF
11736858|CONCLUSIONS: Ebastine (10 mg orally) causes brain histamine H1-receptor occupation of approximately 10%, consistent with its lower incidence of sedative effect, whereas (+)-chlorpheniramine occupied about 50% of brain H1-receptors even at a low but sedative dose of 2 mg; occupancy of (+)-chlorpheniramine was correlated with plasma (+)-chlorpheniramine concentration.|(+)-chlorpheniramine|H1-receptors|53|39|Arg1:T12|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
17498959|Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells.|Sulfated glucosamine|MMP-2|1|4|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|INHIBITOR
15814851|Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer.|estrogen|aromatase|15|3|Arg1:T9|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
23645249|Genistein inhibition of adipose differentiation was accompanied by increased estrogen receptor (ER)-β gene expression and was modestly recapitulated by ERβ selective agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN).|2,3-bis (4-hydroxyphenyl)-propionitrile|ERβ|26|23|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|AGONIST
23558297|AA effects of vinclozolin are mediated by two metabolites, which have an antagonistic effect on the androgen receptor.|vinclozolin|androgen receptor|4|18|Arg1:T8|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST
12535612|A larger conformation change constant for GAD67 than GAD65 supported a significant conformational change induced by the initial PLP binding to GAD67, which affects the other binding site affinity of GAD67.|PLP|GAD67|19|32|Arg1:T7|Arg2:T31|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23019138|Direct-acting CB1 agonists, including Δ(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9β-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia.|9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol|CB1|44|2|Arg1:T21|Arg2:T29|CHEMICAL|GENE-Y|AGONIST
15694390|In addition, two other 5-LO inhibitors (Rev5901 and AA861) did not mimic the effect of NDGA, and the 5-LO metabolites, 5-hydroxyeicosatetraenoic acid and LTB(4), were unable to reverse NDGA-driven suppression of STAT activation or affect basal STAT phosphorylation.|Rev5901|5-LO|9|6|Arg1:T1|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
23424204|Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, BPA significantly decreased the IR, Akt and GLUT4 protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.|BPA|Akt|31|37|Arg1:T14|Arg2:T17|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
14642426|Thus, it can be suggested that the inhibitory action of ginseng saponins against the immobilization stress-induced increase of plasma IL-6 level would be in periphery; at least in part, mediated by blocking norepinephrine- and/or epinephrine-induced increase of IL-6 level in macrophage rather than in the brain.|norepinephrine|IL-6|36|41|Arg1:T9|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23424207|The obtained results showed that Cd increased lipid peroxidation and abnormal sperm count and decreased plasma testosterone, lactate dehydrogenase, acid phosphatase, alkaline phosphatase and testicular steroidogenic enzymes: 3β-hydroxysteroid dehydrogenase (HSD), 17β-HSD activities as well as epididymal sperm counts and motility, while RUT and Se treatment reversed this change to control values.|Cd|lactate dehydrogenase|6|19|Arg1:T21|Arg2:T41|CHEMICAL|GENE-N|INHIBITOR
23288144|In addition, blocking of AhR activation by resveratrol, a well-known AhR antagonist, prevented the SUN-induced CYP1A1 gene expression, further confirms the involvement of AhR.|SUN|CYP1A1|18|19|Arg1:T3|Arg2:T21|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9313928|In addition, three IP ligands, iloprost, carbacyclin and isocarbacyclin, and one TP ligand, STA2, bound to this receptor with Ki values comparable to the Ki values of these compounds for the IP and TP receptors, respectively.|isocarbacyclin|IP|12|5|Arg1:T36|Arg2:T89|CHEMICAL|GENE-Y|DIRECT-REGULATOR
10475242|  Troglitazone and rosiglitazone (BRL49653), members of the thiazolidinedione (TZD) class of antidiabetic drugs, are peroxisome proliferator-activated receptor gamma (PPARgamma) ligands that induce adipocyte differentiation and increase the expression of PPARgamma protein.|Troglitazone|PPARgamma|1|38|Arg1:T1|Arg2:T15|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
9007522|  The effects of NS-49 ((R)-(-)-3'-(2-amino-1-hydroxyethyl)-4'-fluoromethane sulfonanilide hydrochloride), an alpha 1A-adrenoceptor-selective agonist, on intraurethral pressure and blood pressure were investigated in anesthetized dogs.|NS-49|alpha 1A-adrenoceptor|4|23|Arg1:T6|Arg2:T22|CHEMICAL|GENE-Y|AGONIST
10598120|Thus vasopeptidase inhibition with omapatrilat was more effective than ACE inhibition with captopril in preventing changes in LV geometry and premature mortality in hamsters with dilated heart failure.|captopril|ACE|13|10|Arg1:T7|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
12416991|The reduction of 5alpha-dihydroprogesterone (5alpha-DHP), the last step in allopregnanolone biosynthesis, is catalyzed by 3alpha-hydroxysteroid dehydrogenases (3alpha-HSDs).|5alpha-dihydroprogesterone|3alpha-hydroxysteroid dehydrogenases|4|19|Arg1:T9|Arg2:T45|CHEMICAL|GENE-N|SUBSTRATE
11922402|ICI 182,780 (fulvestrant) (Faslodex) and ICI 164,384 are competitive inhibitors of estrogen by binding to the estrogen receptor (ER).|ICI 182,780|estrogen receptor|1|21|Arg1:T7|Arg2:T24|CHEMICAL|GENE-Y|INHIBITOR
8667211|  Previous studies by this research team proved that vasodilating prostaglandins (PGs) E1, E2 and I2 inhibit carbonic anhydrase (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs. Relying on these findings, as well as on our clinical observations, we studied in vitro and in vivo the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on CA I and CA II.|PGs|carbonic anhydrase|12|20|Arg1:T9|Arg2:T15|CHEMICAL|GENE-N|INHIBITOR
12213059|6-Chloro-3-(1-methylcyclobutyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (54) was found to bind and activate the SUR1/Kir6.2 K(ATP) channels in the low nanomolar range and to be at least 1000 times more potent than the reference compound diazoxide with respect to inhibition of insulin release from rat islets.|diazoxide|K(ATP) channels|45|22|Arg1:T14|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR
10373224|  The functional inhibitory characteristics of the angiotensin II type 1 receptor blockers (ARB) candesartan; irbesartan; and losartan and its active metabolite EXP 3174 (EXP) were studied in rabbit aortic strips and rat portal vein preparations in vitro.|irbesartan|angiotensin II type 1 receptor|18|7|Arg1:T1|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
23319591|Methylation of histone H3 on lysine 4 by the lysine methyltransferase SET1 protein is needed for normal clock gene expression.|lysine|histone H3|6|3|Arg1:T1|Arg2:T17|CHEMICAL|GENE-N|PART-OF
11920914|  The rates of inhibition of mouse acetylcholinesterase (AChE; EC 3.1.1.7) by paraoxon, haloxon, DDVP and enantiomers of neutral alkyl methylphosphonyl thioates and cationic alkyl methylphosphonyl thiocholines were measured in the presence and absence of AChE peripheral site inhibitors: gallamine, d-tubocurarine, propidium, atropine and derivatives of coumarin.|DDVP|AChE|19|9|Arg1:T15|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
17620346|All the above COX-2 inhibitors except for rofecoxib had no reactivity with the aldehyde group of benzaldehyde used as a model compound of allysine aldehyde under a physiological pH condition.|rofecoxib|COX-2|8|4|Arg1:T2|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
23296142|Insertion of ERα was blocked by the ER antagonist ICI 182,780 or with the protein kinase C (PKC) pathway inhibitor bisindolylmaleimide (BIS).|BIS|protein kinase C|25|15|Arg1:T4|Arg2:T14|CHEMICAL|GENE-N|INHIBITOR
23220589|The reactivation of brain AChE inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure.|BT-03|AChE|27|5|Arg1:T19|Arg2:T30|CHEMICAL|GENE-Y|ACTIVATOR
23397054|The brain-to-plasma partition coefficient of elacridar in the wild-type mice was 0.82, as compared with 3.5 in Mdr1a/b(-/-) mice, 6.6 in Bcrp1(-/-) mice, and 15 in Mdr1a/b(-/-)Bcrp1(-/-) mice, indicating that both P-gp and Bcrp limit the brain distribution of elacridar.|elacridar|P-gp|57|49|Arg1:T2|Arg2:T14|CHEMICAL|GENE-N|SUBSTRATE
17340133|Limited availability of L-arginine increases DNA-binding activity of NF-kappaB and contributes to regulation of iNOS expression.|L-arginine|NF-kappaB|4|9|Arg1:T10|Arg2:T29|CHEMICAL|GENE-N|ACTIVATOR
16326016|Our microarray analysis of the rodent hypothalamus has revealed that estradiol increases the expression of a number of glial-specific genes, including glutamine synthetase, an enzyme that inactivates glutamate through its conversion to glutamine.|glutamate|glutamine synthetase|30|23|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|SUBSTRATE
23256819|Second, in order to study the response of RHE to chemical sensitizers, the ((13)C)methyldodecanesulfonate was chosen as an NMR probe, and we compared adducts formed on human serum albumin (HSA) in solution and adducts formed in RHE.|((13)C)methyldodecanesulfonate|human serum albumin|16|36|Arg1:T9|Arg2:T11|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23581848|Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.|hydroxamate|histone deacetylase|7|16|Arg1:T7|Arg2:T13|CHEMICAL|GENE-N|INHIBITOR
17049513|  Recent studies have reported that imatinib mesylate, a kinase inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS.|imatinib mesylate|BCR|6|18|Arg1:T4|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
17896959|Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action.|cibenzoline|ion channel|17|2|Arg1:T10|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
12063084|The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.|aripiprazole|human 5-HT1A receptor|3|12|Arg1:T11|Arg2:T19|CHEMICAL|GENE-Y|AGONIST
17899080|  Recently, it was shown that glycoproteins with N-glycans close to the NH(2) terminus can directly enter the calnexin/calreticulin cycle and bypass BiP binding.|NH(2)|glycoproteins|13|7|Arg1:T7|Arg2:T16|CHEMICAL|GENE-N|PART-OF
23047001|  Glycogen synthase kinase-3β (GSK-3β) plays a key role in type II diabetes and Alzheimer's diseases, to which non-ATP competitive inhibitors represent an effectively therapeutical approach due to their good specificity.|ATP|GSK-3β|23|5|Arg1:T1|Arg2:T10|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12871155|  The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described.|4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine|AChE|47|4|Arg1:T5|Arg2:T17|CHEMICAL|GENE-Y|INHIBITOR
18627212|  Irbesartan (Aprovel, Avapro, Irbetan, Karvea), an angiotensin II receptor type 1 antagonist, is approved in many countries worldwide for the treatment of hypertension.|Avapro|angiotensin II receptor type 1|5|13|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|ANTAGONIST
23583259|Rilpivirine, etravirine, and efavirenz, but not nevirapine or delavirdine, were identified as agonists of hPXR, as assessed in mechanistic experiments, and inducers of CYP3A4, as determined in primary cultures of human hepatocytes.|Rilpivirine|CYP3A4|1|30|Arg1:T10|Arg2:T48|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
22614004|We hypothesized that DCA will also reverse the 'pseudohypoxic' mitochondrial signals that lead to HIF1α activation in cancer, even in the absence of hypoxia and inhibit cancer angiogenesis.|DCA|HIF1α|4|16|Arg1:T9|Arg2:T25|CHEMICAL|GENE-Y|ACTIVATOR
23536519|Resveratrol (100 μM) significantly decreased the glycolytic enzymes (pyruvate kinase and lactate dehydrogenase) in Caco2 cells, while an increase in citrate synthase activity and a decrease in glucose consumption were observed in both cell lines.|Resveratrol|citrate synthase|1|26|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|ACTIVATOR
16842172|Low doses of dopamine D2 receptor agonists such as bromocriptine and pergolide may be able to enhance working memory and executive functions, but these effects may be dependent on the nature of the tasks used and the baseline performance levels of the subjects.|pergolide|dopamine D2 receptor|12|4|Arg1:T7|Arg2:T10|CHEMICAL|GENE-Y|AGONIST
16855072|In nondiabetic obese subjects, treatment with sitagliptin 200 mg bid was generally well tolerated without associated hypoglycemia and led to maximal inhibition of plasma DPP-4 activity, increased active GLP-1, and reduced glycemic excursion.|sitagliptin|GLP-1|8|31|Arg1:T9|Arg2:T12|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23449981|Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen.|phosphatidylcholine|SM synthase|9|17|Arg1:T6|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
15947036|Moreover, 4-methylhistamine potently activated the hH(4)R (pEC(50) = 7.4 +/- 0.1; alpha = 1), and this response was competitively antagonized by the selective H(4)R antagonist JNJ 7777120 [1-[(5-chloro-1H-indol-2-yl)-carbonyl]-4-methylpiperazine] (pA(2) = 7.8).|4-methylhistamine|hH(4)R|3|7|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|ACTIVATOR
15618715|By comparing the inhibition potential between rat and human CMVs, the inhibition of BSEP- and MRP2-mediated transport by midecamycin and cyclosporin A was relatively similar whereas the inhibitory effect on BSEP-mediated transport by cloxacillin and glibenclamide was more marked in humans than in rats.|cloxacillin|BSEP|35|32|Arg1:T2|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
17228881|Some clinically used compounds, such as acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective hCA VI inhibitory activity, with inhibition constants of 0.8-79 nM.|dichlorophenamide|hCA VI|14|35|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
9570468|  5-HT receptor antagonists with selectivity for 5-HT1A WAY-100635 (N-[2-[-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohe xanecarboxamide), 5-HT1B GR 127935 (N-[methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'(5-methyl-1,2, 4-oxadiazol-3-yl)[1,1-biphenyl]-4-carboxamide x HCl), 5-HT2C SB 200646A (N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl) and 5-HT2A (ketanserin, fananserin and MDL 100,151 ((+/-)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipe ridinemethanol) receptors were tested for cataleptogenic responses in rats.|N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea x HCl|5-HT2C|61|57|Arg1:T8|Arg2:T33|CHEMICAL|GENE-Y|ANTAGONIST
23200255|N-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses PDE3 inhibition.|N|PDE4|1|10|Arg1:T3|Arg2:T12|CHEMICAL|GENE-N|INHIBITOR
15192023|Hydralazine induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, adrenomedullin, haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.|Hydralazine|adrenomedullin|1|17|Arg1:T10|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
17929114|Dasatinib (formerly BMS-354825), AP23464, SKI-606, and PD166326 are classified as Src/Abl inhibitors, while nilotinib (AMN107) and INNO-406 (NS-187) belong to the latter subclass of inhibitors.|INNO-406|Abl|25|17|Arg1:T3|Arg2:T36|CHEMICAL|GENE-Y|INHIBITOR
15229223|Here we present the characterization of its mechanism of action showing that melatonin is a specific inhibitor of E(2)-induced ERalpha-mediated transcription in both estrogen response element- and AP1-containing promoters, whereas ERbeta-mediated transactivation is not inhibited or even activated at certain promoters.|melatonin|ERalpha|13|24|Arg1:T14|Arg2:T28|CHEMICAL|GENE-Y|INHIBITOR
9525919|For example, it is clear that the closed conformation of the regulatory N-terminal domain in Ca2+-bound cardiac troponin C (cTnC) presents a much different binding surface for Ca2+-sensitizing compounds than previously thought.|Ca2+|cTnC|17|22|Arg1:T6|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23381882|Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p-Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs.|Midazolam|CYP3A4|14|16|Arg1:T13|Arg2:T24|CHEMICAL|GENE-Y|SUBSTRATE
11682453|In mesenteric artery, BMY7378, 5-methylurapidil, WB4101 and prazosin were inhibited contraction to noradrenaline The good correlation for pA(2) values of antagonists in native alpha(1D)- (rat thoracic aorta) adrenoceptor subtype and pK(i) values in rat cloned alpha(1d)-adrenoceptor with the pA(2) values estimated in the mouse mesenteric artery was obtained.|BMY7378|rat cloned alpha(1d)-adrenoceptor|5|49|Arg1:T3|Arg2:T18|CHEMICAL|GENE-Y|ANTAGONIST
1600046|A number of selective 5-HT3 antagonists have been developed including ondansetron, granisetron, tropisetron renzapride and zacopride.|zacopride|5-HT3|18|5|Arg1:T10|Arg2:T23|CHEMICAL|GENE-Y|ANTAGONIST
22537794|RESULTS: (+/-)-, R-, and S-modafinil bind to the DAT and inhibit DA uptake less potently than cocaine, with R-modafinil having approximately threefold higher affinity than its S-enantiomer.|DA|DAT|18|15|Arg1:T25|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
23303191|Glucose-free medium, leading to depletion of the UDP-sugars, markedly reduced hyaluronan synthesis by all HAS isoenzymes while raising its concentration from 5 to 25 mm had a moderate stimulatory effect.|UDP|HAS|9|17|Arg1:T22|Arg2:T40|CHEMICAL|GENE-N|SUBSTRATE
16781459|While either blockage of HO activity by the HO inhibitor, tin protoporphyrin IX, or down-regulation of HO-1 expression by HO-1 small interfering RNA (siRNA) reversed the inhibitory effects of H(2)S on iNOS expression and NO production, HO-1 overexpression produced the same inhibitory effects of H(2)S.|NO|iNOS|43|40|Arg1:T6|Arg2:T45|CHEMICAL|GENE-Y|PRODUCT-OF
15664409|As thiamine metabolism deficiencies have been seen in placental infarcts previously, these indicate that PP20/hTPK may have a role in placental diseases.|thiamine|PP20|2|16|Arg1:T3|Arg2:T19|CHEMICAL|GENE-Y|SUBSTRATE
17498959|  In the present study, sulfated glucosamine (SGlc) that has been reported to relieve joint pain and inflammation in many arthritis patients was studied for its inhibitory effects on MMP-2 and MMP-9 in human fibrosarcoma cells.|SGlc|MMP-2|9|32|Arg1:T4|Arg2:T10|CHEMICAL|GENE-Y|INHIBITOR
16864903|Amlexanox, which also binds to S100A12, inhibited the THP-1 migration induced by S100A12.|Amlexanox|S100A12|1|7|Arg1:T8|Arg2:T21|CHEMICAL|GENE-Y|DIRECT-REGULATOR
22972179|Phosphorylation of AMPK at Thr172 increased by 1.4-fold within 5 min, and remained elevated throughout a 30-min time course, in response to 2-deoxyglucose.|Thr|AMPK|5|3|Arg1:T4|Arg2:T22|CHEMICAL|GENE-N|PART-OF
12213053|  A series of mazindol (2) and homomazindol (3) analogues with a variety of electron-donating and electron-withdrawing groups in the pendant aryl group and the benzo ring C, as well as H, methoxy, and alkyl groups replacing the hydroxyl group were synthesized, and their binding affinities at the dopamine transporter (DAT) on rat or guinea pig striatal membranes were determined.|alkyl|dopamine transporter|41|56|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|DIRECT-REGULATOR
10685879|Kinetic analysis of monoamine uptake inhibition by procaine in COS cells expressing rat DAT, NET or SERT revealed a competitive action similar to that of cocaine.|monoamine|SERT|4|18|Arg1:T10|Arg2:T39|CHEMICAL|GENE-Y|SUBSTRATE
12213829|Micromolar Ntp dose-dependently increased the mean open channel probability in ligand-free solution (P(O(max))) and attenuated the ATP inhibition of K(IR)6.2/SUR1, but had no effect on homomeric K(IR)6.2 channels.|ATP|SUR1|25|33|Arg1:T15|Arg2:T46|CHEMICAL|GENE-Y|INHIBITOR
2226440|  Catecholamines (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, EC 1.14.16.1).|Catecholamines|EC 1.14.16.1|1|19|Arg1:T1|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
1472079|Cadmium did not increase the breakdown of UDPGA by microsomal UDPGA pyrophosphatase but strongly decreased (30-66%) the synthesis of the cofactor in the cytosol by inhibiting UDP-glucose dehydrogenase (UDPGDH).|Cadmium|UDPGDH|1|33|Arg1:T35|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
16418310|Phase II studies of multitargeted agents, which include inhibition of VEGFR tyrosine kinase in their repertoire (sorafenib, sunitinib and AG 013736), show clear second-line activity in metastatic RCC.|AG 013736|VEGFR|23|12|Arg1:T6|Arg2:T22|CHEMICAL|GENE-N|INHIBITOR
23213199|Pretreatment with E(2) prevented MPTP opening induced by H(2)O(2), which preceded loss of mitochondrial membrane potential.|H(2)O(2)|MPTP|12|8|Arg1:T8|Arg2:T15|CHEMICAL|GENE-N|ACTIVATOR
17082235|Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPARgamma agonistic activity at concentrations comparable with those reached under pharmacological treatment.|glipizide|PPARgamma|8|24|Arg1:T11|Arg2:T35|CHEMICAL|GENE-Y|AGONIST
12538485|SU11248, a novel small molecule receptor tyrosine kinase inhibitor with direct antitumor as well as antiangiogenic activity via targeting the vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), KIT, and FLT3 receptor tyrosine kinases, was used as the pharmacological agent in these studies.|SU11248|platelet-derived growth factor|1|30|Arg1:T4|Arg2:T21|CHEMICAL|GENE-N|INHIBITOR
22708686|When combined, mianserin antagonized the effects of the full kappa-opioid receptor agonists in [(35)S]GTPgammaS assays and reduced the stimulation of p38 MAPK and ERK1/2 phosphorylation by dynorphin A.|mianserin|p38|4|28|Arg1:T9|Arg2:T31|CHEMICAL|GENE-N|INHIBITOR
3004501|Kinetic analysis revealed that the inhibition of the leukotriene C synthetase reaction by diethylcarbamazine was competitive with respect to LTA4.|diethylcarbamazine|leukotriene C synthetase|14|9|Arg1:T24|Arg2:T39|CHEMICAL|GENE-Y|INHIBITOR
23388095|Inducible heme-oxygenase 1 mRNA expressions were significantly higher in the DMOG group.|DMOG|heme-oxygenase 1|11|2|Arg1:T9|Arg2:T22|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
10076535|Down-regulation of prostate-specific antigen (PSA) expression, an AR-target gene, by estramustine and bicalutamide was accompanied by the blockade of the mutated androgen receptor.|estramustine|AR|15|11|Arg1:T18|Arg2:T51|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
10351938|We find that FP causes a decrease in stimulated eosinophil secretion of LTC4 that is regulated by phospholipase A2 (PLA2).|LTC4|PLA2|13|21|Arg1:T6|Arg2:T27|CHEMICAL|GENE-Y|PRODUCT-OF
15689518|  L-serine dehydratase (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or 2-oxobutyrate.|L-serine|SDH|24|4|Arg1:T2|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE
15206110|Apart from the consequences of iron deprivation, gallium exerts cytotoxic effects by direct interaction with the iron-dependent enzyme ribonucleotide reductase, resulting in reduced dNTP pools and inhibition of DNA synthesis.|gallium|ribonucleotide reductase|9|20|Arg1:T30|Arg2:T40|CHEMICAL|GENE-N|DIRECT-REGULATOR
23394205|Optimization from a high quality screening hit within tight SAR space led to compound 6 (AZ20) which inhibits ATR immunoprecipitated from HeLa nuclear extracts with an IC50 of 5 nM and ATR mediated phosphorylation of Chk1 in HT29 colorectal adenocarcinoma tumor cells with an IC50 of 50 nM.|AZ20|Chk1|17|38|Arg1:T2|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
18794803|The CRAF inhibitor sorafenib was found to induce a time-dependent reduction in both BAD phosphorylation and Bcl-2 expression in the D594G/G469E lines only.|sorafenib|BAD|4|14|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|INHIBITOR
15204055|The patients were divided into two groups according to the 5HT-2A affinity of the individual medications (high 5HT-2A affinity--clozapine, olanzapine, risperidone vs.|clozapine|5HT-2A|22|19|Arg1:T7|Arg2:T18|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23517912|The results suggested that fisetin treatment inhibits mTORC1 activity in an Akt-dependent manner.|fisetin|Akt|5|12|Arg1:T18|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR
18381445|  Statins are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors broadly used for the control of hypercholesterolemia.|Statins|3-hydroxy-3-methylglutaryl-CoA reductase|1|3|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|INHIBITOR
15577244|Especially, the compound 1 showed strong inhibition (IC50=1.33 microM) against the enzyme tyrosinase, as compared to the standard tyrosinase inhibitors kojic acid (IC50=16.67 microM) and L-mimosine (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes.|kojic acid|tyrosinase|25|16|Arg1:T3|Arg2:T7|CHEMICAL|GENE-Y|INHIBITOR
15526107|In conclusion, the fact that, on the one hand, the cardiovascular effects of carteolol were not attenuated by the beta(1)-adrenoceptor blocker bisoprolol and, on the other, carteolol significantly decreased lymphocyte beta(2)-adrenoceptor density and function is in favour of the idea that the ISA of carteolol is mediated by beta(2)-adrenoceptors.|carteolol|beta(1)-adrenoceptor|17|23|Arg1:T6|Arg2:T20|CHEMICAL|GENE-Y|INHIBITOR
12085361|Direct transport of rifampicin could be shown for OATP-C (apparent K(m) value 13 micromol/L) and OATP8 (2.3 micromol/L).|rifampicin|OATP8|4|21|Arg1:T8|Arg2:T41|CHEMICAL|GENE-Y|SUBSTRATE
9231746|The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other.|nicardipine|PDE 1A2|24|14|Arg1:T13|Arg2:T26|CHEMICAL|GENE-Y|INHIBITOR
15985434|To understand this interaction, we determined the crystal structure of PDXK in complex with (R)-roscovitine, N6-methyl-(R)-roscovitine, and O6-(R)-roscovitine, the two latter derivatives being designed to bind to PDXK but not to CDKs. Structural analysis revealed that these three roscovitines bind similarly in the pyridoxal-binding site of PDXK rather than in the anticipated ATP-binding site.|N6-methyl-(R)-roscovitine|PDXK|21|43|Arg1:T18|Arg2:T35|CHEMICAL|GENE-Y|DIRECT-REGULATOR
9353417|Tiapride, a D2 antagonist that lacks antipsychotic activity, was also included.|Tiapride|D2|1|4|Arg1:T22|Arg2:T34|CHEMICAL|GENE-Y|ANTAGONIST
9486667|HERG/IKr channels are a prime target for the pharmacological management of arrhythmias and are selectively blocked by class III antiarrhythmic methanesulfonanilide drugs, such as dofetilide, E4031, and MK-499, at submicromolar concentrations.|MK-499|IKr|31|2|Arg1:T11|Arg2:T28|CHEMICAL|GENE-N|INHIBITOR
23394218|Discovery of 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases.|4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide|kinases|3|35|Arg1:T3|Arg2:T10|CHEMICAL|GENE-N|INHIBITOR
16874462|  Proline oxidase (POX), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of proline to pyrroline- 5-carboxylate (P5C).|pyrroline- 5-carboxylate|Proline oxidase|19|1|Arg1:T4|Arg2:T12|CHEMICAL|GENE-Y|PRODUCT-OF
16533791|The antitumor activity of YM-359445 was also tested in nude mice bearing various established tumors and compared with other VEGFR2 tyrosine kinase inhibitors (ZD6474, CP-547632, CGP79787, SU11248, and AZD2171), a cytotoxic agent (paclitaxel), and an epidermal growth factor receptor tyrosine kinase inhibitor (gefitinib).|CGP79787|tyrosine kinase|29|21|Arg1:T16|Arg2:T39|CHEMICAL|GENE-N|INHIBITOR
23064031|NFD suppressed EGF-mediated protein levels of c-Jun and c-Fos, and reduced MMP-9 expression and activity, concomitantly with a marked inhibition on cell migration and invasion without obvious cellular cytotoxicity.|NFD|c-Jun|1|7|Arg1:T6|Arg2:T24|CHEMICAL|GENE-Y|INDIRECT-DOWNREGULATOR
23103426|Hepatic mitochondrial complex II activity was practically unchanged by (PhSe)(2), whereas it significantly inhibited renal complex II activity.|(PhSe)(2)|renal complex II|10|21|Arg1:T23|Arg2:T43|CHEMICAL|GENE-N|INHIBITOR
6701456|The binding of FHA-HIS was inhibited on 35-79% of the platelets by the histamine H1 receptor antagonists diphenhydramine and clemastine.|clemastine|histamine H1 receptor|21|15|Arg1:T4|Arg2:T13|CHEMICAL|GENE-Y|ANTAGONIST
10432475|In conclusion, (-)-pindolol modulates, both alone and together with 5-HT reuptake inhibitors, dopaminergic, adrenergic, and serotonergic transmission in the FCX via a complex pattern of actions at beta 1/2-ARs, 5-HT1A, and 5-HT1B receptors.|(-)-pindolol|5-HT1B|4|42|Arg1:T19|Arg2:T51|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23287539|The differential neuroprotective effect could be due to the stereo-specific augmentation of Cu/Zn-SOD activity by trans-hinokiresinol, when compared with cis-hinokiresinol.|trans-hinokiresinol|SOD|16|14|Arg1:T18|Arg2:T22|CHEMICAL|GENE-N|ACTIVATOR
10432475|The selective 5-HT1A receptor antagonist, WAY100,635, slightly attenuated the (-)-pindolol-induced increase in DA and NAD levels, while the selective 5-HT1B antagonist, SB224,289, was ineffective.|WAY100,635|5-HT1A|7|3|Arg1:T35|Arg2:T55|CHEMICAL|GENE-Y|ANTAGONIST
23432429|Coumarin 7-hydroxylation, catalyzed by P450 2A13, was strongly inhibited by 2'-methoxy-5,7-dihydroxyflavone, 2-ethynylnaphthalene, 2'-methoxyflavone, 2-naphththalene propargyl ether, acenaphthene, acenaphthylene, naphthalene, 1-acetylpyrene, flavanone, chrysin, 3-ethynylphenanthrene, flavone, and 7-hydroxyflavone; these chemicals induced Type I spectral changes with low Ks values.|flavone|P450 2A13|37|6|Arg1:T4|Arg2:T49|CHEMICAL|GENE-Y|INHIBITOR
23581551|The fluoroindole compound with three carbons in the side chain and one amide group exhibited a selectivity index of 35 (Ki/IC50) with high inhibition of MPO activity (IC50 = 18 nM), whereas its effect on SERT was in the micromolar range.|amide|MPO|13|28|Arg1:T8|Arg2:T19|CHEMICAL|GENE-Y|INHIBITOR
12213059|Several compounds, e.g., 3-propylamino- (30), 3-isopropylamino- (34), 3-(S)-sec-butylamino- (37), and 3-(1-methylcyclopropyl)amino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide (53), which were found to be potent and beta-cell selective activators of K(ATP) channels in vitro, were found to inhibit insulin secretion in rats with minimal effects on blood pressure and to exhibit good oral pharmacokinetic properties.|3-isopropylamino|insulin|11|63|Arg1:T16|Arg2:T21|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
23356880|Its head-space aroma displayed new volatile phytomolecules and also had higher levels of green volatiles from the lipoxygenase (LOX)-pathway (one having as precursors the polyunsaturated fatty acids containing a cis-cis-1,4-pentadiene system).|cis-cis-1,4-pentadiene|LOX|34|20|Arg1:T2|Arg2:T13|CHEMICAL|GENE-N|SUBSTRATE
23142425|  Gene polymorphisms of the 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes-cytochrome P450 (CYP) monooxygenase 2A13 (CYP2A13) and UDP-glucuronosyltransferases (UGT)-2B7 could contribute to the levels of NNK-related metabolites in urine, thereby increasing the susceptibility to urothelial carcinoma (UC).|NNK|UDP-glucuronosyltransferases (UGT)-2B7|40|29|Arg1:T19|Arg2:T33|CHEMICAL|GENE-Y|SUBSTRATE
9525919|Identification of binding sites for bepridil and trifluoperazine on cardiac troponin C.|trifluoperazine|cardiac troponin C|8|10|Arg1:T17|Arg2:T26|CHEMICAL|GENE-Y|DIRECT-REGULATOR
12504917|  Rasagiline [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible monoamine oxidase (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.|Rasagiline|monoamine oxidase|1|15|Arg1:T1|Arg2:T42|CHEMICAL|GENE-N|INHIBITOR
15277241|GSTZ1-1 is identical with maleylacetoacetate isomerase, which catalyzes the penultimate step in the catabolic pathways for phenylalanine and tyrosine.|tyrosine|maleylacetoacetate isomerase|20|5|Arg1:T10|Arg2:T23|CHEMICAL|GENE-N|SUBSTRATE
23605691|Oxycodone is primarily metabolized in the liver by the cytochrome P450 (CYP) enzymes with CYP3A as the major metabolic pathway and CYP2D6 as the minor metabolic pathway to noroxycodone, oxymorphone and noroxymorphone.|noroxymorphone|CYP2D6|35|24|Arg1:T14|Arg2:T25|CHEMICAL|GENE-Y|SUBSTRATE
12646997|RESULTS: Icariin and papaverine showed dose-dependent inhibitory effects on PDE5 and PDE4 activities.|Icariin|PDE5|3|11|Arg1:T5|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
1712335|In anesthetized spontaneously hypertensive rats, the antihypertensive activity of carvedilol was nearly abolished by combined pretreatment of the rats with high doses of the alpha 1 adrenoceptor antagonist, prazosin (1 mg/kg, iv), and the nonselective beta adrenoceptor antagonist, propranolol (3 mg/kg, iv), suggesting that the majority of the antihypertensive response produced by carvedilol may be accounted for by blockade of beta and alpha 1 adrenoceptors.|propranolol|beta adrenoceptor|46|42|Arg1:T16|Arg2:T41|CHEMICAL|GENE-N|ANTAGONIST
2262902|  To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v. adenosine agonists, N6-(R-phenylisopropyl)adenosine (R-PIA), N6-(S-phenylisopropyl)adenosine, 5'-(N-cyclopropyl)-carboxamidoadenosine, antagonists, theophylline and 8-p-(sulfophenyl)theophylline as well as enprofylline on ethanol-(i.p.)-induced motor incoordination was evaluated by rotorod.|8-p-(sulfophenyl)theophylline|adenosine|56|28|Arg1:T18|Arg2:T37|CHEMICAL|GENE-N|ANTAGONIST
23624148|Sciadopitysin caused a significant elevation of alkaline phosphatase activity, collagen synthesis, osteocalcin production, mineralization, and glutathione content in the cells (P<0.05).|Sciadopitysin|osteocalcin|1|14|Arg1:T11|Arg2:T27|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
15985434|(R)-Roscovitine (CYC202, Seliciclib) is a relatively selective inhibitor of cyclin-dependent kinases (CDKs), currently evaluated for the treatment of cancers, neurodegenerative disorders, renal diseases, and several viral infections.|CYC202|CDKs|6|19|Arg1:T12|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
23339625|We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively.|MDZ|CYP3A|44|53|Arg1:T4|Arg2:T17|CHEMICAL|GENE-N|SUBSTRATE
12183691|Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2.|TEA|OCTN2|8|17|Arg1:T8|Arg2:T28|CHEMICAL|GENE-Y|SUBSTRATE
23200901|Bidirectional transport assays of the Aconitum alkaloids were performed with or without P-gp (cyclosporine A and verapamil), BCRP (Ko143) and MRP2 (MK571) inhibitors.|cyclosporine A|P-gp|15|13|Arg1:T20|Arg2:T45|CHEMICAL|GENE-N|INHIBITOR
10611634|Yohimbine displays marked affinity at human (h)alpha(2A)-, halpha(2B)- and halpha(2C)-ARs, significant affinity for h5-HT(1A), h5-HT(1B), h5-HT(1D), and hD(2) receptors and weak affinity for hD(3) receptors.|Yohimbine|h5-HT(1D)|1|41|Arg1:T37|Arg2:T67|CHEMICAL|GENE-Y|DIRECT-REGULATOR
15240882|  Thyroid hormones are involved in the regulation of many physiological processes and regulate gene transcription by binding to their nuclear receptors TRalpha and TRbeta.|Thyroid hormones|TRbeta|1|24|Arg1:T1|Arg2:T9|CHEMICAL|GENE-Y|DIRECT-REGULATOR
16921342|  Phospholipase D (PLD) catalyzes the hydrolysis of the phosphodiester bond of glycerophospholipid phosphatidylcholine to generate phosphatidic acid (PA) and choline.|phosphatidic acid|Phospholipase D|18|1|Arg1:T1|Arg2:T14|CHEMICAL|GENE-N|PRODUCT-OF
23292752|FXa inhibitors, e.g. rivaroxaban and apixaban, are potent, oral direct inhibitors of prothrombinase-bound, clot-associated or free FXa. Both agents have a rapid onset of action, a wide therapeutic window, little or no interaction with food and other drugs, minimal inter-patient variability, and display similar pharmacokinetics in different patient populations.|apixaban|FXa|8|1|Arg1:T2|Arg2:T23|CHEMICAL|GENE-Y|INHIBITOR
17664022|  The inhibitory effect of clonidine (non-selective alpha2-adrenoceptor agonist) and oxymetazoline (alpha2A-adrenoceptor selective agonist) was compared on basal and stimulated gastric motor activity (gastric tone and contractions) using the balloon method in the rat.|clonidine|alpha2-adrenoceptor|5|8|Arg1:T10|Arg2:T26|CHEMICAL|GENE-N|AGONIST
23643631|In conclusion, our findings suggest melamine increased inflammation and oxidative stress via activation of NF-κB/COX-2 and NOX/ROS pathway, and first revealed the critical role of NOX in melamine-induced ROS production, suggesting the potential of NOX inhibitor against melamine toxicity.|melamine|NF-κB|7|16|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|ACTIVATOR
16781459|  Hydrogen sulfide (H(2)S), a regulatory gaseous molecule that is endogenously synthesized by cystathionine gamma-lyase (CSE) and/or cystathionine beta-synthase (CBS) from L-cysteine (L-Cys) metabolism, is a putative vasodilator, and its role in nitric oxide (NO) production is unexplored.|Hydrogen sulfide|CBS|1|29|Arg1:T1|Arg2:T50|CHEMICAL|GENE-Y|PRODUCT-OF
23295227|Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.|fidarestat|AR|41|30|Arg1:T22|Arg2:T52|CHEMICAL|GENE-Y|INHIBITOR
23146871|This approach was used to compare the uptake of Mn(3+)Tf into neuronal cell lines with published descriptions of Fe(3+) uptake via the Tf mechanism, and to obtain quantitative information on Mn uptake via the Tf mechanism.|Fe(3+)|Tf|23|30|Arg1:T3|Arg2:T29|CHEMICAL|GENE-Y|SUBSTRATE
17075268|  BACKGROUND: Histamine synthesized by histidine decarboxylase (HDC) from L-histidine is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity.|Histamine|histidine decarboxylase|3|6|Arg1:T3|Arg2:T32|CHEMICAL|GENE-Y|PRODUCT-OF
22080037|Mercury induces the expression of cyclooxygenase-2 and inducible nitric oxide synthase.|Mercury|cyclooxygenase-2|1|6|Arg1:T6|Arg2:T19|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
23042953|These results provide a rationale for future design of therapeutic apolipoprotein mimetic peptides and provide new insights into the interaction of hydrophobic residues on apolipoproteins with phospholipids in the lipid microdomain created by the ABCA1 transporter during the cholesterol efflux process.|cholesterol|ABCA1|39|35|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|SUBSTRATE
23256625|This work investigated the drug interaction potential of GSK1292263, a novel GPR119 agonist, with the HMG-coA reductase inhibitors simvastatin and rosuvastatin.|rosuvastatin|HMG-coA reductase|23|18|Arg1:T8|Arg2:T22|CHEMICAL|GENE-Y|INHIBITOR
23291264|In addition, urinary CCL2 rather than KIM-1 increased in chronic renal failure rats after administration of low-dose cisplatin (2mg/kg), suggesting that urinary CCL2 was selective for cisplatin-induced nephrotoxicity in renal impairment.|cisplatin|KIM-1|19|8|Arg1:T6|Arg2:T18|CHEMICAL|GENE-Y|INDIRECT-UPREGULATOR
12498985|Inhibition of p38(MAPK) by SB203580 (10 microM) enhanced DEM-induced increases in L-cystine transport and GSH, whereas inhibition of p42/p44(MAPK) (PD98059, 10 microM) had no effect.|PD98059|MAPK|30|27|Arg1:T2|Arg2:T32|CHEMICAL|GENE-N|INHIBITOR
23578608|Results showed that oral administration of plant stanyl hemisuccinate (2×, 5×) and plant stanyl sorbitol succinate (2×, 5×) effectively attenuated the serum total cholesterol and low density lipoprotein cholesterol levels, while had no effect on the serum triacylglycerol and high density lipoprotein cholesterol.|stanyl hemisuccinate|low density lipoprotein|8|32|Arg1:T5|Arg2:T26|CHEMICAL|GENE-N|INDIRECT-DOWNREGULATOR
6222739|The effective binding of medroxyprogesterone acetate to the glucocorticoid receptor was confirmed by direct binding studies utilizing a tritiated derivative of this steroid.|medroxyprogesterone acetate|glucocorticoid receptor|5|9|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|DIRECT-REGULATOR
23361846|  Methadone N-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and CYP3A4, but clinical disposition is often attributed to CYP3A4.|Methadone|CYP3A4|1|15|Arg1:T1|Arg2:T32|CHEMICAL|GENE-Y|SUBSTRATE
11488610|I- was less able and Cs+ was more able to quench the fluorescence of Trp residues in the holoenzyme of GAD (holoGAD) than the apoenzyme (apoGAD).|Trp|holoGAD|15|23|Arg1:T16|Arg2:T44|CHEMICAL|GENE-Y|PART-OF
18574460|Estimated affinities for the fast-inactivated channel state were 81 nM, 312 nM and 227 nM for 4-iodopropofol, 4-bromopropofol and 4-chloropropofol in Na(V)1.4, and 450 nM for 4-chloropropofol in Na(V)1.2. Recovery from fast inactivation was prolonged in the presence of drug leading to an accumulation of block during repetitive stimulation at high frequencies (100 Hz).|4-iodopropofol|Na(V)1.4|18|24|Arg1:T1|Arg2:T21|CHEMICAL|GENE-Y|INHIBITOR
23203941|A new vitamin B(12)-GLP-1 conjugate is investigated and shown to have insulinotropic properties similar to the unmodified peptide.|vitamin B(12)|GLP-1|3|9|Arg1:T1|Arg2:T4|CHEMICAL|GENE-Y|no_relation
23204443|Additionally, we show that S1P(1) antagonism reverses experimental autoimmune encephalomyelitis in mice without acting on S1P(1) expressed within the central nervous system, demonstrating that lymphocyte sequestration via S1P(1) antagonism is sufficient to alleviate autoimmune pathology.|NONE|S1P(1)|NONE|20|NONE|Arg2:T15|NONE|GENE-Y|no_relation
23374865|  Two fan-shaped bile acid trimers have been synthesized via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) 'click chemistry', and their extraction experiments of cresol red sodium (CR) and pyrene were investigated in the polar and non-polar solvents, respectively.|cresol red sodium|NONE|29|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
23246471|(18)F-FLT-PET images clearly showed that 3-drug PEG-b-PCL micelles dramatically reduce tumor volumes over paclitaxel and vehicle controls.|paclitaxel|NONE|17|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
17403374|KLF15-/- liver and skeletal muscle show markedly reduced mRNA expression of amino acid-degrading enzymes.|amino acid|KLF15|12|1|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|no_relation
6703688|Peroxisomal AGT 1 activity was more affected than the mitochondrial.|NONE|AGT 1|NONE|2|NONE|Arg2:T33|NONE|GENE-Y|no_relation
23466232|The newly synthesized compounds displayed different inhibition profile towards yeast α-glycosidase and rat intestinal α-glycosidase.|NONE|yeast α-glycosidase|NONE|10|NONE|Arg2:T5|NONE|GENE-Y|no_relation
17595315|Molecular modeling and protein docking studies suggested that A287P is involved in the interaction of POR:CYP17A1 but not in the POR:CYP19A1 interaction.|NONE|POR|NONE|16|NONE|Arg2:T38|NONE|GENE-Y|no_relation
23353698|Peripheral blood mononuclear cell from healthy donors were not affected by quercetin treatment.|quercetin|NONE|12|NONE|Arg1:T11|NONE|CHEMICAL|NONE|no_relation
23063590|  Cholesterol is associated with the regulation of melanogenesis which is the major physiological defense against solar irradiation.|Cholesterol|NONE|1|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
11304699|The striking distal predilection of nabumetone may be, at least partially, explained by distal bowel over-expression of COX-2 and PPAR-delta.|nabumetone|PPAR-delta|6|22|Arg1:T4|Arg2:T16|CHEMICAL|GENE-N|no_relation
20204178|Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis.|paricalcitol|NONE|7|NONE|Arg1:T19|NONE|CHEMICAL|NONE|no_relation
10871202|  Low plasma fibrinolytic activity in association with increased plasma plasminogen activator inhibitor 1 (PAI-1) levels has been linked to an increased risk of atherosclerosis in obesity and type 2 diabetes.|NONE|PAI-1|NONE|15|NONE|Arg2:T14|NONE|GENE-Y|no_relation
23077105|In summary, EE increased the expression of hepatic Mrp3 transcriptionally and independently of any cholestatic manifestation and required participation of an ER, most likely ER-α, through its phosphorylation.|NONE|ER-α|NONE|27|NONE|Arg2:T22|NONE|GENE-Y|no_relation
12818701|Pupillary dilator response curves were generated by intravenous injection of norepinephrine in pentobarbital-anesthetized rats.|norepinephrine|NONE|11|NONE|Arg1:T12|NONE|CHEMICAL|NONE|no_relation
12817472|This short review focuses on the urokinase receptor (u-PAR), a central molecule involved in tumor-associated invasion and metastasis, and summarizes the transcriptional regulation of u-PAR.|NONE|u-PAR|NONE|29|NONE|Arg2:T5|NONE|GENE-Y|no_relation
23432429|In addition, benzo[c]phenanthrene, fluoranthene, 2,3-dihydroxy-2,3-dihydrofluoranthene, pyrene, 1-hydroxypyrene, 1-nitropyrene, 1-acetylpyrene, 2-acetylpyrene, 2,5,2',5'-tetrachlorobiphenyl, 7-hydroxyflavone, chrysin, and galangin were found to induce a Type I spectral change only with P450 2A13.|pyrene|P450 2A13|14|43|Arg1:T12|Arg2:T48|CHEMICAL|GENE-Y|no_relation
17016511|Either calcium transients or contractility were measured using the calcium-sensitive dye Calcium-Green 1AM or video edge detection, respectively.|Calcium|NONE|12|NONE|Arg1:T18|NONE|CHEMICAL|NONE|no_relation
23614367|Using stereotaxic surgical techniques and lentiviral vectors expressing specific short hairpin RNA (shRNA), we could steadily knock down Grb10 expression in the hippocampus.|NONE|Grb10|NONE|22|NONE|Arg2:T3|NONE|GENE-Y|no_relation
15283765|(4) cBS is caused by mutations in the chloride channel ClC-Kb with similar clinical characteristics as seen under combination of thiazides and furosemide, (5) GS is caused by mutations in the thiazide-sensitive sodium-chloride cotransporter NCCT resembling the effect of long-term thiazide administration.|thiazide|NCCT|46|40|Arg1:T14|Arg2:T34|CHEMICAL|GENE-Y|no_relation
22751286|Dietary flaxseed oil supplementation ameliorates the effect of cisplatin on brush border membrane enzymes and antioxidant system in rat intestine.|cisplatin|NONE|9|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
23318431|Inhibition of these pathways, as well as inhibition of reactive oxygen species (ROS) with antioxidants, prevents IR-induced invasion.|oxygen|NONE|12|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
11959556|The two most resistant PRSP strains had a second change in PBP2x (M(339)-->F) in a conserved motif.|NONE|PBP2x|NONE|12|NONE|Arg2:T32|NONE|GENE-Y|no_relation
12126787|In contrast, glyburide which does not exhibit antioxidant properties, did not affect the AGE-induced VEGF expression.|glyburide|VEGF|4|17|Arg1:T7|Arg2:T9|CHEMICAL|GENE-Y|no_relation
23627352|Buchwald-Hartwig coupling reaction of substituted anilines with pivaloyl protected 2,4-diamino-6-bromo-pyrido[2,3-d]pyrimidine was successfully explored to synthesize these analogs.|pivaloyl|NONE|8|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
7610922|Millimolar increases in extracellular calcium ([Ca2+]o, EC50 = 8 mM) cause a rapid elevation in [Ca2+]i after a calcitonin dose-dependent pretreatment of cells (pretreatment EC50 = 0.2 nM sCT).|Ca2+|sCT|23|39|Arg1:T23|Arg2:T45|CHEMICAL|GENE-N|no_relation
23500411|This synthesis features a highly efficient and stereoselective introduction of the C17-OH via E-ring cleavage/F-ring formation, D-ring oxidation, and F-ring cleavage/E-ring formation.|OH|NONE|13|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
23394555|Following the rapid expanding knowledge on TMPKs and the rising interests in TMPKs as a drug target, in this review we try to describe current research on TMPKs in various organisms of eukaryotes, prokaryotes and viruses and to provide information for designing new potential inhibitors against TMPKs.|NONE|TMPKs|NONE|7|NONE|Arg2:T24|NONE|GENE-Y|no_relation
23287710|However, risk assessment of acrylamide remains difficult because the carcinogenic mechanisms are still unknown and in particular the molecular effects of low level acrylamide exposure as seen by dietary intake are not well understood.|acrylamide|NONE|25|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
23620436|Tumor incidence, latency, localization, and immunohistochemistry (AR, PCNA, smooth muscle α-actin, p63, MGMT, and E-cadherin) were studied in both lobes.|NONE|p63|NONE|19|NONE|Arg2:T15|NONE|GENE-N|no_relation
23557688|Environmental pesticide exposure modulates cytokines, arginase and ornithine decarboxylase expression in human placenta.|ornithine|ornithine decarboxylase|9|9|Arg1:T3|Arg2:T25|CHEMICAL|GENE-Y|no_relation
23444963|In conclusion, greater consumption of kimchi improved FBG and serum total cholesterol in young healthy adults.|cholesterol|NONE|13|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
19930708|Antiproliferative effect of exemestane in lung cancer cells.|exemestane|NONE|4|NONE|Arg1:T14|NONE|CHEMICAL|NONE|no_relation
10494028|First, we demonstrate that the level of apo CIII secretion by HepG2 cells is controlled by serum factors whereas apo CIII mRNA levels are not and even increase under conditions when apo CIII secretion dramatically decreases.|NONE|apo CIII|NONE|21|NONE|Arg2:T28|NONE|GENE-Y|no_relation
23208609|H295R cells incubated with 2-ITX also showed significantly reduced androgen and increased pregnenolone and progesterone levels.|pregnenolone|NONE|13|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23289710|Mammalian Trit1 is a tRNA([Ser]Sec)-isopentenyl transferase required for full selenoprotein expression.|Ser|selenoprotein|8|17|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|no_relation
23292752|The risk of metabolic drug-drug interactions also appears to differ between OACs: VKAs > rivaroxaban > apixaban > dabigatran.|apixaban|NONE|18|NONE|Arg1:T20|NONE|CHEMICAL|NONE|no_relation
23223234|Alleles of RPB1 (RPO21) with elevated slippage rates were identified among 6-azauracil-sensitive mutants and were also isolated using a slippage-dependent reporter gene.|6-azauracil|RPO21|14|5|Arg1:T1|Arg2:T5|CHEMICAL|GENE-Y|no_relation
23337607|These data indicate that BPA exerts an age-dependent detrimental impact on primate brain development, at blood levels within the range measured in humans having only environmental contact with BPA.|BPA|NONE|5|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
20025554|Due to the small sample size used, further studies should be performed, particularly to assess the safety of mitiglinide treatment.|mitiglinide|NONE|21|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
23261524|Importantly, modulation of p53 interaction with its main inhibitor, Mdm2, has been highlighted as a promising therapeutic target.|NONE|Mdm2|NONE|12|NONE|Arg2:T16|NONE|GENE-Y|no_relation
17588737|Notably, when GSH depletion occurred, p66Shc protein expression increased by about 300% with respect to control (P<.001; LipE vs.|NONE|LipE|NONE|25|NONE|Arg2:T29|NONE|GENE-Y|no_relation
20371872|Using wild type RTFs, 4.8 mol S-1 was bound per mol filament (seven actins), whereas with E59D/D75Y RTFs, the number of binding sites was reduced by approximately 23% to 3.7. Altogether, these results suggest that the reduction in force and ATPase activation is possibly due to a thin filament conformation that promotes fewer accessible S-1-binding sites.|NONE|RTFs|NONE|22|NONE|Arg2:T7|NONE|GENE-N|no_relation
8032658|The present study was undertaken to isolate and characterize pharmacologically homogeneous populations of 5-hydroxytryptamine (5-HT) receptors from a possible mixed receptor population mediating concentration of the longitudinal muscle of rat stomach fundus.|5-hydroxytryptamine|5-hydroxytryptamine (5-HT) receptors|14|14|Arg1:T7|Arg2:T60|CHEMICAL|GENE-N|no_relation
18505444|Kv1.2 and Kv2.1 were associated with IK(DR); Slo and KCNN4 were associated with IK(Ca); and Kv1.4 and Kv4.3 were associated with Ito.|NONE|Kv4.3|NONE|26|NONE|Arg2:T23|NONE|GENE-Y|no_relation
23237450|Here, we introduce a method to purify GPCRs in nanodiscs, which incorporates GPCRs into lipid bilayers immediately after membrane solubilization, followed by single-step purification.|NONE|GPCRs|NONE|15|NONE|Arg2:T8|NONE|GENE-N|no_relation
17397529|Prenatal diagnosis has been preformed in glutathione synthetase deficiency.|glutathione|NONE|7|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
9145928|This modification of the propranolol structure has no effect on the affinity of both enantiomers for the wild-type 5-HT1A receptor, which provides an alternative hypothesis for the interaction of Asn386 with the oxypropanol oxygen atoms.|oxygen|5-HT1A|35|19|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|no_relation
11959556|All eight PISP strains had at least two alterations--T(338)-->P or A or H(394)-->Y in PBP2X and T(445)-->A in BPB2b.|NONE|PBP2X|NONE|29|NONE|Arg2:T53|NONE|GENE-Y|no_relation
1336906|It is concluded that the vitamin D enzyme system present in UMR-106 cells is able to metabolize dihydrotachysterol3 very efficiently to a series of metabolites but is incapable of producing peak H.|dihydrotachysterol3|NONE|18|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
23042953|By simulated annealing analysis and molecular dynamics modeling, two hydrophobic amino acids, F-18 and W-21, in the hinge region were predicted to be relatively surface-exposed and to interact with the aqueous solvent.|amino acids|NONE|12|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
12366848|(iv) Strains in which the Ca2+ binding sites of calmodulin were eliminated and strains in which the calcineurin subunit genes were disrupted demonstrated enhanced azole sensitivity; conversely, a mutant with constitutively activated calcineurin phosphatase demonstrated decreased azole sensitivity.|azole|calmodulin|27|12|Arg1:T1|Arg2:T50|CHEMICAL|GENE-N|no_relation
1475066|Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX.|soman|NONE|20|NONE|Arg1:T18|NONE|CHEMICAL|NONE|no_relation
23155202|  Among the artemisinin-based combination therapy (ACT) regimens, artemisinin derivative, artemether in combination with lumefantrine (artemether-lumefantrine, AL) has achieved excellent results in the fight against malarial scourge.|artemisinin|NONE|3|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
12720300|Because plasmin is known to be a major activator of TGF-beta1 in vivo, we hypothesized that reduced plasmin activity may be responsible for the observed dysregulation of TGF-beta1 processing in these behaviorally benign tumors.|NONE|TGF-beta1|NONE|11|NONE|Arg2:T8|NONE|GENE-Y|no_relation
23395804|Intraperitoneal injection of ovine PRL (oPRL) increased ncc and prlra transcripts, but did not affect nhe3b or ecac.|NONE|oPRL|NONE|7|NONE|Arg2:T27|NONE|GENE-Y|no_relation
12297509|Finally, the failure of ADP and epinephrine to inhibit basal, as opposed to PGI(2)-stimulated, cAMP formation highlights the need during platelet activation for G(i) signaling pathways that involve effectors other than adenylyl cyclase.|epinephrine|adenylyl cyclase|8|42|Arg1:T15|Arg2:T47|CHEMICAL|GENE-N|no_relation
23136062|How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates?|(68)Ge|NONE|17|NONE|Arg1:T38|NONE|CHEMICAL|NONE|no_relation
23572405|Circulating levels of ghrelin are decreased; leptin, insulin, glucagon are unchanged; adiponectin are increased during hyperthyroidism.|NONE|adiponectin|NONE|16|NONE|Arg2:T9|NONE|GENE-Y|no_relation
12850267|We have cloned from a phage library of rat kidney cDNA four new KATI cDNAs containing different 5' untranslated regions (UTRs).|NONE|UTRs|NONE|23|NONE|Arg2:T29|NONE|GENE-N|no_relation
17353078|METHODS: The experiments were designed that rats received an intravenous injection of 1mg/kg fluvastatin followed 10min later, by an intravenous injection of 10mg/kg Klebsiella pneumoniae LPS, the latter inducing endotoxic shock amongst conscious rats.|fluvastatin|NONE|15|NONE|Arg1:T21|NONE|CHEMICAL|NONE|no_relation
10611634|In analogy, yohimbine enhances FCX levels of DA and NAD, yet suppresses those of 5-HT, the latter effect being antagonized by WAY100,635.|NAD|NONE|11|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
15728856|We report that RGS9 knock-out mice develop abnormal involuntary movements when inhibition of dopaminergic transmission is followed by activation of D2-like dopamine receptors (DRs).|dopamine|DRs|22|25|Arg1:T1|Arg2:T13|CHEMICAL|GENE-Y|no_relation
17603759|This enzyme co-purified with cytosolic L-malate dehydrogenase (cMDH) upon further chromatography on Blue Sepharose.|Blue Sepharose|cMDH|15|9|Arg1:T24|Arg2:T36|CHEMICAL|GENE-Y|no_relation
23208609|In this work, the effects of 2-ITX, 4-isopropylthioxanthone (4-ITX), 2,4-diethylthio xanthone (2,4-diethyl-TX), 2-chlorothioxanthone (2-chloro-TX), and 1-chloro-4-propoxythioxanthone (1-chloro-4-propoxy-TX) on steroidogenesis and androgen and estrogen receptor-mediated transcription activation have been studied using human H295R adrenocarcinoma cells and yeast hormone bioassays, respectively.|1-chloro-4-propoxythioxanthone|androgen and estrogen receptor|27|34|Arg1:T21|Arg2:T37|CHEMICAL|GENE-N|no_relation
8667211|We also followed in vitro the effects on these isozymes of NSAIDs associated to histamine, Ca, PGE2 and acetazolamide.|histamine|NONE|15|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
23537005|Of the nine hydroxylated metabolites of BDE-47 produced by human liver microsomes, seven metabolites were identified using authentic standards.|BDE-47|NONE|7|NONE|Arg1:T18|NONE|CHEMICAL|NONE|no_relation
15843826|These findings clearly demonstrate that Am80 is a potential inhibitor of angiogenesis caused by the interaction between vascular endothelial cells and myeloma cells, and might be a useful therapeutic agent against MM.|Am80|NONE|6|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
22972179|The objective of this study was to examine the effect of AMP-activated protein kinase (AMPK) activation by 2-deoxyglucose on protein synthesis and the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway in bovine mammary epithelial cells.|rapamycin|mTORC1|29|33|Arg1:T3|Arg2:T21|CHEMICAL|GENE-N|no_relation
11791081|The epidemiological data do not suggest any negative effect of the progestogens administered together with estrogens on cardiovascular morbidity or mortality.|estrogens|NONE|16|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
23561155|To enhance the (13)C-enrichment and yields of labelled lycopene from the hp-1 tomato cell line, cultures were first grown in (13)C-glucose media for three serial batches and produced increasing proportions of uniformly labelled lycopene (14.3±1.2%, 39.6±0.5%, and 48.9±1.5%) with consistent yields (from 5.8 to 9mg/L).|(13)C-glucose|NONE|25|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
9399970|Naloxone (0.1 - 10 mg/kg) antagonized the stimulus effects of dezocine, (+)-propoxyphene and fentanyl in a dose-related manner, whereas doses of naloxone that antagonized fentanyl's rate-decreasing effects failed to antagonize the rate-decreasing effects of dezocine and (+)-propoxyphene.|dezocine|NONE|13|NONE|Arg1:T39|NONE|CHEMICAL|NONE|no_relation
1403790|The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.|clozapine|5-hydroxytryptamine1C|6|12|Arg1:T47|Arg2:T66|CHEMICAL|GENE-N|no_relation
22381584|Both CHPG- and LY-induced outward currents were mediated by a TEA-sensitive potassium conductance.|CHPG|NONE|2|NONE|Arg1:T9|NONE|CHEMICAL|NONE|no_relation
23117790|In addition, hypothalamic BDNF may play an important role in this effect of orexin-A.|NONE|BDNF|NONE|5|NONE|Arg2:T19|NONE|GENE-Y|no_relation
23211523|We examined the role of β-catenin in FSHβ gene expression in LβT2 gonadotrope cells.|NONE|β-catenin|NONE|6|NONE|Arg2:T33|NONE|GENE-Y|no_relation
17315049|Sitagliptin does not cause a higher rate of hypoglycemia in comparison to metformin or placebo.|metformin|NONE|13|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23335392|The sulfonylurea agent tolbutamide (100 µM) converted the positive slope to negative slope conductance, indicating mediation by K-ATP channels (ATP-sensitive K+ channels).|tolbutamide|ATP-sensitive K+ channels|4|24|Arg1:T28|Arg2:T54|CHEMICAL|GENE-N|no_relation
19610651|Our data demonstrate that the FAK-VEGFR-3 interaction can be targeted by small druglike molecules and this interaction can provide the basis for highly specific novel cancer therapeutics.|NONE|FAK|NONE|6|NONE|Arg2:T12|NONE|GENE-Y|no_relation
23371451|Intracellular glutathione (GSH) was measured in HDMVEC after cysteamine exposure of 0, 0.1 or 1.0 mM.|cysteamine|NONE|11|NONE|Arg1:T21|NONE|CHEMICAL|NONE|no_relation
23276728|Moreover, it impaired STAT3 translocation to the nucleus and significantly reduced STAT3 transcriptional activity by a mechanism that was independent from STAT3 phosphorylation.|NONE|STAT3|NONE|5|NONE|Arg2:T18|NONE|GENE-Y|no_relation
23123771|An Indian butyrylcholinesterase variant L307P is not structurally stable: A molecular dynamics simulation study.|NONE|L307P|NONE|5|NONE|Arg2:T29|NONE|GENE-N|no_relation
23613012|We designed a prospective study to investigate the HDL subfractions in treatment naïve subjects with hypogonadism and the effects of 2 different testosterone replacement regimens on the HDL subfractions.|testosterone|HDL|23|28|Arg1:T5|Arg2:T22|CHEMICAL|GENE-N|no_relation
23640283|In this mat, which was realized by an electrospinning technique, each component serves a unique function: the carbon coating acts as both an adsorption material for capturing pollutants and as a charge-transfer material, the Ag nanoparticles act as a visible-light sensitizing agent and also as a charge-transfer material, finally the TiO2 nanocable mat acts as a UV sensitive photocatalytic matrix and as the flexible substrate for the other functional components.|carbon|NONE|21|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23523258|Rats were repeated administered with physiological saline (negative control group), ketoconazole (75mg/kg, positive control group) or varied doses of Sch B (experimental groups) for three consecutive days.|Sch B|NONE|26|NONE|Arg1:T8|NONE|CHEMICAL|NONE|no_relation
15240758|Zinc blocked the GABA response with an IC50 value of 7.3 microM in a noncompetitive manner.|Zinc|NONE|1|NONE|Arg1:T17|NONE|CHEMICAL|NONE|no_relation
23293126|In nonsmokers, LDL and cholesterol were negatively correlated with SOD and correlated with malondialdehyde (MDA), and cholesterol was negatively correlated with Zn. HDL was negatively correlated with MDA in all the sprayers, but was correlated with GPx in smokers and with Zn in nonsmokers.|Zn|GPx|48|43|Arg1:T16|Arg2:T34|CHEMICAL|GENE-N|no_relation
12898700|Expression and regulation of L-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL).|L-cystine|system xc-|5|8|Arg1:T16|Arg2:T38|CHEMICAL|GENE-Y|no_relation
16627864|MEASUREMENTS: Hepatocellular metabolism and liver blood flow were measured by plasma disappearance rate of indocyanine green (PDR(ICG)) as a sensitive marker of liver function.|indocyanine green|NONE|16|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
15992586|Thus, A-381393 is a novel selective D4 antagonist that will enhance the ability to study dopamine D4 receptors both in vitro and in vivo.|dopamine|dopamine D4 receptors|17|17|Arg1:T10|Arg2:T32|CHEMICAL|GENE-N|no_relation
10418858|  Atherogenesis in the vasculature is accelerated by changes in the dynamic equilibrium between endogenous tissue plasminogen activator and plasminogen activator inhibitor-1 (PAI-1).|NONE|tissue plasminogen activator|NONE|15|NONE|Arg2:T2|NONE|GENE-Y|no_relation
23296142|Membrane-initiated estradiol signaling in immortalized hypothalamic N-38 neurons.|estradiol|NONE|2|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
23367873|Selectivity against the four individual JAK family enzymes, JAK1, 2, 3 and TYK2, is now a key goal since they each play subtly different roles in cytokine-induced cell signaling.|NONE|JAK1, 2, 3|NONE|10|NONE|Arg2:T23|NONE|GENE-N|no_relation
23220616|The decrease in hepatic methionine was reflected by decreased sulfur-containing methionine metabolites, including S-adenosylmethionine, homocysteine, cysteine, and hypotaurine in liver and plasma.|sulfur|NONE|10|NONE|Arg1:T11|NONE|CHEMICAL|NONE|no_relation
10433694|  In mammals, two separate but homologous cytosolic quinone reductases have been identified: NAD(P)H:quinone oxidoreductase type 1 (QR1) (EC 1.6.99.2) and quinone reductase type 2 (QR2).|quinone|NAD(P)H:quinone oxidoreductase type 1|21|15|Arg1:T10|Arg2:T28|CHEMICAL|GENE-Y|no_relation
3812589|Fibroblasts, cultured from the patient, were unable to grow in medium in which homocysteine replaced methionine and incorporated abnormally small amounts of [14C]-methyl-tetrahydrofolate but normal amounts of [14C]-propionate into protein.|[14C]-methyl-tetrahydrofolate|NONE|25|NONE|Arg1:T8|NONE|CHEMICAL|NONE|no_relation
23328126|Insulin-resistant, nondiabetic subjects were treated with Omega-3-Acid Ethyl Esters (4 g/day) or placebo for 12 weeks.|Omega-3-Acid Ethyl Esters|Insulin|8|1|Arg1:T3|Arg2:T12|CHEMICAL|GENE-Y|no_relation
21741846|Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.|NONE|hPepT2|NONE|4|NONE|Arg2:T11|NONE|GENE-Y|no_relation
23104244|Among the tested CYP isoforms (1A1, 1A2, 1B1, 2B1, 2C11, 2E1, 3A1, 3A2, and 4A1), CYP1B1 and 4A1 were increased by GGT extracts.|NONE|CYP1B1 and 4A1|NONE|27|NONE|Arg2:T25|NONE|GENE-N|no_relation
12023686|Five hours after oral administration of valsartan, a 48% increase in cGMP was observed versus a 10.9% increase with losartan.|cGMP|NONE|14|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
23585332|  tert-Butylhydroquinone (tBHQ) is a commonly used antioxidant additive that is approved for human use by both the Food and Agriculture Organization and the World Health Organization (FAO/WHO).|tBHQ|NONE|3|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
23382381|In DNA-damaged supervillin knockdown cells, p53 knockdown or inhibition partially rescues the loss of cell metabolic activity, a measure of cell proliferation.|NONE|supervillin|NONE|3|NONE|Arg2:T30|NONE|GENE-Y|no_relation
8951675|AL-4943A applied topically from 5 min to 24 hrs prior to histamine challenge effectively and concentration-dependently inhibited the vascular permeability response, indicating the compound has an acceptable onset and a long duration of action.|AL-4943A|NONE|1|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
23528251|The aim of the present study was to investigate a possible link between CAR and HIFα.|NONE|HIFα|NONE|16|NONE|Arg2:T19|NONE|GENE-Y|no_relation
9730867|In this study, the characterization of betaAR subtype(s) (beta1, beta2, and beta3) involved in the regulation of interleukin (IL)-3, IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF), and interferon-gamma (IFN-gamma) mRNA accumulation was studied by using various betaAR agonists and antagonists.|NONE|betaAR|NONE|8|NONE|Arg2:T31|NONE|GENE-N|no_relation
23557687|  Transient developmental exposure to 0.1μM bisphenol A (BPA) results in larval zebrafish hyperactivity and learning impairments in the adult, while exposure to 80μM BPA results in teratogenic responses, including craniofacial abnormalities and edema.|BPA|NONE|9|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
15276688|Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.|dopamine|NONE|4|NONE|Arg1:T31|NONE|CHEMICAL|NONE|no_relation
8740147|After loading of isolated perfused lungs with 3H-noradrenaline (MAO and catechol-O-methyltransferase (COMT) inhibited), the efflux of 3H-noradrenaline was measured for 30 min.|O|COMT|13|14|Arg1:T28|Arg2:T56|CHEMICAL|GENE-Y|no_relation
16010412|Transient transfection of ERbeta cDNA into cells can decrease the estrogen-like properties of the ERalpha:tamoxifen complex, whereas an increase in the amount of ERbeta is associated with tamoxifen-resistant breast cancer.|tamoxifen|ERbeta|31|27|Arg1:T14|Arg2:T36|CHEMICAL|GENE-Y|no_relation
12358053|However, treatment of control tissue with flunixin led to increases in mucosal permeability, whereas treatment with etodolac had no significant effect.|flunixin|NONE|8|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
23465612|This work culminated in compounds such as 31, which possess good BACE-1 potency, excellent permeability and a low P-gp efflux ratio.|NONE|BACE-1|NONE|13|NONE|Arg2:T6|NONE|GENE-Y|no_relation
23270282|Different effects were discovered: crambescins inhibited K(+) currents with the following potency: NcrambA2 > CrambC1 > CrambA2, while Cramb816 lacked an effect.|K(+)|NONE|8|NONE|Arg1:T49|NONE|CHEMICAL|NONE|no_relation
7756657|The results of this analysis suggest the following: (1) In most pediatric cases of topoisomerase II inhibitor-associated leukemia, there is disruption of the breakpoint cluster region of the ALL-1 gene at chromosomal band 11q23.|NONE|topoisomerase II|NONE|18|NONE|Arg2:T10|NONE|GENE-Y|no_relation
7625729|In this model, the potency of drospirenone was about a third that of cyproterone acetate.|cyproterone acetate|NONE|15|NONE|Arg1:T23|NONE|CHEMICAL|NONE|no_relation
16679384|Human liver microsomes supplemented with NADPH generated the dihydroisoquinolinium ion metabolite along with other hydroxylated metabolites, whereas when supplemented with t-butyl peroxide, only the dihydroisoquinolinium ion metabolite was observed.|dihydroisoquinolinium|NONE|27|NONE|Arg1:T20|NONE|CHEMICAL|NONE|no_relation
16792938|The phenotypic detection methods evaluated included visual examination of antibiogram plates to identify the presence of scattered colonies located near the edge of the inhibition halo of cefoxitin, cefotaxime, ceftazidime and aztreonam, and a double-disc synergy test using cloxacillin (500 mg) to inhibit AmpC enzymes.|ceftazidime|AmpC|32|49|Arg1:T5|Arg2:T13|CHEMICAL|GENE-Y|no_relation
1351412|Local stinging can be a problem in some patients with betaxolol.|betaxolol|NONE|11|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
23553767|We fit sex-specific multivariable regression models to compare bone outcomes between Asians and Caucasians, adjusting for age, age at menarche (girls), lean mass, ulnar length, dietary calcium intake and physical activity.|calcium|NONE|34|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
12170055|METHODS: The ability of meperidine to bind to and inhibit forskolin-stimulated cyclic adenosine monophosphate formation as mediated by the three alpha(2)-adrenoceptor subtypes transiently transfected into COS-7 cells has been tested.|cyclic adenosine monophosphate|alpha(2)-adrenoceptor|13|22|Arg1:T20|Arg2:T39|CHEMICAL|GENE-N|no_relation
23224291|  Freshly established cultures of primary hepatocytes progressively adopt a foetal-like phenotype and display increased production of connexin43.|NONE|connexin43|NONE|17|NONE|Arg2:T12|NONE|GENE-Y|no_relation
22469988|We also report that the miRNA-dependent regulation of hexokinase expression is not limited to HK2 as miR-138 targets HK1 via a specific recognition motif located in its 3'UTR.|NONE|HK1|NONE|19|NONE|Arg2:T9|NONE|GENE-Y|no_relation
7625729|Drospirenone did not induce glucocorticoid receptor-driven transactivation.|Drospirenone|glucocorticoid receptor|1|5|Arg1:T8|Arg2:T47|CHEMICAL|GENE-Y|no_relation
11489456|  The present series of studies is the first to investigate the pharmacological mechanisms underlying d-fenfluramine- and d-norfenfluramine-induced hypophagia in the rat using highly selective serotonin 5-HT2 receptor antagonists.|d-norfenfluramine|5-HT2|17|26|Arg1:T6|Arg2:T29|CHEMICAL|GENE-N|no_relation
23623790|Modulation of GABA-induced chloride currents (IGABA) by piperine and SCT-66 and activation of TRPV1 was studied using the two-microelectrode-voltage-clamp technique and fast perfusion.|GABA|TRPV1|3|16|Arg1:T10|Arg2:T29|CHEMICAL|GENE-Y|no_relation
23229510|E235-mediated induction of senescence was not dependent on p21 or p53; however, p21 conferred protection against the growth inhibitory effects of E235.|E235|p21|24|15|Arg1:T4|Arg2:T15|CHEMICAL|GENE-Y|no_relation
23576175|Attenuation of Gouty Arthritis by Emodinol in Monosodium Urate Crystal-Treated Mice.|Emodinol|NONE|6|NONE|Arg1:T8|NONE|CHEMICAL|NONE|no_relation
23535349|An increased risk of ischemic stroke was associated with the use of risperidone (aOR=3.5, 95% CI 3.3-4.6) and quetiapine (aOR=2.7, 95% CI 2.0-3.6) during the 30 days prior to stroke: however, no significant risk was observed with olanzapine (aOR=1.2, 95% CI 0.7-2.0).|quetiapine|NONE|23|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
12963636|CONCLUSIONS: Our data show that PI3Kgamma is critical for the induction of hypertrophy, fibrosis, and cardiac dysfunction function in response to beta-adrenergic receptor stimulation in vivo.|NONE|beta-adrenergic receptor|NONE|25|NONE|Arg2:T15|NONE|GENE-N|no_relation
10418979|Data from a number of ovariectomized rat model manipulations (i.e. hypophysectomy, low calcium diet and drug combinations) demonstrate a strong parallel between the antiosteopenic effects of raloxifene and estrogen.|estrogen|NONE|33|NONE|Arg1:T32|NONE|CHEMICAL|NONE|no_relation
23270282|Differential Effects of Crambescins and Crambescidin 816 in Voltage-Gated Sodium, Potassium and Calcium Channels in Neurons.|Calcium|Voltage-Gated Sodium, Potassium and Calcium Channels|14|9|Arg1:T57|Arg2:T71|CHEMICAL|GENE-N|no_relation
23239534|Complexes smaller than Mg(2+)(H2O)3 cannot be formed in this source because charge separation into MgOH(+)(H2O) and H3O(+) is a lower-energy pathway than simple water loss from Mg(2+)(H2O)3.|Mg(2+)(H2O)3|NONE|4|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
14672731|Structure-affinity and -activity relationships were studied on a variety of compounds related to NOMAC in order to assess its specificity as a progestin.|progestin|NONE|23|NONE|Arg1:T36|NONE|CHEMICAL|NONE|no_relation
17389761|Surprisingly, R18 was only able to dissociate FOXO3a, but not BAD as previously proposed, from 14-3-3 binding and induced apoptosis partially through liberation and reactivation of FOXO3a.|NONE|FOXO3a|NONE|30|NONE|Arg2:T9|NONE|GENE-Y|no_relation
16495723|These findings suggest that monoamine oxidase inhibitors can modulate the discriminative stimulus effects of cocaine for at least 24 h, and may be useful for treatment of cocaine abuse.|cocaine|monoamine oxidase|15|5|Arg1:T15|Arg2:T35|CHEMICAL|GENE-N|no_relation
23327533|Metabolism via N-oxidation was predominant in dog and rat, while in monkey and human, metabolism proceeded primarily via oxidation of indole-containing moiety.|N|NONE|3|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
23008503|Third, COX-1 was localized in goblet and Brunner's gland cells, Meissner's and Auerbach's plexus, smooth muscle cells, and arterioles; and COX-2 was observed in capillaries, venules, and basal granulated cells.|NONE|COX-2|NONE|29|NONE|Arg2:T17|NONE|GENE-Y|no_relation
23633563|This was concomitant with decreased binding of LXRα to the putative LXRE on 11β-HSD1 and G6Pase.|NONE|LXRα|NONE|8|NONE|Arg2:T11|NONE|GENE-Y|no_relation
9859690|As this drug crosses the blood brain barrier, zolmitriptan has both peripheral and central actions over the espinal trigeminal nucleus, which is rich in 5-HT1B/D receptors.|zolmitriptan|5-HT1B/D|10|27|Arg1:T2|Arg2:T11|CHEMICAL|GENE-N|no_relation
23459442|Women with Val/Val genotype reported greater difficulty concentrating and irritability than men with Val/Val or Met carrier genotypes.|Val|NONE|15|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
8836913|In all of these comparisons, consensus interferon had a higher activity when compared, on a mass basis, with IFN-alpha 2a and IFN-alpha 2b, although the activity was the same for all of these parameters on an antiviral unit basis.|NONE|interferon|NONE|8|NONE|Arg2:T12|NONE|GENE-N|no_relation
23397054|We examined the role of P-gp and Bcrp on brain penetration of elacridar using Friend leukemia virus strain B wild-type, Mdr1a/b(-/-), Bcrp1(-/-), and Mdr1a/b(-/-)Bcrp1(-/-) mice.|elacridar|Bcrp1|13|37|Arg1:T8|Arg2:T29|CHEMICAL|GENE-Y|no_relation
16809898|  BACKGROUND: L-arginine (L-arg) participates in numerous biological functions including urea and nitric oxide synthesis.|nitric oxide|NONE|15|NONE|Arg1:T22|NONE|CHEMICAL|NONE|no_relation
15070163|The Salix extract inhibited the LPS-induced release of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 with IC50-values of 180.0, 33.0 and 86.0 microg/ml, respectively.|NONE|interleukin-6|NONE|15|NONE|Arg2:T18|NONE|GENE-Y|no_relation
16597468|  Leishmania species express three phosphoribosyltransferase enzymes, hypoxanthine-guanine phosphoribosyltransferase (HGPRT), adenine phosphoribosyltransferase (APRT), and xanthine phosphoribosyltransferase (XPRT), which enable this genus to acquire purine nutrients from their hosts.|adenine|hypoxanthine-guanine phosphoribosyltransferase|14|8|Arg1:T2|Arg2:T15|CHEMICAL|GENE-Y|no_relation
17588565|  Neuromuscular blocking drugs produce muscle weakness by interaction with nicotinic-acetylcholine receptors.|acetylcholine|nicotinic-acetylcholine receptors|11|10|Arg1:T15|Arg2:T20|CHEMICAL|GENE-N|no_relation
11141093|The 6-carbamate 4 was almost as potent as physostigmine and was 60- and 550-fold more potent than the 7-carbamate 5 and the 8-carbamate 6, respectively.|6-carbamate|NONE|2|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
12498985|The recently cloned transporter xCT forms a heteromultimeric complex with the heavy chain of 4F2 cell surface antigen (4F2hc/CD98).|NONE|xCT|NONE|5|NONE|Arg2:T42|NONE|GENE-Y|no_relation
10950934|DDAH2 expression predominates in highly vascularized tissues that express the endothelial NOS isoform and in immune tissues that can express iNOS.|NONE|DDAH2|NONE|1|NONE|Arg2:T29|NONE|GENE-Y|no_relation
23294566|This pattern of androgen and oestrogen regulation was confirmed in VCaP cells and was also observed for FKBP5, a well-characterized androgen-regulated gene.|oestrogen|FKBP5|6|18|Arg1:T7|Arg2:T29|CHEMICAL|GENE-Y|no_relation
23386250|Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain.|NONE|nuclear factor of activated T-cells|NONE|3|NONE|Arg2:T27|NONE|GENE-N|no_relation
23454144|Oxidative stress may be the starter point, as it leads to the activation of transcription factors and signaling pathways, including NF-kB and p38 MAPK, which leads to the release of cytokines and chemokines.|NONE|NF-kB|NONE|23|NONE|Arg2:T2|NONE|GENE-N|no_relation
23643932|In contrast, LXA4 from different sources neither increased [Ca(2+)]i and extracellular-signal-regulated kinase (ERK) phosphorylation, nor did it induce a decrease in cAMP levels or a translocation of β-arrestin.|LXA4|β-arrestin|4|38|Arg1:T5|Arg2:T23|CHEMICAL|GENE-N|no_relation
17369473|Total AMP content and total AMP/ATP did not change.|ATP|NONE|7|NONE|Arg1:T19|NONE|CHEMICAL|NONE|no_relation
18684057|  Denileukin diftitox (Ontak) is a novel recombinant fusion protein consisting of peptide sequences for the enzymatically active and membrane translocation domain of diphtheria toxin linked to human IL-2.|NONE|Denileukin diftitox|NONE|1|NONE|Arg2:T2|NONE|GENE-Y|no_relation
16199482|Prolonged Ca2+ contraction signals that correspond with CH in coronary vascular muscle cells (VMC) to the same dual-constrictor stimulus, serotonin + the thromboxane analog U-46619, in estrogen-deprived VMC were suppressed by >72 h in 17beta-estradiol.|Ca2+|NONE|2|NONE|Arg1:T14|NONE|CHEMICAL|NONE|no_relation
23261524|Finally, this novel BiFC approach was exploited to identify potential modulators of p53-Mdm2 complex formation among a commercially available chemical library of 33 protein phosphatase inhibitors.|NONE|Mdm2|NONE|15|NONE|Arg2:T7|NONE|GENE-Y|no_relation
3758193|  In this study we investigated the affinity of several 4-chlorinated and 1-ene derivatives of 17 alpha-methyltestosterone (MT) and 17 alpha-methyl-5 alpha-dihydrotestosterone (MDHT) to the androgen receptor, and, additionally, the effect of a few MT-derived steroids on the activity of the 5 alpha-reductase enzyme present in the rat seminal vesicle.|17 alpha-methyltestosterone|5 alpha-reductase|15|48|Arg1:T20|Arg2:T27|CHEMICAL|GENE-N|no_relation
12244074|In monocytes, the inflammatory cytokine tumor necrosis factor alpha (TNF-alpha) stimulates CD44 sulfation, and this correlates with the induction of CD44-mediated adhesion events.|NONE|tumor necrosis factor alpha|NONE|7|NONE|Arg2:T23|NONE|GENE-Y|no_relation
10953053|The mechanism by which retigabine enhanced KCNQ2/Q3 currents involved large, drug-induced, leftward shifts in the voltage dependence of channel activation (-33.1 +/- 2.6 mV, n = 4, by 10 microM retigabine).|retigabine|KCNQ2/Q3|5|7|Arg1:T16|Arg2:T27|CHEMICAL|GENE-N|no_relation
7476290|Thus, the increased number of IGF-I receptors in erythrocytes of PE subjects yields a net increase in receptor tyrosine kinase.|tyrosine|receptor tyrosine kinase|20|19|Arg1:T1|Arg2:T5|CHEMICAL|GENE-N|no_relation
16437532|There is no evidence from DON vs RIV/Bullock of a difference between donepezil and rivastigmine for cognitive function, activities of daily living and behavioural disturbance at two years.|rivastigmine|NONE|15|NONE|Arg1:T24|NONE|CHEMICAL|NONE|no_relation
22397675|The two major factors determining the rate of IVM release from ISI were miscibility of the solvent with water and the viscosity of the polymer solutions.|IVM|NONE|9|NONE|Arg1:T14|NONE|CHEMICAL|NONE|no_relation
23613149|Dietary Flaxseed Oil Supplementation Mitigates the Effect of Lead on the Enzymes of Carbohydrate Metabolism, Brush Border Membrane, and Oxidative Stress in Rat Kidney Tissues.|Carbohydrate|NONE|14|NONE|Arg1:T25|NONE|CHEMICAL|NONE|no_relation
23298292|The method consists of antisolvent co-precipitation from an aqueous solution containing both an amino acid core material (e.g. D,L-valine), and either bovine serum albumin (BSA) or lysozyme (Lys) as model proteins.|amino acid|Lys|14|37|Arg1:T1|Arg2:T8|CHEMICAL|GENE-Y|no_relation
16818276|Here we have analyzed the role of nucleoside transporters in nucleoside-derived drug bioavailability and action in mantle cell lymphoma (MCL) cells.|nucleoside|nucleoside transporters|11|8|Arg1:T12|Arg2:T31|CHEMICAL|GENE-N|no_relation
10229494|  Phospholipase A2 (PLA2) and phospholipid methylases (PLM) play significant roles in transmitter release and membrane signal transduction, respectively.|NONE|PLM|NONE|10|NONE|Arg2:T32|NONE|GENE-N|no_relation
23518413|With the neo gene selection marker in the intron following the mutation, resulting in reduced expression of the SMC6 gene, the mice were reduced in size, but fertile and had normal lifespans.|NONE|neo|NONE|3|NONE|Arg2:T13|NONE|GENE-Y|no_relation
11054378|In contrast, the moieties of sulfasalazine, 5-aminosalicylic acid, and sulfapyridine or 4-aminosalicylic acid had no effect.|sulfapyridine|NONE|13|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
23214973|The capture capability for proteins was evaluated through a novel dual-labeled bovine serum albumin (BSA) that utilizes fluorescence resonance energy transfer (FRET).|NONE|bovine serum albumin|NONE|12|NONE|Arg2:T10|NONE|GENE-Y|no_relation
23458730|The inhibitory effects of multiple doses of baicalin (0.90g/kg, i.v., 12days) on the metabolism of DXM were similar to those observed following a single dose in rats.|DXM|NONE|20|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
23378624|Our results highlight the role of β-cell dysfunction in the pathophysiology of NODAT and indicate the potential value of proinsulin for identification of RTR at increased risk for NODAT.|NONE|proinsulin|NONE|20|NONE|Arg2:T6|NONE|GENE-Y|no_relation
23349501|Obesity significantly decreased DHA-derived 17-hydroxydocosahexaenoic acid (17-HDHA, resolvin D1 precursor) and protectin D1 levels in murine adipose tissue.|17-HDHA|NONE|8|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
9710435|In T84 cells, ibuprofen inhibited the forskolin-dependent Isc in a concentration-dependent manner, having an apparent Ki of 142 microM.|forskolin|NONE|8|NONE|Arg1:T9|NONE|CHEMICAL|NONE|no_relation
23388095|Pharmacological modulation of oxygen sensing system by DMOG in an in vitro model of vascular IR effectively preserved endothelial function.|oxygen|NONE|4|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
14602594|Likewise, the Rif(r) mutant possessed a mutation in the rpoB gene (encoding the RNA polymerase beta subunit).|NONE|RNA polymerase beta|NONE|19|NONE|Arg2:T16|NONE|GENE-N|no_relation
23630454|Growth retardation was rescued in flies by reintroducing PICK1 in neurosecretory cells producing somatotropic peptides.|NONE|PICK1|NONE|9|NONE|Arg2:T25|NONE|GENE-Y|no_relation
17194761|We present crystal structures of recombinant human and rat aspartoacylase refined to 2.8- and 1.8-A resolution, respectively.|NONE|aspartoacylase|NONE|10|NONE|Arg2:T16|NONE|GENE-N|no_relation
10567921|The crucial role of Gb(3) for the signal transduction of IFN-alpha-mediated antiviral activity is now reported.|Gb(3)|IFN-alpha|5|14|Arg1:T16|Arg2:T48|CHEMICAL|GENE-N|no_relation
17317527|Animals were exposed to aluminum chloride at a dose of 172.5mg/kg/d orally for 10 weeks.|aluminum chloride|NONE|5|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
11330337|A series of compounds, representative of the principal classes of acetylcholinesterase inhibitors, displaced [3H]-oxotremorine-M binding with high-to-moderate potency (ambenonium>neostigmine=pyridostigmine=tacrine>physostigmine> edrophonium=galanthamine>desoxypeganine) whereas only ambenonium and tacrine displaced [3H]-quinuclinidyl benzilate binding.|[3H]-oxotremorine-M|acetylcholinesterase|16|12|Arg1:T28|Arg2:T54|CHEMICAL|GENE-Y|no_relation
17203585|The expression of glycans was examined by lectin-histochemistry using Vicia villosa lectin (VVL) for terminal alpha/beta N-acetylgalactosamine (alpha/beta GalNAc); Galanthus nivalus lectin (GNL) for terminal mannose alpha-1,3 (Man alpha-1,3); Peanut agglutinin (PNA) for galactose beta-1,3N-acetylgalactosamine (Gal beta-1,3 GalNAc); Erythrina cristagalli lectin (ECL) for galactose beta-1,4 N-acetylglucosamine (Gal beta-1,4 GlcNAc); Sambucus nigra lectin (SNA) for sialic acid alpha-2.6 galactose (SA alpha-2,6 Gal); Maackia amurensis lectin II (MAL II) for sialic acid alpha-2,3 (SA alpha-2,3); Wheat germ agglutinin (WGA) for terminal N-acetylglucosamine with/ without sialic acid (GlcNAc wo SA); succynilated WGA (sWGA) for terminal N-acetylglucosamine without sialic acid (terminal GlcNAc without SA); Griffonia simplicifolia lectin II (GSL II) for terminal alpha/beta N-acetylglucosamine (alpha/beta GlcNAc terminal); and Lotus tetragonolobus lectin (LTL) alpha-fucose.|mannose alpha-1,3|WGA|33|108|Arg1:T19|Arg2:T50|CHEMICAL|GENE-N|no_relation
19445548|Slight differences were evident in the adverse event profiles of atomoxetine and stimulants, both immediate- and extended-release.|atomoxetine|NONE|11|NONE|Arg1:T42|NONE|CHEMICAL|NONE|no_relation
19852528|In the US, oral palonosetron is approved for the prevention of CINV in the acute phase following MEC (although this formulation is not currently available), and intravenous palonosetron is indicated for the prevention of postoperative nausea and vomiting (PONV) in the first 24 hours following surgery.|palonosetron|NONE|6|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
10917903|  Previous studies reveal that supplementation of human diets with gamma-linolenic acid (GLA) reduces the generation of lipid mediators of inflammation and attenuates clinical symptoms of chronic inflammatory disorders such as rheumatoid arthritis.|gamma-linolenic acid|NONE|10|NONE|Arg1:T20|NONE|CHEMICAL|NONE|no_relation
16897483|Cm-ADH1 has strong preference for NAPDH as a co-factor, whereas Cm-ADH2 preferentially uses NADH.|NAPDH|Cm-ADH2|6|12|Arg1:T11|Arg2:T34|CHEMICAL|GENE-N|no_relation
22614014|In this study, utilizing mice deficient in CTSK, we demonstrate the critical involvement of this potent collagenase in tumor progression in bone.|NONE|collagenase|NONE|19|NONE|Arg2:T7|NONE|GENE-N|no_relation
22981459|Plasma concentrations of intramuscularly-administered atropine, diazepam and HI-6 reached a peak within 15min and were eliminated rapidly within 4h.|atropine|NONE|5|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
18773878|Phosphorylation of replication protein A (RPA2 subunit) and formation of damage-induced foci were strikingly evident following IC(50) doses of RTX.|RTX|RPA2|25|7|Arg1:T4|Arg2:T21|CHEMICAL|GENE-Y|no_relation
23478800|However, Rac1 activation was not affected by Jak2 or Stat3 RNA interference, suggesting that the effect of cucurbitacin I occurs through a Jak2-independent mechanism.|cucurbitacin I|Jak2|20|25|Arg1:T10|Arg2:T53|CHEMICAL|GENE-N|no_relation
17062721|  The intended therapeutic effect of gonadotropin-releasing hormone (GnRH) agonists is hypogonadism, a major cause of acquired osteoporosis in men.|NONE|gonadotropin-releasing hormone|NONE|6|NONE|Arg2:T13|NONE|GENE-Y|no_relation
23494481|Our data suggest that depletion of mitochondrial glutathione leads to mitochondrial dysfunction and apoptosis.|glutathione|NONE|8|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
23330847|Hydroxy-terminated conjugated polymer nanoparticles have near-unity bright fraction and reveal cholesterol-dependence of IGF1R nanodomains.|cholesterol|IGF1R nanodomains|11|13|Arg1:T9|Arg2:T13|CHEMICAL|GENE-N|no_relation
12183670|Results from Schild analyses suggest that bupropion competitively inhibits nicotine-evoked [(3)H]DA overflow, whereas evidence for receptor reserve was obtained upon assessment of bupropion inhibition of nicotine-evoked [(3)H]NE overflow.|bupropion|NONE|7|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
19281809|In rats with mild or moderate streptozotocin-induced diabetes, the degree of the antihyperglycemic effects of sergliflozin etabonate correlated with the severity of the diabetic condition.|streptozotocin|NONE|7|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
10666203|Streptokinase-induced platelet activation is dependent on both antistreptokinase-Fc receptor interactions and cleavage of PAR-1.|NONE|Streptokinase|NONE|1|NONE|Arg2:T12|NONE|GENE-N|no_relation
8676079|Since osteoblasts and mature osteoclasts expressed IL-11R alpha mRNA, both bone-forming and bone-resorbing cells are potential targets of IL-11.|NONE|IL-11|NONE|20|NONE|Arg2:T20|NONE|GENE-Y|no_relation
23645211|Rats intoxicated with Cd for 30 days, significantly increased tissue malondialdehyde (MDA) levels and significantly decreased enzymatic antioxidants superoxide dismutase, glutathione peroxidase and catalase in the frontal cortex tissue.|glutathione|catalase|25|28|Arg1:T2|Arg2:T27|CHEMICAL|GENE-Y|no_relation
23416143|Citrus narirutin fraction (CNF), contained 75% of narirutin, was obtained by an ultra-sonicated extraction and further purification.|narirutin|NONE|12|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23000451|  Cocaine addiction affects millions of people with disastrous personal and social consequences.|Cocaine|NONE|1|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
10071758|Total beta-receptor expression on undifferentiated (monocyte) and PMA-differentiated U937 cells was established using receptor binding studies on membrane fractions with a radio ligand.|NONE|beta-receptor|NONE|2|NONE|Arg2:T14|NONE|GENE-N|no_relation
15224175|These control responses were: unaffected by SB224289, BRL15572, rauwolscine or the combinations of SB224289 + BRL15572, BRL15572 + rauwolscine, rauwolscine + prazosin, SB224289 + prazosin, or SB224289 + prazosin + imiloxan; slightly blocked by SB224289 + rauwolscine; and markedly blocked by SB224289 + rauwolscine + prazosin, SB224289 + prazosin + BRL44408 or SB224289 + prazosin + MK912.|SB224289|NONE|57|NONE|Arg1:T30|NONE|CHEMICAL|NONE|no_relation
11383749|These results provide an experimental rationale for the evaluation of minocycline in human trauma patients.|minocycline|NONE|11|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23588252|The fraction of proximal renal cells with elevated 8-oxodeoxyguanosine (8-OH-dG) was only increased at the high dose and did not differ by sex.|8-OH-dG|NONE|11|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
18568240|Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition.|NONE|TNF-alpha|NONE|6|NONE|Arg2:T37|NONE|GENE-Y|no_relation
23212047|Our current results could offer new insights into not only the ADP-ribosylation of small molecules but also signal transduction events via enzymatic nucleoside modification by toxin-related enzymes.|ADP|NONE|12|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
23562495|In an investigation into the participation of TRP channels and ASICs in CAT's antinociceptive mechanism, we used capsaicin (2.2μg/paw), cinnamaldehyde (10mmol/paw), menthol (1.2mmol/paw) and acidified saline (2% acetic acid, pH 1.98).|acetic acid|ASICs|40|11|Arg1:T9|Arg2:T27|CHEMICAL|GENE-N|no_relation
17194886|Rats received oral administration of either triflusal or aspirin.|aspirin|NONE|9|NONE|Arg1:T12|NONE|CHEMICAL|NONE|no_relation
23607523|  The biosynthetic gene cluster for the pyralomicin antibiotics has been cloned and sequenced from Nonomuraea spiralis IMC A-0156.|pyralomicin|NONE|7|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23439383|The consequence of CaMKII activation is the rapid recruitment of AMPA receptors to the synapse.|AMPA|AMPA receptors|11|11|Arg1:T2|Arg2:T8|CHEMICAL|GENE-N|no_relation
20800906|Mice were retested with ABR at 1 and 2 months to determine the efficacy of the different steroid treatments in controlling hearing loss.|steroid|NONE|18|NONE|Arg1:T16|NONE|CHEMICAL|NONE|no_relation
17325243|As such, this polymorphism may account for the apparent link between altered endothelial function, L-arginine, and nitric oxide metabolism and predisposition to essential hypertension.|nitric oxide|NONE|20|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
23571107|Using mice lacking neurofibromin 1 (Nf1) in type II collagen-expressing cells, (Nf1col2(-/-) mutant mice), we then show that lack of neurofibromin in post-mitotic chondrocytes triggers a number of phenotypes reminiscent of the ones observed in mice characterized by FGFR gain-of-function mutations.|NONE|col2|NONE|17|NONE|Arg2:T36|NONE|GENE-N|no_relation
14672731|An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.|nomegestrol acetate|NONE|4|NONE|Arg1:T39|NONE|CHEMICAL|NONE|no_relation
16978033|Fingolimod (FTY720), a synthetic sphingosine phosphate receptor modulator that reduces the recirculation of lymphocytes to blood and peripheral tissues including inflammatory lesions and graft sites is undergoing phase III trials.|Fingolimod|sphingosine phosphate receptor|1|8|Arg1:T13|Arg2:T28|CHEMICAL|GENE-N|no_relation
23349208|Concomitantly, thromboxane B (TXB)2 and leukotriene B (LTB)4 in supernatants decreased, while levels of TXB3 and LTB5 increased.|LTB5|NONE|25|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
16484281|Withdrawal from free-choice ethanol consumption results in increased packing density of glutamine synthetase-immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats.|alcohol|glutamine synthetase|20|12|Arg1:T17|Arg2:T32|CHEMICAL|GENE-Y|no_relation
16325050|CONCLUSIONS: Codon 389 beta1AR polymorphism is a determinant not only of hemodynamic effects but also of PRA.|NONE|beta1AR|NONE|5|NONE|Arg2:T13|NONE|GENE-Y|no_relation
19203467|METHODS: Male rats were administered PLZ (10 mg/kg) or VIG (1,000 mg/kg) i.p., and the rats were euthanized 4 hours later and the brains removed for analysis of levels of GABA and ALA (by electron capture gas chromatography after derivatization) and activities of MAO, GABA-T and ALA-T (radiochemical assays).|ALA|ALA-T|39|56|Arg1:T43|Arg2:T76|CHEMICAL|GENE-N|no_relation
23384446|The effect of inorganic arsenic on endothelium-dependent relaxation: Role of NADPH oxidase and hydrogen peroxide.|NADPH|NADPH oxidase|12|12|Arg1:T33|Arg2:T43|CHEMICAL|GENE-N|no_relation
22718275|In addition to a previously described oxysterol, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), we provide evidence for the chemical structures of three new oxysterols in the brain and/or liver tissue of Dhcr7-KO mice, two of which were quantified.|oxysterol|Dhcr7|7|32|Arg1:T24|Arg2:T32|CHEMICAL|GENE-Y|no_relation
8622623|5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.|sumatriptan|5-hydroxytryptamine1B receptors|8|25|Arg1:T26|Arg2:T36|CHEMICAL|GENE-Y|no_relation
23322284|Pathophysiology in relation with the essential elements including copper, magnesium, zinc, manganese, chromium, and calcium has been reported in women with insulin resistance.|chromium|insulin|17|27|Arg1:T15|Arg2:T27|CHEMICAL|GENE-Y|no_relation
23340897|Furthermore, there was no association between 25(OH)D and in vivo insulin sensitivity or β-cell function relative to insulin sensitivity (disposition index) in all groups combined or in each group separately.CONCLUSIONSOur data in obese youth show 1) no differences in plasma 25(OH)D concentrations across the glucose tolerance groups, and 2) no relationship between 25(OH)D and in vivo insulin sensitivity and β-cell function relative to insulin sensitivity in any of the groups.|glucose|insulin|57|82|Arg1:T4|Arg2:T19|CHEMICAL|GENE-Y|no_relation
10917903|  Previous studies reveal that supplementation of human diets with gamma-linolenic acid (GLA) reduces the generation of lipid mediators of inflammation and attenuates clinical symptoms of chronic inflammatory disorders such as rheumatoid arthritis.|GLA|NONE|13|NONE|Arg1:T26|NONE|CHEMICAL|NONE|no_relation
23200901|  Aconitum alkaloids including aconitine (AC), mesaconitine (MA), hypaconitine (HA), are highly toxic.|aconitine|NONE|4|NONE|Arg1:T15|NONE|CHEMICAL|NONE|no_relation
23352980|Among these proteins, PIM1 functioned as an oncogene and was found to act as a crucial mediator in radioresistant NSCLC cells.|NONE|PIM1|NONE|5|NONE|Arg2:T22|NONE|GENE-Y|no_relation
17289086|Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells.|serotonin|human serotonin transporter|9|8|Arg1:T12|Arg2:T23|CHEMICAL|GENE-Y|no_relation
23103446|Accordingly, cells with the reduced expression of P-gp concomitantly failed to provide resistance to nilotinib, however, they exhibited a significant resistance to DNR.|nilotinib|P-gp|16|9|Arg1:T3|Arg2:T15|CHEMICAL|GENE-Y|no_relation
23147375|At early time-point PAH exposure, large-scale gene expression analysis resulted in characteristic molecular signatures for each PAH, and supervised analysis identified 1183 outlier genes as a distinct molecular signature discerning PAHs from the normal control group.|PAHs|NONE|33|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
10917903|The objective of this study was to design a supplementation strategy that maintained the capacity of GLA to reduce lipid mediators without causing elevations in serum AA levels.|AA|NONE|27|NONE|Arg1:T19|NONE|CHEMICAL|NONE|no_relation
12488248|  Basolateral uptake of organic anions in renal proximal tubule cells is indirectly coupled to the Na(+) gradient through Na(+)-dicarboxylate cotransport and organic anion/dicarboxylate exchange.|Na(+)|NONE|16|NONE|Arg1:T33|NONE|CHEMICAL|NONE|no_relation
23274887|We showed that GCs stimulate the expression of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), a coregulator of the GCs receptor (GR), and that the overexpression of PGC-1α represses genes important for β-cell development and function.|NONE|PGC-1α|NONE|14|NONE|Arg2:T8|NONE|GENE-Y|no_relation
2877081|Against acid secretion from the vagally innervated gastric fistula and Heidenhain pouch of dogs stimulated with submaximal doses of histamine, methacholine and gastrin, nizatidine was, respectively, 6.5, 5 and 4.7 times as active as cimetidine by i.v. administration.|nizatidine|gastrin|26|24|Arg1:T10|Arg2:T20|CHEMICAL|GENE-Y|no_relation
17203264|The content of L-malic acid was determined for different types of wine, and polyvinylpolypyrrolidone (PVPP) was used as a bleaching agent with red wine.|L-malic acid|NONE|4|NONE|Arg1:T17|NONE|CHEMICAL|NONE|no_relation
23316965|Particularly MMP-2 and MMP-9 contribute to the degradation and reorganization of the ECM components and are involved in the pathophysiology of cardiovascular remodeling.|NONE|MMP-2|NONE|2|NONE|Arg2:T8|NONE|GENE-Y|no_relation
1983158|Using the hot-plate test, it was observed that the two doses of tripelennamine and the higher doses of chlorpheniramine and cimetidine had antinociceptive activity.|tripelennamine|NONE|14|NONE|Arg1:T13|NONE|CHEMICAL|NONE|no_relation
19445548|Rarely, atomoxetine may also be associated with serious liver injury; postmarketing data show that three patients have had liver-related adverse events deemed probably related to atomoxetine treatment.|atomoxetine|NONE|3|NONE|Arg1:T46|NONE|CHEMICAL|NONE|no_relation
23353748|The results suggest that the existence of benzimidazole ring and substitution of the imidazolyl-3-position with a naphthylacyl or 4-methoxyphenacyl group were vital for modulating cytotoxic activity.|imidazolyl|NONE|14|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
12414107|SPR activity was relatively high compared with the activity of GTP cyclohydrolase I (GCH), the rate-limiting biosynthetic enzyme of BH4, and was more widely distributed than GCH activity.|NONE|GTP cyclohydrolase I|NONE|11|NONE|Arg2:T14|NONE|GENE-Y|no_relation
10517265|  The possible interaction between cholecystokinin (CCK) and 5-hydroxytryptamine (5-HT) was evaluated in vitro in the longitudinal muscle-myenteric plexus of the guinea-pig ileum.|5-HT|CCK|12|7|Arg1:T18|Arg2:T32|CHEMICAL|GENE-Y|no_relation
23017408|To understand the effect of l-phenylalanine (l-phe) on the PAL activity, total phenolic amount, and phenolic constituents, isolates were evaluated with 100mg/l l-phe.|l-phenylalanine|PAL|6|12|Arg1:T4|Arg2:T19|CHEMICAL|GENE-N|no_relation
23221633|Using classic double-strand breaks (DSBs) markers, we studied the roles of Smad proteins in DDR and the crosstalk between TGFβ and ATM pathways.|NONE|ATM|NONE|25|NONE|Arg2:T18|NONE|GENE-Y|no_relation
11518758|Activity of each metabolic step in the conversion of alpha-LNA to DHA was determined by comparison of the ratios of the integrated concentration of (13)C-product to (13)C-precursor in plasma total lipid fractions.|DHA|NONE|12|NONE|Arg1:T24|NONE|CHEMICAL|NONE|no_relation
23294566|The androgen responsiveness of these enhancers was verified by luciferase reporter gene assays and site-directed mutagenesis analysis.|androgen|NONE|2|NONE|Arg1:T12|NONE|CHEMICAL|NONE|no_relation
23327877|Flavonoids such as green tea catechins and quercetin glycosides have been shown to modulate the function of some OATPs. In the present study, the extent to which six substituted quercetin derivatives (1-6) affected the function of OATP1B1 and OATP1B3 was investigated.|quercetin|OATP1B3|32|43|Arg1:T10|Arg2:T26|CHEMICAL|GENE-Y|no_relation
10353435|  RATIONALE: d-Fenfluramine stimulates the release of serotonin (5-HT) and is a potent inhibitor of the re-uptake of 5-HT into nerve terminals.|5-HT|NONE|10|NONE|Arg1:T12|NONE|CHEMICAL|NONE|no_relation
10841524|The pancreatic duct expresses NHE1 in the basolateral membrane, and NHE2 and NHE3 in the luminal membrane, but does not contain NHE4 or NHE5.|NONE|NHE5|NONE|26|NONE|Arg2:T36|NONE|GENE-Y|no_relation
22935616|Although ablation of daf-2 or pdk-1 completely suppressed akt-1-dependent apoptosis, the transcriptional activation of CEP-1 was unaffected, suggesting that daf-2 and pdk-1 act independently or downstream of cep-1 and akt-1.|NONE|CEP-1|NONE|16|NONE|Arg2:T53|NONE|GENE-Y|no_relation
23192339|However, the molecular mechanisms of GIP secretion and high fat diet (HFD)-induced GIP hypersecretion remain unclear, primarily due to difficulties in separating K-cells from other intestinal epithelial cells in vivo.|NONE|GIP|NONE|7|NONE|Arg2:T19|NONE|GENE-Y|no_relation
2653642|Concomitant administration of somatostatin did not influence these effects of cysteamine.|somatostatin|somatostatin|4|4|Arg1:T18|Arg2:T29|CHEMICAL|GENE-Y|no_relation
22841391|The array analysis indicated that methylselenol exposure changed the expression of 11 protein targets related to the regulation of cell cycle and apoptosis.|methylselenol|NONE|6|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
15198480|  Liddle's syndrome is an autosomal dominant disease characterized by sodium-sensitive early hypertension and mutations in either the beta- or gamma-subunit of the amiloride-sensitive epithelial sodium channel encoded by SCNN1B and SCNN1G.|sodium|SCNN1G|26|32|Arg1:T3|Arg2:T14|CHEMICAL|GENE-Y|no_relation
19445548|Atomoxetine did not differ significantly from or was noninferior to immediate-release methylphenidate in children and adolescents with ADHD with regard to efficacy, and was significantly more effective than standard current therapy (any combination of medicines [excluding atomoxetine] and/or behavioral counseling, or no treatment).|methylphenidate|NONE|12|NONE|Arg1:T27|NONE|CHEMICAL|NONE|no_relation
10898598|The actual phosphorylating agent is formed within seconds from POCl(3) in water, has a half-life of approximately 2 min, and is identified as phosphorodichloridic acid [HOP(O)Cl(2)] by (31)P NMR and derivatization with dimethylamine to HOP(O)(NMe(2))(2).|phosphorodichloridic acid|NONE|29|NONE|Arg1:T10|NONE|CHEMICAL|NONE|no_relation
23438471|A critical role in organismal homeostatic functions is played by the aryl hydrocarbon receptor (AHR) complex, which senses environmental and endogenous compounds, influences metabolic responses controlling phase I/II gene expression, and modulates vital phenomena such as development, inflammation and adaptive immunity.|aryl hydrocarbon|AHR|12|16|Arg1:T1|Arg2:T7|CHEMICAL|GENE-Y|no_relation
23044489|In this short review paper, after a presentation of some of the key points of the pathophysiology of NA-induced SE and a quick survey of the potential therapeutic avenues in the context of delayed treatment of NA-induced SE, we will review the recent data we obtained showing that KET, in combination with atropine sulfate (AS), with or without a benzodiazepine, considerably reduces soman-induced neuroinflammation, provides neuroprotection, histologically and functionally, and also positively modify soman-induced changes in brain metabolism.|soman|NONE|84|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
23389956|  The late-gestation surge in fetal plasma cortisol is critical for maturation of fetal organ systems.|cortisol|NONE|7|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
10901669|In addition, sex-dependent differences of TCDD and HxCB were observed on the hepatic vitamin K cycle enzyme activities in female and male rats.|TCDD|NONE|7|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
23395825|Glutathione (GSH), oxidized glutathione (GSSG) and total thiol (total-SH) content, GSH reductase (GR) and GSH peroxidase (GSH-Px) activities, malondialdehyde (MDA) level, as well as 4-hydroxynonenal (4-HNE) and MDA modified proteins in homogenates of cerebral cortex were measured.|GSH|GSH-Px|19|28|Arg1:T23|Arg2:T40|CHEMICAL|GENE-N|no_relation
14633707|  Oncogenic forms of the small GTPase Ras increase the resistance of cells to killing by ionizing radiation (IR).|NONE|Ras|NONE|7|NONE|Arg2:T28|NONE|GENE-N|no_relation
23266269|Ganodermanondiol protected human liver-derived HepG2 cells through nuclear factor-E2-related factor 2 (Nrf2) pathway-dependent heme oxygenase-1 expressions.|Ganodermanondiol|heme oxygenase-1|1|16|Arg1:T5|Arg2:T20|CHEMICAL|GENE-Y|no_relation
8398139|  We report the cloning and characterization of a novel serotonin receptor, designated as 5-HT7, which is coupled to the stimulation of adenylyl cyclase.|serotonin|5-HT7|10|15|Arg1:T3|Arg2:T13|CHEMICAL|GENE-Y|no_relation
23026700|Our findings suggest that CSEE may regulate hepatic lipid homeostasis related with an AMPK-dependent signaling pathway.|NONE|AMPK|NONE|14|NONE|Arg2:T8|NONE|GENE-N|no_relation
23621813|WT MEFs (wild-type mouse embryonic fibroblasts) and tumorigenic cell lines p53(-/-)+H-RasV12 and p53(-/-)+p53(N236S)+H-RasV12 were used for evaluating active structures, targeting p53(N236S) (corresponding to p53(N239S) in humans) mutation.|NONE|p53|NONE|13|NONE|Arg2:T6|NONE|GENE-Y|no_relation
23561205|Curcumin dose-dependently suppressed viability of K1 cells as well as its cell attachment, spreading, migration and invasion abilities.|Curcumin|NONE|1|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
15155769|Three-dimensional models of wild-type and mutated CrAT and COT support this hypothesis.|NONE|CrAT|NONE|7|NONE|Arg2:T21|NONE|GENE-Y|no_relation
23220413|Taken together, these results suggest that TDCPP alters the transcription of genes involved in the HPT axis and changes whole-body concentrations of thyroid hormones in zebrafish embryos/larvae, thus causing an endocrine disruption of the thyroid system.|TDCPP|NONE|8|NONE|Arg1:T4|NONE|CHEMICAL|NONE|no_relation
11118042|These data indicate that the sulfide and sulfone derivatives of sulindac exert COX-dependent effects by distinct mechanisms.|sulindac|COX|11|13|Arg1:T4|Arg2:T18|CHEMICAL|GENE-N|no_relation
16291771|TMG and NES are the most potent progestins synthesized to date, followed by two of the older progestins, keto-desogestrel (keto-DSG) and levonorgestrel (LNG).|LNG|NONE|28|NONE|Arg1:T14|NONE|CHEMICAL|NONE|no_relation
22820932|  It is well established that both estrogen loss and type II diabetes mellitus (DMII) can impair bone metabolism, but whether estrogen loss exacerbates the effects of DMII is unclear.|estrogen|NONE|7|NONE|Arg1:T6|NONE|CHEMICAL|NONE|no_relation
23327533|Pathway 2, oxidation occurred at indole-containing moiety to form M2.|indole|NONE|7|NONE|Arg1:T9|NONE|CHEMICAL|NONE|no_relation
10913016|We conclude that selective beta(1)-adrenoceptor stimulation causes hypertrophic growth of ventricular cardiomyocytes by a mechanism that is independent of cAMP but dependent on a tyrosine kinase and ODC.|tyrosine|ODC|29|32|Arg1:T4|Arg2:T18|CHEMICAL|GENE-Y|no_relation
16959378|These age-related alterations in extracellular l-glutamate regulation may be key contributors to the increased susceptibility of the aged brain to excitotoxic insults such as stroke and hypoxia.|l-glutamate|NONE|6|NONE|Arg1:T3|NONE|CHEMICAL|NONE|no_relation
9039330|Mutations of the Gs alpha-subunit gene can mimic this situation in some women with the McCune-Albright syndrome (Malchoff et al., 1994).|NONE|Gs alpha|NONE|4|NONE|Arg2:T32|NONE|GENE-N|no_relation
16690332|The hypothesis that an additional NO-binding cavity is present in BA-HNS is also consistent with the effect of the NO concentration on its rebinding.|NO|BA-HNS|6|11|Arg1:T2|Arg2:T29|CHEMICAL|GENE-N|no_relation
23091169|Here, we have investigated the temporal sequence of molecular and pathological perturbations at early stages of phenobarbital (PB) mediated liver tumor promotion in vivo.|phenobarbital|NONE|18|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
11736858|Receptor occupancies increased with increasing plasma concentration of (+)-chlorpheniramine, but not with concentration of carebastine, an active metabolite of ebastine.|(+)-chlorpheniramine|NONE|9|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
15240345|Oxalate was formed from exogenous glycolate only when cells were exposed to high concentrations.|Oxalate|NONE|1|NONE|Arg1:T29|NONE|CHEMICAL|NONE|no_relation
23403203|Inhibition of GJIC by antofine may undermine the neuroprotective effect of astrocytes in CNS.|antofine|NONE|5|NONE|Arg1:T9|NONE|CHEMICAL|NONE|no_relation
23564646|Five chemicals were used: two compounds known to react with cysteine residues, 2,4-dinitrochlorobenzene (DNCB) and cinnamaldehyde (CinA); one sensitizer known to exhibit mixed reactivity to cysteine and lysine residues, isophorone diisocyanate (IPDI); and one reacting specifically with lysine residues, trimellitic anhydride (TMA) and croton oil a well-known irritant.|DNCB|NONE|17|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
17355958|To understand oxidation mechanisms by GSSG or nitric oxide-related nitrosylation we studied effects on glutaredoxins (Grx), which catalyze GSH-dependent thiol-disulfide redox reactions, particularly reversible glutathionylation of protein sulfhydryl groups.|GSH|Grx|22|17|Arg1:T16|Arg2:T32|CHEMICAL|GENE-N|no_relation
23322164|These cell lines, including mock-transduced controls, were loaded with decanoic acid and carnitine, followed by the measurement of the acylcarnitine profile in the extracellular medium.|carnitine|NONE|15|NONE|Arg1:T19|NONE|CHEMICAL|NONE|no_relation
23643093|These results suggested that specific benzophenanthridine alkaloids and 2-arylbenzofuran neolignans isolated from Zanthoxylum capense show strong anticancer activity in HCT116 colon carcinoma cells.|benzophenanthridine alkaloids|NONE|6|NONE|Arg1:T5|NONE|CHEMICAL|NONE|no_relation
12431845|In microdialysis studies, atomoxetine increased extracellular (EX) levels of NE in prefrontal cortex (PFC) 3-fold, but did not alter 5-HT(EX) levels.|NE|NONE|13|NONE|Arg1:T24|NONE|CHEMICAL|NONE|no_relation
17417877|Additionally, preincubation of C6 cells with DMI, hyperforin, and hyperoside led to a loss of second messenger cAMP after beta2-adrenergic stimulating conditions with terbutaline.|terbutaline|NONE|27|NONE|Arg1:T8|NONE|CHEMICAL|NONE|no_relation
23001627|Serum and hippocampus malondialdehyde (MDA) levels were determined using the thiobarbituric-acid reactive substances method.|thiobarbituric-acid|NONE|13|NONE|Arg1:T34|NONE|CHEMICAL|NONE|no_relation
15694390|  The Janus kinase (JAK) and signal transducers and activators of transcription (STAT) signal cascades are major pathways that mediate the inflammatory functions of interferon-gamma (IFN-gamma), an important pro-inflammatory cytokine.|NONE|Janus kinase|NONE|2|NONE|Arg2:T36|NONE|GENE-N|no_relation
23163726|In the present study we describe these two interfaces and relate the structure to its tendency to form monomers and its efficiency in the hydrolysis of GTP.|GTP|NONE|27|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
23195954|Serine protease activity of calnuc: regulation by Zn2+ and G proteins.|Zn2+|G proteins|9|11|Arg1:T18|Arg2:T40|CHEMICAL|GENE-N|no_relation
15843826|We next examined the inhibitory effect of a novel synthetic retinoid Am80 (Tamibarotene) on both myeloma cells and HUVECs. Am80 is specific for the retinoic-acid receptor-alpha/beta, and has therapeutic effects in all-trans retinoic acid resistant acute promyelocytic leukemia.|all-trans retinoic acid|retinoic-acid receptor-alpha/beta|36|28|Arg1:T8|Arg2:T18|CHEMICAL|GENE-N|no_relation
23111828|Griseofulvin is an antifungal substance that interferes with the microtubule apparatus and inhibits centrosomal clustering.|Griseofulvin|NONE|1|NONE|Arg1:T7|NONE|CHEMICAL|NONE|no_relation
23567961|  FLT3 and PDGFR tyrosine kinases are important targets for therapy of different types of leukemia.|tyrosine|PDGFR|4|3|Arg1:T1|Arg2:T13|CHEMICAL|GENE-N|no_relation
10340919|RESULTS: In terms of inhibition of TXB2 generation, diclofenac was about 1 order of magnitude more potent than meloxicam, indicated by a diclofenac EC50 (concentration of drug required to cause 50% of maximum effect) that was about 10 times lower than that of meloxicam (EC50 diclofenac single doses: 37.50+/-29.64; EC50 meloxicam single doses: 677.50+/-189.08).|meloxicam|NONE|21|NONE|Arg1:T23|NONE|CHEMICAL|NONE|no_relation
16533791|In mice bearing various established tumors, including paclitaxel-resistant tumors, once daily oral administration of YM-359445 at doses of 0.5 to 4 mg/kg not only inhibited tumor growth but also reduced its vasculature.|YM-359445|NONE|17|NONE|Arg1:T2|NONE|CHEMICAL|NONE|no_relation
8842678|Both the A-form (MAO-A) and B-form (MAO-B) of MAO were inhibited after long-term administration of all the drugs except nortriptyline (MAO-A was not affected) and maprotiline (neither MAO-A nor MAO-B were affected).|maprotiline|MAO-B|32|37|Arg1:T13|Arg2:T39|CHEMICAL|GENE-Y|no_relation
14766200|The expression pattern in the rats was very similar to that in the chicks, but there were some differences between the chicks and rats in the amount of DDAH1 detected in the heart, liver, lung, and DRG.|NONE|DDAH1|NONE|30|NONE|Arg2:T14|NONE|GENE-N|no_relation
23266269|  Ganodermanondiol, a biologically active compound, was isolated from the Lingzhi mushroom (Ganoderma lucidum).|Ganodermanondiol|NONE|1|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
11056242|Expression of MCP-1 was analyzed at the levels of protein and messenger RNA.|NONE|MCP-1|NONE|3|NONE|Arg2:T13|NONE|GENE-Y|no_relation
23626400|Moreover, pentablock copolymer based nanoparticles exhibited continuous release of triamcinolone acetonide.|triamcinolone acetonide|NONE|11|NONE|Arg1:T1|NONE|CHEMICAL|NONE|no_relation
17210712|Transfection of HCC cells with OTC resulted in resistance to rhArg.|NONE|rhArg|NONE|11|NONE|Arg2:T18|NONE|GENE-N|no_relation
